0001757073-23-000010.txt : 20230216 0001757073-23-000010.hdr.sgml : 20230216 20230216161141 ACCESSION NUMBER: 0001757073-23-000010 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 150 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230216 DATE AS OF CHANGE: 20230216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Envista Holdings Corp CENTRAL INDEX KEY: 0001757073 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 832206728 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39054 FILM NUMBER: 23638631 BUSINESS ADDRESS: STREET 1: 200 S. KRAEMER BLVD., BLDG. E CITY: BREA STATE: CA ZIP: 92821 BUSINESS PHONE: 714-817-5418 MAIL ADDRESS: STREET 1: 200 S. KRAEMER BLVD., BLDG. E CITY: BREA STATE: CA ZIP: 92821 FORMER COMPANY: FORMER CONFORMED NAME: DH Dental Holding Corp. DATE OF NAME CHANGE: 20181025 10-K 1 nvst-20221231.htm 10-K nvst-20221231
false2022FY0001757073http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Memberhttp://fasb.org/us-gaap/2022#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense0.0475862P3YP3Y00017570732022-01-012022-12-3100017570732023-02-10xbrli:shares00017570732022-07-01iso4217:USD00017570732022-12-3100017570732021-12-31iso4217:USDxbrli:shares00017570732021-01-012021-12-3100017570732020-01-012020-12-310001757073us-gaap:CommonStockMember2019-12-310001757073us-gaap:AdditionalPaidInCapitalMember2019-12-310001757073us-gaap:RetainedEarningsMember2019-12-310001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001757073us-gaap:ParentMember2019-12-310001757073us-gaap:NoncontrollingInterestMember2019-12-310001757073us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310001757073us-gaap:ParentMember2020-01-012020-12-310001757073us-gaap:RetainedEarningsMember2020-01-012020-12-310001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310001757073us-gaap:NoncontrollingInterestMember2020-01-012020-12-310001757073us-gaap:CommonStockMember2020-12-310001757073us-gaap:AdditionalPaidInCapitalMember2020-12-310001757073us-gaap:RetainedEarningsMember2020-12-310001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001757073us-gaap:ParentMember2020-12-310001757073us-gaap:NoncontrollingInterestMember2020-12-310001757073us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001757073us-gaap:ParentMember2021-01-012021-12-310001757073us-gaap:RetainedEarningsMember2021-01-012021-12-310001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310001757073us-gaap:CommonStockMember2021-12-310001757073us-gaap:AdditionalPaidInCapitalMember2021-12-310001757073us-gaap:RetainedEarningsMember2021-12-310001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001757073us-gaap:ParentMember2021-12-310001757073us-gaap:NoncontrollingInterestMember2021-12-310001757073us-gaap:AdditionalPaidInCapitalMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-12-310001757073srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsMember2021-12-310001757073srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:ParentMember2021-12-310001757073us-gaap:CommonStockMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2021-12-310001757073us-gaap:AdditionalPaidInCapitalMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2021-12-310001757073us-gaap:RetainedEarningsMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2021-12-310001757073us-gaap:AccumulatedOtherComprehensiveIncomeMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2021-12-310001757073us-gaap:ParentMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2021-12-310001757073us-gaap:NoncontrollingInterestMembersrt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember2021-12-310001757073us-gaap:NoncontrollingInterestMember2022-01-012022-12-310001757073us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001757073us-gaap:ParentMember2022-01-012022-12-310001757073us-gaap:RetainedEarningsMember2022-01-012022-12-310001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-310001757073us-gaap:CommonStockMember2022-12-310001757073us-gaap:AdditionalPaidInCapitalMember2022-12-310001757073us-gaap:RetainedEarningsMember2022-12-310001757073us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001757073us-gaap:ParentMember2022-12-310001757073us-gaap:NoncontrollingInterestMember2022-12-3100017570732020-12-3100017570732019-12-31nvst:segment0001757073us-gaap:BuildingMember2022-01-012022-12-310001757073srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2022-01-012022-12-310001757073srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2022-01-012022-12-310001757073us-gaap:ConvertibleDebtMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-12-310001757073srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-12-310001757073nvst:OsteogenicsBiomedicalIncMember2022-07-052022-07-050001757073nvst:CarestreamDentalTechnologyMember2022-04-202022-04-200001757073nvst:CarestreamDentalTechnologyMember2022-04-200001757073nvst:OsteogenicsBiomedicalIncMember2022-07-050001757073nvst:CarestreamDentalTechnologyMember2022-01-012022-12-310001757073nvst:OsteogenicsBiomedicalIncMember2022-01-012022-12-310001757073nvst:OsteogenicsBiomedicalIncCarestreamDentalTechnologyMember2022-01-012022-12-310001757073us-gaap:DiscontinuedOperationsDisposedOfBySaleMembernvst:PlamencaMember2021-12-310001757073us-gaap:DiscontinuedOperationsDisposedOfBySaleMembernvst:PlamencaMember2022-01-012022-12-310001757073us-gaap:DiscontinuedOperationsDisposedOfBySaleMembernvst:PlamencaMember2021-01-012021-12-310001757073us-gaap:DiscontinuedOperationsDisposedOfBySaleMembernvst:PlamencaMember2020-01-012020-12-310001757073us-gaap:LandAndLandImprovementsMember2022-12-310001757073us-gaap:LandAndLandImprovementsMember2021-12-310001757073us-gaap:BuildingAndBuildingImprovementsMember2022-12-310001757073us-gaap:BuildingAndBuildingImprovementsMember2021-12-310001757073us-gaap:MachineryAndEquipmentMember2022-12-310001757073us-gaap:MachineryAndEquipmentMember2021-12-310001757073us-gaap:ConstructionInProgressMember2022-12-310001757073us-gaap:ConstructionInProgressMember2021-12-310001757073srt:MaximumMember2022-12-31xbrli:pure0001757073nvst:SpecialtyProductsandTechnologiesMember2021-12-310001757073nvst:EquipmentandConsumablesMember2021-12-310001757073nvst:SpecialtyProductsandTechnologiesMember2022-01-012022-12-310001757073nvst:EquipmentandConsumablesMember2022-01-012022-12-310001757073nvst:SpecialtyProductsandTechnologiesMember2022-12-310001757073nvst:EquipmentandConsumablesMember2022-12-310001757073us-gaap:PatentedTechnologyMember2022-12-310001757073us-gaap:PatentedTechnologyMember2021-12-310001757073us-gaap:CustomerRelationshipsMember2022-12-310001757073us-gaap:CustomerRelationshipsMember2021-12-310001757073us-gaap:TrademarksAndTradeNamesMember2022-12-310001757073us-gaap:TrademarksAndTradeNamesMember2021-12-310001757073us-gaap:TrademarksAndTradeNamesMember2022-12-310001757073us-gaap:TrademarksAndTradeNamesMember2021-12-310001757073nvst:EuroTermLoanDue2024Member2022-12-31iso4217:EUR0001757073nvst:USTermLoanDue2024Member2019-09-200001757073us-gaap:NetInvestmentHedgingMembernvst:ForeignCurrencyDenominatedDebtMember2022-12-310001757073us-gaap:NetInvestmentHedgingMembernvst:ForeignCurrencyDenominatedDebtMember2022-01-012022-12-310001757073us-gaap:NetInvestmentHedgingMemberus-gaap:InterestRateContractMember2022-12-310001757073us-gaap:NetInvestmentHedgingMemberus-gaap:InterestRateContractMember2022-01-012022-12-310001757073us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2022-12-310001757073us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2022-01-012022-12-310001757073us-gaap:NetInvestmentHedgingMembernvst:ForeignCurrencyDenominatedDebtMember2021-12-310001757073us-gaap:NetInvestmentHedgingMembernvst:ForeignCurrencyDenominatedDebtMember2021-01-012021-12-310001757073us-gaap:NetInvestmentHedgingMemberus-gaap:InterestRateContractMember2021-12-310001757073us-gaap:NetInvestmentHedgingMemberus-gaap:InterestRateContractMember2021-01-012021-12-310001757073us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2021-12-310001757073us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2021-01-012021-12-310001757073us-gaap:LongTermDebtMember2022-12-310001757073us-gaap:LongTermDebtMember2021-12-310001757073us-gaap:FairValueInputsLevel1Member2022-12-310001757073us-gaap:FairValueInputsLevel2Member2022-12-310001757073us-gaap:FairValueInputsLevel3Member2022-12-310001757073us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel1Member2021-12-310001757073us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Member2021-12-310001757073us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMember2021-12-310001757073us-gaap:InterestRateSwapMember2021-12-310001757073us-gaap:CurrencySwapMemberus-gaap:FairValueInputsLevel1Member2021-12-310001757073us-gaap:CurrencySwapMemberus-gaap:FairValueInputsLevel2Member2021-12-310001757073us-gaap:FairValueInputsLevel3Memberus-gaap:CurrencySwapMember2021-12-310001757073us-gaap:CurrencySwapMember2021-12-310001757073us-gaap:FairValueInputsLevel1Member2021-12-310001757073us-gaap:FairValueInputsLevel2Member2021-12-310001757073us-gaap:FairValueInputsLevel3Member2021-12-310001757073us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310001757073us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001757073us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310001757073us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001757073us-gaap:InterestRateSwapMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310001757073us-gaap:InterestRateSwapMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001757073us-gaap:InterestRateSwapMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310001757073us-gaap:InterestRateSwapMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001757073us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:CurrencySwapMember2022-12-310001757073us-gaap:CurrencySwapMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310001757073us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:CurrencySwapMember2021-12-310001757073us-gaap:CurrencySwapMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001757073us-gaap:PensionPlansDefinedBenefitMember2021-12-310001757073us-gaap:PensionPlansDefinedBenefitMember2020-12-310001757073us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-12-310001757073us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001757073us-gaap:PensionPlansDefinedBenefitMember2022-12-310001757073us-gaap:PensionPlansDefinedBenefitMember2020-01-012020-12-310001757073us-gaap:CostOfSalesMember2022-01-012022-12-310001757073us-gaap:CostOfSalesMember2021-01-012021-12-310001757073us-gaap:CostOfSalesMember2020-01-012020-12-310001757073us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-12-310001757073us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-12-310001757073us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-12-310001757073srt:ScenarioForecastMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-012023-12-310001757073us-gaap:PensionPlansDefinedBenefitMembersrt:MinimumMember2022-01-012022-12-310001757073srt:MaximumMemberus-gaap:PensionPlansDefinedBenefitMember2022-01-012022-12-310001757073us-gaap:PensionPlansDefinedBenefitMembersrt:MinimumMember2021-01-012021-12-310001757073srt:MaximumMemberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001757073us-gaap:PensionPlansDefinedBenefitMembersrt:WeightedAverageMember2022-01-012022-12-310001757073us-gaap:PensionPlansDefinedBenefitMembersrt:WeightedAverageMember2021-01-012021-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2022-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2022-12-310001757073us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2022-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2022-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherContractMember2022-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Memberus-gaap:OtherContractMember2022-12-310001757073us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:OtherContractMember2022-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:OtherContractMember2022-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2022-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2022-12-310001757073us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2022-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Member2022-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:MutualFundMember2022-12-310001757073us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-12-310001757073us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2022-01-012022-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2021-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2021-12-310001757073us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2021-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2021-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherContractMember2021-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Memberus-gaap:OtherContractMember2021-12-310001757073us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMemberus-gaap:OtherContractMember2021-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Memberus-gaap:OtherContractMember2021-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel1Member2021-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel2Member2021-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueInputsLevel12And3Member2021-12-310001757073us-gaap:PensionPlansDefinedBenefitMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:MutualFundMember2021-12-310001757073us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2020-12-310001757073us-gaap:FairValueInputsLevel3Memberus-gaap:PensionPlansDefinedBenefitMember2021-01-012021-12-310001757073nvst:USTermLoanDue2024Member2022-12-310001757073nvst:USTermLoanDue2024Member2021-12-310001757073nvst:EuroTermLoanDue2024Member2021-12-310001757073nvst:A2.375ConvertibleSeniorNotesMemberus-gaap:ConvertibleDebtMember2022-12-310001757073nvst:A2.375ConvertibleSeniorNotesMemberus-gaap:ConvertibleDebtMember2021-12-310001757073us-gaap:OtherDebtSecuritiesMember2022-12-310001757073us-gaap:OtherDebtSecuritiesMember2021-12-3100017570732019-09-202019-09-200001757073nvst:USTermLoanDue2024Member2019-09-202019-09-200001757073nvst:EuroTermLoanDue2024Member2019-09-202019-09-200001757073nvst:EuroTermLoanDue2024Member2019-09-200001757073us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2019-09-202019-09-200001757073nvst:EuroTermLoanDue2024Member2021-02-092021-02-090001757073us-gaap:RevolvingCreditFacilityMember2019-09-202019-09-200001757073us-gaap:RevolvingCreditFacilityMember2021-06-152021-06-150001757073us-gaap:RevolvingCreditFacilityMember2021-06-150001757073us-gaap:RevolvingCreditFacilityMember2022-12-310001757073us-gaap:RevolvingCreditFacilityMemberus-gaap:StandbyLettersOfCreditMember2022-12-310001757073us-gaap:RevolvingCreditFacilityMember2021-12-310001757073us-gaap:LondonInterbankOfferedRateLIBORMembersrt:MinimumMembernvst:CreditFacilityMember2022-01-012022-12-310001757073srt:MaximumMemberus-gaap:LondonInterbankOfferedRateLIBORMembernvst:CreditFacilityMember2022-01-012022-12-310001757073us-gaap:BaseRateMembersrt:MinimumMember2022-01-012022-12-310001757073srt:MaximumMemberus-gaap:BaseRateMember2022-01-012022-12-310001757073srt:MinimumMember2022-01-012022-12-310001757073srt:MaximumMember2022-01-012022-12-310001757073nvst:USTermLoanDue2024Member2022-01-012022-12-310001757073nvst:USTermLoanDue2024Member2021-01-012021-12-310001757073nvst:EuroTermLoanDue2024Member2022-01-012022-12-310001757073nvst:EuroTermLoanDue2024Member2021-01-012021-12-310001757073us-gaap:ConvertibleDebtMembernvst:A2.375ConvertibleSeniorNotesOverAllotmentOptionMember2020-05-210001757073nvst:A2.375ConvertibleSeniorNotesMemberus-gaap:ConvertibleDebtMember2020-05-210001757073nvst:A2.375ConvertibleSeniorNotesMemberus-gaap:ConvertibleDebtMember2020-05-212020-05-210001757073nvst:A2.375ConvertibleSeniorNotesMemberus-gaap:ConvertibleDebtMember2021-01-012021-12-310001757073nvst:A2.375ConvertibleSeniorNotesMemberus-gaap:ConvertibleDebtMember2022-01-012022-12-31nvst:tradingDay0001757073us-gaap:ConvertibleDebtMembernvst:A2.375ConvertibleSeniorNotesCappedCallsMember2020-05-212020-05-210001757073us-gaap:ConvertibleDebtMembernvst:A2.375ConvertibleSeniorNotesCappedCallsMember2020-05-21nvst:vote0001757073us-gaap:CommonStockMember2022-01-012022-12-310001757073us-gaap:CommonStockMember2021-01-012021-12-310001757073us-gaap:CommonStockMember2020-01-012020-12-310001757073nvst:A2019OmnibusIncentivePlanMember2019-09-300001757073nvst:A2019OmnibusIncentivePlanMembersrt:MinimumMember2019-09-302019-09-300001757073srt:MaximumMembernvst:A2019OmnibusIncentivePlanMember2019-09-302019-09-300001757073nvst:A2019OmnibusIncentivePlanMember2019-09-302019-09-300001757073nvst:A2019OmnibusIncentivePlanMembersrt:MinimumMemberus-gaap:RestrictedStockUnitsRSUMember2019-09-302019-09-300001757073srt:MaximumMembernvst:A2019OmnibusIncentivePlanMemberus-gaap:RestrictedStockUnitsRSUMember2019-09-302019-09-300001757073nvst:PacificDentalServicesMemberus-gaap:RestrictedStockUnitsRSUMember2021-12-230001757073nvst:PacificDentalServicesMemberus-gaap:RestrictedStockUnitsRSUMember2021-12-232021-12-230001757073nvst:PacificDentalServicesMemberus-gaap:RestrictedStockUnitsRSUMember2022-12-310001757073us-gaap:EmployeeStockOptionMembersrt:MinimumMember2022-01-012022-12-310001757073srt:MaximumMemberus-gaap:EmployeeStockOptionMember2022-01-012022-12-310001757073us-gaap:EmployeeStockOptionMembersrt:MinimumMember2021-01-012021-12-310001757073srt:MaximumMemberus-gaap:EmployeeStockOptionMember2021-01-012021-12-310001757073us-gaap:EmployeeStockOptionMembersrt:MinimumMember2020-01-012020-12-310001757073srt:MaximumMemberus-gaap:EmployeeStockOptionMember2020-01-012020-12-310001757073us-gaap:EmployeeStockOptionMember2022-01-012022-12-310001757073us-gaap:EmployeeStockOptionMember2021-01-012021-12-310001757073us-gaap:EmployeeStockOptionMember2020-01-012020-12-310001757073nvst:RestrictedStockUnitsAndPerformanceStockUnitsMember2022-01-012022-12-310001757073nvst:RestrictedStockUnitsAndPerformanceStockUnitsMember2021-01-012021-12-310001757073nvst:RestrictedStockUnitsAndPerformanceStockUnitsMember2020-01-012020-12-310001757073nvst:RangeOneMember2022-01-012022-12-310001757073nvst:RangeOneMember2022-12-310001757073nvst:RangeTwoMember2022-01-012022-12-310001757073nvst:RangeTwoMember2022-12-310001757073nvst:RangeThreeMember2022-01-012022-12-310001757073nvst:RangeThreeMember2022-12-310001757073nvst:RangeFourMember2022-01-012022-12-310001757073nvst:RangeFourMember2022-12-310001757073nvst:RangeFiveMember2022-01-012022-12-310001757073nvst:RangeFiveMember2022-12-310001757073us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001757073us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001757073us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-12-310001757073us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-12-310001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-310001757073us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-12-310001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-01-012020-12-310001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-12-310001757073us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-12-310001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310001757073us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-12-310001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-12-310001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-12-310001757073us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310001757073us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-12-310001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-12-310001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-12-310001757073us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001757073us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310001757073us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310001757073srt:NorthAmericaMembernvst:SpecialtyProductsandTechnologiesMember2022-01-012022-12-310001757073srt:NorthAmericaMembernvst:EquipmentandConsumablesMember2022-01-012022-12-310001757073srt:NorthAmericaMember2022-01-012022-12-310001757073nvst:SpecialtyProductsandTechnologiesMembernvst:WesternEuropeMember2022-01-012022-12-310001757073nvst:WesternEuropeMembernvst:EquipmentandConsumablesMember2022-01-012022-12-310001757073nvst:WesternEuropeMember2022-01-012022-12-310001757073nvst:SpecialtyProductsandTechnologiesMembernvst:OtherDevelopedMarketsMember2022-01-012022-12-310001757073nvst:OtherDevelopedMarketsMembernvst:EquipmentandConsumablesMember2022-01-012022-12-310001757073nvst:OtherDevelopedMarketsMember2022-01-012022-12-310001757073nvst:SpecialtyProductsandTechnologiesMembernvst:HighGrowthMarketsMember2022-01-012022-12-310001757073nvst:EquipmentandConsumablesMembernvst:HighGrowthMarketsMember2022-01-012022-12-310001757073nvst:HighGrowthMarketsMember2022-01-012022-12-310001757073srt:NorthAmericaMembernvst:SpecialtyProductsandTechnologiesMember2021-01-012021-12-310001757073srt:NorthAmericaMembernvst:EquipmentandConsumablesMember2021-01-012021-12-310001757073srt:NorthAmericaMember2021-01-012021-12-310001757073nvst:SpecialtyProductsandTechnologiesMembernvst:WesternEuropeMember2021-01-012021-12-310001757073nvst:WesternEuropeMembernvst:EquipmentandConsumablesMember2021-01-012021-12-310001757073nvst:WesternEuropeMember2021-01-012021-12-310001757073nvst:SpecialtyProductsandTechnologiesMembernvst:OtherDevelopedMarketsMember2021-01-012021-12-310001757073nvst:OtherDevelopedMarketsMembernvst:EquipmentandConsumablesMember2021-01-012021-12-310001757073nvst:OtherDevelopedMarketsMember2021-01-012021-12-310001757073nvst:SpecialtyProductsandTechnologiesMembernvst:HighGrowthMarketsMember2021-01-012021-12-310001757073nvst:EquipmentandConsumablesMembernvst:HighGrowthMarketsMember2021-01-012021-12-310001757073nvst:HighGrowthMarketsMember2021-01-012021-12-310001757073nvst:SpecialtyProductsandTechnologiesMember2021-01-012021-12-310001757073nvst:EquipmentandConsumablesMember2021-01-012021-12-310001757073nvst:ConsumablesMember2022-01-012022-12-310001757073nvst:ConsumablesMember2021-01-012021-12-310001757073nvst:ConsumablesMember2020-01-012020-12-310001757073nvst:EquipmentSalesMember2022-01-012022-12-310001757073nvst:EquipmentSalesMember2021-01-012021-12-310001757073nvst:EquipmentSalesMember2020-01-012020-12-3100017570732023-01-012022-12-310001757073us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembernvst:LargestCustomerMember2022-01-012022-12-310001757073us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembernvst:LargestCustomerMember2021-01-012021-12-310001757073us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMembernvst:LargestCustomerMember2020-01-012020-12-310001757073us-gaap:EmployeeSeveranceMember2021-12-310001757073us-gaap:FacilityClosingMember2021-12-310001757073us-gaap:EmployeeSeveranceMember2022-01-012022-12-310001757073us-gaap:FacilityClosingMember2022-01-012022-12-310001757073us-gaap:EmployeeSeveranceMember2022-12-310001757073us-gaap:FacilityClosingMember2022-12-310001757073nvst:SpecialtyProductsandTechnologiesMember2020-01-012020-12-310001757073nvst:EquipmentandConsumablesMember2020-01-012020-12-310001757073us-gaap:AllOtherSegmentsMember2022-01-012022-12-310001757073us-gaap:AllOtherSegmentsMember2021-01-012021-12-310001757073us-gaap:AllOtherSegmentsMember2020-01-012020-12-310001757073us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMembernvst:ConsolidationOfFacilitiesMember2022-01-012022-12-310001757073us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMembernvst:ConsolidationOfFacilitiesMember2021-01-012021-12-310001757073country:US2022-01-012022-12-310001757073country:US2021-01-012021-12-310001757073country:US2020-01-012020-12-310001757073us-gaap:NonUsMember2022-01-012022-12-310001757073us-gaap:NonUsMember2021-01-012021-12-310001757073us-gaap:NonUsMember2020-01-012020-12-310001757073srt:AffiliatedEntityMemberus-gaap:DomesticCountryMember2022-12-310001757073srt:AffiliatedEntityMemberus-gaap:DomesticCountryMember2021-12-310001757073srt:AffiliatedEntityMemberus-gaap:ForeignCountryMember2022-12-310001757073srt:AffiliatedEntityMemberus-gaap:ForeignCountryMember2021-12-310001757073us-gaap:SegmentContinuingOperationsMember2022-12-310001757073us-gaap:SegmentContinuingOperationsMember2021-12-310001757073us-gaap:StockCompensationPlanMember2022-01-012022-12-310001757073us-gaap:StockCompensationPlanMember2021-01-012021-12-310001757073us-gaap:StockCompensationPlanMember2020-01-012020-12-310001757073nvst:SpecialtyProductsandTechnologiesMemberus-gaap:OperatingSegmentsMember2022-01-012022-12-310001757073nvst:SpecialtyProductsandTechnologiesMemberus-gaap:OperatingSegmentsMember2021-01-012021-12-310001757073nvst:SpecialtyProductsandTechnologiesMemberus-gaap:OperatingSegmentsMember2020-01-012020-12-310001757073us-gaap:OperatingSegmentsMembernvst:EquipmentandConsumablesMember2022-01-012022-12-310001757073us-gaap:OperatingSegmentsMembernvst:EquipmentandConsumablesMember2021-01-012021-12-310001757073us-gaap:OperatingSegmentsMembernvst:EquipmentandConsumablesMember2020-01-012020-12-310001757073us-gaap:CorporateNonSegmentMember2022-01-012022-12-310001757073us-gaap:CorporateNonSegmentMember2021-01-012021-12-310001757073us-gaap:CorporateNonSegmentMember2020-01-012020-12-310001757073nvst:SpecialtyProductsandTechnologiesMemberus-gaap:OperatingSegmentsMember2022-12-310001757073nvst:SpecialtyProductsandTechnologiesMemberus-gaap:OperatingSegmentsMember2021-12-310001757073us-gaap:OperatingSegmentsMembernvst:EquipmentandConsumablesMember2022-12-310001757073us-gaap:OperatingSegmentsMembernvst:EquipmentandConsumablesMember2021-12-310001757073us-gaap:MaterialReconcilingItemsMember2022-12-310001757073us-gaap:MaterialReconcilingItemsMember2021-12-310001757073us-gaap:CorporateNonSegmentMember2022-12-310001757073us-gaap:CorporateNonSegmentMember2021-12-310001757073country:CN2022-01-012022-12-310001757073country:CN2021-01-012021-12-310001757073country:CN2020-01-012020-12-310001757073nvst:AllOtherCountriesMember2022-01-012022-12-310001757073nvst:AllOtherCountriesMember2021-01-012021-12-310001757073nvst:AllOtherCountriesMember2020-01-012020-12-310001757073country:US2022-12-310001757073country:US2021-12-310001757073country:SE2022-12-310001757073country:SE2021-12-310001757073country:MX2022-12-310001757073country:MX2021-12-310001757073nvst:AllOtherCountriesMember2022-12-310001757073nvst:AllOtherCountriesMember2021-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________
FORM 10-K
(Mark One)
☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2022
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from         to    
Commission File Number: 001-39054
nvst-20221231_g1.jpg
ENVISTA HOLDINGS CORPORATION
(Exact name of registrant as specified in its charter)
Delaware83-2206728
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification Number)
200 S. Kraemer Blvd., Building E92821-6208
Brea, California
(Address of Principal Executive Offices)(Zip Code)
Registrant’s telephone number, including area code: 714-817-7000
Securities Registered Pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $0.01 par valueNVSTNew York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act:
NONE



Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes   ☒     No  ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
Yes   ☐     No  ☒
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.     Yes   ☒     No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     Yes   ☒     No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer☒ Accelerated filer☐
Non-accelerated filer☐ Smaller reporting company☐
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).
Yes   ☐     No  ☒
As of February 10, 2023, the number of shares of the Registrant’s common stock outstanding was 163,231,502. The aggregate market value of the common stock of the Registrant held by non-affiliates on July 1, 2022, the last business day of the Registrant’s most recently completed second fiscal quarter, was $4.7 billion (based upon the closing price of $39.14 of the Registrant's common stock as reported on the New York Stock Exchange on such date).
 ____________________________________
DOCUMENTS INCORPORATED BY REFERENCE
Part III incorporates certain information by reference from the Registrant’s proxy statement for its 2023 annual meeting of stockholders to be filed pursuant to Regulation 14A within 120 days after Registrant’s fiscal year-end. With the exception of the sections of the 2023 Proxy Statement specifically incorporated herein by reference, the 2023 Proxy Statement is not deemed to be filed as part of this Form 10-K.
In this Annual Report, the terms “Envista” or the “Company” refer to Envista Holdings Corporation, Envista Holdings Corporation and its consolidated subsidiaries or the consolidated subsidiaries of Envista Holdings Corporation, as the context requires.
***


We own or have rights to trademarks, service marks or trade names that we use in connection with the operation of our business. In addition, our names, logos and website names and addresses are owned by us or licensed by us. We also own or have the rights to copyrights that protect the content of our solutions. Solely for convenience, the trademarks, service marks, trade names and copyrights referred to in this report are listed without the ©, ® and ™ symbols, but we will assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensors to these trademarks, service marks, trade names and copyrights.
This report may include trademarks, service marks or trade names of other companies. Our use or display of other parties’ trademarks, service marks, trade names or products is not intended to, and does not imply a relationship with, or endorsement or sponsorship of us by, the trademark, service mark or trade name owners.
***
Unless otherwise indicated, information contained in this report concerning our industry and the markets in which we operate is based on information from independent industry and research organizations, other third-party sources (including industry publications, surveys and forecasts), and management estimates. Management estimates are derived from publicly available information released by independent industry analysts and third-party sources, as well as data from our internal research, and are based on assumptions made by us upon reviewing such data and our knowledge of such industry and markets that we believe to be reasonable. Although we believe the data from these third-party sources is reliable, we have not independently verified any third-party information.
***
Unless otherwise indicated, all financial data in this Annual Report refer to continuing operations only.


TABLE OF CONTENTS
  PAGE
INFORMATION RELATING TO FORWARD-LOOKING STATEMENTS
PART I
Item 1.
Item 1A.
Item 1B.
Item 2.
Item 3.
Item 4.
PART II
Item 5.
Item 6.
Item 7.
Item 7A.
Item 8.
Item 9.
Item 9A.
Item 9B.
Item 9C.
PART III
Item 10.
Item 11.
Item 12.
Item 13.
Item 14.
PART IV
Item 15.
Item 16.



INFORMATION RELATING TO FORWARD-LOOKING STATEMENTS
Certain statements included or incorporated by reference in this Annual Report are “forward-looking statements” within the meaning of the U.S. federal securities laws. All statements other than historical factual information are forward-looking statements, including without limitation statements regarding: projections of revenue, expenses, profit, profit margins, tax rates, tax provisions, cash flows, pension and benefit obligations and funding requirements, our liquidity position or other projected financial measures; management’s plans and strategies for future operations, including statements relating to anticipated operating performance, cost reductions, restructuring activities, new product and service developments, competitive strengths or market position, acquisitions and the integration thereof, divestitures, spin-offs, split-offs or other distributions, strategic opportunities, securities offerings, stock repurchases, dividends and executive compensation; growth, declines and other trends in markets we sell into; future regulatory approvals and the timing thereof; outstanding claims, legal proceedings, tax audits and assessments and other contingent liabilities; future foreign currency exchange rates and fluctuations in those rates; the anticipated timing of any of the foregoing; assumptions underlying any of the foregoing; and any other statements that address events or developments that Envista intends or believes will or may occur in the future. Terminology such as “believe,” “anticipate,” “should,” “could,” “intend,” “will,” “plan,” “expect,” “estimate,” “project,” “target,” “may,” “possible,” “potential,” “forecast” and “positioned” and similar references to future periods are intended to identify forward-looking statements, although not all forward-looking statements are accompanied by such words. Forward-looking statements are based on assumptions and assessments made by our management in light of their experience and perceptions of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. These forward-looking statements are subject to a number of risks and uncertainties, including but not limited to the risks and uncertainties set forth under “Item 1A. Risk Factors” in this Annual Report.
Forward-looking statements are not guarantees of future performance and actual results may differ materially from the results, developments and business decisions contemplated by our forward-looking statements. Accordingly, you should not place undue reliance on any such forward-looking statements. Forward-looking statements contained herein speak only as of the date of this Annual Report. Except to the extent required by applicable law, we do not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.


1

PART I
ITEM 1. BUSINESS
Overview
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr united by a shared purpose: to partner with professionals to improve lives by digitizing, personalizing and democratizing oral care. We help our customers deliver the best possible patient care through industry-leading solutions, technologies, and services. Our diversified portfolio of solutions covers a broad range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. We offer comprehensive solutions to support implant-based tooth replacements, orthodontic treatments, digital imaging and diagnostics. We further support the dental community with leading solutions in restoratives, endodontics, rotary, infection prevention and loupes.

We were formed in 2018, as a wholly-owned subsidiary of Danaher Corporation (“Danaher”), to serve as the ultimate parent company of the dental platform of Danaher. On September 20, 2019, we completed our initial public offering and on December 18, 2019, Danaher completed the disposition of its ownership interest in us.

With a foundation comprised of the proven Envista Business System (“EBS”) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, we are well equipped to meet the end-to-end needs of dental professionals worldwide. We are one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. We serve more than a million dentists in over 140 countries through one of the largest commercial organizations in the dental products industry and through our dealer partners. In 2022, we generated total sales of $2.6 billion, of which approximately 83% were derived from sales of consumables, services and spare parts.

We were built through the acquisition and integration of over 25 leading dental businesses and brands over the course of more than 15 years. Our core leadership team has been in place since 2016 and has extensive dental and healthcare industry experience and we have over 12,700 employees to execute on our purpose to partner with professionals to improve lives. Since 2016, we have leveraged EBS to streamline our operating structure, reduced our number of sites from over 230 to under 100, and significantly transformed our business. EBS is a set of lean, innovation, growth and leadership-focused tools and processes that differentiates us and underpins our competitive advantage. The application of EBS has reduced costs and business complexity, freeing up resources that we have invested in acquisitions, research and development for new product development focusing on implant-based tooth replacements, digital imaging and workflow solutions, aligners, and infection prevention as well as growing our direct sales infrastructure, especially in emerging markets (which we have historically defined as developing markets of the world, which prior to the COVID-19 pandemic, experienced extended periods of accelerated growth in gross domestic product and infrastructure, including Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia)).
The Dental market is large, attractive, and has a number of secular drivers that we believe will support growth for several years to come. These include the digitization of dental practices globally, which is transforming the way dentists diagnose and treat patients, leading to better clinical outcomes. In addition, we believe future growth in the dental industry will be driven by an aging population, the current under penetration of dental procedures, especially in emerging markets, improving access to complex procedures due to increasing technological innovation, an increasing demand for cosmetic dentistry, and the growth of Dental Service Organizations (“DSOs”), which are expected to drive increasing penetration and access to care globally. Orthodontics and implants both have less than 10% market penetration globally and are areas where we have a significant market presence.
We are a leading dental provider in emerging markets. In 2022, we generated approximately $563 million, or 22%, of our sales from emerging markets. Our growing scale in these markets has been driven by strategic investments in underpenetrated markets, to benefit from the future growth potential associated with expanding access to dental care in these regions.
Our commercial organization includes over 3,000 employees with deep clinical, product and workflow expertise who interact with customers on a daily basis. We are also a leading global provider of clinical training to enhance patient access to high-quality dental care, reaching over 250,000 dental professionals annually through more than 4,000 training and education events we directly organize. Through our trusted brands, innovative product offerings and comprehensive customer service, we have established strong relationships globally with key constituencies, including DSOs, dental specialists, general dentists, and dental laboratories. We believe the continuing expansion of our global commercial organization will provide us with significant opportunities for future growth as we increase our penetration in various geographic markets.
2

Innovation is a core part of our strategy and our research and development (“R&D”) expenditure has been approximately $287.3 million since 2020. We target our R&D efforts to address customers’ unmet needs and our commercial scale gives us deep insight into all fields of dentistry. Through our investments in R&D, we have supported multiple new product development initiatives, such as the DTX software suite, the N1TM implant system, and SparkTM clear aligners, each of which is discussed in more detail below.
Our business is operated through two segments: Specialty Products & Technologies, which is comprised of our Implant-Based Tooth Replacement and Orthodontic Solutions businesses, and Equipment & Consumables, which is comprised of our Imaging & Diagnostic Solutions and Everyday Dental businesses.
The following table presents the Company’s revenues disaggregated by geographical region for the years ended December 31, 2022 and 2021 ($ in millions).
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Year ended December 31, 2022
Geographical region:
North America$711.1 $655.3 $1,366.4 
Western Europe388.9 121.1 510.0 
Other developed markets91.0 38.6 129.6 
Emerging markets407.6 155.5 563.1 
Total$1,598.6 $970.5 $2,569.1 
Year ended December 31, 2021
Geographical region:
North America$668.9 $659.3 $1,328.2 
Western Europe366.6 125.9 492.5
Other developed markets98.2 41.2 139.4
Emerging markets374.1 174.7 548.8
Total$1,507.8 $1,001.1 $2,508.9 
Specialty Products & Technologies
Our Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. We typically market these products directly to end-users through our commercial organization, and 89% of our 2022 sales for this segment were direct sales. In 2022, our Specialty Products & Technologies segment generated $1.6 billion of sales, representing year-over-year sales and core sales increase of 6.0% and 9.1%, respectively. In 2022, 45% of segment sales were derived from North America, 24% from Western Europe, 6% from other developed markets, and 25% from emerging markets. Sales of consumables, services and spare parts comprised 94% of segment sales in 2022. This segment is comprised of our Implant-Based Tooth Replacement and Orthodontic Solutions businesses and includes the Nobel Biocare, Ormco, Spark, Implant Direct, Alpha-Bio Tec, and Orascoptic brands among others.
Equipment & Consumables
Our Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements; and infection prevention products. In 2022, our Equipment & Consumables segment generated $1.0 billion of sales. In 2022, 68% of segment sales were derived from North America, 12% from Western Europe, 4% from other developed markets, and 16% from emerging markets. We distribute our Equipment & Consumables segment products primarily through our channel partners, representing approximately 89% of sales in this segment in 2022. This segment is comprised of our Imaging & Diagnostic Solutions and Everyday Dental businesses and includes the Kerr, Metrex, DEXIS, i-CAT, and DTX brands among others.
3

Acquisitions and Divestitures
Our growth strategy contemplates future acquisitions and we continually evaluate potential acquisitions that either strategically fit with our existing portfolio or expand our portfolio into new and attractive business areas. Our operations and results can be affected by the rate and extent to which appropriate acquisition opportunities are available, acquired businesses are effectively integrated and anticipated synergies or cost savings are achieved. During the year ended December 31, 2022, we completed two acquisitions.
On July 5, 2022, we acquired all of the equity of Osteogenics Biomedical Inc., Allotech LLC and OBI Biologics, Inc. (together "Osteogenics") for total consideration of approximately $128.2 million, subject to certain customary adjustments as provided in the Equity Purchase Agreement dated May 17, 2022. Osteogenics develops innovative regenerative solutions for periodontists, oral and maxillofacial surgeons, and clinicians involved in implant dentistry throughout the world, and is part of the Company’s Specialty Products & Technologies segment.
On April 20, 2022, we completed the acquisition of Carestream Dental Technology Parent Limited’s (“Carestream Dental”) intraoral scanner business (the “Intraoral Scanner Business”) for total consideration of $580.3 million, including contingent consideration of $7.5 million, and subject to certain customary adjustments as provided in the Stock and Asset Purchase Agreement dated December 21, 2021 and as subsequently amended by the closing agreement dated as of April 20, 2022. The Intraoral Scanner Business manufactures, markets, sells, commercializes, distributes, services, trains, supports, and maintains operations of intraoral scanners and software, and is part of our Equipment & Consumables segment. We purchased the Intraoral Scanner Business through the acquisition of certain assets and the assumption of certain liabilities as well as the acquisition of all of the equity of certain subsidiaries of Carestream Dental.
Additionally, on December 31, 2021, we closed the divestiture of our KaVo Treatment Unit and Instrument Business (the “Divestiture”). With the Divestiture and the two recent acquisitions, we continue to make significant progress toward our long-term goal of transforming our product portfolio towards higher growth and higher margin segments of dentistry.
Restructuring Activities
We implemented significant restructuring activities across our businesses to execute our strategy, streamline operations, take advantage of available capacity and resources and to adjust our cost structure. For additional information regarding our restructuring activities, please refer to Note 20 to our audited consolidated financial statements included elsewhere in this Annual Report.
COVID-19 Impact
The extent of the impact of the COVID-19 pandemic on our business remains uncertain and difficult to predict because of the dynamic and evolving nature of the situation. The global impact of the outbreak continues to adversely affect many industries, and different geographies continue to reflect the effects of public health restrictions in various ways. The economic recovery following the impact of the COVID-19 pandemic is only partially underway and has been gradual, uneven and characterized by meaningful dispersion across sectors and regions with uncertainty regarding its ultimate length and trajectory. During the year ended December 31, 2022, notwithstanding improvement in many markets in which we operate due to a return to more normalized business operations, certain markets continued to be adversely impacted by COVID-19. In particular, sales decreased in China due to lockdowns early in the year and a subsequent relaxing of restrictions, which resulted in increased infection rates.

Please refer to “Item 1A. Risk Factors--Risks Related to Our Business” and “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” for a more detailed discussion of the potential impact of the COVID-19 pandemic and associated economic disruptions, and the actual operational and financial impacts that we have experienced to date.
Russia-Ukraine Conflict
Russia’s invasion of Ukraine and the global response to this invasion, including sanctions imposed by the U.S. and other countries, could have an adverse impact on our business, including our ability to market and sell products in the affected regions, potentially heightening our risk of cyber security attacks, impacting our ability to enforce our intellectual property rights in Russia, creating disruptions in the global supply chain, and potentially having an adverse impact on the global economy, financial markets, energy markets, currency rates and otherwise. Russia’s invasion of Ukraine did not have a material impact on our financial position or results of operations as of and for the year ended December 31, 2022.


4

General Economic Conditions
In addition to industry-specific factors, we, like other businesses, face challenges related to global economic conditions, including rising inflation, increasing interest rates, fluctuating foreign currency exchange rates, slowing economic growth, and continuing supply chain disruptions. Dental costs are largely out-of-pocket for the consumer and thus utilization rates can vary significantly depending on economic growth. While many of our products are considered necessary by patients regardless of the economic environment, certain products and services that support discretionary dental procedures may be more susceptible to changes in economic conditions.

Our Purpose
Our purpose is to partner with dental professionals to improve quality of life by digitizing, personalizing, and democratizing oral care.
•Digitize. Our broad portfolio of diagnostic equipment and clinical software solutions empowers dental professionals to effectively capture and visualize patient anatomy allowing the clinician to develop and execute integrated, efficient, and predictable treatment plans.

•Personalize. Our digitized workflows enable the development and communication of personalized treatment plans. When coupled with our world class implant and orthodontic solutions, we support clinicians in delivering confidence to patients around the world.
•Democratize. Our integrated workflows improve the efficiency of care and accelerate the productivity of clinicians, allowing them to treat more patients with more predictable outcomes. We are committed to working with dental professionals to improve access to dental care around the world.
Our Strategy
Our strategic focus is comprised of three key elements, which are based on the EBS strategic areas of Lean, Innovation, Growth and Leadership.
◦“Establish a Strong Foundation”: We have been successful in the past in driving continuous improvements and margin expansion through the application of EBS. Beginning in 2016, we consolidated our operating companies, substantially reduced our manufacturing sites, consolidated sales offices, streamlined our R&D organization, and centralized our direct and indirect procurement organizations. We simplified our portfolio by reducing the number of our imaging brands and exiting lower growth/margin businesses. We have also executed cost reduction initiatives. We continue to pursue a number of ongoing strategic initiatives across our operating companies relating to efficient sourcing and improvements in manufacturing and back-office support, all with a focus on continually improving quality, delivery, cost, growth and innovation.

◦“Reinvest for Growth”: Streamlining our business operations and reducing costs has allowed us to reposition ourselves to create a digital and consumable workflow-oriented portfolio. We have invested in our Specialty Products & Technology segment, adding manufacturing capacity and personnel to these businesses, with plans for further investment in 2023. We intend to drive shareholder value by deploying capital to acquire or invest in other businesses that strategically fit into or extend our product offering into new or attractive adjacent markets - the recent Intraoral Scanner Business and Osteogenics acquisitions are examples of this strategy in action. We are planning to expand our clinical training and education infrastructure to further increase brand loyalty, deepen our relationships with dental practitioners and further enhance patient access to high quality dental care. We believe these investments better position us to effectively meet the needs of our customers, particularly the growing DSO segment, which values a comprehensive, end-to-end product offering with the ability to roll out new technologies and procedure-focused trainings at scale.

◦“Maintain and Pursue Long-Term Market Leadership”: As we seek to continue to improve our business and drive increased cash flow, we expect to strategically invest in innovation in order to better serve our customers and accelerate organic growth. We have invested significant resources in the following areas which we believe will help drive long-term market leadership:

•Digital Workflow: We have developed our Diagnostic and Treatment Planning Software, DTX, to meet the growing demands for digital connectivity of dental practices.

5

▪Specialty Products & Technologies: We have launched several new products in our Orthodontic Solutions business over the past few years, which have contributed meaningfully to our overall sales in the segment. Since 2020, we have expanded capacity for our Spark clear aligners and added over 1,000 new employees to our Orthodontic Solutions business. Our R&D expenditures in our Implant-Based Tooth Replacement business accelerated the development of new implant systems such as N1. We will continue to invest in our global commercial footprint and product innovation to grow our strong position in the Implant and Orthodontics markets, both of which are underpenetrated.

▪Emerging Markets: We are a leading dental product provider in emerging markets, with R&D, product management, operations, regulatory affairs, sales and marketing, and customer service resources focused on these markets. We have built a business that generated less than $30 million in sales in 2011 to one that generated $563 million in sales in 2022. We expect to continue to invest in emerging markets as we believe this will be a strong growth driver for our business in the future. We have succeeded in emerging markets by harnessing our existing go-to-market infrastructure, building familiarity with local customer needs and regulations, and establishing dedicated locally-based management resources.

Our Industry
Within the global dental products industry, we believe segments such as Implant-Based Tooth Replacements, Orthodontic Treatments, and Imaging and Diagnostics Solutions will grow at a more rapid pace than the overall market. We believe future growth of the dental products industry will be driven by an aging population, the current under penetration of dental procedures, especially in emerging markets, improving access to complex procedures due to increasing technological innovation, an increasing demand for cosmetic dentistry, and growth of DSOs, which are expected to drive increasing penetration and access to care globally.
While both equipment and consumables represent significant expenditures for dental service providers, the sales dynamics for each differ. The sale of equipment depends on technological advancements, dentists’ willingness to invest in new technologies, opening of new offices and replacement demand. On the other hand, consumables are more dependent on patient volume. We believe large multi-category manufacturers that provide a broad portfolio of equipment and consumables have more recession-resilient product portfolios and can gain meaningful competitive advantage over their peers as larger customers increasingly seek package deals and consolidate suppliers, and digital dentistry adoption creates links between different products in the dental practitioners’ offices.
While the U.S. represents a significant portion of the global dental products industry, we have also been focused on building significant scale in emerging markets. Prevalence and penetration of treatments is largely tied to socio-economic factors such as availability and affordability of care. We expect generally improving economic trends and increased consumer disposable income in emerging markets, as well as advancements in technological innovation that reduces complexity and cost and increases efficiency, will help drive penetration of dental care in these under-served markets.
Key Segments Within the Dental Products Industry
◦Implant-Based Tooth Replacements: The implant industry is significant and enjoys higher margins and growth than the overall dental products market. The U.S. and the Greater China region represent key growth drivers for this industry. In the U.S., implant penetration far lags other developed markets such as Germany, Spain and Italy. In China, the prevalence of severe tooth loss is higher than in the U.S., while implant penetration is far below the U.S. We expect product innovation and increased affordability to help drive future growth in emerging markets.
◦Orthodontic Solutions: Traditional wires and brackets systems continue to be the preferred choice in complex and young adult cases, due to their better clinical outcomes. In recent years, clear aligners have become an increasingly popular treatment option and are expected to grow at a significantly faster pace than traditional metal wires and brackets. Clear aligners are aesthetically pleasing and clinically proven to be effective in less severe cases, which combined with technological advancements that have significantly increased the number of providers offering orthodontic treatments, have expanded the addressable market for orthodontic procedures. Going forward, we believe this product segment will continue to grow at a high pace as aesthetics become increasingly important to patients.
6

◦Imaging & Diagnostics: Imaging (both x-ray and other visualization solutions) is considered the entry-point for many dental diagnostic exams and subsequent treatments. The rapid adoption of digital technologies in the imaging segment has transformed dental practices and has increased access to care as well as the quality of care delivered to patients. We believe enhanced connectivity amongst different types of dental imaging/diagnostic equipment and integration with downstream treatment planning and treatment delivery solutions will further improve dental workflows and lead to better treatment outcomes. We believe digitalization and connectivity will continue to drive high growth in this segment.
Growth Drivers
We believe that many product offerings in our core business are underpenetrated globally and present a significant opportunity for growth through the continued penetration of our differentiated products. Beyond our core business, there are also a number of adjacent dental products, which we believe provide an opportunity to further grow and expand our product offerings in the future.
We believe continued growth in both the global dental industry and global dental products market will be driven by a variety of factors, including:
◦An aging population. According to the World Health Organization, in 2020 there were nearly 1 billion people aged 60 or over in the world, comprising 13% of the global population. By 2050, that number is expected to double to approximately 2.1 billion people and comprise 22% of the world’s population, largely driven by aging in low and middle-income countries. With the aging of the population, prevalence of dental conditions, including edentulism (full tooth loss), dry mouth, root and coronal caries, and periodontitis, increases. As the global population continues to age, we believe older patients will help drive increased demand for dental products and services.
◦The current under penetration of dental procedures, especially in emerging markets. According to the Global Economy and Development Working Paper 100 of the Brookings Institution, it is estimated that between 2015 and 2030, the middle class population in emerging markets will grow by approximately 2.4 billion people, from 2.0 billion to 4.4 billion. This major demographic shift is generating a large, new customer base with increased access to dental products and services along with the resources to pay for them. According to the World Health Organization, the number of dentists in China is approximately 45 per 100,000 people compared to 60 in the U.S. and 85 in Germany. The expansion of training opportunities for dental professionals in emerging markets is also leading to increased patient awareness and access to premium dental products and procedures, further facilitating the market’s growth.
◦Improving access to complex procedures due to increasing technological innovation. The market for digital dental solutions has grown substantially in recent years due to increased demand from dentists and dental professionals for increased efficiency and better product workflows, with rapid adoption of these technologies not only in the U.S. and Europe, but also in emerging markets. Digital dental solutions enhance the workflow of dentists from diagnostics to treatment. Providing better diagnostics allows dentists to more effectively treat patient needs, often at lower cost. Beyond diagnostics, digital dental solutions are also increasingly being utilized in implant, orthodontic and restorative treatment planning. This simplifies case planning and execution, which is especially relevant for newer dentists as technology helps to de-skill complex procedures and increase outcome predictability.
◦An increasing demand for cosmetic dentistry. Increased awareness of the importance of oral health maintenance and increasing consumer focus on cosmetic dentistry continues to act as a meaningful growth driver for the global dental industry. Orthodontic procedures are increasingly aesthetically driven as evidenced by the rapid adoption of clear aligners. We believe aesthetically-driven patients seeking an increasing number of tooth replacement procedures and teeth straightening procedures will continue to drive the demand for dental implants and aligners.
◦Growth of DSOs, which are expected to drive increasing penetration and access to dental care globally. In the U.S. and globally, increasing demand for dental services has driven the growth of alternative care delivery networks. DSOs in the U.S. are focused on underserved markets where access to general as well as complex dental care is relatively underpenetrated. Globally, growth of private insurance as well as private provider networks provide access to more complex procedures that are not covered under social insurance. We believe the continued growth of these care delivery networks will increase demand for dental products and more complex procedures which require more advanced technologies.
7

Our Competitive Strengths
We believe we have significant competitive strengths, including:
◦Envista Business System. We believe our deep-rooted commitment to EBS helps drive our success and market leadership and differentiates us in the dental industry. EBS encompasses not only lean tools and processes, but also methods for driving innovation, growth and leadership. Within the EBS framework, we pursue a number of ongoing strategic initiatives relating to streamlining business operations, portfolio simplification, reduction of costs, redeployment of resources, customer insight generation, product development and commercialization, efficient sourcing, and improvement in manufacturing and back-office support, all with a focus on continually improving quality, delivery, cost, growth and innovation.

◦Brand leadership with a long track record and strong brand recognition. We built our business around brands with long histories of innovation and strong brand recognition in the dental products market. The founder of Nobel Biocare introduced the world’s first dental implant and Nobel Biocare has since become a world leader in the field of innovative implant-based tooth replacements. Ormco has over 60 years of distinguished history providing orthodontists with high quality, innovative products. Multiple brands within our Imaging & Diagnostic Solutions and Everyday Dental businesses have more than 100 years of history in dental products. We believe the long history and leadership of our well-known brands in the dental products industry enhances our connections with both patients and providers and supports our strong market position.

◦Attractive portfolio with leadership in key attractive segments. We believe we have one of the most attractive offerings in the industry, enabling us to be a vendor of choice for many dental practitioners, dental laboratories, distributors and DSOs. The breadth and depth of our product offerings address a broad range of dentists’ clinical needs from consumables to digital equipment solutions. Our catalog of products covers the spectrum from value-focused products to premium brands, allowing providers to fully address patient needs in different market segments. Within our product portfolio, we believe we are one of the largest manufacturers in implants and orthodontics and have one of the largest installed bases of imaging devices. Our broad product offering positions us particularly well to serve the needs of DSOs, which have been one of the fastest growing segments of our customer base.
◦Global commercial reach. Our operating companies serve more than a million dentists in over 140 countries through one of the largest customer-facing sales teams in the dental products industry and through a diverse, global dealer network. We believe our diverse sales channels, global manufacturing and distribution, and local market knowledge help us to better address customers’ needs. We are also a leading global provider of clinical training to enhance patient access to high-quality dental care. In 2022, we generated 51% of our sales from markets outside of the U.S.
◦Strong position in emerging markets. Emerging markets represented 22% of our total sales in 2022. We are a leading dental provider in emerging markets with dedicated R&D, product management, operations, regulatory affairs, sales and marketing, and customer service resources focused on these markets. With this structure, we believe that we are well positioned to capture additional share in emerging markets.
◦Track record of innovation. Our operating companies have a long track record of successful innovation, having pioneered many new dental product categories since their inception. Our strong commercial infrastructure allows us to obtain insights into unmet needs at the practitioner level and translate them into differentiated products. Our focus on innovation has yielded many differentiated products over the years, such as NobelActive dental implants, Damon bracket and wire system and i-CAT 3D imaging system. Our new product development activities are complemented by externally sourcing technologies through a broad network of partnerships, collaborations, and investments involving third-party research institutions, universities and innovative start-up companies.
◦Experienced management team with extensive dental industry experience. Our executive officer team has extensive dental and healthcare industry experience and a proven track record of applying EBS to execute on our strategic and operational goals. Under their leadership, we have undertaken a significant transformation to better position our business for organic and inorganic growth and diversify our sales globally. We believe our management team will continue to drive growth and profitability in our business in the future.
8

Our Business Segments
The table below describes the percentage of our total annual sales attributable to each of our segments over each of the three years ended December 31, 2022. For additional information regarding sales, operating profit and identifiable assets by segment, please refer to Note 23 in our audited consolidated financial statements included elsewhere in this Annual Report.
202220212020
Specialty Products & Technologies62%60%58%
Equipment & Consumables38%40%42%
Specialty Products & Technologies
Our Specialty Products & Technologies segment, including our Nobel Biocare and Ormco brands, develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. We have a strong direct relationship with our customers through a sales force of more than 2,300 employees. In 2022, direct sales to end-users represented 89% of segment sales and sales from consumables, services and spare parts comprised 94% of segment sales. We believe strong industry fundamentals and new product solution introductions in this segment will continue to drive substantial growth for us.
Implant-Based Tooth Replacements
We are a world leader in the field of innovative implant-based tooth replacements offering a full portfolio of solutions that enable dentists to deliver single-tooth to full-mouth restorations. One of our brands, Nobel Biocare is the pioneer of implant science grounded in clinical research and has introduced a number of solutions that have become widely adopted in the premium implant industry. Our comprehensive product offering includes dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics. We also offer a comprehensive education program to fully train our broad range of clinical customers, from clinicians performing basic implant procedures to the most advanced practitioners, with the goal of enhancing patient access to high-quality dental care. Our customers include oral surgeons, prosthodontists and periodontists. Other well-known implant brands in our portfolio include Alpha-Bio Tec, Implant Direct, and Nobel-ProceraTM.

The table below provides a summary description of select solutions and products offered by our Implant-Based Tooth Replacement business:

nvst-20221231_g2.jpg
9

Our Implant-Based Tooth Replacement brands have a long history of innovation, which include both the first documented case of a titanium implant placement in a human and introduction of the concept of living bone adhering to an artificial implant (known as osseointegration). Today, our Nobel Biocare brand offers several implant systems and is integrating them with the DTX suite of software applications described below. Currently, NobelActive is our top implant system in terms of sales and number of placements. NobelActive offers high primary stability allowing patients to receive and use prosthetics the same day as the implant is placed. The most recent example of our innovation leadership is the N1 implant system, which was launched in Europe in 2020 and received clearance from the U.S. Food and Drug Administration in 2021, with authorization for sale in further regions pending, and which we believe will be a significant product and will simplify the implant procedure. N1’s unique implant and site preparation method was created with the goal to reduce complexity and streamline workflows during implant and restorative procedures. Through our Implant Direct and Alpha-Bio Tec value implant businesses, we also offer a variety of implant systems that cover a broad range of price points in the market. Implant Direct also offers a complete prosthetic portfolio which includes our SMARTbase™ abutments. Our recent Osteogenics acquisition added innovative regenerative solutions to our portfolio.
Since being acquired in 2014, Nobel Biocare has focused on reinvigorating its product offerings and has released over 30 new products. Among these are, the comprehensive software packages ‘DTX Studio Implant,’ which is used for treatment planning of dental implants, and ‘DTX Studio Lab,’ which is used for prosthetics treatment planning. These software packages are now integrated in our broader DTX software suite, which also includes the new ‘DTX Studio Clinic’ software package offered with our imaging devices. With DTX, clinicians can use one software ecosystem from image acquisition and diagnosis to treatment planning, implant surgery, and restoration planning and placement, as well as collaborate with treatment partners such as other dentists or laboratories on one digital platform. We believe this will enable significant clinical workflow efficiencies and more predictable clinical outcomes.
Orthodontic Solutions
For over 60 years, our Orthodontic Solutions businesses have provided orthodontic professionals with high quality, innovative products backed by educational support to enhance the lives of their patients. We are a leading manufacturer and provider of advanced orthodontic technology and services designed to move malpositioned teeth and jaws. Our products include brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, and are marketed under the OrmcoTM, DamonTM, InsigniaTM, AOATM and SparkTM brands. We also offer a comprehensive education system to fully train our clinical customers from basic to the most advanced movements, with the goal of enhancing patient access to high-quality dental care. Customers of our Orthodontic Solutions are primarily orthodontists.

The table below provides a summary description of select solutions and products offered by our Orthodontic Solutions business:

nvst-20221231_g3.jpg

We are a leader in passive self-ligating metal brackets, marketed as the Damon System. Passive self-ligation is a method of moving teeth using a fraction of the force levels required by brackets that utilize ligatures. In 2018, we launched our next generation product, DQ2TM, which offers twice the rotational control as the predecessor bracket, allowing for optimal precision, predictability and efficiency. In 2018, we launched Symetri™ Clear, an advanced aesthetic ceramic bracket designed for refined strength, patient comfort and easy debonding without fracturing. In 2019, we launched SmartArch™, a patented laser-engineered archwire designed to enable clinicians to move into a finish wire after just two archwires, reducing treatment time. In 2021, we launched the Damon UltimaTM System, a revolutionary passive self-ligation braces technology that is the first true full-expression system designed for faster and more precise finishing. Most recently, in 2022 we launched the UltimaTM Hook, the only re-positionable hook designed to save time for doctors.
10

Having historically focused on brackets and wires, we commercially launched our clear aligner system in several markets including North America, Europe, and China. Spark is a clear aligner system designed for mild to complex malocclusion that is made with TruGEN™ and TruGEN XR™, the latest generation of aligner material. It is designed to deliver higher sustained force retention for efficiency and a high level of transparency for aesthetics. Spark aligners are also designed with polished, scalloped edges to enhance patient comfort. Over the past three years, we launched a suite of upgrades to our Spark clear aligner Approver™ software designed to improve the customer experience with flexibility and customization features. In addition, we introduced a number of new aligner features including TruRoot for Spark™ Clear Aligners that allow doctors to see actual roots in the treatment plan; and Spark’s Integrated Hooks, the innovative alternative to traditional hooks and button cutouts. We also partnered with industry leading intra oral scanner companies as part of our commitment to making imaging integrations seamless. We believe that Spark will provide growth opportunities for our Orthodontic Solutions business over the next several years.
Equipment & Consumables
Our Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements; and infection prevention products. Products in this segment are sold primarily through dental distributors, with 89% of segment sales for the year ended December 31, 2022 made through our channel partners. Sales from consumables, services and spare parts comprised approximately 65% of segment sales in 2022.
Imaging & Diagnostic Solutions
Our Imaging & Diagnostic Solutions business is focused on imaging, X-ray, and intraoral scanner solutions used in dental offices, clinics and hospitals. The dental imaging business was primarily established through the acquisition of Gendex in 2004 and PaloDExTM Group Oy in 2009, but also includes products from numerous other acquisitions, including the acquisition of Carestream’s Intraoral Scanner business in 2022. Our equipment products are marketed under a variety of brands, including DEXIS, Gendex, and i-CAT.
The table below provides a summary description of select solutions and products offered by our Imaging & Diagnostic Solutions business:

nvst-20221231_g4.jpg
Our Imaging business was the pioneer in 2D/panoramic and 3D imaging and has one of the largest installed bases of dental imaging devices in the industry with over 150,000 imaging devices currently utilized in dental practices. We hold a leading position in 3D imaging through the i-CAT and DEXIS brands. The i-CAT FLX V17 is the business’ latest 3D CBCT offering and features a wide range of field of views, enabling a clinician to capture high quality images of the full oral-facial complex at high resolution with low radiation. This helps clinicians to more effectively treat orthodontics, complex oral surgery, implantology and airway cases. Beginning in 2017, we launched the OP3DTM family, a scalable modular imaging system, providing clinicians with the flexibility to upgrade to the latest 3D imaging technology as they expand their capabilities and grow their practices. Our DEXIS brand is an industry leader in intraoral X-Ray digital sensors, which provide two-dimensional images of the mouth. The DEXIS TitaniumTM is our flagship sensor and captures high quality images with low radiation and has advanced durable materials that make it highly reliable. Our acquisition of the Intraoral Scanner Business in April 2022 added intraoral scanners and related software to our Imaging portfolio.

11

The ‘DTX Studio Clinic’ software package is offered on many of our imaging products, allowing dental professionals to store and access a broad variety of clinical patient images (e.g., 2D/3D/IOS/pictures) in one place. In combination with the ‘DTX Studio Implant’ and ‘DTX Studio Lab’ software packages, clinicians can use one software ecosystem from image acquisition and diagnosis to treatment planning, implant surgery and restoration planning and placement, as well as collaborate with treatment partners such as other dentists or laboratories on one digital platform. We believe this will enable significant clinical workflow efficiencies and more predictable clinical outcomes.
Everyday Dental Solutions
Our Everyday Dental business markets a broad offering of general dental products that are used in dental offices, clinics and hospitals. The business was primarily established through the acquisition of Sybron Dental Specialties in 2006, as well as numerous other acquisitions. Our products are marketed under a variety of brands, including KerrTM, MetrexTM, Total Care, PentronTM, OptibondTM, HarmonizeTM, SonicfillTM, Sybron EndoTM and CaviWipesTM.
The table below provides a summary description of select solutions and products offered by our Everyday Dental business:

nvst-20221231_g5.jpg
Our products have strong brand and product recognition across many product categories, including restorative, endodontics, and infection control. We offer several products designed to repair and restore fractured or otherwise damaged teeth. The SonicFill composite bulk fill system replaces conventional time-consuming, multi-stage layering techniques with a single fill system that eliminates a liner or final capping layer. We also offer cements and bonding agents, including the leading OptiBondTM line of products. Our Endodontics business offers a variety of products used in the endodontic workflow which help clinicians to locate, shape, clean and fill root canals. We also produce curing lights and other products including impression materials, burs, amalgams and waxes under several brands. During 2020, we launched SimpliShadeTM, a universal composite featuring three shades resulting in quicker shade-matching, leading to faster chair times and streamlining restoration workflows and inventory management. In 2022, we introduced the ZenFlex ONE file system for endodontic root canal procedures, offering high cutting efficiency and minimal invasiveness at an affordable price.
Through our Metrex brand, we have a significant position within infection prevention products, which include the CaviWipes and CaviCideTM product lines and are well positioned in both the dental and general medical market segments. In 2022, we launched CaviWipes HP, the newest member of the CaviWipes family providing a fast one minute universal contact time from an alcohol-free hydrogen peroxide formulation that qualifies for the EPA’s Emerging Viral Pathogen claim.
International Operations
We are a global dental company. Our products and services are available worldwide, and our principal markets outside the U.S. are in Europe, Asia, the Middle East and Latin America. In 2022, we generated 53% of our sales in North America, 20% of our sales in Western Europe, 22% of our sales in emerging markets and 5% of our sales in other developed markets.
We also have operations around the world, and this geographic diversity allows us to draw on the skills of a worldwide workforce, provides greater stability to our operations, allows us to drive economies of scale, provides sales streams that may help offset economic trends that are specific to individual economies and offers us an opportunity to access new markets for products. In addition, we believe that our future growth depends in part on our ability to continue developing products and sales models that successfully target emerging markets.
The manner in which our products and services are sold outside the U.S. differs by business and by region. Most of our sales in non-U.S. markets are made by our subsidiaries located outside the U.S., though we also sell directly from the U.S. into non-U.S. markets through various representatives and distributors and, in some cases, directly. In countries with low sales volumes, we generally sell through representatives and distributors.
12

Information about the effects of foreign currency fluctuations on our business is set forth in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.” For a discussion of risks related to our non-U.S. operations and foreign currency exchange, please refer to “Item 1A. Risk Factors—Risks Related to Our Business” and “Risks Factors—General Risks.”
Sales and Distribution
Typical customers and end-users of our products include general dentists, dental specialists, dental hygienists, dental laboratories and other oral health professionals, including DSOs, as well as educational, medical and governmental entities and third-party distributors. These customers choose dental products based on the factors described under the section entitled “Business—Competition.”
In 2022, we distributed approximately 41% of our products through third-party distributors. Certain highly technical products, such as dental implant systems, orthodontic appliances, dental laboratory equipment and consumables, and endodontic instruments and materials are typically sold directly to dental professionals and dental laboratories.
One customer, Henry Schein, Inc. (“Henry Schein”), accounted for approximately 11% of our sales for 2022, 12% of our sales for 2021 and 11% of our sales for 2020. Other than Henry Schein, no single customer accounted for more than 10% of combined sales in 2022, 2021, or 2020.
While a sizable portion of our sales are derived from distributors, most of our marketing and advertising activities are directed towards the end-users of our products (e.g., dentists, hygienists and other oral health professionals, DSOs, laboratories and universities). In addition to our marketing efforts, as noted above, we conduct significant training and education programs globally for these end-users to enhance patient access to high-quality dental care. In these programs, our employees and/or experts in the respective clinical fields demonstrate the proper use of our products. We maintain educational and consulting relationships with key experts who assist us in developing new products, new indicated uses for our products and educational programs for health care providers and consumers. We also maintain educational and consulting relationships with dental associations around the world.
Research and Development
We invest substantially in the development of new products. We conduct research and development activities for the purpose of designing and developing new products and applications that address customer needs and emerging trends, as well as enhancing the functionality, effectiveness, ease of use and reliability of our existing products. Our research and development efforts include internal initiatives as well as collaborations with external parties such as research institutions, dental and medical schools and initiatives that use licensed or acquired technology. We expect to continue investing in research and development at a rate consistent with our past practice, with the goal of maintaining or improving our competitive position, and entering new markets.
We generally conduct research and development activities on a business-by-business basis, primarily in North America, the Middle East, Asia and Europe. We anticipate that we will continue to make significant expenditures for research and development as we seek to provide a continuing flow of innovative products to maintain and improve our competitive position. For a discussion of the risks related to the need to develop and commercialize new products and product enhancements, please refer to “Item 1A. Risk Factors—Risks Related to Our Business.” Customer-sponsored research and development was not significant in 2022, 2021 or 2020.
Intellectual Property
We own numerous patents, trademarks, copyrights, trade secrets and licenses to intellectual property owned by others. Although in the aggregate our intellectual property is important to our operations, we do not consider any single patent, trademark, copyright, trade secret or license to be of material importance to any segment or to the business as a whole. Our products and technologies are protected by over 1,900 granted patents. From time to time, we engage in litigation to protect our intellectual property rights. For a discussion of risks related to our intellectual property, please refer to “Item 1A. Risk Factors—Risks Related to Our Business.” All capitalized brands and product names throughout this document are trademarks owned by, or licensed to, us.
13

Human Capital Resources
As of December 31, 2022, we employed approximately 12,700 persons, of whom approximately 3,000 were employed in the U.S. and approximately 9,700 were employed outside of the U.S. We have collective bargaining arrangements and union contracts in certain countries, particularly in Europe where certain of our employees are represented by unions and/or works councils. For a discussion of risks related to employee relations, please refer to “Item 1A. Risk Factors—General Risks.”

Our success depends on our ability to attract, develop and retain a talented employee base. We aspire to help our employees thrive both personally and professionally. As part of these efforts, we strive to embody our core values, offer a competitive compensation and benefits program, foster a community where everyone feels included, respected and engaged, and provide ample professional development opportunities.

Our Board of Directors reviews human capital matters at each quarterly meeting, including periodic updates on succession planning, leadership development, talent acquisition and retention, diversity and inclusion, employee engagement, total rewards, and culture of the Company, among other topics. The Compensation Committee of the Board of Directors oversees our executive and equity compensation programs. We evaluate and manage risks relating to our human capital strategy as part of our enterprise risk management program.

Core Values

We endeavor to embody our values in everything we do and in our various programs and initiatives:
•Customer Centricity
•Innovation
•Respect
•Continuous Improvement
•Leadership

Compensation and Benefits Program

Our compensation programs and practices are designed to attract employees, motivate and reward performance, drive growth and support retention. We offer competitive compensation packages based on market data, which include base salary with annual merit increases and may also include annual cash performance incentives, commissions, overtime opportunities, allowances and, in some countries where these are customary, additional monthly payments. In addition, employees in select senior management roles may receive long-term compensation in the form of equity awards. We regularly review our compensation structure to ensure that we remain competitive, reward top performance, as well as to ensure internal equity. We are pleased that we maintained 99% gender pay equity in the U.S. and 99% race/ethnicity pay equity in the U.S. in 2022. In the U.S., our benefits package includes health (medical, dental & vision) insurance, paid time off, paid parental leave, a retirement plan and life and disability coverage. Outside of the U.S., we offer our employees robust benefits based on local regulations and best practices of the countries in which we operate. Globally, we offer an Employee Assistance Program to all employees to support the mental health and well-being of employees and their families.

14

Diversity and Inclusion

Our commitment to diversity and inclusion supports the ability of our employees to show up every day as their authentic selves, creating greater opportunities for teamwork, more thoughtful debate, and more reasons to celebrate. We are committed to a culture where diversity, respect, belonging and authenticity are valued. We drive diversity and inclusion by way of diverse candidate slates for executive and professional level roles and sales roles and we ensure succession plan talent is diverse in representation. We have a Diversity and Inclusion (D&I) Council, consisting of leaders within the Company to drive accountability and results for our diversity and inclusion strategic efforts and initiatives. We have four standing Diversity and Inclusion Committees in the areas of talent acquisition and engagement, education and learning, events and celebrations, and global communication. We have two Employee Resource Groups: a women’s and multicultural employee resource group, as well as learning events during historical heritage months throughout the year to celebrate our workforce. In 2022, we hosted multiple Company-wide D&I events for our employees, customers and dental students. Additionally, we have strategically partnered with the Consortium for early career diverse talent and with historically Black colleges and universities (HBCUs) and Hispanic Serving Institutions (HSIs) to further advance our workforce diversity efforts.

Learning and Development Opportunities

We aim to empower our employees to thrive in their current roles, as well as to support employees’ aspirations to move into different roles. We have a promote-from-within culture with opportunities across our operating companies. We periodically assess succession planning for certain key positions and review our workforce to identify high potential employees for future growth and development. We support our employees through a multitude of training and development programs, including training on our EBS and EBS tools through our Envista Business System University, individual development plans (which encourages our employees to take charge of their learning and growth opportunities and provides access to hundreds of online courses), job rotations, and various management trainings. We also have several programs focused on early career development, including internship programs and our six-year General Management Development Program. This commitment to our employees’ professional development reflects both our Continuous Improvement and Leadership core values.

Employee Engagement

In 2022, we completed our second annual employee engagement survey as a standalone public company. We had a 91% participation rate in this survey, with 78% of respondents reporting feeling engaged at work and 82% believing their managers are leading effectively. The results of this survey showed improvement from our inaugural survey. We use the feedback from these surveys to better understand whether our employees have the tools, resources, training and development opportunities to succeed. We assess our employee engagement annually and future surveys will help us benchmark our progress over time and compare our results with companies in our sector. Communication is at the core of our engagement efforts and we host monthly CEO Forums for all employees, to keep our employees informed and to provide opportunities for employees globally to ask senior management questions.

Community

Our employees have a long history of providing support and care in our communities, donating time, resources, and funds to local causes. In March 2021, we leveraged our expertise in oral health and founded the Envista Smile Project, a 501(c)(3) philanthropic foundation designed to improve the smiles and oral health of disadvantaged communities by supporting increased access to oral care and oral health education. The Envista Smile Project’s mission is to collaborate with dental professionals and Envista employee volunteers to donate products, treatment, and oral health education to communities in need around the world. The Envista Smile Project’s giving strategy focuses on three areas: mission trips, education, and monetary donations to oral health focused, non-profit organizations.

15

Safe Work Environment

We value the safety of our employees and in 2022, have further enhanced our safety program for remote and field-based employees. Environmental health and safety (“EHS”) significant sites, such as manufacturing, distribution, research and development sites and large offices, are supported through a combination of on-site and remote EHS professionals. Incident reporting and investigation, auditing, and corporate oversight provide for a collaborative and transparent environment to address and minimize potential gaps.

Additional information about our human capital resources, as well as information related to our sustainability efforts, is included in our annual Sustainability Report (located on the Investors subpage of our website www.envistaco.com). Information on our website, including the Sustainability Report, shall not be deemed incorporated by reference into this Form 10-K.

Materials
Our manufacturing operations employ a wide variety of raw materials, including metallic-based components, electronic components, chemicals, plastics and other petroleum-based products, and prices of oil and gas also affect our costs for freight and utilities. We purchase raw materials from a large number of independent sources around the world. No single supplier is material, although for some components that require particular specifications or qualifications there may be a single supplier or a limited number of suppliers that can readily provide such components. We utilize a number of techniques to address potential disruption in and other risks relating to our supply chain, including in certain cases the use of safety stock, alternative materials and qualification of multiple supply sources. During 2022, we had no raw material shortages that had a material effect on our business. For a further discussion of risks related to the materials and components required for our operations, please refer to “Item 1A. Risk Factors—Risks Related to Our Business.”
Competition
Although our businesses generally operate in highly competitive markets, our competitive position cannot be determined accurately in the aggregate or by segment, since none of our competitors offer all of the same product and service lines and serve all of the same markets as we do. Because of the range of the products and services we sell and the variety of markets we serve, we encounter a wide variety of competitors, including well-established regional competitors, competitors who are more specialized than we are in particular markets, as well as larger companies or divisions of larger companies with substantial sales, marketing, research and financial capabilities. We face increased competition in a number of our served markets as a result of the entry of competitors based in low-cost manufacturing locations, and increasing consolidation in particular markets. Key competitive factors vary among our businesses and product and service lines, but include the specific factors noted above with respect to each segment and typically also include price, quality, performance, delivery speed, applications expertise, distribution channel access, service and support, technology and innovation, breadth of product, service and software offerings and brand name recognition. For a discussion of risks related to competition, please refer to “Item 1A. Risk Factors—Risks Related to Our Industry.”
Seasonal Nature of Business
Based on historical experience, we generally have more sales in the second half of the calendar year than in the first half of the calendar year, with the first quarter typically having the lowest sales of the year. Based on historical customer buying patterns, we generally have more sales in the fourth quarter than in any other quarter of the year, driven in particular by capital spending in our Equipment & Consumables segment. As a result of this seasonality in sales, profitability in our Equipment & Consumables segment also tends to be higher in the second half of the year. There are no assurances that these historical trends will continue in the future.
Regulatory Matters
We face extensive government regulation both within and outside the U.S. relating to the development, manufacture, marketing, sale and distribution of our products, software and services. The following sections describe certain significant regulations applicable to our operations. These are not the only regulations that our businesses must comply with. For a description of risks related to the regulations that our businesses are subject to, please refer to “Item 1A. Risk Factors—Risks Related to Laws and Regulations.”
16

Medical Device Regulations
Most of our products are classified as medical devices and are subject to restrictions under domestic and foreign laws, rules, regulations, self-regulatory codes, circulars and orders, including, but not limited to, the U.S. Food, Drug, and Cosmetic Act (the “FDCA”). The FDCA requires these products, when sold in the U.S., to be safe and effective for their intended uses and to comply with the regulations administered by the U.S. Food and Drug Administration (the “FDA”). The FDA regulates the design, development, research, preclinical and clinical testing, introduction, manufacture, advertising, labeling, packaging, marketing, distribution, import and export and record keeping for such products. Certain medical device products are also regulated by comparable agencies in non-U.S. countries in which they are produced or sold.

Unless an exemption applies, the FDA requires that a manufacturer introducing a new medical device or a new indication for use of an existing medical device obtain either a Section 510(k) premarket notification clearance or a premarket approval (“PMA”) before introducing it into the U.S. market. The type of marketing authorization is generally linked to the classification of the device. The FDA classifies medical devices into one of three classes (Class I, II or III) based on the degree of risk the FDA determines to be associated with a device and the level of regulatory control deemed necessary to ensure the device’s safety and effectiveness.

Our products are either classified as Class I or Class II devices in the U.S. Most of our Class II and certain of our Class I devices are marketed pursuant to 510(k) pre-marketing clearances. The FDA also enforces additional regulations regarding the safety of X-ray emitting devices that we currently market. The process of obtaining a Section 510(k) clearance generally requires the submission of performance data and clinical data, which in some cases can be extensive, to demonstrate that the device is “substantially equivalent” to a device that was on the market before 1976 or to a device that has been found by the FDA to be “substantially equivalent” to such a pre-1976 device. A predecessor device is referred to as “predicate device.” As a result, FDA clearance requirements may extend the development process for a considerable length of time.

Medical devices can be marketed only for the indications for which they are cleared or approved. After a device has received 510(k) clearance for a specific intended use, any change or modification that significantly affects its safety or effectiveness, such as a significant change in the design, materials, method of manufacture or intended use, may require a new 510(k) clearance or PMA approval and payment of an FDA user fee. The determination as to whether or not a modification could significantly affect the device’s safety or effectiveness is initially left to the manufacturer using available FDA guidance; however, the FDA may review this determination to evaluate the regulatory status of the modified product at any time and may require the manufacturer to cease marketing and recall the modified device until 510(k) clearance or PMA approval is obtained.

Any devices we manufacture and distribute are subject to pervasive and continuing regulation by the FDA and certain state agencies. These include product listing and establishment registration requirements, which help facilitate FDA inspections and other regulatory actions. As a medical device manufacturer, all of our manufacturing facilities are subject to inspection on a routine basis by the FDA. We are required to adhere to the Current Good Manufacturing Practices (“cGMP”) requirements, as set forth in the Quality Systems Regulation (“QSR”), which require, manufacturers, including third-party manufacturers, to follow stringent design, testing, control, documentation and other quality assurance procedures during all phases of the design and manufacturing process.
We must also comply with post-market surveillance regulations, including medical device reporting, or MDR, requirements which require that we review and report to the FDA any incident in which our products may have caused or contributed to a death or serious injury. We must also report any incident in which our product has malfunctioned if that malfunction would likely cause or contribute to a death or serious injury if it were to recur.
Labeling and promotional activities are subject to scrutiny by the FDA and, in certain circumstances, by the Federal Trade Commission. Medical devices approved or cleared by the FDA may not be promoted for unapproved or uncleared uses, otherwise known as “off-label” promotion. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses.
In the European Union, our products are subject to the medical device laws of the various member states, which are currently based on a Directive of the European Commission. However, the EU has adopted the EU Medical Device Regulation (the “EU MDR”) which imposes stricter requirements for the marketing and sale of medical devices, including in the area of clinical evaluation requirements, quality systems and post-market surveillance. Manufacturers of currently approved medical devices had until May 2021 to meet the requirements of the EU MDR. Complying with the EU MDR required modifications
17

to our quality management systems, additional resources in certain functions, and required and will continue to require updates to technical files, among other changes.

Other Healthcare Laws

In addition to the U.S. Foreign Corrupt Practices Act, the UK Bribery Act and similar anti-bribery laws, we are also subject to various health care related laws regulating fraud and abuse, research and development, pricing and sales and marketing practices and the privacy and security of health information, including the U.S. federal regulations described below. Many states, foreign countries and supranational bodies have also adopted laws and regulations similar to, and in some cases more stringent than, the U.S. federal regulations discussed above and below.
◦The Federal Anti-Kickback Statute prohibits persons from knowingly and willfully soliciting, offering, receiving or providing remuneration in any form (including any kickback, bribe, or certain rebate), directly or indirectly, to induce or reward the referral of business payable under a government healthcare program, such as Medicare or Medicaid, or in return for the purchase, lease, order, arranging for, or recommendation of items or services covered under a government health care program. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.

◦The Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) prohibits knowingly and willfully (1) executing, or attempting to execute, a scheme to defraud any health care benefit program, including private payors, or (2) falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for health care benefits, items or services. Similar to the Federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the healthcare fraud statute implemented under HIPAA or specific intent to violate it in order to have committed a violation.

◦The False Claims Act imposes liability on any person or entity that, among other things, knowingly presents, or causes to be presented, a false or fraudulent claim for payment by a federal health care program, knowingly makes, uses or causes to be made or used, a false record or statement material to a false or fraudulent claim, or knowingly makes a false statement to avoid, decrease or conceal an obligation to pay money to the U.S. federal government. The qui tam provisions of the False Claims Act allow a private individual to bring actions on behalf of the federal government alleging that the defendant has submitted a false claim to the federal government, and to share in any monetary recovery. In addition, the government may assert that a claim including items and services resulting from a violation of the U.S. Federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the civil False Claims Act.
◦The federal Civil Monetary Penalties Law prohibits, among other things, the offering or transferring of remuneration to a Medicare or Medicaid beneficiary that the person knows or should know is likely to influence the beneficiary’s selection of a particular supplier of Medicare or Medicaid payable items or services.
◦The Open Payments Act requires manufacturers of medical devices covered under Medicare, Medicaid or the Children’s Health Insurance Program, subject to specific exceptions, to record payments and other transfers of value to a broad range of healthcare providers (including dentists) and teaching hospitals and to report this data as well as ownership and investments interests held by the physicians described above and their immediate family members to the Department of Health and Human Services (“HHS”) for subsequent public disclosure. Similar reporting requirements have also been enacted on the state level, and an increasing number of countries worldwide either have adopted or are considering similar laws requiring transparency of interactions with health care professionals.
Federal consumer protection and unfair competition laws broadly regulate marketplace activities and activities that potentially harm consumers. Analogous U.S. state laws and regulations, such as state anti-kickback and false claims laws, also may apply to our business practices, including but not limited to, research, distribution, sales and marketing arrangements and claims involving healthcare items or services reimbursed by any third-party payor, including private insurers. Further, there are state laws that require medical device manufacturers to comply with the voluntary compliance guidelines and the relevant compliance guidance promulgated by the U.S. federal government, or otherwise restrict payments that may be made to healthcare providers and other potential referral sources; state laws and regulations that require manufacturers to file reports relating to pricing and marketing information, which requires tracking gifts and other remuneration and items of value provided to healthcare professionals and entities; state and local laws requiring the registration of sales representatives; and state laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts.
18

For a discussion of risks related to regulation by the FDA and comparable agencies of other countries, and the other regulatory regimes referenced above, please refer to “Item 1A. Risk Factors—Risks Related to Laws and Regulations.”
Healthcare Reform
In the U.S. and certain foreign jurisdictions, there have been, and we expect there will continue to be, a number of legislative and regulatory changes to the healthcare system. For example, there have been numerous political and legal efforts to expand, repeal, replace or modify the U.S. Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act (collectively, the “PPACA”), since the law’s enactment. The U.S. Supreme Court rejected the latest such case on June 17, 2021, when the Court held that the plaintiffs lacked standing to challenge the PPACA’s requirement to obtain minimum essential health insurance coverage or the individual mandate and dismissed the case without specifically ruling on the constitutionality of the PPACA. Federal regulatory agencies continue to interpret and modify PPACA regulations and guidance related to the PPACA, often as a result of presidential directives or the interplay with state law requirements.

Moreover, there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which has resulted in several Congressional inquiries and proposed and enacted legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs and reform government program reimbursement methodologies for medical products. Individual states in the U.S. have also become increasingly active in implementing regulations designed to control product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures and, in some cases, mechanisms to encourage importation from other countries and bulk purchasing.
Coverage and Reimbursement
Dental procedures and products are often paid for out-of-pocket. For products where third-party coverage and reimbursement is available, sales will depend, in part, on the extent to which such product will be covered by third-party payors, such as federal, state and foreign government healthcare programs, commercial insurance and managed healthcare organizations, and the level of reimbursement for such product by third-party payors. Decisions regarding the extent of coverage and amount of reimbursement to be provided are made on a plan-by-plan basis. These third-party payors are increasingly reducing reimbursements for medical products and services and, in international markets, many countries have instituted price ceilings on specific products and therapies. Price ceilings, decreases in third-party reimbursement for any product or a decision by a third-party payor not to cover a product could reduce dentist usage and patient demand for the product.
Data Privacy and Security Laws
As a global manufacturer of medical devices, having access to and processing confidential, personal and/or sensitive data in the course of our business, we are subject to U.S. (federal and state) and international data privacy, security and data breach notification laws, which may govern the collection, use, disclosure and protection of health-related and other personal and/or sensitive information. Failure to comply with these statutory requirements, or mere publication of data breaches pursuant to these statutory requirements, can subject our company to legal, regulatory, and reputational risks, as well as the financial risks that can accompany regulatory investigations and enforcement actions and private litigation.

For example, in the U.S., HIPAA privacy, security, and breach notification rules require certain of our operations to maintain controls to protect the confidentiality, availability, and integrity of patient health information. In addition, individual states regulate data breach notification requirements as well as more general privacy and security requirements. Entities that are found to be in violation of HIPAA, for example as the result of a breach of unsecured protected health information, a complaint about privacy practices, or an audit by HHS, may be subject to significant civil, criminal and administrative fines and penalties and/or additional reporting and oversight obligations if required to enter into a resolution agreement and corrective action plan with HHS to settle allegations of HIPAA non-compliance.

The Health Information Technology for Economic and Clinical Health (“HITECH”) Act was enacted as an update to HIPAA and makes business associates of covered entities directly liable for compliance with certain HIPAA requirements, strengthens the limitations on the use and disclosure of protected health information without individual authorizations, and contemplates enforcement of noncompliance with HIPAA due to willful neglect. These changes have stimulated increased enforcement activity and enhanced the potential that health care providers will be subject to financial penalties for violations of HIPAA. In addition, the Secretary of HHS is required to perform periodic audits to ensure covered entities (and their business associates, as that term is defined under HIPAA) comply with the applicable HIPAA requirements, increasing the likelihood that a HIPAA violation will result in an enforcement action.
19


In addition to the federal HIPAA regulations, most states also have laws that protect the confidentiality and security of sensitive personal information, and a minority of states explicitly include health information within the scope of the law. These state laws can differ in scope compared to HIPAA, and could apply to protect information or be triggered to report a data breach even where HIPAA does not (and vice-versa). Certain of these laws grant individuals rights to access, correct, or delete personal information, and we may be required to expend significant resources to comply with these laws. Further, all 50 states and the District of Columbia have adopted data breach notification laws that impose, in varying degrees, an obligation to notify affected persons and/or state regulators in the event of a data breach or compromise, including when their personal information has or may have been acquired by an unauthorized person.

Some state breach notification laws may also impose physical and electronic security requirements regarding the safeguarding of personal information, such as social security numbers and bank and credit card account numbers. Violation of state privacy, security, and breach notification laws can trigger significant monetary penalties or significant legal liability. In addition, certain states’ privacy, security, and data breach laws, including, for example, the California Consumer Privacy Act (as amended by the California Privacy Rights Act, the “CCPA”), include private rights of action that may expose us to private litigation regarding our privacy and security practices and significant damages awards or settlements in civil litigation. Numerous other states have adopted within the past three years or are in the process of adopting various privacy-related laws and regulations. Complying with comprehensive state privacy laws and other existing, emerging and changing privacy requirements could cause the Company to incur substantial costs or require it to change its business practices and policies.

We are also subject to the General Data Protection Regulation (“GDPR”), the primary data protection law in the European Union and European Economic Area (collectively, the EU), as well as associated EU member state data protection laws and the UK GDPR in the United Kingdom. These laws impose significant requirements for covered businesses (controllers and processors) of personal data, including, for example, standards for obtaining consent from individuals to process their personal data, more robust disclosures to individuals, an individual data rights regime, timelines for data breach notifications, limitations on retention and secondary uses of information, requirements pertaining to health data and pseudonymised (i.e., deidentified) data, restrictions on data transfers outside of the EU, and obligations when we contract third-party processors in connection with the processing of personal data. The GDPR allows EU member states certain flexibility to make additional laws and regulations concerning the same issues, including, for example, further limiting the processing of genetic, biometric or health data. Failure to comply with the requirements of the GDPR may result in fines of up to €20,000,000 or up to 4% of the total worldwide annual turnover of the preceding financial year, whichever is higher. Other administrative penalties may be imposed under the applicable national data protection laws of the EU member states.

On August 20, 2021, China promulgated the Personal Information Protection Act Law (“PIPL”), which took effect on November 1, 2021. The PIPL imposes specific rules for processing personal information and it also specifies that the law shall also apply to personal information activities carried out outside China but for the purpose of providing products or services to PRC citizens. The PIPL carries maximum penalties of CNY50 million or 5% of the annual revenue of entities that process personal data.

Other countries throughout the world have or are in the process of passing laws that contain similar requirements to the GDPR and the PIPL. Data localization laws have also been passed or are under consideration in several countries (such as China and Russia), which require personal information relating to their citizens to be maintained on local servers and impose additional data transfer restrictions.

For a discussion of risks related to compliance with data privacy and security laws, please refer to “Item 1A. Risk Factors--Risks Related to Our Business.”

Environmental Laws and Regulations
Our operations and properties are subject to laws and regulations relating to environmental protection, including those governing air emissions, water discharges and waste management, and workplace health and safety. In addition, certain of our products are regulated by the U.S. Environmental Protection Agency and comparable state regulatory agencies. For a discussion of the environmental laws and regulations that our operations, products and services are subject to and other environmental contingencies, please refer to Note 15 to our audited consolidated financial statements included in this Annual Report as well as the discussion above relating to dental amalgam. For a discussion of risks related to compliance with environmental and health and safety laws and risks related to past or future releases of, or exposures to, hazardous substances, please refer to “Item 1A. Risk Factors—Risks Related to Laws and Regulations.”
20

Export/Import Compliance
We are required to comply with various U.S. export/import control and economic sanctions laws, including the regulations administered by the U.S. Department of Treasury, Office of Foreign Assets Control, which implement economic sanctions imposed against designated countries, governments and persons based on U.S. foreign policy and national security considerations, and the import regulatory activities of the U.S. Customs and Border Protection. Other nations’ governments have implemented similar export and import control regulations, which may affect our operations or transactions subject to their jurisdictions. For a discussion of risks related to export/import control and economic sanctions laws, please refer to “Item 1A. Risk Factors—Risks Related to Laws and Regulations.”
Legal Proceedings
We are, from time to time, subject to a variety of litigation and other legal and regulatory proceedings and claims incidental to our business. Please refer to Note 15 to our audited consolidated financial statements in this Annual Report for more information.
Available Information
We maintain an internet website at www.envistaco.com. We make available on the Investors subpage of our website (under the link “Filings & Reports”), free of charge, our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as reasonably practicable after we electronically file or furnish such reports with the SEC. Our internet site and the information contained on or connected to that site are not incorporated by reference into this Form 10-K.

21

ITEM 1A. RISK FACTORS
You should carefully consider the risks and uncertainties described below, together with the information included elsewhere in this Annual Report on Form 10-K and other documents we file with the SEC. The risks and uncertainties described below are those that we have identified as material, but are not the only risks and uncertainties facing us. Our business is also subject to general risks and uncertainties that affect many other companies, such as market conditions, economic conditions, geopolitical events, changes in laws, regulations or accounting rules, fluctuations in interest rates, terrorism, wars or conflicts, major health concerns, natural disasters or other disruptions of expected business conditions. Additional risks and uncertainties not currently known to us or that we currently believe are immaterial also may impair our business, including our results of operations, liquidity and financial condition.

Risk Factors Summary
The following is a summary of the principal risks that could adversely affect our business, operations and financial results:

•Conditions in the global economy, especially with respect to the particular markets we serve and the volatility of the financial markets may adversely affect our business and financial statements.
•International economic, political, legal compliance and business factors could negatively affect our financial statements.
•The COVID-19 pandemic has had and could continue to have a material adverse effect on our business and results of operations.
•Significant developments or uncertainties stemming from trade policies could adversely affect our business.
•Our growth could suffer if the markets into which we sell our products and services decline.
•Our financial results are subject to fluctuations in the cost and availability of commodities.
•If we cannot adjust our manufacturing capacity or the purchases required for our manufacturing activities to reflect changes in market conditions and customer demand, our profitability may suffer.
•If we suffer loss to our facilities, supply chains, distribution systems or information technology systems due to catastrophe or other events, our operations could be seriously harmed.
•The manufacture of many of our products is a highly exacting and complex process.
•A significant disruption in, or breach in security of, our information technology systems or data or violation of data privacy laws could adversely affect our business, reputation and financial statements.
•Data privacy and security laws relating to the handling of personal information (including personal health information) are evolving across the world and may be drafted, interpreted or applied in a manner that results in increased costs, legal claims, fines against us, reputational damage or impedes delivery.
•Our growth depends in part on the timely development and commercialization, and customer acceptance, of new and enhanced products and services based on technological innovation.
•Our ability to attract, develop and retain our key personnel is critical to our success
•Any inability to consummate acquisitions at our historical rate and at appropriate prices, and to make appropriate investments that support our long-term strategy, could negatively impact our growth rate and stock price.
•Our acquisition of businesses, investments, joint ventures and other strategic relationships could negatively impact our financial statements.
•The indemnification provisions of acquisition agreements by which we have acquired companies may not fully protect us and as a result we may face unexpected liabilities.
•We may fail to realize the anticipated benefits of the IOS Acquisition.
•Divestitures or other dispositions could negatively impact our business, and contingent liabilities from businesses that we or our predecessors have sold could adversely affect our financial statements.
•Our rebranding of our Imaging Business and China Business will likely involve substantial costs and may not be favorably received by our customers.
•Inventories maintained by our distributors and customers may fluctuate from time to time.
•We are dependent upon a limited number of distributors for a significant portion of our sales.
•If we do not or cannot adequately protect our intellectual property, or if third parties infringe our intellectual property rights, we may suffer competitive injury or expend significant resources enforcing our rights.
•Third parties may claim that we are infringing or misappropriating their intellectual property rights and we could suffer significant litigation expenses, losses or licensing expenses or be prevented from selling products or services.
•Defects and unanticipated use or inadequate disclosure with respect to our products or services (including software), or allegations thereof, could adversely affect our business, reputation and financial statements.
22

•Our restructuring actions could have long-term adverse effects on our business.
•Climate related risks may have an impact on our business.
•We have outstanding indebtedness of approximately $1.4 billion as of February 10, 2023, and in the future we may incur additional indebtedness.
•We may not be able to generate sufficient cash to service all of our indebtedness.
•We may be unable to raise the funds necessary to repurchase the convertible notes for cash following a fundamental change, or to pay any cash amounts due upon conversion.
•The conditional conversion feature of the convertible notes, if triggered, may adversely affect our financial condition and operating results.
•The capped call transactions may affect the value of the convertible notes and our common stock.
•We are subject to counterparty risk with respect to the capped calls transactions.
•Our variable rate indebtedness exposes us to interest rate volatility and we may be adversely affected by the anticipated cessation of LIBOR.
•The industries that we serve have undergone, and are in the process of undergoing, significant changes in an effort to reduce costs.
•We face intense competition.
•Changes in governmental regulations may reduce demand for our products or services or increase our expenses.
•Certain of our businesses are subject to extensive regulation by the FDA and comparable agencies of other countries.
•Off-label marketing or misleading advertising of our products could result in substantial penalties.
•Certain modifications to our products may require new 510(k) clearances or other marketing authorizations and may require us to recall or cease marketing our products.
•Our operations, products and services expose us to the risk of environmental, health and safety liabilities.
•Our businesses are subject to extensive regulation.
•The price of our common stock may continue to be volatile.
•Certain provisions in our governing documents and of Delaware law may prevent or delay an acquisition of us, which could decrease the trading price of our common stock.
•Our governing documents contain exclusive forum provisions for certain types of actions and proceedings.
•Conversion of the convertible notes may dilute the ownership interest of our stockholders.
•The issuance or sale of shares of our common stock, or rights to acquire shares of our common stock, could depress the trading price of our common stock and the convertible notes.
•We may be required to recognize impairment charges for our goodwill and other intangible assets.
•Foreign currency exchange rates may adversely affect our financial statements.
•Changes in tax law relating to multinational corporations could adversely affect our tax position.
•We are subject to a variety of litigation and other legal and regulatory proceedings in the course of our business.
•Work stoppages, union and works council campaigns and other labor disputes could adversely impact our productivity and results of operations.
•Our reputation, ability to do business and financial statements may be impaired by improper conduct by any of our employees, agents or business partners.

23

Risks Related to Our Business
Conditions in the global economy, especially with respect to the particular markets we serve and the volatility of the financial markets may adversely affect our business and financial statements.
Our business is sensitive to general economic conditions. Sustained inflation, rising interest rates, slower global economic growth, continuing supply chain disruptions, geopolitical tensions, actual or anticipated default on sovereign debt, volatility in the currency and credit markets, consumer confidence, high levels of unemployment or underemployment (and a corresponding increase in the uninsured and underinsured population), reduced levels of capital expenditures, changes or anticipation of potential changes in government trade, fiscal, tax and monetary policies, changes in capital requirements for financial institutions, government deficit reduction and budget negotiation dynamics, sequestration, austerity measures, social or political unrest, the impact of the COVID-19 pandemic and other challenges that affect the global economy have previously and may continue to adversely affect us and our distributors, customers and suppliers. Our success also depends upon the continued strength of the markets we serve. In many markets, dental reimbursement is largely out of pocket for the consumer and thus utilization rates can vary significantly depending on economic growth. While many of our products are considered necessary by patients regardless of the economic environment, certain products and services that support discretionary dental procedures may be susceptible to changes in economic conditions. The above factors can have the effect of:
◦reducing demand for our products and services (in this Annual Report, references to products and services also includes software), limiting the financing available to our customers and suppliers, increasing order cancellations and resulting in longer sales cycles and slower adoption of new technologies;
◦increasing the difficulty in collecting accounts receivable and the risk of excess and obsolete inventories;
◦increasing price competition in our served markets;
◦supply interruptions, which could disrupt our ability to produce our products;
◦increasing the risk of impairment of goodwill and other long-lived assets, and the risk that we may not be able to fully recover the value of other assets such as real estate and tax assets;
◦increasing the risk that counterparties to our contractual arrangements will change their terms of sale, become insolvent or otherwise unable to fulfill their contractual obligations which, in addition to increasing the risks identified above, could result in preference actions against us; and
◦adversely impacting market sizes.
There can be no assurance that the capital markets will be available to us or that the lenders participating in our credit facilities will be able to provide financing in accordance with their contractual obligations. When growth in the global economy or in any of the markets we serve slows for a significant period, there is significant deterioration in the global economy or such markets or when improvements in the global economy do not benefit the markets we serve, our business and financial statements could be adversely affected.
International economic, political, legal, compliance and business factors could negatively affect our financial statements.
In 2022, 51% of our sales were derived from customers outside the U.S. In addition, many of our manufacturing operations, suppliers and employees are located outside the U.S. Since our growth strategy depends in part on our ability to further penetrate markets outside the U.S. and increase the localization of our products and services, we expect to continue to increase our sales and presence outside the U.S., particularly in the emerging markets. Our international business (and particularly our business in emerging markets) is subject to risks that are customarily encountered in non-U.S. operations, including:
◦interruption in the transportation of materials to us and finished goods to our customers;
◦differences in terms of sale, including payment terms;
◦local product preferences and product requirements;
◦changes in a country’s or region’s political or economic conditions, such as the devaluation of particular currencies;
◦trade protection measures, embargoes and import or export restrictions and requirements;
◦unexpected changes in laws or regulatory requirements, including changes in tax laws;
24

◦capital controls and limitations on ownership and on repatriation of earnings and cash;
◦the potential for nationalization of enterprises;
◦changes in medical reimbursement policies and programs;
◦limitations on legal rights and our ability to enforce such rights;
◦difficulty in staffing and managing widespread operations;
◦differing labor regulations;
◦difficulties in implementing restructuring actions on a timely or comprehensive basis;
◦differing protection of intellectual property;
◦greater uncertainty, risk, expense and delay in commercializing products in certain foreign jurisdictions, including with respect to product and other regulatory approvals; and
◦other factors beyond our control, such has terrorism, war, natural disasters and pandemics, including fluctuations in the severity and duration of the COVID-19 pandemic and resulting restrictions on business activity which may vary significantly by region.
Any of these risks could negatively affect our financial statements, business, growth rate, competitive position, results of operations and financial condition.
For example, we generate approximately 10% of our annual sales from Greater China. Accordingly, our business, financial condition and results of operations may be adversely influenced by evolving political, economic and social conditions in China generally. Late in 2022, the Chinese authorities relaxed certain COVID-19 restrictions in parts of China, which has resulted in an increase in COVID-19 cases and has impacted our business in China. Additionally, China’s government continues to play a significant role in regulating industry development by imposing industrial policies, and it maintains control over China’s economic growth through setting monetary policy and determining treatment of particular industries or companies. For example, China has implemented volume-based procurement policies, a series of centralized reforms instituted in China on both a national and regional basis that has resulted in significant price cuts for medical and dental consumables. Further, considerable uncertainty exists regarding the long-term effects of the expansionary monetary and fiscal policies adopted by the central banks and financial authorities of some of the world’s leading economies, including the U.S. and China. Any uncertainty or adverse changes to economic conditions in China or the policies of China’s government or its laws and regulations could have a material adverse effect on the overall economic growth of China and could impact our business and operating results, leading to a reduction in demand for our products and adversely affecting our business, growth rate, competitive position, results of operations and financial condition.

In addition, Russia’s invasion of Ukraine and the global response to this invasion, including sanctions imposed by the U.S. and other countries, has had and may continue to have an adverse impact on our business, including by impacting our ability to market and sell products in Russia, by potentially heightening our risk of cyber-attacks, by impacting our ability to enforce our intellectual property rights in Russia, by creating disruptions in the global supply chain, and by potentially having an adverse impact on the global economy, financial markets, energy markets, currency rates and otherwise.

The COVID-19 pandemic has had and could continue to have a material adverse effect on our business and results of operations.

Our global operations and the nature of the business of our dental customers expose us to risks associated with public health crises and outbreaks of epidemic, pandemic, or contagious diseases, such as the COVID-19 pandemic. To date, COVID-19 has had, and may continue to have, an adverse impact on our operations, our supply chains and distribution systems, and our revenues and expenses, including as a result of preventive and precautionary measures that we, our dental customers, other businesses, and governments have taken. The increase in consumer demand resulting from the lifting of lockdowns has created significant challenges for supply chains as a result of labor and raw material shortages, which could lead to reduced earnings for many industries.

25

As a result of the COVID-19 outbreak, we have experienced and may continue to experience significant business disruptions, including restrictions on our ability to travel and distribute our products, temporary closures of most of our facilities, temporary reduced production capacity at certain sites when there are local outbreaks causing higher than usual employee absences due to illness or quarantine requirements, as well as reduction in access to our customers due to prolonged shelter-in-place and/or self-quarantine mandates and significant and unpredictable reductions in the demand for our products. As more business and activities have shifted online and many of our employees are working remotely, we may also be more vulnerable to cyber security threats and attempts to breach our security networks.

Significant developments or uncertainties stemming from trade policies and regulations could have an adverse effect on our business

Trade policies and disputes at times result in increased tariffs, trade barriers, and other protectionist measures, which can increase our manufacturing costs, make our products less competitive, reduce demand for our products, limit our ability to sell to certain customers, limit our ability to procure components or raw materials, or impede or slow the movement of our goods across borders. Increasing protectionism and economic nationalism may lead to further changes in trade policies and regulations, domestic sourcing initiatives, or other formal and informal measures that could make it more difficult to sell our products in, or restrict our access to, some markets.

In particular, trade tensions between the U.S. and China have led to increased tariffs and trade restrictions. It is difficult to predict what further trade-related actions governments may take, which may include trade restrictions and additional or increased tariffs and export controls imposed on short notice, and we may be unable to quickly and effectively react to or mitigate such actions.

Additionally, in connection with the ongoing conflict between Russia and Ukraine, governments including the U.S., United Kingdom, and those of the European Union have imposed export controls on certain products and financial and economic sanctions on certain industry sectors and parties in Russia which has triggered retaliatory sanctions by the Russian government and its allies. Although these export controls and sanctions did not have a material impact on our financial position or results of operations as of and for the year ended December 31, 2022, the outcome and future impacts of the conflict and governmental responses thereto remain highly uncertain. Existing and future sanctions may have broad and pervasive impacts to the global economy and our operations, which could materially and adversely affect our business and results of operations.

We cannot predict whether additional U.S. and foreign customs quotas, duties (including antidumping or countervailing duties), tariffs, taxes or other charges or restrictions, requirements as to where raw materials must be purchased or other restrictions on our imports will be imposed in the future or adversely modified, or what effect such actions would have on our costs of operations. Future quotas, duties or tariffs may adversely affect our business, financial condition, results of operations or cash flows. Future trade agreements could also provide our competitors with an advantage over us, or increase our costs, either of which could adversely affect our business, financial condition, results of operations or cash flows. Furthermore, trade disputes and protectionist measures, or continued uncertainty about such matters, could result in declining consumer confidence and slowing economic growth or recession, and could cause our customers to reduce, cancel, or alter the timing of their purchases with us. Sustained geopolitical tensions could lead to long-term changes in global trade and supply chains, and decoupling of global trade networks, which could have a material adverse effect on our business and growth prospects.

Our growth could suffer if the markets into which we sell our products and services decline, do not grow as anticipated or experience cyclicality.
Our growth depends in part on the growth of the markets which we serve, and visibility into these markets is limited (particularly for markets into which we sell through distribution). Any decline or lower than expected growth in our served markets could diminish demand for our products and services, which would adversely affect our financial statements. Our quarterly sales and profits depend substantially on the volume and timing of orders received during the fiscal quarter, which are difficult to forecast. Certain of our businesses operate in industries that may also experience periodic, cyclical downturns.
26

In addition, in certain of our businesses, demand depends on customers’ capital spending budgets, government funding policies, and matters of public policy and government budget dynamics, as well as product and economic cycles, which can affect the spending decisions of these entities. Demand for our products and services is also sensitive to changes in customer order patterns, which may be affected by announced price changes, marketing or promotional programs, new product introductions, the timing of industry trade shows and changes in distributor or customer inventory levels due to distributor or customer management thereof or other factors. Any of these factors could adversely affect our growth and results of operations in any given period.

Our financial results are subject to fluctuations in the cost and availability of commodities that we use in our operations.
As further discussed in the section entitled “Item 1. Business—Materials,” our manufacturing and other operations employ a wide variety of components, raw materials and other commodities, including metallic-based components, electronic components, chemicals, plastics and other petroleum-based products. Prices for and availability of these components, raw materials and other commodities have fluctuated significantly in the past. Any sustained interruption in the supply of these items, including as a result of shipping risks, such as container shortages, blocked shipping lanes, and port backlogs, could adversely affect our business. In addition, due to, among other items, the highly competitive nature of the industries that we serve, the cost-containment efforts of our customers, and the terms of certain contracts we are party to, there can be no assurance that the marketplace will support higher prices or that price increases and productivity gains, procurement deflation projects or savings will fully offset any raw material cost increases in the future. If we are unable to fully recover higher commodity costs through price increases or offset these increases through cost reductions, or if there is a time delay between the increase in costs and our ability to recover or offset these costs, our margins and profitability could decline and our financial statements could be adversely affected.

If we cannot adjust our manufacturing capacity or the purchases required for our manufacturing activities to reflect changes in market conditions and customer demand, our profitability may suffer. In addition, our reliance upon sole or limited sources of supply for certain materials, components and services could cause production interruptions, delays and inefficiencies.
We purchase materials, components and equipment from third parties for use in our manufacturing operations, including metallic-based components, electronic components, chemicals, plastics and other petroleum-based products. Our profitability could be adversely impacted if we are unable to adjust our purchases to reflect changes in customer demand and market fluctuations, including those caused by seasonality or cyclicality. During a market upturn, suppliers may extend lead times, limit supplies or increase prices. If we cannot purchase sufficient products at competitive prices and quality and on a timely enough basis to meet increasing demand, we may not be able to satisfy market demand, product shipments may be delayed, our costs may increase or we may breach our contractual commitments and incur liabilities. Conversely, in order to secure supplies for the production of products, we sometimes enter into non-cancelable purchase commitments with vendors, which could impact our ability to adjust our inventory to reflect declining market demands. If demand for our products is less than we expect, we may experience additional excess and obsolete inventories and be forced to incur additional charges and our profitability may suffer. For example, we have recently experienced and may continue to experience inflationary increases in our manufacturing costs and operating expenses. Prolonged inflation may also reduce or delay orders for our products and for certain products we may be unable to satisfy demand, both of which could adversely impact our sales and results of operations.
In addition, some of our businesses purchase certain materials, components and services from sole or limited source suppliers for reasons of quality assurance, regulatory requirements, cost effectiveness, availability or uniqueness of design. If these or other suppliers encounter financial, operating or other difficulties or if our relationship with them changes, we may not be able to establish additional or replacement suppliers in a timely or cost-effective manner, including as a result of FDA and other regulations that require, among other things, validation of materials and components prior to their use in our products, which could further negatively impact our business and results of operations. The supply chains for our businesses could also be disrupted by supplier capacity constraints, bankruptcy or exiting of the business for other reasons, decreased availability of key raw materials or commodities and external events such as natural disasters, pandemic health issues, including COVID-19 and related lockdowns and restrictions, war, terrorist actions, cyber-attacks, widespread protests and civil unrest, governmental actions and legislative or regulatory changes. Any of these factors could result in production interruptions, delays, extended lead times and inefficiencies. The supply chains for our businesses have also been impacted by the recent COVID-19 related lockdowns in China and the Russia-Ukraine conflict. Failure to obtain the needed supply of these products or to offset the increased costs could adversely impact our operating results.
27

Because we cannot always immediately adapt our production capacity and related cost structures to changing market conditions, our manufacturing capacity may at times exceed or fall short of our production requirements. Any or all of these problems could result in the loss of customers, provide an opportunity for competing products to gain market acceptance and otherwise adversely affect our financial statements.
If we suffer loss to our facilities, supply chains, distribution systems or information technology systems due to catastrophe or other events, our operations could be seriously harmed.
Our facilities, supply chains, distribution systems and information technology systems are subject to catastrophic loss due to fire, flood, earthquake, hurricane, public health crises (including the COVID-19 pandemic), war, terrorism, widespread protests and civil unrest, or other natural or man-made disasters. For example, our corporate headquarters and many of our operations, including certain of our manufacturing facilities, are located in California, which is prone to earthquakes and wildfires, in addition to the other risks discussed above. If any of these facilities, supply chains or systems were to experience a catastrophic loss, it could disrupt our operations, delay production and shipments, result in defective products or services, damage customer relationships and our reputation and result in legal exposure and large repair or replacement expenses. The third-party insurance coverage that we maintain will vary from time to time in both type and amount depending on cost, availability and our decisions regarding risk retention, and may be unavailable or insufficient to protect us against such losses.
The manufacture of many of our products is a highly exacting and complex process, and if we directly or indirectly encounter problems manufacturing products, our reputation, business and financial statements could suffer.
The manufacture of many of our products is a highly exacting and complex process, due in part to strict regulatory requirements. Problems can arise during manufacturing for a variety of reasons, including equipment malfunction, failure to follow specific protocols and procedures, problems with raw materials, natural disasters and environmental factors, and if not discovered before the product is released to market could result in recalls and product liability exposure. Because of the time required to approve and license certain regulated manufacturing facilities and other stringent regulations of the FDA and similar agencies regarding the manufacture of certain of our products, an alternative manufacturer may not be available on a timely basis to replace such production capacity. Any of these manufacturing problems could result in significant costs, liability and lost sales, loss of market share as well as negative publicity and damage to our reputation that could reduce demand for our products.
A significant disruption in, or breach in security of, our information technology systems or data or violation of data privacy laws could adversely affect our business, reputation and financial statements.
We rely on information technology systems, some of which are provided and/or managed by third parties, to process, transmit and store electronic information (including sensitive data, confidential business information, health information, intellectual property, and personal data relating to employees, customers, other business partners and patients), and to manage or support a variety of critical business processes and activities (such as receiving and fulfilling orders, billing, collecting and making payments, shipping products, providing services and support to customers and fulfilling contractual obligations). In addition, some of our software products and services incorporate information technology that may house personal data and some products or software we sell to customers may connect to our systems for maintenance or other purposes.
28

These systems, products and services (including those we acquire through business acquisitions) may be materially impacted and/or disrupted by information security incidents. This includes incidents such as ransomware, malware, viruses, phishing, social engineering, human error or malfeasance, power outages, hardware failures, telecommunication or utility failures, catastrophes or other unforeseen events. In any such circumstances our system redundancy and other disaster recovery planning may be ineffective or inadequate. This existing risk is potentially compounded by the increased number of our employees with hybrid or full-time remote schedules and the related increase in remote access to our systems. Cyber-attacks may also target hardware, software and information installed, stored or transmitted in our products after such products have been purchased and incorporated into third-party products, facilities or infrastructure. Security breaches of our systems, regardless of whether the breach is attributable to a vulnerability in our products or services, or security breaches of third parties’ systems on which we rely to process, store, or transmit electronic information, could result in the misappropriation, destruction or unauthorized disclosure of confidential information or personal data belonging to us or our employees, partners, customers, patients or suppliers. Like most multinational corporations, our information technology systems have been subject to computer viruses, malicious codes, unauthorized access and other cyber-attacks, and we expect the sophistication and frequency of such attacks to continue to increase. Unauthorized tampering, adulteration or interference with our products may also adversely affect product functionality and result in loss of data, risk to patient safety and product recalls or field actions. Additionally, if our business relationship with a third-party provider of information technology systems or services is negatively affected, or if one of our providers were to terminate its agreement with us without adequate notice, we would suffer a significant business disruption.
Any of the cyber-attacks, breaches or other disruptions or damage described above could interrupt our operations or the operations of our customers and partners; delay production and shipments; result in theft of our and our customers’ intellectual property and trade secrets; damage customer, patient, business partner and employee relationships; harm our reputation; result in defective products or services; or lead to legal or regulatory claims, proceedings, liability and/or penalties. These events may also result in increased costs for security and remediation. All of the foregoing could adversely affect our business, reputation and financial statements.
If we are unable to maintain reliable information technology systems and appropriate controls with respect to global data privacy and security requirements and prevent data breaches, we may suffer adverse regulatory consequences, fines, business disruption and litigation.
As cyber threats continue to evolve, we may be required to expend significant capital and other resources to protect against the threat of security breaches or to mitigate and alleviate problems caused by security incidents, including unauthorized access to protected health information and personal information stored in our information systems, and the introduction of computer viruses or other malicious software programs to our systems. Our security measures may be inadequate to prevent security breaches, especially those carried out by malicious third parties and our business operations and reputation could be materially adversely affected by these events and any resulting federal and state fines and penalties, legal claims or proceedings, and cancellation of contracts if security breaches are not prevented. The healthcare industry is currently experiencing increased attention on compliance with regulations that require us to safeguard protected health information and mitigate cyber-attacks. There are also significant costs associated with a data breach, including investigation costs, remediation and mitigation costs, notification costs, attorney fees, and the potential for reputational harm and lost revenues due to a loss in confidence. We cannot predict the costs to comply with these laws or the costs associated with a potential data breach, which could have a material adverse effect on our business, results of operations, financial position and cash flows, and our business reputation.
We have installed privacy/security protection systems and devices on our network in an attempt to prevent cyber-threats and other unauthorized access to information. However, there can be no assurance that any such threats or unauthorized access will not occur or, if they do occur, that they will be adequately addressed. In addition, our technology may fail to adequately secure the confidential and personal information we maintain. In such circumstances, we may be held liable to individuals and regulators, which could result in fines, litigation or adverse publicity that could have a material adverse effect on our business and consolidated financial condition, results of operations and cash flows. Even if we are not held liable, any resulting negative publicity could harm our business and divide the attention of management. Our risk and exposure to these matters remain heightened because of the evolving nature of these threats, increased regulatory enforcement and the expansion of consumer rights under data privacy and security laws.
29

We believe that our subcontractors and vendors take precautionary measures to prevent problems that could affect our business operations as a result of failure or disruption to their information systems. However, there is no guarantee such efforts will be successful in preventing a disruption, and it is possible that we may be impacted by third party information system failures. The occurrence of any information system failures with our vendors could result in interruptions, delays, loss or corruption of data and cessations or interruptions in the availability of these systems. All of these events or circumstances, among others, could have an adverse effect on our business, results of operations, financial position and cash flows, and they could harm our business reputation.

Data privacy and security laws relating to the handling of personal information (including personal health information) are evolving across the world and may be drafted, interpreted or applied in a manner that results in increased costs, legal claims, fines against us, reputational damage or impedes delivery.
As a global organization, we are subject to data privacy and security laws, regulations, and customer-imposed controls in numerous jurisdictions as a result of having access to and processing confidential, personal and/or sensitive data in the course of our business. For example, in the U.S., the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) privacy, security, and breach notification rules require certain of our operations to maintain controls to protect the confidentiality, availability, and integrity of patient health information. In addition, individual states regulate data breach notification requirements as well as more general privacy and security requirements. Entities within the U.S. that are found to be in violation of HIPAA, for example as the result of a breach of unsecured protected health information, a complaint about privacy practices, or an audit by HHS, may be subject to significant civil, criminal and administrative fines and penalties and/or additional reporting and oversight obligations if required to enter into a resolution agreement and corrective action plan with HHS to settle allegations of HIPAA non-compliance.

Based on the annual revisions for 2022, penalties for HIPAA violations can range from $127 to $1.919 million dollars per violation, with a maximum fine of $1.919 million for identical violations during a calendar year. In 2018, a nation-wide health benefit company paid $16 million to HHS following a data breach. Prior to this record payment, the largest HIPAA fine was $5.55 million. Under the law, state attorneys general have authority to bring civil enforcement actions under HIPAA, and attorneys general are actively engaged in enforcement. In addition, any penalties assessed under HIPAA could be in addition to other penalties assessed by a state for a data breach in violation of state laws.

The Health Information Technology for Economic and Clinical Health (“HITECH”) Act was enacted as an update to HIPAA and makes business associates of covered entities directly liable for compliance with certain HIPAA requirements, strengthens the limitations on the use and disclosure of protected health information without individual authorizations, and contemplates enforcement of noncompliance with HIPAA due to willful neglect. These changes have stimulated increased enforcement activity and enhanced the potential that health care providers will be subject to financial penalties for violations of HIPAA. In addition, the Secretary of HHS is required to perform periodic audits to ensure covered entities (and their business associates, as that term is defined under HIPAA) comply with the applicable HIPAA requirements, increasing the likelihood that a HIPAA violation will result in an enforcement action.

In addition to the federal HIPAA regulations, most states also have laws that protect the confidentiality of health information and other personal information, and these laws may be broader in scope with respect to protected health information and other personal information than HIPAA. Certain of these laws grant individuals various rights with respect to personal information, and we may be required to expend significant resources to comply with these laws. Further, all 50 states and the District of Columbia have adopted data breach notification laws that impose, in varying degrees, an obligation to notify affected persons and/or state regulators in the event of a data breach or compromise, including when their personal information has or may have been accessed by an unauthorized person.

30

Some state breach notification laws may also impose physical and electronic security requirements regarding the safeguarding of personal information, such as social security numbers and bank and credit card account numbers. Violation of state privacy, security, and breach notification laws can trigger significant monetary penalties. In addition, certain states’ privacy, security, and data breach laws, including, for example, the CCPA include private rights of action that may expose us to private litigation regarding our privacy and security practices and significant damages awards or settlements in civil litigation. Specifically, the CCPA gave California residents certain rights to access and delete their personal information, opt out of certain personal information sharing, and receive detailed information about how their personal information is used. The California Privacy Rights Act, which went into effect on January 1, 2023, significantly amended the CCPA and imposed additional data protection obligations on covered businesses, including additional consumer rights processes, limitations on data uses, new audit requirements for higher risk processing, and opt outs for certain uses of sensitive data. It also created a new California data protection agency authorized to issue substantive regulations and could result in increased privacy and information security enforcement.

In addition, as federal, state and local governments consider adopting new privacy and security legislation, our operations may be subject to different standards in different geographical regions. This may require significantly more resources for compliance and increase the risk of regulatory enforcement and private litigation with respect to our privacy and security practices.

We are also subject to the General Data Protection Regulation (“GDPR”), the primary data protection law in the European Union and European Economic Area (collectively, the EU), as well as associated EU member state data protection laws and the UK GDPR in the United Kingdom. These laws impose significant requirements for covered businesses (controllers and processors) of personal data, including, for example, standards for obtaining consent from individuals to process their personal data, disclosures to individuals, an individual data rights regime, specified timelines for data breach notifications, limitations on retention and secondary uses of information, requirements pertaining to health data and pseudonymised (i.e., deidentified) data, restrictions on data transfers outside of the EU, and obligations when we contract third-party processors in connection with the processing of personal data. The GDPR allows EU member states certain flexibility to make additional laws and regulations concerning the same issues, including, for example, further limiting the processing of genetic, biometric or health data. Failure to comply with the requirements of the GDPR may result in fines of up to €20,000,000 or up to 4% of the total worldwide annual turnover of the preceding financial year, whichever is higher. Other administrative penalties may be imposed under the applicable national data protection laws of the EU member states.

We rely on legal mechanisms for transferring certain personal data outside of the EU. These mechanisms include the EU Standard Contractual Clauses, or SCCs, and until July 2020, the U.S. Privacy Shield Framework. In July 2020, the Court of Justice of the European Union issued the “Schrems II” decision, invalidating the Privacy Shield Framework and requiring additional due diligence and assessments to be carried out when using Standard Contractual Clauses as transfer mechanisms. This decision has created uncertainty in how businesses may transfer data out of the EU and may result in increased costs and complexity and hinder our transfer of data out of the EU and corresponding business operations.

Other countries (for example Brazil and China) have or are in the process of passing laws that contain similar requirements to the GDPR. Data localization laws have also been passed or are under consideration in several countries (such as China and Russia), which require personal information relating to their citizens to be maintained on local servers and impose additional data transfer restrictions.

Compliance with the varying data privacy regulations across the U.S. and around the world have required significant expenditures and may require additional expenditures and changes in our products or business models that increase complexity and competition. We may also experience less demand for our products if we are unable to engineer these to enable our customers to comply with their obligations under data privacy laws.

In addition, government enforcement actions can be costly and interrupt the regular operation of our business, and data breaches or violations of data privacy laws can result in fines, reputational damage and civil lawsuits, any of which may adversely affect our business, reputation and financial statements.
31

Our growth depends in part on the timely development and commercialization, and customer acceptance, of new and enhanced products and services based on technological innovation.
We generally sell our products and services in an industry that is characterized by rapid technological changes, frequent new product introductions and changing industry standards. If we do not develop innovative new and enhanced products and services on a timely basis, our offerings will become obsolete over time and our competitive position and financial statements will suffer. Our success will depend on several factors, including our ability to:
◦correctly identify customer needs and preferences and predict future needs and preferences;
◦allocate our research and development funding to products and services with higher growth prospects;
◦anticipate and respond to our competitors’ development of new products and services and technological innovations;
◦differentiate our offerings from our competitors’ offerings and avoid commoditization;
◦innovate and develop new technologies and applications, and acquire or obtain rights to third-party technologies that may have valuable applications in our served markets;
◦obtain adequate intellectual property rights with respect to key technologies before our competitors do;
◦successfully commercialize new technologies in a timely manner, price them competitively and cost-effectively manufacture and deliver sufficient volumes of new products of appropriate quality on time;
◦obtain necessary regulatory approvals of appropriate scope (including by demonstrating satisfactory clinical results where required); and
◦stimulate customer demand for and convince customers to adopt new technologies.
If we fail to accurately predict future customer needs and preferences or fail to produce viable technologies, we may invest heavily in research and development of products and services that do not lead to significant sales, which would adversely affect our profitability.
Even if we successfully innovate and develop new and enhanced products and services, we may incur substantial costs in doing so, and our profitability may suffer. In addition, promising new offerings may fail to reach the market or realize only limited commercial success because of real or perceived efficacy or safety concerns, failure to achieve positive clinical outcomes, uncertainty over third-party reimbursement or entrenched patterns of clinical practice. For additional information on third-party reimbursement of dental products, please refer to “Item 1. Business—Regulatory Matters.”
Our ability to attract, develop and retain our key personnel is critical to our success.
Our success depends to a significant extent upon the continued service of our executive officers and key management and technical personnel and on our ability to continue to attract, retain, and develop qualified personnel. The competition for these employees is intense. The loss of the services of key personnel could have a material adverse effect on our operating results. In addition, there could be a material adverse effect on us should the turnover rates for key personnel increase significantly or if we are unable to continue to attract qualified personnel.

Our success also depends on our ability to execute leadership succession plans. The inability to successfully transition key management roles could have a material adverse effect on our operating results.

Any inability to consummate acquisitions at our historical rate and at appropriate prices, and to make appropriate investments that support our long-term strategy, could negatively impact our growth rate and stock price.
Our ability to grow sales, earnings and cash flow at or above our historic rates depends in part upon our ability to identify and successfully acquire and integrate businesses at appropriate prices and realize anticipated synergies, and to make appropriate investments that support our long-term strategy. We may not be able to consummate acquisitions at rates similar to the past, which could adversely impact our growth rate and our stock price. Promising acquisitions and investments are difficult to identify and complete for a number of reasons, including high valuations, competition among prospective buyers, the availability of affordable funding in the capital markets and the need to satisfy applicable closing conditions and obtain applicable antitrust and other regulatory approvals on acceptable terms. In addition, competition for acquisitions and investments may result in higher purchase prices. Changes in accounting or regulatory requirements or instability in the credit markets could also adversely impact our ability to consummate acquisitions and investments.
32

Our acquisition of businesses, investments, joint ventures and other strategic relationships could negatively impact our financial statements.
As part of our business strategy we acquire businesses, make investments and enter into joint ventures and other strategic relationships in the ordinary course; please refer to “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” for additional details. Acquisitions, investments, joint ventures and strategic relationships involve a number of financial, accounting, managerial, operational, legal, compliance and other risks and challenges, including the following, any of which could adversely affect our business and financial statements:
◦Any business, technology, service or product that we acquire or invest in could under-perform relative to our expectations and the price that we paid or not perform in accordance with our anticipated timetable, or we could fail to operate any such business profitably.
◦We may incur or assume significant debt in connection with our acquisitions, investments, joint ventures or strategic relationships, which could also cause a deterioration of our credit ratings, result in increased borrowing costs and interest expense and diminish our future access to the capital markets.
◦Acquisitions, investments, joint ventures or strategic relationships could cause our financial results to differ from our own or the investment community’s expectations in any given period, or over the long-term.
◦Pre-closing and post-closing earnings charges could adversely impact operating results in any given period, and the impact may be substantially different from period to period.
◦Acquisitions, investments, joint ventures or strategic relationships could create demands on our management, operational resources and financial and internal control systems that we are unable to effectively address.
◦We could experience difficulty in integrating personnel, operations and financial and other controls and systems and retaining key employees and customers.
◦We may be unable to achieve cost savings or other synergies anticipated in connection with an acquisition, investment, joint venture or strategic relationship.
◦We may assume unknown liabilities, known contingent liabilities that become realized, known liabilities that prove greater than anticipated, internal control deficiencies or exposure to regulatory sanctions resulting from the acquired company’s or investee’s activities and the realization of any of these liabilities or deficiencies may increase our expenses, adversely affect our financial position or cause us to fail to meet our public financial reporting obligations.
◦In connection with acquisitions and joint ventures, we often enter into post-closing financial arrangements such as purchase price adjustments, earn-out obligations and indemnification obligations, which may have unpredictable financial results.
◦As a result of our acquisitions and investments, we have recorded significant goodwill and other assets on our balance sheet and if we are not able to realize the value of these assets, or if the fair value of our investments declines, we may be required to incur impairment charges.
◦We may have interests that diverge from those of our joint venture partners or other strategic partners and we may not be able to direct the management and operations of the joint venture or other strategic relationship in the manner we believe is most appropriate, exposing us to additional risk.
◦Investing in or making loans to early-stage companies often entails a high degree of risk, and we may not achieve the strategic, technological, financial or commercial benefits we anticipate; we may lose our investment or fail to recoup our loan; or our investment may be illiquid for a greater-than-expected period of time.
Our ability to acquire other businesses or technologies, make strategic investments or integrate acquired businesses effectively may also be impaired by the effects of the COVID-19 pandemic, government actions in light of the pandemic, trade tensions and increased global scrutiny of foreign investments. For example, a number of countries, including the U.S. and countries in Europe and the Asia-Pacific region, are considering or have adopted restrictions on foreign investments. Governments may continue to adopt or tighten restrictions of this nature, and such restrictions could negatively impact our business and financial results.

33

The indemnification provisions of acquisition agreements by which we have acquired companies may not fully protect us and as a result we may face unexpected liabilities.
Certain of the acquisition agreements by which we have acquired companies require the former owners to indemnify us against certain liabilities related to the operation of the acquired company before we acquired it. In most of these agreements, however, the liability of the former owners is limited and certain former owners may be unable to meet their indemnification responsibilities. We cannot assure you that these indemnification provisions will protect us fully or at all, and as a result we may face unexpected liabilities that adversely affect our financial statements.

We may fail to realize the anticipated benefits of the IOS Acquisition or those benefits may take longer to realize than expected. We may also encounter significant difficulties in integrating the Intraoral Scanner Business into our operations.

Our ability to realize the anticipated benefits of the IOS Acquisition will depend, to a large extent, on our ability to integrate the Intraoral Scanner Business into ours. We have and may continue to devote significant management attention and resources to integrate the business practices and operations of the Intraoral Scanner Business with ours. This integration process may be disruptive to our and the Intraoral Scanner businesses, and, if implemented ineffectively, could restrict realization of the expected benefits. In addition, we may fail to realize some of the anticipated benefits of the IOS Acquisition if the integration process takes longer than expected or is more costly than expected. Potential difficulties we may encounter in the integration process include:

•The inability to successfully combine operations in a manner that would result in the anticipated benefits of the IOS Acquisition in the time frame currently anticipated or at all;
•Complexities associated with managing the expanded operations and new products;
•Integrating personnel;
•Creation of uniform standards, internal controls, procedures, policies and information systems;
•Unforeseen increased expenses, delays or regulatory issues associated with integrating the operations and products into our portfolio; and
•Performance shortfalls as a result of the diversion of management attention caused by completing the integration of the operations.

Even if we are able to integrate the Intraoral Scanner Business successfully, this integration may not result in the realization of the full benefits that we currently expect, nor can we give assurances that these benefits will be achieved when expected or at all. Moreover, the integration of the Intraoral Scanner Business may result in unanticipated problems, expenses, liabilities, regulatory risks and competitive responses that could have material adverse consequences. In addition, at the time of closing the IOS Acquisition, there was, and there continues to be, pending litigation against the seller of the Intraoral Scanner Business, to which one of our subsidiaries was added as a defendant after closing. While we do not view this litigation as material, the defense of such litigation, and any other future claims that may arise, may require significant time, attention and resources of our management and other employees within the Company, potentially diverting their attention from our business.

Divestitures or other dispositions could negatively impact our business, and contingent liabilities from businesses that we or our predecessors have sold could adversely affect our financial statements.
We continually assess the strategic fit of our existing businesses and may divest, spin-off, split-off or otherwise dispose of businesses that are deemed not to fit with our strategic plan or are not achieving the desired return on investment. These transactions pose risks and challenges that could negatively impact our business and financial statements. For example, when we decide to sell or otherwise dispose of a business or assets, we may be unable to do so on satisfactory terms within our anticipated timeframe or at all, and even after reaching a definitive agreement to sell or dispose a business the sale is typically subject to satisfaction of pre-closing conditions which may not become satisfied. In addition, divestitures or other dispositions may dilute our earnings per share, have other adverse tax, financial and accounting impacts and distract management, and disputes may arise with buyers. In addition, we have retained responsibility for and/or have agreed to indemnify buyers against some known and unknown contingent liabilities related to certain businesses or assets we or our predecessors have sold or disposed. The resolution of these contingencies has not had a material effect on our financial statements, but we cannot be certain that this favorable pattern will continue.
34

We are in the process of rebranding our Imaging Business, our China Business, and many of our products, which will likely involve substantial costs and may not be favorably received by our customers.

We no longer own the “KaVo” brand name, or any variation of the name, logos or related intellectual property rights. We have and will likely continue to incur substantial costs to rebrand our Imaging Business, our China Business, and a number of our products worldwide, which may also require the expenditure of regulatory product registration costs. Rebranding efforts may not be complete before the agreement with Planmeca allowing us to use the “KaVo” brand expires, potentially causing substantial inventory write-offs. We cannot be certain that our customers will be receptive to our proposed rebranding. A failure in our rebranding efforts may affect our ability to attract and retain customers, resulting in reduced revenues.

Inventories maintained by our distributors and customers may fluctuate from time to time.
We rely in part on our distributor and customer relationships and predictions of distributor and customer inventory levels in projecting future demand levels and financial results. These inventory levels may fluctuate, and may differ from our predictions, resulting in our projections of future results being different than expected. These changes may be influenced by changing relationships with the distributor and customers, economic conditions, supply chain disruption and end-user preference for particular products. There can be no assurance that our distributors and customers will maintain levels of inventory in accordance with our predictions or past history, or that the timing of distributors’ or customers’ inventory build or liquidation will be in accordance with our predictions or past history.
We are dependent upon a limited number of distributors for a significant portion of our sales, and loss of a key distributor could result in a loss of a significant amount of our sales. In addition, adverse changes in our relationships with, or the financial condition, performance, purchasing patterns or inventory levels of, key distributors and other channel partners could adversely affect our financial statements.
Historically, a substantial portion of our sales had come from a limited number of distributors, particularly Henry Schein, which accounted for approximately 11% of our sales in 2022 and 12% of our sales in 2021. It is anticipated that Henry Schein will continue to be the largest contributor to our sales for the foreseeable future. We do not currently have a master distribution agreement in place with Henry Schein for the distribution of our products in the U.S. and Canada. There can be no assurance that Henry Schein or any particular distributor will purchase any particular quantity of products from us or continue to purchase any products at all. If Henry Schein or any other key distributor or channel partner significantly reduces the volume of products purchased from us, it would have an adverse effect on our consolidated financial statements.
Our key distributors and other channel partners typically have valuable relationships with customers and end-users. Some of these distributors and other partners also sell our competitors’ products or compete with us directly, and if they favor competing products for any reason they may fail to market our products effectively. Adverse changes in our relationships with these distributors and other partners, reduction or discontinuation of their purchases from us or adverse developments in their financial condition, performance or purchasing patterns, could adversely affect our business and financial statements. The levels of inventory maintained by our distributors and other channel partners, and changes in those levels, can also significantly impact our results of operations in any given period. In addition, the consolidation of distributors and customers in certain of our served industries could adversely impact our business and consolidated financial statements.

35

If we do not or cannot adequately protect our intellectual property, or if third parties infringe our intellectual property rights, we may suffer competitive injury or expend significant resources enforcing our rights.
Many of the markets we serve are technology-driven, and as a result intellectual property rights play a significant role in product development and differentiation. We own numerous patents, trademarks, copyrights, trade secrets and other intellectual property and licenses to intellectual property owned by others, which in aggregate are important to our business. The intellectual property rights that we obtain, however, may not be sufficiently broad or otherwise may not provide us a significant competitive advantage, and patents may not be issued for pending or future patent applications owned by or licensed to us. In addition, the steps that we and our licensors have taken to maintain and protect our intellectual property may not prevent it from being challenged, invalidated, circumvented, designed-around or becoming subject to compulsory licensing, particularly in countries where intellectual property rights are not highly developed or protected. The laws of foreign countries in which we do business or contemplate doing business in the future may not recognize intellectual property rights or protect them to the same extent as do the laws of the U.S. In some circumstances, enforcement may not be available to us because an infringer has a dominant intellectual property position or for other business reasons, or countries may require compulsory licensing of our intellectual property. We also rely on nondisclosure and noncompetition agreements with employees, consultants and other parties to protect, in part, trade secrets and other proprietary rights. There can be no assurance that these agreements will adequately protect our trade secrets and other proprietary rights and will not be breached, that we will have adequate remedies for any breach, that others will not independently develop substantially equivalent proprietary information or that third parties will not otherwise gain access to our trade secrets or other proprietary rights. Our failure to obtain or maintain intellectual property rights that convey competitive advantage, adequately protect our intellectual property or detect or prevent circumvention or unauthorized use of such property and the cost of enforcing our intellectual property rights could adversely impact our business, including our competitive position, and financial statements.
Third parties may claim that we are infringing or misappropriating their intellectual property rights and we could suffer significant litigation expenses, losses or licensing expenses or be prevented from selling products or services.
From time to time, we receive notices from third parties alleging intellectual property infringement or misappropriation of third parties’ intellectual property and cannot be certain that the conduct of our business does not and will not infringe or misappropriate the intellectual property rights of others. Any dispute or litigation regarding intellectual property could be costly and time-consuming to defend due to the complexity of many of our technologies and the uncertainty of intellectual property litigation. Our intellectual property portfolio may not be useful in asserting a counterclaim, or negotiating a license, in response to a claim of infringement or misappropriation. In addition, as a result of such claims of infringement or misappropriation, we could lose our rights to critical technology, be unable to license critical technology or sell critical products and services, be required to pay substantial damages or license fees with respect to the infringed rights, be required to license technology or other intellectual property rights from others, be required to cease marketing, manufacturing or using certain products or be required to redesign, re-engineer or re-brand our products at substantial cost, any of which could adversely impact our business, including our competitive position, and financial statements. Third-party intellectual property rights may also make it more difficult or expensive for us to meet market demand for particular product or design innovations. If we are required to seek licenses under patents or other intellectual property rights of others, we may not be able to acquire these licenses on acceptable terms, if at all. Even if we successfully defend against claims of infringement or misappropriation, we may incur significant costs and diversion of management attention and resources, which could adversely affect our business and financial statements.
36

Defects and unanticipated use or inadequate disclosure with respect to our products or services (including software), or allegations thereof, could adversely affect our business, reputation and financial statements.
Manufacturing or design defects or “bugs” in, unanticipated use of, safety or quality issues (or the perception of such issues) with respect to, “off label” use of, or inadequate disclosure of risks relating to the use of products and services that we make or sell (including items that we source from third parties) can lead to personal injury, death, property damage, loss of profits or other liability. These events could lead to recalls or safety alerts, result in the removal of a product or service from the market and result in product liability or similar claims being brought against us. Any potential product liability claims could exceed the amount of our insurance coverage or may be excluded from coverage under the terms of the policy. Our insurance may not be renewed at a cost and level of coverage comparable to that then in effect. Recalls, removals and product liability and similar claims (regardless of their validity or ultimate outcome) can result in significant costs, as well as negative publicity and damage to our reputation that could reduce demand for our products and services. Our business can also be affected by studies of the utilization, safety and efficacy of medical device products and components that are conducted by industry participants, government agencies and others. Any of the above can result in the discontinuation of marketing of such products in one or more countries, and may give rise to claims for damages from persons who believe they have been injured as a result of product issues, including claims by individuals or groups seeking to represent a class.
For a discussion of risks pertaining to the dental amalgam sold by us, see “Item 1. Business—Regulatory Matters—Medical Device Regulations.”
Our restructuring and site consolidation actions could have long-term adverse effects on our business.
We are currently implementing significant restructuring and site consolidation activities across our businesses to adjust our cost structure and to increase our operational efficiency, and we may engage in similar activities in the future. These restructuring and consolidation activities and our regular ongoing cost reduction activities (including in connection with the integration of acquired businesses) reduce our available talent, assets and other resources and could slow improvements in our products and services, adversely affect our ability to respond to customers, limit our ability to increase production quickly if demand for our products increases and trigger adverse public attention. As part of our site consolidation initiatives, we may also lose favorable tax incentives or not be able to renew leases on acceptable terms. We may make changes to certain capital projects, close certain production operations and abandon leases for certain facilities that will not be used in our operations. Further, these activities may cause employees or third parties to raise claims against us, potentially resulting in additional costs and/or causing delays in implementation. In addition, delays in implementing planned restructuring activities, site consolidation or other productivity improvements, unexpected costs or failure to meet targeted improvements may diminish the operational or financial benefits we expect to realize from such actions. Moreover, we may not succeed in implementing present or future restructuring activities, site consolidation, or cost reduction activities. Realizing the anticipated benefits from these initiatives, if any benefits are achieved at all, may take several years, and we may be unable to achieve our targeted cost efficiencies and gross margin improvements. Additionally, we may have insufficient access to capital to fund investments in these strategic initiatives, or our business strategy may change from time to time, which could delay our ability to implement initiatives that we believe are important to our business. Any of the circumstances described above could adversely impact our business and financial statements.

We may be adversely affected by climate-related risks or by legal, regulatory or market responses to such risks.

The long-term effects of climate-related risks are difficult to predict and may be widespread. The impacts of climate change may include physical risks (such as rising sea levels or changes in weather patterns), social and human effects (such as population dislocations or harm to health and well-being), compliance costs and transition risks (such as regulatory or technology changes), shifts in market trends (such as customers putting an increased priority on purchasing products that are sustainably made) and other adverse effects. Any of our primary locations may be vulnerable to the adverse effects of climate-related risks. For example, our corporate headquarters are located in California, which has historically experienced, and is likely to continue to experience, climate-related events including drought, water scarcity, flooding, heat waves, wildfires and resultant air quality impacts and power shutoffs associated with wildfire prevention. The effects of climate-related risks could also impair the availability and cost of certain products, commodities and energy (including utilities), which in turn may impact our ability to procure goods or services required for the operation of our business at the quantities and levels we require.

37

In addition, the increasing concern over climate change has resulted and may continue to result in more regional, federal, and/or global legal and regulatory requirements relating to climate change, including regulating greenhouse gas emissions, alternative energy policies and sustainability initiatives. If legislation or regulations are enacted or promulgated in the U.S. or in any other jurisdictions in which we do business that impose more stringent restrictions and requirements than our current legal or regulatory obligations, we may experience disruptions in, or increases in the costs associated with, sourcing, manufacturing and distributing our products, which may adversely affect our business, results of operations and financial condition. Any such regulatory changes could have a significant effect on our operating and financial decisions, including those involving capital expenditures to reduce emissions and comply with other regulatory requirements.

Risks Related to Our Indebtedness

We have outstanding indebtedness of approximately $1.4 billion, and in the future we may incur additional indebtedness. This indebtedness could adversely affect our businesses and our ability to meet our obligations.

As of February 10, 2023, we had outstanding indebtedness of approximately $1.4 billion, including approximately $0.9 billion under our amended and restated credit agreement ( the “Amended Credit Agreement”), $518 million under our Convertible Senior Notes due June 1, 2025 (the “Notes”), and had an additional $750 million of borrowing capacity under the revolving credit facility pursuant to the Amended Credit Agreement, with the ability to request further increases to the revolving credit facility up to $350 million.
Please refer to Note 16 to our audited consolidated financial statements included in this Annual Report. This debt could have important, adverse consequences to us and our security holders, including:
◦increasing our vulnerability to adverse economic and industry conditions;
◦limiting our ability to obtain additional financing;
◦requiring the dedication of a substantial portion of our cash flow from operations to service our indebtedness, which will reduce the amount of cash available for other purposes;
◦limiting our flexibility to plan for, or react to, changes in our businesses and industries;
◦diluting the interests of our existing stockholders as a result of issuing shares of our common stock upon conversion of the Notes; and
◦placing us at a possible competitive disadvantage with competitors that are less leveraged than us or have better access to capital.
Our business may not generate sufficient funds, and we may otherwise be unable to maintain sufficient cash reserves, to pay amounts due under our indebtedness, and our cash needs may increase in the future. The Amended Credit Agreement contains restrictive covenants that limit our ability to engage in activities that may be in our long-term interest, including for example EBITDA-based leverage and interest coverage ratios. If we breach any of these restrictions and cannot obtain a waiver from the lenders on favorable terms, subject to applicable cure periods, the outstanding indebtedness (and any other indebtedness with cross-default provisions) could be declared immediately due and payable, which would adversely affect our liquidity and financial statements.

The risks described above will increase with the amount of indebtedness we incur, and in the future we may incur significant indebtedness in addition to the indebtedness described above.

We may not be able to generate sufficient cash to service all of our indebtedness and may be forced to take other actions to satisfy our obligations under our indebtedness, which may not be successful and may adversely affect our ability to pay dividends.
Our ability to make scheduled payments on or refinance our debt obligations depends on our financial condition and operating performance, which are subject to prevailing economic and competitive conditions and to certain financial, business, legislative, regulatory and other factors beyond our control. We may be unable to maintain a level of cash flows from operating activities sufficient to permit us to pay the principal and interest on our indebtedness.
38

If our cash flows and capital resources are insufficient to fund our debt service obligations, we could face substantial liquidity problems and could be forced to reduce or delay investments and capital expenditures, or to dispose of material assets or operations, alter our dividend policy (if we pay dividends), seek additional debt or equity capital or restructure or refinance our indebtedness. We may not be able to effect any such alternative measures on commercially reasonable terms or at all and, even if successful, those alternative actions may not allow us to meet our scheduled debt service obligations. The instruments that may govern our indebtedness in the future may restrict our ability to dispose of assets and may restrict the use of proceeds from those dispositions. We may not be able to consummate those dispositions or to obtain proceeds in an amount sufficient to meet any debt service obligations when due.
In addition, we conduct our operations through our subsidiaries. Accordingly, repayment of our indebtedness will depend on the generation of cash flow by our subsidiaries, including certain international subsidiaries, and their ability to make such cash available to us, by dividend, debt repayment or otherwise. Our subsidiaries may not have any obligation to pay amounts due on our indebtedness or to make funds available for that purpose. Our subsidiaries may not be able to, or may not be permitted to, make adequate distributions to enable us to make payments in respect of our indebtedness. Each subsidiary is a distinct legal entity and, under certain circumstances, legal, tax and contractual restrictions may limit our ability to obtain cash from our subsidiaries. In the event that we do not receive distributions from our subsidiaries, we may be unable to make required principal and interest payments on our indebtedness.
Our inability to generate sufficient cash flows to satisfy our debt obligations, or to refinance our indebtedness on commercially reasonable terms or at all, may materially adversely affect our business, financial condition and results of operations and our ability to satisfy our obligations under our indebtedness or pay dividends on our common stock.

We may be unable to raise the funds necessary to repurchase the Notes for cash following a fundamental change, or to pay any cash amounts due upon conversion, and our other indebtedness may limit our ability to repurchase the Notes or pay cash upon their conversion.
Holders of the Notes may require us to repurchase their Notes following a fundamental change at a cash repurchase price generally equal to the principal amount of the Notes to be repurchased, plus accrued and unpaid interest, if any. In addition, upon conversion, we will satisfy part or all of our conversion obligation in cash. We may not have enough available cash or be able to obtain financing at the time we are required to repurchase the Notes or pay the cash amounts due upon conversion. In addition, applicable law, regulatory authorities and the agreements governing our other indebtedness may restrict our ability to repurchase the Notes or pay the cash amounts due upon conversion. Our failure to repurchase Notes or to pay the cash amounts due upon conversion when required will constitute a default under the indenture governing the Notes between us and Wilmington Trust, National Association, as trustee, dated as of May 21, 2020 (the “Indenture”). A default under the Indenture or the fundamental change itself could also lead to a default under agreements governing our other indebtedness, which may result in that other indebtedness becoming immediately payable in full. We may not have sufficient funds to satisfy all amounts due under the other indebtedness and the Notes.
The conditional conversion feature of the Notes, if triggered, may adversely affect our financial condition and operating results.
In the event the conditional conversion feature of the Notes is triggered, holders of Notes will be entitled to convert the Notes at any time during specified periods at their option. We made an irrevocable election to satisfy the principal amounts of Notes outstanding upon conversion with cash. If one or more holders elect to convert their Notes, we would be required to settle a portion or all of our conversion obligation through the payment of cash, which could adversely affect our liquidity. In addition, even if holders do not elect to convert their Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital. As of December 31, 2022, one of the conditions allowing the Note holders to convert the Notes was satisfied. As a result, as of December 31, 2022, the Notes are classified as a current liability. The conversion conditions are tested quarterly.

39

The capped call transactions we entered into in connection with the Notes may affect the value of the Notes and our common stock.

In connection with the sale of the Notes, we entered into capped call transactions (the “Capped Calls”) with the initial purchasers of the Notes, their respective affiliates and other financial institutions (the “option counterparties”). The Capped Calls are expected generally to reduce the potential dilution upon any conversion of the Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted Notes, as the case may be, with such reduction and/or offset subject to a cap.

In connection with establishing their hedges of the Capped Calls, the option counterparties or their affiliates entered into various derivative transactions with respect to our common stock. These parties may modify their hedge positions in the future by entering into or unwinding various derivatives with respect to our common stock and/or purchasing or selling our common stock or other securities of ours in secondary market transactions prior to the maturity of the Notes (and are likely to do so during any observation period related to a conversion of the Notes). This activity could cause or avoid an increase or a decrease in the market price of our common stock or the Notes.

We are subject to counterparty risk with respect to the Capped Calls.

The option counterparties are financial institutions, and we will be subject to the risk that any or all of them might default under the Capped Calls. Our exposure to the credit risk of the option counterparties will not be secured by any collateral. Past global economic conditions have resulted in the actual or perceived failure or financial difficulties of many financial institutions. If an option counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings with a claim equal to our exposure at that time under the Capped Calls with such option counterparty. Our exposure will depend on many factors but, generally, an increase in our exposure will be correlated to an increase in the market price and in the volatility of our common stock. In addition, upon a default by an option counterparty, we may suffer adverse tax consequences and more dilution than we currently anticipate with respect to our common stock. We can provide no assurances as to the financial stability or viability of the option counterparties.

Our variable rate indebtedness exposes us to interest rate volatility, which could cause our debt service obligations to increase significantly, and we may be adversely affected by the anticipated cessation of LIBOR.

Borrowings under certain of our facilities, including our Amended Credit Agreement, are made at variable rates of interest and expose us to interest rate volatility. Interest rates increased during 2022. If interest rates continue to increase, our debt service obligations on certain of our variable rate indebtedness will increase even though the amount borrowed remains the same, and our net income and cash flows, including cash available for servicing our indebtedness, will correspondingly decrease.

In addition, certain of our financial arrangements, including our Amended Credit Agreement, bear interest rates that fluctuate with changes in short-term prevailing interest rates, including the London Interbank Offered Rate (“LIBOR”) (or metrics derived from or related to LIBOR). On July 27, 2017, the United Kingdom’s Financial Conduct Authority announced that it intends to stop persuading or compelling banks to submit LIBOR rates after 2021. All LIBOR tenors relevant to us will cease to be published or will no longer be representative after June 30, 2023. U.S. bank regulators have advised banks to cease writing, subject to certain limited exceptions, new U.S. Dollar LIBOR contracts after 2021 and the New York Federal Reserve’s Alternative Reference Rates Committee (“ARCC”) has identified the Secured Overnight Financing Rate (“SOFR”) as the recommended risk-free alternative rate for USD LIBOR. Our Amended Credit Agreement provides for the use of SOFR as a replacement rate upon a LIBOR cessation event. SOFR is a relatively new reference rate and has a very limited history. There are significant differences between LIBOR and SOFR, such as LIBOR being an unsecured lending rate while SOFR is a secured lending rate, and SOFR is an overnight rate while LIBOR reflects term rates at different maturities. If our LIBOR-based borrowings are converted to SOFR, the differences between LIBOR and SOFR, plus the recommended spread adjustment, could result in interest costs that are higher than if LIBOR remained available, which could have a material adverse effect on our operating results.

40

Risks Related to Our Industry
The industries that we serve have undergone, and are in the process of undergoing, significant changes in an effort to reduce costs, which could adversely affect our financial statements.
The industries that we serve have undergone, and are in the process of undergoing, significant changes in an effort to reduce costs, including the following:
◦Governmental and private health care providers and payors around the world are increasingly utilizing managed care for the delivery of health care services, centralizing purchasing, limiting the number of vendors that may participate in purchasing programs, forming group purchasing organizations and integrated health delivery networks and pursuing consolidation to improve their purchasing leverage and using competitive bid processes to procure health care products and services.
◦Certain of our customers, and the end-users to whom our customers supply products, rely on government funding of and reimbursement for health care products and services and research activities. The health care austerity measures in other countries and other potential health care reform changes and government austerity measures have reduced and may further reduce the amount of government funding or reimbursement available to customers or end-users of our products and services and/or the volume of medical procedures using our products and services. Other countries, as well as some private payors, also control the price of health care products, directly or indirectly, through reimbursement, payment, pricing or coverage limitations, tying reimbursement to outcomes or (in the case of governmental entities) compulsory licensing. For example, China has implemented volume-based procurement policies, a series of centralized reforms instituted in China on both a national and regional basis that has resulted in significant price cuts for medical and dental consumables. Global economic uncertainty or deterioration can also adversely impact government funding and reimbursement.

These changes, as well as other impacts from market demand, government regulations, third-party coverage and reimbursement policies and societal pressures have started changing the way health care is delivered, reimbursed and funded and may cause participants in the health care industry and related industries that we serve to purchase fewer of our products and services, reduce the prices they are willing to pay for our products or services, reduce the amounts of reimbursement and funding available for our products and services from governmental agencies or third-party payors, heighten clinical data requirements, reduce the volume of medical procedures that use our products and services, affect the acceptance rate of new technologies and products and increase our compliance and other costs. In addition, we may be excluded from important market segments or unable to enter into contracts with group purchasing organizations and integrated health networks on terms acceptable to us, and even if we do enter into such contracts they may be on terms that negatively affect our current or future profitability. All of the factors described above could adversely affect our business and financial statements.
We face intense competition and if we are unable to compete effectively, we may experience decreased demand and decreased market share. Even if we compete effectively, we may be required to reduce prices for our products and services.
Our businesses operate in industries that are intensely competitive and have been subject to increasing consolidation. Because of the range of the products and services we sell and the variety of markets we serve, we encounter a wide variety of competitors. See “Item 1. Business—Competition.” In order to compete effectively, we must retain longstanding relationships with major customers and continue to grow our business by establishing relationships with new customers and external experts, continually developing new products and services to maintain and expand our brand recognition and leadership position in various product and service categories and penetrating new markets, including emerging markets. In addition, significant shifts in industry market share have occurred and may in the future occur in connection with product problems, safety alerts and publications about products, reflecting the competitive significance of product quality, product efficacy and quality systems in our industry. Our failure to compete effectively and/or pricing pressures resulting from competition may adversely impact our financial statements, and our expansion into new markets may result in greater-than-expected risks, liabilities and expenses. In addition, we are exposed to the risk that our competitors or our customers may introduce private label, generic, or low-cost products that compete with our products at lower price points. If these competitors’ products capture significant market share or decrease market prices overall, this could have an adverse effect on our financial statements.
41

Risks Related to Laws and Regulations
Changes in governmental regulations may reduce demand for our products or services or increase our expenses.
We compete in markets in which we and our customers must comply with supranational, federal, state, local and other jurisdictional regulations, such as regulations governing health and safety, the environment, food and drugs and privacy. We develop, configure and market our products and services to meet customer needs created by these regulations. These regulations are complex, change frequently, have tended to become more stringent over time and may be inconsistent across jurisdictions. Any significant change in any of these regulations (or in the interpretation or application thereof) could reduce demand for, increase our costs of producing or delay the introduction of new or modified products and services, or could restrict our existing activities, products and services. For example, in response to the COVID-19 pandemic, federal, state, local and foreign governmental authorities have imposed, and may continue to impose, protocols and restrictions intended to contain the spread of the virus, including limitations on the size of gatherings, closures of work facilities, schools, public buildings and businesses, quarantines, lockdowns and travel restrictions. Such restrictions have disrupted and may continue to disrupt our business operations and reduce demand for our products or services.

Certain of our businesses are subject to extensive regulation by the FDA and comparable agencies of other countries, as well as laws regulating fraud and abuse in the health care industry and the privacy and security of health information. Failure to comply with those regulations could adversely affect our reputation, ability to do business and financial statements.

Most of our products are medical devices subject to regulation by the U.S. Food and Drug Administration (the “FDA”), by other federal and state governmental agencies, by comparable agencies of other countries and regions, by certain accrediting bodies and by regulations governing hazardous materials (or the manufacture and sale of products containing any such materials). The FDA and these other regulatory authorities enforce additional regulations regarding the safety of X-ray emitting devices. The global regulatory environment has become increasingly stringent and unpredictable. Several countries that did not have regulatory requirements for medical devices have established such requirements in recent years, and other countries have expanded, or plan to expand, their existing regulations. For example, the EU MDR imposes stricter requirements for the marketing and sale of medical devices, including in the area of clinical evaluation requirements, quality systems and post-market surveillance. Medical devices that have been assessed and/or certified under the EU Medical Device Directive may continue to be placed on the market until 2024 (or until the expiry of their certificates, if applicable and earlier); however, requirements regarding the distribution, marketing and sale including quality systems and post-market surveillance have to be observed by manufacturers, importers and distributors as of the application date. Complying with the EU MDR required modifications to our quality management systems, additional resources in certain functions, and required and will continue to require updates to technical files, among other changes. Failure to meet these requirements could adversely impact our business in the EU and other regions that tie their product registrations to the EU requirements.

Similarly, under the Physician Payment Sunshine Act, we are required to collect and report detailed information regarding certain financial relationships we have with covered recipients, including physicians, dentists, teaching hospitals, and certain other non-physician practitioners. We or our subsidiaries may be required to report information under certain state transparency laws that address circumstances not covered by the Physician Payment Sunshine Act, and some of these state laws, as well as the federal law, can be unclear. We are also subject to foreign regulations requiring transparency of certain interactions between suppliers and their customers. While we believe we have substantially compliant programs and controls in place satisfying the above laws and requirements, such compliance imposes additional costs on us and the requirements are sometimes unclear.

42

To varying degrees, these regulators require us to comply with laws and regulations governing the development, testing, manufacturing, labeling, marketing, distribution and post-marketing surveillance of our products. We cannot guarantee that we will be able to obtain regulatory clearance (such as 510(k) clearance) or approvals for our new products or modifications to (or additional indications or uses of) existing products within our anticipated timeframe or at all, and if we do obtain such clearance or approval it may be time-consuming, costly and subject to restrictions. Our ability to obtain such regulatory clearances or approvals will depend on many factors and the process for obtaining such clearances or approvals could change over time. Even after initial regulatory clearance or approval, we are subject to periodic inspection by these regulatory authorities, and if safety issues arise, we may be required to amend conditions for use of a product, such as providing additional warnings on the product’s label or narrowing its approved intended use, which could reduce the product’s market acceptance. Failure to obtain required regulatory clearances or approvals before marketing our products (or before implementing modifications to or promoting additional indications or uses of our products), other violations of these regulations, failure to remediate inspectional observations to the satisfaction of these regulatory authorities and real or perceived efficacy or safety concerns or trends of adverse events with respect to our products (even after obtaining clearance for distribution) have led to FDA Form 483 Inspectional Observations, and can lead to warning letters, notices to customers, declining sales, loss of customers, loss of market share, remediation and increased compliance costs, mandatory recalls, seizures of adulterated or misbranded products, injunctions, administrative detentions, refusals to permit importations, partial or total shutdown of production facilities or the implementation of operating restrictions, narrowing of permitted uses for a product, suspension or withdrawal of approvals and pre-market notification rescissions. We are also subject to various laws regulating fraud and abuse, pricing and sales and marketing practices in the health care industry and the privacy and security of health information as well as manufacturing and quality standards, including the federal regulations described in “Item 1. Business —Regulatory Matters.” Ensuring that our internal operations and business arrangements with third parties comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that government authorities will conclude that our business practices do not comply with current or future statutes, regulations, agency guidance or case law involving applicable fraud and abuse or other healthcare laws and regulations.
Noncompliance with these standards can result in, among other things, fines, expenses, injunctions, civil penalties, recalls or seizures of products, total or partial suspension of production, refusal of the government to grant 510(k) clearance of devices, withdrawal of marketing approvals, criminal prosecutions and other adverse effects referenced below under “Our businesses are subject to extensive regulation; failure to comply with those regulations could adversely affect our financial statements and our business, including our reputation.” Further, defending against any such actions can be costly and time-consuming and may require significant personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired.
Off-label marketing or misleading advertising of our products could result in substantial penalties.
The FDA, the Federal Trade Commission (“FTC”) and, in some cases, the Environmental Protection Agency (“EPA”) strictly regulate the promotional claims that may be made about approved or cleared products. In particular, any clearances we may receive only permit us to market our products for the uses indicated on the labeling cleared by the FDA. We may request additional label indications for our current products, and the FDA may deny those requests outright, require additional expensive performance or clinical data to support any additional indications or impose limitations on the intended use of any cleared products as a condition of clearance. If the FDA determines that we have marketed or advertised our products for off-label use, we could be subject to fines, injunctions or other penalties. It is also possible that other federal, state or foreign enforcement authorities might take action if they consider our business activities to constitute promotion of an off-label use or misbranding, which could result in significant penalties, including, but not limited to, criminal, civil and administrative penalties, substantial monetary penalties, damages, fines, disgorgement, exclusion from participation in government healthcare programs, and/or the curtailment of our operations. Any of these events could significantly harm our business and results of operations and cause our stock price to decline.
43

Certain modifications to our products may require new 510(k) clearances or other marketing authorizations and may require us to recall or cease marketing our products.
Once a medical device is permitted to be legally marketed in the U.S. pursuant to a 510(k) clearance, a manufacturer may be required to notify the FDA of certain modifications to the device. Manufacturers determine in the first instance whether a change to a product requires a new premarket submission, but the FDA may review any manufacturer’s decision. The FDA may not agree with our decisions regarding whether new clearances are necessary. We have made modifications to our products in the past and have determined based on our review of the applicable FDA regulations and guidance that in certain instances new 510(k) clearances or other premarket submissions were not required. We may make similar modifications or add additional features in the future that we believe do not require a new 510(k) clearance. If the FDA disagrees with our determinations and requires us to submit new 510(k) notifications, we may be required to cease marketing or to recall the modified product until we obtain clearance, and we may be subject to significant regulatory fines or penalties.
Our operations, products and services expose us to the risk of environmental, health and safety liabilities, costs and violations that could adversely affect our business, reputation and financial statements.
Our operations, products and services are subject to environmental laws and regulations, which impose limitations on the discharge of pollutants into the environment, establish standards for the use, generation, treatment, storage and disposal of hazardous and non-hazardous wastes and impose end-of-life disposal and take-back programs. We must also comply with various health and safety regulations in the U.S. and abroad in connection with our operations. We cannot assure you that our environmental, health and safety compliance program (or the compliance programs of businesses we acquire) have been or will at all times be effective. Failure to comply with any of these laws could result in civil and criminal, monetary and non-monetary penalties and damage to our reputation. In addition, we cannot provide assurance that our costs of complying with current or future environmental protection and health and safety laws will not exceed our estimates or adversely affect our financial statements.
In addition, we may incur costs related to remedial efforts or alleged environmental damage associated with past or current waste disposal practices or other hazardous materials handling practices. We are also from time to time party to personal injury, property damage or other claims brought by private parties alleging injury or damage due to the presence of or exposure to hazardous substances. We may also become subject to additional remedial, compliance or personal injury costs due to future events such as changes in existing laws or regulations, changes in agency direction or enforcement policies, developments in remediation technologies, changes in the conduct of our operations and changes in accounting rules. For additional information regarding these risks, please refer to Note 15 to our audited consolidated financial statements included in this Annual Report. We cannot assure you that our liabilities arising from past or future releases of, or exposures to, hazardous substances will not exceed our estimates or adversely affect our reputation and financial statements or that we will not be subject to additional claims for personal injury or remediation in the future based on our past, present or future business activities.
Our businesses are subject to extensive regulation; failure to comply with those regulations could adversely affect our financial statements and our business, including our reputation.
In addition to the environmental, health, safety, health care, medical device, anticorruption, data privacy and other regulations noted elsewhere in this Annual Report, our businesses are subject to extensive regulation by U.S. and non-U.S. governmental and self-regulatory entities at the supranational, federal, state, local and other jurisdictional levels.
We are required to comply with various import laws and export control and economic sanctions laws, which may affect our transactions with certain customers, business partners and other persons and dealings between our employees and between our subsidiaries. In certain circumstances, export control and economic sanctions regulations may prohibit the export of certain products, services and technologies. In other circumstances, we may be required to obtain an export license before exporting the controlled item. Compliance with the various import laws that apply to our businesses can restrict our access to, and increase the cost of obtaining, certain products and at times can interrupt our supply of imported inventory.
44

Our products and operations are also often subject to differing national industrial standards, and failure to comply with these rules could result in withdrawal of certifications needed to sell our products and services and otherwise adversely impact our business and financial statements. Non-compliance with applicable requirements (or any alleged or perceived failure to comply) could result in import detentions, fines, damages, civil and administrative penalties, injunctions, suspensions or losses of regulatory approvals, recall or seizure of products, operating restrictions, refusal of the government to approve product export applications or allow us to enter into supply contracts, disbarment from selling to certain governmental agencies or exclusion from government funded healthcare programs, such as Medicare and Medicaid or similar programs in other countries or jurisdictions, integrity oversight and reporting obligations to resolve allegations of non-compliance, disruption of our business, limitation on our ability to manufacture, import, export and sell products and services, loss of customers, significant legal and investigatory fees, disgorgement, individual imprisonment, reputational harm, contractual damages, diminished profits, curtailment or restricting of business operations, criminal prosecution and other monetary and non-monetary penalties. For additional information regarding these risks, please refer to the section entitled “Business—Regulatory Matters.”
Risks Related to Ownership of Our Stock
The price of our common stock may continue to be volatile, which could lead to securities litigation brought against us or cause investors to lose the value of their investment.
We have a limited trading history and there may be wide fluctuations in the market value of our common stock as a result of many factors. From our IPO through February 10, 2023, the sales price of our common stock as reported by the NYSE has ranged from a low sales price of $10.08 on March 19, 2020 to a high sales price of $52.03 on March 29, 2022. Factors that may cause the market price of our common stock to fluctuate, some of which may be beyond our control, include:

◦our quarterly or annual earnings, or those of other companies in our industry;
◦actual or anticipated fluctuations in our operating results;
◦changes in earnings estimated by securities analysts or our ability to meet those estimates;
◦the operating and stock price performance of other comparable companies;
◦changes to the regulatory and legal environment in which we operate;
◦macroeconomic conditions and the economic impact of the COVID-19 pandemic, inflation and rising interest rates and global conflicts, including the Russia-Ukraine war;
◦unusual events such as significant acquisitions by us and our competitors, divestitures, litigation, regulatory actions and other factors, including factors unrelated to our operating performance;
◦overall market fluctuations and domestic and worldwide economic conditions; and
◦other factors described in these “Risk Factors” and elsewhere in this Annual Report.
Stock markets in general have experienced volatility recently that has often been unrelated to the operating performance of a particular company. These broad market fluctuations may adversely affect the trading price of our common stock. In the past, periods of volatility in the overall market and the market price of a company’s securities have often been followed by securities litigation brought against these companies. Such litigation, if instituted against us, could result in substantial costs and a diversion of our management’s attention and resources. In addition, as a result of this volatility, investors may not be able to sell their common stock at or above the purchase price.

Certain provisions in our second amended and restated certificate of incorporation, our second amended and restated bylaws, the Indenture governing the Notes, and of Delaware law, may prevent or delay an acquisition of us, which could decrease the trading price of our common stock.
Our second amended and restated certificate of incorporation and second amended and restated bylaws contain, and Delaware law contains, provisions that are intended to deter coercive takeover practices and inadequate takeover bids and to encourage prospective acquirers to negotiate with our board of directors rather than to attempt an unsolicited takeover not approved by our board of directors. These provisions include, among others:
◦the inability of our stockholders to call a special meeting;
◦the inability of our stockholders to act by written consent;
45

◦rules regarding how stockholders may present proposals or nominate directors for election at stockholder meetings;
◦the right of our board of directors to issue preferred stock without stockholder approval;
◦the division of our board of directors into three classes of directors, with each class serving a staggered three-year term, subject to a phased-in declassification whereby Class III directors were elected to a one-year term at the 2022 annual meeting, Class I directors will be elected to a one-year term at the 2023 annual meeting and Class II directors will be elected to a one-year term at the 2024 annual meeting such that effective as of the 2024 annual meeting, our board of directors will be fully declassified, and until the full declassification of the Board as of the date of the 2024 annual meeting, this classified board provision could have the effect of making the replacement of incumbent directors more time consuming and difficult;

◦prior to our board of directors being fully declassified, stockholders may only remove directors with cause; and
◦the ability of our directors, and not stockholders, to fill vacancies (including those resulting from an enlargement of our board of directors) on our board of directors.
Additionally, certain provisions in the Notes and the Indenture governing the Notes could make a third party attempt to acquire us more difficult or expensive. For example, if a takeover constitutes a fundamental change, then holders of the Notes will have the right to require us to repurchase their Notes for cash. In addition, if a takeover constitutes a make-whole fundamental change, then we may be required to temporarily increase the conversion rate. In either case, and in other cases, our obligations under the Notes and the Indenture could increase the cost of acquiring us or otherwise discourage a third party from acquiring us or removing incumbent management, including in a transaction that holders of our securities may view as favorable.

In addition, because we have not chosen to be exempt from Section 203 of the Delaware General Corporation Law (the “DGCL”), this provision could also delay or prevent a change of control that you may favor. Section 203 provides that, subject to limited exceptions, persons that acquire, or are affiliated with a person that acquires, more than 15% of the outstanding voting stock of a Delaware corporation (an “interested stockholder”) shall not engage in any business combination with that corporation, including by merger, consolidation or acquisitions of additional shares, for a three-year period following the date on which the person became an interested stockholder, unless (i) prior to such time, the board of directors of such corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder; (ii) upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of such corporation at the time the transaction commenced (excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) the voting stock owned by directors who are also officers or held in employee benefit plans in which the employees do not have a confidential right to tender or vote stock held by the plan); or (iii) on or subsequent to such time the business combination is approved by the board of directors of such corporation and authorized at a meeting of stockholders by the affirmative vote of at least two-thirds of the outstanding voting stock of such corporation not owned by the interested stockholder.

We believe these provisions will protect our stockholders from coercive or otherwise unfair takeover tactics by requiring potential acquirers to negotiate with our board of directors and by providing our board of directors with more time to assess any acquisition proposal. These provisions are not intended to make us immune from takeovers. However, these provisions will apply even if the offer may be considered beneficial by some stockholders and could delay or prevent an acquisition that our board of directors determines is in the best interests of us and our stockholders. These provisions may also prevent or discourage attempts to remove and replace incumbent directors.
46

Our second amended and restated certificate of incorporation designates the state courts in the State of Delaware or, if no state court located within the State of Delaware has jurisdiction, the federal court for the District of Delaware, as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could discourage lawsuits against us and our directors, officers, employees and stockholders.
Our second amended and restated certificate of incorporation provides that unless our board of directors otherwise determines, the state courts in the State of Delaware or, if no state court located within the State of Delaware has jurisdiction, the federal court for the District of Delaware, will be the sole and exclusive forum for any derivative action or proceeding brought on behalf of us, any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers, employees or stockholders to us or our stockholders, any action asserting a claim arising pursuant to any provision of the DGCL or our second amended and restated certificate of incorporation or bylaws, or any action asserting a claim governed by the internal affairs doctrine. This provision would not apply to claims brought to enforce a duty or liability created by the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or any other claim for which the federal courts have exclusive jurisdiction.

In addition, our second amended and restated bylaws, as amended, provide that the federal district courts of the U.S. will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, unless we consent in writing to the selection of an alternative forum.

These exclusive forum provisions may limit the ability of our stockholders to bring a claim in a judicial forum that such stockholders find favorable for disputes with us or our directors or officers, which may discourage such lawsuits against us and our directors, officers, employees and stockholders.

Conversion of the Notes may dilute the ownership interest of our stockholders or may otherwise depress the prices of our common stock.

The conversion of some or all of the Notes may dilute the ownership interests of our stockholders. Upon conversion of the Notes, we have the option to pay or deliver, as the case may be, cash, shares of our common stock, or a combination of cash and shares of our common stock to satisfy any Notes conversion value in excess of the principal amount. If we elect to settle the value in excess of the principal amount in shares of our common stock or a combination of cash and shares of our common stock, any sales in the public market of our common stock issuable upon such conversion could adversely affect prevailing market prices of our common stock. In addition, the existence of the Notes may encourage short selling by market participants because the conversion of the Notes could be used to satisfy short positions, or anticipated conversion of the Notes into shares of our common stock could depress the price of our common stock.

The issuance or sale of shares of our common stock, or rights to acquire shares of our common stock, could depress the trading price of our common stock and the Notes.

We may conduct future offerings of our common stock, preferred stock or other securities that are convertible into or exercisable for our common stock to finance our operations or fund acquisitions, or for other purposes. In addition, we have reserved 20,656,197 shares of common stock for the exercise of stock options or vesting of restricted stock units. The Indenture for the Notes does not restrict our ability to issue additional equity securities in the future. If we issue additional shares of our common stock or rights to acquire shares of our common stock, if any of our existing stockholders sells a substantial amount of our common stock, or if the market perceives that such issuances or sales may occur, then the trading price of our common stock, and, accordingly, the Notes may significantly decline. In addition, our issuance of additional shares of common stock will dilute the ownership interests of our existing common stockholders, including holders of Notes who have received shares of our common stock upon conversion of their Notes.

47

General Risks

We may be required to recognize impairment charges for our goodwill and other intangible assets.
As of December 31, 2022, the net carrying value of our goodwill and other intangible assets totaled approximately $4.6 billion. In accordance with generally accepted accounting principles, we periodically assess these assets to determine if they are impaired. Significant negative industry or economic trends, disruptions to our business, inability to effectively integrate acquired businesses, unexpected significant changes or planned changes in use of our assets, changes in the structure of our business, divestitures, market capitalization declines, or increases in associated discount rates may impair our goodwill and other intangible assets. Any charges relating to such impairments would adversely affect our results of operations in the periods recognized.

Foreign currency exchange rates may adversely affect our financial statements.
Sales and purchases in currencies other than the U.S. dollar expose us to fluctuations in foreign currencies relative to the U.S. dollar and, given our global operations, may adversely affect our financial statements. Increased strength of the U.S. dollar increases the effective price of our products sold in U.S. dollars into other countries, which may require us to lower our prices or adversely affect sales to the extent we do not increase local currency prices. Decreased strength of the U.S. dollar could adversely affect the cost of materials, products and services we purchase overseas. Sales and expenses of our non-U.S. businesses are also translated into U.S. dollars for reporting purposes and the strengthening or weakening of the U.S. dollar could result in unfavorable translation effects. In addition, certain of our businesses may invoice customers in a currency other than the business’ functional currency, and movements in the invoiced currency relative to the functional currency could also result in unfavorable translation effects. We also face exchange rate risk from our investments in subsidiaries owned and operated in foreign countries.
Changes in tax law relating to multinational corporations could adversely affect our tax position.
The U.S. Congress, government agencies in non-U.S. jurisdictions where we and our affiliates do business, and the Organisation for Economic Co-operation and Development (“OECD”) have recently focused on issues related to the taxation of multinational corporations. One example is in the area of “base erosion and profit shifting,” where profits are claimed to be earned for tax purposes in low-tax jurisdictions, or payments are made between affiliates from a jurisdiction with high tax rates to a jurisdiction with lower tax rates. The OECD has released several components of its comprehensive plan to create an agreed set of international rules for addressing base erosion and profit shifting. As a result, the tax laws in the U.S. and other countries in which we do business could change on a prospective or retroactive basis, and any such changes could adversely affect our business and financial statements.
We are subject to a variety of litigation and other legal and regulatory proceedings in the course of our business that could adversely affect our business and financial statements.
We are or could be subject to a variety of litigation and other legal and regulatory proceedings incidental to our business (or the business operations of previously-owned or subsequently-purchased entities), including claims or counterclaims for damages arising out of the use of products or services and claims relating to intellectual property matters, employment matters, tax matters, commercial disputes, breach of contract claims, competition and sales and trading practices, environmental matters, personal injury, insurance coverage, acquisition-related matters and general statutory claims or other claims pursuant to law, as well as regulatory or judicial subpoenas, requests for information, investigations and enforcement. We may also become involved in lawsuits as a result of past or future acquisitions or as a result of liabilities retained from, or representations, warranties or indemnities provided in connection with, businesses acquired or divested by us or our predecessors. The types of claims made in lawsuits may include claims for compensatory damages, incidental damages, consequential damages, and punitive damages (and in some types of cases, treble damages) and/or injunctive relief. The pursuit or defense of these lawsuits may divert our management’s attention, we may incur significant expenses in pursuing or defending these lawsuits, and we may be required to pay damage awards or settlements or become subject to equitable remedies that could adversely affect our operations and financial statements. Moreover, any insurance or indemnification rights that we may have may be insufficient or unavailable to protect us against such losses. In addition, developments in proceedings in any given period may require us to adjust the loss contingency estimates that we have recorded in our financial statements, record estimates for liabilities or assets previously not susceptible of reasonable estimates or pay cash settlements or judgments. Any of these developments could adversely affect our financial statements in any particular period. We cannot assure you that our liabilities in connection with litigation and other legal and regulatory proceedings will not exceed our estimates or adversely affect our financial statements and business.
48

Work stoppages, union and works council campaigns and other labor disputes could adversely impact our productivity and results of operations.
Certain of our U.S. and non-U.S. employees are subject to collective labor arrangements. We are subject to potential work stoppages, union and works council campaigns and other labor disputes, any of which could adversely impact our financial statements and business, including our productivity and reputation.
Our reputation, ability to do business and financial statements may be impaired by improper conduct by any of our employees, agents or business partners.
We cannot provide assurance that our internal controls and compliance systems will always protect us from acts committed by our employees, agents or business partners (or of businesses we acquire or partner with) that would violate U.S. and/or non-U.S. laws, including the laws governing payments to government officials, bribery, fraud, kickbacks and false claims, pricing, sales and marketing practices, conflicts of interest, competition, employment practices and workplace behavior, export and import compliance, economic and trade sanctions, money laundering and data privacy. In particular, the U.S. Foreign Corrupt Practices Act, the UK Bribery Act and similar anti-bribery laws in other jurisdictions generally prohibit companies and their intermediaries from making improper payments to government officials for the purpose of obtaining or retaining business, and we operate in many parts of the world that have experienced governmental corruption to some degree. Any such improper actions or allegations of such acts could damage our reputation and subject us to civil or criminal investigations in the U.S. and in other jurisdictions and related stockholder lawsuits, could lead to substantial civil and criminal, monetary and non-monetary penalties and could cause us to incur significant legal and investigatory fees. In addition, the government may seek to hold us liable for violations committed by companies in which we invest or that we acquire. We also rely on our suppliers to adhere to our supplier standards of conduct, and material violations of such standards of conduct could occur that could have a material effect on our business, reputation and financial statements.


49

ITEM 1B. UNRESOLVED STAFF COMMENTS
Not applicable.

ITEM 2. PROPERTIES
Our corporate headquarters are located in Brea, California in a facility that we lease. As of December 31, 2022, our facilities included approximately 34 significant office, research and development, manufacturing and distribution facilities. Thirteen of these facilities are located in the U.S. in six states and 21 are located outside the U.S. in 13 other countries, primarily in Europe and to a lesser extent in Asia, the rest of North America, Latin America and the Middle East. These facilities cover approximately 2.6 million square feet, of which approximately 0.6 million square feet are owned and approximately 2.0 million square feet are leased. Particularly outside the U.S., facilities often serve more than one business segment and may be used for multiple purposes, such as administration, sales, manufacturing, warehousing and/or distribution.

We consider our facilities suitable and adequate for the purposes for which they are used and do not anticipate difficulty in renewing existing leases as they expire or in finding alternative facilities. We believe our properties and equipment have been well-maintained. Please refer to Note 8 to our audited consolidated financial statements for additional information with respect to our lease commitments.

ITEM 3. LEGAL PROCEEDINGS
We are, from time to time, subject to a variety of litigation and other legal and regulatory proceedings and claims incidental to our business. Based upon our experience, current information and applicable law, we do not believe that these proceedings and claims will have a material effect on our financial position, results of operations or cash flows. However, in the event of unexpected further developments, it is possible that the ultimate resolution of these matters, or other similar matters, if unfavorable, may be materially adverse to our financial position, results of operations or cash flows. For additional information, please see Note 15 to our audited consolidated financial statements.

ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
50

PART II
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Information with Respect to our Common Stock
Our common stock is listed on the New York Stock Exchange, or NYSE, and trades under the symbol “NVST.”
The number of holders of record of our common stock as of February 10, 2023 was 21. This number of holders of record does not represent the actual number of beneficial owners of our common stock because shares are frequently held in “street name” by securities dealers and others for the benefit of individual owners who have the right to vote their shares.
Performance Graph
The following performance graph and related information shall not be deemed “soliciting material” or “filed” with the Securities and Exchange Commission, nor shall such information be incorporated by reference into any future filings under the Securities Act of 1933 or the Exchange Act, each as amended, except to the extent that we specifically incorporate it by reference into such filing.
The following graph shows a comparison of cumulative total stockholder return, calculated on a dividend-reinvested basis, for the Company, the S&P 500 Index and the S&P Health Care Index from September 18, 2019, the first day our stock traded on the NYSE, through December 31, 2022. The graph assumes $100 was invested in each of our common stock, the S&P 500 Index, and the S&P Health Care Index as of the market close on September 18, 2019. The S&P 500 Stock Index and the S&P Health Care Index are included for comparative purposes only. They do not necessarily reflect management’s opinion that such indices are an appropriate measure of the relative performance of the stock involved, and they are not intended to forecast or be indicative of possible future performance of our common stock. Note that historic stock price performance is not necessarily indicative of future stock price performance.
nvst-20221231_g6.gif

Performance Graph Table
September 18, 2019December 31, 2019December 31, 2020December 31, 2021December 31, 2022
Envista Holdings Corporation$100 $106 $121 $161 $120 
S&P 500 Index$100 $108 $128 $165 $135 
S&P 500 Health Care Index$100 $113 $126 $156 $150 
51

Dividend Policy
We have no present intention to pay cash dividends on our common stock. Any determination to pay dividends to holders of our common stock will be at the discretion of our board of directors and will depend upon many factors, including our financial condition, results of operations, projections, liquidity, earnings, legal requirements, restrictions in the agreements governing our existing indebtedness and any other indebtedness we may enter into and other factors that our board of directors deems relevant.
Recent Sales of Unregistered Securities
On January 21, 2022, we completed the issuance of 273,522 restricted stock units (“RSUs”) to Pacific Dental Services, LLC (“PDS”) pursuant to a development agreement by and between the Company and PDS dated as of December 23, 2021 (the “Development Agreement”) and a share issuance agreement entered into by the parties on the same date. The RSUs will vest upon achievement of certain milestones pursuant to the Development Agreement and will convert on a 1-for-1 basis into shares of our common stock upon vesting. The issuance of these securities was effected without registration in reliance on Section 4(a)(2) of the Securities Act as a sale by the Company not involving a public offering. No underwriters were involved with the issuance of such securities.
ITEM 6. [Reserved]

52

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
INTRODUCTION
Management’s Discussion and Analysis of Financial Condition and Results of Operations of our business is designed to provide a reader of our financial statements with a narrative from the perspective of management. You should read the following discussion in conjunction with the sections entitled “Envista Holdings Corporation Audited Consolidated Financial Statements” included in this Annual Report on Form 10-K. This section of the Form 10-K generally discusses 2022 and 2021 items and year-to-year comparisons between 2022 and 2021. Discussion of 2020 items and year-to-year comparisons between 2021 and 2020 are not included in this Form 10-K, and can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.
Management’s Discussion and Analysis of Financial Condition and Results of Operations is divided into six sections:
◦Overview
◦Results of Operations
◦Liquidity and Capital Resources
◦Qualitative and Quantitative Disclosures About Market Risk
◦Critical Accounting Estimates
◦New Accounting Standards

OVERVIEW
General
We provide products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. We help our customers deliver the best possible patient care through industry-leading solutions, technologies, and services. With leading brand names, innovative technology and significant market positions, we are a leading worldwide provider of a broad range of solutions to support implant-based tooth replacements, orthodontic treatments, digital imaging and diagnostics, as well as general dental consumables, equipment and services, and are dedicated to driving technological innovations that help dental professionals improve clinical outcomes and enhance productivity. Our research and development, manufacturing, sales, distribution, service and administrative facilities are located in more than 30 countries across North America, Asia, Europe, the Middle East and Latin America.

During 2022, 51% of our sales were derived from customers outside the United States. As a global provider of dental consumables, equipment and services, our operations are affected by worldwide, regional and industry-specific economic and political factors. Given the broad range of dental products, software and services provided and geographies served, we do not use any indices other than general economic trends to predict our overall outlook. Our individual businesses monitor key competitors and customers, including to the extent possible their sales, to gauge relative performance and the outlook for the future.
As a result of our geographic and product line diversity, we face a variety of opportunities and challenges, including rapid technological development in most of our served markets, the expansion and evolution of opportunities in emerging markets, trends and costs associated with a global labor force, consolidation of our competitors and increasing regulation. We operate in a highly competitive business environment in most markets, and our long-term growth and profitability will depend in particular on our ability to expand our business in emerging geographies and emerging market segments, identify, consummate and integrate appropriate acquisitions, develop innovative and differentiated new products and services, expand and improve the effectiveness of our sales force, continue to reduce costs and improve operating efficiency and quality and effectively address the demands of an increasingly regulated global environment. We are making significant investments to address the rapid pace of technological change in our served markets and to globalize our manufacturing, research and development and customer-facing resources (particularly in emerging markets and our dental implant business) in order to be responsive to our customers throughout the world and improve the efficiency of our operations.
53

Key Trends and Conditions Affecting Our Results of Operations
COVID-19
The extent of the impact of the COVID-19 pandemic on our business remains uncertain and difficult to predict because of the dynamic and evolving nature of the situation. The global impact of the outbreak continues to adversely affect many industries, and different geographies continue to reflect the effects of public health restrictions in various ways. The economic recovery following the impact of the COVID-19 pandemic is only partially underway and has been gradual, uneven and characterized by meaningful dispersion across sectors and regions with uncertainty regarding its ultimate length and trajectory. During the year ended December 31, 2022, notwithstanding improvement in many markets in which we operate due to a return to more normalized business operations, certain markets continued to be adversely impacted by COVID-19. In particular, sales decreased in China due to lockdowns early in the year and a subsequent relaxing of restrictions, which resulted in increased infection rates.

Russia-Ukraine Conflict
Russia’s invasion of Ukraine and the global response to this invasion, including sanctions imposed by the U.S. and other countries, could have an adverse impact on our business, including our ability to market and sell products in the affected regions, potentially heightening our risk of cyber security attacks, impacting our ability to enforce our intellectual property rights in Russia, creating disruptions in the global supply chain, and potentially having an adverse impact on the global economy, financial markets, energy markets, currency rates and otherwise. Russia’s invasion of Ukraine did not have a material impact on our financial position or results of operations as of and for the year ended December 31, 2022.

Industry Trends
We operate in the large and growing global dental products industry. We believe growth in the global dental industry will be driven by:
◦an aging population;
◦the current under penetration of dental procedures, especially in emerging markets;
◦improving access to complex procedures due to increasing technological innovation;
◦an increasing demand for cosmetic dentistry; and
◦growth of DSOs, which are expected to drive increasing penetration of, and access to, dental care globally.

Product Development, New Product Launches and Commercial Investment
A key element of our targeted value creation strategy is to drive growth through portfolio development and product innovation. Our future growth and success depend on both our pipeline of new products and technologies, including new products and technologies that we may obtain through license or acquisition, and the expansion of the use of our existing products and technologies. We believe we are a leader in dental research and development (“R&D”), with approximately $287.3 million of R&D expenditures since 2020 and a track record of product innovation, business development and commercialization.
We continue transforming our portfolio by investing in our Implant-Based Tooth Replacement and Orthodontic Solutions businesses and also making investments in emerging markets, critical to our growth strategy. The cost reduction initiatives we have taken and will continue to undertake in the future allow us to further invest in this growth strategy, which in turn we believe should improve our margins.
Our continued investment in Spark, our clear aligner system, has led to increased manufacturing capacity and continues to gain market adoption as orthodontists and their patients see the benefits of the clear, stain resistant and comfortable design. We believe that Spark will provide growth opportunities for our Orthodontic Solutions business over the next several years.
54

Foreign Exchange Rates
Significant portions of our sales and costs are exposed to changes in foreign exchange rates. During the year ended December 31, 2022, our products were sold in more than 140 countries and 51% of our sales were to customers outside of the United States. We seek to manage our foreign exchange risk, in part, through our operations, including managing same-currency sales in relation to same-currency costs and same-currency assets in relation to same-currency liabilities. As our operations use multiple foreign currencies, including the euro, British pound, Brazilian real, Australian dollar, Japanese yen, Canadian dollar and Chinese yuan, changes in those currencies relative to the U.S. dollar will impact our sales, cost of sales and expenses, and consequently, net income. Exchange rate fluctuations in emerging markets may also directly affect our customers’ ability to buy our products in these geographic markets.

On a year-over-year basis, currency exchange rates negatively impacted reported sales by 3.5% for the year ended December 31, 2022 compared to the comparable period of 2021, primarily due to the strengthening of the U.S. dollar against most major currencies. Any future strengthening of the U.S. dollar against major currencies would adversely impact our sales and results of operations and any weakening of the U.S. dollar against major currencies would positively impact our sales and results of operations.
General Economic Conditions
In addition to industry-specific factors, we, like other businesses, face challenges related to global economic conditions, including rising inflation, increasing interest rates, fluctuating foreign currency exchange rates, slowing economic growth, and continuing supply chain disruptions. Dental costs are largely out-of-pocket for the consumer and thus utilization rates can vary significantly depending on economic growth. While many of our products are considered necessary by patients regardless of the economic environment, certain products and services that support discretionary dental procedures may be more susceptible to changes in economic conditions.
Other countries, as well as some private payors, also control the price of health care products, directly or indirectly, through reimbursement, payment, pricing or coverage limitations, tying reimbursement to outcomes or (in the case of governmental entities) compulsory licensing. For example, China has implemented volume-based procurement policies, a series of centralized reforms instituted in China on both a national and regional basis that has resulted in significant price cuts for medical and dental consumables.

Manufacturing and Supply
To date, COVID-19 has had, and may continue to have, an adverse impact on our supply chains and distribution systems. The increase in consumer demand resulting from the lifting of lockdowns has created significant challenges for supply chains as a result of labor and raw material shortages.
In order to sell our products, we must be able to reliably produce and ship our products in sufficient quantities. Many of our products involve complex manufacturing processes and are produced at one or a limited number of manufacturing sites.
Minor deviations in our manufacturing or logistical processes, unpredictability of a product’s regulatory or commercial success or failure, the lead time necessary to construct highly technical and complex manufacturing sites and shifting customer demand increase the potential for capacity imbalances. For a discussion of risks relating to our manufacturing process, refer to “Item 1A. Risk Factors—Risks Related to Our Business.”
Components of Sales and Costs and Expenses
Sales
Our sales are primarily derived from the sale of dental consumables, equipment and services to third-party distributors and end-users. For additional information regarding our products, including descriptions of our products, refer to “Item 1. Business—Business Segments.”
55

Costs and Expenses and Other
Cost of sales consists primarily of cost of materials, facilities and other infrastructure used to manufacture our products and shipping and handling costs attributable to delivering our products to our customers. Also included in cost of sales are productivity improvement and restructuring expenses related to our manufacturing operations.

Selling, general and administrative (“SG&A”) expenses consist of, among other things, the costs of selling, marketing, promotion, advertising and administration (including business technology, facilities, legal, finance, human resources, business development and procurement) and amortization expense for intangible assets that have been acquired through business combinations. Also included in SG&A are productivity improvement and restructuring expenses related to our administrative operations.

R&D expenses consist of project costs specific to new product R&D and product lifecycle management, overhead costs associated with R&D operations, regulatory costs, product registrations and investments that support local market clinical trials for approved indications. We manage overall R&D based on our strategic opportunities and do not disaggregate our R&D expenses by the nature of the expense or by product as we do not use or maintain such information in managing our business.
Nonoperating income (expense) consists of the non-service cost components of net periodic benefit costs (which include interest costs, expected return on plan assets, amortization of prior service cost or credits and actuarial gains and losses) and interest expense, net.
Business Performance
During the year ended December 31, 2022, our sales increased 2.4%, while core sales increased 4.1% as compared to the comparable period of 2021. The impact of foreign currency exchange rates reduced sales in the year ended December 31, 2022, by 3.5% compared to the comparable period of 2021.
Acquisitions and Divestitures
Our growth strategy contemplates future acquisitions and we continually evaluate potential acquisitions that either strategically fit with our existing portfolio or expand our portfolio into new and attractive business areas. Our operations and results can be affected by the rate and extent to which appropriate acquisition opportunities are available, acquired businesses are effectively integrated and anticipated synergies or cost savings are achieved. During the year ended December 31, 2022, we completed two acquisitions.

On April 20, 2022, we completed our acquisition of Carestream Dental’s Intraoral Scanner Business for total consideration of approximately $580.3 million, including contingent consideration of $7.5 million, and subject to certain customary adjustments as provided in the Purchase Agreement. The Intraoral Scanner Business manufactures, markets, sells, commercializes, distributes, services, trains, supports, and maintains operations of intraoral scanners and software, and is part of our Equipment & Consumables segment. We purchased the Intraoral Scanner Business through the acquisition of certain assets and the assumption of certain liabilities as well as the acquisition of all of the equity of certain subsidiaries of Carestream Dental.

On July 5, 2022, we acquired all of the equity of Osteogenics for total consideration of approximately $128.2 million, subject to certain customary adjustments as provided in the Equity Purchase Agreement dated May 17, 2022. Osteogenics develops innovative regenerative solutions for periodontists, oral and maxillofacial surgeons, and clinicians involved in implant dentistry throughout the world, and is part of our Specialty Products & Technologies segment.

56

On December 31, 2021, we sold substantially all of the KaVo Treatment Unit and Instrument Business (the “Divestiture”) to planmeca Verwaltungs Gmbh, Germany (“Planmeca”), pursuant to the master sale and purchase agreement (the “Purchase Agreement”) among the Company, Planmeca, and Planmeca Oy, as guarantor. Additionally, on December 30, 2021, we entered into an amendment to the Purchase Agreement (the "Amendment"), providing that the transfer of net assets in Russia, China and Brazil (the "Relevant Jurisdictions") be deferred until the purchaser had formed entities for such transfer of assets in each such Relevant Jurisdiction and the applicable asset transfer agreement could be executed and consummated (each such asset transfer, a "Deferred Local Closing"). Except for the implementation of the Deferred Local Closings and related matters regarding the assets in the Relevant Jurisdictions, the provisions, terms and conditions of the Purchase Agreement were not materially amended by the Amendment. The Amendment did not alter the preliminary purchase price that Planmeca paid to the Company upon the closing of the Divestiture. At December 31, 2021, we recorded a liability of $10.8 million for the proceeds related to the Relevant Jurisdictions. As of December 31, 2022, all three Relevant Jurisdictions have closed and the related liability associated with the proceeds released. In accordance with the terms of the Purchase Agreement, we received total net cash consideration of $386.4 million.

The Divestiture was part of our strategy to structurally improve our long-term margins and represented a strategic shift with a major effect on our operations and financial results as described in Accounting Standards Codification (“ASC“) 205-20. The sale met the criteria to be accounted for as a discontinued operation. Accordingly, we have applied discontinued operations treatment for the Divestiture as required by ASC 205-20. In accordance with ASC 205-20, we reclassified the Divestiture to assets and liabilities held for sale on our Consolidated Balance Sheets and reclassified the financial results of the Divestiture in our Consolidated Statements of Operations for all periods presented. Our Consolidated Statements of Cash Flows include the financial results of the KaVo Treatment Unit and Instrument Business for all periods presented. We also revised our discussion and presentation of operating and financial results to be reflective of our continuing operations as required by ASC 205-20. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.

With the sale of the KaVo Treatment Unit and Instrument business and our two recent acquisitions, we continue to make significant progress toward our long-term goal of re-calibrating our product portfolio to higher growth and higher margin segments. The Divestiture and the acquisitions shifted our revenue mix from approximately 50% each for the Specialty Products & Technology and Equipment & Consumables segments to 62% for the Specialty Products & Technology segment and 38% for the Equipment & Consumables segment. The Specialty Products & Technology segment is a higher growth and higher margin business than the Equipment & Consumables segment. These transactions have allowed us to focus more on higher value and higher margin consumables, imaging, and digital workflow solutions.
Non-GAAP Measures
In order to establish period-to-period comparability, we include the non-GAAP measure of core sales in this report. References to the non-GAAP measure of core sales (also referred to as core revenues or sales/revenues from existing businesses) refer to sales calculated according to GAAP, but excluding:
•sales from acquired businesses;
•sales from discontinued products; and
•the impact of currency translation.
We exclude sales from acquired businesses in order to provide accurate year over year comparisons. Sales from discontinued products includes major brands or major products that we have made the decision to discontinue as part of a portfolio restructuring. Discontinued brands or products consist of those which we (1) are no longer manufacturing, (2) are no longer investing in the research or development of, and (3) expect to discontinue all significant sales of within one year from the decision date to discontinue. The portion of sales attributable to discontinued brands or products is calculated as the net decline of the applicable discontinued brand or product from period-to-period. We exclude sales from discontinued products because discontinued products do not have a continuing contribution to operations and management believes that excluding such items provides investors with a means of evaluating our on-going operations and facilitates comparisons to our peers.
57

The portion of sales attributable to currency translation is calculated as the difference between:
•the period-to-period change in sales; and
•the period-to-period change in sales after applying current period foreign exchange rates to the prior year period.
Core sales growth should be considered in addition to, and not as a replacement for or superior to, sales, and may not be comparable to similarly titled measures reported by other companies. We believe that reporting the non-GAAP financial measure of core sales growth provides useful information to investors by helping identify underlying growth trends in our on-going business and facilitating comparisons of our sales performance with our performance in prior and future periods and to our peers. We also use core sales growth to measure our operating and financial performance. We exclude the effect of currency translation from core sales because currency translation is not under our control, is subject to volatility and can obscure underlying business trends.
Throughout this discussion, references to sales volume refer to the impact of both price and unit sales and references to productivity improvements generally refer to improved cost-efficiencies resulting from the ongoing application of EBS. We believe our deep-rooted commitment to EBS helps drive our market leadership and differentiates us in the dental products industry. EBS encompasses not only lean tools and processes, but also methods for driving growth, innovation and leadership. Within the EBS framework, we pursue a number of ongoing strategic initiatives relating to streamlining business operations, portfolio simplification, reduction of costs, redeployment of resources, customer insight generation, product development and commercialization, efficient sourcing, and improvement in manufacturing and back-office support, all with a focus on continually improving quality, delivery, cost, growth and innovation.

RESULTS OF OPERATIONS
The following discussion and analysis of our consolidated statements of earnings should be read along with our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K. Unless otherwise indicated, all financial data in this Annual Report on Form 10K refer to continuing operations only. For more information on the consolidated basis of preparation, see Note 1 to our audited consolidated financial statements elsewhere in this Annual Report on Form 10-K.

Years Ended December 31,% Change% Change
($ in millions)2022202120202022/20212021/2020
Sales$2,569.1 100.0%$2,508.9 100.0%$1,929.1 100.0%2.4 %30.1 %
Cost of sales1,094.3 42.6%1,082.4 43.1%874.3 45.3%1.1 %23.8 %
Gross profit1,474.8 57.4%1,426.5 56.9%1,054.8 54.7%3.4 %35.2 %
Operating costs:
SG&A expenses1,055.5 41.1%1,019.8 40.6%924.6 47.9%3.5 %10.3 %
R&D expenses100.1 3.9%100.5 4.0%86.7 4.5%(0.4)%15.9 %
Operating profit319.2 12.4%306.2 12.2%43.5 2.3%4.2 %603.9 %
Nonoperating income (expense):
Other income (expense)3.1 0.1%2.4 0.1%(1.0)(0.1)%29.2 %NM
Interest expense, net(38.4)(1.5)%(54.1)(2.2)%(62.5)(3.2)%(29.0)%(13.4)%
Income (loss) before income taxes283.9 11.1%254.5 10.1%(20.0)(1.0)%11.6 %NM
Income tax (benefit) expense45.9 1.8%(9.0)(0.4)%(62.5)(3.2)%NM(85.6)%
Income from continuing operations238.0 9.3%263.5 10.5%42.5 2.2%(9.7)%520.0 %
Income (loss) from discontinued operations, net of tax5.1 0.2%77.0 3.1%(9.2)(0.5)%(93.4)%NM
Net income$243.1 9.5%$340.5 13.6%$33.3 1.7%(28.6)%922.5 %
Effective tax rate16.2 %(3.5)%312.5 %
58

Non-meaningful percentage change related to year-to-year comparisons are designated as NM.
Business Segments
Sales by business segment were as follows ($ in millions):
For the Years Ended December 31,
202220212020
Specialty Products & Technologies$1,598.6 $1,507.8 $1,117.3 
Equipment & Consumables970.5 1,001.1 811.8 
Total$2,569.1 $2,508.9 $1,929.1 

GAAP Reconciliation
Sales and Core Sales Growth
2022 vs. 20212021 vs. 2020
Total sales growth (GAAP)2.4 %30.1 %
Less the impact of:
Acquisitions(1.8)%— %
Discontinued products— %0.4 %
Currency exchange rates 3.5 %(1.5)%
Core sales growth (non-GAAP)4.1 %29.0 %
Sales and core sales growth for the year ended December 31, 2022 increased 2.4% and 4.1%, respectively, compared to the comparable period in 2021. An increase in sales volume positively impacted sales growth by 2.5% on a period-over-period basis, combined with a price increase of 1.6%. Sales in developed markets increased primarily due to strong growth in Western Europe combined with a modest increase in North America. Sales in emerging markets increased primarily due to continued recovery from the COVID-19 pandemic, partially offset by a decrease in China sales due to localized responses to the pandemic, including lockdowns early in the year and subsequent relaxing of restrictions which resulted in an increase to infection rates.
COST OF SALES AND GROSS PROFIT MARGIN
For the Years Ended December 31,
($ in millions)202220212020
Cost of sales$1,094.3 $1,082.4 $874.3 
Gross profit margin57.4 %56.9 %54.7 %
The increase in cost of sales during the year ended December 31, 2022, as compared to the comparable period in 2021, was primarily due to higher sales and the unfavorable impact of higher costs due to inflation, partially offset by lower restructuring spend.
The increase in gross profit margin during the year ended December 31, 2022, as compared to the comparable period in 2021, was primarily due to an increase in sales volume and price, combined with lower restructuring spend, partially offset by the unfavorable impact from foreign exchange rates and higher costs due to inflation.
59

OPERATING EXPENSES
For the Years Ended December 31,
($ in millions)202220212020
Selling, general and administrative expenses$1,055.5 $1,019.8 $924.6 
Research and development expenses$100.1 $100.5 $86.7 
SG&A as a % of sales41.1 %40.6 %47.9 %
R&D as a % of sales3.9 %4.0 %4.5 %
The increase in SG&A expenses as a percentage of sales for the year ended December 31, 2022 as compared to the comparable period of 2021, was primarily due to higher sales and marketing expenses, increased amortization of intangible assets and acquisition related costs, partially offset by higher sales volume.
R&D expenses as a percentage of sales for the year ended December 31, 2022, was consistent with the comparable period in 2021.
OTHER INCOME (EXPENSE), NET
Included in other income (expense) for the years ended December 31, 2022 and 2021 were $3.1 million and $2.6 million, respectively of other income (expense) components of net periodic benefit costs.

INTEREST COSTS AND FINANCING
Interest costs were $38.4 million and $54.1 million for the years ended December 31, 2022 and 2021, respectively. The decrease in interest expense for the year ended December 31, 2022 as compared to the comparable period of 2021 was primarily due to the absence of accretive interest expense related to the convertible debt discount as a result of adopting ASU 2020-06 and overall lower debt outstanding, partially offset by higher interest rates.
For a discussion of our outstanding indebtedness, refer to Note 16 to our audited consolidated financial statements elsewhere in this Annual Report on Form 10-K.

INCOME TAXES
For the Years Ended December 31,
202220212020
Effective tax rate16.2 %(3.5)%312.5 %

Our effective tax rate for the year ended December 31, 2022 was 16.2% compared to (3.5)% in 2021. The change in the effective rate was primarily due to the Company’s geographical mix of earnings and certain Swiss discrete tax benefits in 2021 not recurring in 2022.

SPECIALTY PRODUCTS & TECHNOLOGIES
Our Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, including regenerative products, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products.
60

Specialty Products & Technologies Selected Financial Data
For the Years Ended December 31,
($ in millions)202220212020
Sales$1,598.6 $1,507.8 $1,117.3 
Operating profit268.6 272.3 65.8 
Depreciation 20.5 24.0 20.6 
Amortization60.2 60.0 60.0 
Operating profit as a % of sales16.8 %18.1 %5.9 %
Depreciation as a % of sales1.3 %1.6 %1.8 %
Amortization as a % of sales3.8 %4.0 %5.4 %
GAAP Reconciliation
Sales and Core Sales Growth
2022 vs. 20212021 vs. 2020
Total sales growth (GAAP)6.0 %34.9 %
Less the impact of:
Acquisitions(1.1)%— %
Discontinued products— %(0.1)%
Currency exchange rates4.2 %(1.8)%
Core sales growth (non-GAAP)9.1 %33.0 %
Sales
Sales and core sales growth for the year ended December 31, 2022 increased 6.0% and 9.1%%, respectively, compared to the comparable period in 2021. Sales growth increased by 8.4% due to higher volume as demand improved for implant systems and orthodontic products, combined with an increase in sales price which impacted sales growth by 0.7% on a period-over-period basis.
Sales in developed markets, for the year ended December 31, 2022, increased primarily due to an increase in North America, Western Europe, Eastern Europe and as well as sales in emerging markets, primarily due to reduced impact of COVID-19 measures. Additionally, sales for the year ended December 31, 2022 were also positively impacted by the acquisition of Osteogenics.
Operating Profit

Operating profit margin was 16.8% for the year ended December 31, 2022, as compared to an operating profit margin of 18.1% for the comparable period of 2021. The decrease in operating profit margin for the year ended December 31, 2022, was primarily due to unfavorable product mix as well as investments in our long-term growth initiatives, including higher sales and marketing expenses and the impact of inflation. The costs were partially offset by higher sales volume and price.
EQUIPMENT & CONSUMABLES
Our Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
61

Equipment & Consumables Selected Financial Data
For the Year Ended December 31,
($ in millions)202220212020
Sales$970.5 $1,001.1 $811.8 
Operating profit172.4 153.8 53.6 
Depreciation 8.8 9.9 11.4 
Amortization45.8 21.5 27.3 
Operating profit as a % of sales17.8 %15.4 %6.6 %
Depreciation as a % of sales0.9 %1.0 %1.4 %
Amortization as a % of sales4.7 %2.1 %3.4 %
GAAP Reconciliation
Sales and Core Sales Growth
2022 vs. 20212021 vs. 2020
Total sales growth (GAAP)(3.1)%23.3 %
Less the impact of:
Acquisitions(2.8)%1.0 %
Currency exchange rates2.5 %(0.9)%
Core sales growth (non-GAAP)(3.4)%23.4 %
Sales
Sales and core sales growth for the year ended December 31, 2022 decreased 3.1% and 3.4%, respectively, compared to the comparable period in 2021. Price positively impacted sales growth by 2.9% on a period-over-period basis, while sales decreased by 6.3% due to lower demand for our imaging products and infection prevention products, offset by increased demand in our restorative and endodontic solutions.
Sales in developed markets, for the year ended December 31, 2022, decreased primarily due to a decrease in North America and Western Europe combined with the decrease in sales in China and other emerging markets. Sales for the year ended December 31, 2022 were positively impacted by the acquisition of the Intraoral Scanner Business.

Operating Profit
Operating profit margin was 17.8% for the year ended December 31, 2022, as compared to an operating profit margin of 15.4% for the comparable period of 2021. The increase in operating profit margin was primarily due to higher sales price, favorable product mix, and lower restructuring costs, partially offset by lower sales volume, increased amortization of intangibles, and an unfavorable incremental material price costs due in part to inflation.
LIQUIDITY AND CAPITAL RESOURCES
We assess our liquidity in terms of our ability to generate cash to fund our operating and investing activities. We continue to generate substantial cash from operating activities and believe that our operating cash flow and other sources of liquidity are sufficient to allow us to manage our capital structure on a short-term and long-term basis and continue investing in existing businesses and consummating strategic acquisitions.

62

Following is an overview of our cash flows and liquidity, which includes the cash flows of the KaVo Treatment Unit and Instrument Business for all periods presented:

Overview of Cash Flows and Liquidity
Year Ended December 31,
($ in millions)202220212020
Net cash provided by operating activities$182.7 $361.6 $283.9 
Acquisitions, net of cash acquired$(696.2)$(2.1)$(40.7)
Payments for additions to property, plant and equipment(75.7)(54.7)(47.7)
Proceeds from sales of property, plant and equipment3.3 11.6 5.3 
Proceeds from sale of KaVo Treatment Unit and Instrument Business73.9 312.5 — 
Proceeds from the settlement of derivative financial instruments56.0 11.4 14.0 
All other investing activities(18.6)(16.0)— 
Net cash (used in) provided by investing activities$(657.3)$262.7 $(69.1)
Proceeds from revolving line of credit$124.0 $— $249.8 
Repayment of revolving line of credit(124.0)— (250.0)
Proceeds from borrowing0.3— — 
Repayments of borrowing(0.5)(475.7)— 
Proceeds from issuance of convertible senior notes— — 517.5 
Payment of debt issuance and other deferred financing costs— (2.3)(17.2)
Purchase of capped calls related to issuance of convertible senior notes— — (20.7)
Proceeds from stock option exercises21.8 19.5 13.8 
Tax withholding payment related to net settlement of equity awards(9.1)(7.2)(5.0)
All other financing activities— 0.1 4.3 
Net cash provided by (used in) financing activities$12.5 $(465.6)$492.5 

Operating Activities
Cash flows from operating activities can fluctuate significantly from period-to-period due to working capital needs and the timing of payments for income taxes, restructuring activities, pension funding and other items impacting cash flows.

Net cash provided by operating activities was $182.7 million during the year ended December 31, 2022 and $361.6 million in 2021. The decrease was primarily due to lower net income, higher incentive compensation payout, transaction costs associated with acquisitions and timing of tax payments.

Investing Activities
Cash flows relating to investing activities consist primarily of cash used for capital expenditures and acquisitions. Capital expenditures are made primarily for increasing capacity, replacing equipment, supporting new product development and improving information technology systems.
Net cash used in investing activities was $657.3 million during the year ended December 31, 2022, as compared to $262.7 million provided by investing activities for the comparable period in 2021. This increase in cash used in investing activities during 2022 was primarily due to the acquisitions of Osteogenics and the Intraoral Scanner Business, and higher purchase of property, plant and equipment, partially offset by proceeds from the sale of the Kavo Treatment Unit and Instruments Business and the settlement of derivative financial instruments.

63

Financing Activities and Indebtedness
Net cash provided by financing activities was $12.5 million during the year ended December 31, 2022, compared to $465.6 million used in financing activities for the comparable period of 2021. The increase in cash provided by financing activities during 2022 was due to our repayment of $472.0 million of the Euro Term Loan Facility in February 2021 in connection with an amendment to the Credit Agreement.

For a description of our outstanding debt as of December 31, 2022 and the senior credit facilities, refer to Note 16 to our audited consolidated financial statements in this Annual Report on Form 10-K.
We intend to satisfy any short-term liquidity needs that are not met through operating cash flow and available cash primarily through our revolving credit facility.
As of December 31, 2022, we had no borrowings outstanding under the revolving credit facility and we had the ability to incur an additional $750 million of indebtedness in direct borrowings under the revolving credit facility. As of December 31, 2022, we were in compliance with all of our debt covenants.

Cash and Cash Requirements
As of December 31, 2022, $606.9 million of cash and cash equivalents were held on deposit with financial institutions. Of this amount, $92.7 million was held within the United States and $514.2 million was held outside of the United States. We will continue to have cash requirements to support working capital needs, capital expenditures and acquisitions, pay interest and service debt, pay taxes and any related interest or penalties and fund our restructuring activities as required and support other business needs. We generally intend to use available cash and internally generated funds to meet these cash requirements, but in the event that additional liquidity is required, particularly in connection with acquisitions, we may need to enter into new credit facilities or access the capital markets. We may also access the capital markets from time to time to take advantage of favorable interest rate environments or other market conditions. However, there is no guarantee that we will be able to obtain alternative sources of financing on commercially reasonable terms or at all. See “Item 1A. Risk Factors—Risks Related to Our Business.”
While repatriation of some cash held outside the United States may be restricted by local laws, most of our foreign cash could be repatriated to the United States. Following enactment of the Tax Cut and Jobs Act of 2017 (“TCJA”) and the associated transition tax, in general, repatriation of cash to the United States can be completed with no incremental U.S. tax; however, repatriation of cash could subject us to non-U.S. jurisdictional taxes on distributions. The cash that our non-U.S. subsidiaries hold for indefinite reinvestment is generally used to finance foreign operations and investments, including acquisitions. The income taxes, if any, applicable to such earnings including basis differences in our foreign subsidiaries are not readily determinable.
As of February 10, 2023, we believe that we have sufficient sources of liquidity to satisfy our cash needs over the next 12 months and beyond, including our cash needs in the United States.
Purchase Obligations
The Company’s purchase obligations primarily consist of agreements to purchase goods or services that are enforceable and legally binding and that specify all significant terms, including fixed or minimum quantities to be purchased, fixed, minimum or variable price provisions and the approximate timing of the transaction.
The following table sets forth, by period due or year of expected expiration, as applicable, a summary of purchase obligations as of December 31, 2022,
Amount of Commitment Expiration per Period
($ in millions)Total Less Than One Year1-3 Years4-5 YearsMore Than 5 Years
Purchase Obligations$84.6$77.9$3.2$2.4$1.1

For a description of our remaining contractual obligations, such as debt and leases see “Item 8. Financial Statements and Supplementary Data - Notes to Consolidated Financial Statements - Note 16 - Debt and Credit Facilities” and “-Note 8 - Leases.”

64

Off-Balance Sheet Arrangements
Guarantees and Related Instruments
The following table sets forth, by period due or year of expected expiration, as applicable, a summary of our off-balance sheet commitments as of December 31, 2022.
Amount of Commitment Expiration per Period
($ in millions)Total Less Than One Year1-3 Years4-5 YearsMore Than 5 Years
Guarantees and related instruments$19.0$14.5$3.4$0.4$0.7
Guarantees consist primarily of outstanding standby letters of credit and bank guarantees. These guarantees have been provided in connection with certain arrangements with vendors, customers, financing counterparties and governmental entities to secure our obligations and/or performance requirements related to specific transactions.
Other Off-Balance Sheet Arrangements
In the normal course of business, we periodically enter into agreements that require us to indemnify customers, suppliers or other business partners for specific risks, such as claims for injury or property damage arising out of our products or services or claims alleging that our products or services infringe third-party intellectual property. We have not included any such indemnification provisions in the contractual obligations table above. Historically, we have not experienced significant losses on these types of indemnification obligations.

Debt Financing Transactions
Credit Agreement

On September 20, 2019, we entered into a credit agreement (the “Credit Agreement”) with a syndicate of banks under which we borrowed approximately $1.3 billion, consisting of the three-year $650.0 million senior term loan facility and the three-year €600.0 million senior euro term loan facility (collectively the “Term Loans”). The Credit Agreement also included the five-year, $250.0 million revolving credit facility.

On February 9, 2021, in connection with an amendment to the Credit Agreement, we repaid $472.0 million of our senior euro term loan facility.

On June 15, 2021, we entered into an amended and restated credit agreement (the “Amended Credit Agreement”) with a syndicate of banks, The Amended Credit Agreement amends and restates our Credit Agreement, originally dated September 20, 2019 (as amended by Amendment No. 1 to Credit Agreement dated as of May 6, 2020, Amendment No. 2 to Credit Agreement dated as of May 19, 2020, and Amendment No. 3 to Credit Agreement dated as of February 9, 2021).

Under the Amended Credit Agreement: (a) the maturity date of our existing Term Loans has been extended to September 20, 2024, (b) the revolving credit facility has been increased from $250.0 million to $750.0 million, (c) we may request further increases to the revolving credit facility in an aggregate amount not to exceed $350.0 million, (d) the amount of cash and cash equivalents permitted to be netted in the definition of “Consolidated Funded Indebtedness” has been increased to up to the greater of (i) $250.0 million and (ii) 50% of Consolidated EBITDA as of the most recent measurement period, and (e) the floor on Eurocurrency rate loans applicable to the revolving credit facility and the senior term loan has been reduced to zero, in each case subject to and in accordance with the terms and conditions of the Amended Credit Agreement. We paid fees aggregating approximately $2.1 million in connection with the Amended Credit Agreement.

65

Convertible Senior Notes (the “Notes”)

On May 21, 2020, we issued the Notes due on June 1, 2025, unless earlier repurchased, redeemed or converted. The aggregate principal amount, which includes the initial purchasers’ exercise in full of their option to purchase an additional $68 million principal amount of the Notes, was $517.5 million. The net proceeds from the issuance, after deducting purchasers’ discounts and estimated offering expenses, were $502.6 million. The Notes accrue interest at a rate of 2.375% per annum, payable semi-annually in arrears on June 1 and December 1 of each year, beginning on December 1, 2020. The Notes have an initial conversion rate of 47.5862 shares of our common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $21.01 per share of our common stock and is subject to adjustment upon the occurrence of specified events. The Notes have customary provisions relating to the occurrence of “Events of Default” (as defined in the Indenture governing the Notes).

Capped Call Transactions

In connection with the offering of the Notes, we entered into the Capped Calls with certain counterparties. The Capped Calls each have an initial strike price of approximately $21.01 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Notes. The Capped Calls have initial cap prices of $23.79 per share, subject to certain adjustments. The Capped Calls cover, subject to anti-dilution adjustments, 2.9 million shares of the Company's common stock. The Capped Calls are generally intended to reduce or offset the potential dilution from shares of common stock issued upon any conversion of the Notes with such reduction or offset, as the case may be, subject to a cap based on the cap price. The cost of $20.7 million incurred in connection with the Capped Calls was recorded as a reduction to additional paid-in capital.

Legal Proceedings
Please refer to Note 15 to our audited consolidated financial statements included in this Annual Report for information regarding legal proceedings and contingencies, and for a discussion of risks related to legal proceedings and contingencies, please refer to “Item 1A. Risk Factors—General Risks.”

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are exposed to market risk from changes in foreign currency exchange rates and commodity prices as well as credit risk, each of which could impact our consolidated financial statements. We generally address our exposure to these risks through our normal operating activities. Please refer to Note 2 to our audited consolidated financial statements included in this Annual Report for information regarding derivative financial instruments and discussion of exposures to foreign currency and foreign currency-denominated debt.
Interest Rate Risk
Certain of our borrowings are at variable rates of interest, which may expose us to interest rate risk. We have a $650 million senior term loan facility and a €208 million senior euro term loan facility. To manage our interest rate risk, we entered into an interest rate swap agreement during 2022, which matured in September 2022, to convert a portion of the senior term loan variable rate borrowing into a fixed rate borrowing. A 100 basis point increase in the interest rate related to the senior term loan and the senior euro term loan would have increased our interest expense by $7.0 million for 2022.

Currency Exchange Rate Risk
We face transactional exchange rate risk from transactions with customers in countries outside the United States and from intercompany transactions between affiliates. Transactional exchange rate risk arises from the purchase and sale of goods and services in currencies other than our functional currency or the functional currency of our applicable subsidiary. We also face translational exchange rate risk related to the translation of financial statements of our foreign operations into U.S. dollars, our functional currency. Costs incurred and sales recorded by subsidiaries operating outside of the United States are translated into U.S. dollars using exchange rates effective during the respective period. As a result, we are exposed to movements in the exchange rates of various currencies against the U.S. dollar. In particular, we have more sales in European currencies than we have expenses in those currencies. Therefore, when European currencies strengthen or weaken against the U.S. dollar, operating profits are increased or decreased, respectively. The effect of a change in currency exchange rates on our net investment in international subsidiaries is reflected in the accumulated other comprehensive loss component of equity.
66

We have generally accepted the exposure to exchange rate movements without using derivative financial instruments to manage this risk. Both positive and negative movements in currency exchange rates against the U.S. dollar will therefore continue to affect the reported amount of sales and net earnings in our consolidated financial statements. In addition, we have assets and liabilities held in foreign currencies. A 10% depreciation in major currencies relative to the U.S. dollar as of December 31, 2022 would have reduced equity by approximately $248 million.
Credit Risk
We are exposed to potential credit losses in the event of nonperformance by counterparties to our financial instruments. Financial instruments that potentially subject us to credit risk primarily consist of receivables from customers. For additional information on our credit risk from customers, please refer to “Item 1. Business.”
Our businesses perform credit evaluations of our customers’ financial conditions as appropriate and also obtain collateral or other security when appropriate.
Commodity Price Risk
For a discussion of risks relating to commodity prices, refer to “Item 1A. Risk Factors—Risks Related to Our Business.”

CRITICAL ACCOUNTING ESTIMATES
Management’s discussion and analysis of our financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, sales and expenses, and related disclosure of contingent assets and liabilities. We base these estimates and judgments on historical experience, the current economic environment and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ materially from these estimates and judgments.
We believe the following accounting estimates are most critical to an understanding of our financial statements. Estimates are considered to be critical if they meet both of the following criteria: (1) the estimate requires assumptions about material matters that are uncertain at the time the estimate is made, and (2) material changes in the estimate are reasonably likely from period-to-period. For a detailed discussion on the application of these and other accounting estimates, refer to Note 2 to our audited consolidated financial statements.
Business Combinations – Purchase-Price Allocation

Our growth strategy contemplates future acquisitions that either strategically fit with our existing portfolio or expand our portfolio. As a result, accounting for such business combinations requires the allocation of purchase price to the various assets and liabilities of the acquired business at their respective fair values. We use all available information to make these fair value determinations. Determining the fair value of assets acquired requires judgement and assumptions regarding future projection of sales and operating margin, including discount rates.

Acquired Intangibles

Our business acquisitions typically result in the recognition of goodwill, patents, technology, customer relationships and other intangible assets, which affect the amount of future period amortization expense and possible impairment charges that we may incur. Refer to Notes 2, 3 and 9 to our audited consolidated financial statements for a description of our policies relating to acquisitions, goodwill and acquired intangibles.
On the first business day of the fourth quarter of 2022, we performed our annual goodwill impairment test. We first assessed qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount or performed a quantitative impairment test. When tested quantitatively, the estimated fair value of reporting units was determined using a combination of techniques, including an income approach and a market-based approach. The discounted cash flow model (i.e., an income approach) requires judgments and assumptions about projected sales growth, future operating margins, discount rates and terminal values. In evaluating the estimates derived by the market-based approach, management makes judgments about the relevance and reliability of the multiples by considering factors unique to our reporting units, including operating results, business plans, economic projections, anticipated future cash flows, business trends and our market capitalization. There are inherent uncertainties related to these assumptions and our judgment in applying them to the analysis of goodwill impairment. Our analysis indicated that the fair values of our reporting units exceeded their carrying values and consequently did not result in an impairment charge.

67

We review identified intangible assets for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. We also test intangible assets with indefinite lives at least annually for impairment. Determining whether an impairment loss occurred requires a comparison of the carrying amount to the sum of discounted cash flows expected to be generated by the asset. These analyses require us to make judgments and estimates about future sales, expenses, market conditions and discount rates related to these assets.
If actual results are not consistent with our estimates and assumptions, goodwill and other intangible assets may be overstated and a charge would need to be taken against net income which would adversely affect our consolidated financial statements.
Contingent Liabilities
As discussed in Note 15 to our audited consolidated financial statements, we are, from time to time, subject to a variety of litigation and similar contingent liabilities incidental to our business (or the business operations of previously owned entities). We recognize a liability for any contingency that is known or probable of occurrence and reasonably estimable. These assessments require judgments concerning matters such as litigation developments and outcomes, the anticipated outcome of negotiations, the number of future claims and the cost of both pending and future claims. In addition, because most contingencies are resolved over long periods of time, liabilities may change in the future due to various factors, including those discussed in Note 15 to our audited consolidated financial statements. If the reserves we established with respect to these contingent liabilities are inadequate, we would be required to incur an expense equal to the amount of the loss incurred in excess of the reserves, which would adversely affect our financial statements.
Pension Plans
For a description of our pension accounting practices, refer to Note 13 to our audited consolidated financial statements. Calculations of the amount of pension costs and obligations depend on the assumptions used in the actuarial valuations, including assumptions regarding discount rates, expected return on plan assets, rates of salary increases, health care cost trend rates, mortality rates and other factors. If the assumptions used in calculating pension costs and obligations are incorrect or if the factors underlying the assumptions change (as a result of differences in actual experience, changes in key economic indicators or other factors) our financial statements could be materially affected. A 50 basis point reduction in the discount rates used for the plans for 2022 would have increased the net obligation by $6.2 million ($4.8 million on an after-tax basis) from the amounts recorded in the financial statements as of December 31, 2022. A 50 basis point increase in the discount rates used for the plans for 2022 would have decreased the net obligation by $5.4 million ($4.2 million on an after-tax basis) from the amounts recorded in the financial statements as of December 31, 2022.
The plan assets consist of various insurance contracts, equity and debt securities as determined by the administrator of each plan. The estimated long-term rate of return ranged from 3.50% to 4.10%. A 50 basis points decrease in the expected long-term rate of return on plan assets for 2023 would result in an increase of $0.4 million in pension expense for the plans for 2023.

Income Taxes

For a description of our income tax accounting policies, refer to Note 21 to our audited consolidated financial statements. We establish valuation allowances for our deferred tax assets if it is more likely than not that some or all of the deferred tax asset will not be realized. This requires us to make judgments and estimates regarding: (1) the ability under tax law to carry back losses, (2) timing and amount of the reversal of taxable temporary differences, (3) expected future taxable income of the appropriate character, and (4) the impact of prudent and feasible tax planning strategies that the Company would implement to prevent an otherwise expiring tax attribute to be unutilized. Future changes to enacted tax rates would also impact the amounts of deferred tax assets and liabilities and could have an adverse impact on our financial statements.

We provide for unrecognized tax benefits when, based upon the technical merits, it is “more likely than not” that an uncertain tax position will not be sustained upon examination. Judgment is required in evaluating tax positions and determining income tax provisions. We re-evaluate the technical merits of our tax positions and may recognize an uncertain tax benefit in certain circumstances, including when: (1) a tax audit is completed; (2) applicable tax laws change, including a tax case ruling or legislative guidance; or (3) the applicable statute of limitations expires.
An increase of 1.0% in our 2022 nominal tax rate would have resulted in additional income tax expense for the year ended December 31, 2022 of $2.8 million.

68

On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on our current analysis of the provisions, we do not believe this legislation will have a material impact on our financial statements.

NEW ACCOUNTING STANDARDS
For a discussion of the new accounting standards impacting us, refer to Note 2 to our audited consolidated financial statements in this Annual Report on Form 10-K.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The information required by this item is included under “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

INDEX TO FINANCIAL STATEMENTS AND SCHEDULE
Page
Envista Holdings Corporation Audited Annual Consolidated Financial Statements:
69

Report of Management on Envista Holdings Corporation’s Internal Control Over Financial Reporting

The management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. Internal control over financial reporting is defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Securities Exchange Act of 1934.

The Company’s management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2022. In making this assessment, the Company’s management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in “Internal Control-Integrated Framework” (2013 framework). Based on this assessment, management concluded that, as of December 31, 2022, the Company’s internal control over financial reporting is effective.

The Company’s independent registered public accounting firm has issued an audit report on the effectiveness of the Company’s internal control over financial reporting. This report dated February 16, 2023 appears on page 73 of this
Form 10-K.
70

Report of Independent Registered Public Accounting Firm
To the Stockholders and the Board of Directors of Envista Holdings Corporation

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Envista Holdings Corporation (the Company) as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive income, changes in equity and cash flows for each of the three years in the period ended December 31, 2022, the related notes, and financial statement schedule listed in the Index at Item 15(a) (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February 16, 2023 expressed an unqualified opinion thereon.

Adoption of ASU No. 2020-06

As discussed in Note 2 to the consolidated financial statements, the Company changed its method of accounting for convertible instruments in 2022 due to the adoption of ASU 2020-06 Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40).

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
71

Goodwill Impairment
Description of the Matter
As discussed in Note 9 to the consolidated financial statements, the Company’s annual test date for goodwill impairment is the first business day of its fiscal fourth quarter. Total goodwill as of December 31, 2022 was $3.5 billion and represented 53% of total assets. As discussed in Note 9 of the consolidated financial statements, goodwill is not amortized but rather is tested for impairment at least annually at the reporting unit level. The Company did not record any impairment of the carrying value of goodwill during the year ended December 31, 2022.
Auditing management’s goodwill impairment test for one of the Company’s reporting units was challenging and judgmental due to the estimation required to determine the fair value of the reporting unit. In particular, the significant judgments underlying the fair value estimate of this reporting unit relate to the assumption of future cash flows based on estimates of financial forecasts. This significant assumption is affected by estimated future market and economic conditions.

How We Addressed the Matter in Our Audit
We obtained an understanding, evaluated the design, and tested the operating effectiveness of controls over the Company’s goodwill impairment evaluation process. For example, we tested controls over management’s review of the estimated fair value of the reporting unit, the significant assumption utilized in the estimation of the fair value of the reporting unit, discussed above, and the data inputs utilized in the fair value estimate.

To test the estimated fair value of the Company’s reporting unit, our principal audit procedures included (i) evaluating the significant assumption, discussed above, and (ii) testing the underlying data used by the Company in its analysis. For example, we compared the significant assumption used by management, to historical results, the Company’s business model and other relevant factors. We also evaluated the consistency and appropriateness of the significant assumption selected for use in the discounted cash flow method against forecasts. We performed sensitivity analyses of the significant assumption to evaluate changes in fair value of the reporting unit to determine if contrary evidence exists. We also assessed the historical accuracy of management’s forecasts of financial results used in developing fair value estimates to assist in evaluating the reliability of the forecast utilized in the estimate.
Business Combinations
Description of the MatterIn April 2022, the Company completed its acquisition of the Carestream Dental Technology Parent Limited’s Intraoral Scanner Business (the Intraoral Scanner Business) for total consideration of $580.3 million, as disclosed in Note 3 to the consolidated financial statements. The transaction was accounted for as a business combination.
Auditing the Company's accounting for its acquisition of the Intraoral Scanner Business was complex due to the significant estimation required by management to determine the fair value of certain acquired intangible assets. The significant estimation was primarily due to the judgment utilized in the inputs of the valuation model used by management to measure the fair value of the acquired developed technology asset and the sensitivity of the fair value.
How We Addressed the Matter in Our Audit
We tested the Company's controls over its acquisition of the Intraoral Scanner Business. For example, we tested controls over the recognition and measurement of the developed technology asset and the consideration transferred, inclusive of the valuation models and underlying assumptions used to develop such estimates.
To test the estimated fair value of the developed technology asset, we performed audit procedures that included, among others, testing the significant assumptions used in the model, including the completeness and accuracy of the underlying data.
As part of these procedures, we assessed the reasonableness of the estimates used in the valuation by (i) assessing the historical results compared to projected results, (ii) engaging valuation specialists to assess the methods, models, and assumptions used within the valuation, and (iii) verifying underlying assumptions utilized by management in the valuation of the acquired asset, including the key inputs, inclusive of the revenue projections attributable to the acquired asset.

/s/Ernst & Young LLP

We have served as the Company's auditor since 2018.

Irvine, California

February 16, 2023
72

Report of Independent Registered Public Accounting Firm

To the Stockholders and the Board of Directors of Envista Holdings Corporation

Opinion on Internal Control Over Financial Reporting

We have audited Envista Holdings Corporation’s internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Envista Holdings Corporation (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive income, changes in equity and cash flows for each of the three years in the period ended December 31, 2022, the related notes, and financial statement schedule listed in the Index at Item 15(a) and our report dated February 16, 2023 expressed an unqualified opinion thereon.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Report of Management on Envista Holdings Corporation’s Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.

Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ Ernst & Young LLP
Irvine, California

February 16, 2023
73

ENVISTA HOLDINGS CORPORATION
CONSOLIDATED BALANCE SHEETS
($ in millions, except share amounts)
As of December 31,
20222021
ASSETS
Current assets:
Cash and cash equivalents$606.9 $1,073.6 
Trade accounts receivable, less allowance for credit losses of $16.2 and $20.7, respectively
393.5 331.9 
Inventories, net300.8 263.8 
Prepaid expenses and other current assets123.4 154.3 
Assets held for sale— 12.2 
Total current assets1,424.6 1,835.8 
Property, plant and equipment, net293.6 264.1 
Operating lease right-of-use assets131.8 128.1 
Other long-term assets153.7 167.8 
Goodwill3,496.6 3,132.0 
Other intangible assets, net1,086.7 1,046.4 
Total assets$6,587.0 $6,574.2 
LIABILITIES AND EQUITY
Current liabilities:
Short-term debt$510.0 $432.4 
Trade accounts payable228.3 185.8 
Accrued expenses and other liabilities471.4 562.3 
Operating lease liabilities27.0 23.7 
Liabilities held for sale— 4.0 
Total current liabilities1,236.7 1,208.2 
Operating lease liabilities121.4 120.4 
Other long-term liabilities151.3 304.2 
Long-term debt870.7 883.4 
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.01 par value, 15.0 million shares authorized; no shares issued or outstanding at December 31, 2022 and December 31, 2021
— — 
Common stock - $0.01 par value, 500.0 million shares authorized; 163.7 million shares issued and 163.2 million shares outstanding at December 31, 2022; 162.0 million shares issued and 161.6 million shares outstanding at December 31, 2021
1.6 1.6 
Additional paid-in capital3,699.0 3,732.6 
Retained earnings731.4 466.9 
Accumulated other comprehensive loss(225.1)(143.5)
Total Envista stockholders’ equity4,206.9 4,057.6 
Noncontrolling interests— 0.4 
Total stockholders’ equity4,206.9 4,058.0 
Total liabilities and stockholders’ equity$6,587.0 $6,574.2 
See the accompanying Notes to the Consolidated Financial Statements.
74

ENVISTA HOLDINGS CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
($ and shares in millions, except per share amounts)
 Year Ended December 31,
 202220212020
Sales$2,569.1 $2,508.9 $1,929.1 
Cost of sales1,094.3 1,082.4 874.3 
Gross profit1,474.8 1,426.5 1,054.8 
Operating expenses:
Selling, general and administrative1,055.5 1,019.8 924.6 
Research and development100.1 100.5 86.7 
Operating profit319.2 306.2 43.5 
Nonoperating income (expense):
Other income (expense)3.1 2.4 (1.0)
Interest expense, net(38.4)(54.1)(62.5)
Income (loss) before income taxes283.9 254.5 (20.0)
Income tax expense (benefit)45.9 (9.0)(62.5)
Income from continuing operations, net of tax 238.0 263.5 42.5 
Income (loss) from discontinued operations, net of tax (Note 4)5.1 77.0 (9.2)
Net income$243.1 $340.5 $33.3 
Earnings per share:
Earnings from continuing operations - basic$1.46 $1.63 $0.27 
Earnings from continuing operations - diluted$1.34 $1.48 $0.26 
Earnings (loss) from discontinued operations - basic$0.03 $0.48 $(0.06)
Earnings (loss)from discontinued operations - diluted$0.03 $0.43 $(0.06)
Earnings - basic$1.49 $2.11 $0.21 
Earnings - diluted$1.37 $1.92 *$0.20 
Average common stock and common equivalent shares outstanding:
Basic162.9 161.2 159.6 
Diluted177.6 177.6 164.1 
* Earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. The sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding.
See the accompanying Notes to the Consolidated Financial Statements.
75

ENVISTA HOLDINGS CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
($ in millions)
Year Ended December 31,
202220212020
Net income$243.1 $340.5 $33.3 
Other comprehensive (loss) income, net of income taxes:
Foreign currency translation adjustments(100.9)(77.1)53.9 
Cash flow hedge adjustments1.7 4.6 (6.4)
Pension plan adjustments17.6 20.8 4.9 
Total other comprehensive (loss) income, net of income taxes(81.6)(51.7)52.4 
Comprehensive income $161.5 $288.8 $85.7 
See the accompanying Notes to the Consolidated Financial Statements.
76


ENVISTA HOLDINGS CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
 ($ in millions)
Common StockAdditional Paid-in CapitalRetained EarningsAccumulated Other
Comprehensive Loss		Total
Envista
Equity		Noncontrolling Interests
Balance, December 31, 2019$1.6 $3,589.7 $93.1 $(144.2)$3,540.2 $2.6 
Common stock-based award activity— 32.2 — — 32.2 — 
Equity component of convertible senior notes, net of financing costs and taxes— 77.9 — — 77.9 — 
Purchase of capped calls related to issuance of convertible senior notes, net of taxes— (15.7)— — (15.7)— 
Separation related adjustments— 0.3 — — 0.3 — 
Net income— — 33.3 — 33.3 — 
Other comprehensive income— — — 52.4 52.4 — 
Changes in noncontrolling interests— — — — — (2.2)
Balance, December 31, 20201.6 3,684.4 126.4 (91.8)3,720.6 0.4 
Common stock-based award activity— 41.4 — — 41.4 — 
Separation related adjustments— 6.8 — — 6.8 — 
Net income— — 340.5 — 340.5 — 
Other comprehensive loss— — — (51.7)(51.7)— 
Balance, December 31, 20211.6 3,732.6 466.9 (143.5)4,057.6 0.4 
Cumulative effect of adjustment related to change in accounting principle. (Note 16)— (77.8)21.4 — (56.4)— 
Balance, January 1, 20221.6 3,654.8 488.3 (143.5)4,001.2 0.4 
Change in noncontrolling interest— — — — — (0.4)
Common stock-based award activity— 44.2 — — 44.2 — 
Net income— — 243.1 — 243.1 — 
Other comprehensive loss— — — (81.6)(81.6)— 
Balance, December 31, 2022$1.6 $3,699.0 $731.4 $(225.1)$4,206.9 $— 

See the accompanying Notes to the Consolidated Financial Statements.

77

ENVISTA HOLDINGS CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
($ in millions)
 Year Ended December 31,
 202220212020
Cash flows from operating activities:
Net income $243.1 $340.5 $33.3 
Noncash items:
Depreciation31.8 40.8 42.4 
Amortization106.0 82.8 90.2 
Allowance for credit losses4.8 5.6 23.0 
Stock-based compensation expense30.5 28.2 22.6 
Gain on sale of property, plant and equipment(1.9)(2.2)— 
Gain on sale of KaVo treatment unit and instrument business(8.9)(11.7)— 
Restructuring charges4.7 10.8 11.1 
Impairment charges6.4 18.4 32.6 
Fair value adjustment of acquisition-related inventory9.5 — — 
Amortization of right-of-use assets24.3 28.3 30.5 
Amortization of debt discount and issuance costs4.1 23.3 13.4 
Change in deferred income taxes(29.0)(59.0)(91.4)
Change in trade accounts receivable(71.0)(43.2)71.9 
Change in inventories(39.9)(66.0)11.9 
Change in trade accounts payable44.5 (20.3)21.6 
Change in prepaid expenses and other assets(11.7)(11.5)(2.5)
Change in accrued expenses and other liabilities(133.0)34.3 10.0 
Change in operating lease liabilities(31.6)(37.5)(36.7)
Net cash provided by operating activities182.7 361.6 283.9 
Cash flows from investing activities:
Acquisitions, net of cash acquired(696.2)(2.1)(40.7)
Payments for additions to property, plant and equipment(75.7)(54.7)(47.7)
Proceeds from sales of property, plant and equipment3.3 11.6 5.3 
Proceeds from sale of KaVo treatment unit and instrument business, net73.9 312.5 — 
Proceeds from the settlement of derivative financial instruments56.0 11.4 14.0 
All other investing activities, net(18.6)(16.0)— 
Net cash (used in) provided by investing activities(657.3)262.7 (69.1)
Cash flows from financing activities:
Proceeds from revolving line of credit124.0— 249.8
Repayment of revolving line of credit(124.0)— (250.0)
Proceeds from borrowing0.3 — — 
Repayment of borrowing(0.5)(475.7)— 
Proceeds from issuance of convertible senior notes— — 517.5 
Payment of debt issuance and other deferred financing costs— (2.3)(17.2)
Purchase of capped calls related to issuance of convertible senior notes— — (20.7)
Proceeds from stock option exercises21.8 19.5 13.8 
Tax withholding payment related to net settlement of equity awards(9.1)(7.2)(5.0)
All other financing activities— 0.1 4.3 
78

Net cash provided by (used in) financing activities12.5 (465.6)492.5 
Effect of exchange rate changes on cash and cash equivalents(4.6)26.0 (29.6)
Net change in cash and cash equivalents(466.7)184.7 677.7 
Beginning balance of cash and cash equivalents1,073.6 888.9 211.2 
Ending balance of cash and cash equivalents$606.9 $1,073.6 $888.9 
Supplemental data:
Cash paid for interest$38.4 $35.7 $56.7 
Cash paid for taxes$119.2 $84.0 $28.6 
ROU assets obtained in exchange for operating lease obligations$36.0 $24.7 $28.1 
See the accompanying Notes to the Consolidated Financial Statements.
79

ENVISTA HOLDINGS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1. BUSINESS AND BASIS OF PRESENTATION
Business Overview

The Company provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. The Company is a worldwide provider of a broad range of dental implants, orthodontic appliances, general dental consumables, equipment and services and is dedicated to driving technological innovations that help dental professionals improve clinical outcomes and enhance productivity.

The Company was formed in 2018, as a wholly-owned subsidiary of Danaher Corporation (“Danaher”), to serve as the ultimate parent company of the dental platform of Danaher. On September 20, 2019, the Company completed its initial public offering and on December 18, 2019, Danaher completed the disposition of its ownership interest in the Company referred to herein as the “Separation”.

The Company operates in two business segments: Specialty Products & Technologies and Equipment & Consumables.
The Company’s Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Company’s Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.

Basis of Presentation
The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP").

As discussed in Note 4, Discontinued Operations, on December 31, 2021, the Company sold its KaVo dental treatment unit and instrument business (the "KaVo Treatment Unit and Instrument Business"), which was part of the Company’s Equipment and Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.

Risks and Uncertainties

The Company is subject to risks and uncertainties as a result of the novel coronavirus (“COVID-19”) pandemic.

The extent of the impact of the COVID-19 pandemic on the Company remains uncertain and difficult to predict because of the dynamic and evolving nature of the situation. The global impact of the outbreak continues to adversely affect many industries, and different geographies continue to reflect the effects of public health restrictions in various ways. The economic recovery following the impact of the COVID-19 pandemic is only partially underway and has been gradual, uneven and characterized by meaningful dispersion across sectors and regions with uncertainty regarding its ultimate length and trajectory. During the year ended December 31, 2022, notwithstanding improvement in many markets in which the Company operates due to a return to more normalized business operations, certain markets continued to be adversely impacted by COVID-19. In particular, sales decreased in China due to lockdowns early in the year and a subsequent relaxing of restrictions, which resulted in increased infection rates.

In addition, Russia’s invasion of Ukraine and the global response to this invasion, including sanctions imposed by the U.S. and other countries, could have an adverse impact on the Company’s business, including impacting the Company’s ability to market and sell products in the affected regions, potentially heightening our risk of cyber security attacks, impacting its ability to enforce its intellectual property rights in Russia, creating disruptions in the global supply chain, and by potentially having an adverse impact on the global economy, financial markets, energy markets, currency rates and otherwise.

80


NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Accounting Principles
The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The Consolidated Financial Statements include the accounts of the Company and its subsidiaries. The Consolidated Financial Statements also reflect the impact of noncontrolling interests. Noncontrolling interests do not have a significant impact on the Company’s consolidated results of operations, therefore income attributable to noncontrolling interests are not presented separately in the Company’s Consolidated Statements of Operations. Income attributable to noncontrolling interests have been reflected in selling, general and administrative expenses and were insignificant in all periods presented. Reclassifications of certain prior year amounts have been made to conform to the current year presentation.
Use of Estimates
The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The Company bases these estimates on historical experience, the current economic environment and on various other assumptions that are believed to be reasonable under the circumstances. However, uncertainties associated with these estimates exist and actual results may differ materially from these estimates.
Acquisitions
The Company continually evaluates potential acquisitions that either strategically fit with the Company’s existing portfolio or expand the Company’s portfolio into new and attractive business areas. Among other things, goodwill arises because the purchase prices for these businesses reflect a number of factors including the future earnings and cash flow potential of these businesses, the multiple to earnings, cash flow and other factors at which similar businesses have been purchased by other acquirers, the competitive nature of the processes by which the Company acquired the businesses, avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance the Company’s existing product offerings to key target markets and enter into new and profitable businesses and the complementary strategic fit and resulting synergies these businesses bring to existing operations.
We account for acquisitions under Accounting Standards Codification (“ASC“) 805 Business Combinations and use the acquisition method of accounting. The consideration transferred for the acquisition of a subsidiary comprises (i) fair values of the assets transferred; (ii) liabilities assumed of the acquired business; and (iii) fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired, and liabilities and contingent liabilities assumed in a business combination are, with limited exceptions, measured initially at their fair values at the acquisition date.
The Company makes an initial allocation of the purchase price at the date of acquisition based upon its estimation of the fair value of the acquired assets and assumed liabilities. The Company obtains the information used to estimate the fair values during due diligence and through other sources. In the months after closing, up to 12 months, as the Company obtains additional information that existed at the acquisition date about these assets and liabilities, it is able to refine the estimates of fair value and more accurately allocate the purchase price. Only items that existed as of the acquisition date are considered for subsequent adjustment. The Company makes the appropriate adjustments to the purchase price allocation prior to completion of the measurement period, as required.
Cash and Cash Equivalents
The Company considers all highly liquid investments with a maturity of three months or less at the date of purchase to be cash equivalents.
Accounts Receivable and Allowances for Credit Losses
All trade accounts receivable are reported on the accompanying Consolidated Balance Sheets adjusted for any write-offs and net of allowances for credit losses. The allowances for credit losses represent management’s best estimate of the credit losses expected from the Company’s trade accounts receivable portfolio. Determination of the allowances requires management to exercise judgment about the timing, frequency and severity of credit losses that could materially affect the provision for credit losses and, therefore, net income. The Company regularly performs detailed reviews of its portfolios to determine if an impairment has occurred and evaluates the collectability of receivables based on a combination of various financial and qualitative factors that may affect customers’ ability to pay, including customers’ financial condition, debt-servicing ability, past payment experience and credit bureau information and forecasts. In circumstances where the Company is aware of a
81

specific customer’s inability to meet its financial obligations, a specific reserve is recorded against amounts due to reduce the recognized receivable to the amount reasonably expected to be collected.
Inventory Valuation
Inventories include the costs of material, labor and overhead. Inventories are stated at the lower of cost or net realizable value primarily using the first-in, first-out method. Market value for raw materials is based on replacement costs and for other inventory classifications is based on net realizable value. The Company periodically evaluates the quantities on hand relative to current and historical selling prices and historical and projected sales volume. Based on this evaluation, provisions are made to write inventory down to its net realizable value.
Property, Plant and Equipment
Property, plant and equipment are carried at cost. The provision for depreciation has been computed principally by the straight-line method based on the estimated useful lives of the depreciable assets as follows:
CategoryUseful Life
Buildings
30 years
Leased assets and leasehold improvementsAmortized over the lesser of the economic life of the asset or the term of the lease
Machinery, equipment and other assets
3 – 10 years
Estimated useful lives are periodically reviewed and, when appropriate, changes to estimates are made prospectively.
Leases
The Company determines if an arrangement is a lease at inception and evaluates each lease agreement to determine whether the lease is an operating or finance lease. For leases where the Company is the lessee, right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The ROU asset also consists of any prepaid lease payments, lease incentives received, costs which will be incurred in exiting a lease and the amount of any asset or liability recognized on business combinations relating to favorable or unfavorable lease terms. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense using the accelerated interest method of recognition. In certain of the Company’s lease agreements, the rental payments are adjusted periodically to reflect actual charges incurred for common area maintenance, utilities, inflation and/or changes in other indexes.
Investments
Investments over which the Company has a significant influence but not a controlling interest, are accounted for using the equity method of accounting which requires the Company to record its initial investment at cost and adjust the balance each period for the Company’s share of the investee’s income or loss and dividends paid. No significant realized or unrealized gains or losses were recorded during the three years ended December 31, 2022, 2021 and 2020 with respect to these investments.
Fair Value of Financial Instruments
The Company’s financial instruments consist primarily of cash and cash equivalents, trade accounts receivable, nonqualified deferred compensation plans, contingent consideration, derivatives, trade accounts payable and long-term debt. Due to their short-term nature, the carrying values for cash and cash equivalents, trade accounts receivable and trade accounts payable approximate fair value. Refer to Note 12 for the fair values of the Company’s other financial instruments.
82

Goodwill and Other Intangible Assets
Goodwill and other intangible assets result from the Company’s acquisition of existing businesses. In accordance with accounting standards related to business combinations, goodwill is not amortized; however, certain finite-lived identifiable intangible assets, primarily customer relationships and acquired technology, are amortized over their estimated useful lives. Goodwill and indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. The Company first assessed qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount or performed a quantitative impairment test. When tested quantitatively, the Company uses a combination of techniques, including an income approach and a market-based approach to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. In making this assessment, management relies on a number of factors, including expected future operating results, business plans, economic projections, anticipated future cash flows, business trends and the Company’s market capitalization. The Company’s reporting units are the financial components of operating segments which constitute businesses for which discrete financial information is available and is regularly reviewed by segment management. The Company did not record any impairment loss for goodwill or indefinite-lived intangible assets in 2022, 2021 and 2020.
Management reviews the carrying amounts of other finite-lived intangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable based on undiscounted estimated cash flows, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities.

Refer to Note 9 for additional information about the Company’s goodwill and other intangible assets.

Revenue Recognition
The Company derives revenues primarily from the sale of Specialty Products & Technologies and Equipment & Consumables products and services. Revenue is recognized when control of the promised products or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services (the transaction price). A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606. For equipment, consumables and spare parts sold by the Company, control transfers to the customer at a point in time. To indicate the transfer of control, the Company must have a present right to payment, legal title must have passed to the customer, the customer must have the significant risks and rewards of ownership, and where acceptance is not a formality, the customer must have accepted the product or service. The Company’s principal terms of sale are FOB Shipping Point, or equivalent, and, as such, the Company primarily transfers control and records revenue for product sales upon shipment. Sales arrangements with delivery terms that are not FOB Shipping Point are not recognized upon shipment and the transfer of control for revenue recognition is evaluated based on the associated shipping terms and customer obligations. If a performance obligation to the customer with respect to a sales transaction remains to be fulfilled following shipment (typically installation or acceptance by the customer), revenue recognition for that performance obligation is deferred until such commitments have been fulfilled. Returns for products sold are estimated and recorded as a reduction of revenue at the time of sale. Customer allowances and rebates, consisting primarily of volume discounts and other short-term incentive programs, are recorded as a reduction of revenue at the time of sale because these allowances reflect a reduction in the transaction price. Product returns, customer allowances and rebates are estimated based on historical experience and known trends. For extended warranty and service, control transfers to the customer over the term of the arrangement. Revenue for extended warranty and service is recognized based upon the period of time elapsed under the arrangement.
For a contract with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation on a relative standalone selling price basis using the Company’s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers; however, when prices in standalone sales are not available the Company may use third-party pricing for similar products or services or estimate the standalone selling price. Allocation of the transaction price is determined at the contracts’ inception. The Company does not adjust transaction price for the effects of a significant financing component when the period between the transfer of the promised good or service to the customer and payment for that good or service by the customer is expected to be one year or less.
83

Shipping and Handling
Shipping and handling costs are considered a fulfillment cost and are included as a component of cost of sales. Revenue derived from shipping and handling costs billed to customers is included in sales.
Advertising
Advertising costs are expensed as incurred.
Research and Development
The Company conducts research and development activities for the purpose of developing new products, enhancing the functionality, effectiveness, ease of use and reliability of the Company’s existing products and expanding the applications for which uses of the Company’s products are appropriate. Research and development costs are expensed as incurred.
Income Taxes
Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted rates expected to be in effect during the year in which the differences reverse. Deferred tax assets generally represent items that can be used as a tax deduction or credit in the Company’s tax return in future years for which the tax benefit has already been reflected on the Company’s Consolidated Statements of Operations. The Company establishes valuation allowances for its deferred tax assets if it is more likely than not that some or all of the deferred tax assets will not be realized. Deferred tax liabilities generally represent items that have already been taken as a deduction on the Company’s tax return but have not yet been recognized as an expense in the Company’s Consolidated Statements of Operations. The effect on deferred tax assets and liabilities due to a change in tax rates is recognized in income tax expense in the period that includes the enactment date. The Company provides for unrecognized tax benefits when, based upon the technical merits, it is “more likely than not” that an uncertain tax position will not be sustained upon examination. Judgment is required in evaluating tax positions and determining income tax provisions. The Company re-evaluates the technical merits of its tax positions and may recognize an uncertain tax benefit in certain circumstances, including when: (1) a tax audit is completed; (2) applicable tax laws change, including a tax case ruling or legislative guidance; or (3) the applicable statute of limitations expires. The Company recognizes potential accrued interest and penalties associated with unrecognized tax positions in income tax expense.
On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on the Company’s current analysis of the provisions, the Company does not believe this legislation will have a material impact on its Consolidated Financial Statements.

Restructuring
The Company periodically initiates restructuring activities to appropriately position the Company’s cost base relative to prevailing economic conditions and associated customer demand as well as in connection with certain acquisitions. Costs associated with productivity improvement and restructuring actions can include termination benefits and related charges in addition to facility closure, contract termination and other related activities. The Company records the cost of the restructuring activities when impairment is identified or when the associated liability is incurred. Refer to Note 20 for additional information.
Foreign Currency Translation
Exchange rate adjustments resulting from foreign currency transactions are recognized in net income, whereas effects resulting from the translation of financial statements are reflected as a component of accumulated other comprehensive loss within equity. Assets and liabilities of subsidiaries operating outside the United States with a functional currency other than U.S. dollars are translated into U.S. dollars using year-end exchange rates and income statement accounts are translated at weighted average rates. Net foreign currency transaction gains or losses were not material in any of the years presented.
Derivative Financial Instruments
The Company is neither a dealer nor a trader in derivative instruments. The Company has generally accepted the exposure to transactional exchange rate movements without using derivative instruments to manage this risk, although the Company from time to time partially hedges its net investments in foreign operations against adverse movements in exchange rates through foreign currency-denominated debt and cross-currency swaps. The Company may at times also enter into interest rate swaps to mitigate a portion of its interest rate risk related to the Company’s debt. The derivative instruments are recorded on the Consolidated Balance Sheets as either an asset or liability measured at fair value. To the extent the interest rate swap qualifies as an effective hedge, changes in fair value are recognized in accumulated other comprehensive loss within equity.
84

Changes in the value of the foreign currency denominated debt and cross-currency swaps designated as hedges of the Company’s net investment in foreign operations based on spot rates are recognized in accumulated other comprehensive loss within equity and offset changes in the value of the Company’s foreign currency denominated operations. Refer to Note 11 for additional information on derivative financial instruments.
Loss Contingencies
The Company records a reserve for loss contingencies when it is both probable that a loss will be incurred and the amount of the loss is reasonably estimable. The Company evaluates pending litigation and other contingencies at least quarterly and adjusts the reserve for such contingencies for changes in probable and reasonably estimable losses.
Accumulated Other Comprehensive Loss
Foreign currency translation adjustments are generally not adjusted for income taxes as they relate to indefinite investments in non-U.S. subsidiaries. Foreign currency translation adjustments related to the Company’s cross-currency swap arrangements and foreign currency denominated debt that are designated as net investment hedges are adjusted for income taxes as those arrangements are not indefinite. Changes in the funded status of the pension plans, net of taxes, are recognized in the year in which the changes occur and reported in other comprehensive loss.
Stock-Based Compensation
The Company accounts for stock-based compensation by measuring the cost of employee services received in exchange for all equity awards granted, including stock options, restricted stock units (“RSUs”) and performance stock units (“PSUs”), based on the fair value of the award as of the grant date. Equity-based compensation expense is recognized net of an estimated forfeiture rate on a straight-line basis over the requisite service period of the award, except that in the case of RSUs compensation expense is recognized using an accelerated attribution method. Refer to Note 17 for additional information on the stock-based compensation plan in which certain employees of the Company participate.

Pension Plans
The Company measures its pension assets and obligations that determine the funded status as of the end of the Company’s fiscal year, and recognizes an asset for an over funded status or a liability for an underfunded status in its Consolidated Balance Sheets. Changes in the funded status of the pension plans are recognized in the year in which the changes occur and reported in other comprehensive loss. Refer to Note 13 for additional information on the Company’s pension plans including a discussion of the actuarial assumptions, the Company’s policy for recognizing the associated gains and losses and the method used to estimate service and interest cost components.

Accounting Standards Recently Adopted

In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2021-08, Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805), which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts, rather than at fair value. This standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The Company adopted this guidance on January 1, 2022, which did not have a significant impact on the Company’s Consolidated Financial Statements.

In August 2020, the FASB issued ASU 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40),” (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. This guidance is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU 2020-06 was effective for public entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Effective January 1, 2022, the Company adopted ASU 2020-06 using the modified retrospective adoption approach. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption. The comparative prior year information has not been restated and continues to be presented according to accounting standards in effect for those periods.

85

The adoption of ASU 2020-06 resulted in a $75.0 million increase to the carrying value of the convertible notes due 2025, net of deferred debt issuance costs and unamortized discount and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption resulted in a $21.4 million increase to retained earnings and an $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs. Refer to Note 16 for a further discussion of the impact of adopting ASU 2020-06.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. ASU 2020-04 is effective for public entities through December 31, 2022. However, in December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 to defer the effective date of ASU 2020-04 from December 31, 2022 to December 31, 2024. The Company adopted ASU 2020-04 as of December 31, 2022 and its adoption did not have an impact on the Company’s Consolidated Financial Statements.

NOTE 3. ACQUISITIONS
The Company completed the following acquisitions, using the acquisition method of accounting during, the year ended December 31, 2022:

Osteogenics Biomedical Inc., Allotech LLC and OBI Biologics, Inc.
On July 5, 2022, the Company acquired all of the equity of Osteogenics Biomedical Inc., Allotech LLC and OBI Biologics, Inc. (together "Osteogenics") for total consideration of approximately $128.2 million, subject to certain customary adjustments as provided in the Equity Purchase Agreement dated May 17, 2022. Osteogenics develops innovative regenerative solutions for periodontists, oral and maxillofacial surgeons, and clinicians involved in implant dentistry throughout the world, and is part of the Company’s Specialty Products & Technologies segment.

Carestream Dental Technology Parent Limited’s Intraoral Scanner Business
On April 20, 2022, the Company completed the acquisition of Carestream Dental Technology Parent Limited’s (“Carestream Dental”) intraoral scanner business (the “Intraoral Scanner Business”) for total consideration of $580.3 million, including contingent consideration of $7.5 million, and subject to certain customary adjustments as provided in the Stock and Asset Purchase Agreement dated December 21, 2021 and as subsequently amended by the closing agreement dated as of April 20, 2022. The Intraoral Scanner Business manufactures, markets, sells, commercializes, distributes, services, trains, supports, and maintains operations of intraoral scanners and software, and is part of the Company’s Equipment & Consumables segment. The Company purchased the Intraoral Scanner Business through the acquisition of certain assets and the assumption of certain liabilities as well as the acquisition of all of the equity of certain subsidiaries of Carestream Dental.

86

The following table summarizes the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates ($ in millions):

Osteogenics
July 5, 2022		Intraoral Scanner Business
April 20, 2022
Assets acquired:
   Cash$2.1 $2.7 
   Accounts receivable2.5 0.1 
   Inventories13.3 6.1 
   Intangible assets53.0 129.8 
   Property, plant and equipment— 0.3 
   Prepaids and Other Current Assets1.3 — 
   Goodwill77.3 373.1 
   Non-current deferred tax asset— 96.0 
   Operating lease right-of-use assets2.6 0.9 
   Other long-term assets4.9 0.2 
       Total assets acquired157.0 609.2 
Liabilities assumed:
   Accounts payable (4.1)(0.5)
   Accrued expenses and other liabilities (2.5)(27.9)
   Non-current deferred tax liability(14.3)— 
   Other long-term liabilities(5.8)— 
   Operating lease liabilities(2.1)(0.5)
       Total liabilities assumed(28.8)(28.9)
Total net assets acquired$128.2 $580.3 

The Company may up to 12 months after closing refine the estimates of fair value and more accurately allocate the purchase price. Only items that existed as of the acquisition date are considered for subsequent adjustment. The finalization of the acquisition valuation assessment for these acquisitions may result in a change in the valuation of deferred taxes and goodwill, which could have a material impact on the Company’s financial statements.

The intangible assets acquired consist of trade name, developed technology, and customer relationships. The weighted average amortization period of the acquired intangible assets in the aggregate is 8 and 10 years for the Intraoral Scanner Business and Osteogenics, respectively.

The excess of the purchase price over the fair value assigned to the assets acquired and liabilities assumed represents the goodwill resulting from the acquisitions. Goodwill attributable to the acquisitions has been recorded as a non-current asset and is not amortized, but is subject to review at least on an annual basis for impairment. Goodwill recognized was primarily attributable to expected operating efficiencies and expansion opportunities in the businesses acquired. Goodwill is not deductible for income tax purposes. The pro forma impact of the acquisitions is not presented as the acquisitions were not considered material to the Company's Consolidated Financial Statements.

Legal, accounting, and other professional service costs associated with the acquisitions were $14.5 million for the year ended December 31, 2022, and have been recorded as selling, general and administrative expense in the Consolidated Statements of Operations.

87

NOTE 4. DISCONTINUED OPERATIONS
On December 31, 2021, the Company sold substantially all of the KaVo Treatment Unit and Instrument Business (the “Divestiture”) to planmeca Verwaltungs Gmbh, Germany (“Planmeca”), pursuant to the master sale and purchase agreement (the “Purchase Agreement”) among the Company, Planmeca, and Planmeca Oy, as guarantor. On December 30, 2021, the Company entered into an amendment to the Purchase Agreement (the "Amendment"), providing that the transfer of net assets in Russia, China and Brazil (the "Relevant Jurisdictions") would be deferred until the purchaser had formed entities for such transfer of assets in each such Relevant Jurisdiction and the applicable asset transfer agreement could be executed and consummated (each such asset transfer, a "Deferred Local Closing"). Except for the implementation of the Deferred Local Closings and related matters regarding the assets in the Relevant Jurisdictions, the provisions, terms and conditions of the Purchase Agreement were not materially amended by the Amendment. The Amendment did not alter the preliminary purchase price that Planmeca paid to the Company upon the closing of the Divestiture and the Company recognized the applicable gain or loss at the time of each Relevant Jurisdiction’s applicable closing. At December 31, 2021, the Company recorded a liability of $10.8 million for the proceeds related to the Relevant Jurisdictions. At December 31, 2022, all three Relevant Jurisdictions have closed and the related liability associated with the proceeds released. In accordance with the terms of the Purchase Agreement, the Company received total net cash consideration of $386.4 million.

The results of the Divestiture are presented as discontinued operations for all periods presented in the accompanying Consolidated Financial Statements, with the exception of the Consolidated Statements of Cash Flows which include the financial results of the KaVo Treatment Unit and Instrument Business for all periods presented.

The carrying amounts of the assets and liabilities of the Divestiture held for sale are as follows ($ in millions):
December 31, 2021
ASSETS
Current assets:
Assets for Relevant Jurisdictions$12.2 
Current assets held for sale$12.2 
LIABILITIES AND EQUITY
Current liabilities:
Liabilities for Relevant Jurisdictions$4.0 
Current liabilities held for sale$4.0 

For the years ended December 31, 2021 and 2020, the amounts represent activity for the entire Divestiture, while amounts for the year ended December 31, 2022, represent activity for the remaining Relevant Jurisdictions prior to closing. The operating results of the Divestiture are reflected in the Consolidated Statements of Operations within income from discontinued operations, net of tax as follows ($ in millions):
 Year Ended December 31
 202220212020
Sales$11.7 $413.5 $352.9 
Cost of sales9.1 234.6 249.6 
Gross profit2.6 178.9 103.3 
Operating expenses:
Selling, general and administrative3.2 75.6 99.3 
Research and development— 16.1 14.1 
Operating (loss) profit(0.6)87.2 (10.1)
Income tax expense— 21.9 (0.9)
(Loss) income from discontinued operations(0.6)65.3 (9.2)
Gain on sale of discontinued operations, net of tax5.7 11.7 — 
Net income (loss) from discontinued operations$5.1 $77.0 $(9.2)
88

Significant non-cash operating items and capital expenditures for the Divestiture are reflected in the cash flows from operations as follows ($ in millions):
Year Ended December 31
202220212020
Cash flows from operating activities
Non-cash restructuring charges$— $— $9.6 
Impairment charges$— $— $10.5 
Depreciation and amortization1
$— $5.8 $10.9 
Cash flows from investing activities:
Capital expenditures$— $6.7 $3.8 
1 Depreciation and amortization were no longer recognized once the business was classified as discontinued operations as of August 27, 2021.

NOTE 5. CREDIT LOSSES

The allowance for credit losses is a valuation account deducted from accounts receivable to present the net amount expected to be collected. Accounts receivable are charged off against the allowance when management believes the uncollectibility of an accounts receivable balance is confirmed.

Management estimates the adequacy of the allowance by using relevant available information, from internal and external sources, relating to past events, current conditions and forecasts. Historical credit loss experience provides the basis for estimation of expected credit losses and is adjusted as necessary using the relevant information available. The allowance for credit losses is measured on a collective basis when similar risk characteristics exist. The Company has identified one portfolio segment based on the following risk characteristics: geographic regions, product lines, default rates and customer specific factors.

The factors used by management in its credit loss analysis are inherently subject to uncertainty. If actual results are not consistent with management’s estimates and assumptions, the allowance for credit losses may be overstated or understated and a charge or credit to net income (loss) may be required.

The rollforward of the allowance for credit losses is summarized as follows ($ in millions):

Balance at December 31, 2021$20.7 
Foreign currency translation(0.8)
Provision for credit losses4.8 
Write-offs charged against the allowance(4.1)
Recoveries(4.4)
Balance at December 31, 2022$16.2 

NOTE 6. INVENTORIES
The classes of inventory as of December 31 are summarized as follows ($ in millions):
20222021
Finished goods$229.2 $214.3 
Work in process23.9 22.0 
Raw materials103.4 88.3 
Reserve for inventory obsolescence(55.7)(60.8)
Total$300.8 $263.8 

89

NOTE 7. PROPERTY, PLANT AND EQUIPMENT
The classes of property, plant and equipment as of December 31 are summarized as follows ($ in millions):
20222021
Land and improvements$10.0 $10.7 
Buildings and improvements154.5 168.7 
Machinery, equipment and other assets370.2 354.5 
Construction in progress71.2 45.6 
Gross property, plant and equipment605.9 579.5 
Less: accumulated depreciation(312.3)(315.4)
Property, plant and equipment, net$293.6 $264.1 


NOTE 8. LEASES
The Company has operating leases for office space, warehouses, distribution centers, research and development and manufacturing facilities, equipment and vehicles. Many leases include one or more options to renew, some of which include options to extend the lease for up to 20 years and some leases include options to terminate the lease within 30 days. The Company regularly evaluates the renewal options and, when the options are reasonably certain of being exercised, they are included in the lease term. In certain of the Company’s lease agreements, the rental payments are adjusted periodically to reflect actual charges incurred for common area maintenance, utilities, inflation and/or changes in other indexes. The Company has elected to combine lease and non-lease components for leases of all asset classes where the Company is the lessee. At inception, the Company determines whether an agreement represents a lease and, at commencement, evaluates each lease agreement to determine whether the lease is an operating or finance lease.
Variable lease costs consist primarily of taxes, insurance, and common area or other maintenance costs for leased facilities and vehicles, which are paid based on actual costs incurred.
The components of operating lease expense for the years ended December 31 were as follows ($ in millions):
20222021
Fixed operating lease expense (a)
$31.7 $32.4 
Variable operating lease expense7.2 6.1 
Total operating lease expense$38.9 $38.5 
______________
(a)    Includes short-term leases and sublease income, both of which were not significant.
The following table presents the weighted average remaining lease term and weighted average discount rates related to the Company’s operating leases as of December 31:
20222021
Weighted average remaining lease term8 years9 years
Weighted average discount rate4.1 %3.5 %
90

The following table presents the maturity of the Company’s operating lease liabilities as of December 31, 2022 ($ in millions):
2023$32.2 
202428.7 
202523.9 
202619.8 
202716.8 
Thereafter50.3 
Total operating lease payments171.7 
Less: imputed interest(23.3)
Total operating lease liabilities$148.4 
As of December 31, 2022, the Company had no additional significant operating or finance leases that had not yet commenced.

NOTE 9. GOODWILL AND OTHER INTANGIBLE ASSETS
The Company performed its annual goodwill impairment test on the first business day of the fourth quarter of 2022. The Company used a combination of techniques, including an income approach and a market-based approach in performing its annual goodwill impairment test to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value amount. The Company’s reporting units are the financial components of operating segments which constitute businesses for which discrete financial information is available and regularly reviewed by segment management.

No goodwill impairment charges were recorded for the years ended December 31, 2022, 2021 and 2020 and no “triggering” events have occurred subsequent to the performance of the 2022 annual impairment test. The factors used by management in its impairment analysis are inherently subject to uncertainty. If actual results are not consistent with management’s estimates and assumptions, goodwill and other intangible assets may be overstated and a charge to net income may be required.
The following is a rollforward of the Company’s goodwill by segment ($ in millions):
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Balance, December 31, 2021$2,029.7 $1,102.3 $3,132.0 
Acquisitions77.3 373.1 450.4 
Foreign currency translation(59.2)(26.6)(85.8)
Balance, December 31, 2022$2,047.8 $1,448.8 $3,496.6 
91

Finite-lived intangible assets are amortized over the shorter of their legal or estimated useful life. The following summarizes the gross carrying value and accumulated amortization for each major category of intangible asset as of December 31 ($ in millions): 
20222021
Gross
Carrying
Amount		Accumulated
Amortization		Gross
Carrying
Amount		Accumulated
Amortization
Finite-lived intangibles:
Patents and technology$432.2 $(236.4)$313.8 $(215.3)
Customer relationships and other intangibles924.1 (648.7)907.4 (610.9)
Trademarks and trade names224.8 (100.2)216.3 (75.4)
Total finite-lived intangibles1,581.1 (985.3)1,437.5 (901.6)
Indefinite-lived intangibles:
Trademarks and trade names490.9 — 510.5 — 
Total intangibles$2,072.0 $(985.3)$1,948.0 $(901.6)
Total intangible amortization expense in 2022, 2021 and 2020 was $106.0 million, $81.5 million and $87.3 million, respectively. Based on the intangible assets recorded as of December 31, 2022, amortization expense is estimated as follows for the next five years and thereafter:

Years Ending December 31,
2023$99.3 
202489.6
202589.1
202681.1
202776.5
Thereafter160.2 
$595.8 
NOTE 10. ACCRUED EXPENSES AND OTHER LIABILITIES
Accrued expenses and other liabilities as of December 31 were as follows ($ in millions):
20222021
CurrentNoncurrentCurrentNoncurrent
Compensation and benefits$148.0 $17.5 $188.9 $17.9 
Sales and product allowances85.1 1.3 75.4 1.2 
Contract liabilities78.9 8.6 60.1 5.1 
Taxes, income and other42.1 68.6 48.1 201.4 
Restructuring-related employee severance, benefits and other18.9 — 21.9 — 
Pension benefits5.6 17.5 5.6 41.7 
Loss contingencies8.1 27.6 8.4 30.3 
Derivative financial instruments— — 19.6 — 
Other84.7 10.2 134.3 6.6 
Total$471.4 $151.3 $562.3 $304.2 

92

NOTE 11.  HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS
The Company has foreign currency denominated long-term debt in the amount of €208.0 million. This senior unsecured term loan facility represents a partial hedge of the Company’s net investment in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The euro senior unsecured term loan facility is designated and qualifies as a non-derivative hedging instrument. Accordingly, the foreign currency translation of the euro senior unsecured term loan facility is recorded in accumulated other comprehensive loss in equity in the accompanying Consolidated Balance Sheets, offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive loss in equity (see Note 18). Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive loss into income during the period of change. The euro senior unsecured term loan facility matures in September 2024. Refer to Note 16 for a further discussion of the above loan facility.

The Company has used cross-currency swap derivative contracts to partially hedge its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The cross-currency swap derivative contracts were agreements to exchange fixed-rate payments in one currency for fixed-rate payments in another currency. The Company maintained cross-currency swap derivative contracts with respect to its $650.0 million senior unsecured term loan facility. These contracts effectively converted the $650.0 million senior unsecured term loan facility to an obligation denominated in euros and partially offset the impact of changes in currency rates on foreign currency denominated net investments. During the year ended December 31, 2022, the Company settled all of its cross-currency swap derivative contracts and as of December 31, 2022 did not have any cross-currency swap derivative contracts outstanding. The changes in the fair value of these instruments were recorded in accumulated other comprehensive loss in equity, in the accompanying Consolidated Balance Sheets, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that was also recorded in accumulated other comprehensive loss as reflected in Note 18. Any ineffective portions of net investment hedges were reclassified from accumulated other comprehensive loss into income during the period of change. The interest income or expense from these swaps was recorded in interest expense, net in the Company’s Consolidated Statements of Operations consistent with the classification of interest expense attributable to the underlying debt.

The Company has also used interest rate swap derivative contracts to reduce its variability of cash flows related to interest payments with respect to its senior unsecured term loans. The interest rate swap contracts exchanged interest payments based on variable rates for interest payments based on fixed rates. During the year ended December 31, 2022, the existing interest rate swap matured. As of December 31, 2022, the Company did not have any outstanding interest rate swap contracts. The changes in the fair value of these instruments were recorded in accumulated other comprehensive loss in equity (see Note 18). Any ineffective portions of the cash flow hedges were reclassified from accumulated other comprehensive loss into income during the period of change. The interest income or expense from these swaps was recorded in interest expense in the Company’s Consolidated Statements of Operations consistent with the classification of interest expense attributable to the underlying debt.
The following table summarizes the notional values as of December 31, 2022 and 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the years ended December 31, 2022 and 2021 ($ in millions):
Notional AmountGain Recognized in OCI
Year Ended December 31, 2022
Foreign currency denominated debt$222.7 $13.8 
Interest rate contract— 2.2 
Foreign currency contracts— 68.5 
Total$222.7 $84.5 
93

Notional AmountGain Recognized in OCI
Year Ended December 31, 2021
Foreign currency denominated debt$236.5 $32.5 
Interest rate contracts250.0 6.1 
Foreign currency contracts650.0 49.7 
Total$1,136.5 $88.3 

Gains or losses related to the foreign currency contracts and foreign currency denominated debt were classified as foreign currency translation adjustments in the schedule of changes in OCI in Note 18, as these items were attributable to the Company’s hedges of its net investment in foreign operations. Gains or losses related to the interest rate contracts were classified as cash flow hedge adjustments in the schedule of changes in OCI in Note 18. The Company did not reclassify any deferred gains or losses related to net investment and cash flow hedges from accumulated other comprehensive loss to income during the year ended December 31, 2022. The Company reclassified $10.2 million, net of tax, of certain deferred losses related to its net investment hedges from accumulated other comprehensive loss to income during the year ended December 31, 2021 related to the Divestiture. In addition, the Company did not have any ineffectiveness related to net investment and cash flow hedges during the years ended December 31, 2022 and 2021. The cash inflows and outflows associated with the Company’s derivative contracts designated as net investment hedges are classified in investing activities in the accompanying Consolidated Statements of Cash Flows.

The Company’s derivative instruments, as well as its non-derivative debt instruments designated and qualifying as net investment hedges, were classified as of December 31, 2022 and 2021, in the Company’s Consolidated Balance Sheets as follows ($ in millions):
20222021
Derivative liabilities:
Accrued expenses and other liabilities$— $19.6 
Nonderivative hedging instruments:
Long-term debt$222.7 $236.5 
Amounts related to the Company’s derivatives expected to be reclassified from accumulated other comprehensive loss to net income during the next 12 months are not significant.

NOTE 12. FAIR VALUE MEASUREMENTS
Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value where the Company’s assets and liabilities are required to be carried at fair value and provide for certain disclosures related to the valuation methods used within a valuation hierarchy as established within the accounting standards. This hierarchy prioritizes the inputs into three broad levels as follows: Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, or other observable characteristics for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation; and Level 3 inputs are unobservable inputs based on the Company’s assumptions. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety.
94

A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions):
Quoted Prices in
Active Market
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total
December 31, 2022:
Liabilities:
Deferred compensation plans$— $15.8 $— $15.8 
Contingent consideration$— $— $6.0 $6.0 
December 31, 2021:
Liabilities:
Interest rate swap derivative contracts$— $2.2 $— $2.2 
Cross-currency swap derivative contracts$— $17.4 $— $17.4 
Deferred compensation plans$— $16.5 $— $16.5 
Derivative Instruments
The cross-currency and interest rate swap derivative contracts were classified as Level 2 in the fair value hierarchy as they are measured using the income approach with the relevant interest rates, foreign currency current exchange rates and forward curves as inputs. Refer to Note 11 for additional information.

Deferred Compensation Plans
Certain management employees of the Company participate in nonqualified deferred compensation programs that permit such employees to defer a portion of their compensation, on a pretax basis. All amounts deferred under this plan are unfunded, unsecured obligations and are presented as a component of the Company’s compensation and benefits accrual included in accrued expenses in the accompanying Consolidated Balance Sheets (refer to Note 10). Participants may choose among alternative earnings rates for the amounts they defer, which are primarily based on investment options within the Company’s 401(k) program. Changes in the deferred compensation liability under these programs are recognized based on changes in the fair value of the participants’ accounts, which are based on the applicable earnings rates on investment options within the Company’s 401(k) program. Amounts voluntarily deferred by employees into the Company stock fund and amounts contributed to participant accounts by the Company are deemed invested in the Company’s common stock and future distributions of such contributions will be made solely in shares of Company common stock, and therefore are not reflected in the above amounts.
Contingent Consideration
Contingent consideration represents a cash hold back intended to be used for certain liabilities related to the Company’s acquisition of the Intraoral Scanner Business (as further discussed in Note 3). Contingent consideration was classified as Level 3 in the fair value hierarchy as the estimated fair value was measured using a probability weighted discounted cash flow model.
95

Fair Value of Financial Instruments
The carrying amounts and fair values of the Company’s financial instruments as of December 31, were as follows ($ in millions):
20222021
 Carrying AmountFair ValueCarrying AmountFair Value
Liabilities:
Contingent consideration$6.0 $6.0 $— $— 
Interest rate swap derivative contracts$— $— $2.2 $2.2 
Cross-currency swap derivative contracts$— $— $17.4 $17.4 
Convertible senior notes due 2025$510.0 $873.0 $432.1 $1,162.5 
Long-term debt$870.7 $870.7 $883.4 $883.4 
The fair value of long-term debt approximates the carrying value as these borrowings are based on variable market rates. The fair value of the convertible senior notes due 2025 was determined based on the quoted bid price of the convertible senior notes in an over-the-counter market on December 31, 2022 and 2021. The convertible senior notes are considered as Level 2 of the fair value hierarchy. The fair values of cash and cash equivalents, which consist primarily of money market funds, time and demand deposits, trade accounts receivable, net and trade accounts payable approximate their carrying amounts due to the short-term maturities of these instruments.

Refer to Note 13 for information related to the fair value of the Company sponsored defined benefit pension plan assets.

NOTE 13. PENSION AND OTHER BENEFIT PLANS
Certain of the Company’s employees participate in defined benefit pension plans and under certain of these plans, benefit accruals continue. In general, the Company’s policy is to fund these plans based on considerations relating to legal requirements, underlying asset returns, the plan’s funded status, the anticipated deductibility of the contribution, local practices, market conditions, interest rates and other factors.
In connection with the Company’s restructuring activities (see Note 20), the Company had a reduction in participants in certain plans, which contributed to the change in the funded status through plan settlements and curtailments.
96

The following sets forth the funded status of the Company’s plans as of the most recent actuarial valuations using measurement dates of December 31 ($ in millions):
Pension Benefits
20222021
Change in pension benefit obligation:
Benefit obligation at beginning of year$(129.1)$(171.6)
Service cost(5.5)(7.3)
Interest cost(1.8)(1.2)
Employee contributions(2.5)(3.1)
Benefits and other expenses paid3.0 3.3 
Actuarial gain 27.3 13.0 
Amendments, settlements and curtailments7.7 33.2 
Foreign exchange rate impact3.4 4.6 
Benefit obligation at end of year(97.5)(129.1)
Change in plan assets:
Fair value of plan assets at beginning of year80.6 104.1 
Actual return on plan assets(1.7)5.8 
Employer contributions5.5 6.0 
Employee contributions2.5 3.1 
Amendments and settlements(6.6)(32.8)
Benefits and other expenses paid(3.1)(3.3)
Foreign exchange rate impact(2.8)(2.3)
Fair value of plan assets at end of year74.4 80.6 
Funded status$(23.1)$(48.5)

Weighted average assumptions used to determine benefit obligations at date of measurement:
December 31,
20222021
Discount rate3.9 %1.5 %
Rate of compensation increase2.8 %2.2 %
Components of net periodic pension cost:
Year Ended December 31,
($ in millions)202220212020
Service cost$(5.5)$(7.3)$(9.7)
Interest cost(1.8)(1.2)(1.6)
Expected return on plan assets2.6 3.3 3.7 
Amortization of prior service credit and initial net obligation0.3 0.4 0.4 
Amortization of actuarial gain (loss)0.1 (0.7)(1.4)
Net settlement and curtailment gain (loss)1.9 0.8 (1.4)
Net periodic pension cost$(2.4)$(4.7)$(10.0)
97


The following table represents the service cost and other net periodic benefit costs of the defined benefit pension plans incurred during the years ended December 31, 2022, 2021 and 2020 ($ in millions):
202220212020
Service cost:
    Cost of goods sold$(0.8)$(0.8)$(1.2)
    Selling, general and administrative(4.7)(6.5)(8.5)
Other net periodic pension costs:
Other income (expense)3.1 2.6 (0.3)
Total$(2.4)$(4.7)$(10.0)
Weighted average assumptions used to determine net periodic pension cost at date of measurement: 
Year Ended December 31,
20222021
Discount rate2.4 %1.0 %
Expected long-term return on plan assets3.3 %3.2 %
Rate of compensation increase2.2 %1.3 %

The discount rate reflects the market rate on December 31 of the prior year for high-quality fixed-income investments with maturities corresponding to the Company’s benefit obligations and is subject to change each year. The rates appropriate for each plan are determined based on investment grade instruments with maturities approximately equal to the average expected benefit payout under the plan. The Company periodically updates the mortality assumptions used to estimate the projected benefit obligation.

Included in accumulated other comprehensive loss as of December 31, 2022 are the following amounts that have not yet been recognized in net periodic pension cost: unrecognized prior service credits of $2.3 million ($1.8 million, net of tax) and unrecognized actuarial gain of $17.5 million ($13.6 million, net of tax). The unrecognized actuarial gain and prior service credits, net, are calculated as the difference between the actuarially determined projected benefit obligation and the value of the plan assets less accrued pension costs as of December 31, 2022. The amounts included in accumulated comprehensive income (loss) and expected to be recognized in net periodic pension costs during the year ending December 31, 2023 is a prior service credit of $0.4 million ($0.3 million, net of tax) and an actuarial gain of $1.4 million ($1.1 million, net of tax), respectively. No plan assets are expected to be returned to the Company during the year ending December 31, 2023.

Selection of Expected Rate of Return on Assets
The expected rate of return reflects the asset allocation of the plans and is based primarily on contractual earnings rates included in existing insurance contracts as well as on broad, publicly-traded equity and fixed-income indices and forward-looking estimates of active portfolio and investment management. Long-term rate of return on asset assumptions for the plans were determined on a plan-by-plan basis based on the composition of assets and ranged from 2.3% to 5.3% in 2022 and 1.8% to 5.3% in 2021, with a weighted average rate of return assumption of 3.3% and 3.2% in 2022 and 2021, respectively.
Plan Assets
Plan assets are invested in various insurance contracts, equity and debt securities as determined by the administrator of each plan.
The Company has some investments that are valued using Net Asset Value (“NAV”) as a practical expedient. In addition, some of the investments valued using NAV may only allow redemption monthly, quarterly, semiannually or annually and require up to 90 days prior written notice. These investments valued using NAV primarily consist of mutual funds which allow the Company to diversify the portfolio.
98

The fair values of the Company’s pension plan assets as of December 31, 2022, by asset category, were as follows ($ in millions):
Quoted Prices in
Active Market
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total
Cash and cash equivalents$8.4 $— $— $8.4 
Insurance contracts— — 49.7 49.7 
Total$8.4 $— $49.7 $58.1 
Investments measured at NAV (a):
Mutual funds16.3 
Total assets at fair value$74.4 
______________
(a)The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the total plan assets.
The following table summarizes the changes in Level 3 pension plan assets measured at fair value on a recurring basis for the year ended December 31, 2022 (in millions):
Fair Value at January 1Return on Plan AssetsNet Purchases/(Settlements)Transfers Into/(Out of) Level 3Fair Value at December 31
Insurance contracts$50.1 $(0.1)$(0.3)$— $49.7 

The fair values of the Company’s pension plan assets as of December 31, 2021, by asset category, were as follows ($ in millions):
Quoted Prices in
Active Market
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total
Cash and cash equivalents$0.3 $— $— $0.3 
Insurance contracts— — 50.1 50.1 
Total$0.3 $— $50.1 $50.4 
Investments measured at NAV (a):
Mutual funds30.2 
Total assets at fair value$80.6 
______________
(a)The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the total plan assets.
The following table summarizes the changes in Level 3 pension plan assets measured at fair value on a recurring basis for the year ended December 31, 2021 (in millions):
Fair Value at January 1Return on Plan AssetsNet Purchases/(Settlements)Transfers Into/(Out of) Level 3Fair Value at December 31
Insurance contracts$77.2 $(0.6)$(26.5)$— $50.1 
Insurance contracts are valued based upon the quoted prices of the underlying investments of the insurance company. Mutual funds are valued using the NAV based on the information provided by the asset fund managers, which reflects the plan’s share of the fair value of the net assets of the investment.
The methods described above may produce a fair value estimate that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes the valuation methods are appropriate and consistent with the methods used by other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.
99

Expected Contributions
During 2022, the Company contributed $5.5 million to its defined benefit pension plans. During 2023, the Company’s cash contribution requirements for its defined benefit pension plans are expected to be approximately $5.5 million.
The following sets forth benefit payments, which reflect expected future service, as appropriate, at December 31, 2022, are expected to be paid by the plans in the periods indicated ($ in millions):
2023$5.6 
2024$5.1 
2025$5.1 
2026$4.8 
2027$4.8 
2028 - 2032$24.1 
Other Matters
U.S. employees not covered by defined benefit plans are generally covered by defined contribution plans, which provide for Company funding based on a percentage of compensation. The Company provides eligible employees the opportunity to participate in defined contribution savings plans (commonly known as 401(k) plans), which permit contributions on a before-tax basis. Employees may contribute to various investment alternatives. In most of these plans, the Company matches a portion of the employees’ contributions. The Company’s contributions to these plans amounted to $19.1 million, $18.0 million and $11.0 million for the years ended December 31, 2022, 2021 and 2020, respectively.
A limited number of the Company’s subsidiaries, primarily outside of the United States, participate in multiemployer defined benefit plans that require the Company to periodically contribute funds to the plan. Multi-employer pension plans are designed to cover employees from multiple employers. These plans allow multiple employers to pool their pension resources and realize efficiencies associated with the daily administration of the plan. The risks of participating in a multiemployer plan differ from the risks of participating in a single-employer plan in the following respects: (1) assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers, (2) if a participating employer ceases contributing to the plan, the unfunded obligations of the plan may be required to be borne by the remaining participating employers and (3) if the Company elects to stop participating in the plan, the Company may be required to pay the plan an amount based on the unfunded status of the plan.
The Company’s expense for multiemployer pension plans totaled $1.6 million, $3.9 million and $8.2 million for the years ended December 31, 2022, 2021 and 2020, respectively.

NOTE 14. WARRANTY
The Company generally accrues estimated warranty costs at the time of sale. In general, manufactured products are warranted against defects in material and workmanship when properly used for their intended purpose, installed correctly and appropriately maintained. Warranty periods depend on the nature of the product and range from 90 days up to the life of the product. The amount of the accrued warranty liability is determined based on historical information such as past experience, product failure rates or number of units repaired, estimated cost of material and labor and in certain instances estimated property damage. The accrued warranty liability is reviewed on a quarterly basis and may be adjusted as additional information regarding expected warranty costs becomes known.
The following is a rollforward of the Company’s accrued warranty liability ($ in millions):
Balance at December 31, 2021$9.4 
Accruals for warranties issued during the year15.3 
Settlements made(15.1)
Divestiture(0.1)
Effect of foreign currency translation(0.3)
Balance at December 31, 2022$9.2 

100

NOTE 15. LITIGATION AND CONTINGENCIES
The Company records accruals for loss contingencies associated with legal matters when it is probable that a liability will be incurred, and the amount of the loss can be reasonably estimated.

If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss does not meet the known or probable level but is reasonably possible, it is disclosed if deemed material and if such loss or range of loss can be reasonably estimated, the estimated loss or range of loss is disclosed. The Company’s reserves consist of specific reserves for individual claims and additional amounts for anticipated developments of these claims as well as for incurred but not yet reported claims. The specific reserves for individual known claims are quantified with the assistance of legal counsel and outside risk professionals where appropriate. In addition, outside risk professionals assist in the determination of reserves for certain incurred but not yet reported claims through evaluation of the Company’s specific loss history, actual claims reported and industry trends among statistical and other factors. The Company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated and has accrued $35.7 million and $38.7 million as of December 31, 2022 and 2021, respectively, which are included in accrued liabilities in the Consolidated Balance Sheets. The Company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with ASC 450-20-25. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions including timing of related payments. The ability to make such estimates and judgments can be affected by various factors including, among other things, whether damages sought in the proceedings are unsubstantiated or indeterminate; legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; procedural or jurisdictional issues; the uncertainty and unpredictability of the number of potential claims; or there are numerous parties involved. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated. In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's Consolidated Balance Sheets, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company’s results of operations and cash flows for that period.

The Company is subject to various environmental laws and regulations both within and outside of the United States. The operations of the Company involve the use of substances regulated under environmental laws, primarily in manufacturing processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws or potential enforcement actions by regulatory agencies, management believes that such compliance or potential enforcement actions will not have a material impact on the Company’s financial position, results of operations, or liquidity.

As of December 31, 2022, the Company had $19.0 million of guarantees consisting primarily of outstanding standby letters of credit and bank guarantees. These guarantees have been provided in connection with certain arrangements with vendors, customers, insurance providers, financing counterparties and governmental entities to secure the Company’s obligations and/or performance requirements related to specific transactions.

NOTE 16. DEBT AND CREDIT FACILITIES
The components of the Company’s debt as of December 31, were as follows, net of debt discount and debt issuance costs ($ in millions):
20222021
Senior term loan facility due 2024 (the “Term Loan”)
$648.3 $647.3 
Senior euro term loan facility due 2024 (the “Euro Term Loan”)222.4 236.1 
Convertible senior notes due 2025
510.0 432.1 
Other— 0.3 
Total debt1,380.7 1,315.8 
Less: current portion(510.0)(432.4)
Long-term debt$870.7 $883.4 

101

The Company’s contractual minimum principal payments are as follows ($ in millions):

2023$— 
2024872.7 
2025517.5 
Total$1,390.2 

Credit Agreement
On September 20, 2019, the Company entered into a credit agreement (the “Credit Agreement”) with a syndicate of banks under which Envista borrowed approximately $1.3 billion, consisting of the three-year $650.0 million Term Loan and the three-year €600.0 million Euro Term Loan (together with the Term Loan, the “Term Loans”). The Credit Agreement also included the five-year, $250.0 million revolving credit facility (together with the Term Loans, the “Senior Credit Facilities”).

On February 9, 2021, in connection with an amendment to the Credit Agreement, the Company repaid $472.0 million of its Euro Term Loan.

On June 15, 2021, the Company entered into an amended and restated credit agreement (the “Amended Credit Agreement”) with a syndicate of banks. The Amended Credit Agreement amends and restates the Company’s Credit Agreement, originally dated September 20, 2019 (as amended by Amendment No. 1 to Credit Agreement dated as of May 6, 2020, Amendment No. 2 to Credit Agreement dated as of May 19, 2020, and Amendment No. 3 to Credit Agreement dated as of February 9, 2021).

Under the Amended Credit Agreement: (a) the maturity date of the Company’s existing Term Loans has been extended to September 20, 2024, (b) the revolving credit facility has been increased from $250.0 million to $750.0 million, (c) the Company may request further increases to the revolving credit facility in an aggregate amount not to exceed $350.0 million, (d) the amount of cash and cash equivalents permitted to be netted in the definition of “Consolidated Funded Indebtedness” has been increased to up to the greater of (i) $250.0 million and (ii) 50% of Consolidated EBITDA as of the most recent measurement period, and (e) the floor on Eurocurrency rate loans applicable to the revolving credit facility and the Term Loan has been reduced to zero, in each case subject to and in accordance with the terms and conditions of the Amended Credit Agreement. The Company paid fees aggregating approximately $2.1 million in connection with the Amended Credit Agreement.

The revolving credit facility includes an aggregate available borrowing capacity of $750.0 million with a $20.0 million sublimit for the issuance of standby letters of credit and can be used for working capital and other general corporate purposes. As of December 31, 2022 and December 31, 2021, there were no borrowings outstanding under the revolving credit facility.
Under the Senior Credit Facilities, borrowings bear interest as follows: (1) Eurocurrency Rate Loans (as defined in the Amended Credit Agreement) bear interest at a variable rate equal to the London inter-bank offered (“LIBOR”) rate plus a margin of between 0.785% and 1.625%, depending on the Company’s Consolidated Leverage Ratio (as defined in the Amended Credit Agreement) as of the last day of the immediately preceding fiscal quarter; and (2) Base Rate Loans (as defined in the Amended Credit Agreement) bear interest at a variable rate equal to (a) the highest of (i) the Federal funds rate (as published by the Federal Reserve Bank of New York from time to time) plus 0.50%, (ii) Bank of America’s “prime rate” as publicly announced from time to time and (iii) the Eurocurrency Rate (as defined in the Amended Credit Agreement) plus 1.0%, plus (b) a margin of between 0.00% and 0.625%, depending on the Company’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter. In no event will Eurocurrency Rate Loans or Base Rate Loans bear interest at a rate lower than 0.0%. The Amended Credit Agreement provides for the use of Secured Overnight Financing Rate (“SOFR”) as a replacement rate upon a LIBOR cessation event. In addition, the Company is required to pay a per annum facility fee of between 0.09% and 0.225% depending on the Company’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter and based on the aggregate commitments under the revolving credit facility, whether drawn or not.
102

The interest rates for borrowings under the Term Loan were 5.98% and 1.25% as of December 31, 2022 and 2021, respectively. The interest rate for borrowings under the Euro Term Loan was 3.28% and 0.95% as of December 31, 2022 and 2021, respectively. Interest is payable quarterly for the Term Loans. The Amended Credit Agreement requires the Company to maintain a Consolidated Leverage Ratio of 3.75 to 1.00 or less and includes a provision that the maximum Consolidated Leverage Ratio will be increased to 4.25 to 1.00 for the four consecutive full fiscal quarters immediately following the consummation of any acquisition by the Company or any subsidiary of the Company in which the purchase price exceeds $100.0 million. The Amended Credit Agreement also requires the Company to maintain a Consolidated Interest Coverage Ratio (as defined in the Amended Credit Agreement) of at least 3.00 to 1.00. The Amended Credit Agreement contains customary representations, warranties, conditions precedent, events of default, indemnities and affirmative and negative covenants, including covenants that, among other things, limit or restrict the Company’s and/or the Company’s subsidiaries ability, subject to certain exceptions and qualifications, to incur liens or indebtedness, merge, consolidate or sell or otherwise transfer assets, make dividends or distributions, enter into transactions with the Company’s affiliates and use proceeds of the debt financing for other than permitted uses. The Amended Credit Agreement also contains customary events of default. Upon the occurrence and during the continuance of an event of default, the lenders may declare the outstanding advances and all other obligations under the Amended Credit Agreement immediately due and payable. The Company was in compliance with all of its debt covenants as of December 31, 2022.
Convertible Senior Notes (the “Notes”)

On May 21, 2020, the Company issued the Notes due on June 1, 2025, unless earlier repurchased, redeemed or converted. The aggregate principal amount, which includes the initial purchasers’ exercise in full of their option to purchase an additional $67.5 million principal amount of the Notes, was $517.5 million. The net proceeds from the issuance, after deducting purchasers’ discounts and estimated offering expenses, were $502.6 million. The Company used part of the net proceeds to pay for the capped call transactions (“Capped Calls”) as further described below. The Notes accrue interest at a rate of 2.375% per annum, payable semi-annually in arrears on June 1 and December 1 of each year, beginning on December 1, 2020. The Notes have an initial conversion rate of 47.5862 shares of the Company’s common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $21.01 per share of the Company’s common stock and is subject to adjustment upon the occurrence of specified events. The Notes are governed by an indenture dated as of May 21, 2020 (the “Indenture”) between the Company and Wilmington Trust, National Association, as trustee. The Indenture does not contain any financial covenants or any restrictions on the payment of dividends, the incurrence of senior debt or other indebtedness or the issuance or repurchase of the Company’s securities by the Company.

Prior to the adoption of ASU 2020-06, the Company separated the carrying amounts of the Notes and total issuance costs incurred into liability and equity components. For the Notes, the carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that did not have an associated convertible feature, while the carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the Notes. Total issuance costs incurred were then allocated to the liability and equity components of the Notes based on their relative values.

Due to the Company’s adoption of ASU 2020-06 on January 1, 2022, the Notes and related issuance costs incurred are no longer required to be bifurcated into separate liability and equity components. This resulted in a $75.0 million increase to the carrying value of the Notes due 2025, comprised of unamortized discount of $76.5 million and deferred debt issuance costs of $1.5 million and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption of ASU 2020-06 resulted in a $21.4 million increase to retained earnings and an $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs.

The Notes are the Company’s senior, unsecured obligations and are (i) equal in right of payment with the Company’s existing and future senior, unsecured indebtedness; (ii) senior in right of payment to the Company’s existing and future indebtedness that is expressly subordinated to the Notes; (iii) effectively subordinated to the Company’s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness; and (iv) structurally subordinated to all existing and future indebtedness and other liabilities, including trade payables, and (to the extent the Company is not a holder thereof) preferred equity, if any, of the Company’s subsidiaries.

103

Holders of the Notes may convert their Notes at any time on or after December 2, 2024 until the close of business on the second scheduled trading day preceding the maturity date. Holders of the Notes will also have the right to convert the Notes prior to December 2, 2024, but only upon the occurrence of specified events. In December 2021, the Company made the irrevocable election to settle all Notes conversions through combination settlement, satisfying the principal amount outstanding with cash and any Notes conversion value in excess of the principal amount in cash, shares of the Company’s common stock or a combination of both. If a fundamental change occurs prior to the maturity date, holders of the Notes may require the Company to repurchase all or a portion of their Notes for cash at a repurchase price equal to 100.0% of the principal amount plus any accrued and unpaid interest. In addition, if specific corporate events occur prior to the maturity date, the Company would increase the conversion rate for a holder who elects to convert its Notes in connection with such an event in certain circumstances. As of December 31, 2022 and 2021, the stock price exceeded 130% of the conversion price of $21.01 in 20 days of the final 30 trading days ended December 31, 2022 and 2021, which satisfied one of the conditions permitting early conversion by holders of the Notes, therefore, the Notes are classified as short-term debt.

The Notes will be redeemable, in whole or in part, at the Company’s option at any time, and from time to time, on or after June 1, 2023 and on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding the redemption date, but only if the last reported sale price per share of the Company’s common stock exceeds 130.0% of the conversion price on (i) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (ii) the trading day immediately before the date the Company sends such notice. In addition, calling any Note for redemption will constitute a “Make-Whole Fundamental Change” (as defined in the Indenture) with respect to that Note, in which case the conversion rate applicable to the conversion of that Note will be increased in certain circumstances if it is converted after it is called for redemption.

The following table sets forth total interest expense recognized related to the Notes ($ in millions):

Year Ended December 31,
20222021
Contractual interest expense
$12.3 $12.3 
Amortization of debt issuance costs
2.9 1.9 
Amortization of debt discount
— 19.0 
Total interest expense
$15.2 $33.2 

For the years ended December 31, 2022 and 2021, the debt discount and debt issuance costs were amortized using an annual effective interest rate of 3.0% and 7.3%, respectively, to interest expense over the term of the Notes.

As of December 31, 2022 and 2021, the if-converted value of the Notes exceeded the outstanding principal amount by $311.7 million and $592.1 million, respectively.

104

Debt Discount and Debt Issuance Costs

As of December 31, 2022 and 2021, remaining unamortized debt discount and debt issuance costs for the Term Loan, Euro Term Loan and Convertible Senior Notes are as follows ($ in millions):
20222021
Debt Issuance CostsDebt DiscountDebt Issuance CostsDebt Discount
Convertible Senior Notes$7.5 $— $8.9 $76.5 
Term Loan1.7 — 2.7 — 
Euro Term Loan0.3 — 0.5 — 
$9.5 $— $12.1 $76.5 

The above unamortized debt discount and debt issuance costs have been netted against their respective aggregate principal amounts of the related debt and are being amortized to interest expense over the term of the respective debt.
Capped Call Transactions
In connection with the offering of the Notes, the Company entered into Capped Calls with certain counterparties. The Capped Calls each have an initial strike price of approximately $21.01 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Notes. The Capped Calls have initial cap prices of $23.79 per share, subject to certain adjustments. The Capped Calls cover, subject to anti-dilution adjustments, 2.9 million shares of the Company's common stock. The Capped Calls are generally intended to reduce or offset the potential dilution from shares of common stock issued upon any conversion of the Notes with such reduction or offset, as the case may be, subject to a cap based on the cap price. As the Capped Call transactions are considered indexed to the Company's own stock and are considered equity classified, they are recorded in equity and are not accounted for as derivatives. The cost of $20.7 million incurred in connection with the Capped Calls was recorded as a reduction to additional paid-in capital.

NOTE 17. STOCK TRANSACTIONS AND STOCK-BASED COMPENSATION
Capital Stock
Under the Company’s amended and restated certificate of incorporation, the Company’s authorized capital stock consists of 500.0 million shares of common stock with a par value of $0.01 per share and 15.0 million shares of preferred stock with a par value of $0.01 per share. No preferred shares were issued or outstanding as of December 31, 2022 and 2021.
Each share of the Company’s common stock entitles the holder to one vote on all matters to be voted upon by common stockholders. The Company’s Board of Directors (the “Board”) is authorized to issue shares of preferred stock in one or more series and has discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series of preferred stock. The Board’s authority to issue preferred stock with voting rights or conversion rights that, if exercised, could adversely affect the voting power of the holders of common stock, could potentially discourage attempts by third parties to obtain control of the Company through certain types of takeover practices.
The following table summarizes the Company’s stock activity (shares in millions):
Year Ended December 31,
202220212020
Common stock - shares issued:
Balance, beginning of period162.0 160.2 158.7 
Issuance of common stock 1.7 1.8 1.5 
Balance, end of period163.7 162.0 160.2 
105

Stock-Based Compensation
The Company adopted the 2019 Omnibus Incentive Plan (the “Stock Plan”) that provides for the grant of stock appreciation rights, restricted stock units (“RSUs”), and performance stock units (‘PSUs”) (collectively, “Stock Awards”), as well as stock options (“Options”). A total of 21.0 million shares of the Company’s common stock have been authorized for issuance under the Stock Plan. Under the Stock Plan, stock-based grants are awarded at a price equal to the fair market value at the date of grant based upon the closing price on that date. Options and Stock Awards generally vest over a period of three to five years. Options expire ten years after the date of grant.
RSUs issued under the Stock Plan provide for the issuance of a share of the Company’s common stock at no cost to the holder. The RSUs granted to employees provide for time-based vesting, generally over a three to five-year period. Prior to vesting, RSUs granted under the Stock Plan do not have dividend equivalent rights, do not have voting rights and the shares underlying the RSUs are not considered issued and outstanding. PSUs issued under the Stock Plan provide for the issuance of a share of the Company’s common stock based on the achievement of various financial performance metric targets and market conditions, which are set at the time of grant.

The Company accounts for stock-based compensation by measuring all RSUs, PSUs and Options at fair value as of the grant date. The Company recognizes the compensation expense over the requisite service period (which is generally the vesting period but may be shorter than the vesting period if the employee becomes retirement eligible before the end of the vesting period). The fair value for RSU awards is calculated using the closing price of the Company’s common stock on the date of grant. The fair value of the Options granted is calculated using a Black-Scholes option pricing model (“Black-Scholes”).
On December 23, 2021 and January 21, 2022, the Company entered into and finalized, respectively, an RSU agreement with Pacific Dental Services (“PDS”) which awarded PDS RSUs with a fair value of $12.5 million, or 273,522 RSUs, based on the Company’s stock price on December 23, 2021. The RSUs vest over approximately three years and contain performance milestones. All of the 273,522 RSUs remained unvested as of December 31, 2022.
The following summarizes the assumptions used in the Black-Scholes model to value Options granted during the years ended December 31:
202220212020
Risk-free interest rate
1.9 – 3.1%
1.0 – 1.3%
0.4 – 1.2%
Weighted average volatility33.6 %25.3 %25.3 %
Dividend yield— %— %— %
Expected years until exercise
6.0
6.0
6.0
The risk-free rate of interest for periods within the contractual life of the awards is based on a zero-coupon U.S. government instrument with a maturity period that approximates the award’s expected term. The weighted average volatility used in the Black-Scholes model to value Options was estimated based on an average historical stock price volatility of a peer group of companies. The dividend yield was 0.0% as the Company does not offer a dividend. To estimate the option exercise timing used in the valuation model, in addition to considering the vesting period and contractual term of the Option, the Company analyzes and considers actual historical exercise experience for previously granted awards.
The amount of stock-based compensation expense recognized during a period is also based on the portion of the awards that are ultimately expected to vest. The Company estimates pre-vesting forfeitures at the time of grant by analyzing historical data and revises those estimates in subsequent periods if actual forfeitures differ from those estimates. The Company has estimated an annual forfeiture rate of 6.0% for the years ended December 31, 2022, 2021 and 2020.
The following summarizes the components of the Company’s stock-based compensation expense for the years ended December 31 ($ in millions):
202220212020
RSUs / PSUs$19.3 $15.5 $13.3 
Options11.2 12.2 8.9 
Total stock-based compensation expense$30.5 $27.7 $22.2 

106

The Company’s stock-based compensation is primarily recognized as a component of selling, general and administrative expenses in the accompanying Consolidated Statements of Operations. As of December 31, 2022, $43.6 million of total unrecognized compensation cost related to Options and RSUs/PSUs is expected to be recognized over a weighted average period of approximately two years.

The following summarizes the Company’s Option activity (in millions; except price per share and numbers of years):
Number of Stock Options
Weighted
Average
Exercise Price
Weighted Average
Remaining
Contractual Term
(in years)
Aggregate
Intrinsic
Value
Outstanding as of December 31, 20198.0 $17.81 
Granted
2.2 $26.14 
Exercised
(1.0)$14.01 
Cancelled/forfeited
(1.1)$21.17 
Outstanding as of December 31, 20208.1 $20.08 
Granted
1.7 $38.15 
Exercised
(1.3)$15.74 
Cancelled/forfeited
(0.6)$26.74 
Outstanding as of December 31, 20217.9 $24.16 
Granted
0.5 $48.23 
Exercised
(1.2)$18.61 
Cancelled/forfeited
(0.7)$30.29 
Outstanding as of December 31, 20226.5 $26.24 6.3$59.7 
Vested and expected to vest as of December 31, 2022
6.3 $26.09 6.3$58.8 
Vested as of December 31, 2022
3.2 $22.01 5.4$39.3 

Options outstanding as of December 31, 2022 are summarized below (in millions; except price per share and numbers of years):
OutstandingExercisable
Exercise PriceNumber of Stock OptionsAverage
Exercise Price		Average
Remaining
Life
(in years)		Number of Stock OptionsAverage
Exercise Price
$9.74 to 12.65
0.4 $12.00 2.40.4 $12.00 
$12.66 to 19.22
1.6 $17.95 4.81.3 $17.66 
$19.23 to 26.50
2.7 $24.15 6.51.0 $24.10 
$26.51 to $41.95
1.4 $36.74 7.90.5 $35.85 
$41.96 to 48.52
0.4 $48.01 8.9— $43.30 
The intrinsic value of Options is calculated as the amount by which the market price of the Company’s stock exceeds the exercise price of the Option. The aggregate intrinsic value of Options exercised during the years ended December 31, 2022, 2021 and 2020 was $31 million, $33 million and $12 million, respectively.
107

The following summarizes information on unvested RSU and PSU activity related to the Company’s employees and non-employee directors (in millions; except weighted average grant-date fair value):
Number of
RSUs/PSUs		Weighted Average
Grant-Date Fair Value
Unvested at December 31, 20192.1 $19.60 
Granted0.7 $25.76 
Vested(0.5)$17.87 
Forfeited(0.4)$20.98 
Unvested at December 31, 20201.9 $22.01 
Granted0.5 $38.76 
Vested(0.5)$20.34 
Forfeited(0.2)$26.54 
Unvested at December 31, 20211.7 $26.82 
Granted0.6 $47.80 
Vested(0.5)$24.85 
Forfeited(0.3)$33.62 
Unvested at December 31, 20221.5 $34.85 

The Company recognizes tax benefits for stock compensation in certain jurisdictions, primarily the United States, where tax deductions are based on market value at exercise or release and may exceed the grant-date value. The Company realized such tax benefits of $4 million, $4 million and $1 million in 2022, 2021 and 2020, respectively, related to the exercise of Options and $1 million in each of the years ended December 31, 2022, 2021 and 2020, related to the vesting and release of RSUs and PSUs. For all periods presented, the tax benefits were included as a component of income tax expense and as an operating cash inflow in the accompanying Consolidated Financial Statements.
In connection with the exercise of certain Options and the vesting of RSUs and PSUs, a number of shares sufficient to fund statutory minimum tax withholding requirements has been withheld from the total shares issued or released to the award holders (though under the terms of the applicable plan, the shares are considered to have been issued and are not added back to the pool of shares available for grant). During the year ended December 31, 2022, 192.4 thousand shares with an aggregate value of $9 million were withheld to satisfy the requirement. During the year ended December 31, 2021, 181.7 thousand shares with an aggregate value of $7 million were withheld to satisfy the requirement.
108

NOTE 18. ACCUMULATED OTHER COMPREHENSIVE LOSS
The changes in accumulated other comprehensive loss by component are summarized below ($ in millions):
Foreign Currency Translation AdjustmentsUnrealized Gain (Loss) on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Balance, December 31, 2019$(116.4)$0.1 $(27.9)$(144.2)
Other comprehensive income (loss) before reclassifications:
Increase (decrease)26.0 (8.4)3.9 21.5 
Income tax impact27.9 2.0 (1.1)28.8 
Other comprehensive income (loss) before reclassifications, net of income taxes53.9 (6.4)2.8 50.3 
Amounts reclassified from accumulated other comprehensive (loss) income:
Increase— — 2.9 2.9 
Income tax impact— — (0.8)(0.8)
Amounts reclassified from accumulated other comprehensive (loss) income, net of income taxes— — 2.1 2.1 
Net current period other comprehensive income (loss), net of income taxes
53.9 (6.4)4.9 52.4 
Balance, December 31, 2020$(62.5)$(6.3)$(23.0)$(91.8)
Other comprehensive loss before reclassifications:
(Decrease) increase(72.7)6.1 21.9 (44.7)
Income tax impact(17.0)(1.5)(4.7)(23.2)
Other comprehensive (loss) income before reclassifications, net of income taxes(89.7)4.6 17.2 (67.9)
Amounts reclassified from accumulated other comprehensive loss income:
Increase15.9 — 5.0 20.9 
Income tax impact(3.3)— (1.4)(4.7)
Amounts reclassified from accumulated other comprehensive loss, net of income taxes12.6 — 3.6 16.2 
Net current period other comprehensive (loss) income, net of income taxes(77.1)4.6 20.8 (51.7)
Balance, December 31, 2021$(139.6)$(1.7)$(2.2)$(143.5)
Other comprehensive loss before reclassifications:
(Decrease) increase(80.5)2.2 24.6 (53.7)
Income tax impact(20.4)(0.5)(5.2)(26.1)
Other comprehensive (loss) income before reclassifications, net of income taxes(100.9)1.7 19.4 (79.8)
Amounts reclassified from accumulated other comprehensive loss income:
Increase— — (2.3)(2.3)
Income tax impact— — 0.5 0.5 
Amounts reclassified from accumulated other comprehensive loss, net of income taxes— — (1.8)(1.8)
Net current period other comprehensive (loss) income, net of income taxes(100.9)1.7 17.6 (81.6)
Balance, December 31, 2022$(240.5)$— $15.4 $(225.1)


109

NOTE 19. REVENUE
The following table presents the Company’s revenues disaggregated by geographical region for the years ended December 31, 2022 and 2021 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenues. The Company has historically defined emerging markets as developing markets of the world, which prior to the COVID-19 pandemic, experienced extended periods of accelerated growth in gross domestic product and infrastructure, including Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets of the world that are not emerging markets.
Year Ended December 31, 2022
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Geographical region:
North America$711.1 $655.3 $1,366.4 
Western Europe388.9 121.1 510.0 
Other developed markets91.0 38.6 129.6 
Emerging markets407.6 155.5 563.1 
Total$1,598.6 $970.5 $2,569.1 

Year Ended December 31, 2021
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Geographical region:
North America$668.9 $659.3 $1,328.2 
Western Europe366.6 125.9 492.5 
Other developed markets98.2 41.2 139.4 
Emerging markets374.1 174.7 548.8 
Total$1,507.8 $1,001.1 $2,508.9 

Sales by Major Product Group:
Year Ended December 31,
($ in millions)202220212020
Consumables$2,147.5 $2,067.9 $1,590.7 
Equipment421.6 441.0 338.4 
Total$2,569.1 $2,508.9 $1,929.1 
Consumable products include implants, regenerative products, prosthetics, orthodontic brackets, aligners and lab products from our Specialty Products & Technologies business segment and traditional consumables such as bonding agents and cements, impression materials, infection prevention products and restorative products from the Company’s Equipment & Consumables business segment. The Company’s equipment products include digital imaging systems, software and other visualization and magnification systems.

Remaining Performance Obligations
ASC 606 requires disclosure of remaining performance obligations that represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. Remaining performance obligations include noncancelable purchase orders, extended warranty and service agreements and do not include revenue from contracts with customers with an original term of one year or less.

110

As of December 31, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was $52.7 million and the Company expects to recognize revenue on the majority of this amount over the next 12 months.
Contract Liabilities
The Company often receives cash payments from customers in advance of the Company’s performance resulting in contract liabilities. These contract liabilities are classified as either current or long-term in the Consolidated Balance Sheets based on the timing of when the Company expects to recognize revenue. As of December 31, 2022 and 2021, the contract liabilities were $87.5 million and $65.2 million, respectively, and are included within accrued expenses and other liabilities and other long-term liabilities in the accompanying Consolidated Balance Sheets. The increase in the contract liability balance during the years ended December 31, 2022 and 2021, is primarily due to cash payments received in advance of satisfying performance obligations, partially offset by revenue recognized during the period that was included in the contract liability balance at December 31, 2021 and 2020, respectively.
Revenue recognized during the years ended December 31, 2022 and 2021 that was included in the contract liability balance at December 31, 2021 and December 31, 2020 was $52.8 million and $38.4 million, respectively.
Significant Customers
Sales to the Company’s largest customer were 11%, 12%, and 11% of sales for the years ended December 31, 2022, 2021 and 2020, respectively.

NOTE 20. RESTRUCTURING ACTIVITIES AND RELATED IMPAIRMENTS
Restructuring Activities
The Company’s restructuring activities are undertaken as necessary to implement management’s strategy, streamline operations, take advantage of available capacity and resources, and ultimately achieve net cost reductions. These activities generally relate to the realignment of existing manufacturing capacity and closure of facilities and other exit or disposal activities, as it relates to executing the Company’s strategy, pursuant to significant restructuring programs.
The related liability which is included in accrued liabilities in the Consolidated Balance Sheets is summarized below ($ in millions):
Employee Severance
and Related		Facility Exit
and Related		Total
Balance, December 31, 2021$21.4 $0.5 21.9 
Costs incurred20.8 5.7 26.5 
Paid/settled(24.0)(5.5)(29.5)
Balance, December 31, 2022$18.2 $0.7 $18.9 

Restructuring related charges recorded for the years ended December 31 by segment were as follows ($ in millions): 
202220212020
Specialty Products & Technologies$14.7 $25.2 $43.8 
Equipment & Consumables19.7 32.1 34.6 
Other3.2 6.3 6.0 
Total$37.6 $63.6 $84.4 
111

The restructuring related charges incurred during the years ended December 31, are reflected in the following captions in the accompanying Consolidated Statements of Operations ($ in millions):
202220212020
Cost of sales$13.6 $35.9 $18.3 
Selling, general and administrative expenses24.0 27.7 66.1 
Total$37.6 $63.6 $84.4 
Impairments

During the year ended December 31, 2022 and 2021, the Company made the decision to consolidate certain facilities in an effort to improve its cost structure. For the year ended December 31, 2022, the Company recognized a non-cash loss of $11.1 million with the majority of this loss consisting of $4.8 million related to the impairment of certain fixed assets and leases, which are included in selling, general and administrative expense and cost of sales and $4.7 million of inventory write-offs, which is included in cost of sales. For the year ended December 31, 2021, the Company recognized a non-cash loss of $29.8 million with the majority of this loss consisting of $19.0 million related to the impairment of certain fixed assets and leases, which are included in selling, general and administrative expense and cost of sales and $10.8 million of inventory write-offs, which is included in cost of sales.

NOTE 21. INCOME TAXES
Income (loss) before income taxes for the years ended December 31 were as follows ($ in millions):
202220212020
United States$21.9 $35.0 $(64.3)
International262.0 219.5 44.3 
Total$283.9 $254.5 $(20.0)
The provision (benefit) for income taxes for the years ended December 31 were as follows ($ in millions):
202220212020
Current:
Federal U.S.$42.5 $17.7 $13.1 
Non-U.S.22.4 26.9 13.5 
State and local8.6 4.4 0.9 
Deferred:
Federal U.S.(31.3)(2.2)(13.1)
Non-U.S.11.3 (57.5)(72.7)
State and local(7.6)1.7 (4.2)
Income tax provision (benefit)$45.9 $(9.0)$(62.5)
112

Deferred tax assets and deferred tax liabilities are classified as long-term and are included in other long-term assets and other long-term liabilities, respectively, in the accompanying Consolidated Balance Sheets. Significant components of deferred tax assets and liabilities as of December 31 were as follows ($ in millions):
20222021
Deferred tax assets:
Inventories$15.4 $17.4 
Pension benefits6.2 11.5 
Other accruals and prepayments45.3 54.3 
Lease liabilities35.5 34.2 
Stock-based compensation expense7.5 6.8 
Interest expense36.0 8.7 
Capitalized research expenses15.1 3.8 
Tax credit and loss carryforwards38.2 117.3 
Valuation allowances(38.7)(90.0)
Total deferred tax asset160.5 164.0 
Deferred tax liabilities:
Property, plant and equipment(5.7)(9.6)
Unrealized gains and losses(6.2)(6.5)
Right-of-use assets(31.5)(30.3)
Goodwill and other intangible assets(92.2)(192.3)
Total deferred tax liability(135.6)(238.7)
Net deferred tax asset (liability)$24.9 $(74.7)
Deferred taxes associated with U.S. entities consist of net deferred tax liabilities of $15.1 million and $133.0 million as of December 31, 2022 and 2021, respectively. Deferred taxes associated with non-U.S. entities consist of net deferred tax assets of $40.0 million and $58.5 million as of December 31, 2022 and 2021, respectively. During 2022, the Company’s valuation allowance decreased by $51.3 million primarily due to a corresponding expiration of certain foreign net operating losses.

The Company’s intent is to permanently reinvest substantially all funds outside of the United States and current plans do not demonstrate a need to repatriate the cash to fund U.S. operations. However, if these funds were repatriated, they would likely not be subject to United States federal income tax under the previously taxed income or the dividend exemption rules. The Company would likely be required to accrue and pay United States state and local taxes and withholding taxes payable to various countries. It is not practicable to estimate the tax impact of the reversal of the outside basis difference, or the repatriation of cash due to the complexity of its hypothetical calculation.

The 2022 decrease in the deferred tax liability for goodwill and other intangible assets included an income tax benefit of approximately $100.2 million related primarily to the acquisition of amortizable deferred tax assets associated with the Intraoral Scanner Business acquisition partially offset with deferred tax liabilities established in connection with the Osteogenics acquisition.

Current tax law in the United States imposes tax on U.S. stockholders for global intangible low-taxed income (“GILTI”) earned by certain foreign subsidiaries. The Company is required to make an accounting policy election of either: (1) treating taxes due on future amounts included in the U.S. taxable income related to GILTI as a current period tax expense when incurred (“the period cost method”); or (2) factoring such amounts into the Company’s measurement of its deferred tax its deferred tax expense (the “deferred method”). In 2018, the Company elected the period cost method for its accounting for GILTI.

113

The effective income tax rate for the years ended December 31 varies from the U.S. statutory federal income tax rate as follows:
Percentage of Pretax Income
202220212020
Statutory federal income tax rate21.0 %21.0 %21.0 %
Increase (decrease) in tax rate resulting from:
State income taxes (net of federal income tax benefit)0.3 1.2 17.0 
Impact of foreign operations(5.0)(6.4)80.4 
Foreign-Derived Intangible Income (“FDII”)(0.7)— — 
Subpart F and GILTI, net of foreign tax credits6.7 6.4 (72.4)
Change in uncertain tax positions(0.5)— 3.4 
Research and experimentation credits and other(1.6)(1.6)13.2 
Permanent differences and other(0.9)2.7 (20.3)
Excess tax benefit from stock-based compensation(1.6)(1.9)11.6 
Valuation allowance release on certain Swiss NOLs— (8.1)— 
Impact of step-up of Swiss assets(1.5)(16.8)258.6 
Effective income tax rate16.2 %(3.5)%312.5 %
The Company realized tax benefits of $7.2 million, $6.7 million, and $4.2 million in 2022, 2021 and 2020 respectively, for tax deductions attributable to stock-based compensation, of which, the excess tax benefit over the amount recorded for financial reporting purposes was $4.6 million, $4.8 million and $2.3 million in 2022, 2021 and 2020, respectively. As required by ASU 2016-09, Compensation—Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”), the excess tax benefits for the years ended December 31, 2022, 2021 and 2020 have been included in the provision for income taxes.
The Company evaluates the future realizability of tax credits and loss carryforwards considering the anticipated future earnings of the Company’s subsidiaries as well as tax planning strategies in the associated jurisdictions. Included in deferred income taxes as of December 31, 2022 are tax benefits for U.S. and non-U.S. net operating loss carryforwards totaling $35.5 million ($29.1 million of which the Company does not expect to realize and has corresponding valuation allowances). Certain of the losses can be carried forward indefinitely and others can be carried forward to various dates from 2023 through 2042.
As of December 31, 2022, gross unrecognized tax benefits totaled $6.6 million ($9.2 million, including $2.6 million associated with potential interest and penalties). As of December 31, 2021, gross unrecognized tax benefits totaled $5.7 million ($7.6 million, including $1.9 million associated with potential interest and penalties). The Company recognized $0.6 million, $(0.1) million and $0.0 million in potential interest and penalties associated with uncertain tax positions during 2022, 2021 and 2020, respectively. To the extent unrecognized tax benefits (including interest and penalties) are recognized with respect to uncertain tax positions, the tax expense in future periods would be reduced by $9.2 million based upon the tax positions as of December 31, 2022. The Company recognized interest and penalties related to unrecognized tax benefits within income taxes in the accompanying Consolidated Statements of Operations. Unrecognized tax benefits and associated accrued interest and penalties are included in taxes, income and other accrued expenses as detailed in Note 10.
114

A reconciliation of the beginning and ending amount of unrecognized tax benefits, excluding amounts accrued for potential interest and penalties, is as follows ($ in millions):
202220212020
Unrecognized tax benefits, beginning of year$5.7 $7.1 $9.1 
Additions based on tax positions related to the current year0.3 0.3 0.3 
Additions for tax positions of prior years4.2 — 0.3 
Reductions for tax positions of prior years— (0.3)(1.7)
Lapse of statute of limitations(2.3)(1.0)(1.0)
Settlements(1.1)(0.4)— 
Effect of foreign currency translation(0.2)— 0.1 
Unrecognized tax benefits, end of year$6.6 $5.7 $7.1 
The Company is routinely examined by various domestic and international taxing authorities and operations in certain U.S. states and foreign jurisdictions remain subject to routine examination for tax years beginning with 2009.
The Company estimates that it is reasonably possible that the amount of unrecognized tax benefits may be reduced by approximately $2.7 million within twelve months through resolution of worldwide tax matters, payments of tax audit settlements and/or statute of limitations expirations.
The Company operates in various non-U.S. tax jurisdictions where “tax holiday” income tax incentives have been granted for a specific period. These tax benefits are not material to the Company’s financial statements.

NOTE 22.  EARNINGS PER SHARE
Earnings per share is calculated by dividing the applicable income by the weighted average number of shares of common stock outstanding for the applicable period. Diluted earnings per share is computed based on the weighted average number of common shares outstanding plus the effect of dilutive potential shares outstanding during the period using the treasury stock method. Dilutive potential common shares include employee equity options, non-vested shares and similar instruments granted by the Company and the assumed conversion impact of the Notes. The Company will settle any Notes conversions through a combination settlement by satisfying the principal amount outstanding with cash and any Notes conversion value in excess of the principal amount in cash or shares of the Company’s common stock or any combination thereof. As such, the Company uses the treasury stock method for the assumed conversion of the Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. As the Company will settle the principal amount of the Notes in cash upon conversion, the Notes do not have an impact on the Company's diluted earnings per share until the average share price of the Company’s common stock exceeds the conversion price of $21.01 per share in any applicable period. See the computation of earnings per share below for the dilutive impact of the Notes for the years ended December 31, 2022, 2021 and 2020.

In connection with the offering of the Notes, the Company entered into Capped Calls (see further discussion in Note 16), which are intended to reduce or offset the potential dilution from shares of common stock issued upon conversion of the Notes. However, this impact is not included when calculating potentially dilutive shares since their effect is anti-dilutive. The Capped Calls will mitigate dilution from the conversion of the Notes up to the Company’s common stock price of $23.79. If the Notes are converted at a price higher than $23.79 per share, the Capped Calls will no longer mitigate dilution from the conversion of the Notes.

115

The table below presents the computation of basic and diluted earnings per share ($ and shares in millions, except per share amounts):
Year Ended December 31,
202220212020
Numerator:
Income from continuing operations, net of tax$238.0 $263.5 42.5 
Income (loss) from discontinued operations, net of tax$5.1 $77.0 $(9.2)
Net income $243.1 $340.5 $33.3 
Denominator:
Weighted-average common shares outstanding used in basic earnings (loss) per share162.9 161.2 159.6 
Incremental common shares from:
Assumed exercise of dilutive options and vesting of dilutive restricted stock units3.2 4.4 2.2 
Assumed conversion of the Notes11.5 12.0 2.3 
Weighted average common shares outstanding used in diluted earnings (loss) per share177.6 177.6 164.1 
Earnings per share:
Earnings from continuing operations - basic$1.46 $1.63 $0.27 
Earnings from continuing operations - diluted$1.34 $1.48 $0.26 
Earnings (loss) from discontinued operations - basic$0.03 $0.48 $(0.06)
Earnings (loss) from discontinued operations - diluted$0.03 $0.43 $(0.06)
Earnings - basic$1.49 $2.11 $0.21 
Earnings - diluted$1.37 $1.92 *$0.20 
* Earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. The sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding.

The following table presents the number of outstanding securities not included in the computation of diluted income per share, because their effect was anti-dilutive (in millions):

Year Ended December 31,
202220212020
Stock-based awards1.5 1.2 4.1 

NOTE 23. SEGMENT INFORMATION
The Company operates and reports its results in two separate business segments, the Specialty Products & Technologies and Equipment & Consumables segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income (expense), interest expense and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. The identifiable assets by segment are those used in each segment’s operations. Inter-segment amounts are not significant and are eliminated to arrive at combined totals.

The Company’s Specialty Products & Technologies products include implants, regenerative products, prosthetics, orthodontic brackets, aligners and lab products. The Company’s Equipment & Consumables products include traditional consumables such as bonding agents and cements, impression materials, infection prevention products and restorative
116

products, while the Company’s equipment products include digital imaging systems, software and other visualization and magnification systems.

On December 31, 2021, the Company completed the sale of its KaVo Treatment Unit and Instrument Business, which is part of the Company’s Equipment & Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business. Refer to Note 4 for more information on the Company’s discontinued operations.

Detailed segment data as of and for the years ended December 31 is as follows ($ in millions):
202220212020
Sales:
Specialty Products & Technologies$1,598.6 $1,507.8 $1,117.3 
Equipment & Consumables970.5 1,001.1 811.8 
Total$2,569.1 $2,508.9 $1,929.1 
Operating profit and reconciliation to income (loss) before taxes:
Specialty Products & Technologies$268.6 $272.3 $65.8 
Equipment & Consumables172.4 153.8 53.6 
Other(121.8)(119.9)(75.9)
Operating profit319.2 306.2 43.5 
Nonoperating income (expense):
   Other income (expense)3.1 2.4 (1.0)
   Interest expense, net(38.4)(54.1)(62.5)
Income (loss) before taxes$283.9 $254.5 $(20.0)
Depreciation and amortization:
Specialty Products & Technologies$80.7 $84.0 $80.6 
Equipment & Consumables54.6 31.4 38.7 
Other2.5 2.4 2.4 
Total$137.8 $117.8 $121.7 
Capital expenditures, gross:
Specialty Products & Technologies$48.8 $37.2 $36.4 
Equipment & Consumables20.6 10.6 5.8 
Other2.7 1.3 1.7 
Total$72.1 $49.1 $43.9 
Identifiable assets:December 31, 2022December 31, 2021
Specialty Products & Technologies$3,475.7 $3,498.2 
Equipment & Consumables2,455.3 1,946.1 
Held for sale— 12.2 
Other656.0 1,117.7 
Total$6,587.0 $6,574.2 
117

Operations in Geographical Areas: 
Year Ended December 31,
($ in millions)202220212020
Sales:
United States$1,261.9 $1,223.4 $960.1 
China222.2 236.7 198.2 
All other (each country individually less than 5% of total sales)1,085.0 1,048.8 770.8 
Total$2,569.1 $2,508.9 $1,929.1 
Property, plant and equipment, net:December 31, 2022December 31, 2021
United States$183.4 $157.1 
Sweden41.4 49.0 
Mexico15.2 8.8 
All other (each country individually less than 5% of total long-lived assets)53.6 49.2 
Total$293.6 $264.1 

118

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
Not applicable.

ITEM 9A. CONTROLS AND PROCEDURES
Our management, with the participation of our President and Chief Executive Officer, and Senior Vice President and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this report. Based on such evaluation, our President and Chief Executive Officer, and Senior Vice President and Chief Financial Officer, have concluded that, as of the end of such period, our disclosure controls and procedures were effective.
Management’s annual report on its internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) and the independent registered public accounting firm’s audit report on the effectiveness of the Company’s internal control over financial reporting are included in the Company’s financial statements for the year ended December 31, 2022 included in Item 8 of this Annual Report on Form 10-K, under the headings “Report of Management on Envista Holdings Corporation’s Internal Control Over Financial Reporting” and “Report of Independent Registered Public Accounting Firm,” respectively, and are incorporated herein by reference.
There have been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during our most recent completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION
Not applicable.
ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
Not applicable.
119

PART III
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Other than the information below, the information required under this Item is incorporated herein by reference to our definitive proxy statement to be filed with the SEC no later than 120 days after the end of our fiscal year ended December 31, 2022.
Code of Ethics
We have adopted a code of business conduct and ethics for directors, officers (including our principal executive officer, principal financial officer and principal accounting officer) and employees, known as the Code of Conduct. The Code of Conduct is available in the “Investors—Governance” section of our website at www.envistaco.com.
We intend to disclose any amendment to the Code of Conduct that relates to any element of the code of ethics definition enumerated in Item 406(b) of Regulation S-K, and any waiver from a provision of the Code of Conduct granted to any director, principal executive officer, principal financial officer, principal accounting officer, or any of our other executive officers, in the “Investors—Governance” section of our website, at www.envistaco.com, within four business days following the date of such amendment or waiver.

ITEM 11. EXECUTIVE COMPENSATION
The information required under this Item is incorporated herein by reference to our definitive proxy statement to be filed with the SEC no later than 120 days after the end of our fiscal year ended December 31, 2022.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
The information required under this Item is incorporated herein by reference to our definitive proxy statement to be filed with the SEC no later than 120 days after the end of our fiscal year ended December 31, 2022.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information required under this Item is incorporated herein by reference to our definitive proxy statement to be filed with the SEC no later than 120 days after the end of our fiscal year ended December 31, 2022.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
The information required under this Item is incorporated herein by reference to our definitive proxy statement to be filed with the SEC no later than 120 days after the end of our fiscal year ended December 31, 2022.

120

PART IV

ITEM 15. EXHIBIT AND FINANCIAL STATEMENT SCHEDULES
a)    The following documents are filed as part of this report.
(1)Financial Statements. The financial statements are set forth under “Item 8. Financial Statements and Supplementary Data” of this Annual Report on Form 10-K.
(2)Schedules. An index of financial statement schedules is set forth below. Schedules other than those listed below have been omitted from this Annual Report on Form 10-K because they are not required, are not applicable or the required information is included in the financial statements or the notes thereto.
 Page Number in
Form 10-K
Schedule:

(3)Exhibits. The exhibits listed in the accompanying Exhibit Index are filed or incorporated by reference as part of this Annual Report on Form 10-K.

ITEM 16. FORM 10-K SUMMARY
None.

EXHIBIT INDEX
Exhibit
Number		Description
2.1
2.2
2.3
2.4
2.5
2.6
2.7
3.1
121

3.2
4.1
4.2
4.3
4.4
10.1
10.2*
10.3*
10.4*
10.5*
10.6*
10.7*
10.8*
10.9*
10.10*
10.11*
10.12*
10.13*
10.14*
10.15*
122

10.16*
10.17*
10.18*
10.19*
10.20*
10.21
10.22*
21.1
23.1
24.1
31.1
31.2
32.1
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. (c)
101.SCHXBRL Taxonomy Extension Schema Document (c)
101.CALXBRL Taxonomy Extension Calculation Linkbase Document (c)
101.DEFXBRL Taxonomy Extension Definition Linkbase Document (c)
101.LABXBRL Taxonomy Extension Label Linkbase Document (c)
101.PREXBRL Taxonomy Extension Presentation Linkbase Document (c)
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
______________
*    Indicates management contract or compensatory plan, contract or arrangement.
(a)    Applies to Messrs. Aghdaei and Nance.
(b)    Applies to Messrs. Eriksson, Kyrillos and Yu.
(c)    Exhibit 101 to this report includes the following documents formatted in XBRL (Extensible Business Reporting Language): (i) Consolidated Balance Sheets as of December 31, 2022 and 2021, (ii) Consolidated Statements of Operations for the years ended December 31, 2022, 2021 and 2020, (iii) Consolidated Statements of Comprehensive Income for the years ended December 31, 2022, 2021 and 2020, (iv) Consolidated Statements of Changes in Equity for the years ended December 31, 2022, 2021 and 2020, (v) Consolidated Statements of Cash Flows for the years ended December 31, 2022, 2021 and 2020 and (vi) Notes to Consolidated Financial Statements.
123

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: February 16, 2023ENVISTA HOLDINGS CORPORATION
By:/s/ Amir Aghdaei
Amir Aghdaei
President and Chief Executive Officer


POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Amir Aghdaei and Howard H. Yu, and each or any one of them, his or her lawful attorneys-in-fact and agents, for such person in any and all capacities, to sign any and all amendments to this report and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that either of said attorneys-in-fact and agent, or substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
SignatureTitleDate
/s/ Amir AghdaeiPresident, Chief Executive Officer
(Principal Executive Officer) and Director		February 16, 2023
Amir Aghdaei
/s/ Howard H. YuSenior Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)		February 16, 2023
Howard H. Yu
/s/ Scott HuennekensChairman of the BoardFebruary 16, 2023
Scott Huennekens
/s/ Wendy CarruthersDirectorFebruary 16, 2023
Wendy Carruthers
/s/ Kieran T. GallahueDirectorFebruary 16, 2023
Kieran T. Gallahue
/s/ Barbara HulitDirectorFebruary 16, 2023
Barbara Hulit
/s/ Vivek JainDirectorFebruary 16, 2023
Vivek Jain
/s/ Daniel A. RaskasDirectorFebruary 16, 2023
Daniel A. Raskas
/s/ Christine TsingosDirectorFebruary 16, 2023
Christine Tsingos

124

ENVISTA HOLDINGS CORPORATION
SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS
($ in millions)
Classification
Balance at
Beginning of
Period (a)
Charged to
Costs &
Expenses		Impact of
Currency		Write Offs,
Write Downs  &
Deductions		Recoveries
Balance at End of Period (a)
Year ended December 31, 2022:
Allowances deducted from asset account— — — — — — 
Allowance for credit losses$20.7 $4.8 $(0.8)$(4.1)$(4.4)$16.2 
Year ended December 31, 2021:
Allowances deducted from asset account— — — — — — 
Allowance for credit losses$30.5 $4.7 $(1.5)$(7.3)$(5.7)$20.7 
Year ended December 31, 2020:
Allowances deducted from asset account— — — — — — 
Allowance for credit losses$18.7 $19.2 $0.3 $(7.7)$— $30.5 
______________
(a)Amounts include allowance for credit losses classified as current.

125
 EX-10.6 2 envista-november2022grantx.htm EX-10.6 Document

Exhibit 10.06

ENVISTA HOLDINGS CORPORATION
2019 OMNIBUS INCENTIVE PLAN
RESTRICTED STOCK UNIT AGREEMENT
Unless otherwise defined herein, the terms defined in the Envista Holdings Corporation 2019 Omnibus Incentive Plan, as amended (the “Plan”), will have the same defined meanings in this Restricted Stock Unit Agreement (the “Agreement”).
I.GRANT NOTICE
Name: #ParticipantName#
Employee ID: #EmployeeID#
The undersigned Participant has been granted an Award of Restricted Stock Units, subject to the terms and conditions of the Plan and this Agreement, as follows (each of the following capitalized terms are defined terms having the meaning indicated below):

Date of Grant #GrantDate#
Number of Restricted Stock Units#QuantityGranted#
Vesting Schedule
                       #VestDate_1# #VestQty_1# #Vest%_1#
                       #VestDate_2# #VestQty_2# #Vest%_2#
                       #VestDate_3# #VestQty_3# #Vest%_3#



    



II.AGREEMENT
1.Grant of RSUs. Envista Holdings Corporation (the “Company”) hereby grants to the Participant named in this Grant Notice (the “Participant”), an Award of Restricted Stock Units (“RSUs”) to acquire the number of shares of Company Common Stock (“Share”), subject to the terms and conditions of this Agreement and the Plan, which are incorporated herein by reference.
2.Vesting.
    (a)    Vesting Schedule. Except as may otherwise be set forth in this Agreement or in the Plan, with respect to each Tranche of RSUs granted under this Agreement (a “Tranche” consists of all RSUs as to which the Time-Based Vesting Criteria are scheduled to be satisfied on the same date), the Tranche shall not vest unless the Participant continues to be actively employed with the Company or an Eligible Subsidiary for the period required to satisfy the Time-Based Vesting Criteria applicable to such Tranche (the date on which the Time-Based Vesting Criteria applicable to a Tranche are scheduled to be satisfied is the “Time-Based Vesting Date”). Vesting shall be determined separately for each Tranche. The Time-Based Vesting Criteria applicable to any Tranche are referred to as “Vesting Conditions,” and the date upon which all Vesting Conditions applicable to that Tranche are satisfied is referred to as the “Vesting Date” for such Tranche. The Vesting Conditions shall be established by the Compensation Committee (the “Committee”) of the Company’s Board of Directors (or by one or more members of Company management, if such power has been delegated in accordance with the Plan and applicable law) and reflected in the account maintained for the Participant by an external third party administrator of the RSUs. Further, during any approved leave of absence (and without limiting the application of any other rules governing leaves of absence that the Committee may approve from time to time pursuant to the Plan), to the extent permitted by applicable law, the Committee shall have discretion to provide that the vesting of the RSUs shall be frozen as of the first day of the leave (or as of any subsequent day during such leave, as applicable) and shall not resume until and unless the Participant returns to active employment.
    (b)    Fractional RSU Vesting. In the event the Participant is vested in a fractional portion of an RSU (a “Fractional Portion”), such Fractional Portion will be rounded up and converted into a whole Share and issued to the Participant; provided that to the extent rounding a fractional share up would result in the imposition of either (i) individual tax and penalty interest charges imposed under Section 409A of the U.S. Internal Revenue Code of 1986, as amended (“Section 409A”), or (ii) adverse tax consequences if the Participant is located outside of the United States, the fractional Share will be rounded down without the payment of any consideration in respect of such fractional share.
(c)    Addenda. The provisions of any addenda attached hereto are incorporated by reference herein and made a part of this Agreement, and to the extent any provision in any such addenda conflicts with any provision set forth elsewhere in this Agreement, the provision set forth in such addenda shall control.
3.Form and Timing of Payment; Conditions to Issuance of Shares.
(a)    Form and Timing of Payment. The Award of RSUs represents the right to receive a number of Shares equal to the number of RSUs that vest pursuant to the Vesting Conditions. Unless and until the RSUs have vested in the manner set forth in Sections 2 and 4, the Participant shall have no right to payment of any such RSUs. Prior to actual issuance of any Shares underlying the RSUs, such RSUs will represent an unsecured obligation of the Company, payable (if at all) only from the general assets of the Company. Subject to the other terms of the Plan and this Agreement, with respect to any Tranche that vests in accordance with Sections 2 and 4, the underlying Shares will be paid to the Participant in whole Shares within 90 days of the Vesting Date for that Tranche. The Shares shall not be issued under the Plan unless the issuance and delivery of such Shares comply with (or are exempt from) all applicable requirements of law, including (without limitation) the Securities Act, the rules and regulations promulgated thereunder, state securities laws and regulations, and the regulations of any stock exchange or other securities market on which the Company’s securities may then be traded. The Committee may require the Participant to take any reasonable action in order to comply with any such rules or regulations.
2

(b)    Acknowledgment of Potential Securities Law Restrictions. Unless a registration statement under the Securities Act covers the Shares issued upon vesting of an RSU, the Committee may require that the Participant agree in writing to acquire such Shares for investment and not for public resale or distribution, unless and until the Shares subject to the RSUs are registered under the Securities Act. The Committee may also require the Participant to acknowledge that the Participant shall not sell or transfer such Shares except in compliance with all applicable laws, and may apply such other restrictions as it deems appropriate. The Participant acknowledges that the U.S. federal securities laws prohibit trading in the stock of the Company by persons who are in possession of material, non-public information, and also acknowledges and understands the other restrictions set forth in the Company’s Insider Trading Policy.
4.Termination.
    (a)    General. In the event the Participant’s active employment or other active service-providing relationship, as applicable, with the Company or an Eligible Subsidiary terminates (the date of any such termination is referred to as the “Termination Date”) for any reason (other than death, Early Retirement or Normal Retirement) whether or not in breach of applicable labor laws, unless contrary to applicable law and unless otherwise provided by the Administrator either initially or subsequent to the grant of the RSUs, all RSUs that are unvested as of the Termination Date shall automatically terminate as of the Termination Date and the Participant’s right to receive further RSUs under the Plan shall also terminate as of the Termination Date. The Committee shall have discretion to determine whether the Participant has ceased to be actively employed by (or, if the Participant is a consultant or director, has ceased actively providing services to) the Company or an Eligible Subsidiary, and the effective date on which such active employment (or active service-providing relationship, as applicable) terminated. The Participant’s active employer-employee or other active service-providing relationship, as applicable, will not be extended by any notice period mandated under applicable law (e.g., active employment shall not include a period of “garden leave,” paid administrative leave or similar period pursuant to applicable law). Unless the Committee provides otherwise (1) termination of the Participant’s employment will include instances in which the Participant is terminated and immediately rehired as an independent contractor, and (2) the spin-off, sale, or disposition of the Participant’s employer from the Company or an Eligible Subsidiary (whether by transfer of shares, assets or otherwise) such that the Participant’s employer no longer constitutes an Eligible Subsidiary will constitute a termination of employment or service.
    (b)    Death. In the event the Participant’s active employment or other active service-providing relationship with the Company or an Eligible Subsidiary terminates as a result of death, unless contrary to applicable law and unless otherwise provided by the Administrator either initially or subsequent to the grant of the RSUs, the Participant’s estate will become vested in a pro rata amount of each unvested Tranche based on the number of complete twelve-month periods between the Date of Grant and the date of the Participant’s death divided by the total number of twelve-month periods between the Date of Grant and the Time-Based Vesting Date applicable to such Tranche. Notwithstanding anything in the Plan or this Agreement to the contrary, for purposes of this Section, any partial twelve-month period between the Date of Grant and the date of death shall be considered a complete twelve-month period and any Fractional Portion that results from applying the pro rata methodology shall be rounded up to a whole Share.
(c)    Retirement.
(i)    Upon termination of employment (or other active service-providing relationship, as applicable) by reason of the Participant’s Early Retirement, unless contrary to applicable law and unless otherwise provided by the Committee either initially or subsequent to the grant of RSUs, with respect to each Tranche that is unvested as of the Early Retirement date, a pro-rata portion of such Tranche (i.e. based on the ratio of (x) the number of full or partial months worked by the Participant from the Date of Grant to the Early Retirement date to (y) the total number of months in the original time-based vesting schedule of such Tranche) will vest as of the Time-Based Vesting Date for such Tranche.
(ii)    Upon termination of employment (or other active service-providing relationship) by reason of the Participant’s Normal Retirement, unless contrary to applicable law and
3

unless otherwise provided by the Committee either initially or subsequent to the grant of the RSUs, with respect to each Tranche that is unvested as of the Normal Retirement date, such Tranche will vest as of the Time-Based Vesting Date for such Tranche.
(d)    Gross Misconduct. If the Participant’s employment with the Company or an Eligible Subsidiary is terminated for Gross Misconduct as determined by the Administrator, the Administrator in its sole discretion may provide that all, or any portion specified by the Administrator, of the Participant’s unvested RSUs shall automatically terminate as of the time of termination without consideration. The Participant acknowledges and agrees that the Participant’s termination of employment shall also be deemed to be a termination of employment by reason of the Participant’s Gross Misconduct if, after the Participant’s employment has terminated, facts and circumstances are discovered or confirmed by the Company that would have justified a termination for Gross Misconduct.
(e)    Violation of Post-Termination Covenant. To the extent that any of the Participant’s RSUs remain outstanding under the terms of the Plan or this Agreement after the Termination Date, such RSUs shall expire as of the date the Participant violates any covenant not to compete or other post-termination covenant that exists between the Participant on the one hand and the Company or any Subsidiary of the Company, on the other hand.
(f)    Substantial Corporate Change. Notwithstanding any other provision in this Agreement to the contrary, in the event (i) a Substantial Corporate Change occurs, (ii) the RSUs are effectively assumed or continued by the surviving or acquiring corporation in such Substantial Corporate Change (as determined by the Board or the Committee), and (iii) the Participant is terminated without Gross Misconduct or, if the Participant participates in the Envista Holdings Corporation Severance and Change in Control Plan, the Participant is terminated due to an “Involuntary Termination” or “Good Reason Resignation” (as defined in the Severance and Change in Control Plan), in each case within 24 months following the Substantial Corporate Change, then any unvested RSUs held by the Participant shall vest in full as of the Participant’s termination date.
5.Non-Transferability of RSUs. Unless the Committee determines otherwise in advance in writing, RSUs may not be transferred in any manner otherwise than by will or by the applicable laws of descent or distribution. The terms of the Plan and this Agreement shall be binding upon the executors, administrators, heirs and permitted successors and assigns of the Participant.
6.Amendment of RSUs or Plan.
(a)The Plan and this Agreement constitute the entire understanding of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the Participant with respect to the subject matter hereof. The Participant expressly warrants that the Participant is not accepting this Agreement in reliance on any promises, representations, or inducements other than those contained herein. The Board may amend, modify or terminate the Plan or the RSUs in any respect at any time; provided, however, that modifications to this Agreement or the Plan that materially and adversely affect the Participant’s rights hereunder can be made only in an express written contract signed by the Company and the Participant. Notwithstanding anything to the contrary in the Plan or this Agreement, the Company reserves the right to revise this Agreement and the Participant’s rights under outstanding RSUs as it deems necessary or advisable, in its sole discretion and without the consent of the Participant, (1) upon a Substantial Corporate Change, (2) as required by law, or (3) to comply with Section 409A or to otherwise avoid imposition of any additional tax or income recognition under Section 409A in connection with the RSUs; provided, however, that the Company shall not make any change that would alter the rights of the Participant under Section 4(f) of the Agreement.
(b) The Participant acknowledges and agrees that if the Participant changes classification from a full-time employee to a part-time employee the Committee may in its sole discretion reduce or eliminate the Participant’s unvested RSUs.
4

7.Tax Obligations.
        (a)    Withholding Taxes. Regardless of any action the Company or any Eligible Subsidiary employing the Participant (the “Employer”) takes with respect to any or all federal, state, local or foreign income tax, social insurance, payroll tax, payment on account or other Tax Related-Items (“Tax-Related Items”), the Participant acknowledges that the ultimate liability for all Tax Related-Items associated with the RSUs is and remains the Participant’s responsibility and that the Company and the Employer (i) make no representations or undertakings regarding the treatment of any Tax Related-Items in connection with any aspect of the RSUs, including, but not limited to, the grant or vesting of the RSUs, the delivery of Shares, the subsequent sale of Shares acquired at vesting and the receipt of any dividends or dividend equivalents; and (ii) do not commit to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate the Participant’s liability for Tax Related-Items. Further, if the Participant is subject to tax in more than one jurisdiction, the Participant acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax Related-Items in more than one jurisdiction.
            (i)    This Section 7(a)(i) shall apply to the Participant only if the Participant is not subject to Section 16 of the Securities Exchange Act of 1934 as of the date the relevant RSU first becomes includible in the gross income of the Participant for purposes of Tax Related-Items. The Participant shall, no later than the date as of which the value of an RSU first becomes includible in the gross income of the Participant for purposes of Tax Related-Items, pay to the Company and/or the Employer, or make arrangements satisfactory to the Administrator regarding payment of, all Tax Related-Items required by applicable law to be withheld by the Company and/or the Employer with respect to the RSU.  The obligations of the Company under the Plan shall be conditional on the making of such payments or arrangements, and the Company and/or the Employer shall, to the extent permitted by applicable law, have the right to deduct any such Tax Related-Items from any payment of any kind otherwise due to the Participant.  The Company shall have the right to require the Participant to remit to the Company an amount in cash sufficient to satisfy any applicable withholding requirements related thereto.  With the approval of the Administrator, the Participant may satisfy the foregoing requirement by either (i) electing to have the Company withhold from delivery of Shares or (ii) delivering already owned unrestricted Shares, in each case, having a value up to the maximum amount of tax required to be withheld (or such other rate that will not cause adverse accounting consequences for the Company).  Any such Shares shall be valued at their Fair Market Value on the date as of which the amount of Tax Related-Items to be withheld is determined.  Such an election may be made with respect to all or any portion of the Shares to be delivered pursuant to the RSUs.  The Company may also use any other method or combination of methods of obtaining the necessary payment or proceeds, as permitted by applicable law, to satisfy its withholding obligation with respect to any RSU.
        (ii)    This Section 7(a)(ii) shall apply to the Participant only if the Participant is subject to Section 16 of the Securities Exchange Act of 1934 as of the date the relevant RSU first becomes includible in the gross income of the Participant for purposes of Tax Related-Items. All Tax Related-Items legally payable by the Participant in respect of the RSUs shall be satisfied by the Company, withholding a number of the Shares that would otherwise be delivered to the Participant upon the vesting or settlement of the RSUs with a Fair Market Value, determined as of the date of the relevant taxable event, equal to the minimum statutory withholding amount that applies to the Participant, rounded up to the nearest whole share (“Net Settlement”). The Net Settlement mechanism described in this paragraph was approved by the Committee prior to the Date of Grant in a manner intended to constitute “approval in advance” by the Committee for purposes of Rule 16b3-(e) under the Securities Exchange Act of 1934, as amended.
(iii)     If the obligation for Tax Related-Items is satisfied by net settlement, for tax purposes, the Participant shall be deemed to have been issued the full number of Shares issued upon vesting of the RSUs notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax Related-Items.
    (b)    Code Section 409A. Payments made pursuant to this Plan and this Agreement are intended to qualify for an exemption from or comply with Section 409A. Notwithstanding any provision in this Agreement, the Company reserves the right, to the extent the Company deems necessary or
5

advisable in its sole discretion, to unilaterally amend or modify the Plan and/or this Agreement to ensure that all RSUs granted to Participants who are United States taxpayers are made in such a manner that either qualifies for exemption from or complies with Section 409A; provided, however, that the Company makes no representations that the Plan or the RSUs shall be exempt from or comply with Section 409A and makes no undertaking to preclude Section 409A from applying to the Plan or any RSUs granted thereunder. If this Agreement fails to meet the requirements of Section 409A, neither the Company nor any of its Eligible Subsidiaries shall have any liability for any tax, penalty or interest imposed on the Participant by Section 409A, and the Participant shall have no recourse against the Company or any of its Eligible Subsidiaries for payment of any such tax, penalty or interest imposed by Section 409A.
Notwithstanding anything to the contrary in this Agreement, these provisions shall apply to any payments and benefits otherwise payable to or provided to the Participant under this Agreement. For purposes of Section 409A, each “payment” (as defined by Section 409A) made under this Agreement shall be considered a “separate payment.” In addition, for purposes of Section 409A, payments shall be deemed exempt from the definition of deferred compensation under Section 409A to the fullest extent possible under (i) the “short-term deferral” exemption of Treasury Regulation § 1.409A-1(b)(4), and (ii) (with respect to amounts paid as separation pay no later than the second calendar year following the calendar year containing the Participant’s “separation from service” (as defined for purposes of Section 409A)) the “two years/two-times” involuntary separation pay exemption of Treasury Regulation § 1.409A-1(b)(9)(iii), which are hereby incorporated by reference.
For purposes of making a payment under this Agreement, if any amount is payable as a result of a Substantial Corporate Change, such event must also constitute a “change in ownership or effective control” of the Company or a “change in the ownership of a substantial portion of the assets” of the Company within the meaning of Section 409A.
If the Participant is a “specified employee” as defined in Section 409A (and as applied according to procedures of the Company and its Subsidiaries) as of the Participant's separation from service, to the extent any payment under this Agreement constitutes deferred compensation (after taking into account any applicable exemptions from Section 409A), and such payment is payable by reason of a separation from service, then to the extent required by Section 409A, no payments due under this Agreement may be made until the earlier of: (i) the first day of the seventh month following the Participant’s separation from service, or (ii) the Participant’s date of death; provided, however, that any payments delayed during this six-month period shall be paid in the aggregate in a lump sum, without interest, on the first day of the seventh month following the Participant’s separation from service.
8.Rights as Shareholder. Until all requirements for vesting of the RSUs pursuant to the terms of this Agreement and the Plan have been satisfied, the Participant shall not be deemed to be a shareholder of the Company, and shall have no dividend rights or voting rights with respect to the RSUs or any Shares underlying or issuable in respect of such RSUs until such Shares are actually issued to the Participant.
9.No Employment Contract. Nothing in the Plan or this Agreement constitutes an employment or service contract between the Company and the Participant and this Agreement shall not confer upon the Participant any right to continuation of employment or service with the Company or any of its Eligible Subsidiaries, nor shall this Agreement interfere in any way with the Company’s or any of its Eligible Subsidiaries right to terminate the Participant’s employment or at any time, with or without cause (subject to any employment or service agreement the Participant may otherwise have with the Company or an Eligible Subsidiary thereof and/or applicable law).
10.Board Authority. The Board and/or the Committee shall have the power to interpret this Agreement and to adopt such rules for the administration, interpretation and application of this Agreement as are consistent therewith and to interpret or revoke any such rules (including, but not limited to, the determination of whether any RSUs have vested). All interpretations and determinations made by the Board and/or the Committee in good faith shall be final and binding upon the Participant, the Company and all other interested persons and such determinations of the Board and/or the Committee do not have to be uniform nor do they have to consider whether Plan participants are similarly situated.
6

11.Headings. The captions used in this Agreement and the Plan are inserted for convenience and shall not be deemed to be a part of the RSUs for construction and interpretation.
12.Electronic Delivery.
(a)    If the Participant executes this Agreement electronically, for the avoidance of doubt, the Participant acknowledges and agrees that the Participant's execution of this Agreement electronically (through an on-line system established and maintained by the Company or a third party designated by the Company, or otherwise) shall have the same binding legal effect as would execution of this Agreement in paper form. The Participant acknowledges that upon request of the Company the Participant shall also provide an executed, paper form of this Agreement.
(b)    If the Participant executes this Agreement in paper form, for the avoidance of doubt the parties acknowledge and agree that it is their intent that any agreement previously or subsequently entered into between the parties that is executed electronically shall have the same binding legal effect as if such agreement were executed in paper form.
(c)    If the Participant executes this Agreement multiple times (for example, if the Participant first executes this Agreement in electronic form and subsequently executes this Agreement in paper form), the Participant acknowledges and agrees that (i) no matter how many versions of this Agreement are executed and in whatever medium, this Agreement only evidences a single Award relating to the number of RSUs set forth in the Grant Notice and (ii) this Agreement shall be effective as of the earliest execution of this Agreement by the parties, whether in paper form or electronically, and the subsequent execution of this Agreement in the same or a different medium shall in no way impair the binding legal effect of this Agreement as of the time of original execution.
(d)    The Company may, in its sole discretion, decide to deliver by electronic means any documents related to the RSUs, to participation in the Plan, or to future awards granted under the Plan, or otherwise required to be delivered to the Participant pursuant to the Plan or under applicable law, including but not limited to, the Plan, this Agreement, the Plan prospectus and any reports of the Company generally provided to shareholders. Such means of electronic delivery may include, but do not necessarily include, the delivery of a link to the Company’s intranet or the internet site of a third party involved in administering the Plan, the delivery of documents via electronic mail (“e-mail”) or such other means of electronic delivery specified by the Company. By executing this Agreement, the Participant hereby consents to receive such documents by electronic delivery. At the Participant’s written request to the Secretary of the Company, the Company shall provide a paper copy of any document at no cost to the Participant.

13.Data Privacy. The Company is located at 200 S. Kraemer Blvd., Building E, Brea, California 92821, United States of America and grants RSUs under the Plan to employees of the Company and its Subsidiaries in its sole discretion. In conjunction with the Company’s grant of the RSUs under the Plan and its ongoing administration of such awards, the Company is providing the following information about its data collection, processing and transfer practices (“Personal Data Activities”). In accepting the grant of the RSUs, the Participant expressly and explicitly consents to the Personal Data Activities as described herein.

(a)Data Collection, Processing and Usage. The Company collects, processes and uses the Participant’s personal data, including the Participant’s name, home address, e-mail address, and telephone number, date of birth, social insurance / passport number or other identification number (e.g. resident registration number), salary, citizenship, job title, any Shares or directorships held in the Company, and details of all RSUs or any other equity compensation awards granted, canceled, exercised, vested, or outstanding in the Participant’s favor, which the Company receives from the Participant or the Employer ("Personal Information"). In granting the RSUs under the Plan, the Company will collect the Participant’s Personal Information for purposes of allocating Shares and implementing, administering and managing the Plan. The Company’s legal basis for the collection, processing and usage of the Participant’s Personal Information is the Participant’s consent.

7

(b)Stock Plan Administration Service Provider. The Company transfers the Participant’s Personal Information to Fidelity Stock Plan Services LLC, an independent service provider based in the United States, which assists the Company with the implementation, administration and management of the Plan (the “Stock Plan Administrator”). In the future, the Company may select a different Stock Plan Administrator and share the Participant’s Personal Information with another company that serves in a similar manner. The Stock Plan Administrator will open an account for the Participant to receive and trade Shares acquired under the Plan. The Participant will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to the Participant’s ability to participate in the Plan.

(c)International Data Transfers. The Company and the Stock Plan Administrator are based in the United States. The Participant should note that the Participant’s country of residence may have enacted data privacy laws that are different from the United States. The Company’s legal basis for the transfer of the Participant’s Personal Information to the United States is the Participant’s consent.

(d)Voluntariness and Consequences of Consent Denial or Withdrawal. The Participant’s participation in the Plan and the Participant's grant of consent is purely voluntary. The Participant may deny or withdraw the Participant's consent at any time. If the Participant does not consent, or if the Participant later withdraws the Participant's consent, the Participant may be unable to participate in the Plan. This would not affect the Participant’s existing employment or salary; instead, the Participant merely may forfeit the opportunities associated with the Plan.

(e)Data Subjects Rights. The Participant may have a number of rights under the data privacy laws in the Participant’s country of residence. For example, the Participant’s rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in the Participant’s country of residence, and/or (vi) request a list with the names and addresses of any potential recipients of the Participant’s Personal Information. To receive clarification regarding the Participant’s rights or to exercise the Participant's rights, the Participant should contact the Participant's local human resources department.
14.Waiver of Right to Jury Trial. EACH PARTY, TO THE FULLEST EXTENT PERMITTED BY LAW, WAIVES ANY RIGHT OR EXPECTATION AGAINST THE OTHER TO TRIAL OR ADJUDICATION BY A JURY OF ANY CLAIM, CAUSE OR ACTION ARISING WITH RESPECT TO THE RSUS OR HEREUNDER, OR THE RIGHTS, DUTIES OR LIABILITIES CREATED HEREBY.
15.Agreement Severable. In the event that any provision of this Agreement shall be held invalid or unenforceable, such provision shall be severable from, and such invalidity or unenforceability shall not be construed to have any effect on, the remaining provisions of this Agreement.
16.Governing Law and Venue. The laws of the State of Delaware (other than its choice of law provisions) shall govern this Agreement and its interpretation. For purposes of litigating any dispute that arises with respect to the RSUs, this Agreement or the Plan, the parties hereby submit to and consent to the jurisdiction of the State of Delaware, and agree that such litigation shall be conducted in the courts of New Castle County, or the United States Federal court for the District of Delaware, and no other courts; and waive, to the fullest extent permitted by law, any objection that the laying of the venue of any legal or equitable proceedings related to, concerning or arising from such dispute which is brought in any such court is improper or that such proceedings have been brought in an inconvenient forum. Any claim under the Plan, this Agreement or the RSUs must be commenced by the Participant within twelve (12) months of the earliest date on which the Participant’s claim first arises, or the Participant’s cause of action accrues, or such claim will be deemed waived by the Participant.
17.Nature of RSUs. In accepting the RSUs, the Participant acknowledges and agrees that:
(a)    the Plan is established voluntarily by the Company, it is discretionary in nature and may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan;
8

(b)    the award of RSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future awards of RSUs, benefits in lieu of RSUs or other equity awards, even if RSUs have been awarded in the past;
    (c)    all decisions with respect to future equity awards, if any, shall be at the sole discretion of the Company;
    (d)    the Participant’s participation in the Plan is voluntary;
    (e)    the award of RSUs and the Shares subject to the RSUs, and the income from and value of same, are an extraordinary item that (i) does not constitute compensation of any kind for services of any kind rendered to the Company or any Subsidiary, and (ii) is outside the scope of the Participant’s employment or service contract, if any;
    (f)    the award of RSUs and the Shares subject to the RSUs, and the income from and value of same are not part of normal or expected compensation or salary for any purposes, including, but not limited to, calculating any severance, resignation, termination, redundancy, end of service payments, bonuses, holiday pay, long-service awards, pension or retirement or welfare benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company or any Subsidiary;
(g) the award of RSUs and any Shares acquired under the Plan, and the income from and value of same, are not intended to replace or supplement any pension rights or compensation;
    (h)    unless otherwise expressly agreed with the Company, the RSUs and the Shares subject to the RSUs, and the income from and value of same, are not granted as consideration for, or in connection with, any service the Participant may provide as a director of any Subsidiary;
    (i)    the future value of the underlying Shares is unknown and cannot be predicted with certainty;
    (j)    the value of the Shares acquired upon vesting/settlement of the RSUs may increase or decrease in value;
    (k)    in consideration of the award of RSUs, no claim or entitlement to compensation or damages shall arise from termination of the RSUs or from any diminution in value of the RSUs or the Shares upon vesting of the RSUs resulting from termination of the Participant’s employment or continuous service with the Company or any Subsidiary (for any reason whatsoever and whether or not in breach of applicable labor laws of the jurisdiction where the Participant is employed or the terms of the Participant’s employment agreement, if any), and in consideration of the grant of the RSUs, the Participant agrees not to institute any claim against the Company or any Subsidiary; if, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen, then, by signing this Agreement/electronically accepting this Agreement, the Participant shall be deemed to have irrevocably waived the Participant’s entitlement to pursue or seek remedy for any such claim; and
(l)    neither the Company, the Employer nor any other Eligible Subsidiary shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the United
9

States Dollar that may affect the value of the RSUs or of any amounts due to the Participant pursuant to the settlement of the RSUs or the subsequent sale of any Shares acquired upon vesting.
18.Language.    The Participant acknowledges that the Participant is proficient in the English language and understands the terms of this Agreement. If the Participant has received the Plan, this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control, unless otherwise prescribed by applicable law.
19.Severability. The provisions of this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.
20.Waiver. The Participant acknowledges that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by the Participant or any other participant.
21.Insider Trading/Market Abuse Laws. By accepting the RSUs, the Participant acknowledges that the Participant is bound by all the terms and conditions of any Company insider trading policy as may be in effect from time to time. The Participant further acknowledges that, depending on the Participant’s country, the Participant may be or may become subject to insider trading restrictions and/or market abuse laws, which may affect the Participant’s ability to accept, acquire, sell or otherwise dispose of Shares, rights to Shares (e.g., RSUs) or rights linked to the value of Shares under the Plan during such times as the Participant is considered to have “inside information” regarding the Company (as defined by the laws in the applicable jurisdictions). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders the Participant placed before the Participant possessed inside information. Furthermore, the Participant could be prohibited from (i) disclosing the inside information to any third party, which may include fellow employees and (ii) “tipping” third parties or causing them otherwise to buy or sell securities. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any Company insider trading policy as may be in effect from time to time. The Participant acknowledges that it is the Participant’s personal responsibility to comply with any applicable restrictions, and the Participant should speak to the Participant's personal advisor on this matter.
22.Legal and Tax Compliance; Cooperation. If the Participant resides or is employed outside of the United States, the Participant agrees, as a condition of the grant of the RSUs, to repatriate all payments attributable to the Shares and/or cash acquired under the Plan (including, but not limited to, dividends and any proceeds derived from the sale of Shares acquired pursuant to the RSUs) if required by and in accordance with local foreign exchange rules and regulations in the Participant ‘s country of residence (and country of employment, if different). In addition, the Participant also agrees to take any and all actions, and consent to any and all actions taken by the Company and its Eligible Subsidiaries, as may be required to allow the Company and its Eligible Subsidiaries to comply with local laws, rules and regulations in the Participant’s country of residence (and country of employment, if different). Finally, the Participant agrees to take any and all actions as may be required to comply with the Participant’s personal legal and tax obligations under local laws, rules and regulations in the Participant ‘s country of residence (and country of employment, if different).
23.Private Offering. The grant of the RSUs is not intended to be a public offering of securities in the Participant’s country of residence (and country of employment, if different). The Company has not submitted any registration statement, prospectus or other filing with the local securities authorities with respect to the grant of the RSUs (unless otherwise required under local law). No employee of the Company is permitted to advise the Participant on whether the Participant should acquire Shares under the Plan or provide the Participant with any legal, tax or financial advice with respect to the grant of the RSUs. Investment in Shares involves a degree of risk. Before deciding to acquire Shares pursuant to the RSUs, the Participant should carefully consider all risk factors and tax considerations relevant to the acquisition of Shares under the Plan or the disposition of them. Further, the Participant should carefully review all of the materials related to
10

the RSUs and the Plan, and the Participant should consult with the Participant’s personal legal, tax and financial advisors for professional advice in relation to the Participant’s personal circumstances.
24.Foreign Asset/Account Reporting Requirements and Exchange Controls. The Participant’s country may have certain foreign asset/ account reporting requirements and exchange controls which may affect the Participant’s ability to acquire or hold Shares under the Plan or cash received from participating in the Plan (including any dividends paid on Shares, sale proceeds resulting from the sale of Shares acquired under the Plan) in a brokerage or bank account outside the Participant’s country. The Participant may be required to report such accounts, assets, or transactions to the tax or other authorities in the Participant’s country. The Participant may be required to repatriate sale proceeds or other funds received as a result of the Participant’s participation in the Plan to the Participant’s country through a designated bank or broker within a certain time after receipt. The Participant acknowledges that it is the Participant’s responsibility to be compliant with such regulations and the Participant should consult the Participant's personal legal advisor for any details.
25.Addendums. Notwithstanding any provisions in this Agreement, the RSUs and any Shares subject to the RSUs shall be subject to any special terms and conditions for the Participant’s country of employment and country of residence, if different, as set forth in the addenda attached hereto. Moreover, if the Participant relocates to one of the countries included in such addenda, the special terms and conditions for such country will apply to the Participant, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons and provided the imposition of the term or condition will not result in any adverse accounting expense with respect to the RSUs (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate the Participant’s transfer). All addenda attached hereto constitute part of this Agreement.
26.Imposition of Other Requirements. The Company reserves the right to impose other requirements on the Participant’s participation in the Plan, on the RSUs and on any Shares subject to the RSUs, to the extent the Company determines it is necessary or advisable for legal or administrative reasons and provided the imposition of the term or condition will not result in any adverse accounting expense to the Company, and to require the Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.
27.Recoupment. The RSUs granted pursuant to this Agreement are subject to the terms of the Envista Holdings Corporation Recoupment Policy in the form approved by the Committee from time to time (including any successor thereto, the “Policy”) if and to the extent such Policy by its terms applies to the RSUs, and to the terms required by applicable law; and the terms of the Policy and such applicable law are incorporated by reference herein and made a part hereof. For purposes of the foregoing, the Participant expressly and explicitly authorizes the Company to issue instructions, on the Participant’s behalf, to any brokerage firm and/or third party administrator engaged by the Company to hold the Participant’s Shares and other amounts acquired pursuant to the Participant’s RSUs, to re-convey, transfer or otherwise return such Shares and/or other amounts to the Company upon the Company’s enforcement of the Policy. To the extent that this Agreement and the Policy conflict, the terms of the Policy shall prevail.
28.Notices. The Company may, directly or through its third party stock plan administrator, endeavor to provide certain notices to the Participant regarding certain events relating to awards that the Participant may have received or may in the future receive under the Plan, such as notices reminding the Participant of the vesting or expiration date of certain awards. The Participant acknowledges and agrees that (1) the Company has no obligation (whether pursuant to this Agreement or otherwise) to provide any such notices; (2) to the extent the Company does provide any such notices to the Participant the Company does not thereby assume any obligation to provide any such notices or other notices; and (3) the Company, its Subsidiaries and the third party stock plan administrator have no liability for, and the Participant has no right whatsoever (whether pursuant to this Agreement or otherwise) to make any claim against the Company, any of its Subsidiaries or the third party stock plan administrator based on any allegations of, damages or harm suffered by the Participant as a result of the Company’s failure to provide
11

any such notices or the Participant’s failure to receive any such notices. The Participant further agrees to notify the Company upon any change in the Participant's residence address.
29.Limitations on Liability. Notwithstanding any other provisions of the Plan or this Agreement, no individual acting as a director, employee, or agent of the Company or any of its Subsidiaries will be liable to the Participant or the Participant’s spouse, beneficiary, or any other person or entity for any claim, loss, liability, or expense incurred in connection with the Plan, nor will such individual be personally liable because of any contract or other instrument the Participant executes in such other capacity. No member of the Board or of the Committee will be liable for any action or determination (including, but limited to, any decision not to act) made in good faith with respect to the Plan or any RSUs.
30.Consent and Agreement With Respect to Plan. The Participant (a) acknowledges that the Plan and the prospectus relating thereto are available to the Participant on the website maintained by the Company’s third party stock plan administrator; (b) represents that the Participant has read and is familiar with the terms and provisions thereof, has had an opportunity to obtain the advice of counsel of the Participant's choice prior to executing this Agreement and fully understands all provisions of this Agreement and the Plan; (c) accepts these RSUs subject to all of the terms and provisions thereof; and (d) agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under the Plan or this Agreement.


12

[If this Agreement is signed in paper form, complete and execute the following:]

PARTICIPANTENVISTA HOLDINGS CORPORATION
#Signature#
SignatureSignature
#ParticipantName#
Print NamePrint Name
Title


Declaration of Data Privacy Consent. By providing the additional signature below, the undersigned explicitly declares the Participant's consent to the data processing operations described in Section 13 of this Agreement. This includes, without limitation, the transfer of the Participant’s Personal Information to, and the processing of such data by, the Company, the Employer or, as the case may be, the Stock Plan Administrator in the United States. The undersigned may withdraw the Participant's consent at any time, with future effect and for any or no reason as described in Section 13 of this Agreement.

PARTICIPANT:
#Signature#
Signature
        

13

ADDENDUM A
This Addendum includes additional terms and conditions that govern the RSUs granted to the Participant if the Participant works and/or resides in one of the countries listed herein. Capitalized terms used but not defined herein shall have the same meanings ascribed to them in the Grant Notice, the Agreement or the Plan.
This Addendum may also include information regarding exchange controls, tax and certain other issues of which the Participant should be aware with respect to the Participant’s participation in the Plan. The information is based on the securities, exchange control, tax and other laws in effect as of February 2022. Such laws are often complex and change frequently. As a result, the Company strongly recommends that the Participant not rely on the information contained herein as the only source of information relating to the consequences of the Participant’s participation in the Plan because the information may be out of date at the time the Participant vests in the RSUs or sells Shares acquired under the Plan.
In addition, this Addendum is general in nature and may not apply to the Participant’s particular situation, and the Company is not in a position to assure the Participant of any particular result. Accordingly, the Participant should seek appropriate professional advice as to how the relevant laws in the Participant’s country apply to the Participant’s specific situation.
If the Participant is a citizen or resident (or is considered as such for local tax purposes) of a country other than the one in which the Participant is currently residing and/or working, or if the Participant transfers employment and/or residency to another country after the grant of the RSUs, the information contained herein may not be applicable to the Participant in the same manner.
EUROPEAN UNION (“EU”) / EUROPEAN ECONOMIC AREA (“EEA”) 1 AND SWITZERLAND
Data Privacy
If the Participant resides and/or is employed in the EU / EEA, the following provision replaces Section 13 of the Agreement:
The Company is located at 200 S. Kraemer Blvd., Building E, Brea California 92821 and grants RSUs under the Plan to employees of the Company and its Subsidiaries in its sole discretion. The Participant should review the following information about the Company’s data processing practices.
(a)Data Collection, Processing and Usage. Pursuant to applicable data protection laws, the Participant is hereby notified that the Company collects, processes, and uses certain personally-identifiable information about the Participant; specifically, including the Participant’s name, home address, email address and telephone number, date of birth, social insurance / passport number or other identification number (e.g. resident registration number), salary, citizenship, job title, any Shares or directorships held in the Company, and details of all RSUs or any other equity compensation awards granted, canceled, exercised, vested, or outstanding in the Participant’s favor, which the Company receives from the Participant or the Employer ("Personal Information"). In granting the RSUs under the Plan, the Company will collect the Participant’s Personal Information for purposes of allocating Shares and implementing, administering and managing the Plan. The Company’s legal basis for collecting, processing and using the Participant's Personal Information will be the Company's necessity to execute its contractual obligations under this Agreement and to comply with its legal obligations. The Participant’s refusal to provide personal data may affect the Participant’s ability to participate in the Plan. As such, by participating in the Plan, the Participant voluntarily acknowledges the collection, processing and use, of the Participant’s Personal Information as described herein.
(b)Stock Plan Administration Service Provider. The Company transfers participant data to Fidelity Stock Plan Services LLC, an independent service provider based in the United States, which assists the Company with the implementation, administration and management of the Plan (the “Stock Plan Administrator”). In the future, the Company may select a different Stock Plan Administrator and share the Participant’s Personal Information with another company that serves in a similar manner. The Stock Plan Administrator will open an account for the Participant to receive and trade Shares
1 For the avoidance of doubt, references to the European Union / European Economic Area in this Addendum include currently the United Kingdom.
14

acquired under the Plan. The Participant will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to the Participant’s ability to participate in the Plan.
(c)International Data Transfers. The Company and the Stock Plan Administrator are based in the United States. The Company can only meet its contractual obligations to the Participant if the Participant’s Personal Information is transferred to the United States. The Company’s legal basis for the transfer of the Participant’s Personal Information to the United States is to satisfy its contractual obligations under the terms of this Agreement and/or its use of the standard data protection clauses adopted by the EU Commission.
(d)Data Retention. The Company will use the Participant’s Personal Information only as long as is necessary to implement, administer and manage the Participant’s participation in the Plan or as required to comply with legal or regulatory obligations, including under tax and securities laws. When the Company no longer needs the Participant’s Personal Information, the Company will remove it from its systems. If the Company keeps the Participant’s data longer, it would be to satisfy legal or regulatory obligations and the Company’s legal basis would be for compliance with relevant laws or regulations.
(e)Data Subjects Rights. The Participant may have a number of rights under data privacy laws in the Participant’s country of residence (and country of employment, if different). For example, the Participant’s rights may include the right to (i) request access or copies of personal data the Company processes pursuant to this Agreement, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) request restrictions on processing, (v) lodge complaints with competent authorities in the Participant’s country of residence (and country of employment, if different), and/or (vi) request a list with the names and addresses of any potential recipients of the Participant’s Personal Information. To receive clarification regarding the Participant’s rights or to exercise the Participant's rights, the Participant should contact the Participant's local human resources department.
AUSTRALIA
Australia Offer Document
The Participant understands that the offering of the Plan in Australia is intended to qualify for exemption from the prospectus requirements under Class Order 14/1000 issued by the Australian Securities and Investments Commission. Participation in the Plan is subject to the terms and conditions set forth in the Australian Offer Document (delivered to the Participant separately), the Plan and the Agreement provided to the Participant.
RSUs Conditioned on Satisfaction of Regulatory Obligations
If the Participant is (a) a director of a Subsidiary incorporated in Australia, or (b) a person who is a management-level executive of a Subsidiary incorporated in Australia and who also is a director of a Subsidiary incorporated outside of Australia, the grant of the RSUs is conditioned upon satisfaction of the shareholder approval provisions of section 200B of the Corporations Act 2001 (Cth) in Australia.
Tax Information
The Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) (the “Act”) applies (subject to the conditions in that Act).
Exchange Control Notice
Exchange control reporting is required for cash transactions exceeding A$10,000 and international fund transfers of any amount. The Australian bank assisting with the transaction will file the report for the Participant. If there is no Australian bank involved in the transfer, the Participant will be responsible for filing the report.
BELGIUM
Foreign Asset/Account Reporting Information
The Participant is required to report any securities (e.g., Shares acquired under the Plan) or bank accounts (including brokerage accounts) opened and maintained outside of Belgium on the Participant's annual tax return. The Participant will also be required to complete a separate report, providing the National Bank of
15

Belgium with details regarding any such account (including the account number, the name of the bank in which such account is held and the country in which such account is located). This report, as well as additional information on how to complete it, can be found on the website of the National Bank of Belgium, www.nbb.be, under Kredietcentrales / Centrales des crédits caption.
Stock Exchange Tax Information
A stock exchange tax applies to transactions executed by a Belgian resident through a non-Belgian financial intermediary, such as a U.S. broker. The stock exchange tax will apply when Shares acquired pursuant to the RSUs are sold. The Participant should consult with a personal tax or financial advisor for additional details on the Participant’s obligations with respect to the stock exchange tax.
Annual Securities Account Tax
An annual securities accounts tax may be payable if the total value of securities held in a Belgian or foreign securities account (e.g., Shares acquired under the Plan) exceeds a certain threshold on four reference dates within the relevant reporting period (i.e., December 31, March 31, June 30 and September 30). In such case, the tax will be due on the value of the qualifying securities held in such account. The Participant should consult with a personal tax or financial advisor for additional details on the Participant’s obligations with respect to the annual securities account tax.
BRAZIL
Labor Law Policy and Acknowledgment
The following provision supplements Section 17 of the Agreement:
By accepting the RSUs, the Participant agrees that the Participant is (i) making an investment decision; (ii) the Shares will be issued to the Participant only if the Vesting Conditions are met and (iii) the value of the underlying Shares is not fixed and may increase or decrease in value over the vesting period without compensation to the Participant.
Compliance with Law
By accepting the RSUs, the Participant acknowledges that the Participant agrees to comply with applicable Brazilian laws and to pay any and all applicable taxes associated with the vesting of the RSUs, and the sale of Shares acquired under the Plan and the receipt of any dividends.
Foreign Asset/Account Reporting Information
If the Participant is a resident or domiciled in Brazil, the Participant may be required to submit an annual declaration of assets and rights held outside of Brazil to the Central Bank of Brazil. If the aggregate value of such assets and rights is US$100,000 or more but less than US$100,000,000, a declaration must be submitted annually. If the aggregate value exceeds US$100,000,000, a declaration must be submitted quarterly.
Tax on Financial Transactions (IOF)
Repatriation of funds (e.g., the proceeds from the sale of Shares) into Brazil and the conversion of USD into BRL associated with such fund transfers may be subject to the Tax on Financial Transactions. It is the Participant's responsibility to comply with any applicable Tax on Financial Transactions arising from the Participant's participation in the Plan. The Participant should consult with the Participant's personal tax advisor for additional details.
CANADA
RSUs Payable Only in Shares
RSUs granted to Participants in Canada shall be paid in Shares only. In no event shall any of such RSUs be paid in cash, notwithstanding any discretion contained in the Plan, or any provision in the Agreement to the contrary.
Forfeiture Upon Termination of Employment
The following provision replaces Section 4(a) of the Agreement:
16

Until vested, the RSU shall be subject to forfeiture in the event of the termination of the Participant's employment, where termination of employment means the date on which the Participant is no longer actively providing services to the Company (including, for this purpose, all Eligible Subsidiaries) for any reason, whether such termination is occasioned by the Participant, by the Company or any of its Eligible Subsidiaries, with or without cause, and whether or not later found to be invalid or unlawful; by mutual agreement or by operation of law (“Termination of Employment”). For the avoidance of doubt, unless explicitly required by applicable legislation, the date on which any Termination of Employment occurs shall not be extended by any notice period or period for which pay in lieu of notice or related damages or payments are provided or mandated under local law (including, but not limited to, statute, contract, regulatory law and/or common or civil law), and the Participant shall have no right to full or pro-rated vesting or compensation for lost vesting related to such periods. For greater clarity, the date on which Termination of Employment occurs shall not be extended by any period of “garden leave”, paid administrative leave or similar period under local law. The Administrator shall have the exclusive discretion to determine when the Participant ceased to actively provide services to the Employer for the purposes of this RSU (including, subject to statutory protections, whether the Participant may still be considered to be providing services while on an approved leave of absence). Unless the Committee provides otherwise (1) Termination of Employment shall include instances in which the Participant is terminated and immediately rehired as an independent contractor, and (2) the spin-off, sale, or disposition of the Participant’s employer from the Company or an Eligible Subsidiary (whether by transfer of shares, assets or otherwise) such that the Participant’s employer no longer constitutes an Eligible Subsidiary shall constitute a Termination of Employment.
If, notwithstanding the foregoing, applicable employment legislation explicitly requires continued vesting during a statutory notice period, the Participant’s right to vest in the RSU, if any, will terminate effective as of the last day of the minimum statutory notice period, but the Participant will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of the Participant’s statutory notice period, nor will the Participant be entitled to any compensation for the lost vesting.
Sections 4(b) through 4(e) of the Agreement shall continue to apply to the Participant; provided, however, that any reference to termination of employment, termination of an active service-providing relationship, “no longer actively employed (or is no longer actively providing services, as applicable)” or similar language shall be interpreted to mean Termination of Employment as defined in this Addendum A.
The following two provisions apply if the Participant is a resident of Quebec:
Consent to Receive Information in English
The parties acknowledge that it is their express wish that the Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be written in English.
Les parties reconnaissent avoir exigé la rédaction en anglais du présent Contrat, ainsi que de tous documents exécutés, avis donnés ou procédures judiciaires intentées, en vertu du, ou liés directement ou indirectement, au présent Contrat.
Grant for Future Services
The following provision supplements Section 17 of the Agreement:
(m)    By accepting the RSUs, the Participant acknowledges, understands and agrees that the Options relate to future services to be performed and are not a bonus or compensation for past services.
Data Privacy
The following provision supplements Section 13 of the Agreement:
The Participant hereby authorizes the Company and the Company’s representatives to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Participant’s awards under the Plan. The Participant further authorizes the Company, its Subsidiaries, and the Stock Plan Administrator, to disclose and discuss the Participant’s participation in
17

the Plan with their respective advisors. The Participant further authorizes the Company and its Subsidiaries to record such information and to keep such information in the Participant's employee file.
Securities Law Notice
The Participant is permitted to sell Shares acquired under the Plan through the designated broker appointed under the Plan, if any (or any other broker acceptable to the Company), provided the resale of Shares acquired under the Plan takes place outside of Canada through the facilities of a stock exchange on which the Shares is listed. The Shares are currently listed on the New York Stock Exchange.
Foreign Asset/Account Reporting Information
Foreign property, including the RSUs, Shares acquired under the Plan, and other rights to receive shares of a non-Canadian company held by a Canadian resident must generally be reported annually on a Form T1135 (Foreign Income Verification Statement) if the total cost of the foreign property exceeds C$100,000 at any time during the year. Thus, unvested RSUs must be reported – generally at a nil cost – if the C$100,000 cost threshold is exceeded because the Participant holds other foreign property. When Shares are acquired, their cost generally is the adjusted cost base (“ACB”) of the Shares. The ACB would ordinarily equal the fair market value of the Shares at the time of acquisition, but if the Participant owns other shares of the Company, this ACB may need to be averaged with the ACB of the other shares. The Participant should consult the Participant's personal legal advisor to ensure compliance with applicable reporting obligations.
CHILE
Securities Law Notice
The grant of the RSUs is not intended to be a public offering of securities in Chile but instead is intended to be a private placement.
a)The starting date of the offer will be the Date of Grant (as defined in the Agreement), and this offer conforms to General Ruling No. 336 of the Chilean Commission of the Financial Market (“CMF”);
b)The offer deals with securities not registered in the Registry of Securities or in the Registry of Foreign Securities of the CMF, and therefore such securities are not subject to its oversight;
c)The issuer is not obligated to provide public information in Chile regarding the foreign securities, as such securities are not registered with the CMF; and
d)The foreign securities shall not be subject to public offering as long as they are not registered with the corresponding registry of securities in Chile.
a)La fecha de inicio de la oferta será el de la fecha de otorgamiento (o “Date of Grant”, según este término se define en el documento denominado “Agreement”) y esta oferta se acoge a la norma de Carácter General N° 336 de la Comisión para el Mercado Financiero de Chile (“CMF”);
b)La oferta versa sobre valores no inscritos en el Registro de Valores o en el Registro de Valores Extranjeros que lleva la CMF, por lo que tales valores no están sujetos a la fiscalización de ésta;
c)Por tratar de valores no inscritos en la CMF no existe la obligación por parte del emisor de entregar en Chile información pública respecto de esos valores; y
d)Esos valores no podrán ser objeto de oferta pública mientras no sean inscritos en el registro de valores correspondiente.
Exchange Control Notice
If the Participant is a resident of Chile, the Participant is not required to repatriate any proceeds obtained from the sale of Shares or the receipt of dividends to Chile. However, if the Participant is a resident of Chile and decides to repatriate proceeds from the sale of Shares or the receipt of dividends and the amount of the proceeds to be repatriated exceeds US$10,000, the Participant must effect such repatriation through the Formal Exchange Market. It is unnecessary to convert any repatriated funds into Chilean currency.
18

Please note that exchange control regulations in Chile are subject to change. The Participant should consult with the Participant’s personal legal advisor regarding any exchange control obligations that the Participant may have prior to the vesting of the RSUs.
Foreign Asset/Account Reporting Information
The Chilean Internal Revenue Service (“CIRS”) requires all taxpayers to provide information annually regarding: (i) the taxes paid abroad which they will use as a credit against Chilean income taxes, and (ii) the results of foreign investments. These annual reporting obligations must be complied with by submitting a sworn statement setting forth this information before June 30 of each year. The sworn statement disclosing this information (or Formularios) must be submitted electronically through the CIRS website: www.sii.cl, using Form 1929. In addition, the Participant will be personally responsible for reporting taxable income on Form 22.
CHINA
The following provision applies if the Participant is subject to exchange control restrictions and regulations in the People's Republic of China (“PRC”), including the requirements imposed by the PRC State Administration of Foreign Exchange (“SAFE”), as determined by the Company in its sole discretion:
Settlement Notice
Notwithstanding anything to the contrary in the Plan or the Agreement, no Shares will be issued to the Participant in settlement of the RSUs unless and until all necessary exchange control or other approvals with respect to the RSUs under the Plan have been obtained from the SAFE or its local counterpart (“SAFE Approval”). In the event that SAFE Approval has not been obtained prior to any date(s) on which the RSUs are scheduled to vest in accordance with the vesting schedule set forth in the Agreement, any Shares which are contemplated to be issued in settlement of such vested RSUs shall be held by the Company in escrow on behalf of the Participant until SAFE Approval is obtained.
Exchange Control Restrictions Applicable to Participants who are PRC Nationals
If the Participant is a local national of the PRC, the Participant understands and agrees that upon RSU vesting the underlying Shares may be sold immediately or, at the Company’s discretion, at a later time. The Participant further agrees that the Company is authorized to instruct its designated broker to assist with the mandatory sale of such Shares (on the Participant’s behalf pursuant to this authorization), and the Participant expressly authorizes such broker to complete the sale of such Shares. The Participant acknowledges that the Company’s designated broker is under no obligation to arrange for the sale of the Shares at any particular price. Upon the sale of the Shares, the Company agrees to pay the cash proceeds from the sale, less any brokerage fees or commissions, to the Participant in accordance with applicable exchange control laws and regulations and provided any liability for Tax Related-Items resulting from the vesting of the RSUs has been satisfied. Due to fluctuations in the Share price and/or the U.S. Dollar exchange rate between the Vesting Date and (if later) the date on which the Shares are sold, the sale proceeds may be more or less than the fair market value of the Shares on the Vesting Date. The Participant understands and agrees that the Company is not responsible for the amount of any loss the Participant may incur and that the Company assumes no liability for any fluctuations in the Share price and/or U.S. Dollar exchange rate.
The Participant understands and agrees that, due to exchange control laws in China, the Participant will be required to immediately repatriate to China the cash proceeds from the sale of any Shares acquired at vesting of the RSUs and any dividends received in relation to the Shares. The Participant further understands that, under local law, such repatriation of the cash proceeds may need to be effectuated through a special exchange control account to be approved by the local foreign exchange administration, and the Participant hereby consents and agrees that the proceeds from the sale of Shares acquired under the Plan and any dividends received in relation to the Shares may be transferred to such special account prior to being delivered to the Participant. The proceeds may be paid to the Participant in U.S. Dollars or local currency at the Company’s discretion (as of the Date of Grant, the proceeds are paid to the Participant in local currency). In the event the proceeds are paid to the Participant in U.S. Dollars, the Participant understands that the Participant will be required to set up a U.S. Dollar bank account in China and provide the bank account details to the Employer and/or the Company so that the proceeds may be deposited into this account.
19

If the proceeds are paid to the Participant in local currency, the Participant agrees to bear any currency fluctuation risk between the time the Shares are sold or dividends are paid and the time the proceeds are distributed to the Participant through any such special account.
Exchange Control Notice Applicable to Participants in the PRC
If the Participant is a local national of the PRC, the Participant understands that exchange control restrictions may limit the Participant’s ability to access and/or convert funds received under the Plan, particularly if these amounts exceed US$50,000. The Participant should confirm the procedures and requirements for withdrawals and conversions of foreign currency with the Participant's local bank prior to the vesting of the RSUs/sale of Shares.
The Participant agrees to comply with any other requirements that may be imposed by the Company in the future in order to facilitate compliance with exchange control requirements in the PRC.
COLOMBIA
Labor Law Acknowledgement
The following provision supplements Section 17 of the Agreement:
The Participant acknowledges that pursuant to Article 15 of Law 50/1990 (Article 128 of the Colombian Labor Code), the Plan, the RSUs, the underlying Shares, and any other amounts or payments granted or realized from participation in the Plan do not constitute a component of the Participant’s “salary” for any purpose. To this extent, they will not be included and/or considered for purposes of calculating any and all labor benefits, such as legal/fringe benefits, vacations, indemnities, payroll taxes, social insurance contributions or any other labor-related amount which may be payable.
Securities Law Notice
The Shares are not and will not be registered with the Colombian registry of publicly traded securities (Registro Nacional de Valores y Emisores), and therefore, the Shares cannot be offered to the public in Colombia. Nothing in the Agreement shall be construed as making a public offer of securities, or the promotion of financial products in Colombia.
Exchange Control Notice
Foreign investments must be registered with the Central Bank of Colombia (Banco de la República). Upon the subsequent sale or other disposition of investments held abroad, the registration with the Central Bank must be canceled, the proceeds from the sale or other disposition of the Shares must be repatriated to Colombia and the appropriate Central Bank form must be filed (usually with the Participant’s local bank). The Participant acknowledges that the Participant personally is responsible for complying with Colombian exchange control requirements.
Foreign Asset/Account Reporting Information
An annual informative return must be filed with the Colombian Tax Office detailing any assets held abroad (including the Shares acquired under the Plan). If the individual value of any of these assets exceeds a certain threshold, each asset must be described (e.g., its nature and its value) and the jurisdiction in which it is located must be disclosed. The Participant acknowledges that the Participant personally is responsible for complying with this tax reporting requirement.
CROATIA
Exchange Control Notice
The Participant must report any foreign investments (including Shares acquired under the Plan) to the Croatian National Bank for statistical purposes. However, because exchange control regulations may change without notice, the Participant should consult with the Participant's legal advisor to ensure compliance with current regulations. The Participant acknowledges that the Participant personally is responsible for complying with Croatian exchange control laws.
20

CZECH REPUBLIC
Exchange Control Notice
Upon request of the Czech National Bank (the “CNB”), the Participant may need to report the following to the CNB: foreign direct investments, financial credits from abroad, investment in foreign securities and associated collection and payments (Shares and proceeds from the sale of the Shares may be included in this reporting requirement). The Participant may need to report the following even in the absence of a request from the CNB: foreign direct investments with a value of CZK 2,500,000 or more in the aggregate or other foreign financial assets with a value of CZK 200,000,00 or more. Because exchange control regulations change frequently and without notice, the Participant should consult the Participant's personal legal advisor prior to vesting of the RSUs and the sale of Shares to ensure compliance with current regulations. It is the Participant’s responsibility to comply with Czech exchange control laws, and neither the Company nor any Subsidiary will be liable for any resulting fines or penalties.

21


DENMARK
Danish Stock Option Act
Notwithstanding anything in this Agreement to the contrary, the treatment of the RSUs upon the Participant’s termination of employment with the Company or an Eligible Subsidiary, as applicable, shall be governed by the Danish Stock Option Act, as in effect at the time of the Participant’s termination (as determined by the Committee in its discretion in consultation with legal counsel). By accepting the RSUs, the Participant acknowledges that the Participant has received a Danish translation of an Employer Statement, which is being provided to comply with the Danish Stock Option Act.
Foreign Asset/Account Reporting Information
The establishment of an account holding Shares or an account holding cash outside Denmark must be reported to the Danish Tax Administration. The form which should be used in this respect may be obtained from a local bank.
The requirement to report certain information to the Danish Tax Administration via Form V or K was eliminated effective January 1, 2019. However, the Participant must still report the foreign bank/broker accounts and their deposits, and Shares held in a foreign bank or broker in the Participant's tax return under the section on foreign affairs and income.
ECUADOR
Foreign Asset/Account Reporting Information
The Participant will be responsible for including any RSUs that vested during the previous fiscal year in the Participant's annual Net Worth Declaration if the Participant's net worth exceeds the thresholds set forth in the law. The Net Worth Declaration must be filed in May of the following year using the electronic form on the tax authorities’ website (www.sri.gob.ec). Penalties will apply to a late filing and it is not possible to seek an extension.
ESTONIA
Participant Responsibility for Fringe Benefits Tax.
The following provision supplements Section 7 of the Agreement:
The Participant understands that the Participant generally would not be subject to taxation in Estonia when the RSUs vest and Shares are issued under the Plan and instead, the Employer generally would be subject to a fringe benefits tax (“FBT”) unless an exemption otherwise applies. Notwithstanding the foregoing, as a condition to the grant of the RSUs and the Participant’s participation in the Plan, the Participant expressly agrees that the Participant shall bear the cost of any FBT that may be payable upon the issuance of the Shares issued in settlement of the RSUs upon vesting, and the Company and/or the Employer will seek indemnification / reimbursement from the Participant for any FBT that is payable. For purposes of the foregoing, the Company shall reduce the number of Shares otherwise issuable to the Participant upon vesting of the RSUs by a number of Shares equal to an amount determined by the Company to be appropriate to offset the FBT, and may otherwise recover any FBT by any other means referred to in Section 7 of the Agreement. The Participant further acknowledges and agrees that the Company and/or Employer shall have discretion to seek indemnification for any FBT that may be payable upon the issuance of the Shares issued in settlement of the RSUs upon vesting and that such discretion is not imbalanced or harmful to the Participant, and the Participant unconditionally and irrevocably waives any rights to amend or dispute its validity on the basis of any law or regulation of Estonia or any other jurisdiction.

Language Consent
By accepting the RSUs, the Participant confirms having read and understood the documents related to the grant, which were provided in the English language, and that he or she does not need the translation thereof into the Estonian language. The Participant accepts the terms of those documents accordingly.
22

Võttes vastu piiratud aktsiaühikute (RSUs) pakkumise, kinnitab Osaleja, et ta on ingliskeelsena esitatud pakkumisega seotud dokumendid läbi lugenud ja nendest aru saanud ning et ta ei vaja nende tõlkimist eesti keelde. Sellest tulenevalt Osaleja nõustub viidatud dokumentide tingimustega.
FINLAND
Foreign Asset/Account Reporting Information. There are no specific reporting requirements with respect to foreign assets/accounts. However, the Participant should check the Participant’s pre-completed tax return to confirm that the ownership of Shares and other securities (foreign or domestic) are correctly reported. If the Participant finds any errors or omissions, the Participant must make the necessary corrections electronically or by sending specific paper forms to the local tax authorities.
FRANCE
Consent to Receive Information in English
By accepting the RSUs, the Participant confirms having read and understood the Plan, the Grant Notice, the Agreement and this Addendum, including all terms and conditions included therein, which were provided in the English language. The Participant accepts the terms of those documents accordingly.
Consentement afin de Recevoir des Informations en Anglais
En acceptant les  droits sur des actions assujettis à restrictions (« restricted stock units » ou « RSUs »), le Participant confirme avoir lu et compris le Plan, la Notification d’Attribution, le Contrat et la présente Annexe B, en ce compris tous les termes et conditions y relatifs, qui ont été fournis en langue anglaise. Le Participant accepte les termes de ces documents en connaissance de cause.
Tax Information
The RSUs granted under the Agreement are not intended to be a tax-qualified RSUs.
Foreign Asset/Account Reporting Information
The Participant may hold any Shares acquired under the Plan, any sales proceeds resulting from the sale of Shares or any dividends paid on such Shares outside of France, provided the Participant declares all foreign accounts, whether open, current, or closed, in the Participant's income tax return. Failure to complete this reporting triggers penalties for the resident. Further, French residents with foreign account balances exceeding prescribed amounts may have additional monthly reporting obligations.
GERMANY
Exchange Control Notice
German residents must report cross-border payments (made or received) in excess of €12,500 to the Deutsche Bundesbank. Such reporting obligation might arise when Shares are issued to employees and when Shares are subsequently sold by the employees. The Participant is personally responsible for complying with applicable reporting obligations and should consult with the Participant 's personal legal advisor for additional information about these reporting obligations.
HUNGARY
None.
INDIA
Exchange Control Notice
The Participant must repatriate any proceeds from the sale of the Shares and any cash dividends acquired under the Plan to India and convert the proceeds into local currency within a certain period from the time of receipt (90 days for sale proceeds and within 180 days for dividend payments, or within such other period of time as may be required under applicable regulations and to convert the proceeds into local currency). The Participant will receive a foreign inward remittance certificate (“FIRC”) from the bank where the Participant deposits the foreign currency. The Participant should maintain the FIRC as
23

evidence of the repatriation of funds in the event the Reserve Bank of India or the Employer requests proof of repatriation.
It is the Participant’s responsibility to comply with exchange control laws in India, and neither the Company nor the Employer will be liable for any fines or penalties resulting from the Participant’s failure to comply with applicable laws.
Foreign Asset/Account Reporting Information
The Participant is required to declare the Participant's foreign bank accounts and any foreign financial assets (including Shares held outside India) in the Participant’s annual tax return.  It is the Participant’s responsibility to comply with this reporting obligation and the Participant should consult the Participant's personal advisor in this regard as significant penalties may apply in the case of non-compliance.
INDONESIA
Language Consent
A translation of the documents relating to this grant into Bahasa Indonesia can be provided to Participant upon request to Envista’s Corporate Compensation department.  By accepting the RSUs, the Participant (i) confirms having read and understood the documents relating to the RSUs (i.e., the Plan and the Agreement) which were provided in the English language, (ii) accepts the terms of those documents accordingly, and (iii) agrees not to challenge the validity of this document based on Law No. 24 of 2009 on National Flag, Language, Coat of Arms and National Anthem or the implementing Presidential Regulation (when issued).
Persetujuan Bahasa
Terjemahan dari dokumen-dokumen terkait dengan pemberian ini ke Bahasa Indonesia dapat disediakan untuk Peserta berdasarkan permintaan kepada Envista’s Corporate Compensation department. Dengan menerima Pemberian, Peserta (i) memberikan konfirmasi bahwa anda telah membaca dan memahami dokumen-dokumen berkaitan dengan Pemberian ini (yaitu, Program dan Perjanjian) yang disediakan dalam Bahasa Inggris, (ii) menerima persyaratan di dalam dokumen-dokumen tersebut, dan (iii) setuju untuk tidak mengajukan keberatan atas keberlakuan dari dokumen ini berdasarkan Undang-Undang No. 24 Tahun 2009 tentang Bendera, Bahasa dan Lambang Negara serta Lagu Kebangsaan ataupun Peraturan Presiden sebagai pelaksanaannya (ketika diterbitkan).
Exchange Control Notice
Indonesian residents repatriating funds (e.g., remittance of proceeds from the sale of Shares into Indonesia) into Indonesia, the Indonesian bank through which the transaction is made will submit a report of the transaction to the Bank of Indonesia. For transactions of US$10,000 or more (or its equivalent in other currency), a more detailed description of the transaction must be included in the report and the Participant may be required to provide information about the transaction to the bank in order to complete the transaction. For foreign currency transactions exceeding US$25,000, the underlying document of that transaction will have to be submitted to the relevant local bank.
ITALY
Plan Document Acknowledgement
In accepting the RSUs, the Participant acknowledges that the Participant has received a copy of the Plan and the Agreement, has reviewed the Plan and the Agreement (including this Addendum), in their entirety and fully understands and accepts all provisions of the Plan and the Agreement (including this Addendum).
The Participant further acknowledges that the Participant has read and specifically and expressly approves without limitation, the following sections of the Agreement: Section 7: Tax Obligations; Section 16: Governing Law and Venue; Section 17: Nature of RSUs; Section 25: Addendums; Section 26: Imposition of Other Requirements; Section 27: Recoupment; and the Data Privacy section above.
Foreign Asset/Account Reporting Information
Italian residents who, at any time during the fiscal year, hold foreign financial assets (including cash and Shares) which may generate income taxable in Italy are required to report these assets on their annual tax returns (UNICO Form, RW Schedule) for the year during which the assets are held, or on a special form
24

if no tax return is due. These reporting obligations will also apply to Italian residents who are the beneficial owners of foreign financial assets under Italian money laundering provisions. Italian residents should consult with their personal tax advisor to determine their personal reporting obligations.
Foreign Asset Tax
The value of any Shares (and other financial assets) held outside Italy by individuals resident of Italy may be subject to a foreign asset tax. The taxable amount will be the fair market value of the financial assets (e.g., Shares) assessed at the end of the calendar year. The value of financial assets held abroad must be reported in Form RM of the annual return. The Participant should consult the Participant's personal tax advisor for additional information on the foreign asset tax.
JAPAN
Foreign Asset/Account Reporting Information
The Participant will be required to report details of any assets held outside Japan as of December 31st to the extent such assets have a total net fair market value exceeding ¥50,000,000. This report is due by March 15 each year. The Participant should consult with the Participant's personal tax advisor as to whether the reporting obligation applies to him or her and whether the requirement extends to any outstanding RSUs or Shares acquired under the Plan.
KOREA
Exchange Control Notice
If the Participant realizes US$500,000 or more from the sale of Shares or the receipt of any dividends with respect to RSUs granted prior to July 18, 2017, Korean exchange control laws may require the Participant to repatriate the proceeds back to Korea within three (3) years of the sale/receipt.
Foreign Asset/Account Reporting Information
Korean residents must declare all foreign financial accounts (e.g., non-Korean bank accounts, brokerage accounts) to the Korean tax authority and file a report with respect to such accounts in June of the following year if the monthly balance of such accounts exceeds KRW 500 million (or an equivalent amount in foreign currency) on any month-end date during a calendar year. The Participant should consult with the his / her personal tax advisor to determine the Participant's personal reporting obligations.
MEXICO
Labor Law Acknowledgement
The following provision supplements Section 17 of the Agreement.
By accepting the RSUs, the Participant acknowledges that the Participant understands and agrees that: (i) the RSUs are not related to the salary and other contractual benefits granted to the Participant by the Employer; and (ii) any modification of the Plan or its termination shall not constitute a change or impairment of the terms and conditions of employment.
Policy Statement
The grant of the RSUs the Company is making under the Plan is unilateral and discretionary and, therefore, the Company reserves the absolute right to amend it and discontinue it at any time without any liability.
The Company, with registered offices at 200 S. Kraemer Blvd., Building E, Brea, California 92821, is solely responsible for the administration of the Plan. Participation in the Plan and the acquisition of Shares under the Plan does not, in any way establish an employment relationship between the Participant and the Company since the Participant is participating in the Plan on a wholly commercial basis and the Participant’s sole employer is the Subsidiary employing the Participant, as applicable, nor does it establish any rights between the Participant and the Employer.
Plan Document Acknowledgment
By participating in the Plan, Participant acknowledges that the Participant has received copies of the Plan and the Agreement, has reviewed the Plan and the Agreement in their entirety and fully understands and accept all provisions of the Plan and the Agreement.
25

In addition, by participating in the Plan, the Participant further acknowledges that the Participant has read and specifically and expressly approves the terms and conditions in Section 17 of the Agreement, in which the following is clearly described and established: (i) participation in the Plan does not constitute an acquired right; (ii) the Plan and participation in the Plan is offered by the Company on a wholly discretionary basis; (iii) participation in the Plan is voluntary; and (iv) the Company and its Subsidiaries are not responsible for any decrease in the value of the Shares underlying the RSUs.
Finally, the Participant hereby declares that the Participant does not reserve any action or right to bring any claim against the Company for any compensation or damages as a result of participation in the Plan and therefore grants a full and broad release to the Employer and the Company and its Subsidiaries with respect to any claim that may arise under the Plan.

26

Spanish Translation
Reconocimiento de la Ley Laboral
Esta disposición complementa la Sección 17 del Acuerdo.
Al aceptar el RSU,el Participante reconoce entiende y acuerda que: (i) la RSU no se encuentra relacionada con el salario ni con otras prestaciones contractuales concedidas al Participante por del patrón; y (ii) cualquier modificación del Plan o su terminación no constituye un cambio o detrimento en los términos y condiciones de empleo.
Declaración de Política
La concesión del RSU que la Compañía está haciendo bajo el Plan es unilateral y discrecional y, por lo tanto, la Compañía se reserva el derecho absoluto de modificar y discontinuar el mismo en cualquier momento, sin ninguna responsabilidad.
La Compañía, con oficinas registradas ubicadas en 200 S. Kraemer Blvd., Building E, Brea, California 92821, es la única responsable por la administración del Plan. La participación en el Plan y la adquisición de Acciones no establece de forma alguna, una relación de trabajo entre el Participante y la Compañía, ya que la participación en el Plan por parte del Participante es completamente comercial y el único patrón es Subsidiaria que esta contratando al que tiene la RSU, en caso de ser aplicable, así como tampoco establece ningún derecho entre el que tiene la RSU y el patrón.
Reconocimiento del Plan de Documentos
Al participar en el Plan, el Participante reconoce que ha recibido copias del Plan y del Acuerdo, mismos que ha revisado en su totalidad y los entiende completamente y, que ha entendido y aceptado las disposiciones contenidas en el Plan y en el Acuerdo.
Adicionalmente, al participar en el Plan, el Participante reconoce que ha leído, y que aprueba específica y expresamente los términos y condiciones contenidos en la Sección 17 del Acuerdo, en la cual se encuentra claramente descrito y establecido lo siguiente: (i) la participación en el Plan no constituye un derecho adquirido; (ii) el Plan y la participación en el mismo es ofrecida por la Compañía de forma enteramente discrecional; (iii) la participación en el Plan es voluntaria; y (iv) la Compañía, así como sus Subsidiarias no son responsables por cualquier detrimento en el valor de las Acciones en relación con la RSU.
Finalmente, el Participante declara que no se reserva ninguna acción o derecho para interponer una demanda en contra de la Compañía por compensación, daño o perjuicio alguno como resultado de la participación en el Plan y en consecuencia, otorga el más amplio finiquito a su patrón, así como a la Compañía, a sus Subsidiarias con respecto a cualquier demanda que pudiera originarse en virtud del Plan.
NETHERLANDS
None.
POLAND
Foreign Asset/Account Reporting Information
Polish residents holding foreign securities (e.g., Shares) and/or maintaining accounts abroad are obligated to file quarterly reports with the National Bank of Poland incorporating information on transactions and balances of the securities and cash deposited in such accounts if the value of such securities and cash (when combined with all other assets held abroad) exceeds PLN 7,000,000.
Exchange Control Notice
Polish residents are also required to transfer funds through a bank account in Poland if the transferred amount in any single transaction exceeds a specified threshold (currently EUR 15,000). Polish residents are required to store documents connected with foreign exchange transactions for a period of five years from the date the exchange transaction was made.

27

PORTUGAL
Language Consent.
The Participant hereby expressly declares that the Participant has full knowledge of the English language and has read, understood and freely accepted and agreed with the terms and conditions established in the Plan and the Agreement.
Conhecimento da Língua. 
Pela presente, o Participante declara expressamente que tem pleno conhecimento da língua inglesa e que leu, compreendeu e livremente aceitou e concordou com os termos e condições estabelecidas no Plano e no Acordo (Agreement em inglés).
RUSSIA
Labor Law Acknowledgement
The Participant understands that if the Participant continues to hold the Shares acquired under the Plan after an involuntary termination of employment, the Participant will be ineligible to receive unemployment benefits in Russia.
U.S. Transaction
Any Shares issued upon vesting of the RSUs shall be delivered to the Participant through a brokerage account with the Stock Plan Administrator established in the United States. The Participant may hold the Shares in the Participant’s brokerage account in the United States; however, in no event will the Shares issued to the Participant and/or share certificates or other instruments be delivered to the Participant in Russia. The Participant is not permitted to make any public advertising or announcements regarding the RSUs or Shares in Russia, or promote these Shares to other Russian legal entities or individuals, and the Participant is not permitted to sell Shares acquired upon vesting of the RSUs directly to other Russian legal entities or residents. The Participant is permitted to sell Shares only on the New York Stock Exchange and only through a United States broker.
Foreign Asset/Account Reporting Information
The Participant is required to report the opening, closing or change of details of any foreign bank account to Russian tax authorities within one month of opening, closing or change of details of such account. The Participant is also required to report (i) the beginning and ending balances in such a foreign bank account each year, and (ii) transactions related to such a foreign account during the year to the Russian tax authorities, on or before June 1 of the following year.  The tax authorities may require supporting documents related to transactions in such foreign bank accounts.  The Participant should consult the Participant's personal tax advisor to determine and ensure compliance with the Participant's foreign asset/account reporting obligations.  As of January 1, 2020, the Participant also will be required to report the Participant's foreign brokerage accounts and foreign accounts with other financial institutions (financial market organizations). Certain specific exceptions from the reporting requirements may apply.
Anti-Corruption Legislation Information
Individuals holding public office in Russia, as well as their spouses and dependent children, may be prohibited from opening or maintaining a foreign brokerage or bank account and holding any securities, whether acquired directly or indirectly, in a foreign company (including the Shares acquired under the Plan). The Participant should consult with the Participant's personal legal advisor to determine whether this restriction applies to the Participant’s circumstances.
28



Data Privacy. This data privacy consent replaces Section 13 of the Agreement:
1.    Purposes for processing of the Personal Data
1.    Цели обработки Персональных данных
1.1.Granting to the Participant restricted share units or rights to purchase shares of common stock.1.1.
Предоставление Субъектам персональных данных ограниченных прав на акции (RSU) или прав покупки обыкновенных акций.
1.2.
Compliance with the effective Russian Federation laws;
1.2.
Соблюдение действующего законодательства Российской Федерации;
2.    The Participant hereby grants consent to processing of the personal data listed below
2.    Субъект персональных данных настоящим дает согласие на обработку перечисленных ниже персональных данных
2.1.
Last name, first name, patronymic, year, month, date and place of birth, gender, age, address, citizenship, information on education, contact details (home address(es), direct office, home and mobile telephone numbers, e-mail address, etc.), photographs;2.1.
Фамилия, имя, отчество, год, месяц, дата и место рождения, пол, возраст, адрес, гражданство, сведения об образовании, контактная информация (домашний(е) адрес(а), номера прямого офисного, домашнего и мобильного телефонов, адрес электронной почты и др.), фотографии;
2.2.
Information contained in personal identification documents (including passport details), tax identification number and number of the State Pension Insurance Certificate, including photocopies of passports, visas, work permits, drivers licenses, other personal documents;
2.2.
Сведения, содержащиеся в документах, удостоверяющих личность, в том числе паспортные данные, ИНН и номер страхового свидетельства государственного пенсионного страхования, в том числе фотокопии паспортов, виз, разрешений на работу, водительских удостоверений, других личных документов;
2.3.
Information on employment, including the list of duties, information on the current and former employers, information on promotions, disciplinary sanctions, transfer to other position / work, etc.;2.3.
Информация о трудовой деятельности, включая должностные обязанности, информация о текущем и прежних работодателях, сведения о повышениях, дисциплинарных взысканиях, переводах на другую должность/работу, и т.д.;
2.4.
Information on the Participant’s salary amount, information on salary changes, on participation in employer benefit plans and programs, on bonuses paid, etc.;
2.4.
Информация о размере заработной платы Субъекта персональных данных, данные об изменении заработной платы, об участии в премиальных системах и программах Работодателя, информация о выплаченных премиях, и т.д.;
2.5.
Information on work time, including hours scheduled for work per week and hours actually worked;
2.5.
Сведения о рабочем времени, включая нормальную продолжительность рабочего времени в неделю и количество фактически отработанного рабочего времени;
29

2.6.
Information on potential membership of certain categories of employees having rights for guarantees and benefits in accordance with the Russian Federation Labor Code and other effective legislation;
2.6.
Сведения о принадлежности к определенным категориям работников, которым предоставляются гарантии и льготы в соответствии с Трудовым кодексом Российской Федерации и иным действующим законодательством;
2.7.
Information on the Participant’s tax status (exempt, tax resident status, etc.);
2.7.
Информация о налоговом статусе Субъекта персональных данных (освобождение от уплаты налогов, является ли налоговым резидентом и т.д.);
2.8.
Information on shares of Common Stock or directorships held by the Participant, details of all awards or any other entitlement to shares of Common Stock awarded, cancelled, exercised, vested, unvested or outstanding;
2.8.
Информация об обыкновенных акциях или членстве в совете директоров Субъекта персональных данных, обо всех программах вознаграждения или иных правах на получение обыкновенных акций, которые были предоставлены, аннулированы, исполнены, погашены, непогашены или подлежат выплате.
2.9.
Any other information, which may become necessary to the Company in connection with the purposes specified in Clause 2 above.
2.9.
Любые иные данные, которые могут потребоваться Операторам в связи с осуществлением целей, указанных в п. 3 выше.
the “Personal Data”
далее – «Персональные данные»
3.1.    The Participant hereby consents to performing the following operations with the Personal Data:
3.1.    Субъект персональных данных настоящим дает согласие на совершение с Персональными данными перечисленных ниже действий:
3.1.1.
processing of the Personal Data, including collection, systematization, accumulation, storage, verification (renewal, modification), use, dissemination (including transfer), impersonalizing, blockage, destruction;
3.1.1.
обработка Персональных данных, включая сбор, систематизацию, накопление, хранение, уточнение (обновление, изменение), использование, распространение (в том числе передача), обезличивание, блокирование, уничтожение персональных данных;
3.1.2.
transborder transfer of the Personal Data to оperators located on the territory of foreign states. The Participant hereby confirms that he was notified of the fact that the recipients of the Personal Data may be located in foreign states that do not ensure adequate protection of rights of personal data subjects;
3.1.2.
трансграничная передача Персональных данных операторам на территории любых иностранных государств. Субъект персональных данных настоящим подтверждает, что он был уведомлен о том, что получатели Персональных данных могут находиться в иностранных государствах, не обеспечивающих адекватной защиты прав субъектов персональных данных;
30

3.1.3.
including Personal Data into generally accessible sources of personal data (including directories, address books and other), placing Personal Data on the Company’s web-sites on the Internet.
3.1.3.
включение Персональных данных в общедоступные источники персональных данных (в том числе справочники, адресные книги и т.п.), размещение Персональных данных на сайтах Операторов в сети Интернет.
3.2.    General description of the data processing methods used by the Company
3.2.    Общее описание используемых Оператором(ами) способов обработки персональных данных
3.2.1.
When processing the Personal Data, the Company undertakes the necessary organizational and technical measures for protecting the Personal Data from unlawful or accidental access to them, from destruction, change, blockage, copying, dissemination of Personal Data, as well as from other unlawful actions.
3.2.1.При обработке Персональных данных Операторы принимают необходимые организационные и технические меры для защиты Персональных данных от неправомерного или случайного доступа к ним, уничтожения, изменения, блокирования, копирования, распространения Персональных данных, а также от иных неправомерных действий.
3.2.2.    
Processing of the Personal Data by the Company shall be performed using the data processing methods that ensure confidentiality of the Personal Data, except where: (1) Personal Data is impersonalized; and (2) in relation to publicly available Personal Data; and in compliance with the established requirements to ensuring the security of personal data, the requirements to the tangible media of biometric personal data and to the technologies for storage of such data outside personal data information systems in accordance with the effective legislation.
3.2.2.    
Обработка Персональных данных Операторами осуществляется при помощи способов, обеспечивающих конфиденциальность таких данных, за исключением следующих случаев: (1) в случае обезличивания Персональных данных; (2) в отношении общедоступных Персональных данных; и при соблюдении установленных требований к обеспечению безопасности персональных данных, требований к материальным носителям биометрических персональных данных и технологиям хранения таких данных вне информационных систем персональных данных в соответствии с действующим законодательством.
4.    Term, revocation procedure
4.    Срок, порядок отзыва
This Statement of Consent is valid for an indefinite term. The Participant may revoke this consent by sending to Company a written notice at least ninety (90) days in advance of the proposed consent revocation date. The Participant agrees that during the specified notice period the Company is not obliged to cease processing of Personal Data or destroy the Personal Data of the Participant.Настоящее согласие действует в течение неопределенного срока. Субъект персональных данных может отозвать настоящее согласие путем направления Оператору(ам) письменного(ых) уведомления(ий) не менее чем за 90 (девяносто) дней до предполагаемой даты отзыва настоящего согласия. Субъект персональных данных соглашается на то, что в течение указанного срока Оператор(ы) не обязан(ы) прекращать обработку персональных данных и уничтожать персональные данные Субъекта персональных данных.
Securities Law Notice
The Participant acknowledges that the Agreement, the grant of the RSUs, the Plan and all other materials the Participant may receive regarding participation in the Plan do not constitute advertising or an offering of securities in Russia, and the Participant's acceptance of the RSUs results in an agreement between the Company and the Participant that is completed in the United States and is governed by the laws of the State of Delaware. Shares to be issued under the Plan have not and will not be registered in Russia, nor will they be admitted for listing on any Russian exchange for trading within Russia. Thus, the Shares described in any Plan documents may not be offered or placed in public circulation in Russia. In no event
31

will the Shares to be issued under the Plan be delivered to the Participant in Russia. All the Shares acquired under the Plan will be maintained on behalf of the Participant outside of Russia. The Participant will not be permitted to sell or otherwise transfer the Shares directly to a Russian legal entity or resident.
Exchange Control Notice
Under current exchange control regulations in Russia, the Participant is required to repatriate certain cash amounts received with respect to the RSUs (including proceeds from the sale of the Shares) to Russia as soon as the Participant intends to use those cash amounts for any purpose, including reinvestment. Such funds must initially be credited to the Participant through a foreign currency account at an authorized bank in Russia. After the funds are initially received in Russia, they may be further remitted to foreign banks in accordance with Russian exchange control laws. As an express statutory exception to the above-mentioned repatriation rule, cash dividends paid on the Shares can be paid directly to a foreign bank or brokerage account opened with a bank located in an OECD (Organization for Economic Co-operation and Development) or FATF (Financial Action Task Force) country. As of January 1, 2018,  cash proceeds from the sale of the Shares listed on one of the foreign stock exchanges on the list provided for by the Russian Federal law “On the Securities Market”, can also be paid directly to a foreign bank or brokerage account opened with a bank located in an OECD or FATF country. Other statutory exceptions may apply, and the Participant should consult with the Participant's personal legal advisory in this regard.
SINGAPORE
Securities Law Notice
The grant of the RSUs is being made pursuant to the “Qualifying Person” exemption” under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (“SFA”) and is not made to Participant with a view to the underlying Shares being subsequently offered for sale to any other party. The Plan has not been, and will not be, lodged or registered as a prospectus with the Monetary Authority of Singapore. The Participant should note that the RSUs are subject to section 257 of the SFA and the Participant should not make (i) any subsequent sale of the Shares in Singapore or (ii) any offer of such subsequent sale of the Shares subject to the RSUs in Singapore, unless such sale or offer is made after six (6) months from the Date of Grant or pursuant to the exemptions under Part XIII Division 1 Subdivision (4) (other than section 280) of the SFA. The Shares are currently traded on the New York Stock Exchange, which is located outside of Singapore, under the ticker symbol “NVST” and the Shares acquired under the Plan may be sold through this exchange.
Chief Executive Officer and Director Notification Requirement
If the Participant is the Chief Executive Officer (the “CEO”), or a director, associate director, or shadow director if a Singapore Subsidiary of the Company, the Participant is subject to certain notification requirements under the Singapore Companies Act, regardless of whether the Participant is resident or employed in Singapore. Among these requirements is an obligation to notify the Singapore Subsidiary in writing when the Participant receives an interest (e.g., RSUs, Shares, etc.) in the Company or any related company. In addition, the Participant must notify the Singapore Subsidiary when the Participant sells the Shares of the Company or any related company (including when the Participant sells the Shares acquired under the Plan). These notifications must be made within two (2) business days of (i) its acquisition or disposal, (ii) any change in a previously-disclosed interest (e.g., upon vesting of the RSUs or when Shares acquired under the Plan are subsequently sold), or (iii) becoming the CEO / or a director.
SPAIN
Nature of RSUs
The following provision supplements Section 17 of the Agreement:
In accepting the grant of the RSUs, the Participant acknowledges that the Participant consents to participation in the Plan and has received a copy of the Plan. The Participant understands that the Company, in its sole discretion, has unilaterally and gratuitously decided to grant RSUs under the Plan to individuals who may be employees of the Company or its Subsidiaries throughout the world. The decision is a limited decision that is entered into upon the express assumption and condition that any RSUs will not economically or otherwise bind the Company or any of its Subsidiaries on an ongoing basis. Consequently, the Participant understands that the RSUs are granted on the assumption and condition that such RSUs and any Shares acquired upon vesting of the RSUs shall not become a part of any employment contract (either with the Company or any of its Subsidiaries) and shall not be considered
32

a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever.
Further, as a condition of the grant of the RSUs, unless otherwise expressly provided for by the Company or set forth in the Agreement, the RSUs will be cancelled without entitlement to any Shares if the Participant terminates employment by reason of, including, but not limited to: resignation, retirement, disciplinary dismissal adjudged to be with cause, disciplinary dismissal adjudged or recognized to be without cause (i.e., subject to a “despido improcedente”), material modification of the terms of employment under Article 41 of the Workers’ Statute, relocation under Article 40 of the Workers’ Statute, Article 50 of the Workers’ Statute, or under Article 10.3 of Royal Decree 1382/1985. The Committee, in its sole discretion, shall determine the date when the Participant’s employment has terminated for purposes of the RSUs.
The Participant understands that the grant of the RSUs would not be granted but for the assumptions and conditions referred to above; thus, the Participant acknowledges and freely accepts that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then any grant of, or right to, the RSUs shall be null and void.
Securities Law Notice
No “offer of securities to the public,” as defined under Spanish law, has taken place or will take place in the Spanish territory in connection with the RSUs. The Plan, the Agreement (including this Addendum) and any other documents evidencing the grant of the RSUs have not, nor will they be, registered with the Comisión Nacional del Mercado de Valores, and none of those documents constitutes a public offering prospectus.
Exchange Control Notice
The Participant must declare the acquisition of the Shares to the Dirección General de Comercio e Inversiones (the “DGCI”) of the Ministry of Economy, Industry and Competitiveness for statistical purposes. The Participant must also declare ownership of any Shares with the Directorate of Foreign Transactions each January while the Shares are owned. In addition, if the Participant wishes to import the ownership title of the Shares (i.e., share certificates) into Spain, the Participant must declare the importation of such securities to the DGCI. The sale of the Shares must also be declared to the DGCI by means of a form D-6 filed in January. The form D-6, generally, must be filed within one (1) month after the sale if the Participant owns more than 10% of the share capital of the Company or the Participant's investment exceeds €1,502,530. In addition, the Participant may be required to electronically declare to the Bank of Spain any foreign accounts (including brokerage accounts held abroad), any foreign instruments (including Shares acquired under the Plan), and any transactions with non-Spanish residents, depending on the balances in such accounts together with the value of such instruments as of December 31 of the relevant year, or the volume of transactions with non-Spanish residents during the relevant year.
Foreign Asset/Account Reporting Information
To the extent the Participant holds rights or assets (e.g., cash or the Shares held in a bank or brokerage account) outside of Spain with a value in excess of €50,000 per type of right or asset as of December 31 each year (or at any time during the year in which the Participant sells or disposes of such right or asset), the Participant is required to report information on such rights and assets on the Participant's tax return for such year. After such rights or assets are initially reported, the reporting obligation will only apply for subsequent years if the value of any previously-reported rights or assets increases by more than €20,000 per type of right or asset as of each subsequent December 31, or if the Participant sells Shares or cancel bank accounts that were previously reported. Failure to comply with this reporting requirement may result in penalties to the Spanish residents.
In addition, the Participant may be required to electronically declare to the Bank of Spain any foreign accounts (including brokerage accounts held abroad), any foreign instruments (including Shares acquired under the Plan), and any transactions with non-Spanish residents (including any payments of Shares made pursuant to the Plan), depending on the balances in such accounts together with the value of such instruments as of December 31 of the relevant year, or the volume of transactions with non-Spanish residents during the relevant year.
Spanish residents should consult with their personal tax and legal advisors to ensure compliance with their personal reporting obligations.
33

SWEDEN
None.
SWITZERLAND
Securities Law Notice
Neither this document nor any other materials relating to the RSUs (i) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services ("FinSA"), (ii) may be publicly distributed nor otherwise made publicly available in Switzerland to any person other than an employee of the Company, or (iii) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 of FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority (FINMA).

34

TAIWAN
Data Privacy
The Participant acknowledges that the Participant has read and understands the terms regarding collection, processing and transfer of personal data contained in Section 13 of the Agreement and agrees that, upon request of the Company or the Employer, the Participant will provide any executed data privacy consent form to the Employer or the Company (or any other agreements or consents that may be required by the Employer or the Company) that the Company and/or the Employer may deem necessary to obtain under the data privacy laws in Participant’s country, either now or in the future. The Participant understands the Participant will not be able to participate in the Plan if the Participant fails to execute any such consent or agreement.
Securities Law Notice
The offer of participation in the Plan is available only for employees of the Company and its Subsidiaries. The offer of participation in the Plan is not a public offer of securities by a Taiwanese company.
Exchange Control Notice
If the Participant is a resident of Taiwan, the Participant may acquire foreign currency, and remit the same out of or into Taiwan, up to US$5,000,000 per year without justification. If the transaction amount is TWD$500,000 or more in a single transaction, the Participant must submit a Foreign Exchange Transaction Form to the remitting bank. If the transaction amount is US$500,000 or more in a single transaction, the Participant may be required to provide additional supporting documentation to the satisfaction of the remitting bank.
THAILAND
Exchange Control Notice
Thai residents realizing US$50,000 or more in a single transaction from the sale of Shares or the payment of dividends are required to repatriate the funds to Thailand immediately following the receipt of the funds and to then either convert such repatriated funds into Thai Baht or deposit the funds into a foreign currency account opened with any commercial bank in Thailand within 360 days of repatriation. Any such commercial bank must be duly authorized by the Bank of Thailand to engage in the purchase, exchange and withdrawal of foreign currency. Further, for repatriated funds of US$50,000 or more, the Participant must specifically report the inward remittance by submitting the Foreign Exchange Transaction Form to an authorized agent, i.e., a commercial bank authorized by the Bank of Thailand to engage in the purchase, exchange and withdrawal of foreign currency.
If the Participant does not comply with this obligation, the Participant may be subject to penalties assessed by the Bank of Thailand. Because exchange control regulations change frequently and without notice, the Participant should consult a legal advisor before selling Shares to ensure compliance with current regulations. It is the Participant’s responsibility to comply with exchange control laws in Thailand, and neither the Company nor any Parent or Subsidiary will be liable for any fines or penalties resulting from the Participant’s failure to comply with applicable laws.
UNITED KINGDOM
Tax Obligations
The following provision supplements Section 7 of the Agreement:
Without limitation to Section 7 of the Agreement, the Participant hereby agrees that the Participant is liable for all Tax Related-Items and hereby covenants to pay all such Tax Related-Items, as and when requested by the Company, or if different, the Employer, or by Her Majesty’s Revenue & Customs (“HMRC”) (or any other tax authority or any other relevant authority). The Participant also hereby agrees to indemnify and keep indemnified the Company and, if different, the Employer, against any Tax Related-Items that they are required to pay or withhold, or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on the Participant’s behalf.
Notwithstanding the foregoing, if the Participant is a director or executive officer of the Company (within the meaning of Section 13(k) of the Exchange Act), the Participant may not be able to indemnify the Company or the Employer for the amount of any income tax not collected from or paid by the Participant,
35

as it may be considered a loan. In this case, the amount of any uncollected amounts may constitute a benefit to the Participant on which additional income tax and National Insurance Contributions may be payable. The Participant will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying the Company or the Employer for the value of any National Insurance Contributions due on this additional benefit, which the Company or the Employer may recover by any of the means referred to in Section 7 of the Agreement.

*    *    *    *    *

36
 EX-23.1 3 exhibit23112312022.htm EX-23.1 Document

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statements:

(1)Registration Statement (Form S-8 No. 333-233810) pertaining to the Envista Holdings Corporation 2019 Omnibus Incentive Plan, the Envista Holdings Corporation Deferred Compensation Plan, the Envista Holdings Corporation Savings Plan, and the Envista Holdings Corporation Unions Savings Plan, and

(2)Registration Statement (Form S-8 No. 333-262985) pertaining to the Envista Holdings Corporation Savings Plan and the Envista Holdings Corporation Deferred Compensation Plan

of our reports dated February 16, 2023, with respect to the consolidated financial statements and schedule of Envista Holdings Corporation, and the effectiveness of internal control over financial reporting of Envista Holdings Corporation included in this Annual Report (Form 10-K) of Envista Holdings Corporation for the year ended December 31, 2022.

/s/ Ernst & Young LLP

Irvine, California
February 16, 2023

 EX-31.1 4 exhibit31112312022.htm EX-31.1 Document

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO
EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Amir Aghdaei, certify that:
1.
I have reviewed this Annual Report on Form 10-K of Envista Holdings Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: February 16, 2023
/s/ Amir Aghdaei
                                Amir Aghdaei
President and Chief Executive Officer


 EX-31.2 5 exhibit31212312022.htm EX-31.2 Document

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO
EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Howard H. Yu, certify that:
1.
I have reviewed this Annual Report on Form 10-K of Envista Holdings Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: February 16, 2023
/s/ Howard H. Yu
                                Howard H. Yu
Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)


 EX-32.1 6 exhibit32112312022.htm EX-32.1 Document

Exhibit 32.1

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Amir Aghdaei, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report on Form 10-K of Envista Holdings Corporation for the fiscal year ended December 31, 2022, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Annual Report on Form 10-K fairly presents, in all material respects, the financial condition and results of operations of Envista Holdings Corporation as of and for the periods presented in the Report.
Date: February 16, 2023
/s/ Amir Aghdaei
Amir Aghdaei
President and Chief Executive Officer
I, Howard H. Yu, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report on Form 10-K of Envista Holdings Corporation for the fiscal year ended December 31, 2022, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Annual Report on Form 10-K fairly presents, in all material respects, the financial condition and results of operations of Envista Holdings Corporation as of and for the periods presented in the Report.
Date: February 16, 2023
/s/ Howard H. Yu
Howard H. Yu
Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)


 EX-101.SCH 7 nvst-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 0000002 - Document - Audit Information link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - Consolidated Statements of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Business And Basis Of Presentation link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Summary Of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Discontinued Operations link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Credit Losses link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Property, Plant And Equipment link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Goodwill And Other Intangible Assets link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Accrued Expenses And Other Liabilities link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Hedging Transactions And Derivative Financial Instruments link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Pension And Other Benefit Plans link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Warranty link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Litigation And Contingencies link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Debt And Credit Facilities link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Stock Transactions And Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Accumulated Other Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - Restructuring Activities And Related Impairments link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - Schedule II - Valuation and Qualifying Accounts link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - Summary Of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - Summary Of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - Acquisitions (Tables) link:presentationLink link:calculationLink link:definitionLink 0000036 - Disclosure - Discontinued Operations (Tables) link:presentationLink link:calculationLink link:definitionLink 0000037 - Disclosure - Credit Losses (Tables) link:presentationLink link:calculationLink link:definitionLink 0000038 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 0000039 - Disclosure - Property, Plant And Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 0000041 - Disclosure - Goodwill And Other Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 0000042 - Disclosure - Accrued Expenses And Other Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 0000043 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 0000044 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 0000045 - Disclosure - Pension And Other Benefit Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 0000046 - Disclosure - Warranty (Tables) link:presentationLink link:calculationLink link:definitionLink 0000047 - Disclosure - Debt And Credit Facilities (Tables) link:presentationLink link:calculationLink link:definitionLink 0000048 - Disclosure - Stock Transactions And Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 0000049 - Disclosure - Accumulated Other Comprehensive Loss (Tables) link:presentationLink link:calculationLink link:definitionLink 0000050 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 0000051 - Disclosure - Restructuring Activities And Related Impairments (Tables) link:presentationLink link:calculationLink link:definitionLink 0000052 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 0000053 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 0000054 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 0000055 - Disclosure - Business And Basis Of Presentation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000056 - Disclosure - Summary Of Significant Accounting Policies - Estimated Useful Lives of Depreciable Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000057 - Disclosure - Summary Of Significant Accounting Policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000058 - Disclosure - Acquisitions - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000059 - Disclosure - Acquisitions - Fair Values of Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 0000060 - Disclosure - Discontinued Operations - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000061 - Disclosure - Discontinued Operations - Carrying Amount of Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000062 - Disclosure - Discontinued Operations - Operating Results (Details) link:presentationLink link:calculationLink link:definitionLink 0000063 - Disclosure - Discontinued Operations - Significant Non-Cash Operating Items and Capital Expenditures (Details) link:presentationLink link:calculationLink link:definitionLink 0000064 - Disclosure - Credit Losses - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000065 - Disclosure - Credit Losses - Allowance for Credit Losses (Details) link:presentationLink link:calculationLink link:definitionLink 0000066 - Disclosure - Inventories - Summary (Details) link:presentationLink link:calculationLink link:definitionLink 0000067 - Disclosure - Property, Plant And Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 0000068 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000069 - Disclosure - Leases - Components of Lease Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000070 - Disclosure - Leases - Weighted Average Remaining Lease Term and Discount Rate (Details) link:presentationLink link:calculationLink link:definitionLink 0000071 - Disclosure - Leases - Maturities of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000071 - Disclosure - Leases - Maturities of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000072 - Disclosure - Goodwill And Other Intangible Assets - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000073 - Disclosure - Goodwill And Other Intangible Assets - Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 0000074 - Disclosure - Goodwill And Other Intangible Assets - Intangible Assets by Major Class (Details) link:presentationLink link:calculationLink link:definitionLink 0000075 - Disclosure - Intangible Assets, Goodwill and Other - Intangible Assets Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000076 - Disclosure - Accrued Expenses And Other Liabilities - Summary (Details) link:presentationLink link:calculationLink link:definitionLink 0000077 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000078 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges (Details) link:presentationLink link:calculationLink link:definitionLink 0000079 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Derivative and Nonderivative Debt Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 0000080 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 0000081 - Disclosure - Fair Value Measurements - Fair Value of Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 0000082 - Disclosure - Pension And Other Benefit Plans - Funded Status Of Pension Plans (Details) link:presentationLink link:calculationLink link:definitionLink 0000083 - Disclosure - Pension And Other Benefit Plans - Weighted Average Assumptions Used To Determine Benefit Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 0000084 - Disclosure - Pension And Other Benefit Plans - Components of Net Periodic Benefit Cost of Defined Benefit Pension Plans (Details) link:presentationLink link:calculationLink link:definitionLink 0000085 - Disclosure - Pension And Other Benefit Plans - Components of Net Periodic Benefit Cost Reflected in the Consolidated Condensed Statement of Earnings (Details) link:presentationLink link:calculationLink link:definitionLink 0000086 - Disclosure - Pension And Other Benefit Plans - Weighted Average Assumptions Used To Determine Net Periodic Pension Cost (Details) link:presentationLink link:calculationLink link:definitionLink 0000087 - Disclosure - Pension And Other Benefit Plans - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000088 - Disclosure - Pension And Other Benefit Plans - Fair Values Of Pension Plan Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000089 - Disclosure - Pension And Other Benefit Plans - Changes in Fair Value of Plan Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000090 - Disclosure - Pension And Other Benefit Plans - Benefit Payments That Reflect Expected Future Service (Details) link:presentationLink link:calculationLink link:definitionLink 0000091 - Disclosure - Warranty - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000092 - Disclosure - Warranty - Warranty Accrual (Details) link:presentationLink link:calculationLink link:definitionLink 0000093 - Disclosure - Litigation And Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000094 - Disclosure - Debt And Credit Facilities - Components Of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 0000095 - Disclosure - Debt And Credit Facilities - Debt Payments (Details) link:presentationLink link:calculationLink link:definitionLink 0000096 - Disclosure - Debt And Credit Facilities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000097 - Disclosure - Debt And Credit Facilities - Interest Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000098 - Disclosure - Debt And Credit Facilities - Unamortized Debt Discount and Issuance Costs (Details) link:presentationLink link:calculationLink link:definitionLink 0000099 - Disclosure - Stock Transactions And Stock-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 0000100 - Disclosure - Stock Transactions And Stock-Based Compensation - Summary of Share Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000101 - Disclosure - Stock Transactions And Stock-Based Compensation - Assumptions Used To Value Options Granted (Details) link:presentationLink link:calculationLink link:definitionLink 0000102 - Disclosure - Stock Transactions And Stock-Based Compensation - Components of Stock-Based Compensation Program (Details) link:presentationLink link:calculationLink link:definitionLink 0000103 - Disclosure - Stock Transactions And Stock-Based Compensation - Option Activity Under The Company's Stock Plans (Details) link:presentationLink link:calculationLink link:definitionLink 0000104 - Disclosure - Stock Transactions And Stock-Based Compensation - Summary Of Options Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 0000105 - Disclosure - Stock Transactions And Stock-Based Compensation - Summary Of Unrecognized RSU And PRU Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000106 - Disclosure - Accumulated Other Comprehensive Loss - Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 0000107 - Disclosure - Revenue - Disaggregation by Revenue Type and Geographical Region (Details) link:presentationLink link:calculationLink link:definitionLink 0000108 - Disclosure - Revenue - Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 0000108 - Disclosure - Revenue - Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 0000109 - Disclosure - Revenue - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000110 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring And Related Costs (Details) link:presentationLink link:calculationLink link:definitionLink 0000111 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring And Other Related Charges By Segment (Details) link:presentationLink link:calculationLink link:definitionLink 0000112 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring Reserve By Type Of Cost (Details) link:presentationLink link:calculationLink link:definitionLink 0000113 - Disclosure - Restructuring Activities And Related Impairments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000114 - Disclosure - Income Taxes - Earnings From Continuing Operations Before Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 0000115 - Disclosure - Income Taxes - Provision For Income Taxes From Continuing Operations (Details) link:presentationLink link:calculationLink link:definitionLink 0000116 - Disclosure - Income Taxes - Deferred Income Tax Assets And Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000117 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000118 - Disclosure - Income Taxes - Reconciliation Of The Statutory Federal Income Tax Rate To The Effective Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 0000119 - Disclosure - Income Taxes - Reconciliation Of Unrecognized Tax Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 0000120 - Disclosure - Earnings Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000121 - Disclosure - Earnings Per Share - Components of Basic and Diluted Earnings per Share (Details) link:presentationLink link:calculationLink link:definitionLink 0000122 - Disclosure - Earnings Per Share - Securities Not Included in the Computation of Diluted Loss Income per Share (Details) link:presentationLink link:calculationLink link:definitionLink 0000123 - Disclosure - Segment Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000124 - Disclosure - Segment Information - Segment Results (Details) link:presentationLink link:calculationLink link:definitionLink 0000125 - Disclosure - Segment Information - Schedule Of Operations In Geographical Areas (Details) link:presentationLink link:calculationLink link:definitionLink 0000126 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 nvst-20221231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 nvst-20221231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 nvst-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Non-cash restructuring charges Disposal Group Including Discontinued Operations, Non- Cash Restructuring Charges Disposal Group Including Discontinued Operations, Non- Cash Restructuring Charges Business Acquisition [Axis] Business Acquisition [Axis] Recoveries SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery Non-U.S. Current Foreign Tax Expense (Benefit) US term loan due 2024 Term Loan US Term Loan Due 2024 [Member] US Term Loan Due 2024 Foreign Currency Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Total borrowings under term loan Total Borrowings under Term Loan Total Borrowings under Term Loan Allowance for credit losses Accounts Receivable, Credit Loss Expense (Reversal) Total Long-Term Debt, Gross ASSETS Disposal Group, Including Discontinued Operation, Assets [Abstract] Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Deferred: Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Preferred shares outstanding (in shares) Preferred Stock, Shares Outstanding Payments of debt restructuring costs Payments of Debt Restructuring Costs Convertible debt, consecutive trading days (in trading days) Debt Instrument, Convertible, Threshold Consecutive Trading Days Debt Instrument [Axis] Debt Instrument [Axis] Gross property, plant and equipment Property, Plant and Equipment, Gross Schedule of Defined Benefit Plans Disclosures Schedule of Defined Benefit Plans Disclosures [Table Text Block] Capital expenditures, gross Property, Plant and Equipment, Additions Foreign currency contracts Foreign Exchange Contract [Member] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Additional paid-in capital Additional Paid in Capital (Loss) income from discontinued operations Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax Sales Disposal Group, Including Discontinued Operation, Revenue Fair Value Measurement [Domain] Fair Value Measurement [Domain] Margin spread of variable interest rate Debt Instrument, Basis Spread on Variable Rate Depreciation Depreciation Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Schedule of Indefinite-Lived Intangible Assets [Table] Schedule of Indefinite-Lived Intangible Assets [Table] Net deferred tax assets Net deferred tax assets Deferred Tax Assets, Net Interest rate Debt Instrument, Interest Rate, Stated Percentage Contingency provision on the ratio of indebtedness to net capital Ratio of Indebtedness to Net Capital, Contingency Provision Ratio of Indebtedness to Net Capital, Contingency Provision Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Derivative instruments, gain (loss) Derivative Instruments, Gain (Loss) [Table Text Block] Pension Plans Compensation Related Costs, Policy [Policy Text Block] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Operating expenses: Disposal Group, Including Discontinued Operation, Operating Expenses [Abstract] Disposal Group, Including Discontinued Operation, Operating Expenses State and local Current State and Local Tax Expense (Benefit) $12.66 to 19.22 Range Two [Member] Range Two [Member] Cash paid for taxes Income Taxes Paid Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive securities excluded from computation of diluted (loss) income per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Lessee, Operating Lease, Liability, Payment, Due [Abstract] Lessee, Operating Lease, Liability, to be Paid [Abstract] Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Western Europe Western Europe [Member] Western Europe [Member] Schedule of Options Outstanding Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block] Equity Component [Domain] Equity Component [Domain] Loss contingencies Loss Contingency, Accrual, Noncurrent Interest coverage ratio (at least) Interest Coverage Ratio Interest Coverage Ratio Numerator: Earnings Per Share Reconciliation [Abstract] Outstanding, shares (in shares) Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding Additions based on tax positions related to the current year Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Outstanding, average exercise price (in USD per share) Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price Increase (decrease) in tax rate resulting from: Effective Income Tax Rate Reconciliation, Percent [Abstract] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Standby letters of credit Standby Letters of Credit [Member] Convertible debt, stock price trigger (in USD per share) Debt Instrument, Convertible, Stock Price Trigger Fair value of plan assets at beginning of year Fair value of plan assets at end of year Defined benefit plan, plan assets Defined Benefit Plan, Plan Assets, Amount Supplemental data: Supplemental Cash Flow Information [Abstract] Cancelled/forfeited (in USD per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Plan Name [Domain] Plan Name [Domain] Equity component of convertible senior notes, net of financing costs and taxes Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt Line of credit facility, outstanding borrowings Long-Term Line of Credit Entity Address, State or Province Entity Address, State or Province Outstanding at end of year Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term NAV per share, investment redemption, notice period Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Investment Redemption, Notice Period Operating Activities [Domain] Operating Activities [Domain] Award Type [Axis] Award Type [Axis] Actuarial gain Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Settlements Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 2027 Defined Benefit Plan, Expected Future Benefit Payment, Year Five Operating lease liabilities Operating Lease, Liability, Current Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Operating expenses: Costs and Expenses [Abstract] Other net periodic pension costs: Other Net Periodic Pension Costs [Abstract] Other Net Periodic Pension Costs [Abstract] Aggregate Intrinsic Value Share Based Compensation Arrangement by Share Based Payment Award Options, Aggregate Intrinsic Value [Abstract] Share Based Compensation Arrangement by Share Based Payment Award Options, Aggregate Intrinsic Value [Abstract] Accounts receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Property, plant and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Long-term debt Long-term debt Long-Term Debt, Excluding Current Maturities Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] 2019 Omnibus Incentive Plan 2019 Omnibus Incentive Plan [Member] 2019 Omnibus Incentive Plan Schedule of Expected Benefit Payments Schedule of Expected Benefit Payments [Table Text Block] Settlements made Standard and Extended Product Warranty Accrual, Decrease for Payments Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Schedule of Weighted Average Remaining Lease Term and Discount Rate Lessee, Assets and Liabilities [Table Text Block] Lessee, Assets and Liabilities[Table Text Block] Revolving Credit Facility Revolving Credit Facility [Member] Gross profit Disposal Group, Including Discontinued Operation, Gross Profit (Loss) Loss contingencies Loss Contingency, Accrual, Current Current: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Document Type Document Type Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Estimated useful life of depreciable asset Property, Plant and Equipment, Useful Life Largest customer Largest Customer [Member] Largest Customer Service cost: Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Unvested at beginning of year (in USD per share) Unvested at end of year (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Cash and cash equivalent threshold Debt Instrument, Covenant, Cash and Cash Equivalent Threshold Debt Instrument, Covenant, Cash and Cash Equivalent Threshold Exercise Price Range [Axis] Exercise Price Range [Axis] Accrued Expenses and Other Liabilities Other Liabilities Disclosure [Text Block] Total net assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Unrealized gains and losses Deferred Tax Liabilities, Financing Arrangements Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Write-offs charged against the allowance Accounts Receivable, Allowance for Credit Loss, Writeoff Debt Disclosure [Abstract] Debt Disclosure [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Employer contributions Defined Benefit Plan, Plan Assets, Contributions by Employer Restructuring-related employee severance, benefits and other Restructuring Reserve, Noncurrent Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Accounting Policies [Abstract] Total interest expense Interest Expense, Debt Revolving credit facility due 2024 Line of Credit [Member] Variable operating lease expense Variable Lease, Cost Gain on sale of KaVo treatment unit and instrument business Gain (Loss) on Disposition of Business Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Impact of foreign operations Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Customer [Axis] Customer [Axis] Current Other Liabilities, Current [Abstract] Interest cost Defined Benefit Plan, Interest Cost Components Of Stock-Based Compensation Program Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Summary of Assumption Used in the Black-Scholes Value Options Granted Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Liabilities assumed: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract] Schedule of Components of Income Tax Expense (Benefit) Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of derivative instruments in statement of financial position, fair value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Valuation allowance release on certain Swiss NOLs Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Period of recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Vested at end of year Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Other comprehensive (loss) income before reclassifications, net of income taxes Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Derivative Contract [Domain] Derivative Contract [Domain] Gross profit Gross Profit Entity Registrant Name Entity Registrant Name 2026 Defined Benefit Plan, Expected Future Benefit Payment, Year Four Other accruals and prepayments Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Exercise price, upper limit (in USD per share) Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit Equipment & Consumables Equipment and Consumables [Member] Equipment and Consumables Benefits and other expenses paid Defined Benefit Plan, Benefit Obligation, Benefits Paid Pension and Other Benefit Plans Retirement Benefits [Text Block] Leases [Abstract] Leases [Abstract] Mutual funds Mutual Fund [Member] Total stockholders’ equity Balance, beginning of period Balance, end of period Increase (decrease) in stockholders' equity Increase (decrease) in stockholders' equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Minimum Minimum [Member] Conversion ratio Debt Instrument, Convertible, Conversion Ratio Entity Emerging Growth Company Entity Emerging Growth Company Product warranty period Product Warranty Period Product Warranty Period Common stock, par value (in USD per share) Common Stock, Par or Stated Value Per Share Restructuring charges Inventory write-off Inventory Write-down Earnings (loss) from discontinued operations - diluted (in USD per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Excess tax benefit from share-based compensation, operating activities Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount Income tax impact Other Comprehensive Income (Loss) before Reclassifications, Tax Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Operating loss carryforwards, valuation allowances Operating Loss Carryforwards, Valuation Allowance Amortization Amortization of Other Deferred Charges Trading Symbol Trading Symbol Entity File Number Entity File Number Research and experimentation credits and other Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Operating Activities [Axis] Operating Activities [Axis] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Four Outstanding, average remaining life (in years) Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term Amounts reclassified from accumulated other comprehensive loss, net of income taxes Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax Non-U.S. Deferred Foreign Income Tax Expense (Benefit) Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Expected employer contributions within the next year Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year Use of Estimates Use of Estimates, Policy [Policy Text Block] Acquisitions Business Combination Disclosure [Text Block] Raw materials Inventory, Raw Materials, Gross Change in trade accounts payable Increase (Decrease) in Accounts Payable Concentration risk percentage Concentration Risk, Percentage Disposal by abandonment Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Abandonment [Member] Expense for all defined benefit and defined contributions pension plans Postemployment Benefits, Period Expense Income Taxes Income Tax Disclosure [Text Block] Credit Facility [Domain] Credit Facility [Domain] Cash and cash equivalents Defined Benefit Plan, Cash and Cash Equivalents [Member] Gross carrying amount of total intangibles Intangible Assets, Gross (Excluding Goodwill) Earnings - basic (in USD per share) Earnings - basic (in USD per share) Earnings Per Share, Basic Increase Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Liability for proceeds related to the Relevant Jurisdictions Disposal Group, Including Discontinued Operation, Liabilities Accounting Standards Update and Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Other Corporate, Non-Segment [Member] Accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable $26.51 to $41.95 Range Four [Member] Range Four [Member] Indefinite-lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Entity Interactive Data Current Entity Interactive Data Current Pension benefits Liability, Pension and Other Postretirement and Postemployment Benefits, Current Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Income Taxes Income Tax, Policy [Policy Text Block] Lease renewal term (in years) Lessee, Operating Lease, Renewal Term Discontinued Operations and Disposal Groups [Abstract] Discontinued Operations and Disposal Groups [Abstract] Current assets: Assets, Current [Abstract] Recognized potential interest and penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Unrecognized tax benefits, net of offsetting indirect tax benefits Unrecognized Tax Benefits Net Of Offsetting Indirect Tax Benefits Unrecognized tax benefits, net of offsetting indirect tax benefits. Retained earnings Retained Earnings (Accumulated Deficit) Proceeds from issuance of convertible senior notes Proceeds from Convertible Debt Scenario [Domain] Scenario [Domain] Vested at end of year (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price EBITDA threshold Debt Instrument, Covenant, Percentage Of Earnings Before Taxes, Threshold Debt Instrument, Covenant, Percentage Of Earnings Before Taxes, Threshold Document Fiscal Year Focus Document Fiscal Year Focus Defined Benefit Plan, Plan Assets, Category [Domain] Defined Benefit Plan, Plan Assets, Category [Domain] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Consideration Disposal Group, Including Discontinued Operation, Consideration Capitalized research expenses Deferred Tax Assets, in Process Research and Development Indefinite-lived Intangible Assets [Line Items] Indefinite-Lived Intangible Assets [Line Items] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Deferred tax liabilities: Deferred Tax Liabilities, Gross [Abstract] Vested and expected to vest at end of year (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Compensation and benefits Due to Employees, Noncurrent Proceeds from the settlement of derivative financial instruments Proceeds from Derivative Instrument, Investing Activities Patents and technology Patented Technology [Member] Emerging markets High-Growth Markets [Member] The Company defines high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which includes Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). Change in inventories Increase (Decrease) in Inventories $9.74 to 12.65 Range One [Member] Range One [Member] Unamortized discount (premium), net Debt Instrument, Unamortized Discount (Premium), Net Stock-based compensation expense Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Common stock, shares outstanding (in shares) Beginning of period, common stock (in shares) End of period, common stock (in shares) Common Stock, Shares, Outstanding Goodwill Beginning balance Ending balance Goodwill Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Actual return on plan assets Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) Income tax expense (benefit) Income tax provision (benefit) Income Tax Expense (Benefit) Geographical [Domain] Geographical [Domain] Valuation allowances Deferred Tax Assets, Valuation Allowance Net deferred tax liability Net deferred tax liability Deferred Income Tax Liabilities, Net Hedging Relationship [Axis] Hedging Relationship [Axis] Entity Public Float Entity Public Float Balance Sheet Location [Domain] Balance Sheet Location [Domain] Cost of sales Cost of Goods and Services Sold Accrued expenses and other liabilities Swap derivative contracts Derivative Liability Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Osteogenics Biomedical Inc Osteogenics Biomedical Inc [Member] Osteogenics Biomedical Inc 2023 Defined Benefit Plan, Expected Future Benefit Payment, Year One Accounts Receivable, Allowance for Credit Loss [Roll Forward] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Common stock - $0.01 par value, 500.0 million shares authorized; 163.7 million shares issued and 163.2 million shares outstanding at December 31, 2022; 162.0 million shares issued and 161.6 million shares outstanding at December 31, 2021 Common Stock, Value, Issued Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Accruals for warranties issued during the year Standard and Extended Product Warranty Accrual, Increase for Warranties Issued Conversion price (in USD per share) Debt Instrument, Convertible, Conversion Price Schedule of antidilutive securities excluded from computation of earnings per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Loss Contingencies Commitments and Contingencies, Policy [Policy Text Block] Warranty Product Warranty Disclosure [Text Block] Beginning balance of cash and cash equivalents Ending balance of cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Current liabilities: Liabilities, Current [Abstract] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Proceeds from stock option exercises Proceeds from Stock Options Exercised Vested and expected to vest at end of year Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Contract liabilities Contract with Customer, Liability, Current Total Envista Equity Parent [Member] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Income Statement Location [Domain] Income Statement Location [Domain] Amendment Flag Amendment Flag Fixed operating lease expense Operating Lease, Cost Capital expenditures Capital Expenditure, Discontinued Operations If-converted value in excess of principal Debt Instrument, Convertible, If-converted Value in Excess of Principal SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Total other comprehensive (loss) income, net of income taxes Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax Acquisitions Goodwill, Acquired During Period Assets for Relevant Jurisdictions Disposal Group, Including Discontinued Operation, Asset For Relevant Jurisdiction Proceeds, Current Disposal Group, Including Discontinued Operation, Asset For Relevant Jurisdiction Proceeds, Current Restructuring-related employee severance, benefits and other Restructuring Reserve, Current Total liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Construction in progress Construction in Progress [Member] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Non-current deferred tax liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Other long-term assets Other Assets, Noncurrent Goodwill and Other Intangible Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Vested at end of year (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Depreciation and amortization Depreciation, Depletion and Amortization Thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Five Counterparty Name [Axis] Counterparty Name [Axis] All other (each country individually less than 5% of total long-lived assets) All Other Countries [Member] All other countries. Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Excess tax benefit from stock-based compensation Effective Income Tax Reconciliation, Release Of Valuation Allowance On Foreign Losses, Percent Effective Income Tax Reconciliation, Release Of Valuation Allowance On Foreign Losses, Percent Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Change in operating lease liabilities Operating Lease, Payments Stock options Options Share-Based Payment Arrangement, Option [Member] Long-term debt Long-Term Debt [Member] Pension plan adjustments Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Interest expense Deferred Tax Asset, Interest Carryforward Common stock, shares authorized (in shares) Common Stock, Shares Authorized Taxes, income and other Accrued Income Taxes, Current Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Maximum Maximum [Member] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Work in process Inventory, Work in Process, Gross Foreign-Derived Intangible Income (“FDII”) Effective Income Tax Rate Reconciliation, FDII, Percent Business Acquisition [Line Items] Business Acquisition [Line Items] Change in noncontrolling interest Noncontrolling Interest, Period Increase (Decrease) Cash flow hedge adjustments Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent Schedule of Net Benefit Costs Schedule of Net Benefit Costs [Table Text Block] Shipping and Handling Cost of Goods and Service [Policy Text Block] Convertible debt, trading days (in trading days) Debt Instrument, Convertible, Threshold Trading Days Amendments and settlements Defined Benefit Plan, Plan Assets, Payment For Settlement And Amendment Defined Benefit Plan, Plan Assets, Payment For Settlement And Amendment Change in trade accounts receivable Increase (Decrease) in Accounts Receivable Fair value adjustment of acquisition-related inventory Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory Short-term debt Short-Term Debt Title of 12(b) Security Title of 12(b) Security Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Business and Basis of Presentation Summary of Significant Accounting Policies Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Unrecognized actuarial gain, net of tax Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax Net Purchases/(Settlements) Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement Defined Benefit Plan, Assumptions Defined Benefit Plan, Assumptions [Table Text Block] Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Segment Information Segment Reporting Disclosure [Text Block] Litigation And Contingencies Commitments Contingencies and Guarantees [Text Block] Selling, general and administrative expenses Selling, General and Administrative Expenses [Member] Consumables Consumables [Member] Consumables [Member] Net deferred tax liabilities Net deferred tax liabilities Deferred Tax Liabilities, Net LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Fair Value Estimate of Fair Value Measurement [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Average common stock and common equivalent shares outstanding: Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Inventories, net Total Inventory, Net Income Tax Authority [Axis] Income Tax Authority [Axis] Debt Discount Debt Instrument, Unamortized Discount Other Other Accrued Liabilities, Noncurrent Vested and expected to vest at end of year Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Threshold percentage of stock price trigger Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger Earnings from continuing operations - basic (in USD per share) Income (Loss) from Continuing Operations, Per Basic Share Leverage ratio Ratio of Indebtedness to Net Capital Basic (in shares) Weighted-average common shares outstanding used in basic earnings per share (in shares) Weighted Average Number of Shares Outstanding, Basic Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Accrual for legal matters Loss Contingency Accrual Change in plan assets: Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] Convertible senior notes due 2025 2.375% convertible senior notes 2.375% Convertible Senior Notes [Member] 2.375% Convertible Senior Notes [Member] Carestream Dental Technology Carestream Dental Technology [Member] Carestream Dental Technology Notional Amount Derivative, Notional Amount Preferred stock, $0.01 par value, 15.0 million shares authorized; no shares issued or outstanding at December 31, 2022 and December 31, 2021 Preferred Stock, Value, Issued Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Components of unamortized debt discount and issuance costs Schedule of Debt [Table Text Block] Share-based Payment Arrangement, Noncash Expense [Abstract] Share-Based Payment Arrangement, Noncash Expense [Abstract] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Less: current portion Debt, Current Summary of Changes in Level 3 Pension Plan Assets Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Leases Lessee, Leases [Policy Text Block] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Exercisable, shares (in shares) Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Allowance for credit losses Beginning balance Ending balance Accounts Receivable, Allowance for Credit Loss Foreign exchange rate impact Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss) Change in deferred income taxes Increase (Decrease) in Deferred Income Taxes Future amortization of gain (loss), net of tax Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax Noncontrolling Interests Noncontrolling Interest [Member] Depreciation and amortization Depreciation and Amortization, Discontinued Operations Debt instrument, term Debt Instrument, Term Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Goodwill [Roll Forward] Goodwill [Roll Forward] Repayment of revolving line of credit Repayments of Long-Term Lines of Credit Assumed exercise of dilutive options and vesting of dilutive restricted stock units (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Disposal Group Name [Domain] Disposal Group Name [Domain] Acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Current Fiscal Year End Date Current Fiscal Year End Date Other intangible assets, net Intangible Assets, Net (Excluding Goodwill) Gain on sale of property, plant and equipment Gain (Loss) on Disposition of Property Plant Equipment Fair Value, Plan Assets Measured on Recurring Basis [Roll Forward] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Common stock-based award activity APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Employee contributions Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant Concentration Risk Type [Axis] Concentration Risk Type [Axis] Total current liabilities Liabilities, Current Customer Concentration Risk Customer Concentration Risk [Member] Taxes, income and other Accrued Income Taxes, Noncurrent Current liabilities: Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Sales and product allowances Sales And Product Allowances, Current Sales And Product Allowances, Current Discontinued Operations Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Unrecognized tax benefits that would impact effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Remaining performance obligation Revenue, Remaining Performance Obligation, Amount Award expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Nonoperating income (expense): Nonoperating Income (Expense) [Abstract] Exercise price, lower limit (in USD per share) Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit Income Tax Authority [Domain] Income Tax Authority [Domain] All other financing activities Proceeds from (Payments for) Other Financing Activities $19.23 to 26.50 Range Three [Member] Range Three [Member] Decrease in valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Dilution threshold (in USD per share) Derivative, Cap Price, Dilution Threshold Derivative, Cap Price, Dilution Threshold Credit Facility [Axis] Credit Facility [Axis] Insurance contracts Other Contract [Member] Reserve for inventory obsolescence Inventory Valuation Reserves Foreign currency translation Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation Equity [Abstract] Equity [Abstract] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Entity Tax Identification Number Entity Tax Identification Number Number of shares authorized under the Stock Plan (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Restructuring Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block] Pension benefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits Consolidated Entities [Domain] Consolidated Entities [Domain] Share withheld (in shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Impact of Currency SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment Guarantees Guarantor Obligations, Maximum Exposure, Undiscounted Unrecognized actuarial gain, before tax Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax Net settlement and curtailment gain (loss) Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment Summary Of Effective Income Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Net change in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Repayment of borrowing Repayments of Short-Term Debt, Maturing in Three Months or Less Restructuring and related costs Restructuring and Related Costs [Table Text Block] Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Consideration transferred Business Combination, Consideration Transferred City Area Code City Area Code ASSETS Assets [Abstract] 2023 Long-Term Debt, Maturity, Year One Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Variable Rate [Axis] Variable Rate [Axis] Other long-term liabilities Total Other Liabilities, Noncurrent Interest rate contracts Interest Rate Contract [Member] Continuing operations Continuing Operations [Member] Payments for additions to property, plant and equipment Payments to Acquire Property, Plant, and Equipment Weighted Average Weighted Average [Member] 2023 Finite-Lived Intangible Asset, Expected Amortization, Year One Benefit obligation at beginning of year Benefit obligation at end of year Defined Benefit Plan, Benefit Obligation Schedule of earnings per share, basic and diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] ROU assets obtained in exchange for operating lease obligations Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Derivative Financial Instruments Derivatives, Reporting of Derivative Activity [Policy Text Block] Customer [Domain] Customer [Domain] Rate in excess of Federal funds rate Prime Rate Prime Rate Intangible Assets, Gross (Excluding Goodwill) [Abstract] Intangible Assets, Gross (Excluding Goodwill) [Abstract] Amounts reclassified from accumulated other comprehensive loss, net of income taxes Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Rate of compensation increase Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase Gain Recognized in OCI Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments Total operating lease payments Lessee, Operating Lease, Liability, to be Paid Current assets: Disposal Group, Including Discontinued Operation, Assets, Current [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] 2024 Long-Term Debt, Maturity, Year Two Acquisitions Business Combinations Policy [Policy Text Block] Other Other Segments [Member] Rate in excess of Eurocurrency rate Rate in excess of Eurocurrency rate Rate in excess of Eurocurrency rate Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Revolving credit facility maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Prepaids and Other Current Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Property, plant and equipment Deferred Tax Liabilities, Property, Plant and Equipment Write Offs, Write Downs  & Deductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction Balance at beginning of year Balance at end of year Restructuring Reserve Impact of step-up of Swiss assets Effective Income Tax Reconciliation, Impact Of Step Up Assets, Percent Effective Income Tax Reconciliation, Impact Of Step Up Assets, Percent Credit facility Credit Facility [Member] Credit Facility [Member] All other investing activities, net Payments for (Proceeds from) Other Investing Activities Statistical Measurement [Domain] Statistical Measurement [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Decrease in deferred tax liability Increase (Decrease) in Deferred Tax Liabilities, Impact Of Step Up Assets Increase (Decrease) in Deferred Tax Liabilities, Impact Of Step Up Assets Contractual interest expense Interest Expense, Debt, Excluding Amortization Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Lapse of statute of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Net periodic pension cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) United States Domestic Tax Authority [Member] Repayment of debt Repayments of Debt Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Osteogenics Biomedical Inc & Carestream Dental Technology Osteogenics Biomedical Inc & Carestream Dental Technology [Member] Osteogenics Biomedical Inc & Carestream Dental Technology Net income Net income Net Income (Loss) Attributable to Parent Duration of option to terminate lease (in days) Lessee, Operating Lease, Option to Terminate, Term Lessee, Operating Lease, Option to Terminate, Term Weighted average volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Contractual Minimum Principal Payments on Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Amortization of prior service credit and initial net obligation Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Rate of compensation increase Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase Scenario [Axis] Scenario [Axis] Redemption price Debt Instrument, Redemption Price, Percentage Leases Lessee, Operating Leases [Text Block] Plan Name [Axis] Plan Name [Axis] Lease liabilities Deferred Tax Assets, Tax Deferred Expense, Lease Liabilities Deferred Tax Assets, Tax Deferred Expense, Lease Liabilities LIABILITIES AND EQUITY Disposal Group, Including Discontinued Operation, Liabilities [Abstract] Research and Development Research, Development, and Computer Software, Policy [Policy Text Block] Earnings from continuing operations - diluted (in USD per share) Income (Loss) from Continuing Operations, Per Diluted Share Derivative Instrument [Axis] Derivative Instrument [Axis] Goodwill and other intangible assets Deferred Tax Liabilities, Goodwill and Intangible Assets Number of business segments (in segments) Number of operating segments (in segments) Number of Operating Segments Right-of-use assets Deferred Tax Liabilities, Right-of-Use Assets Deferred Tax Liabilities, Right-of-Use Assets Audit Information [Abstract] Audit Information Goodwill [Line Items] Goodwill [Line Items] Accrued expenses and other [Abstract] Accrued expenses and other [Abstract] Accrued expenses and other [Abstract] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Quoted Prices in Active Market (Level 1) Quoted Prices in Active Market (Level 1) Fair Value, Inputs, Level 1 [Member] Schedule of notional amounts of outstanding derivative positions Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Assumed conversion of the Notes (in shares) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities RSUs / PSUs Restricted Stock Units And Performance Stock Units [Member] Restricted Stock Units And Performance Stock Units Unrecognized prior service credits, before tax Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax Liabilities for Relevant Jurisdictions Disposal Group, Including Discontinued Operations, Liability For Relevant Jurisdiction Proceeds, Current Disposal Group, Including Discontinued Operations, Liability For Relevant Jurisdiction Proceeds, Current Cash flows from operating activities Disposal Group, Including Discontinued Operation, Cash Flows from Discontinued Operations [Abstract] Disposal Group, Including Discontinued Operation, Cash Flows from Discontinued Operations New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities The components of accrued expenses and other liabilities Other Liabilities [Table Text Block] Noncash items: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Permanent differences and other Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent Other income (expense) Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component Cancelled/forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Document Annual Report Document Annual Report Recoveries Accounts Receivable, Allowance for Credit Loss, Recovery Geographical [Axis] Geographical [Axis] Plamenca Plamenca [Member] Plamenca Cash Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Derivative financial instruments Derivative Liability, Current Costs incurred Restructuring Costs and Asset Impairment Charges Estimated Useful Lives of Depreciable Assets Schedule of Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Earnings (loss) from discontinued operations - basic (in USD per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share Preferred shares issued (in shares) Preferred Stock, Shares Issued Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Number of RSUs/PSUs Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] 2025 Defined Benefit Plan, Expected Future Benefit Payment, Year Three Restructuring Type [Axis] Restructuring Type [Axis] Pacific Dental Services Pacific Dental Services [Member] Pacific Dental Services Segments [Axis] Segments [Axis] Debt And Credit Facilities Debt Disclosure [Text Block] Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Reductions for tax positions of prior years Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Effect of foreign currency translation Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation Schedule of Allocation of Plan Assets Schedule of Allocation of Plan Assets [Table Text Block] 2023 Lessee, Operating Lease, Liability, to be Paid, Year One 2025 Long-Term Debt, Maturity, Year Three Danaher Affiliated Entity [Member] Consolidation Items [Domain] Consolidation Items [Domain] Revenue Benchmark Revenue Benchmark [Member] Document Period End Date Document Period End Date Specialty Products & Technologies Specialty Products and Technologies [Member] Specialty Products and Technologies Future amortization of prior service cost (credit) Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Schedule of accumulated other comprehensive income (loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Total assets Identifiable assets Assets Earnings per share: Earnings Per Share [Abstract] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Interest rate swap derivative contracts Interest rate swap derivative contracts Interest Rate Swap [Member] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Exercised (in USD per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 2027 Lessee, Operating Lease, Liability, to be Paid, Year Five Long-term debt Long-Term Debt, Fair Value Compensation and benefits Employee-related Liabilities, Current Credit Losses Credit Loss, Financial Instrument [Text Block] Income (loss) before income taxes Earnings from continuing operations before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Segments [Domain] Segments [Domain] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Amortization of debt discount and issuance costs Amortization of Debt Issuance Costs and Discounts Earnings Per Share Earnings Per Share [Text Block] Deferred compensation plans Deferred Compensation Liability, Classified, Noncurrent Provision for credit losses Accounts Receivable, Credit Loss Expense (Reversal), Adjusted for Discontinued Operations Accounts Receivable, Credit Loss Expense (Reversal), Adjusted for Discontinued Operations Cash and Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Including Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Including Goodwill Award Type [Domain] Award Type [Domain] Income Tax Contingency [Table] Income Tax Contingency [Table] Accounts Receivable and Allowances for Credit Losses Receivable [Policy Text Block] Finished goods Inventory, Finished Goods, Gross Net investment hedging Net Investment Hedging [Member] Issuance of common stock (in shares) Stock Issued During Period, Shares, New Issues China CHINA Long-term debt Nonderivative Hedging Instruments Nonderivative Hedging Instruments Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Euro term loan due 2024 Euro Term Loan Euro Term Loan Due 2024 [Member] Euro Term Loan Due 2024 Foreign currency translation Goodwill, Foreign Currency Translation Gain (Loss) Foreign Currency Translation Adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Customer relationships and other intangibles Customer Relationships [Member] Entity Address, City or Town Entity Address, City or Town 2.375% convertible senior notes, capped calls 2.375% Convertible Senior Notes, Capped Calls [Member] 2.375% Convertible Senior Notes, Capped Calls [Member] Unrealized Loss on Cash Flow Hedges Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Foreign exchange rate impact Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) 2028 - 2032 Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Debt Issuance Costs Debt Issuance Costs, Net Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Auditor Name Auditor Name Defined benefit pension plans Pension Plan [Member] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] Net operating loss carryforwards Operating Loss Carryforwards Operating lease liabilities Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation Income tax impact Reclassification from AOCI, Current Period, Tax Trade accounts payable Accounts Payable, Trade, Current Contract liabilities Contract with Customer, Liability, Noncurrent Research and development Research and Development Expense Additions for tax positions of prior years Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Defined Benefit Plan, Plan Assets, Category [Line Items] Defined Benefit Plan, Plan Assets, Category [Line Items] Mutual funds Fair Value Measured at Net Asset Value Per Share [Member] Disposal Group Classification [Axis] Disposal Group Classification [Axis] RSUs / PSUs Restricted Stock Units (RSUs) [Member] Return on Plan Assets Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held Vested and expected to vest at end of year (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Other comprehensive (loss) income, net of income taxes: Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] LIBOR London Interbank Offered Rate (LIBOR) [Member] Sales Revenues Subpart F and GILTI, net of foreign tax credits Effective Income Tax Rate Reconciliation, Subpart F and GILTI, Net of Foreign Tax Credit, Percent Effective Income Tax Rate Reconciliation, Subpart F and GILTI, Net of Foreign Tax Credit, Percent Beginning balance Ending balance Standard and Extended Product Warranty Accrual Income from continuing operations, net of tax Income from continuing operations, net of tax Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent State and local Deferred State and Local Income Tax Expense (Benefit) Total intangible amortization expense Amortization of Intangible Assets Rollforward and Carrying Value Of Goodwill Schedule of Goodwill [Table Text Block] Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Unrealized Pension Costs Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Land and improvements Land and Land Improvements [Member] Inventory Valuation Inventory, Policy [Policy Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Counterparty Name [Domain] Counterparty Name [Domain] Total Envista stockholders’ equity Stockholders' Equity Attributable to Parent Hedging Transactions and Derivative Financial Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Forfeited (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Stock Transactions And Stock-Based Compensation Shareholders' Equity and Share-Based Payments [Text Block] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Three Schedule of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Roll Forward Schedule of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Roll Forward [Table Text Block] Retained Earnings Retained Earnings [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Total operating lease expense Lease, Cost Common Stock Common Stock [Member] Number of reportable segments (in segments) Number of Reportable Segments 2.375% convertible senior notes over allotment option 2.375% Convertible Senior Notes Over Allotment Option [Member] 2.375% Convertible Senior Notes Over Allotment Option [Member] Components of Operating Lease Expense Lease, Cost [Table Text Block] Contingent consideration Business Combination, Contingent Consideration, Liability Summary Information of Unvested RSUs and PSUs Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Revenue Recognition Revenue [Policy Text Block] Statement [Table] Statement [Table] Schedule of Discontinued Operations Disposal Groups, Including Discontinued Operations [Table Text Block] Vested (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Non-cash loss Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down Separation related adjustments Adjustments to Additional Paid in Capital, Increase (Decrease) in Separation Adjustments Adjustments to Additional Paid in Capital, Increase (Decrease) in Separation Adjustments Other developed markets Other Developed Markets [Member] Other developed markets [Member] Operating lease liabilities Operating Lease, Liability, Noncurrent Statistical Measurement [Axis] Statistical Measurement [Axis] Total Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member] Trademarks and trade names of indefinite-live intangibles Indefinite-Lived Intangible Assets (Excluding Goodwill) Disposal Group Name [Axis] Disposal Group Name [Axis] Trade accounts receivable, less allowance for credit losses of $16.2 and $20.7, respectively Accounts Receivable, after Allowance for Credit Loss, Current Convertible senior notes due 2025 Convertible debt, fair value Convertible Debt, Fair Value Disclosures Equity Components [Axis] Equity Components [Axis] Accumulated Other Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Schedule of Acquired Finite-Lived Intangible Assets by Major Class Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block] Statement [Line Items] Statement [Line Items] Unvested (in shares) Unvested at beginning of year (in shares) Unvested at end of year (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Variable Rate Variable Rate [Domain] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Selling, general and administrative Selling, General and Administrative Expense Goodwill and Other Intangible Assets Goodwill Disclosure [Text Block] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Loss Comprehensive Income (Loss) Note [Text Block] Auditor Firm ID Auditor Firm ID Sales and product allowances Sales And Product Allowances, Noncurrent Sales And Product Allowances, Noncurrent Type of Restructuring [Domain] Type of Restructuring [Domain] Document Transition Report Document Transition Report Foreign tax Foreign Tax Authority [Member] 2024 Defined Benefit Plan, Expected Future Benefit Payment, Year Two Foreign currency denominated debt Foreign Currency Denominated Debt [Member] Foreign Currency Denominated debt [Member] Local Phone Number Local Phone Number Schedule of Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Operating profit Operating profit (loss) Operating Income (Loss) Inventories Deferred Tax Assets, Inventory Accounting Standards Recently Adopted New Accounting Pronouncements, Policy [Policy Text Block] Discontinued operations disposed of by sale Discontinued Operations, Disposed of by Sale [Member] Change in prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Unrecognized prior service credits, net of tax Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax Impairment loss Goodwill and Intangible Asset Impairment Income tax expense Discontinued Operation, Tax Effect of Discontinued Operation Future amortization of gain (loss) Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax Convertible debt, capped calls (in shares) Debt Instrument, Convertible, Capped Calls, Shares Debt Instrument, Convertible, Capped Calls, Shares Property, Plant and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Warranty accrual Schedule of Product Warranty Liability [Table Text Block] Preferred stock, par value (in USD per share) Preferred Stock, Par or Stated Value Per Share 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Income Statement [Abstract] Income Statement [Abstract] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Credit Loss [Abstract] Federal U.S. Deferred Federal Income Tax Expense (Benefit) Number of portfolio segments (in segments) Number Of Portfolio Segments Number Of Portfolio Segments Additional Paid-in Capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Adjusted balance Cumulative Effect, Period of Adoption, Adjusted Balance [Member] Earnings per share: Earnings Per Share, Basic [Abstract] Aggregate intrinsic value of options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Derivative [Line Items] Derivative [Line Items] Diluted (in shares) Weighted average common shares outstanding used in diluted earnings (loss) per share (in shares) Weighted Average Number of Shares Outstanding, Diluted Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Expected years until exercise Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Divestiture Standard Product Warranty Accrual, Decrease From Divestiture Of Business Standard Product Warranty Accrual, Decrease From Divestiture Of Business Buildings and improvements Building and Building Improvements [Member] Increase limit of revolving credit facility Debt Instrument, Accordion Feature, Increase Limit Debt Instrument, Accordion Feature, Increase Limit ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Base Rate Base Rate [Member] Contingency provision, purchase price in excess of $100 million Contingency Provision, Purchase Price in Excess of $100 million Contingency Provision, Purchase Price in Excess of $100 million Carrying Amount Reported Value Measurement [Member] Grant (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Assets acquired: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract] Weighted Average Remaining Contractual Term (in years) Share Based Compensation Arrangement By Share Based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract] Share Based Compensation Arrangement By Share Based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract] Schedule of financial assets and liabilities at carrying and fair value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Operating segments Operating Segments [Member] Convertible Debt Convertible Debt [Member] Non-current deferred tax asset Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Vested at end of year Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Cost of sales Disposal Group, Including Discontinued Operation, Costs of Goods Sold Preferred shares authorized (in shares) Preferred Stock, Shares Authorized Impairment charges Impairment of Intangible Assets, Finite-Lived Proceeds from borrowing Proceeds from Short-Term Debt, Maturing in Three Months or Less Common stock, shares issued (in shares) Common Stock, Shares, Issued Liabilities held for sale Current liabilities held for sale Disposal Group, Including Discontinued Operation, Liabilities, Current Acquisition costs Business Combination, Acquisition Related Costs Facility Exit and Related Facility Closing [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Net cash (used in) provided by investing activities Net Cash Provided by (Used in) Investing Activities Gain on sale of discontinued operations, net of tax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax Purchase of capped calls related to issuance of convertible senior notes Payments For Capped Calls, Issuance Of Convertible Senior Notes, Financing Activities Payments For Capped Calls, Issuance Of Convertible Senior Notes, Financing Activities Term loan Debt Instrument, Face Amount Investments Investment, Policy [Policy Text Block] Proceeds from revolving line of credit Proceeds from Long-Term Lines of Credit Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Cash flows from investing activities: Disposal Group, Including Discontinued Operation, Cash Flows From Investing Activities [Abstract] Disposal Group, Including Discontinued Operation, Cash Flows From Investing Activities Segment results Schedule of Segment Reporting Information, by Segment [Table Text Block] Expected forfeiture rate Share Based Compensation Arrangement By Share Based Payment Award, Fair Value Assumptions, Expected Forfeiture Rate Share Based Compensation Arrangement By Share Based Payment Award, Fair Value Assumptions, Expected Forfeiture Rate Entity Current Reporting Status Entity Current Reporting Status Accrued expenses and other liabilities Total Other Liabilities, Current Income (loss) from discontinued operations, net of tax (Note 4) Income (loss) from discontinued operations, net of tax Income (loss) from discontinued operations, net of tax Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Paid/settled Payments for Restructuring Schedule of Net Funded Status Schedule of Net Funded Status [Table Text Block] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Statutory federal income tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Employee Severance and Related Employee Severance [Member] Charged to Costs & Expenses SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Common stock voting rights (in votes per share) Common Stock, Vote per Share Common Stock, Vote per Share Effect of foreign currency translation Standard and Extended Product Warranty Accrual, Foreign Currency Translation Gain (Loss) Fair Values of Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Derivative [Table] Derivative [Table] Outstanding at beginning of year (in shares) Outstanding at end of year (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number $41.96 to 48.52 Range Five [Member] Range Five [Member] State income taxes (net of federal income tax benefit) Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Accounting Principles Basis of Accounting, Policy [Policy Text Block] Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Property, plant and equipment, net Property, plant and equipment, net Property, Plant and Equipment, Net Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Long-term debt Total debt Total debt Long-Term Debt Other income (expense) Other Nonoperating Income (Expense) Balance Sheet Location [Axis] Balance Sheet Location [Axis] Restructuring Activities And Related Impairments Restructuring and Related Activities Disclosure [Text Block] Research and development Disposal Group, Including Discontinued Operation, Research And Development Expense Disposal Group, Including Discontinued Operation, Research And Development Expense Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Schedule of Acquired Indefinite-Lived Intangible Assets by Major Class Schedule of Acquired Indefinite-Lived Intangible Assets by Major Class [Table Text Block] Senior unsecured revolving credit facility Senior Unsecured Revolving Credit Facility Senior Unsecured Revolving Credit Facility Expected long-term return on plan assets Long-term rate of return on asset assumptions Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets Stock-based awards Share-Based Payment Arrangement [Member] Purchase of capped calls related to issuance of convertible senior notes, net of taxes Adjustments To Additional Paid In Capital, Purchase Of Capped Calls Related To Convertible Debt Adjustments To Additional Paid In Capital, Purchase Of Capped Calls Related To Convertible Debt Total current assets Assets, Current Revenue recognized Contract with Customer, Liability, Revenue Recognized Entity Small Business Entity Small Business Measurement Basis [Axis] Measurement Basis [Axis] Amortization of right-of-use assets Operating Lease, Right-of-Use Asset, Amortization Expense Total amortization Finite-Lived Intangible Assets, Net Expected timing of satisfaction Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Accrued expenses and other liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Employee service share-based compensation, tax benefit from exercise of stock options Share-Based Payment Arrangement, Exercise of Option, Tax Benefit Total unrecognized compensation cost related to RSUs/PSUs Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] Number of Stock Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Property, Plant And Equipment Property, Plant and Equipment Disclosure [Text Block] Amortization of debt discount Amortization of Debt Discount (Premium) Future amortization of prior service cost (credit), net of tax Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax Outstanding at end of year Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Consolidated Entities [Axis] Consolidated Entities [Axis] Mexico MEXICO Debt Instrument [Line Items] Debt Instrument [Line Items] Business Combination and Asset Acquisition [Abstract] Equipment Equipment Sales [Member] Equipment Sales [Member] Payment of debt issuance and other deferred financing costs Payments of Debt Issuance Costs Total operating lease liabilities Operating Lease, Liability Balance at Beginning of Period Balance at End of Period SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Two Granted (in USD per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Benefits and other expenses paid Defined Benefit Plan, Plan Assets, Benefits Paid Deferred tax assets: Deferred Tax Assets, Net of Valuation Allowance [Abstract] Costs incurred Restructuring Charges Hedging Relationship [Domain] Hedging Relationship [Domain] Auditor Location Auditor Location Entity Filer Category Entity Filer Category Federal U.S. Current Federal Tax Expense (Benefit) United States UNITED STATES Operating lease right-of-use assets Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right Of Use Asset Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right Of Use Asset Liabilities: Liabilities, Fair Value Disclosure [Abstract] Stock-based compensation expense Share-Based Payment Arrangement, Expense Commitments and contingencies Commitments and Contingencies Security Exchange Name Security Exchange Name Outstanding as of beginning of year (in USD per share) Outstanding as of end of year (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted-average useful life of acquired intangible assets Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Assets held for sale Current assets held for sale Disposal Group, Including Discontinued Operation, Assets, Current Held for sale Segment Reconciling Items [Member] Other long-term liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Sales Revenue from Contract with Customer, Excluding Assessed Tax Operating (loss) profit Disposal Group, Including Discontinued Operation, Operating Income (Loss) Service cost Service costs Defined Benefit Plan, Service Cost Cover [Abstract] Cover [Abstract] Entity Voluntary Filers Entity Voluntary Filers Impairment loss Goodwill, Impairment Loss Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Revenue Revenue from Contract with Customer [Text Block] Segment Reporting [Abstract] Segment Reporting [Abstract] Change in pension benefit obligation: Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] Forecast Forecast [Member] Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Defined Benefit Plan, Plan Assets, Category [Axis] Defined Benefit Plan, Plan Assets, Category [Axis] Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Sweden SWEDEN Amortization of actuarial loss Defined Benefit Plan, Amortization of Gain (Loss) Discount rate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Tax withholding payment related to net settlement of equity awards Tax withholding payment related to net settlement of equity awards Payment, Tax Withholding, Share-Based Payment Arrangement Total liabilities and stockholders’ equity Liabilities and Equity Amortization of debt issuance costs Amortization of Debt Issuance Costs Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] International Non-US [Member] Schedule of Income before Income Tax, Domestic and Foreign Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Tax credit and loss carryforwards Deferred Tax Assets, Tax Credit And Loss Carryforwards Deferred Tax Assets, Tax credit and loss carryforwards Potential interest and penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Earnings - diluted (in USD per share) Earnings - diluted (in USD per share) Earnings Per Share, Diluted Selling, general and administrative Disposal Group, Including Discontinued Operation, General and Administrative Expense Proceeds from sales of property, plant and equipment Proceeds from Sale of Property, Plant, and Equipment Trademarks and trade names Trademarks and Trade Names [Member] Award vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Summary of Share Activity Schedule of Stock by Class [Table Text Block] Consolidation Items [Axis] Consolidation Items [Axis] Exercise Price Range [Domain] Exercise Price Range [Domain] 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Consolidation of facilities Consolidation Of Facilities [Member] Consolidation Of Facilities Gross unrecognized tax benefits Unrecognized tax benefits, beginning of year Unrecognized tax benefits, end of year Unrecognized Tax Benefits Total deferred tax asset Deferred Tax Assets, Net of Valuation Allowance Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Noncurrent Other Liabilities, Noncurrent [Abstract] Facility fee Line of Credit Facility, Commitment Fee Percentage Adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Discount rate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Allowance for Credit Loss Accounts Receivable, Allowance for Credit Loss [Table Text Block] (Decrease) increase before reclassifications Other Comprehensive Income (Loss), before Reclassifications, before Tax Schedule of Maturity Of Operating Lease Liabilities Lessee, Operating Lease, Liability, Maturity [Table Text Block] Change in uncertain tax positions Effective Income Tax Rate Reconciliation, Changes in Prior Year Estimates, Uncertain Tax Positions Effective Income Tax Rate Reconciliation, Changes in Prior Year Estimates, Uncertain Tax Positions Estimated reduction in unrecognized tax benefits within twelve months Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit Entity Address, Address Line One Entity Address, Address Line One Contract liability Contract with Customer, Liability Product and Service [Axis] Product and Service [Axis] Defined Benefit Plan, Plan Assets, Category [Table] Defined Benefit Plan, Plan Assets, Category [Table] Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Other long-term assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Pension benefits Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent Interest expense, net Interest Expense Retirement Plan Type [Axis] Retirement Plan Type [Axis] Inventories Inventory Disclosure [Text Block] Components of debt Schedule of Long-Term Debt Instruments [Table Text Block] Machinery, equipment and other assets Machinery and Equipment [Member] Buildings Building [Member] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Funded status Defined Benefit Plan, Funded (Unfunded) Status of Plan Multiemployer plan, employer contribution cost Multiemployer Plan, Employer Contribution, Cost Schedule of disaggregation of revenue by geographical region and type Disaggregation of Revenue [Table Text Block] Total deferred tax liability Deferred Tax Liabilities, Gross Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward] Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward] Loan facility interest rates Debt Instrument, Interest Rate During Period Employee contributions Defined Benefit Plan, Plan Assets, Contributions by Plan Participant Cross-currency swap derivative contracts Cross-currency swap derivative contracts Currency Swap [Member] Schedule of restructuring reserve by type of cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Schedule II - of Valuation and Qualifying Accounts SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Five Weighted Average Grant-Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Other Other Accrued Liabilities, Current Change in accrued expenses and other liabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Exercisable, average exercise price (in USD per share) Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price Convertible debt expense, capped calls Debt Instrument, Convertible, Capped Calls, Expense Debt Instrument, Convertible, Capped Calls, Expense Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Other Other Debt Obligations [Member] Transfers Into/(Out of) Level 3 Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Assets Transferred into (out of) Level 3 Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Advertising Advertising Cost [Policy Text Block] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] North America North America [Member] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Asset impairment charges Asset Impairment Charges Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Proceeds from sale of KaVo treatment unit and instrument business, net Proceeds from Divestiture of Businesses, Net of Cash Divested Amendments, settlements and curtailments Defined Benefit Plan, Amendments, Settlements, And Curtailments Defined Benefit Plan, Amendments, Settlements, and Other (e.g. curtailments). Cost of sales Cost of Sales [Member] Components of note interest expense Convertible Debt [Table Text Block] Impairment charges Disposal Group, Including Discontinued Operation, Impairment Charges Disposal Group, Including Discontinued Operation, Impairment Charges Derivative financial instruments Derivative Liability, Noncurrent Accounting Standards Update [Extensible List] Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member] EX-101.PRE 11 nvst-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 12 nvst-20221231_g1.jpg GRAPHIC begin 644 nvst-20221231_g1.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# ," @," @,# P,$ P,$!0@%!00$ M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_ MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04 M%!04%!04%!04%!04%!04%!04%!04%!3_P 1" "0 C@# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#]4Z*** "B MBDH 3G%)6)XI\6Z3X/TQ[_5[V.RMD&-S'ECZ #DGV%?,GQ&_:RU'5#+:>%;< MZ=;\C[9.H:5O=5Y"_K7DX[-,-@%^]EKV6Y]#E.0X[.96PT/=ZR>B7S_R/J'6 MO$>F>'[,W.IWMO8V_P#STN) @_6O-=?_ &HO ^CY6&ZN-2D Z6L)Q^;;17QE MJVN:CK]TUSJ%Y->W#=9)Y"Q_,U3VGO7Q5?BFO-M4*:2\]7_D?K6"\.\+3BI8 MVLY/M'1?C=_D?4]Y^V3I\8_T7P]<3#LTUPJ?R5JIQ_MH+GYO"W'^S??_ &NO MG>S\*ZSJ*YM-(O;M3WM[=F_D#5R3X>^*85W-X=U4+Z_89?\ XFN%9SFT]8O_ M ,E_X!Z_^JO#-+W)VOYS=_S/I33?VQ=!FVK>Z-?6^>IA:.0#\RM=]X=^/G@? MQ( D&MQ6\YX\N\!B.?JV!^1KX8OM+O=-;9>6<]J_I+&4/ZU4Y7WK2GQ)CJ4K M54FO-6_K[CGK\!91BHWPLW'T?,OQ_P S],H;B*ZC5XI%D1N05Y!%6#[5^=O@ M_P")WB3P/,K:1JLT4.[)MV;=$?JAR*^DOAE^U-I'B%HK+Q(G]CW_ -T76?\ M1W/N3RGX\>]?68'B'"XMJ$_=EY[?>?F^;\$YAEL75I?O(+LM5ZK_ "N?05%0 M0S1W$:O&P>,C((Y!!J>OJ3\^VT84444""BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDI M: &-7G?Q8^+VF?"_23),5N=3F4_9[-6PS_[3>B^]7/BI\2K+X8^&)M1N-LUT MV4MK;.#(_I]!W-?"7BCQ+J/C#6KK5=5N&N+NY:1AQ'$O$<2^B MKVKGXUW,!TSW-)SM]*#TXK\JJ5)5I.EV^$^A=R,_@/QKU;PQ\;/A5X5*_V?X2NK=ATN#;Q M22?]],Y;]:^;L&E:%E7)5MM>KA\PJ85?N::7G:[^]GS..R"AF#?UK$3:[C:-XBTKQ%:_:-+OK:]@_OP. M&'Z&OS>8%1S5O2=RG7I)!(5/YBO?P_%%:+2KTTUY:/\ R/B\ M9X=X:I%RP59I]I6:_"Q^D=Y86UW&8[BWCFC/570$?K7G7BK]GGP5XI1\Z6-. MN&'$U@?**G_='R_^.UX]\,?VKKNSEBL?%Z?:K?HNH0+AU_WT'#?AS]:^H-'U MBS\06$5]I]S'=VDPW1RQ'*D5]A0Q&!S6GHE+NFE=?UW/R_&X'-^&:RO*4+[2 MBW9_/]&?(7Q$_9;U[PJLUWHC_P!MV"@L5C7$Z#_G:XHRERBX60^C@=?][K7SF9<-Q:=3![] MO\F?=Y#Q[4C*-#--5_,EK\UU]4?/?P=^/NI_#VXAL+]Y;_06.TQELM#[H3_Z M!TK[,T/7['Q+I=OJ6FW*7=I.FY)4YR/\?:OSM\2>'-1\)ZS<:;J=L;:\A."I M[^A![@UWOP-^,EQ\--<6"[9I-!N7"W,?7RCT\Q1ZCOZC\*\_*,XJ82?U;%OW M;VUW3_R/9XHX5H9E0>8Y:ESVO9;27=>?YGW9Q1TJG97T.I6D-S;R++!,@=)$ M.0RD9!!JW_#7Z:G?4_ 6G%V8ZBBBJ$%%%% !1161=>*-&T^X:"ZU:RM9U^]' M-"/".C6WBGQE#&DMZUY*RVEAO&Y$8+\SR%2"5!7 9>>U 'W917Y:?L^_ M\%D+CQ%XTL-'^*WAK2]'TF]E$(U[16E1+,L&_M4>.SX;\$KH]LY6\U M8E#MZB)<%_SR!]-U<6,Q$<)0G6ELD>EEN!J9EC*>$I[R=O1=7\D?.'QF^)$W MQ*\97-[DKIUOF&RB;M&#]XCU;J?R[5PW>COS^%'OWK\/Q%:>(J2JU'>3/Z^P M.#I8##PPU%6C%6#[U>E>![CX9:0R2^((]8U:?N@1$@7\ ^\_G^%>;;2U'DGT MQ5X>JZ$N=14GYJZ^XQQ^%CC:?LI5907]UV?W[_3;!I']G:7/T M"W%L(#G_ 'F&"?\ @5>N+;VEU"I6*&2,CCY01BOS1&Y1SS7>_#CXV>(_AU:9GY["=B4 _V?[A^E?9X'B2,;4\3327=+]#\GS?@*K).M@:[D^TGOZ/ M_/[S[+U[X4>$O$<;&_T"RD8]7CB$;_\ ?2X/ZUXCX_\ V1E19;KPG=L6^]]@ MO&SGV5__ (K\Z]N^'OQ'TGXE:*M_IDN''RS6[G$D3>C#^1KLOK7UM; 8',*: MFX)I[-:/[T?F>%SC-LCKNG&I*+CHXO5?<_S1^:&KZ+J'A[4)K'4K1[.YA.'C ME7!%=G\)?C!JGPQUE60M<:/,P^T69;@C^\OHPKZZ^*WPCTKXH:.T-PBV^HQ* M?L]ZJ_,A]#ZJ>XKX;\4>&]1\(:[<:3J4/D7=N<$=F'8@]P1R*_/,=@,1DU>- M:E+3H_T?]:G[GD^=8+BW"2PN*@N>VL7^%;Z-T/\ P'TK[2^\ M 1SFOT3*\?',,.JBTDM&NS_X)^%9_DM3(\;+#RUB]8ONO\ULSRWXV?"*V^*& M@2- JQ:W:J3;3_=W=]C'^Z?T/XU\.WUG-I]U/:7,30W$+F-T=<%6!P0:_33^ M(U\I?M7_ S6QNX?%EC'B.=A!>JH_P"6F/D?\0,'_P"O7S_$66*Y+X;]'V]'^?J:7[*/Q0,WF^$=0FW,JF6P9FYQU>/\ M/O#_ (%7TVQ].M?FKH&N7/AS6K/5+)]ES9S+*A]P%=?@\5>'K#5K M88@NX5E7/49'(/N.E=/#F/>(H.A4?O1V]/\ @'#QWDT@#Y8HKU+]F?X7Z;\:/CQX+\$:Q<75GINN7PM)Y[)D6:-2K'*E M@1GCN*_4S_ARC\'_ /H-?_ BT_\ MD>C_ (1_\$.?^1C^+W_7IIG_ *'2".X76)87""(R%=OEQ)U\PYS7T?0 4444 %% M%% !1110 4444 %%%% !1110 4444 %?SR_\%!/!.L^"/VNOB2FM1R*VIZG) MJME-(#B:UG.^,J3U"CY/JC#M7]#5>:?&+]GGX>?M :7%I_C[PM9^(8H,_9Y9 MM\NR5"KKGN U '\V>BZ/?>(=4L]*TRUEOM1O9DM[:U@4M)-(QVJJ@=22 M<5_3;\,]#O?"WPW\*:+J4OG:EIVDVEI#O ]I9ZTI)34;R>6[GBSP?+:5FVM?DMXY_Y';Q#_P!A&X_] M&M7Z#?\ !$?_ )+!\1?^P%#_ .E"T ?L+1110 4444 %%%% !1110 4444 % M%%% #37PU^TQXF/B#XI7T*MF#3U6U0=LCYG_ /'F(K[AF<1QNQX &:_-GQ+J M9UCQ#JFH;MWVJXDF)_WF+?UKXCBBLX8>%)?:?Y?\.C]8\.\(JN.JXA_8BDO5 MO_),H5ZK\'/@#J/Q)*W]X[:?H0./.V_O)B.HC!_]#_G7+_";P,WQ#\;6.D_, M+?=YUPR]5B'+?GT'NU??VFZ;;:38P6=G$L%K @C2)!A54# KPLARB.,;KU_ M@6EN[_R1]EQEQ/4RM+!X32I)7;[+I\VB/Y_K8O$8B;J M5:CE+NVVSRGQO^SKX3\8V\C1V:Z-?-S]JLE"<_[2#Y3_ #]Z^2?B1\,]6^&. MM&RU!?,MWR8+M/N2J/3W]17Z%C&!SFN-^)O@"S^(GA2[TNY1%F(WV\QZQR ? M*W]#[&OG5UHTL1)SHO1IZM>:?EV/B3X9_$ M*^^'/BFWU*S9C!NV7%ONXFC/4'^A]:^^]!URU\0Z/:ZE92":UN8Q)&P[@C-? MF_?6,'U+PKJ.@SON;39A)#N_P">4F3C M\&#'_@5?/<-XR=.L\'/9[7Z-;_>?;\>Y33KX:.:45JK)M=4]G\F?0E>#_M0? M#5/$WA5O$%I&!J.EKN=EZO#U8'_=^]^=>\8Q56\M8KZUE@F19(I%*.K="",$ M5][C,-#&4)49[-?<^C/QK+,?4RW%T\52WB_O75?-'YHK\K#'45][_!7QJ?'7 MP]TN_FQK]GN<]?,3@D_[PPW_ J^'_ !KH!\,^+-6THC'V2X>%<_Q*#@'\ M17T!^QOKQ5O$&CN00?+NHQ[_ ''_ /9*_..'JTL+CGAY:7NGZK^F?N_&^%IY MCD\,=3U<;23\I63_ #3^1]0XKFO'OA>+QIX0U;1I<;;J!E5C_"_56_!@#^%= M+GG%-S7ZC4A&I!PDKIZ'\]4JDZ-2-6#LXM->J/S,N;>2RN9;>5=DD;%&5NJD M'!%?77[(OB@ZIX'O=(E8-)IL^4'I')EA_P"/"2OG[X\:(N@_%CQ!;QC:LD_V ME1E(_0M7Y3E,G@\U]D^[7]?,_HW MB:,@#F/V _^3R/A/_V&4_\ 0'K^BBOYV?V MO^3ROA/_ -AE/_1;U_1-0 4444 %%%% !7@_[8O[30_9.^$T/C<^'_\ A)0^ MI0:?]A^U_9<>8LC;M^Q^GE],5[Q7PK_P60_Y-'M/^QFL_P#T5<4 >+_\/QX_ M^B.O_P"%'_\ 'OC#XRN+7P1HNJV0NGANKGSC&Q) B0A M0TK';P%7/M7\Y-=QXX^+/B;XA:#X6T;6M2,^C>&; :?I>GQ_)#;Q@Y9MHX+N M3\S=3QV H _1[XQ?\%K%M[R>S^&'@:.XMT)5-6\22L-_N+>(@@?63\*\!OO^ M"O/[0EW<>;%?^';./_GC#I"E/_'V9OUKP#X0?LM_%?X]+Y_@;P/JFMV0;8=0 M"K!:!AP1Y\I6/(]-V:]9UO\ X)<_M&Z+IK7K>!8[P*NYH;'5K2:7\%$F3^&: M /:/AG_P6D^(6C7D47CGPCH?B/3\X>72_,L;@#UY+H?IM%?I#^S?^UK\._VI M/#[ZAX-U5O[1ME5[[1;T"*]M,\99,D%<_P 2EE]\U_.YXF\*ZQX+UJ[T?7M+ MN]&U>TD\NXL;Z%H9H6]&5@"*V_A7\4O$GP7\=:3XO\):C)I>MZ;+YD4J'Y'' M\4;K_$C#AE/44 ?TA_%;Q5J_@7X<>(_$.B:'_P )+JFE64MY#I/G^0;ORQN, M:N%;#%0:_-C_ (?D2_\ 1'4_\*,__(U?H+^S7\=-)_:,^#?A[QWI06$: MA%LN[3=DVMTAVRQ'Z,#@]P5/>OPV_;X^ I_9Y_:7\3Z':VWV;0=2D_M?2 JX M3[+,2=B^R.)(_P#@% 'ZQ?L1?M_Z=^V%K7B;19?# \):SI4$=Y#:_P!H?;/M M4!8H[@^6F-C>6#Q_RT6OKNOYPOV/_CA)^SO^T/X0\9-,T>EPW(M-41?X[.;Y M)>.^T'>/=%K^C2"XBO(8YH9%EAD4,KHV0P/(((H LT444 <=\5OB+IGPB^&O MB7QIK#8TW0[&6]E7=@R;5RJ+_M.VU1[M7YK_ /#\B7_HCJ?^%&?_ )&KKO\ M@LU\=O[!\!^&_A3IT^V\UV7^U-456Y%I"V(5/L\HW?\ ;"OR"H _>S]B/]N/ M6/VQ]8\28^'B^%-$T.",RZC_ &L;KS)Y"=D07R4_A61B<\87^]6!^V7_ ,%( M!^R/\5K+P8W@!O%'VK2HM3^V#5OLNW?+*FS;Y+]/*SG/\5>D?\$__@*?V>_V M9_#6D7EO]G\0:LG]LZL&7#K<3!2(V]TC$E?^ED5?TO4 5I[B*SADFFD6*&-2S.[8"@9@/=I)&S^50:#_P6$^/>DW2R7H\+ZU$#S%=:64R/K%(AKH_A7_P1 MK^)_B[18-0\6^)M'\$/.@<:?Y;WUU&",XD"%4!]@[5<^('_!%WXDZ!IKW/A3 MQ?H?BV:-=WV*>*33YI/9"Q=,_P"\RT >[_ G_@LMX/\ %M[;Z9\2_#<_@V>1 M@G]K:?(;NRR>[I@21CZ>97Z$>'_$FE^+-#LM8T34+;5M)O8A-;7MG()(9HST M967((K^9#QMX)UWX>>);_P /^)M)N=#UJQ?RKFSNXBDB-]#V(Y!'!'2OK?\ MX)N?MG:C\ _B3IW@CQ!?M)\.O$%VD$L#/\ A+/^$@2[?(U'[)Y'DF(?\\GW9\WVZ5\P?\/QX_\ MHCK_ /A1_P#W-7H/_!5K]F7XF?M#:I\-9?A]X6F\1II,&H)>M#49#;E/ M]:ZYSL;IZ5\!_P##M/\ :4_Z)?>?^#*Q_P#C] 'SKKVI?VSKNH:AY?E?:[B2 MX\O=G;N8MC/XU]"?L1_M@K^QYXN\1ZX?"O\ PE/]KV*67D"_^R^5MD#[L^6^ M>GI7SK?6<^G7UQ:7$?EW$$ABD0_PLIP1Q[UWOP<_9_\ 'W[06J7^F^ /#TGB M*_L(!<7,,<\,/EQEMH.974=?2@#]#O\ A^/'_P!$=?\ \*/_ .YJ3_A^0G_1 M'6_\*/\ ^YJ^1?\ AVG^TI_T2^\_\&5C_P#'Z/\ AVG^TI_T2^\_\&5C_P#' MZ /WU\,ZS_PD7AK2=5\KR&O[2*Z\K=G9O0-C/&<9K8KG? EC<:3X'\.V%Y'Y M-U;:=;PS1\':ZQ*&'''!%?GS_P %-/V^K[X:R77PG^'.I"V\2R1#^W-;M6/F M6,;#(MXF'29E.6;^!3Q\S?( >]_M+_\ !1GX5_LVW%UH\MU)XN\70Y5]$T9U M;R'])YC\D?T^9_\ 9KX(\=?\%F_BWKEQ)_PC/AWPSX8LCG8LT,M[/^+LRH?^ M^*^ 997N)6DD9G=CN9VY))[FO:/@O^QK\7_V@+=;SP;X+O;S26;;_:UTR6MI MQUVR2%0^/]G- 'MNE_\ !7W]H*PN ]Q=>'-23_GE=:2%7_R&Z']:^B?@_P#\ M%J;*^OHK+XF^!O[-B=@K:MX=E:5$SW:WD^;'T/\ Z(Z__A1__'_P#!'/\ Y-'N/^QDO/\ T5!10!]F^*)S:^&] M5D'_ "SMI''X(37YOR"?&_P" >K_$ M[Q5;ZK8W]I;Q16JP&.<-G(9FS\H/]ZM\XIXBIA''#7YKK;1[G#PS6P5#,8SS M"WL[/=75^FFIX#_POWQ__P!#'=?]\Q__ !-'_"_/'Y_YF.Y_[YC_ /B:[W_A MCSQ)_P!!;3?SD_PH_P"&//$G_06TW\Y/\*^"^J9U_>^__@G[/_:W"7:G_P" M?\ \+U35+O6M1N+Z]E\^ZN'+N[*!N8\D\5[+^R->M#\1KRWQ\DU@Y(]PZ$5> M_P"&._$9R/[7TW\Y/\*[OX*?L_ZO\-?%S:O?:A:7$7V5H/+M]V#X3_:6M M5M?C%K3IP)?*?\3$F:V_V2YVA^*$L>[Y9;"4$?1HS_2O0/BQ^SKKWQ!\ J*O.%(ZC-7_@G^S[JWPU\7-J]]J%K<1_9GA"0!LY)4Y^ M8#TK\WI9;BH9K[?D?)S-W\FS]RKY]EM3AM8)U4ZGLTK:[Z:;'T%1117Z0?AI M\4_M7QJGQ4)7J]G&Q^N77_V6J'[,4WD_P/^6D4P/_ '[<_P!*]A^-7[/^ ML_$OQ@-8LM0L[:'[.D 2?=OX)/8'UJM\)/V<]9^'WC>SUR_U"SN(+=)/W<&[ M?ED*YY4>M?FTLMQ;S;ZPH/DYD[^5S]RIY_ERX:^I2JKVGLW&VN]GIL?1U%%% M?I)^&A1110 5_/\ ?\%/O^3XOB1_O6'_ *06]?T U_/]_P %/O\ D^+XD?[U MA_Z06] 'SAX9\3:OX-UZRUG0=2N='U:S?S;:\LY3'-$_3*LO(->F_P##9OQW M_P"BO^,__!U/_P#%5R_P/^%<_P ;?BUX8\"6FH0Z9>YF;=)+(]O&S.Q/4DG)KY0_X+(?\FCVG_8S6?_HJXK[" M^&_A:7P/\._"_AV>X6ZGT?2[73WN(UVK(8H4C+ 'H#MS7Q[_ ,%D/^31[3_L M9K/_ -%7% 'X@U]E?\$V_P!C^V_:>^)UWJGB:!IO ?A?RY;Z$$K]NN'R8K?( M_A^5F?'8 ?QYKXUK]Y?^"4_@&#P7^QQX9O5C5+OQ%=W>K7#=V)E,*?\ D.!* M /K+2='L- TJUTW2[2#3M/M8Q%!:6L8CBB0U:-%% 'R!_P %%/V2 M=*_:$^#>K:Y86,:^/?#=I)>Z;>1IB:YB0%Y+1R/O!E#;,]'QZMG\%J_JE90Z ME6&Y3P0:_E\^(6FPZ+X_\3:?;+MM[34[FWC'HJRLH_04 ?IK_P $2?B-/)%\ M2/ D\A:VC^S:W:19^ZS9AG/XX@KU+_@K]\!?^%A? RS^(.GV^_6/!D^;@JOS M26$Q"R?78_E-[#S*^9_^")[?\9!^-U[?\(N__I7;U^P'BCPWIWC/PWJV@:M; MK=Z5JEI+97<#=)(I%*.OX@F@#^6ZOWK_ ."8GQV_X75^S#H]E>W'G:_X3;^P M[W1VP% &2235FOD#_@I[\=A\%_V8=7L+*?R]?\ M%K'0K3:V'6)U)N9/PBW+GL95H _'_P#:\^-TW[1'[0OB_P 9B5I-,N+LVNEH MW\%G%\D/';5K7C287499<,EA%E8! M_P ")DD]PZT ?=]?B9_P6=_Y.JT/_L5+3_TINJ_;.OQ,_P""SO\ R=5H?_8J M6G_I3=4 ?*G[,O\ R'["2[T/4(8;;7Q"N3:7" 1QSL!_P LW01KGLR<_?%?F:K%&R."* /ZIZ*_ MG\^%?_!2GX_?">QM]/M?%X\0Z9 H6.U\0VRWF%' 'FG$N/\ @=?4?@'_ (+< MZC&8XO&_PSMKG^]=^']0:'\H90^?^_E 'V=^U)^PE\.?VLM8TC5_%,FIZ3J^ MG0M;"_T62*.6>(G(23?&^X*=Q7TW-ZUX=_PY;^"__0S^-O\ P-M/_D>N^^%_ M_!57X!_$::&UO-7'GT\Z,O&/JS"OK32-8L=>TR#4=+O;?4 M=/N(Q)!=6L@DBE4]"K*2"/I0!'X?TMM#T/3].-U-?&SMX[?[5Y M W'&3Q6K110!_+IXY_Y';Q#_ -A&X_\ 1K5^@W_!$?\ Y+!\1?\ L!0_^E"U M^?/CG_D=O$/_ &$;C_T:U?H-_P $1_\ DL'Q%_[ 4/\ Z4+0!^PM%%% 'FW[ M0_Q:MO@7\$_&/CJY"O\ V-I[SP0R=)9S\D*'_>D9!^-?S:^)O$6H^+O$&I:Y MJ]U)?:MJ5S)=W=U,_X+*>*I=%_9;TG28F*_P!M>(K>"4>L M<<4TN/\ OM(Z_$R@#[Y_X)D?L.6'Q^UNY^('CBT^T^!]%N?L]IILGW-4NU 8 MA_6% 5W#^,MMZ*XK]HK&PM]+LX;2U@CMK6!!'%#"H1(U P%51P !7D7[&?P_ MMOAC^RW\,M!MXUC(T2WNY]O>>=?/E/\ WW(U>U4 %TCS+>0]VCW+SW5E/7-?+E?O1_P51^'-MXZ_8_\2Z@\2M?>&[BVU:U M?'(Q*(I!GWCE>OP7H _<'_@CG_R:/?^BH**/\ @CG_ ,FCW'_8R7G_ M **@HH ^Y)!N4CU&*_.+QQHYT#QEK6GE=OD7DJ#Z!B ?RK]':^+_ -JSPH=$ M^(BZHBXM]5@$F[MYB (P_+8?^!5\9Q10=3"QJK[+_!_TC]2\/L8J&8SP\G_$ MCIZK7\KGF'@OQ5=^"?%-CK-G\TUN^2G9U/#*?J#BOO\ \'^,-/\ '&A6VK:9 M-YEM,O(_B1NZL.Q%?G-_.NM^'?Q/UOX;Z@;C3+C= [#SK23F*0#U'K[BOE,E MS?\ L^3A45Z;W[I]T?H_%G"_]MTXU\.TJL597VDNS_0_0W<,45X1X3_:R\+: MQ"@UB*?1KC&&+*98\^S*,_\ CM=9-^T+X!MX&D/B!'4=EAD+?D$K]*IYG@ZL M>:-56\VD?@E;(KH]*853N-2M;(A)KJ&%^H#R ''XU\[^ M.?VN[*&&2W\+VO>)-1\4:I/J&IW;W=Y,.XCP^'?+17._N7WGUN4<"X['KVF+?LH]+J[?RTM\S]%_[=T[K]NMN M?^FJ_P"-7(Y5FC#H0R,,@CD$5\-_ WX17?Q*UY9KH21Z%:.#<2MD>:>OEJ?4 M]_0?A7W#;6\=G;QQ1*L<2*$55& H' %>KE>.K8^FZLZ?+'IK>Y\WG^4X?)\ M0L-1K>TE]K2UO+=ZEGK4,LZ6T1=V6-%ZL> *F/2OF#]JKXJ(L7_"(Z?/F1MK MW[(W*CJB?^S'Z+77CL9# T)5I]-EW?8X$H_ _@S2]&4J6@B'F,/XI#RY_[Z)KR,IS:IF3;^I ME?A?RZ_A7T-:K&C3E4ELE<^,P]">*K0H4U>4FDOF['3MK6GC -[ 3_UU7_&I M[.^M[Q6\B>.;'78P./RK\TVD9FR6:OLW]EGPK)X?^':7TPVS:I*T_/4(/E0? MH3_P*OF,LSR>8U_8JG96NW>Y]_Q!PC2R'"+$2K\S;22M;\;]#VRBBBOK3\X" MBBB@ K^?[_@I]_R?%\2/]ZP_](+>OZ :_G^_X*??\GQ?$C_>L/\ T@MZ .8_ M8#_Y/(^$_P#V&4_] >OZ**_G7_8#_P"3R/A/_P!AE/\ T!Z_HHH **** "BB MB@ KX5_X+(?\FCVG_8S6?_HJXK[JKX5_X+(?\FCVG_8S6?\ Z*N* /Q!K^B; M]@%0O[&OPHQ_T!U_]&/7\[-?T2_L _\ )FOPH_[ R?\ HQZ /H.BBB@ K^8' MXK_\E2\9?]AF\_\ 1[U_3]7\P/Q7_P"2I>,O^PS>?^CWH ^Y?^")_P#R<)XX M_P"Q6?\ ]*[>OV9K\9O^")__ "<)XX_[%9__ $KMZ_9F@#\H_P#@M!\!/)O/ M#'Q=TVWPL^-"UAHU_B +VTA^H\U"?]F,5^8&FZA=:/?VU_93/:WEK*LT,T;8 M:-U.58'U!%?TH?M$?""R^//P5\6>!+T*HU>Q=+>:3D07"_/!)_P"14/X5_-G MKFBWGAW6M0TC4K=K34;">2UN8)!\T4J,5=3[A@10!_2!^S#\9K;]H'X%>$/' M,+1_:=3LE^VQQ](KM/DG7'H)%;'MMK\@/^"K'QV_X6Y^TM>:!8W'G:%X+C.D MPA6RC71.ZZ?Z[]L7_;"M_P#X)^_MMP_LZ_"/XN>'-5ND#Q:>^M^'(9F^634" M%@,(SUWEH'QZ12&OAO4-0NM8OKF^O)GN;NYE::::1LL[L_'CXT>$O ECO5M8ODCGFCY,%NOSS2_P# (U=OPK^DW0=#LO#6AZ=I&FVZ M6>G:=;1VEM;QCB*)%"HH^B@"OS%_X(O_ #,-GXH^+NI6_S3$Z'HQD7^$8>Y MD'U/E(#_ +,@K]3: "OQ,_X+._\ )U6A_P#8J6G_ *4W5?MG7XF?\%G?^3JM M#_[%2T_]*;J@#Y4_9E_Y./\ A5_V->E?^ED5?TO5_-#^S+_R,7.GLWM"2K)_P%\?[ M->Y?\/ OV=_^BKZ%_P!]2_\ Q%=G\+?VF/AA\;-6N=+\#>--,\2:C:P?:9K: MS9MZ1;@N_# <;F4?C0!^3GCK_@CC\:_#K22>']0\-^+H5^ZEO>M:SM]5F4(/ M^^Z^<_'7[&_QO^&HD?7_ (8^(K>"/[]S:V9NX%^LD.]/UK^D&B@#^5N2,PLR M.NUAP0W4&OIK]BS]M?Q1^RQXXL8GO+G4?A[>3JNK:&[ET5&.&G@!^Y*O7C[^ M,'L5^[/^"NW[._@ZX^#[?%*STNUTGQ9I^H6\%Q>6T8C;4(924*R@??93M8,> MI:?-'>6%Y EQ!<1\K+&X#*P]B#FM"OGW]@;4KO5 MOV.?A1/>DM.NC)""W_/.-WC3_P <5:^@J /Y=/'/_([>(?\ L(W'_HUJ_0;_ M ((C_P#)8/B+_P!@*'_TH6O@3XG:=+I/Q*\66,R[9K;5KN%P>S+,X/\ *OMW M_@C#XPL-%_:*\2:'=.L5SK>@NMIN_P"6DD,L^S>W_ * /VCHHHH _/7_ M (+4:/->?L[>$M00;HK/Q/&LG^R'M9P#^:U^,-?T4?MU?!R?XY?LM^.?#5A" M;C5X[0:CI\:C+M<6["547W<*R?\ Z_G7H _I>_9O\26_B[]GWX;:Q;-NAN_ M#U@_R]F\A P_!@17I5?FE_P2'_:IT_6/!/\ PI;7KU8-W\+_L6_$=IW4/>VT&GP(?X MWEN(UP/HNX_\!K^?>OT1_P""L7[7&G_%CQ58?"WPG?K?>'_#ERUSJEW;MF.X MOPI01J1P5B4N"?[SM_=K\[J /W!_X(Y_\FCW'_8R7G_HJ"BC_@CG_P FCW'_ M &,EY_Z*@HH ^Y-OXUY5^T/X!_X3CP!<_9X]^I:?FZMPO5L#YU_%?U"UZJ,\ MT-CH:YL30CB:,J,MI*QV8+%U,#B*>)I/WHM-?UYGYC63^J^W^[7D74C':OP[%8:IA*TJ,UJOZO\ ,_K[+,PI M9IA88JB])+[GU3] S^-+17H_@?XH:#I'DQ>(/!>EZM&O'GQP!9?Q!!5OR%3A MZ<*LN6I/E\VF_P BL=B*^%I\]&BZC[)I/\3S^QTN]U:Y6WLK.>[N&^['%&69 MOH!7NGPS_97U76)HKWQ26TRQ7G[*K S2^Q[(/U]J]/\ "/[0/PRM;98K1%T M'_EBUCL'_D,$5U3_ !]\!1Q[O^$B@(_V4,4DMK(KH6GMP5MF) ME(]&?K^6VOH<1GF!PD;0ES/HE_GL?$X'A'.,RJ.V;(:Z_P3W[]O6OA*U?%Y]B%&*T MZ+HEW9^RX;!Y9P7@959R]Y[M[R?9+^O,Z']EOX1O)NB79+9 2-N3TKXN_::^)P\9>)_[%L9=^F:6Q!96XDFZ,?H M/NC_ (%_>KU#]H;XY1>&+&X\.Z+.'UF8;9IT;_CV4]@?[Y_3\J^1P2WU-?'< M19HI+ZG1?K_D?J/ W#LXR6:XJ-DOA3_]*_R^\Z'X>^#[CQUXNTW1;?=^_D'F M2+_!&.6;\!7Z%Z7IL&DV-M9VR"."WC6)%7HJJ, 5XO\ LR_"D^#] .NZA $U M;4E!5&7F"'J%^K=3_P !KW3%>SP_E[P>'YYKWIZ^BZ(^5XTSJ.:8[V-)WIT[ MI>;ZO]"2BDI:^J/ST**** "OY_O^"GW_ "?%\2/]ZP_](+>OZ :_';]O']AW MXX?&#]JKQOXM\(>!)]8\/:BUI]EO%U"TB$FRTAC;Y9)58896'(H ^#_A7\2= M7^#_ ,0=#\9Z"+?^V=&G^TVOVJ/S(]X!'S+D9ZU]9_\ #X;X_P#_ %*W_@I; M_P".UYY_P[-_:5_Z)C<_^#2Q_P#C]'_#LW]I7_HF-S_X-+'_ ./T >A_\/AO MC_\ ]2M_X*6_^.T?\/AOC_\ ]2M_X*6_^.UYY_P[-_:5_P"B8W/_ (-+'_X_ M1_P[-_:5_P"B8W/_ (-+'_X_0!Z'_P /AOC_ /\ 4K?^"EO_ ([1_P /AOC_ M /\ 4K?^"EO_ ([7GG_#LW]I7_HF-S_X-+'_ ./T?\.S?VE?^B8W/_@TL?\ MX_0!^B7_ 34_;0^(?[57B;QS8^-_P"R?)T>TM9K;^S;0P'=(\@;=ECG[M7? M^"R'_)H]I_V,UG_Z*N*X[_@E5^RW\4?V>?%7Q!N_B!X5E\.P:G96D5H\EW!- MYK(\A8?NI'Q@,.M>S?\ !2[X,^,OCM^SK;^&O NBOKVMC7+:[-I'-%"?*6.4 M,VZ1E7@LO>@#\#*_HE_8!_Y,U^%'_8&3_P!&/7X\_P##LW]I7_HF-S_X-+'_ M ./U^T7['_@?7/AK^S/\/?"_B33VTO7=+TU;>\M&D1S$X=CC?^CWK^GZOP8^(7_!.7]HK6_B!XFU"R^&MQ/9W6 MJ75Q#)_:5DN]&E=E.#.#R#0!Z=_P1/\ ^3A/''_8K/\ ^E=O7[,U^8G_ 2Y M_9+^+'[/OQF\4ZUX_P#"4OA[3KS07LH)Y+NWFWS&XA?;B*1C]U&-?IW0 5^( M7_!6SX##X:?M"1^-=/M_*T/QK";MBJ_(E]'A;@?\"!CE]S(U?M[7S5^WU^SG M3C.TGI0!_/96QX5\, M:CXT\3:3H&D6[7>JZI=Q65I O6261@B+^)-?0_\ P[-_:5_Z)C<_^#2Q_P#C M]?4__!.G_@GQ\0OAW\?(_&WQ3\*G0;'0;5Y=+BENX)_/O'^13B*1N$0R-SWV MT ?I'\"_A3IWP/\ A#X4\"Z7L:VT6QCMVE5<>?+]Z67ZO(7?_@5=_110 5^) MG_!9W_DZK0_^Q4M/_2FZK]LZ_+#_ (*;_L?_ !?^/W[06E^(O ?@V77]'A\/ M6]E)=)>VT(699[AF7$DJG@2+VH _/#]F7_DX_P"%7_8UZ5_Z615_2VRAU*L- MRG@@U^&?P*_X)Y_M!>$_C=\/M=U;X=W%GI.E^(M/O;NX;4;-A%#'(/#DUL\>@74SWVAW.WY)K-W)4 _WD_P!6 MWNOH17GOP?\ B]XH^!?Q TOQCX2O_P"SM9L&.UF7='*CGM*BDRV>H6^%NK*4C&^)R#CW!X/<5^2OQR_X))_&' MX#8K;XB:$I)C>Q=8+U5_VX)",G_<9Z /JSX3_\%G/AWKFFPP_$#PUJ M_AC50 ))],07EHQ[D#9GAUSP%XFTF1#@B[TF>/\ 4KBLK3?AGXOUB80V'A76 M[^4]([?3II&_)5- 'TK^V_\ M]ZU^UQ-9Z+9:6WAKP+IT_VF#3Y)?-GNIL%1 M-,PPORAFVH.!N;EJ^9_ ?@76OB3XST;POX?M3?:SJUTEI:P*/O.YQD^BCJ3V M'->]?"?_ ()Q?'OXM7D"Q>"+GPQISXWZCXF_T&- >^QAYK?\!0U^K7[&G[ ' MA#]D^W;5I)_^$G\>7,/E3ZW-%L2V0_>BMDYV ]V)W-[#Y: /?OA%\/;7X3_" M_P *>#;-Q+;Z%IEOIXEQCS#'&%9_^!$$_C79444 ?@=_P4T^"%U\'_VI_$=^ MENT>@^+)&UVQF"_*SR'-RF>F5FWG'HZ^M?-7@KQEK7P^\5:5XB\.ZC/I.LZ; M.MS:WENV'BD'?G@CL0>".#7]$G[3'[,_A+]J;XH/1D/##WVLOXU?'+_ ()J_&[X,:C9_&S_@KW\5OB/83:9X0T^P^'=E,"KW-G(;J^P>RS, J?54!]Z^,KSX<>+; M"Z:WN_"^LVMR#@PS:?,KY^A7->G?"O\ 8K^-GQAO(HO#_P /=8CMF/.H:I;& MQM5'KYDNT'_@.30!^ZG[)WQB7X]?L]>!_&ID$E[>V*Q:A_LW<7[J?\Y$8CV8 M5^47_!33]C&^^!_Q"O/B#X7T]Y?A[XBN6FE$*_)I=XYR\3 ?=C=LM&>G.S^% M=WZ1_L&_LMZ]^R?\)[SPUK_B6'7KN^OO[0>WLXBMO92,BHZQNWS/G8"20OTK MZ$\2^&]*\8:#?:+KEA;:KI%]$UOZ#JEKJ.F MWD^G:A:RK-;W5K(8Y(G4Y5E9<$$'N*_0OX%_\%D?&?@_2X-*^(_AN#QO#" @ MU:SG%I>D#O(NTI(?NL_:<_X(ZWZWUWKOP5U".XLW+.?"^KS;)(O]F"X; MAAZ+)C']\U\$>./V8?BQ\-;MX?$OPY\2:6$_Y;-ITLD#?[LJ HWX-0!^H%U_ MP6Q^&"6.^W\"^+9;S'$,OV5(\_[XE)_\=KY._:6_X*I_$KXVZ9=^'_#%M%\/ MO#EPK1S+I\YEOIXSP5:XPNT$=0BC_>(KY'TSX7^,-:N!!IWA/7-0F/2.UTV: M1_R537T1\'_^"9/QW^*]U UQX6?P9I#D;]0\2M]E*@^D',I/_ ,>] 'RI'&T MAPHW'D\>@Y-15^UDW_!-O0?@S^RW\0]$\&V,GC/XH:WHYLQJUSY<,DI9U)A@ M5F"0H<<_-D]VZ5^>7_#LW]I7_HF-S_X-+'_X_0!^D7_!'/\ Y-'N/^QDO/\ MT5!179_\$T?@UXS^!7[.<_AGQUHLFA:VVN75V+22:*8^4Z1!6W1LR\E&[T4 M?6E%%% '/>+/">G^--!NM)U2$2VLZ[?<'LRGL0>E?"GQ-^&>I_#/Q"]C>JSV MC9-M=JORRK_0CN*_0D_=[5SOC+P7I?CS1)M,U:W6XMY.G&&1NS*>Q%?/9ME, M,QIWCI-;/]'Y'V?#7$E7(JUI7E2E\2[>:\_S/SHY'O17I?Q6^!.N?#>X>X5& MO]$)^2[C7[@["0?PG]*\V4E6!4XQT-?DN(P]7"U'2K1LT?TW@#E-=XM2_# M1_@?-BQLW1=V:[?PC\$_&'C)E^Q:1)!;'_EXNOW28]*^UEEUO4EY 9<0QGV4_>_'\J] MQVA0 !@5P&J?'+P-H\3&;Q%:2@=K4F8_^. UYGXL_; TBS1X= TR>_GQQ-=' MRH_K@9)_2OI88C+ M(^./B]XG^(4A&J7SBTSE;. [(Q^ Z_CFN/@@EN)HXH4:5V.%5%R23V %?*9A MQ%4KITL(K)]>K_R/TG(^!*6#:Q.9R4FM>5?"O7O^7J$\\ES,\LKM++(268MD MDGDDDU[Y^SM\"7U^ZMO$^N6^S3(VWVEM(O\ KV[.1_<'_CWTZZ_P9_9C>1H= M8\7Q!47#PZ6W4^\O_P 1^?I7T]!"EK&D<:A(U& !P !73DV12AZ> S+%Y94]KA*CB^O9 M^JV9\ ^+_@?XP\'9-WI$EQ;C_EZLQYJ8]?EY'_ @*X=HRG5=M?IJRANH!^M< MYK?P]\.>(\MJFB6-ZQ_CDMU9O^^L9KX[$\*PD[X>=O)_YGZE@?$:M32CC*/- MYQ=OP=_S/SKW&E\[WK[EO/V:_A_??,VB- __ $SNI1^F\BJ:_LM^ E.?[/N6 M]FN6KR7PSCHO22?S?^1])'Q"RF2O*E-?)?YGQ)5BQTR\U6<06=K-=S'I'%&6 M9OP%?=6F_L_^ M+PT/AV*5A_S\R/-^CL17::3H&G:';B'3[&WLH?[D$2H/R M%=='A6JW^^J)+R5_SL>;BO$BA%6PM!M_WFE^5SX]\$_LN^*O$TB3:F%T*Q/5 MI^96'M&/_9B*^DOAW\%?#?P\C62RM?M-_MPU[< -)_P'LOX5Z'V%%?68+)L+ M@;2A&\N[U?\ P#\VS7BC,LV3A5GRP?V8Z+Y]7\QU+117NGR(4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 / %%%% !1110 4444 ?_9 end GRAPHIC 13 nvst-20221231_g2.jpg GRAPHIC begin 644 nvst-20221231_g2.jpg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end GRAPHIC 14 nvst-20221231_g3.jpg GRAPHIC begin 644 nvst-20221231_g3.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X1#X17AI9@ 34T *@ @ ! $[ ( M / (2H=I 0 ! (6IR= $ > 0TNH< < @, /@ M 71I82P@ M3&ES971T !9 # ( 4 0J) $ ( 4 0O)*1 ( #,C4 M )*2 ( #,C4 .H< < @, (G &UL;G,Z9&,] M(FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT'!A8VME="!E;F0])W7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C) MRM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! 0$! M 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" Q$$ M!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I M*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:' MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7 MV-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#Z1HHHH B>9U1Q_>4K@_F:;]HD_P"?2;\T_P#BJGHH @^T2?\ /I-^:?\ Q5'VB3_GTF_- M/_BJGHH @^T2?\^DWYI_\51]HD_Y])OS3_XJIZ* (/M$G_/I-^:?_%4?:)/^ M?2;\T_\ BJGHH @^T2?\^DWYI_\ %4?:)/\ GTF_-/\ XJIZ* (/M$G_ #Z3 M?FG_ ,51]HD_Y])OS3_XJIZ* (/M$G_/I-^:?_%4?:)/^?2;\T_^*J>B@"#[ M1)_SZ3?FG_Q5'VB3_GTF_-/_ (JIZ* (/M$G_/I-^:?_ !5'VB3_ )])OS3_ M .*J>B@"#[1)_P ^DWYI_P#%4?:)/^?2;\T_^*J>B@"#[1)_SZ3?FG_Q5'VB M3_GTF_-/_BJGHH @^T2?\^DWYI_\51]HD_Y])OS3_P"*J>HI9UB&2:-Q-I;C M?M$G_/I-^:?_ !5'VB3_ )])OS3_ .*JL=5B!^\*3^UHO[PJ^21G[:GW+7VB M3_GTF_-/_BJ/M$G_ #Z3?FG_ ,557^U8O[PH_M:'^\*.278/;4^Y:^T2?\^D MWYI_\51]HD_Y])OS3_XJJO\ :T/]\4HU2,]#FCDD'M8/J6?M$G_/I-^:?_%4 M?:)/^?2;\T_^*J :@&Z*Q_X#2_;O]EOQ&*7*RN=,F^T2?\^DWYI_\51]HD_Y M])OS3_XJHA>CV_,4OVO/3].:5BKDGVB3_GTF_-/_ (JC[1)_SZ3?FG_Q5,-W MCKQ^!J-]1CC<*S#)HLV)R2W)_M$G_/I-^:?_ !5'VB3_ )])OS3_ .*IT4RR MC(.:EI;#33V(/M$G_/I-^:?_ !5'VB3_ )])OS3_ .*J>B@9!]HD_P"?2;\T M_P#BJ/M$G_/I-^:?_%5/10!!]HD_Y])OS3_XJC[1)_SZ3?FG_P 54]% $'VB M3_GTF_-/_BJ/M$G_ #Z3?FG_ ,54]% $'VB3_GTF_-/_ (JC[1)_SZ3?FG_Q M53T4 0?:)/\ GTF_-/\ XJC[1)_SZ3?FG_Q53T4 0?:)/^?2;\T_^*H^T2?\ M^DWYI_\ %5/10!!]HD_Y])OS3_XJC[1)_P ^DWYI_P#%5/10!!]HD_Y])OS3 M_P"*H^T2?\^DWYI_\54]% $'VB3_ )])OS3_ .*H^T2?\^DWYI_\54]% $'V MB3_GTF_-/_BJ/M$G_/I-^:?_ !53T4 0?:)/^?2;\T_^*H^T2?\ /I-^:?\ MQ53T4 0?:)/^?2;\T_\ BJ/M$G_/I-^:?_%5/10!!]HD_P"?2;\T_P#BJ/M$ MG_/I-^:?_%5/10!!]HD_Y])OS3_XJC[1)_SZ3?FG_P 54]% $'VB3_GTF_-/ M_BJ/M$G_ #Z3?FG_ ,54]% $'VB3_GTF_-/_ (JC[1)_SZ3?FG_Q53T4 0?: M)/\ GTF_-/\ XJC[1)_SZ3?FG_Q53T4 0?:)/^?2;\T_^*H^T2?\^DWYI_\ M%5/10!!]HD_Y])OS3_XJC[1)_P ^DWYI_P#%5/10!!]HD_Y])OS3_P"*H^T2 M?\^DWYI_\54]% $'VB3_ )])OS3_ .*H^T2?\^DWYI_\54]% $'VB3_GTF_- M/_BJ/M$G_/I-^:?_ !53T4 0?:)/^?2;\T_^*H^T2?\ /I-^:?\ Q53T4 0? M:)/^?2;\T_\ BJ/M$G_/I-^:?_%5/10!!]HD_P"?2;\T_P#BJ/M$G_/I-^:? M_%5/10!!]HD_Y])OS3_XJC[1)_SZ3?FG_P 54]% $'VB3_GTF_-/_BJ^. M_P"/\ZS_ .TIO[QK3NTU*29F6.)?O'*28!&,=,_K[5F_V-=JBG$?S/-=U#6+VT MO([:#[/"S*J _.X(']X@@<_C4T;1-K5K:[_GCL0=N?XF8L?T%5 &[)&>?\FOF<7-RBYPWNT?;X&G-2]E+;E7WG0R?$/4(-,GO46S MNDAD8%L'(7H. ZGTJ"S\=:OKZ6\,"1VLOE"2X>%0NT'[I!R>N#69X8\&6 MT,%S)=21R&ZC$+I&"1OW;E(S[?I6CIWA^'1[B*[M7#"X15.US9VUL,XTFXO5+OY&\=5U!L8GG8^B9)_2F-J&H,<,M\W_;"4_TK:T9(K:6 M62?< 5"C;GN?;Z5K0W,62-SL@X"A>@_*O M_A7>D@HHHK(Z0HHHH ***HZQK-GH6FM>ZC(RQ!EC540N\KL0J(BCEF9B .I M- %ZBN>LO%R3:J--U71]2T6[EB:6V2^\EAHIUQX@T:TO+>TNM7L(+FZV?9X9+E%>;>2 M$VJ3EMQ4XQUP<=* -&BL_5/$&C:&%.M:M8Z<&4NOVNY2+*@@$C<1P"RC/JP] M:A;Q)8#6['34_FJ1@$8SSZ@&M165IGBKP_K2SM MH^NZ9J"VR[YS:WD%[#PS<:\FM6-[86\BQ/)9W4 M4@WL1A<[L9P&]N'O;:*SLTCDDO'NHO**.@=7R&.U<$ M^M),A)[:59(VP<'#*2#@@B@"U167%XGT"?6F MT>#7--DU125:Q2[C,X(&2/+!W< $GBJ^C>++'6V@%K')&)TN77SGB5@()O)? MY-Y8C=R& *@8R02 0#>XT_Q!I5U#;QO+-)!>QNL2( 69B#@ M @DGID5/INOZ/K,US%H^K6-_):L%N$M;E)3"3D .%)VGY3U]#Z4 :%%95EX MI\/ZC9W=WI^NZ;=VUDI:ZF@O(W2W !)+L#A1@$\XZ&H9O&OA6VM5N;CQ-H\5 MN\K0K+)?Q*C.N-R EL;AD9'49% &W102%4EC@#DD]JP-*\;Z#KNO'2M#OX-2 M86QN6N+.:.:%0&"E"RL?G^8'&.AH WZ*S-.\2Z%K%K/=:3K6G7UO;#,\MK=) M(D7&?F*DA> 3S4*>+-$N='DU/2M2L]4M8ID@>2SO(6579E4 N7"@_.#@G)SP M"2 0#9HK+E\3:#;ZL=+GUO3HM14H#9O=QB8%RH0;"<_,64#CG<,=10/$^@'5 MTTH:YIIU%RRI9B[C\YB"00$SN."K9X['TH U**SV\0:,FN)HKZM8KJKC^!S0!HT5CQ>+?#]T9TL-:T^]FMUD:2"UNHY)!L&6&T'.1D9] M,BH-'\;:#KNE_:],U&WGD6S6\ELTGC:X@1E# .@8[3SCGOWH WZ*R=+\3Z3J MN@C5H;R&*V6VCNK@32HK6J/$)1YO)"'8P8Y/3GIS6C=W=O86-9Y3$[(S)'N)*Y1B#CH#TQ0!OT5GGQ!HPUP:,=6L1JI&X6/VE//( MQNSY>=W3GITYK*TGQ]H6N,RZ5=1W)346TYPES#D. Q#8WY*L$.,98CG;@$@ MZ6BL^W\0:-=ZQ-I-KJUC/J4 +36<=RC31@8R60'<.HZCN*75M>TC08$FUW5; M+38I&V))>7"0JS8S@%B,G% %^BLS4O$NA:,J-K&M:?8!U#J;JZ2+]4KOQOH=GXFBT&6]A-_-9/>QIY\8#HN/E&YA\Q&6';"L<@"@#H**R)/%6AV ML.GMJ.JV-A)J2*]K# ^4DZYJ[E;6SC+L%*AG/95 MW$ L3P!GDFDF\5^'K9;%KC7M,B74 #9E[R-1<@XP8\GY^HZ9ZB@#6HHHH ** M** "BBB@ K(\4^);'PAX;N=:U19I+>WVCR[=0TDC,P55521DDD#&:UZ\N^*] MAXI\2^)?#6A^%;"!X[2?^U[BYU&.461>(XBC=T'))+'9GLI/% '2_P#"QM%; MX8_\)W$EU+I7V?SS&B*9@ VTKC=MW!L@_-C@\UIV?B>QO-0NK7(A^RVL=U)) M+<0X5'&02H+]/^&7Q$\):OHSS7,CB^L3I5O+):R^>RL\ M4!(W':P/R]1D]N:;XXT/5OLOC^%_"-SX?AO/ M %RL6GM:K%+-(TNT-Y2$G+8 '=@ ?XAG7\/^!KS2=4\ RZ)H4NE7,=J /:++Q#HNIWES::;J]A=W-F2+F""Y21X"#@ M[U!RO((YJK%XV\*SVT]S!XFT>2"V19)Y4OXBL2LK:&FEQ+=G[-*^D1Z9/=KC MEY;>,E5(/R@CJ%'U/I5 !1132ZC=\P^49(STH =368A@ /J:B+F3@_+CJ >A MJ2(?*23NR26DR^EH?#R;N% 7>P4=6.!15O2H3<:Q:Q@$YD'3VYJ*DN6#9="'M*L8]VC'GNKA MO'EY+;A/W)$<>[N4 4#CL<'\ZJ:;MF M[T*56;Q!HOX"O MA:DJD'9[,_3*?)N1:=;W"RH%NY0?/CW[&#*I"E7./9<*!VZ]:V@NZXMK4;P@ M**HSG"*/E!_'-4-+TV*%XO.3RY]A^56R,DY;Z]!S6UX9LVEU749'.Y+ MQ(W']"*NA*-2HHV%7Y%3>AM65LRKD9"EN<$C^57LNR_NRN<]<4BQRJP5<*F/ MJ<_3']:@W\7E6,S_[/\^*\YL6WN'_ +[LWYL3_6O0P_O5+]D>'C_OA/X2"BBBL3J/)?!OPG\0^'?C/K/BZ_\1+= M:??&4I$K.99@YRJR C: G08)^Z. .*]:HHH *YKQQ97EQI=A>Z=:R7LNEZC# M?-:1$!YT4D.J[B 6"L6 )&2H&1FNEHH YF'Q3+K.I+9Z1HVHM:>2[75Y?6;PQ96:C3-*2[9'C#> M;!+&UO*\9.]3T53@ACE0*]OHH \BOK+4M-M;;1+*SUBPM%T."UMYXM)CO+^] M.)5^RS7 #P0HN4SN !WDAU -:?PZTB[M=5T6YO=.N+=H/!FGV;23P,ACD5G\ MR+D###"DKUZ5Z510!P/BJ_L],^+?AF[O[&ZNUCTO4/+:UM'N7@8O;#?LC#/T M)7(!^_SQDURT.B:YINGV4L/AMKLKHNMM#IMQ!OB03744D%O( =O^KX\O(SM* MCI7J%_\ V/;^)M)NK[Y=4G6:RL6^<[@R^;(N!\H^6#.6_NX!YP=>@#Q=M,NM M:\1:I-JT'B+6=/NO#5U:221Z.-/PQFC;R+=)%5AA3E1*S9P<,V&%6KN/6]2\ M/^*D6"\U>!H+=H=1N=#:ROIRDS,8638AF")RK+&H^<@ G->O5DVWBC1[PV0M MKS>;^XGM;;]TX\R2$N)5Y'&/+?DX!QQG(H X+5+"\N/%-UK0TR^FTV'6M/U" M1/L&-=O-(:TM],NEEDT/7(=LD9C#M)J$;K$6. # M(@;&2,@YZ1Z_<0^(M6\2?V M'H>H6\LG@BZMDCGTZ2WEE?/R1K&RAFQG (&"20I.#C2\4^&=6O;B:PT"QDA$ MO@Z6RC*IY<>\21[8=Y&U25W@ ],D],UWNC^&=+T*:6:PCN&GF18WGN[N6ZE* M+DJ@>5F8*"20H.,DG&2:UJ /'K[2SJ_A_7[FQ/B^_O5\,7EG'%J6E16B)YD? MRP!%@B:5]R\;-ZCGD;ANU_%EB+!M,GL!K.GW<6E?94>TT;^T;2:(,A:VFA56 M=<@8!!CX)^8XP/2J* .-UK3=7UCX-R6']FP6VJS:7&)=-@8+&'"J7MU.< '! M0&-#U*T\_P ,-9"6[L'LQ.WFJWV<>TD2XTV"R9$9E81QH883)*I4E<;T&&& M?F :*>+7-3T?7HQ;W>JP--J:>-X+PWC6;&%EDO@Z3BH \?MM!NA=7FDZY/XJ-S)K[WR6 M]AI\#6TW^D>=%.+EH,(%7:"&E##8548V@LU*RN(-&BT"XT#4;K5D\71Z@;J& MPDDB,;7HD%QYP79Q"P0C.X8.1M!(]CHH Y3Q_/J%OINGOIMHLA^VCS;S^S6O MY+!?+?$T<*?,S[BJ@C.-Y)!&17!:;I4ZV^LW>HQ^+(7'B,7UCJ<>EHUPNZS6 M-9W@6+#*B@#EO$&G/>>/O"=S]D>:&S>[=I?+++"QBPI)Z G) S7#0> M'M2"XC26& M52DD>*/#%I8Z%>Z=<6GAR_MG2XL6@*D+ /*3(' MF!3W7*_,,$Y-6K+0[VTL/ <=OI=Q$+;PU=6]R%MV'E.T$&$?CY6+J>#R2#WS M7-[J]FN6BB!SY:&5VV+P,JN =JYSM&-N@#R*QT/ M4+6;PCIJVQ02.9?* MB:)5++M!$;IN.%!!#*3NOH]G>V^JZI-)XWOR]Q8%KV3388)4>"7>DD=N84>3 M82-Q,3[A@+N*D#U6B@#R:W&LOIUG=W]C/=06GB6"X-]#HLEKK!9:? ;64_:/.CG%T8/E 7;N#2A_E9 /NJ= M""POO[3MK?\ L^]#V_C26\D8VL@00R13E9 ^-K+R 2"<$@'!.*]0HH \_P# MGE:?I.@^']1T"^;6-,60373Z>RPP2$-YDPG8!&\PL3^[9F/F:6="D:LP#J4YQM_=X)'&>UHH \>T-5\)>(/ M#T7B'2+R6>'P].BQ6EJ]Z]HK7 *Q%8PQP$PFX J,8S@U-I>BZIHZZ1!>Z;=H M9/#6H6D:10-*L#M*DD<+L@*H0@VC) )7 )->H'3+,ZRNJF'_ $U;#B8^&=2BTGQE%?V4MY?2>$K2R6<1,_VF58)PZH+K"_U'X)ZG8P6TTU_-HC(( A\QI/*^[MZ[L]NN:QM5D5=2\3S7>@: MGJ47B+3X8]/":;*WF*(V4P297,&';=^]V#YR<\''IE% &?X?M+JP\,Z99ZC+ MYUY;V<44\F[.^14 8Y[Y(-:%%% !1110 4444 %%%% !575-,LM:TNXTW5;: M.ZL[J,QS0R#(=3_GKU%6J* .9\)?#OPKX&>X?PMI$=C)<@"63S9)68#H-SL2 M![#BNFHHH **** "BBB@ JEYB[0W/#L#GV-7:SX-/E2:1II5=68E00>,]: MWL*2R!CP3P<=Z4WYAA7]RSL1E57J1]*:MA*&$9*&W#YV8ZCW_&K$5A"DPG== M\PSASV^@H KVQN[C_2,B,,,>4XQCGUJZHE/WRH'^SUJ2B@"'[*H+%'D5F&"0 MV?T.156[C6VMB\DLC#.-QP#[= *T*1E5UPX##T(S0!F&Z@EN1!N57502Q[56 MC^TRP,]LLLKMP"QVJ.QQG -;:HB#"JH'L*=0!D6.FW6X2WTJKR/W,8R..^3_ M $K7HHH *YWQ'_J&KHJPM<,B1EHU1B.SKN%;47:1RXI)TVF>=2122S$11LY_ MV5S1+9W$$?F3Q.B^NTL?R )K:.MW4;%9+)&7_ID^W]"/ZTXZTC+_ *B6-O\ M;7('_?.:]">(K+:/ZGA4<#A)OWJE_P /S."U'Q)'8RO%'I]W<.GWL (/P/)/ MY55\->/9IM?4?8HHU"';AB[;O3MSCVKOWE%Z-IGB<'^ 8'Z'FJA\/V#2*TFF M09'1O+ (_$5PU*]6>DF>S0P6&I-2A'7ON4X_B6^F(\+)'$8S@)%P WH!T_&H M5\=:$TLLSZ?&LAD ?RSMWMZ@<#\:DUCP1I.JR;IK>97QPT4I4UAS?"B!CFVO M[NW'8/A_\#7,XJ2U.^[1U5MXVT N?E8'=M#!LC/L:U-'\:Z%81W#12L1//N< MR YW8 P./I7E\_PNUB-]]KJ-O*P.09493_4?I5&7P1XJ@7:(1*H.[]U,,9QZ M(]+F^Y,I^C U\V2Z;XIA M9T?3+D><<';&2#_/_(KI=,\-W]N!/K=Z]M(1@0P$O,XSTST'\ZUU(:BE=GLF MOZG:MH=QY$GS@9Y]N?Z5Y]8*56%3U"@'\JKB+6;MHXD7[+IJ'F%@9)9NO#,> MW0XK3M[&<.C&-L%B <=2.HKU,+!P3E+J?-YG6C5E&%/6QWWA_P#X]U^E;U8> M@H4@7<,<5N5Y];XV>YA?X2"BBBLCJ"BBB@ KC?B59PZAI.C6EVN^";7+))$S MC>IDY4^Q'!]J[*B@#Q&XT#2=/M?%EU8Z?;V\VD^)K*/3GB0+]B1FM&985YB^3Y6?F\CRL[L?)CS-W M.ZO9Z* /*/L\J?$8^ UA;[ ^ICQ'T)3[-]\H>W_'X V/3M6-X3M4FUK2Y=1U M_1[/Q2FI%K^VATF4ZK(=S;XI9!.6,)4\,R>6%V$8PM>X44 <)X^L]*?QAX&O M-9MK-HH]6DC\^[C0JC-:S&-=S="9%0@=V"XY KBO"=JDVM:7+J.OZ/9^*4U( MM?VT.DRG59#N;?%+()RQA*GAF3RPNPC&%KW"B@#P[PK9QW.L:8^IZ[HUKXG7 M42=0M(M(E;5)3N;?%+)YY)@*GAF3RPNPC&%I?#NA>'[H>%](^P6!C3Q+JZ7U MDD: %E%UL25!Z((\*W\(4=,5[A10!QWPT58-#U6R@41VUEK=];V\2\+%&L[; M44=E&< #@#BNQHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BHGF=7(6WDBH/M$G_ #Z3?FG_ ,51]HD_Y])OS3_X MJ@">BH/M$G_/I-^:?_%4?:)/^?2;\T_^*H GHJ#[1)_SZ3?FG_Q5'VB3_GTF M_-/_ (J@">BH/M$G_/I-^:?_ !5'VB3_ )])OS3_ .*H GHJ#[1)_P ^DWYI M_P#%4?:)/^?2;\T_^*H GHJ#[1)_SZ3?FG_Q5'VB3_GTF_-/_BJ )Z*@^T2? M\^DWYI_\51]HD_Y])OS3_P"*H GHJ#[1)_SZ3?FG_P 51]HD_P"?2;\T_P#B MJ )Z*@^T2?\ /I-^:?\ Q5'VB3_GTF_-/_BJ )ZK75JLZX(IWVB3_GTF_-/_ M (JCSY/^?2;\T_\ BJ:=F*45)69DMH$3'.VF_P#"/P_W:V/M$G_/I-^:?_%4 M?:)/^?2;\T_^*K3VT^YS?5:78QSX>@889 1[BA/#T4?^JW)_NDBMC[1)_P ^ MDWYI_P#%4?:)/^?2;\T_^*H=63W*CAZ<=C,72&3H^?\ >4&G_P!EY^\BGZ<5 MH?:)/^?2;\T_^*H^T2?\^DWYI_\ %5#=S91MU,_^R(SU3%(='B_N_I6C]HD_ MY])OS3_XJC[1)_SZ3?FG_P 54E&4^BA^!^['MUJ)/#=M&25C&X]6ZD_C6U]H MD_Y])OS3_P"*H^T2?\^DWYI_\55QFX[&4Z49_$9::'&JX"BGKI"C&<$#H/\ M/UK1\^3_ )])OS3_ .*H\^3_ )])OS3_ .*I^TD0L/370(+<1+@"IZ@^T2?\ M^DWYI_\ %4?:)/\ GTF_-/\ XJH;N;I)*R)Z*@^T2?\ /I-^:?\ Q5'VB3_G MTF_-/_BJ0R>BH/M$G_/I-^:?_%4?:)/^?2;\T_\ BJ )Z*@^T2?\^DWYI_\ M%4?:)/\ GTF_-/\ XJ@">BH/M$G_ #Z3?FG_ ,51]HD_Y])OS3_XJ@">BH/M M$G_/I-^:?_%4?:)/^?2;\T_^*H GHJ#[1)_SZ3?FG_Q5'VB3_GTF_-/_ (J@ M">BH/M$G_/I-^:?_ !5'VB3_ )])OS3_ .*H GHJ#[1)_P ^DWYI_P#%4?:) M/^?2;\T_^*H GHJ#[1)_SZ3?FG_Q5'VB3_GTF_-/_BJ )Z*@^T2?\^DWYI_\ M51]HD_Y])OS3_P"*H GHJ#[1)_SZ3?FG_P 51]HD_P"?2;\T_P#BJ )Z*@^T M2?\ /I-^:?\ Q5'VB3_GTF_-/_BJ )Z*@^T2?\^DWYI_\51]HD_Y])OS3_XJ M@">BH/M$G_/I-^:?_%4?:)/^?2;\T_\ BJ )Z*@^T2?\^DWYI_\ %4?:)/\ MGTF_-/\ XJ@">BH/M$G_ #Z3?FG_ ,51]HD_Y])OS3_XJ@">BH/M$G_/I-^: M?_%4?:)/^?2;\T_^*H GHJ#[1)_SZ3?FG_Q5'VB3_GTF_-/_ (J@">BH/M$G M_/I-^:?_ !5'VB3_ )])OS3_ .*H GHJ#[1)_P ^DWYI_P#%4?:)/^?2;\T_ M^*H GHJ#[1)_SZ3?FG_Q5'VB3_GTF_-/_BJ )Z*@^T2?\^DWYI_\51]HD_Y] M)OS3_P"*H GHJ#[1)_SZ3?FG_P 51]HD_P"?2;\T_P#BJ )Z*@^T2?\ /I-^ M:?\ Q5'VB3_GTF_-/_BJ )Z*@^T2?\^DWYI_\51]HD_Y])OS3_XJ@">BH/M$ MG_/I-^:?_%4?:)/^?2;\T_\ BJ )Z*@^T2?\^DWYI_\ %4?:)/\ GTF_-/\ MXJ@">BH/M$G_ #Z3?FG_ ,53DF=G :WD0?WF*X'Y&@"6BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKR7P;K_P 4+SXSZSI_ MB73&A\,Q&7R7:V"1(H/[HQRXS(6&,C)QD\+C%>M4 %5-2U73]&LFO-8O[:PM M5(#3W4RQ("> "S$#FK=<=\2VN$T+2FLHHYK@:Y8&*.60QHS?:%P"P5BHSW"G M'H: -_2/$>A^(/._L'6=/U/R-OF_8KI)O+W9QNVDXS@XSZ&M*O.O$T7BFTM= M5\87%MIUA?:1H=W%906%P]T9G?:^Z1GBCX3RAM3:QS->FE\-K=6_A[7 MM2OH;SPK?7LSSW\MPT;QHODW*.S'R]Q=QA<*<# &V@#U-[NWCO(K62XB6YF5 MGBA9P'D5<;B%ZD#M0:=K&F:PLS:3J-I?+!(8I3;3K((W'56VDX/L> M:\YC\,6H\=^#O/OM8N);G1;YYII-7NMSO_HN2,2?)G>QPN!G;Q\JXR?A[9+= M:/X/T*XU#4K;3[G2;B_\N#4IX7N9UD1-HD5PX5$8GRT(7+;B#B@#UZ[U33[! MBM]?6UL5A>X(FF5,1)C?)R?NKD9/09&:LJRNH9"&5AD$'((KPJZUK4;C0(M2 M;4)I;FW\*>(EM=15MLDR131+#.&7'S%41MPZDY'6MW5;VXN[+QEJ=[KM_I]W MX>@A?3EAO'CCC_T5)5=XE(6;S)2ZD.&!"[1@YH ]4NKNWLK=I[R>*WA4@&25 MPJ@D@#D\--0OH?ANUZCRV5ZQM"_E,4:,M-&&7/4=2/I7(7LU]: MPZIX@&KZHUU:^+8;.&(WTH@6W:XBC:(Q;MC B1^2"1D8(P* /7*BM;NWO8!/ M9SQ7$19E$D3AE)4E6&1W!!!]""*X31%34[R_UO6O$%]8W=GK\UG'$-0,5NL: M2^7% 82?+;S$*MDJ7)D!##Y<97@"_E@U[1+5[MX[26QUJ0PF0B-Y%U),-CH6 M"EN>H!/O0!ZK4-I>6U_:IK=SBNKUW6S>_!#4M=TJZNT:;P] M+=VUR^(YP3;EU<[,!7Z'Y< 'I0!V-%>4W>IP^$KA)(?$6K7NGW?AJXU"^G%W M]IE5D,7EW$/F%DC+^9( H C)4< +6:EQK6G>)-:TI-4D\."7PW-<1?VKK\E^ M;603*D4\QDW"!B&.0C.ON=M 'M%13W5O:^7]JGBA\V011^8X7>YZ*,]2?2O+ M%EU&&VUKP]]KN]!U;?9RK'J/B![FVEB>)+6WO;6[U/[7Y:R1[MB3@[WC8$-B0[ANZ 8 /5J*\DTO7] M:DNE\/Q7-W=:AX2@O9K[=*Q>\9 4LQ(1R_F(YD(/4H#S5GP0=>:^\.:G/JED M;758'>Y,OB*>\?4"8M^Z*!X52-E;DK&0%4L,' P >I45P'C^#4[G5X?L%Q)= MV\%D[SZ98:X^G7B R*/M*;2!(%7=\LC*N1U)-<_+JVK^,=88Z7<2"SAT2TO; M,W>N3:5(%F5F-RZ01,LO*@$-^[4H0%^8Y /5+C5M.LS/E/I2+J^FOH_\ :R:A:MIWE&;[8)U,.P?+HR[=R-DD#I@CCI7:>/KNXA^&OB MG2ET75(K2VT6Y2/4;FXBE24"(XY,S3,3ZLN3@Y- '=07EM>Q![U-7D]SJ5_<^+KG1I]3O+;3+OQ%:VDLD5R\;1Q_V8 MDRQ(X(,8>50#M()W$9RU0VNIB&PUW2!J>O:P6\5OI^GPVNI[)7V6DI/I1;W=O=B0VL M\4PBD:*0QN&V.IP5..A'<=J\2M8Y]7A:PU>\NI%TWQK%:1+;ZW<7'DJ84+1B M^UKQ19:==:OJ<=I+KNK1RI;WLD3/'& 4CWJP95!QC! M&.G0F@#U>BO)-!O;S6[S0?#^J:IJ"V'VK6(S+'?213W36UQLAC:9&$AQ&SL? MFRWEY.<'/5?"R\EOO XFFU.;5<:A>QQWD\OF-+&MU(J'=T(V@8QQCIQ0!UEK M=6][;+<64\5Q"^=LL3AU;!P<$<=1BI:\=\(J-*T/PEJ&F:U>7%UJ&JR6<]J; MQG@>(F4N@ASL4Q[ VY0&^4Y)W&I=.D9? >D275[XBU35M>O9(TAM]7>'SVC\ MYEC,C.!!&%3YFBVNVT??R00#UVHI+JWAN8;>6>))I]WE1,X#2;1D[1U.!R<5 MX[H&J:I=1_V'?:I<163^+YM-GEM]5EN'BB6S$P@6Z8+)S,-N[AADJ#5OQC_: M6C7VB0>";V36K^UEU%5^UW7VF6V_N5$;NW%XMF M9XA4! +!>N 2!GW%>4-<76M:UI.D>&KRXU+2)-$74+:2[\1W5E+ M=2/*P=S+$CNY0!8K M/$@8!=J-D-S\@!89QE5P >HT5P7C:X^V>(H]+M?[2EN(+$W4P36FTNSMHBS# MSI98OWK']V0 %=1U(7.ZN=\(-?\ C >%(M9UK5?+F\+_ &F<6M]+;M--YJ*) M&:-E)(!/?G/.: /7ZAM+RVU"SBN["XBNK:90\4T+AT=3T(8<$?2O*/"NJ7GB MZWT2/Q%K5]:1+X6AU!9;>[:V\VPFU+]GW M2[#3[J:WN+C1?*@N8)#&\;E"%<,"""#@T >@U##=VUS+/%;W$4LEN_ES(CAC M$VT-M8#H=K*<'L0>]>-6?CC6-8DEU."\N((M>X# M'TMQV'&C?S7]SK]SI7]KZG%;?\)?;V9,5[(C^1_9JNT8<'< S9)P0: M/6J*\=OI/$=U?>)9K#4;:P;0KE;:VN-1\27-NEE&D:,C30>4R3!]Q8O*S%@Q M&1M&/8AG:-W![X- !1110 4444 %%%% !1110 4444 %%%>)?'?3/[9\=^ + M#_A'O^$D\W^T?^)7]M^R>?B*(_ZW(V[<;O?;CO0![;17S;H.H:EX T'XE0:9 M87'A.^M;>UO;/1SH(& %'./E[+5;SQI8:!I>GGX@M)X MCOHY-06&TT&W=Y(0B9C4R.D2(F6.YR&;.!R-I /8**\/TCQWXR\9Z'X#TS3= M;MM#U+7+2ZN+S4S9),TGV=B@5(FPN6QN;&,=L 8.-X_\6Z[H]W\.M=#:?XEU MRR@U="^CL9X)I!"J>9A0#\H.]U&,;6 P.0 ?1-%>%>+?'OBK3])\'Z9X>UO4 MM3N=5LGO[C5],T2*\N)P ,*EO\B*@+<_Q#"\YSFM>:CXW\3Z[\+I[_4+OPY? M74EVMQ:RZ?@)-"K RM&^,F2,X /W=Q*]: /?J*** "BBB@ JGJ6JV>E6YFO9 M0B@9QW(JY7FWQ0AD^SRR(V"P52V[&T ' _,F@"]=_%/3E4_V?:RW6.K;@ #5 MB#QE<7:QW,"Q^2X^X1GZ_C7E_ASPUJC>>8$ADCSAR[XVGTZ]\F98U25F/9 ,'\ZS]1\5W^DR(T^EQE@-P:)XW9N> =PSP: /800 MR@@Y!Y!HKD/!GBU-9MX8)O,\Z4,5W0[0I')7(XXY_*NOH **** "BBB@ HHH MH **** "N%NOBYX=LO%$NB70NDDBE\EI_+!CW9QZYQGOBNZKF-2^'/A;5=5_ MM&]TI&NM^]G5V4.?]H X--6ZBU.G!! (Y!Z&BL,^'7LSNT+4;BP_Z8.?.A/_ M !N5_X"17G'Q ^(/B_POKR6*+:B$0@M(D+;)"<\Y/(/L#25V4TDKIGL=%>> M?#7Q]_;NERQ:U,L5Q$X"/*_#@]LD=1CUSS74VOC#P]>Z@;*VU>U>Y#F/R]^" MS#J!GK^%.S1*:>QM4444AA1110 4444 %%%% !45Q:6]VJ+=P13K'(LJ"5 P M5U.589Z$$9![&I:Y_P 9/KJ:+'_PC27#3&Y3[0;/R?M"P*;JFI>,?[%T M>^WZQ%9W5K)<74NCVEM/Z)IUSI]NP:&TFM(WBC(! M *H1@'#'H.Y]:\TU/Q#-8:Y>^,=.U9M21/",5W"@A2*WG+.P4E6'F*FX[]I< M,,D$X&*O76L>.-&T#7[JXBU<6]OH5UZLNGAX+N-,IY:VS$%#\Q(=3@J.3 MDT >BSZ/IET@2YTZTF46[VH$D"L!"X >/D?<(5'M&OK^UO;W2+ M"XN[/'V:XFMD>2#!R-C$97!YXK@'F\6?V[/I;>,+I5_L%=5\Y+&UWI/N=2B9 MC(\D\':P9_E'S]<]#?\ B*_;X*7/B6!UM]1/AYM01T4%8Y?LYD! ;((#=CF@ M#JKJUM[VW:"\@BN(6()CE0,I(((X/'! /U%0OI.FR0R0R:?:M%).+AT:%2KR MA@PD(QRP*@[NN0#VKCM9USQ*=?.G>'I(I;J7PQ/>6\$RJ%>Z$D:H2>WWB,9" M\\^M8EWXAO!X8UZTOK[4IKZUELW%EK^EVZS0JUP$+!HU\B9&*_*5!*D'+9QM M /1Y/#^C2ZU'K$NDV+ZI&-J7S6R&=1@C DQN'!(Z]S3+KPSH-]:0VM[HFG7% MO!*9HH9K2-TCD))+JI& Q)))'.2:X&ZU_P 1VO\ :&M/KDK6UGXFBTU-.%M# MY3V[SQQMN;9OW@2$@A@.!D'G*7WB#Q)+IS^(;777M8?^$F32QIOV:%HQ;K>K M;-\Q4OYC8+$[L ,0%! 8 '?W?AG0;^PAL;[1-.N;2W?S(;>:TC>.-N?F52, M\GD>II+OPQH%_ID.FWVAZ;*-N>50C /)Y [FLCQW_P RW_V' MK7_V:N?L_$&OMIFB>)IM8=X-8U-;-]*\B(101RR&-#&VWS/,3"L2S,#A_E'& M #MM0\+>']7MK:WU;0M-OH+1=MO%@IWB+1QKWA35=% M6;[,-0LIK02A-WE>8A3=MR,XSG&17G&G?$75+>_TL:Q> VNE0S6_B%S"JDS; MITCDX V_-:,=HP")@<8Q76:N-6D^#U])J=W+;:LVD233RP*H:*3RRS(N5Q@? M=SC..>#S0!LZ7X9T;1[.:WL-*L+=;I0+KR;5(QN>II++PIX>T MR,IIN@Z9:(4="L%G'&"K[=XP!T;:N1WVC/2O//"EGJ<>BG1?#^N'1;?1]&M[ MI6BLK;_29[A7DW3#RP/+78%P@1F^8LY/(MZ/XNUK7M0.JF]FL["W\,V6LMIL M$41$LLHF9D+LA;80@'!!X!!'.0#N+7PKX>LM,N--LM!TRWL;K_CXM8K.-(IN MWS(!ANG<5-:>']&T^RAL[#2+&VM8)?/B@AMD1(Y/[ZJ!@-[CFN*FU7Q)H/P_ MD\7W&N#56ETP7!L)K2)(8II-I0QLFQA&I;!#LQ(P=ZD$G0\)3^+4UYK?6K75 MY-,:T+M=:O\ 8%D2X#* J"U6]I!% M>>]>>^+-=O?#_CKQ!<:7&TEY<6&CV<14(2AENKB/< [*I8!C@,0I;&3C-33Z MOXVTC1=6OKN+5$L=-^SWRSZHEDUQ-&KG[3"5MB5V^6-RMA6R2,D8H [S5_#N MB>(%B&O:/8:F(@I-5\.:'KOD?VWHVGZC]FSY'VRU M27RLXSMW XSM'3T'I7 :GXVUJYN9#H MP1W%O,A26&5 Z2*1@J5/!!'8UP/A?6M>B\6PZ=XNO-2M+VZ64K97-C"UG.1ZS::;I6IZO'=R0-(+'1;""69^<"1YK@& M&.,888;:6/1CC! -+Q'X775]-EM]/_L^T:XG26[2[TV.Z@O JA0LT9*EL!4P M0P(V+S@8JOH?@+2=.\/W.E:G9Z?J45Y<_:KB!K%$MM^U54)"=P556- 22,= M:Y/PUKWB;Q=_PB\$FO2Z;]MT"6]O);6V@+R3)+&@(WHZKG<20!CT X(G\-^( M]?\ &D>C6JZPVDRMH<>H7$]M;1,UQ,TC1XQ(K ("A) )W+AEQR =P?"_A\V M$EB="TTVDIC,EO\ 8X_+?RP%3*XP=H50/0* .E6H]*T^*X6>*PMDF61Y5D6% M0P=_OL#CJW<]^]<7X#U!]$^ MAJ+(L[V.E23E(SPY0,V!]<53T+5_&S+;WMY M;ZI)97-C+-=3WRZ>L-N_E[XVMQ!(9-N[*[9-YP5.1@Y .C\2>#EU>SM[73AI M%O:I/)//97^CQWEM<._)J:5>N9M4T^WM4F>-$(>!% M"S(OS,,2CD$$%OO4 >D67AK0M-U!K_3M%TZTO'3RVN8+1$D9>/E+ 9QP./84 M^Y\/Z->Z2-+O-(L;C3U;<+26V1H@AC39M/&C:>+*X"+-;"U3RY BJJA MEQ@X5% ST"@=A4EIHFE:?#:Q6&F6=K'9[A;)#;J@@W?>V #YZ;;VNI7=O#YENMT2K';&BHQ78Q7*]6&=P&*W_ G83P1Z;\0_&FMW6N3VMS$UE96UP=-CNY85F"'9"J1^86Y*J!N7 MYMSJ^*ETO7O&UZOB+3K,:M+W6OV>@1MX@UA;JT\2Q12QWFG0VUU;[H M6=4E4QE'8 G#H A5_P"(C=74_$:TFNKCPJ(-1N;+&N1#,"QG),*UMH5"10PH$1%'0!1P!]*\QN/$GB6VT?5-034[JZGN/$$NBV-K#!;!;=/M! M0.N\+NE"A@N]]F2NY3SF\FM>)--T?5%\07&JZ5:^;;)8:A>V=K=7LK2,5DB6 M&T+(S<+L;9QO.58+R =S%HVF01PI#IMI&D$[7,2I H$-ZOJ6OZQX?U[3-5O]8M M5L-6T:2W-]#9+=!9;B(%7\E6C(#8=< -D -D94Z^NZYXJM%\57]CXC>--$U: MSL[6VDLX7CD61+;?YORACS,2-K(0<\XP >CW?AW1-0U:#5+_1["ZU"VVB"[ MFM4>6+:2R[7(RN"21@\$UHUY?JWB;Q!X>?6M&BU"[U>Y%[86]G=R0VPN(Q<@ MA@ !'$S#8Q3< -S#=N Q27^M>-]-\/WPF^WV.;_3H;"_U6.R>=O.N%CF1TMV M,94 C!PI^HT5Y!XNEU:?2=?T&[U^^N!IFKZ/)#=M#;K*RS3Q#8VV( M(0KC>"%!R "6&0=J]UCQ!HWC1%U[4-4L=,:^BAM)TL8+BPN(F$:!960>=#*T MDA&YML8(& 1P0#T6BBB@ HHHH **** "BBB@ KF_%WP^\,>._L?_ E>F?;_ M +%O^S_Z1+%LW[=WW&7.=B]<]*Z2O+?CAXFN]$TO1[71YKZ:^EO!<3:7ISRQ MSWEK&,R@2Q#=$!E26&.,]<&@#HM-^%'@K2/#^I:)IVA1PV&J "\03REI@.@+ MEBX [ $#D^IJWX@^'GA3Q4^G-X@T:&^.FX%KYCN-HX^4X(WKP/E;(]N363\( MO$$>M^!X5DUZ#5[Z$[YA'.TKVR2$O%&[N S$(0"S#)*DB7WPI\%:EX9LO#][H4TTN.$^'XY8]-".X$"R MKMDR,X*/!_A6YU:]:]T&;4!KKBX<&Y\AMD6\YR MP)92=VN58$Y/)R3D\G)KR[4/V@[S3OB#-I4 MZZ.-/L=2&G75L4N!>2D-LDFC;!B"!LD*QW$+CN#6]=_%#Q'9_%P^';]-!T?3 M6N_)MH]56ZBGO8@HS+%,%,/)S@'!)^7JN4444 %%%% !7"_$P8TS_5[] M\;8]BN3^?-=U7,^.80^E6\I ^28 Y]".?Y4 "/ M%:RZB#(YR2T<4IP[>@^M %"S$EK9Z48[JZ+30J9F-R[>83USD\BM*6P74,)= MF24#@;I&X_6KCZ':[88'F=!;*JQ[WY4 #'0<].]:XMX%4895)% '4> X;&/3 MEAM; PM;K_KFYWDDYQ77UQ/A'5)Q?)IK7,;Q@,1%MY"\G(/UKMJ ,GQ3J%UI M?A>_O=.B::ZBA)B55W'=TSCOCK^%>8^ OB3KUWXDMM+\03P31W .UGCV2(<@ M8)&!WZ>U>R5G7WA[1]2+&^TRUG9A@LT0W?GUH&K7U-&BN:_X1>^TX[O#>MW% MJ@Z6MV/M,/T&X[E_!JR?%>L^*]+\):FUQID)9;=L7MC#?$!U[PU:W=W-#]J=?WB M*0"#[CM5N+2N9\RO8Z"BLCQ+XEL?"ND-J&I%RFX(D<8RTC'L!6?X3\>Z7XND MDALDFAGC3S#'*!]W.,Y!]>U2,Z>BFR2)%&TDK!$0%F9C@ #J:YW2_B!X9UG4 MEL-.U1);AV*HI1E#D=@2,&@#I*CGMH+J,QW,,""0DM''$ I/KBO.+/X.RV%ZH@ MU.*2U,H=G>+]ZH&>G45U'A#Q_8>+)98(T^RW"_-'#(QW2)W(R!T[XS6]K&KV MNAZ7+?WQ;RH\#"#+,2< >I---IB:3/*?%FB>,!XNFO2^HSVP4)!/8D@CCCY M5/R\]>*W_$7BWQ!X2\%V3W5JAOY&6(W$D@D!."22.#G I]C\8M&NV'F:=J4* M%PHE$0=.3@'(/K3OBMJZ6_AN&&&UL[QYRTB_:@6"A1_" 0=QSQ^-*PVTMSEO M#'Q$NE\:2W/BN3"268*&#<$4;=PRO3)Z?4BO6M%UJSU[3EO=/=FC)P0PPRG& M<$?0BOFN59=7U"!SI*VHG@VJEJ927;&%)R3R"!Q7I'P8TZYTW4-5@NXIHIHQ MYYMS:-*D5VT M@/F-$G4 %9^LZ%I_B"SCMM4A>1(I5FB>*9X9(I%SAT MD0AD."1E2."1T)K0KE_'TM[I^@Q:[ILMP'T:X6\GMX78"YMQD3(RCAOW;,PR M#\R+0!%K/@FTN?"__"-Z?8V[Z;>722Z@U[<222.HD61FRP9I9#M !=AC@Y(4 M*=76?"FDZ]=17.H17"W,430K/:7DUK(8V()0M$ZEER =I)&:PI]6GU'QE?7E MA?1IIOA_3"["6Z,-M/=D#BN?MOB9JRW&K0?:M,U=+; M0+O5+>\M-,N+:!I8&52JM([+/&2P^>-@./<4 =Y_PB6A">WD73XT%O9FP2%& M986MR,>4T0.QUY. P.,G&*IVWP^\-VUG=6HLIYHKJS:P<75]/.4MV&&BC:1R M8E(ZA"N<+_=&.9U#QEJWAZ:RU'Q"MM=L=!O=2:"Q$T2C8;?;%@R,KG+D>85S MZ!06!IZGXQ\3W'AO7;;]XDG]BW-U'J,6@WU@EG)&H)C)F(WLRD['4J5*9*G@ M4 >C'0--:_:]-M_I#6?V$OYC M3+J8@NW8=VPU1K&ZO6TJUN-+E2-XQ)& MAR0>DE=-XKUR?P[X:>]MX8[B\>6"U@1R41I9I5B4MC)"AG!/? />@"E;_#CP MM;I,ITZ2Y$UFU@YO+N:Y)MR5/E9D=B%!4$ ?=.2,9.;$7@;0([:ZA>VN+G[7 MY?GRW=]/<2N(VWHOF2.SA0W(4'&2>.37%^./$?BG3O#'BC2+B_LXM1MM.COK M;4K"VDA#0NYC9-AE9HY%920X%=&GLY[66SW07%ZM_*OFN-TZNKA\YR/F13@<< M=*X_4/AY?:MXH^T7=IIL%H-7BU+[5;7UR&?RV5ES:$>4)2$"-,&R1N.!G%.U MGQEXG\-VNL6=^FE7VJ6MK:W=G+!#)!#(LL_DLCH7=@5(R&#'(8<#!!=XK\5Z M]X:C6VDUS0&U!+1YQ!%I5S#Q6;;>"]!L]9&J6]DRW"RO-&AN)&ABD?[T MB0EO+1SDY95!.YN?F.<"Q\5^(O%+1)X932[&2/1[749_[0BDF622X5F2%=C+ ML4;#ESN^\,+PV< M&H6%Q97B>9;W,312IDC\\4?VQJ,=Y'%K$D5NJPNAB 121 MEI&^7D84 8(8\[L T-0\#>'M36W6[LI,06HLP(;J:+S;<=(I=C#S4Z_*^X? M,W'S'.E!HNGVNI37]O:K'<3V\=K(RD[3%&6*+M^Z /,;H._L*\K\3>)[J'XE MK<'5)[+18;N&!=5>ZFBM('AW/A^)?$$VG>!+OQ M#HJQW @MEO%$D;$20C#OQD')CW8]#C(/2@!++P+X$-&\/7'GZ;!.9A"+=);J\FN7CB!SY:-*[ M%%R 2JX!P,]!7-'XA7LVJZ]9V<%JR12V\&C2G+?:7=Q%(7&1D)(PR!CY>XJ% M?%&O2:RNE:-]AAEO-!ANF^%=(TI;L6T$TKWB>7 M<37EU+=;H PKA@S["#\J[2P8\7].\:ZI/XZ.D:G/INFA[J:*+3;VUG@N)H4)" M2PSL3'.6PK%%4;0QRV5Y .@C\%>'H?"UMX MKAN=P;=GO2VO@[0[..)8K-V:*[6]$TUQ++*\RJ55WD=B[D*<#<2 ,#H!7/\ MQ%75KK7O"&FZ?JC6-I?:F\=RL9F1Y L$C@;XI8V"_*>,]=I.0-I9IOC+79[? M1-=NX]/.AZW=K;16T43BXMED)$4C2%]KY(&Y0BXW\$[>0#H-)\$Z!HE_'=Z; M:2QO"'6WC>[FDBM@Y^811.Y2+/3Y O''3BI]7\*:1KE[%=ZA!,9XXS#O@NY8 M/,C)!,V@=7C$)-?OI-0L/[+31H=2GLFM98Y/M#QQ.T32B4-M!WJ2$, M9RH^\"> #8TKPKHNB26CZ79"W-G;/:6^)'81Q.X=D )(QN4?3&!@<54?P%X= M?3K&Q6REAAT^)H;()Q##;0Q.+BU$@8PNTA/RXH=Q8* MOIEB2?QK,T_P)X=TR826EE(-L;Q0QRW1!>;RL+!5('F;V)P><\@'?#PKHHCTY#8(\ M>F6KV=JDC,RI"ZJC(03A@511\V>GN:HV/P^\.:?*M;\.:WXRGN+M+^-=2M+/3[5;29_)>:*+:=J MNS,JABS(B@NP)&W=@23^/_$5KH.JR+8+<75K/8I:WESI%WIUOTIM3L8= M2TN]TUA>V=I+$LD,\RC;L\XE2&5LG>0R\8&^U(0+!_"4WAVYU:^O$BAN-3DC+0QWDMYL"*0"T\H#RL M26.2!@;5&0H-\5?VU/%J%TITRWL%MH)S &F,J^8+<-(XQC+*I M)?RQ@C(P_4O%^N7?AW4(;A;N%[:_TLPZG%I=UIBSI+>QH\0CFRV0 0V&(99! MTY% '=7OA+1-0>_>[LRTFH20RSR+-(C;XL>6ZLK HRX&"N#Q5)/AWX92.Z46 M$K/>&)IYWO)WF=XF+1R>:7+B12QPX.X# S@ #$TGQC=6NL1)J(MX]*NM6U.Q M:9Y)&:.:%V>+YG=@%:..7Y1@ A=N!Q5!?B/K5VNG6\4265S=Z?\ VHSKH=YJ M&R&65UMXS' &=KV^NTU*TFD>-DE$9C";HV ).0S#( Z<\7_ MXNO/$ M,FE0/#;1W'V*675D3)\B9)/)V+SP#(DW7/$?XT ;$OA;19]&OM)FL5DLK^:2 M>XB9V.Z1WWLX.=2&=D1%1'0\E&) M;=Q@?*<\$)_MAT^Q?3;J[GT^)Y@#/#-%&X9TE42#/1].T>\U66RA,T9F,#1$ABDJA\AN RLH^;*MNXN+XJ\2:6]FVO)I&XEFN;N:>:1X7#Q9E=RY56& M0I.T9/')SSVG>)O%>H1>'[/S='AU'7+.34O-^QRM%9P*L7[LIYP,KEIE&X,@ MP"<= 8]6\:Z_8ZI!H3+;6^J06"75[<6^CWNIPLS.Z(J)#AHPWELV78XX4;N6 M !U=]X3T74O[1-Y9EVU/R3=,LTB,YA.8B"K H5(!!7!R :K_ /""^'_[3^W& MTF,GGK'?Y;.-JG>REL@'.1FN4U7XAZY;VNFW4]M;^&H+FQ M29YM:L+EX/M+.4^SO*I3[, 0#YDBG(D!"\$'TB"43V\#W M'O0!)1110 4444 %%%% !1110 5@:_X1M=^:[:B@#BS\,-,3Q=+KMCK.OZ>+BY^UW. MFV6I-#:7$Q R[HO))P,\@' [5'K'PKTW7?$G]J:GKOB*>V^T)<'2'U)FL2ZX M(_=D$@;AG (&>F!Q7<44 %%%% !1110 51UFQ_M'2Y( NYLAE7.-Q!SC/OTJ M]10!\^GP;<:5XBU%[ZV\R.8[HMR'(!.36O86^F:1&]S?;+8M_JH<@$_[6WK7 MM=026-I+-YTMK"\O]]HP6_.@#SG2].GULY_L=I(&0*MU<$KCW []>O/IBL^3 M2;@ZQ]ABT6YG9>'D4LJ*<],E>>.?2O7:* ,'PWX=31Q)(\4*R%B$9%^8(>S' M)R?I6]110 4444 %,G@BN;=X+B-98I%*NCC(8'J"*?03@4 <=<_"CP;$= :%(_[)M55!M79'M('U'-:ID/9:=NST!IW8G%/ M='F_Q ^&M?: MC);NHB:U12Y*GY<@\9Z5YKX(\'^*(/$437UI MXLK%2-W;TJ&*'8^1P?I26B:+>KN5$L]9 ^?5(6^EL!_6N-^(VB:W-8V>H6K_ M &V:S=L".'YH]PQN"C.[I^'6O1,-_>_2F2H6 !/%1RJ]_P!0>IY/X$TW4Y-< M5D_M:W3R\R2W:$A6 /W0PP.IKL/$OA/4M8T&>VCUB2XFR'BCN%5(RP.1DJ,U MT\<9#9[T]PVP\_E6E];@M#R?1?A]K-O;O::CIUNP4$0R+*OEQ\YW AI M:Y3Q_K&MZ-INER^'DMVFGU6UMI!<3>6&1Y0I7/EOPV<$XR $XA@5>M5Y/AU;75U33FNC< MB.2%9&B10D8CQ(JM*,LS*>3UQ5Z?Q_>6_P#;=PVAJUAI=Z-.C=;S]]=W3-&L M:+&4VA294!8OQSP0,T ;%]X,TG4[BW?4%DN(X--FTPP.PV2PR^7OW8&<_NEP M01C)]L5X/!,8L+FRU/7M:U6VGLGL5BN[A (XF7:W^K1=[8Q\\F]AC@C+9HW? MCR]TB/4X-=T6&WU*Q6WF2&VO3-#/#-*(@ZR&-2&5MV5*=EP3NXFUOQZNC:OJ MVG?V:UQ-906;6X28 W4UU*\4<7(^0;E&6R>&)QQR ,G\*&X\3>&1<17EU#X? MBDD74KEXAYY8!5B*Q[22"J/G8%_=K@DYQT>MZ-:>(-'GTW4 Y@FVG=&Y1T96 M#*ZL.C*RJP/J!7#:[X\UZUTSQ):RZ2FFZGHJ6$JO:72W27"W$Q4A-Z)V0K\P M')/8!CI2>/[G38]8@U[1XX-2TY;0QVME>^>MR;ES'"H=DCP?,4JIP:[HL-OJ5BMO,D M-M>F:&>&:41!UD,:D,K;LJ4[+@G=Q5\<^-=5TZ/7[#0;:%+S2[6SN17WZ[NV.0#5/@"SN+6_35-4U+4KJ^\A9;VY>(2K'"X=(U"1JBKN MW$X7)W')/&)M6\%6^JZK=WJ:IJ5A]OMTMKZ&TDC5;J--VT$LA=.)&&8V0\]> M :N:[KS>'O#)U.^M/-N1Y40M+>3=OGD=8TC5V"\%W W$#CD@=*Y[4OB!?Z'9 MZNFM:"BZII\4%Q':V=Z98[J&601 I*T:$,'W J5'\/.&R "ZG@"VM;>SCTK6 MM6TR2WT^+3I9[5X=]U#$"(Q)NC8!EW-AD"M\QYZ8DO/ &EW:7O\ I-]%-=7- MO=I%Y-0A% MM>&X\F8>?MD&^!=Q)0 J?E 4'G)%:T/Q!N-,ANCXLTI;+[/I']K1FUN?M#RQ M*<,K+L0)("4^4%ERWWN,D TU\$00ZA/-9:SJUG:75S]KN-/MIT2*68D,S;@G MFIN8994=5)SD?,V=+2=!BT?4-4N;:ZN'34K@7+V\FPQQ2;0K%"%#?-@9#,PX MXQS7/3^/KG0FN$\9:*NG2+ITFH6ZV5W]J\Y8RHDBR4CQ("\8QRIW_>X-9LOC MG7='\67!\6Z'YM2>VLK@70D998QPYC1MX!9=OW?F4Y/8 UM5^&>DZ MS'>V5[?:E_8U_<-=76CI*BV\LI.XMNV>:N7 ?:KA=W..3GI;73E@T:/3KJXG MOT6'R7FNB#),,8)ZEH=MJ'_"2:!#9W<&CW&K6L5O?F=+A8 M%S)$SF-=CC8#%A9 M$RIV@.K$XW :\_LF MPECM+>X1HY;BYGEA158QJP)95RQ.T#HHP2W6Z+>ZO=?:(]=TF'3YHG C:VN_ MM$4RD9RK%$8$'((*CM@G- &;'X)@MM0FEL=8U:SLKB[-Y-IMM.B0O*2&8AMG MFJ&8;BJN%))R,,P*_P#"&1/JT-U=ZUJUW;6]V;R#3[B9'ABEYP0VSS2 6)"E MRHXP, E0NY1@.?)&%7@[OF)W-Q\HW M&L_%ZUT.\O8+U-&1])5!J,,FMK'.7V*[K;1-&#/M5A@MY>YLJ.0: .UU/0K; M5M2TF^N'F672;EKF 1D!69HGC(;(.1ASTQSBLFR\ Z?97]K(+[4)K&QG:XLM M+ED0V]K*V?F7"!SC*2ZU=8+B]& M%+_9X=C;]H8<,R$G/&,$UKWQQKVB:IXOGO=.AOK'2[BSBL[>"ZVR$S&-0.8P M.=^[EC@_+T^8 ':Z%HUOX?T>+3;-Y7AB>1PTI!;+NSGH .K'MTK-B\'0VVK- M=6>KZI:V&;1 M?^$?5)]1>'52ZF!T#!H J?-(5AU9,ME1DB@#;T[P#I^G7UE(M]?W%CITCS6&F3R(;>T MD;(W+A [8#.%#LP4-P!A<2P>"--@LM#M4GNRFB73W5N2ZY=V612'(7D8E;I@ M\#GUQM5^(UY87.NS6NAPW&DZ"8'N[Q[_ ,MGCDC20M%'Y9W,JL20S*/NX/)" MU[SQUK&A:QXMEU6UM)=-TVXM(;3_ $O8(C,$ :1O*^2/Y][N2VW! #4 ;EMX M%@CNXIK[6M7U-;:*6*TCO9HW^S"0;6(8('<[?E!D9SCWYJO/\.K6?2H])&NZ MU'I7V*&QN+!9XVBN8HUV8.Z,LA9>&\HIGKP>:V?#6L76N:5]KN[2U@!?$4ME M?+=V]PF 1)'( I(Y(Y53D'J,$Z] ',ZAX$TW4;G599KF\1=3,,KQQ.JB">$* M(YXFV[E==B8^8KQ]WDY63P7'=Z;<6NK:WJ^I-/<6\YFN)8P4\B594541%C4; MDY(3<02"W"XZ6B@#F]4\$:=JLVL2S7%W%)JZVHE:)D_=&W8O&R94C.XY.[<# M@<=:T=7T&WUS0_[-U"69L%'2Z0JLTOPWT M]UU9M1U35=1NM5-N\EY/+&LL,D!)ADB\M%5&4D$8&/E&01*LJ*J(BQJ-RK?#K1]9\+7^@W M%.67H3M8C/>KNI>$K>\U"VO]-U"]T6]M[?[ M*)]/\K+PYR(V65'0@'D?+D9.",G._10!C6'AFTT_5;;4([F\FGM[$V0:YG,I M="X1'>%%4 *2C,O+^9)@$ MX\WUS7444 86M>%H]6U"/4+75-0TB_2!K9KFP:/=)$3G8PD1UX/(.-PYP1DY M33_!NE:5J6EW>GK+!_9=C)8V\(?*>7(R,Q;(+%LQCG/.3G)-;U% &1?^&;#4 M]=BU2]\R1X[&>P,)(\MXIBA?<,9S^[ Z]":S++P!96S W6J:GJ(AM'LK-;R6 M-OL43C#!"J LQ 4;Y-[87KR<]510!SUQX.M7L=(BL[^^L+K1X/L]I?6YC,RQ ME55E(=&1@P12.WM_$6O6T/\ WY/_ ,50!/14&RZ_Y[0_]^3_ M /%4;+K_ )[0_P#?D_\ Q5 $]%0;+K_GM#_WY/\ \51LNO\ GM#_ -^3_P#% M4 3T5!LNO^>T/_?D_P#Q5&RZ_P">T/\ WY/_ ,50!/14&RZ_Y[0_]^3_ /%4 M;+K_ )[0_P#?D_\ Q5 $]%0;+K_GM#_WY/\ \51LNO\ GM#_ -^3_P#%4 3T M5!LNO^>T/_?D_P#Q5&RZ_P">T/\ WY/_ ,50!/14&RZ_Y[0_]^3_ /%4;+K_ M )[0_P#?D_\ Q5 $]%0;+K_GM#_WY/\ \51LNO\ GM#_ -^3_P#%4 3T5!LN MO^>T/_?D_P#Q5&RZ_P">T/\ WY/_ ,50!/14&RZ_Y[0_]^3_ /%4;+K_ )[0 M_P#?D_\ Q5 $]%0;+K_GM#_WY/\ \51LNO\ GM#_ -^3_P#%4 3X'I14&RZ_ MY[0_]^3_ /%4;+K_ )[0_P#?D_\ Q5 $]%0;+K_GM#_WY/\ \51LNO\ GM#_ M -^3_P#%4 3T5!LNO^>T/_?D_P#Q5&RZ_P">T/\ WY/_ ,50!/14&RZ_Y[0_ M]^3_ /%4;+K_ )[0_P#?D_\ Q5 $]%0;+K_GM#_WY/\ \51LNO\ GM#_ -^3 M_P#%4 3XHJ#9=?\ /:'_ +\G_P"*HV77_/:'_OR?_BJ )\45!LNO^>T/_?D_ M_%4;+K_GM#_WY/\ \50!/14&RZ_Y[0_]^3_\51LNO^>T/_?D_P#Q5 $]%0;+ MK_GM#_WY/_Q5&RZ_Y[0_]^3_ /%4 3UC>*="E\0:3#;VEVEG032PF9 M \4BN R!E+ XQPPZ]:TMEU_SVA_[\G_XJC9=?\]H?^_)_P#BJ .7O? AO-#U M;3FU+:=2U>+4S((,^7LEADV8W!X[G1M:L9+]U;4M2&I0S MQQ@-;2J8VCP"2&VO$I[9'%='LNO^>T/_ 'Y/_P 51LNO^>T/_?D__%4 > M KK6;75Y==UI)M4U"WBMH;FTM/)BM4B?S$VQ,[ECYAW,2WS# &W%9FO>#KZ. MWUK7-8U&?4;^YBLO*&D:9AK62VF:2.5(FD8R %@S)N+$*V.H4>@;+K_GM#_W MY/\ \51LNO\ GM#_ -^3_P#%4 >:Z1X;U;Q7>>*;O5;V58M373XH+F32I+,9 MMY'D8);RMY@7Y@,L3EBQ'& .DUGP''K.K:Q?2:@\+:A;6<T/_?D__%4;+K_GM#_WY/\ \50!R5YX"NM9M=7E MUW6DFU34+>*VAN;2T\F*U2)_,3;$SN6/F'@ MEO-8L[>V#0:>8XH#!([J0AE8L#O&06SP<$9 7L]EU_SVA_[\G_XJC9=?\]H? M^_)_^*H SM=T%O$/ADZ9?7?E7)\J47=O'MV3QNLB2*C%N Z [23QP2>M85WX M#O-7BU*?7-9BGU*^2W@6:VLS%#!##*)0BQ&1B2S;LL7/5< 8/7;+K_GM#_W MY/\ \51LNO\ GM#_ -^3_P#%4 JZ))I$Z/;&0J#YF MV13O7&#*<@@YP.5ZTNK^ [;7+YY+^[D^S2Z)+I$D4:;6P[(WF*^3@C9P,'GZ M8KI-EU_SVA_[\G_XJC9=?\]H?^_)_P#BJ .2G\ W&N^>WC/61J4C:?)I\#65 MK]D$*2%2\F"[YE)1#GA1M&%ZU#)\/M0UF_N[CQ=X@CU!+G2)=*,5E8_9=JNR M,903(_SY7Z=, 8.>SV77_/:'_OR?_BJ-EU_SVA_[\G_XJ@#C[WP%J.N6FH?\ M))KT5Y>3Z1<:3:S6]AY*0+.H$DK(9&WN2J9P5&%P ,DU=U7P0FK7TTTM^T:3 M:#/HS(L7.)2I,@.>VW[N._6NCV77_/:'_OR?_BJ-EU_SVA_[\G_XJ@#CY_AY M+?,\^H:NIN_L%E;12V]J8Q%-:SO-',%9VR-SJ"A/\)YYXZ31[/6+;SY-=U:& M_ED8>6EM9_9X85 [*7=B23R2Y' P!SFYLNO^>T/_ 'Y/_P 51LNO^>T/_?D_ M_%4 '21UB\0Q[;J>33%ENUQ$J!%FW@ M"+**2FSN^&4D$:6J>!KC4KS6'_M6.*#59+.>2/[(2R2V[QMD-OQM98\8QD$Y MR>E=5LNO^>T/_?D__%4;+K_GM#_WY/\ \50!S&M>!/[7A\6I_:/D_P#"26D= MMGR-WV?9&R;OO#?G=G''2I)O"NK6NL:E<^'=?CTVVU659[J&6Q$[QRA0C/"Y M<*A957ATD7*YQR0>CV77_/:'_OR?_BJ-EU_SVA_[\G_XJ@#E]8\!G5M*\6V9 MU,QGQ(B*9#!N-OMA2+. PW9V9_AZXJQ/X8U2/6M8U'1M=CL6U+R) K60E*21 M +R2P#1LHP5 5NT/_?D_P#Q5&RZ_P">T/\ WY/_ ,50 M!/14&RZ_Y[0_]^3_ /%4;+K_ )[0_P#?D_\ Q5 $]%0;+K_GM#_WY/\ \51L MNO\ GM#_ -^3_P#%4 3T5!LNO^>T/_?D_P#Q5&RZ_P">T/\ WY/_ ,50!/14 M&RZ_Y[0_]^3_ /%4;+K_ )[0_P#?D_\ Q5 $]%0;+K_GM#_WY/\ \51LNO\ MGM#_ -^3_P#%4 3T5!LNO^>T/_?D_P#Q5&RZ_P">T/\ WY/_ ,50!/14&RZ_ MY[0_]^3_ /%4;+K_ )[0_P#?D_\ Q5 $]%0;+K_GM#_WY/\ \51LNO\ GM#_ M -^3_P#%4 3T5!LNO^>T/_?D_P#Q5&RZ_P">T/\ WY/_ ,50!/14&RZ_Y[0_ M]^3_ /%4Y%N X\R6-E[A8R#^>XT 2T444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D! end GRAPHIC 15 nvst-20221231_g4.jpg GRAPHIC begin 644 nvst-20221231_g4.jpg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�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end GRAPHIC 16 nvst-20221231_g5.jpg GRAPHIC begin 644 nvst-20221231_g5.jpg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nvst-20221231_g6.gif GRAPHIC begin 644 nvst-20221231_g6.gif M1TE&.#EA? -X ?< ,P 9@ F0 S _P K K,P K9@ KF0 K MS K_P!5 !5,P!59@!5F0!5S !5_P" " ,P" 9@" F0" S " _P"J "J M,P"J9@"JF0"JS "J_P#5 #5,P#59@#5F0#5S #5_P#_ #_,P#_9@#_F0#_ MS #__S, #, ,S, 9C, F3, S#, _S,K #,K,S,K9C,KF3,KS#,K_S-5 #-5 M,S-59C-5F3-5S#-5_S. #. ,S. 9C. F3. S#. _S.J #.J,S.J9C.JF3.J MS#.J_S/5 #/5,S/59C/5F3/5S#/5_S/_ #/_,S/_9C/_F3/_S#/__V8 &8 M,V8 9F8 F68 S&8 _V8K &8K,V8K9F8KF68KS&8K_V95 &95,V959F95F695 MS&95_V: &: ,V: 9F: F6: S&: _V:J &:J,V:J9F:JF6:JS&:J_V;5 &;5 M,V;59F;5F6;5S&;5_V;_ &;_,V;_9F;_F6;_S&;__YD )D ,YD 9ID F9D MS)D _YDK )DK,YDK9IDKF9DKS)DK_YE5 )E5,YE59IE5F9E5S)E5_YF )F M,YF 9IF F9F S)F _YFJ )FJ,YFJ9IFJF9FJS)FJ_YG5 )G5,YG59IG5F9G5 MS)G5_YG_ )G_,YG_9IG_F9G_S)G__\P ,P ,\P 9LP F

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end XML 18 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover Page - USD ($)
$ in Billions
 12 Months Ended
Dec. 31, 2022
Feb. 10, 2023
Jul. 01, 2022
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2022    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-39054    
Entity Registrant Name ENVISTA HOLDINGS CORPORATION    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 83-2206728    
Entity Address, Address Line One 200 S. Kraemer Blvd., Building E    
Entity Address, City or Town Brea    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 92821-6208    
City Area Code 714    
Local Phone Number 817-7000    
Title of 12(b) Security Common stock, $0.01 par value    
Trading Symbol NVST    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Common Stock, Shares Outstanding   163,231,502  
Entity Public Float     $ 4.7
Documents Incorporated by Reference
Part III incorporates certain information by reference from the Registrant’s proxy statement for its 2023 annual meeting of stockholders to be filed pursuant to Regulation 14A within 120 days after Registrant’s fiscal year-end. With the exception of the sections of the 2023 Proxy Statement specifically incorporated herein by reference, the 2023 Proxy Statement is not deemed to be filed as part of this Form 10-K.
In this Annual Report, the terms “Envista” or the “Company” refer to Envista Holdings Corporation, Envista Holdings Corporation and its consolidated subsidiaries or the consolidated subsidiaries of Envista Holdings Corporation, as the context requires.
***
We own or have rights to trademarks, service marks or trade names that we use in connection with the operation of our business. In addition, our names, logos and website names and addresses are owned by us or licensed by us. We also own or have the rights to copyrights that protect the content of our solutions. Solely for convenience, the trademarks, service marks, trade names and copyrights referred to in this report are listed without the ©, ® and ™ symbols, but we will assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensors to these trademarks, service marks, trade names and copyrights.
This report may include trademarks, service marks or trade names of other companies. Our use or display of other parties’ trademarks, service marks, trade names or products is not intended to, and does not imply a relationship with, or endorsement or sponsorship of us by, the trademark, service mark or trade name owners.
***
Unless otherwise indicated, information contained in this report concerning our industry and the markets in which we operate is based on information from independent industry and research organizations, other third-party sources (including industry publications, surveys and forecasts), and management estimates. Management estimates are derived from publicly available information released by independent industry analysts and third-party sources, as well as data from our internal research, and are based on assumptions made by us upon reviewing such data and our knowledge of such industry and markets that we believe to be reasonable. Although we believe the data from these third-party sources is reliable, we have not independently verified any third-party information.
***
Unless otherwise indicated, all financial data in this Annual Report refer to continuing operations only.
    
Amendment Flag false    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Entity Central Index Key 0001757073    

XML 19 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Audit Information
 12 Months Ended
Dec. 31, 2022
Audit Information [Abstract]  
Auditor Firm ID 42
Auditor Name Ernst & Young LLP
Auditor Location Irvine, California
XML 20 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 606.9 $ 1,073.6
Trade accounts receivable, less allowance for credit losses of $16.2 and $20.7, respectively 393.5 331.9
Inventories, net 300.8 263.8
Prepaid expenses and other current assets 123.4 154.3
Assets held for sale 0.0 12.2
Total current assets 1,424.6 1,835.8
Property, plant and equipment, net 293.6 264.1
Operating lease right-of-use assets 131.8 128.1
Other long-term assets 153.7 167.8
Goodwill 3,496.6 3,132.0
Other intangible assets, net 1,086.7 1,046.4
Total assets 6,587.0 6,574.2
Current liabilities:    
Short-term debt 510.0 432.4
Trade accounts payable 228.3 185.8
Accrued expenses and other liabilities 471.4 562.3
Operating lease liabilities 27.0 23.7
Liabilities held for sale 0.0 4.0
Total current liabilities 1,236.7 1,208.2
Operating lease liabilities 121.4 120.4
Other long-term liabilities 151.3 304.2
Long-term debt 870.7 883.4
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.01 par value, 15.0 million shares authorized; no shares issued or outstanding at December 31, 2022 and December 31, 2021 0.0 0.0
Common stock - $0.01 par value, 500.0 million shares authorized; 163.7 million shares issued and 163.2 million shares outstanding at December 31, 2022; 162.0 million shares issued and 161.6 million shares outstanding at December 31, 2021 1.6 1.6
Additional paid-in capital 3,699.0 3,732.6
Retained earnings 731.4 466.9
Accumulated other comprehensive loss (225.1) (143.5)
Total Envista stockholders’ equity 4,206.9 4,057.6
Noncontrolling interests 0.0 0.4
Total stockholders’ equity 4,206.9 4,058.0
Total liabilities and stockholders’ equity $ 6,587.0 $ 6,574.2
XML 21 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Allowance for credit losses $ 16.2 $ 20.7
Preferred stock, par value (in USD per share) $ 0.01 $ 0.01
Preferred shares authorized (in shares) 15,000,000 15,000,000
Preferred shares issued (in shares) 0 0
Preferred shares outstanding (in shares) 0 0
Common stock, par value (in USD per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 500,000,000.0 500,000,000
Common stock, shares issued (in shares) 163,700,000 162,000,000
Common stock, shares outstanding (in shares) 163,200,000 161,600,000
XML 22 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Sales $ 2,569.1 $ 2,508.9 $ 1,929.1
Cost of sales 1,094.3 1,082.4 874.3
Gross profit 1,474.8 1,426.5 1,054.8
Operating expenses:      
Selling, general and administrative 1,055.5 1,019.8 924.6
Research and development 100.1 100.5 86.7
Operating profit 319.2 306.2 43.5
Nonoperating income (expense):      
Other income (expense) 3.1 2.4 (1.0)
Interest expense, net (38.4) (54.1) (62.5)
Income (loss) before income taxes 283.9 254.5 (20.0)
Income tax expense (benefit) 45.9 (9.0) (62.5)
Income from continuing operations, net of tax 238.0 263.5 42.5
Income (loss) from discontinued operations, net of tax (Note 4) 5.1 77.0 (9.2)
Net income $ 243.1 $ 340.5 $ 33.3
Earnings per share:      
Earnings from continuing operations - basic (in USD per share) $ 1.46 $ 1.63 $ 0.27
Earnings from continuing operations - diluted (in USD per share) 1.34 1.48 0.26
Earnings (loss) from discontinued operations - basic (in USD per share) 0.03 0.48 (0.06)
Earnings (loss) from discontinued operations - diluted (in USD per share) 0.03 0.43 (0.06)
Earnings - basic (in USD per share) 1.49 2.11 0.21
Earnings - diluted (in USD per share) [1] $ 1.37 $ 1.92 $ 0.20
Average common stock and common equivalent shares outstanding:      
Basic (in shares) 162.9 161.2 159.6
Diluted (in shares) 177.6 177.6 164.1
[1] * Earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. The sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding.
XML 23 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of Comprehensive Income [Abstract]      
Net income $ 243.1 $ 340.5 $ 33.3
Other comprehensive (loss) income, net of income taxes:      
Foreign currency translation adjustments (100.9) (77.1) 53.9
Cash flow hedge adjustments 1.7 4.6 (6.4)
Pension plan adjustments 17.6 20.8 4.9
Total other comprehensive (loss) income, net of income taxes (81.6) (51.7) 52.4
Comprehensive income $ 161.5 $ 288.8 $ 85.7
XML 24 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Millions
Total
Total Envista Equity
Total Envista Equity
Adjustment
Total Envista Equity
Adjusted balance
Common Stock
Common Stock
Adjusted balance
Additional Paid-in Capital
Additional Paid-in Capital
Adjustment
Additional Paid-in Capital
Adjusted balance
Retained Earnings
Retained Earnings
Adjustment
Retained Earnings
Adjusted balance
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Adjusted balance
Noncontrolling Interests
Noncontrolling Interests
Adjusted balance
Balance, beginning of period at Dec. 31, 2019   $ 3,540.2     $ 1.6   $ 3,589.7     $ 93.1     $ (144.2)   $ 2.6  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common stock-based award activity   32.2         32.2                  
Equity component of convertible senior notes, net of financing costs and taxes   77.9         77.9                  
Purchase of capped calls related to issuance of convertible senior notes, net of taxes   (15.7)         (15.7)                  
Separation related adjustments   0.3         0.3                  
Net income $ 33.3 33.3               33.3            
Other comprehensive income (loss) 52.4 52.4                     52.4      
Change in noncontrolling interest                             (2.2)  
Balance, end of period at Dec. 31, 2020   3,720.6     1.6   3,684.4     126.4     (91.8)   0.4  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common stock-based award activity   41.4         41.4                  
Separation related adjustments   6.8         6.8                  
Net income 340.5 340.5               340.5            
Other comprehensive income (loss) $ (51.7) (51.7)                     (51.7)      
Accounting Standards Update [Extensible List] Accounting Standards Update 2020-06 [Member]                              
Balance, end of period at Dec. 31, 2021 $ 4,058.0 4,057.6 $ (56.4) $ 4,001.2 1.6 $ 1.6 3,732.6 $ (77.8) $ 3,654.8 466.9 $ 21.4 $ 488.3 (143.5) $ (143.5) 0.4 $ 0.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common stock-based award activity   44.2         44.2                  
Net income 243.1 243.1               243.1            
Other comprehensive income (loss) (81.6) (81.6)                     (81.6)      
Change in noncontrolling interest                             (0.4)  
Balance, end of period at Dec. 31, 2022 $ 4,206.9 $ 4,206.9     $ 1.6   $ 3,699.0     $ 731.4     $ (225.1)   $ 0.0  
XML 25 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net income $ 243.1 $ 340.5 $ 33.3
Noncash items:      
Depreciation 31.8 40.8 42.4
Amortization 106.0 82.8 90.2
Allowance for credit losses 4.8 5.6 23.0
Stock-based compensation expense 30.5 28.2 22.6
Gain on sale of property, plant and equipment (1.9) (2.2) 0.0
Gain on sale of KaVo treatment unit and instrument business (8.9) (11.7) 0.0
Restructuring charges 4.7 10.8 11.1
Impairment charges 6.4 18.4 32.6
Fair value adjustment of acquisition-related inventory 9.5 0.0 0.0
Amortization of right-of-use assets 24.3 28.3 30.5
Amortization of debt discount and issuance costs 4.1 23.3 13.4
Change in deferred income taxes (29.0) (59.0) (91.4)
Change in trade accounts receivable (71.0) (43.2) 71.9
Change in inventories (39.9) (66.0) 11.9
Change in trade accounts payable 44.5 (20.3) 21.6
Change in prepaid expenses and other assets (11.7) (11.5) (2.5)
Change in accrued expenses and other liabilities (133.0) 34.3 10.0
Change in operating lease liabilities (31.6) (37.5) (36.7)
Net cash provided by operating activities 182.7 361.6 283.9
Cash flows from investing activities:      
Acquisitions, net of cash acquired (696.2) (2.1) (40.7)
Payments for additions to property, plant and equipment (75.7) (54.7) (47.7)
Proceeds from sales of property, plant and equipment 3.3 11.6 5.3
Proceeds from sale of KaVo treatment unit and instrument business, net 73.9 312.5 0.0
Proceeds from the settlement of derivative financial instruments 56.0 11.4 14.0
All other investing activities, net (18.6) (16.0) 0.0
Net cash (used in) provided by investing activities (657.3) 262.7 (69.1)
Cash flows from financing activities:      
Proceeds from revolving line of credit 124.0 0.0 249.8
Repayment of revolving line of credit (124.0) 0.0 (250.0)
Proceeds from borrowing 0.3 0.0 0.0
Repayment of borrowing (0.5) (475.7) 0.0
Proceeds from issuance of convertible senior notes 0.0 0.0 517.5
Payment of debt issuance and other deferred financing costs 0.0 (2.3) (17.2)
Purchase of capped calls related to issuance of convertible senior notes 0.0 0.0 (20.7)
Proceeds from stock option exercises 21.8 19.5 13.8
Tax withholding payment related to net settlement of equity awards (9.1) (7.2) (5.0)
All other financing activities 0.0 0.1 4.3
Net cash provided by (used in) financing activities 12.5 (465.6) 492.5
Effect of exchange rate changes on cash and cash equivalents (4.6) 26.0 (29.6)
Net change in cash and cash equivalents (466.7) 184.7 677.7
Beginning balance of cash and cash equivalents 1,073.6 888.9 211.2
Ending balance of cash and cash equivalents 606.9 1,073.6 888.9
Supplemental data:      
Cash paid for interest 38.4 35.7 56.7
Cash paid for taxes 119.2 84.0 28.6
ROU assets obtained in exchange for operating lease obligations $ 36.0 $ 24.7 $ 28.1
XML 26 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Business And Basis Of Presentation
 12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Business and Basis of Presentation BUSINESS AND BASIS OF PRESENTATION
Business Overview

The Company provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. The Company is a worldwide provider of a broad range of dental implants, orthodontic appliances, general dental consumables, equipment and services and is dedicated to driving technological innovations that help dental professionals improve clinical outcomes and enhance productivity.

The Company was formed in 2018, as a wholly-owned subsidiary of Danaher Corporation (“Danaher”), to serve as the ultimate parent company of the dental platform of Danaher. On September 20, 2019, the Company completed its initial public offering and on December 18, 2019, Danaher completed the disposition of its ownership interest in the Company referred to herein as the “Separation”.

The Company operates in two business segments: Specialty Products & Technologies and Equipment & Consumables.
The Company’s Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Company’s Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.

Basis of Presentation
The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP").

As discussed in Note 4, Discontinued Operations, on December 31, 2021, the Company sold its KaVo dental treatment unit and instrument business (the "KaVo Treatment Unit and Instrument Business"), which was part of the Company’s Equipment and Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.

Risks and Uncertainties

The Company is subject to risks and uncertainties as a result of the novel coronavirus (“COVID-19”) pandemic.

The extent of the impact of the COVID-19 pandemic on the Company remains uncertain and difficult to predict because of the dynamic and evolving nature of the situation. The global impact of the outbreak continues to adversely affect many industries, and different geographies continue to reflect the effects of public health restrictions in various ways. The economic recovery following the impact of the COVID-19 pandemic is only partially underway and has been gradual, uneven and characterized by meaningful dispersion across sectors and regions with uncertainty regarding its ultimate length and trajectory. During the year ended December 31, 2022, notwithstanding improvement in many markets in which the Company operates due to a return to more normalized business operations, certain markets continued to be adversely impacted by COVID-19. In particular, sales decreased in China due to lockdowns early in the year and a subsequent relaxing of restrictions, which resulted in increased infection rates.

In addition, Russia’s invasion of Ukraine and the global response to this invasion, including sanctions imposed by the U.S. and other countries, could have an adverse impact on the Company’s business, including impacting the Company’s ability to market and sell products in the affected regions, potentially heightening our risk of cyber security attacks, impacting its ability to enforce its intellectual property rights in Russia, creating disruptions in the global supply chain, and by potentially having an adverse impact on the global economy, financial markets, energy markets, currency rates and otherwise.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Accounting Principles
The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The Consolidated Financial Statements include the accounts of the Company and its subsidiaries. The Consolidated Financial Statements also reflect the impact of noncontrolling interests. Noncontrolling interests do not have a significant impact on the Company’s consolidated results of operations, therefore income attributable to noncontrolling interests are not presented separately in the Company’s Consolidated Statements of Operations. Income attributable to noncontrolling interests have been reflected in selling, general and administrative expenses and were insignificant in all periods presented. Reclassifications of certain prior year amounts have been made to conform to the current year presentation.
Use of Estimates
The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The Company bases these estimates on historical experience, the current economic environment and on various other assumptions that are believed to be reasonable under the circumstances. However, uncertainties associated with these estimates exist and actual results may differ materially from these estimates.
Acquisitions
The Company continually evaluates potential acquisitions that either strategically fit with the Company’s existing portfolio or expand the Company’s portfolio into new and attractive business areas. Among other things, goodwill arises because the purchase prices for these businesses reflect a number of factors including the future earnings and cash flow potential of these businesses, the multiple to earnings, cash flow and other factors at which similar businesses have been purchased by other acquirers, the competitive nature of the processes by which the Company acquired the businesses, avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance the Company’s existing product offerings to key target markets and enter into new and profitable businesses and the complementary strategic fit and resulting synergies these businesses bring to existing operations.
We account for acquisitions under Accounting Standards Codification (“ASC“) 805 Business Combinations and use the acquisition method of accounting. The consideration transferred for the acquisition of a subsidiary comprises (i) fair values of the assets transferred; (ii) liabilities assumed of the acquired business; and (iii) fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired, and liabilities and contingent liabilities assumed in a business combination are, with limited exceptions, measured initially at their fair values at the acquisition date.
The Company makes an initial allocation of the purchase price at the date of acquisition based upon its estimation of the fair value of the acquired assets and assumed liabilities. The Company obtains the information used to estimate the fair values during due diligence and through other sources. In the months after closing, up to 12 months, as the Company obtains additional information that existed at the acquisition date about these assets and liabilities, it is able to refine the estimates of fair value and more accurately allocate the purchase price. Only items that existed as of the acquisition date are considered for subsequent adjustment. The Company makes the appropriate adjustments to the purchase price allocation prior to completion of the measurement period, as required.
Cash and Cash Equivalents
The Company considers all highly liquid investments with a maturity of three months or less at the date of purchase to be cash equivalents.
Accounts Receivable and Allowances for Credit Losses
All trade accounts receivable are reported on the accompanying Consolidated Balance Sheets adjusted for any write-offs and net of allowances for credit losses. The allowances for credit losses represent management’s best estimate of the credit losses expected from the Company’s trade accounts receivable portfolio. Determination of the allowances requires management to exercise judgment about the timing, frequency and severity of credit losses that could materially affect the provision for credit losses and, therefore, net income. The Company regularly performs detailed reviews of its portfolios to determine if an impairment has occurred and evaluates the collectability of receivables based on a combination of various financial and qualitative factors that may affect customers’ ability to pay, including customers’ financial condition, debt-servicing ability, past payment experience and credit bureau information and forecasts. In circumstances where the Company is aware of a
specific customer’s inability to meet its financial obligations, a specific reserve is recorded against amounts due to reduce the recognized receivable to the amount reasonably expected to be collected.
Inventory Valuation
Inventories include the costs of material, labor and overhead. Inventories are stated at the lower of cost or net realizable value primarily using the first-in, first-out method. Market value for raw materials is based on replacement costs and for other inventory classifications is based on net realizable value. The Company periodically evaluates the quantities on hand relative to current and historical selling prices and historical and projected sales volume. Based on this evaluation, provisions are made to write inventory down to its net realizable value.
Property, Plant and Equipment
Property, plant and equipment are carried at cost. The provision for depreciation has been computed principally by the straight-line method based on the estimated useful lives of the depreciable assets as follows:
CategoryUseful Life
Buildings
30 years
Leased assets and leasehold improvementsAmortized over the lesser of the economic life of the asset or the term of the lease
Machinery, equipment and other assets
3 – 10 years
Estimated useful lives are periodically reviewed and, when appropriate, changes to estimates are made prospectively.
Leases
The Company determines if an arrangement is a lease at inception and evaluates each lease agreement to determine whether the lease is an operating or finance lease. For leases where the Company is the lessee, right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The ROU asset also consists of any prepaid lease payments, lease incentives received, costs which will be incurred in exiting a lease and the amount of any asset or liability recognized on business combinations relating to favorable or unfavorable lease terms. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense using the accelerated interest method of recognition. In certain of the Company’s lease agreements, the rental payments are adjusted periodically to reflect actual charges incurred for common area maintenance, utilities, inflation and/or changes in other indexes.
Investments
Investments over which the Company has a significant influence but not a controlling interest, are accounted for using the equity method of accounting which requires the Company to record its initial investment at cost and adjust the balance each period for the Company’s share of the investee’s income or loss and dividends paid. No significant realized or unrealized gains or losses were recorded during the three years ended December 31, 2022, 2021 and 2020 with respect to these investments.
Fair Value of Financial Instruments
The Company’s financial instruments consist primarily of cash and cash equivalents, trade accounts receivable, nonqualified deferred compensation plans, contingent consideration, derivatives, trade accounts payable and long-term debt. Due to their short-term nature, the carrying values for cash and cash equivalents, trade accounts receivable and trade accounts payable approximate fair value. Refer to Note 12 for the fair values of the Company’s other financial instruments.
Goodwill and Other Intangible Assets
Goodwill and other intangible assets result from the Company’s acquisition of existing businesses. In accordance with accounting standards related to business combinations, goodwill is not amortized; however, certain finite-lived identifiable intangible assets, primarily customer relationships and acquired technology, are amortized over their estimated useful lives. Goodwill and indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. The Company first assessed qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount or performed a quantitative impairment test. When tested quantitatively, the Company uses a combination of techniques, including an income approach and a market-based approach to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. In making this assessment, management relies on a number of factors, including expected future operating results, business plans, economic projections, anticipated future cash flows, business trends and the Company’s market capitalization. The Company’s reporting units are the financial components of operating segments which constitute businesses for which discrete financial information is available and is regularly reviewed by segment management. The Company did not record any impairment loss for goodwill or indefinite-lived intangible assets in 2022, 2021 and 2020.
Management reviews the carrying amounts of other finite-lived intangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable based on undiscounted estimated cash flows, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities.

Refer to Note 9 for additional information about the Company’s goodwill and other intangible assets.

Revenue Recognition
The Company derives revenues primarily from the sale of Specialty Products & Technologies and Equipment & Consumables products and services. Revenue is recognized when control of the promised products or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services (the transaction price). A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606. For equipment, consumables and spare parts sold by the Company, control transfers to the customer at a point in time. To indicate the transfer of control, the Company must have a present right to payment, legal title must have passed to the customer, the customer must have the significant risks and rewards of ownership, and where acceptance is not a formality, the customer must have accepted the product or service. The Company’s principal terms of sale are FOB Shipping Point, or equivalent, and, as such, the Company primarily transfers control and records revenue for product sales upon shipment. Sales arrangements with delivery terms that are not FOB Shipping Point are not recognized upon shipment and the transfer of control for revenue recognition is evaluated based on the associated shipping terms and customer obligations. If a performance obligation to the customer with respect to a sales transaction remains to be fulfilled following shipment (typically installation or acceptance by the customer), revenue recognition for that performance obligation is deferred until such commitments have been fulfilled. Returns for products sold are estimated and recorded as a reduction of revenue at the time of sale. Customer allowances and rebates, consisting primarily of volume discounts and other short-term incentive programs, are recorded as a reduction of revenue at the time of sale because these allowances reflect a reduction in the transaction price. Product returns, customer allowances and rebates are estimated based on historical experience and known trends. For extended warranty and service, control transfers to the customer over the term of the arrangement. Revenue for extended warranty and service is recognized based upon the period of time elapsed under the arrangement.
For a contract with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation on a relative standalone selling price basis using the Company’s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers; however, when prices in standalone sales are not available the Company may use third-party pricing for similar products or services or estimate the standalone selling price. Allocation of the transaction price is determined at the contracts’ inception. The Company does not adjust transaction price for the effects of a significant financing component when the period between the transfer of the promised good or service to the customer and payment for that good or service by the customer is expected to be one year or less.
Shipping and Handling
Shipping and handling costs are considered a fulfillment cost and are included as a component of cost of sales. Revenue derived from shipping and handling costs billed to customers is included in sales.
Advertising
Advertising costs are expensed as incurred.
Research and Development
The Company conducts research and development activities for the purpose of developing new products, enhancing the functionality, effectiveness, ease of use and reliability of the Company’s existing products and expanding the applications for which uses of the Company’s products are appropriate. Research and development costs are expensed as incurred.
Income Taxes
Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted rates expected to be in effect during the year in which the differences reverse. Deferred tax assets generally represent items that can be used as a tax deduction or credit in the Company’s tax return in future years for which the tax benefit has already been reflected on the Company’s Consolidated Statements of Operations. The Company establishes valuation allowances for its deferred tax assets if it is more likely than not that some or all of the deferred tax assets will not be realized. Deferred tax liabilities generally represent items that have already been taken as a deduction on the Company’s tax return but have not yet been recognized as an expense in the Company’s Consolidated Statements of Operations. The effect on deferred tax assets and liabilities due to a change in tax rates is recognized in income tax expense in the period that includes the enactment date. The Company provides for unrecognized tax benefits when, based upon the technical merits, it is “more likely than not” that an uncertain tax position will not be sustained upon examination. Judgment is required in evaluating tax positions and determining income tax provisions. The Company re-evaluates the technical merits of its tax positions and may recognize an uncertain tax benefit in certain circumstances, including when: (1) a tax audit is completed; (2) applicable tax laws change, including a tax case ruling or legislative guidance; or (3) the applicable statute of limitations expires. The Company recognizes potential accrued interest and penalties associated with unrecognized tax positions in income tax expense.
On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on the Company’s current analysis of the provisions, the Company does not believe this legislation will have a material impact on its Consolidated Financial Statements.

Restructuring
The Company periodically initiates restructuring activities to appropriately position the Company’s cost base relative to prevailing economic conditions and associated customer demand as well as in connection with certain acquisitions. Costs associated with productivity improvement and restructuring actions can include termination benefits and related charges in addition to facility closure, contract termination and other related activities. The Company records the cost of the restructuring activities when impairment is identified or when the associated liability is incurred. Refer to Note 20 for additional information.
Foreign Currency Translation
Exchange rate adjustments resulting from foreign currency transactions are recognized in net income, whereas effects resulting from the translation of financial statements are reflected as a component of accumulated other comprehensive loss within equity. Assets and liabilities of subsidiaries operating outside the United States with a functional currency other than U.S. dollars are translated into U.S. dollars using year-end exchange rates and income statement accounts are translated at weighted average rates. Net foreign currency transaction gains or losses were not material in any of the years presented.
Derivative Financial Instruments
The Company is neither a dealer nor a trader in derivative instruments. The Company has generally accepted the exposure to transactional exchange rate movements without using derivative instruments to manage this risk, although the Company from time to time partially hedges its net investments in foreign operations against adverse movements in exchange rates through foreign currency-denominated debt and cross-currency swaps. The Company may at times also enter into interest rate swaps to mitigate a portion of its interest rate risk related to the Company’s debt. The derivative instruments are recorded on the Consolidated Balance Sheets as either an asset or liability measured at fair value. To the extent the interest rate swap qualifies as an effective hedge, changes in fair value are recognized in accumulated other comprehensive loss within equity.
Changes in the value of the foreign currency denominated debt and cross-currency swaps designated as hedges of the Company’s net investment in foreign operations based on spot rates are recognized in accumulated other comprehensive loss within equity and offset changes in the value of the Company’s foreign currency denominated operations. Refer to Note 11 for additional information on derivative financial instruments.
Loss Contingencies
The Company records a reserve for loss contingencies when it is both probable that a loss will be incurred and the amount of the loss is reasonably estimable. The Company evaluates pending litigation and other contingencies at least quarterly and adjusts the reserve for such contingencies for changes in probable and reasonably estimable losses.
Accumulated Other Comprehensive Loss
Foreign currency translation adjustments are generally not adjusted for income taxes as they relate to indefinite investments in non-U.S. subsidiaries. Foreign currency translation adjustments related to the Company’s cross-currency swap arrangements and foreign currency denominated debt that are designated as net investment hedges are adjusted for income taxes as those arrangements are not indefinite. Changes in the funded status of the pension plans, net of taxes, are recognized in the year in which the changes occur and reported in other comprehensive loss.
Stock-Based Compensation
The Company accounts for stock-based compensation by measuring the cost of employee services received in exchange for all equity awards granted, including stock options, restricted stock units (“RSUs”) and performance stock units (“PSUs”), based on the fair value of the award as of the grant date. Equity-based compensation expense is recognized net of an estimated forfeiture rate on a straight-line basis over the requisite service period of the award, except that in the case of RSUs compensation expense is recognized using an accelerated attribution method. Refer to Note 17 for additional information on the stock-based compensation plan in which certain employees of the Company participate.

Pension Plans
The Company measures its pension assets and obligations that determine the funded status as of the end of the Company’s fiscal year, and recognizes an asset for an over funded status or a liability for an underfunded status in its Consolidated Balance Sheets. Changes in the funded status of the pension plans are recognized in the year in which the changes occur and reported in other comprehensive loss. Refer to Note 13 for additional information on the Company’s pension plans including a discussion of the actuarial assumptions, the Company’s policy for recognizing the associated gains and losses and the method used to estimate service and interest cost components.

Accounting Standards Recently Adopted

In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2021-08, Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805), which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts, rather than at fair value. This standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The Company adopted this guidance on January 1, 2022, which did not have a significant impact on the Company’s Consolidated Financial Statements.

In August 2020, the FASB issued ASU 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40),” (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. This guidance is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU 2020-06 was effective for public entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Effective January 1, 2022, the Company adopted ASU 2020-06 using the modified retrospective adoption approach. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption. The comparative prior year information has not been restated and continues to be presented according to accounting standards in effect for those periods.
The adoption of ASU 2020-06 resulted in a $75.0 million increase to the carrying value of the convertible notes due 2025, net of deferred debt issuance costs and unamortized discount and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption resulted in a $21.4 million increase to retained earnings and an $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs. Refer to Note 16 for a further discussion of the impact of adopting ASU 2020-06.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. ASU 2020-04 is effective for public entities through December 31, 2022. However, in December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 to defer the effective date of ASU 2020-04 from December 31, 2022 to December 31, 2024. The Company adopted ASU 2020-04 as of December 31, 2022 and its adoption did not have an impact on the Company’s Consolidated Financial Statements.
XML 27 R10.htm IDEA: XBRL DOCUMENT v3.22.4
Summary Of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies BUSINESS AND BASIS OF PRESENTATION
Business Overview

The Company provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. The Company is a worldwide provider of a broad range of dental implants, orthodontic appliances, general dental consumables, equipment and services and is dedicated to driving technological innovations that help dental professionals improve clinical outcomes and enhance productivity.

The Company was formed in 2018, as a wholly-owned subsidiary of Danaher Corporation (“Danaher”), to serve as the ultimate parent company of the dental platform of Danaher. On September 20, 2019, the Company completed its initial public offering and on December 18, 2019, Danaher completed the disposition of its ownership interest in the Company referred to herein as the “Separation”.

The Company operates in two business segments: Specialty Products & Technologies and Equipment & Consumables.
The Company’s Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Company’s Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.

Basis of Presentation
The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP").

As discussed in Note 4, Discontinued Operations, on December 31, 2021, the Company sold its KaVo dental treatment unit and instrument business (the "KaVo Treatment Unit and Instrument Business"), which was part of the Company’s Equipment and Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.

Risks and Uncertainties

The Company is subject to risks and uncertainties as a result of the novel coronavirus (“COVID-19”) pandemic.

The extent of the impact of the COVID-19 pandemic on the Company remains uncertain and difficult to predict because of the dynamic and evolving nature of the situation. The global impact of the outbreak continues to adversely affect many industries, and different geographies continue to reflect the effects of public health restrictions in various ways. The economic recovery following the impact of the COVID-19 pandemic is only partially underway and has been gradual, uneven and characterized by meaningful dispersion across sectors and regions with uncertainty regarding its ultimate length and trajectory. During the year ended December 31, 2022, notwithstanding improvement in many markets in which the Company operates due to a return to more normalized business operations, certain markets continued to be adversely impacted by COVID-19. In particular, sales decreased in China due to lockdowns early in the year and a subsequent relaxing of restrictions, which resulted in increased infection rates.

In addition, Russia’s invasion of Ukraine and the global response to this invasion, including sanctions imposed by the U.S. and other countries, could have an adverse impact on the Company’s business, including impacting the Company’s ability to market and sell products in the affected regions, potentially heightening our risk of cyber security attacks, impacting its ability to enforce its intellectual property rights in Russia, creating disruptions in the global supply chain, and by potentially having an adverse impact on the global economy, financial markets, energy markets, currency rates and otherwise.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Accounting Principles
The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The Consolidated Financial Statements include the accounts of the Company and its subsidiaries. The Consolidated Financial Statements also reflect the impact of noncontrolling interests. Noncontrolling interests do not have a significant impact on the Company’s consolidated results of operations, therefore income attributable to noncontrolling interests are not presented separately in the Company’s Consolidated Statements of Operations. Income attributable to noncontrolling interests have been reflected in selling, general and administrative expenses and were insignificant in all periods presented. Reclassifications of certain prior year amounts have been made to conform to the current year presentation.
Use of Estimates
The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The Company bases these estimates on historical experience, the current economic environment and on various other assumptions that are believed to be reasonable under the circumstances. However, uncertainties associated with these estimates exist and actual results may differ materially from these estimates.
Acquisitions
The Company continually evaluates potential acquisitions that either strategically fit with the Company’s existing portfolio or expand the Company’s portfolio into new and attractive business areas. Among other things, goodwill arises because the purchase prices for these businesses reflect a number of factors including the future earnings and cash flow potential of these businesses, the multiple to earnings, cash flow and other factors at which similar businesses have been purchased by other acquirers, the competitive nature of the processes by which the Company acquired the businesses, avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance the Company’s existing product offerings to key target markets and enter into new and profitable businesses and the complementary strategic fit and resulting synergies these businesses bring to existing operations.
We account for acquisitions under Accounting Standards Codification (“ASC“) 805 Business Combinations and use the acquisition method of accounting. The consideration transferred for the acquisition of a subsidiary comprises (i) fair values of the assets transferred; (ii) liabilities assumed of the acquired business; and (iii) fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired, and liabilities and contingent liabilities assumed in a business combination are, with limited exceptions, measured initially at their fair values at the acquisition date.
The Company makes an initial allocation of the purchase price at the date of acquisition based upon its estimation of the fair value of the acquired assets and assumed liabilities. The Company obtains the information used to estimate the fair values during due diligence and through other sources. In the months after closing, up to 12 months, as the Company obtains additional information that existed at the acquisition date about these assets and liabilities, it is able to refine the estimates of fair value and more accurately allocate the purchase price. Only items that existed as of the acquisition date are considered for subsequent adjustment. The Company makes the appropriate adjustments to the purchase price allocation prior to completion of the measurement period, as required.
Cash and Cash Equivalents
The Company considers all highly liquid investments with a maturity of three months or less at the date of purchase to be cash equivalents.
Accounts Receivable and Allowances for Credit Losses
All trade accounts receivable are reported on the accompanying Consolidated Balance Sheets adjusted for any write-offs and net of allowances for credit losses. The allowances for credit losses represent management’s best estimate of the credit losses expected from the Company’s trade accounts receivable portfolio. Determination of the allowances requires management to exercise judgment about the timing, frequency and severity of credit losses that could materially affect the provision for credit losses and, therefore, net income. The Company regularly performs detailed reviews of its portfolios to determine if an impairment has occurred and evaluates the collectability of receivables based on a combination of various financial and qualitative factors that may affect customers’ ability to pay, including customers’ financial condition, debt-servicing ability, past payment experience and credit bureau information and forecasts. In circumstances where the Company is aware of a
specific customer’s inability to meet its financial obligations, a specific reserve is recorded against amounts due to reduce the recognized receivable to the amount reasonably expected to be collected.
Inventory Valuation
Inventories include the costs of material, labor and overhead. Inventories are stated at the lower of cost or net realizable value primarily using the first-in, first-out method. Market value for raw materials is based on replacement costs and for other inventory classifications is based on net realizable value. The Company periodically evaluates the quantities on hand relative to current and historical selling prices and historical and projected sales volume. Based on this evaluation, provisions are made to write inventory down to its net realizable value.
Property, Plant and Equipment
Property, plant and equipment are carried at cost. The provision for depreciation has been computed principally by the straight-line method based on the estimated useful lives of the depreciable assets as follows:
CategoryUseful Life
Buildings
30 years
Leased assets and leasehold improvementsAmortized over the lesser of the economic life of the asset or the term of the lease
Machinery, equipment and other assets
3 – 10 years
Estimated useful lives are periodically reviewed and, when appropriate, changes to estimates are made prospectively.
Leases
The Company determines if an arrangement is a lease at inception and evaluates each lease agreement to determine whether the lease is an operating or finance lease. For leases where the Company is the lessee, right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The ROU asset also consists of any prepaid lease payments, lease incentives received, costs which will be incurred in exiting a lease and the amount of any asset or liability recognized on business combinations relating to favorable or unfavorable lease terms. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense using the accelerated interest method of recognition. In certain of the Company’s lease agreements, the rental payments are adjusted periodically to reflect actual charges incurred for common area maintenance, utilities, inflation and/or changes in other indexes.
Investments
Investments over which the Company has a significant influence but not a controlling interest, are accounted for using the equity method of accounting which requires the Company to record its initial investment at cost and adjust the balance each period for the Company’s share of the investee’s income or loss and dividends paid. No significant realized or unrealized gains or losses were recorded during the three years ended December 31, 2022, 2021 and 2020 with respect to these investments.
Fair Value of Financial Instruments
The Company’s financial instruments consist primarily of cash and cash equivalents, trade accounts receivable, nonqualified deferred compensation plans, contingent consideration, derivatives, trade accounts payable and long-term debt. Due to their short-term nature, the carrying values for cash and cash equivalents, trade accounts receivable and trade accounts payable approximate fair value. Refer to Note 12 for the fair values of the Company’s other financial instruments.
Goodwill and Other Intangible Assets
Goodwill and other intangible assets result from the Company’s acquisition of existing businesses. In accordance with accounting standards related to business combinations, goodwill is not amortized; however, certain finite-lived identifiable intangible assets, primarily customer relationships and acquired technology, are amortized over their estimated useful lives. Goodwill and indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. The Company first assessed qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount or performed a quantitative impairment test. When tested quantitatively, the Company uses a combination of techniques, including an income approach and a market-based approach to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. In making this assessment, management relies on a number of factors, including expected future operating results, business plans, economic projections, anticipated future cash flows, business trends and the Company’s market capitalization. The Company’s reporting units are the financial components of operating segments which constitute businesses for which discrete financial information is available and is regularly reviewed by segment management. The Company did not record any impairment loss for goodwill or indefinite-lived intangible assets in 2022, 2021 and 2020.
Management reviews the carrying amounts of other finite-lived intangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable based on undiscounted estimated cash flows, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities.

Refer to Note 9 for additional information about the Company’s goodwill and other intangible assets.

Revenue Recognition
The Company derives revenues primarily from the sale of Specialty Products & Technologies and Equipment & Consumables products and services. Revenue is recognized when control of the promised products or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services (the transaction price). A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606. For equipment, consumables and spare parts sold by the Company, control transfers to the customer at a point in time. To indicate the transfer of control, the Company must have a present right to payment, legal title must have passed to the customer, the customer must have the significant risks and rewards of ownership, and where acceptance is not a formality, the customer must have accepted the product or service. The Company’s principal terms of sale are FOB Shipping Point, or equivalent, and, as such, the Company primarily transfers control and records revenue for product sales upon shipment. Sales arrangements with delivery terms that are not FOB Shipping Point are not recognized upon shipment and the transfer of control for revenue recognition is evaluated based on the associated shipping terms and customer obligations. If a performance obligation to the customer with respect to a sales transaction remains to be fulfilled following shipment (typically installation or acceptance by the customer), revenue recognition for that performance obligation is deferred until such commitments have been fulfilled. Returns for products sold are estimated and recorded as a reduction of revenue at the time of sale. Customer allowances and rebates, consisting primarily of volume discounts and other short-term incentive programs, are recorded as a reduction of revenue at the time of sale because these allowances reflect a reduction in the transaction price. Product returns, customer allowances and rebates are estimated based on historical experience and known trends. For extended warranty and service, control transfers to the customer over the term of the arrangement. Revenue for extended warranty and service is recognized based upon the period of time elapsed under the arrangement.
For a contract with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation on a relative standalone selling price basis using the Company’s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers; however, when prices in standalone sales are not available the Company may use third-party pricing for similar products or services or estimate the standalone selling price. Allocation of the transaction price is determined at the contracts’ inception. The Company does not adjust transaction price for the effects of a significant financing component when the period between the transfer of the promised good or service to the customer and payment for that good or service by the customer is expected to be one year or less.
Shipping and Handling
Shipping and handling costs are considered a fulfillment cost and are included as a component of cost of sales. Revenue derived from shipping and handling costs billed to customers is included in sales.
Advertising
Advertising costs are expensed as incurred.
Research and Development
The Company conducts research and development activities for the purpose of developing new products, enhancing the functionality, effectiveness, ease of use and reliability of the Company’s existing products and expanding the applications for which uses of the Company’s products are appropriate. Research and development costs are expensed as incurred.
Income Taxes
Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted rates expected to be in effect during the year in which the differences reverse. Deferred tax assets generally represent items that can be used as a tax deduction or credit in the Company’s tax return in future years for which the tax benefit has already been reflected on the Company’s Consolidated Statements of Operations. The Company establishes valuation allowances for its deferred tax assets if it is more likely than not that some or all of the deferred tax assets will not be realized. Deferred tax liabilities generally represent items that have already been taken as a deduction on the Company’s tax return but have not yet been recognized as an expense in the Company’s Consolidated Statements of Operations. The effect on deferred tax assets and liabilities due to a change in tax rates is recognized in income tax expense in the period that includes the enactment date. The Company provides for unrecognized tax benefits when, based upon the technical merits, it is “more likely than not” that an uncertain tax position will not be sustained upon examination. Judgment is required in evaluating tax positions and determining income tax provisions. The Company re-evaluates the technical merits of its tax positions and may recognize an uncertain tax benefit in certain circumstances, including when: (1) a tax audit is completed; (2) applicable tax laws change, including a tax case ruling or legislative guidance; or (3) the applicable statute of limitations expires. The Company recognizes potential accrued interest and penalties associated with unrecognized tax positions in income tax expense.
On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on the Company’s current analysis of the provisions, the Company does not believe this legislation will have a material impact on its Consolidated Financial Statements.

Restructuring
The Company periodically initiates restructuring activities to appropriately position the Company’s cost base relative to prevailing economic conditions and associated customer demand as well as in connection with certain acquisitions. Costs associated with productivity improvement and restructuring actions can include termination benefits and related charges in addition to facility closure, contract termination and other related activities. The Company records the cost of the restructuring activities when impairment is identified or when the associated liability is incurred. Refer to Note 20 for additional information.
Foreign Currency Translation
Exchange rate adjustments resulting from foreign currency transactions are recognized in net income, whereas effects resulting from the translation of financial statements are reflected as a component of accumulated other comprehensive loss within equity. Assets and liabilities of subsidiaries operating outside the United States with a functional currency other than U.S. dollars are translated into U.S. dollars using year-end exchange rates and income statement accounts are translated at weighted average rates. Net foreign currency transaction gains or losses were not material in any of the years presented.
Derivative Financial Instruments
The Company is neither a dealer nor a trader in derivative instruments. The Company has generally accepted the exposure to transactional exchange rate movements without using derivative instruments to manage this risk, although the Company from time to time partially hedges its net investments in foreign operations against adverse movements in exchange rates through foreign currency-denominated debt and cross-currency swaps. The Company may at times also enter into interest rate swaps to mitigate a portion of its interest rate risk related to the Company’s debt. The derivative instruments are recorded on the Consolidated Balance Sheets as either an asset or liability measured at fair value. To the extent the interest rate swap qualifies as an effective hedge, changes in fair value are recognized in accumulated other comprehensive loss within equity.
Changes in the value of the foreign currency denominated debt and cross-currency swaps designated as hedges of the Company’s net investment in foreign operations based on spot rates are recognized in accumulated other comprehensive loss within equity and offset changes in the value of the Company’s foreign currency denominated operations. Refer to Note 11 for additional information on derivative financial instruments.
Loss Contingencies
The Company records a reserve for loss contingencies when it is both probable that a loss will be incurred and the amount of the loss is reasonably estimable. The Company evaluates pending litigation and other contingencies at least quarterly and adjusts the reserve for such contingencies for changes in probable and reasonably estimable losses.
Accumulated Other Comprehensive Loss
Foreign currency translation adjustments are generally not adjusted for income taxes as they relate to indefinite investments in non-U.S. subsidiaries. Foreign currency translation adjustments related to the Company’s cross-currency swap arrangements and foreign currency denominated debt that are designated as net investment hedges are adjusted for income taxes as those arrangements are not indefinite. Changes in the funded status of the pension plans, net of taxes, are recognized in the year in which the changes occur and reported in other comprehensive loss.
Stock-Based Compensation
The Company accounts for stock-based compensation by measuring the cost of employee services received in exchange for all equity awards granted, including stock options, restricted stock units (“RSUs”) and performance stock units (“PSUs”), based on the fair value of the award as of the grant date. Equity-based compensation expense is recognized net of an estimated forfeiture rate on a straight-line basis over the requisite service period of the award, except that in the case of RSUs compensation expense is recognized using an accelerated attribution method. Refer to Note 17 for additional information on the stock-based compensation plan in which certain employees of the Company participate.

Pension Plans
The Company measures its pension assets and obligations that determine the funded status as of the end of the Company’s fiscal year, and recognizes an asset for an over funded status or a liability for an underfunded status in its Consolidated Balance Sheets. Changes in the funded status of the pension plans are recognized in the year in which the changes occur and reported in other comprehensive loss. Refer to Note 13 for additional information on the Company’s pension plans including a discussion of the actuarial assumptions, the Company’s policy for recognizing the associated gains and losses and the method used to estimate service and interest cost components.

Accounting Standards Recently Adopted

In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2021-08, Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805), which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts, rather than at fair value. This standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The Company adopted this guidance on January 1, 2022, which did not have a significant impact on the Company’s Consolidated Financial Statements.

In August 2020, the FASB issued ASU 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40),” (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. This guidance is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU 2020-06 was effective for public entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Effective January 1, 2022, the Company adopted ASU 2020-06 using the modified retrospective adoption approach. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption. The comparative prior year information has not been restated and continues to be presented according to accounting standards in effect for those periods.
The adoption of ASU 2020-06 resulted in a $75.0 million increase to the carrying value of the convertible notes due 2025, net of deferred debt issuance costs and unamortized discount and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption resulted in a $21.4 million increase to retained earnings and an $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs. Refer to Note 16 for a further discussion of the impact of adopting ASU 2020-06.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. ASU 2020-04 is effective for public entities through December 31, 2022. However, in December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 to defer the effective date of ASU 2020-04 from December 31, 2022 to December 31, 2024. The Company adopted ASU 2020-04 as of December 31, 2022 and its adoption did not have an impact on the Company’s Consolidated Financial Statements.
XML 28 R11.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisitions
 12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
Acquisitions ACQUISITIONS
The Company completed the following acquisitions, using the acquisition method of accounting during, the year ended December 31, 2022:

Osteogenics Biomedical Inc., Allotech LLC and OBI Biologics, Inc.
On July 5, 2022, the Company acquired all of the equity of Osteogenics Biomedical Inc., Allotech LLC and OBI Biologics, Inc. (together "Osteogenics") for total consideration of approximately $128.2 million, subject to certain customary adjustments as provided in the Equity Purchase Agreement dated May 17, 2022. Osteogenics develops innovative regenerative solutions for periodontists, oral and maxillofacial surgeons, and clinicians involved in implant dentistry throughout the world, and is part of the Company’s Specialty Products & Technologies segment.

Carestream Dental Technology Parent Limited’s Intraoral Scanner Business
On April 20, 2022, the Company completed the acquisition of Carestream Dental Technology Parent Limited’s (“Carestream Dental”) intraoral scanner business (the “Intraoral Scanner Business”) for total consideration of $580.3 million, including contingent consideration of $7.5 million, and subject to certain customary adjustments as provided in the Stock and Asset Purchase Agreement dated December 21, 2021 and as subsequently amended by the closing agreement dated as of April 20, 2022. The Intraoral Scanner Business manufactures, markets, sells, commercializes, distributes, services, trains, supports, and maintains operations of intraoral scanners and software, and is part of the Company’s Equipment & Consumables segment. The Company purchased the Intraoral Scanner Business through the acquisition of certain assets and the assumption of certain liabilities as well as the acquisition of all of the equity of certain subsidiaries of Carestream Dental.
The following table summarizes the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates ($ in millions):

Osteogenics
July 5, 2022		Intraoral Scanner Business
April 20, 2022
Assets acquired:
   Cash$2.1 $2.7 
   Accounts receivable2.5 0.1 
   Inventories13.3 6.1 
   Intangible assets53.0 129.8 
   Property, plant and equipment— 0.3 
   Prepaids and Other Current Assets1.3 — 
   Goodwill77.3 373.1 
   Non-current deferred tax asset— 96.0 
   Operating lease right-of-use assets2.6 0.9 
   Other long-term assets4.9 0.2 
       Total assets acquired157.0 609.2 
Liabilities assumed:
   Accounts payable (4.1)(0.5)
   Accrued expenses and other liabilities (2.5)(27.9)
   Non-current deferred tax liability(14.3)— 
   Other long-term liabilities(5.8)— 
   Operating lease liabilities(2.1)(0.5)
       Total liabilities assumed(28.8)(28.9)
Total net assets acquired$128.2 $580.3 

The Company may up to 12 months after closing refine the estimates of fair value and more accurately allocate the purchase price. Only items that existed as of the acquisition date are considered for subsequent adjustment. The finalization of the acquisition valuation assessment for these acquisitions may result in a change in the valuation of deferred taxes and goodwill, which could have a material impact on the Company’s financial statements.

The intangible assets acquired consist of trade name, developed technology, and customer relationships. The weighted average amortization period of the acquired intangible assets in the aggregate is 8 and 10 years for the Intraoral Scanner Business and Osteogenics, respectively.

The excess of the purchase price over the fair value assigned to the assets acquired and liabilities assumed represents the goodwill resulting from the acquisitions. Goodwill attributable to the acquisitions has been recorded as a non-current asset and is not amortized, but is subject to review at least on an annual basis for impairment. Goodwill recognized was primarily attributable to expected operating efficiencies and expansion opportunities in the businesses acquired. Goodwill is not deductible for income tax purposes. The pro forma impact of the acquisitions is not presented as the acquisitions were not considered material to the Company's Consolidated Financial Statements.

Legal, accounting, and other professional service costs associated with the acquisitions were $14.5 million for the year ended December 31, 2022, and have been recorded as selling, general and administrative expense in the Consolidated Statements of Operations.
XML 29 R12.htm IDEA: XBRL DOCUMENT v3.22.4
Discontinued Operations
 12 Months Ended
Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations DISCONTINUED OPERATIONS
On December 31, 2021, the Company sold substantially all of the KaVo Treatment Unit and Instrument Business (the “Divestiture”) to planmeca Verwaltungs Gmbh, Germany (“Planmeca”), pursuant to the master sale and purchase agreement (the “Purchase Agreement”) among the Company, Planmeca, and Planmeca Oy, as guarantor. On December 30, 2021, the Company entered into an amendment to the Purchase Agreement (the "Amendment"), providing that the transfer of net assets in Russia, China and Brazil (the "Relevant Jurisdictions") would be deferred until the purchaser had formed entities for such transfer of assets in each such Relevant Jurisdiction and the applicable asset transfer agreement could be executed and consummated (each such asset transfer, a "Deferred Local Closing"). Except for the implementation of the Deferred Local Closings and related matters regarding the assets in the Relevant Jurisdictions, the provisions, terms and conditions of the Purchase Agreement were not materially amended by the Amendment. The Amendment did not alter the preliminary purchase price that Planmeca paid to the Company upon the closing of the Divestiture and the Company recognized the applicable gain or loss at the time of each Relevant Jurisdiction’s applicable closing. At December 31, 2021, the Company recorded a liability of $10.8 million for the proceeds related to the Relevant Jurisdictions. At December 31, 2022, all three Relevant Jurisdictions have closed and the related liability associated with the proceeds released. In accordance with the terms of the Purchase Agreement, the Company received total net cash consideration of $386.4 million.

The results of the Divestiture are presented as discontinued operations for all periods presented in the accompanying Consolidated Financial Statements, with the exception of the Consolidated Statements of Cash Flows which include the financial results of the KaVo Treatment Unit and Instrument Business for all periods presented.

The carrying amounts of the assets and liabilities of the Divestiture held for sale are as follows ($ in millions):
December 31, 2021
ASSETS
Current assets:
Assets for Relevant Jurisdictions$12.2 
Current assets held for sale$12.2 
LIABILITIES AND EQUITY
Current liabilities:
Liabilities for Relevant Jurisdictions$4.0 
Current liabilities held for sale$4.0 

For the years ended December 31, 2021 and 2020, the amounts represent activity for the entire Divestiture, while amounts for the year ended December 31, 2022, represent activity for the remaining Relevant Jurisdictions prior to closing. The operating results of the Divestiture are reflected in the Consolidated Statements of Operations within income from discontinued operations, net of tax as follows ($ in millions):
 Year Ended December 31
 202220212020
Sales$11.7 $413.5 $352.9 
Cost of sales9.1 234.6 249.6 
Gross profit2.6 178.9 103.3 
Operating expenses:
Selling, general and administrative3.2 75.6 99.3 
Research and development— 16.1 14.1 
Operating (loss) profit(0.6)87.2 (10.1)
Income tax expense— 21.9 (0.9)
(Loss) income from discontinued operations(0.6)65.3 (9.2)
Gain on sale of discontinued operations, net of tax5.7 11.7 — 
Net income (loss) from discontinued operations$5.1 $77.0 $(9.2)
Significant non-cash operating items and capital expenditures for the Divestiture are reflected in the cash flows from operations as follows ($ in millions):
Year Ended December 31
202220212020
Cash flows from operating activities
Non-cash restructuring charges$— $— $9.6 
Impairment charges$— $— $10.5 
Depreciation and amortization1
$— $5.8 $10.9 
Cash flows from investing activities:
Capital expenditures$— $6.7 $3.8 
1 Depreciation and amortization were no longer recognized once the business was classified as discontinued operations as of August 27, 2021.
XML 30 R13.htm IDEA: XBRL DOCUMENT v3.22.4
Credit Losses
 12 Months Ended
Dec. 31, 2022
Credit Loss [Abstract]  
Credit Losses CREDIT LOSSES
The allowance for credit losses is a valuation account deducted from accounts receivable to present the net amount expected to be collected. Accounts receivable are charged off against the allowance when management believes the uncollectibility of an accounts receivable balance is confirmed.

Management estimates the adequacy of the allowance by using relevant available information, from internal and external sources, relating to past events, current conditions and forecasts. Historical credit loss experience provides the basis for estimation of expected credit losses and is adjusted as necessary using the relevant information available. The allowance for credit losses is measured on a collective basis when similar risk characteristics exist. The Company has identified one portfolio segment based on the following risk characteristics: geographic regions, product lines, default rates and customer specific factors.

The factors used by management in its credit loss analysis are inherently subject to uncertainty. If actual results are not consistent with management’s estimates and assumptions, the allowance for credit losses may be overstated or understated and a charge or credit to net income (loss) may be required.

The rollforward of the allowance for credit losses is summarized as follows ($ in millions):

Balance at December 31, 2021$20.7 
Foreign currency translation(0.8)
Provision for credit losses4.8 
Write-offs charged against the allowance(4.1)
Recoveries(4.4)
Balance at December 31, 2022$16.2 
XML 31 R14.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
Inventories INVENTORIES
The classes of inventory as of December 31 are summarized as follows ($ in millions):
20222021
Finished goods$229.2 $214.3 
Work in process23.9 22.0 
Raw materials103.4 88.3 
Reserve for inventory obsolescence(55.7)(60.8)
Total$300.8 $263.8 
XML 32 R15.htm IDEA: XBRL DOCUMENT v3.22.4
Property, Plant And Equipment
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
Property, Plant And Equipment PROPERTY, PLANT AND EQUIPMENT
The classes of property, plant and equipment as of December 31 are summarized as follows ($ in millions):
20222021
Land and improvements$10.0 $10.7 
Buildings and improvements154.5 168.7 
Machinery, equipment and other assets370.2 354.5 
Construction in progress71.2 45.6 
Gross property, plant and equipment605.9 579.5 
Less: accumulated depreciation(312.3)(315.4)
Property, plant and equipment, net$293.6 $264.1 
XML 33 R16.htm IDEA: XBRL DOCUMENT v3.22.4
Leases
 12 Months Ended
Dec. 31, 2022
Leases [Abstract]  
Leases LEASES
The Company has operating leases for office space, warehouses, distribution centers, research and development and manufacturing facilities, equipment and vehicles. Many leases include one or more options to renew, some of which include options to extend the lease for up to 20 years and some leases include options to terminate the lease within 30 days. The Company regularly evaluates the renewal options and, when the options are reasonably certain of being exercised, they are included in the lease term. In certain of the Company’s lease agreements, the rental payments are adjusted periodically to reflect actual charges incurred for common area maintenance, utilities, inflation and/or changes in other indexes. The Company has elected to combine lease and non-lease components for leases of all asset classes where the Company is the lessee. At inception, the Company determines whether an agreement represents a lease and, at commencement, evaluates each lease agreement to determine whether the lease is an operating or finance lease.
Variable lease costs consist primarily of taxes, insurance, and common area or other maintenance costs for leased facilities and vehicles, which are paid based on actual costs incurred.
The components of operating lease expense for the years ended December 31 were as follows ($ in millions):
20222021
Fixed operating lease expense (a)
$31.7 $32.4 
Variable operating lease expense7.2 6.1 
Total operating lease expense$38.9 $38.5 
______________
(a)    Includes short-term leases and sublease income, both of which were not significant.
The following table presents the weighted average remaining lease term and weighted average discount rates related to the Company’s operating leases as of December 31:
20222021
Weighted average remaining lease term8 years9 years
Weighted average discount rate4.1 %3.5 %
The following table presents the maturity of the Company’s operating lease liabilities as of December 31, 2022 ($ in millions):
2023$32.2 
202428.7 
202523.9 
202619.8 
202716.8 
Thereafter50.3 
Total operating lease payments171.7 
Less: imputed interest(23.3)
Total operating lease liabilities$148.4 
As of December 31, 2022, the Company had no additional significant operating or finance leases that had not yet commenced.
XML 34 R17.htm IDEA: XBRL DOCUMENT v3.22.4
Goodwill And Other Intangible Assets
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets GOODWILL AND OTHER INTANGIBLE ASSETS
The Company performed its annual goodwill impairment test on the first business day of the fourth quarter of 2022. The Company used a combination of techniques, including an income approach and a market-based approach in performing its annual goodwill impairment test to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value amount. The Company’s reporting units are the financial components of operating segments which constitute businesses for which discrete financial information is available and regularly reviewed by segment management.

No goodwill impairment charges were recorded for the years ended December 31, 2022, 2021 and 2020 and no “triggering” events have occurred subsequent to the performance of the 2022 annual impairment test. The factors used by management in its impairment analysis are inherently subject to uncertainty. If actual results are not consistent with management’s estimates and assumptions, goodwill and other intangible assets may be overstated and a charge to net income may be required.
The following is a rollforward of the Company’s goodwill by segment ($ in millions):
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Balance, December 31, 2021$2,029.7 $1,102.3 $3,132.0 
Acquisitions77.3 373.1 450.4 
Foreign currency translation(59.2)(26.6)(85.8)
Balance, December 31, 2022$2,047.8 $1,448.8 $3,496.6 
Finite-lived intangible assets are amortized over the shorter of their legal or estimated useful life. The following summarizes the gross carrying value and accumulated amortization for each major category of intangible asset as of December 31 ($ in millions): 
20222021
Gross
Carrying
Amount		Accumulated
Amortization		Gross
Carrying
Amount		Accumulated
Amortization
Finite-lived intangibles:
Patents and technology$432.2 $(236.4)$313.8 $(215.3)
Customer relationships and other intangibles924.1 (648.7)907.4 (610.9)
Trademarks and trade names224.8 (100.2)216.3 (75.4)
Total finite-lived intangibles1,581.1 (985.3)1,437.5 (901.6)
Indefinite-lived intangibles:
Trademarks and trade names490.9 — 510.5 — 
Total intangibles$2,072.0 $(985.3)$1,948.0 $(901.6)
Total intangible amortization expense in 2022, 2021 and 2020 was $106.0 million, $81.5 million and $87.3 million, respectively. Based on the intangible assets recorded as of December 31, 2022, amortization expense is estimated as follows for the next five years and thereafter:

Years Ending December 31,
2023$99.3 
202489.6
202589.1
202681.1
202776.5
Thereafter160.2 
$595.8 
XML 35 R18.htm IDEA: XBRL DOCUMENT v3.22.4
Accrued Expenses And Other Liabilities
 12 Months Ended
Dec. 31, 2022
Accrued expenses and other [Abstract]  
Accrued Expenses and Other Liabilities ACCRUED EXPENSES AND OTHER LIABILITIES
Accrued expenses and other liabilities as of December 31 were as follows ($ in millions):
20222021
CurrentNoncurrentCurrentNoncurrent
Compensation and benefits$148.0 $17.5 $188.9 $17.9 
Sales and product allowances85.1 1.3 75.4 1.2 
Contract liabilities78.9 8.6 60.1 5.1 
Taxes, income and other42.1 68.6 48.1 201.4 
Restructuring-related employee severance, benefits and other18.9 — 21.9 — 
Pension benefits5.6 17.5 5.6 41.7 
Loss contingencies8.1 27.6 8.4 30.3 
Derivative financial instruments— — 19.6 — 
Other84.7 10.2 134.3 6.6 
Total$471.4 $151.3 $562.3 $304.2 
XML 36 R19.htm IDEA: XBRL DOCUMENT v3.22.4
Hedging Transactions And Derivative Financial Instruments
 12 Months Ended
Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Hedging Transactions and Derivative Financial Instruments HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS
The Company has foreign currency denominated long-term debt in the amount of €208.0 million. This senior unsecured term loan facility represents a partial hedge of the Company’s net investment in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The euro senior unsecured term loan facility is designated and qualifies as a non-derivative hedging instrument. Accordingly, the foreign currency translation of the euro senior unsecured term loan facility is recorded in accumulated other comprehensive loss in equity in the accompanying Consolidated Balance Sheets, offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive loss in equity (see Note 18). Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive loss into income during the period of change. The euro senior unsecured term loan facility matures in September 2024. Refer to Note 16 for a further discussion of the above loan facility.

The Company has used cross-currency swap derivative contracts to partially hedge its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The cross-currency swap derivative contracts were agreements to exchange fixed-rate payments in one currency for fixed-rate payments in another currency. The Company maintained cross-currency swap derivative contracts with respect to its $650.0 million senior unsecured term loan facility. These contracts effectively converted the $650.0 million senior unsecured term loan facility to an obligation denominated in euros and partially offset the impact of changes in currency rates on foreign currency denominated net investments. During the year ended December 31, 2022, the Company settled all of its cross-currency swap derivative contracts and as of December 31, 2022 did not have any cross-currency swap derivative contracts outstanding. The changes in the fair value of these instruments were recorded in accumulated other comprehensive loss in equity, in the accompanying Consolidated Balance Sheets, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that was also recorded in accumulated other comprehensive loss as reflected in Note 18. Any ineffective portions of net investment hedges were reclassified from accumulated other comprehensive loss into income during the period of change. The interest income or expense from these swaps was recorded in interest expense, net in the Company’s Consolidated Statements of Operations consistent with the classification of interest expense attributable to the underlying debt.

The Company has also used interest rate swap derivative contracts to reduce its variability of cash flows related to interest payments with respect to its senior unsecured term loans. The interest rate swap contracts exchanged interest payments based on variable rates for interest payments based on fixed rates. During the year ended December 31, 2022, the existing interest rate swap matured. As of December 31, 2022, the Company did not have any outstanding interest rate swap contracts. The changes in the fair value of these instruments were recorded in accumulated other comprehensive loss in equity (see Note 18). Any ineffective portions of the cash flow hedges were reclassified from accumulated other comprehensive loss into income during the period of change. The interest income or expense from these swaps was recorded in interest expense in the Company’s Consolidated Statements of Operations consistent with the classification of interest expense attributable to the underlying debt.
The following table summarizes the notional values as of December 31, 2022 and 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the years ended December 31, 2022 and 2021 ($ in millions):
Notional AmountGain Recognized in OCI
Year Ended December 31, 2022
Foreign currency denominated debt$222.7 $13.8 
Interest rate contract— 2.2 
Foreign currency contracts— 68.5 
Total$222.7 $84.5 
Notional AmountGain Recognized in OCI
Year Ended December 31, 2021
Foreign currency denominated debt$236.5 $32.5 
Interest rate contracts250.0 6.1 
Foreign currency contracts650.0 49.7 
Total$1,136.5 $88.3 

Gains or losses related to the foreign currency contracts and foreign currency denominated debt were classified as foreign currency translation adjustments in the schedule of changes in OCI in Note 18, as these items were attributable to the Company’s hedges of its net investment in foreign operations. Gains or losses related to the interest rate contracts were classified as cash flow hedge adjustments in the schedule of changes in OCI in Note 18. The Company did not reclassify any deferred gains or losses related to net investment and cash flow hedges from accumulated other comprehensive loss to income during the year ended December 31, 2022. The Company reclassified $10.2 million, net of tax, of certain deferred losses related to its net investment hedges from accumulated other comprehensive loss to income during the year ended December 31, 2021 related to the Divestiture. In addition, the Company did not have any ineffectiveness related to net investment and cash flow hedges during the years ended December 31, 2022 and 2021. The cash inflows and outflows associated with the Company’s derivative contracts designated as net investment hedges are classified in investing activities in the accompanying Consolidated Statements of Cash Flows.

The Company’s derivative instruments, as well as its non-derivative debt instruments designated and qualifying as net investment hedges, were classified as of December 31, 2022 and 2021, in the Company’s Consolidated Balance Sheets as follows ($ in millions):
20222021
Derivative liabilities:
Accrued expenses and other liabilities$— $19.6 
Nonderivative hedging instruments:
Long-term debt$222.7 $236.5 
Amounts related to the Company’s derivatives expected to be reclassified from accumulated other comprehensive loss to net income during the next 12 months are not significant.
XML 37 R20.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements
 12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements FAIR VALUE MEASUREMENTS Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value where the Company’s assets and liabilities are required to be carried at fair value and provide for certain disclosures related to the valuation methods used within a valuation hierarchy as established within the accounting standards. This hierarchy prioritizes the inputs into three broad levels as follows: Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, or other observable characteristics for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation; and Level 3 inputs are unobservable inputs based on the Company’s assumptions. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety.
A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions):
Quoted Prices in
Active Market
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total
December 31, 2022:
Liabilities:
Deferred compensation plans$— $15.8 $— $15.8 
Contingent consideration$— $— $6.0 $6.0 
December 31, 2021:
Liabilities:
Interest rate swap derivative contracts$— $2.2 $— $2.2 
Cross-currency swap derivative contracts$— $17.4 $— $17.4 
Deferred compensation plans$— $16.5 $— $16.5 
Derivative Instruments
The cross-currency and interest rate swap derivative contracts were classified as Level 2 in the fair value hierarchy as they are measured using the income approach with the relevant interest rates, foreign currency current exchange rates and forward curves as inputs. Refer to Note 11 for additional information.

Deferred Compensation Plans
Certain management employees of the Company participate in nonqualified deferred compensation programs that permit such employees to defer a portion of their compensation, on a pretax basis. All amounts deferred under this plan are unfunded, unsecured obligations and are presented as a component of the Company’s compensation and benefits accrual included in accrued expenses in the accompanying Consolidated Balance Sheets (refer to Note 10). Participants may choose among alternative earnings rates for the amounts they defer, which are primarily based on investment options within the Company’s 401(k) program. Changes in the deferred compensation liability under these programs are recognized based on changes in the fair value of the participants’ accounts, which are based on the applicable earnings rates on investment options within the Company’s 401(k) program. Amounts voluntarily deferred by employees into the Company stock fund and amounts contributed to participant accounts by the Company are deemed invested in the Company’s common stock and future distributions of such contributions will be made solely in shares of Company common stock, and therefore are not reflected in the above amounts.
Contingent Consideration
Contingent consideration represents a cash hold back intended to be used for certain liabilities related to the Company’s acquisition of the Intraoral Scanner Business (as further discussed in Note 3). Contingent consideration was classified as Level 3 in the fair value hierarchy as the estimated fair value was measured using a probability weighted discounted cash flow model.
Fair Value of Financial Instruments
The carrying amounts and fair values of the Company’s financial instruments as of December 31, were as follows ($ in millions):
20222021
 Carrying AmountFair ValueCarrying AmountFair Value
Liabilities:
Contingent consideration$6.0 $6.0 $— $— 
Interest rate swap derivative contracts$— $— $2.2 $2.2 
Cross-currency swap derivative contracts$— $— $17.4 $17.4 
Convertible senior notes due 2025$510.0 $873.0 $432.1 $1,162.5 
Long-term debt$870.7 $870.7 $883.4 $883.4 
The fair value of long-term debt approximates the carrying value as these borrowings are based on variable market rates. The fair value of the convertible senior notes due 2025 was determined based on the quoted bid price of the convertible senior notes in an over-the-counter market on December 31, 2022 and 2021. The convertible senior notes are considered as Level 2 of the fair value hierarchy. The fair values of cash and cash equivalents, which consist primarily of money market funds, time and demand deposits, trade accounts receivable, net and trade accounts payable approximate their carrying amounts due to the short-term maturities of these instruments.

Refer to Note 13 for information related to the fair value of the Company sponsored defined benefit pension plan assets.
XML 38 R21.htm IDEA: XBRL DOCUMENT v3.22.4
Pension And Other Benefit Plans
 12 Months Ended
Dec. 31, 2022
Retirement Benefits [Abstract]  
Pension and Other Benefit Plans PENSION AND OTHER BENEFIT PLANS
Certain of the Company’s employees participate in defined benefit pension plans and under certain of these plans, benefit accruals continue. In general, the Company’s policy is to fund these plans based on considerations relating to legal requirements, underlying asset returns, the plan’s funded status, the anticipated deductibility of the contribution, local practices, market conditions, interest rates and other factors.
In connection with the Company’s restructuring activities (see Note 20), the Company had a reduction in participants in certain plans, which contributed to the change in the funded status through plan settlements and curtailments.
The following sets forth the funded status of the Company’s plans as of the most recent actuarial valuations using measurement dates of December 31 ($ in millions):
Pension Benefits
20222021
Change in pension benefit obligation:
Benefit obligation at beginning of year$(129.1)$(171.6)
Service cost(5.5)(7.3)
Interest cost(1.8)(1.2)
Employee contributions(2.5)(3.1)
Benefits and other expenses paid3.0 3.3 
Actuarial gain 27.3 13.0 
Amendments, settlements and curtailments7.7 33.2 
Foreign exchange rate impact3.4 4.6 
Benefit obligation at end of year(97.5)(129.1)
Change in plan assets:
Fair value of plan assets at beginning of year80.6 104.1 
Actual return on plan assets(1.7)5.8 
Employer contributions5.5 6.0 
Employee contributions2.5 3.1 
Amendments and settlements(6.6)(32.8)
Benefits and other expenses paid(3.1)(3.3)
Foreign exchange rate impact(2.8)(2.3)
Fair value of plan assets at end of year74.4 80.6 
Funded status$(23.1)$(48.5)

Weighted average assumptions used to determine benefit obligations at date of measurement:
December 31,
20222021
Discount rate3.9 %1.5 %
Rate of compensation increase2.8 %2.2 %
Components of net periodic pension cost:
Year Ended December 31,
($ in millions)202220212020
Service cost$(5.5)$(7.3)$(9.7)
Interest cost(1.8)(1.2)(1.6)
Expected return on plan assets2.6 3.3 3.7 
Amortization of prior service credit and initial net obligation0.3 0.4 0.4 
Amortization of actuarial gain (loss)0.1 (0.7)(1.4)
Net settlement and curtailment gain (loss)1.9 0.8 (1.4)
Net periodic pension cost$(2.4)$(4.7)$(10.0)
The following table represents the service cost and other net periodic benefit costs of the defined benefit pension plans incurred during the years ended December 31, 2022, 2021 and 2020 ($ in millions):
202220212020
Service cost:
    Cost of goods sold$(0.8)$(0.8)$(1.2)
    Selling, general and administrative(4.7)(6.5)(8.5)
Other net periodic pension costs:
Other income (expense)3.1 2.6 (0.3)
Total$(2.4)$(4.7)$(10.0)
Weighted average assumptions used to determine net periodic pension cost at date of measurement: 
Year Ended December 31,
20222021
Discount rate2.4 %1.0 %
Expected long-term return on plan assets3.3 %3.2 %
Rate of compensation increase2.2 %1.3 %

The discount rate reflects the market rate on December 31 of the prior year for high-quality fixed-income investments with maturities corresponding to the Company’s benefit obligations and is subject to change each year. The rates appropriate for each plan are determined based on investment grade instruments with maturities approximately equal to the average expected benefit payout under the plan. The Company periodically updates the mortality assumptions used to estimate the projected benefit obligation.

Included in accumulated other comprehensive loss as of December 31, 2022 are the following amounts that have not yet been recognized in net periodic pension cost: unrecognized prior service credits of $2.3 million ($1.8 million, net of tax) and unrecognized actuarial gain of $17.5 million ($13.6 million, net of tax). The unrecognized actuarial gain and prior service credits, net, are calculated as the difference between the actuarially determined projected benefit obligation and the value of the plan assets less accrued pension costs as of December 31, 2022. The amounts included in accumulated comprehensive income (loss) and expected to be recognized in net periodic pension costs during the year ending December 31, 2023 is a prior service credit of $0.4 million ($0.3 million, net of tax) and an actuarial gain of $1.4 million ($1.1 million, net of tax), respectively. No plan assets are expected to be returned to the Company during the year ending December 31, 2023.

Selection of Expected Rate of Return on Assets
The expected rate of return reflects the asset allocation of the plans and is based primarily on contractual earnings rates included in existing insurance contracts as well as on broad, publicly-traded equity and fixed-income indices and forward-looking estimates of active portfolio and investment management. Long-term rate of return on asset assumptions for the plans were determined on a plan-by-plan basis based on the composition of assets and ranged from 2.3% to 5.3% in 2022 and 1.8% to 5.3% in 2021, with a weighted average rate of return assumption of 3.3% and 3.2% in 2022 and 2021, respectively.
Plan Assets
Plan assets are invested in various insurance contracts, equity and debt securities as determined by the administrator of each plan.
The Company has some investments that are valued using Net Asset Value (“NAV”) as a practical expedient. In addition, some of the investments valued using NAV may only allow redemption monthly, quarterly, semiannually or annually and require up to 90 days prior written notice. These investments valued using NAV primarily consist of mutual funds which allow the Company to diversify the portfolio.
The fair values of the Company’s pension plan assets as of December 31, 2022, by asset category, were as follows ($ in millions):
Quoted Prices in
Active Market
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total
Cash and cash equivalents$8.4 $— $— $8.4 
Insurance contracts— — 49.7 49.7 
Total$8.4 $— $49.7 $58.1 
Investments measured at NAV (a):
Mutual funds16.3 
Total assets at fair value$74.4 
______________
(a)The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the total plan assets.
The following table summarizes the changes in Level 3 pension plan assets measured at fair value on a recurring basis for the year ended December 31, 2022 (in millions):
Fair Value at January 1Return on Plan AssetsNet Purchases/(Settlements)Transfers Into/(Out of) Level 3Fair Value at December 31
Insurance contracts$50.1 $(0.1)$(0.3)$— $49.7 

The fair values of the Company’s pension plan assets as of December 31, 2021, by asset category, were as follows ($ in millions):
Quoted Prices in
Active Market
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total
Cash and cash equivalents$0.3 $— $— $0.3 
Insurance contracts— — 50.1 50.1 
Total$0.3 $— $50.1 $50.4 
Investments measured at NAV (a):
Mutual funds30.2 
Total assets at fair value$80.6 
______________
(a)The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the total plan assets.
The following table summarizes the changes in Level 3 pension plan assets measured at fair value on a recurring basis for the year ended December 31, 2021 (in millions):
Fair Value at January 1Return on Plan AssetsNet Purchases/(Settlements)Transfers Into/(Out of) Level 3Fair Value at December 31
Insurance contracts$77.2 $(0.6)$(26.5)$— $50.1 
Insurance contracts are valued based upon the quoted prices of the underlying investments of the insurance company. Mutual funds are valued using the NAV based on the information provided by the asset fund managers, which reflects the plan’s share of the fair value of the net assets of the investment.
The methods described above may produce a fair value estimate that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes the valuation methods are appropriate and consistent with the methods used by other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.
Expected Contributions
During 2022, the Company contributed $5.5 million to its defined benefit pension plans. During 2023, the Company’s cash contribution requirements for its defined benefit pension plans are expected to be approximately $5.5 million.
The following sets forth benefit payments, which reflect expected future service, as appropriate, at December 31, 2022, are expected to be paid by the plans in the periods indicated ($ in millions):
2023$5.6 
2024$5.1 
2025$5.1 
2026$4.8 
2027$4.8 
2028 - 2032$24.1 
Other Matters
U.S. employees not covered by defined benefit plans are generally covered by defined contribution plans, which provide for Company funding based on a percentage of compensation. The Company provides eligible employees the opportunity to participate in defined contribution savings plans (commonly known as 401(k) plans), which permit contributions on a before-tax basis. Employees may contribute to various investment alternatives. In most of these plans, the Company matches a portion of the employees’ contributions. The Company’s contributions to these plans amounted to $19.1 million, $18.0 million and $11.0 million for the years ended December 31, 2022, 2021 and 2020, respectively.
A limited number of the Company’s subsidiaries, primarily outside of the United States, participate in multiemployer defined benefit plans that require the Company to periodically contribute funds to the plan. Multi-employer pension plans are designed to cover employees from multiple employers. These plans allow multiple employers to pool their pension resources and realize efficiencies associated with the daily administration of the plan. The risks of participating in a multiemployer plan differ from the risks of participating in a single-employer plan in the following respects: (1) assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers, (2) if a participating employer ceases contributing to the plan, the unfunded obligations of the plan may be required to be borne by the remaining participating employers and (3) if the Company elects to stop participating in the plan, the Company may be required to pay the plan an amount based on the unfunded status of the plan.
The Company’s expense for multiemployer pension plans totaled $1.6 million, $3.9 million and $8.2 million for the years ended December 31, 2022, 2021 and 2020, respectively.
XML 39 R22.htm IDEA: XBRL DOCUMENT v3.22.4
Warranty
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Warranty WARRANTY
The Company generally accrues estimated warranty costs at the time of sale. In general, manufactured products are warranted against defects in material and workmanship when properly used for their intended purpose, installed correctly and appropriately maintained. Warranty periods depend on the nature of the product and range from 90 days up to the life of the product. The amount of the accrued warranty liability is determined based on historical information such as past experience, product failure rates or number of units repaired, estimated cost of material and labor and in certain instances estimated property damage. The accrued warranty liability is reviewed on a quarterly basis and may be adjusted as additional information regarding expected warranty costs becomes known.
The following is a rollforward of the Company’s accrued warranty liability ($ in millions):
Balance at December 31, 2021$9.4 
Accruals for warranties issued during the year15.3 
Settlements made(15.1)
Divestiture(0.1)
Effect of foreign currency translation(0.3)
Balance at December 31, 2022$9.2 
XML 40 R23.htm IDEA: XBRL DOCUMENT v3.22.4
Litigation And Contingencies
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Litigation And Contingencies LITIGATION AND CONTINGENCIES
The Company records accruals for loss contingencies associated with legal matters when it is probable that a liability will be incurred, and the amount of the loss can be reasonably estimated.

If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss does not meet the known or probable level but is reasonably possible, it is disclosed if deemed material and if such loss or range of loss can be reasonably estimated, the estimated loss or range of loss is disclosed. The Company’s reserves consist of specific reserves for individual claims and additional amounts for anticipated developments of these claims as well as for incurred but not yet reported claims. The specific reserves for individual known claims are quantified with the assistance of legal counsel and outside risk professionals where appropriate. In addition, outside risk professionals assist in the determination of reserves for certain incurred but not yet reported claims through evaluation of the Company’s specific loss history, actual claims reported and industry trends among statistical and other factors. The Company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated and has accrued $35.7 million and $38.7 million as of December 31, 2022 and 2021, respectively, which are included in accrued liabilities in the Consolidated Balance Sheets. The Company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with ASC 450-20-25. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions including timing of related payments. The ability to make such estimates and judgments can be affected by various factors including, among other things, whether damages sought in the proceedings are unsubstantiated or indeterminate; legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; procedural or jurisdictional issues; the uncertainty and unpredictability of the number of potential claims; or there are numerous parties involved. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated. In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's Consolidated Balance Sheets, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company’s results of operations and cash flows for that period.

The Company is subject to various environmental laws and regulations both within and outside of the United States. The operations of the Company involve the use of substances regulated under environmental laws, primarily in manufacturing processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws or potential enforcement actions by regulatory agencies, management believes that such compliance or potential enforcement actions will not have a material impact on the Company’s financial position, results of operations, or liquidity.

As of December 31, 2022, the Company had $19.0 million of guarantees consisting primarily of outstanding standby letters of credit and bank guarantees. These guarantees have been provided in connection with certain arrangements with vendors, customers, insurance providers, financing counterparties and governmental entities to secure the Company’s obligations and/or performance requirements related to specific transactions.
XML 41 R24.htm IDEA: XBRL DOCUMENT v3.22.4
Debt And Credit Facilities
 12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
Debt And Credit Facilities DEBT AND CREDIT FACILITIES
The components of the Company’s debt as of December 31, were as follows, net of debt discount and debt issuance costs ($ in millions):
20222021
Senior term loan facility due 2024 (the “Term Loan”)
$648.3 $647.3 
Senior euro term loan facility due 2024 (the “Euro Term Loan”)222.4 236.1 
Convertible senior notes due 2025
510.0 432.1 
Other— 0.3 
Total debt1,380.7 1,315.8 
Less: current portion(510.0)(432.4)
Long-term debt$870.7 $883.4 
The Company’s contractual minimum principal payments are as follows ($ in millions):

2023$— 
2024872.7 
2025517.5 
Total$1,390.2 

Credit Agreement
On September 20, 2019, the Company entered into a credit agreement (the “Credit Agreement”) with a syndicate of banks under which Envista borrowed approximately $1.3 billion, consisting of the three-year $650.0 million Term Loan and the three-year €600.0 million Euro Term Loan (together with the Term Loan, the “Term Loans”). The Credit Agreement also included the five-year, $250.0 million revolving credit facility (together with the Term Loans, the “Senior Credit Facilities”).

On February 9, 2021, in connection with an amendment to the Credit Agreement, the Company repaid $472.0 million of its Euro Term Loan.

On June 15, 2021, the Company entered into an amended and restated credit agreement (the “Amended Credit Agreement”) with a syndicate of banks. The Amended Credit Agreement amends and restates the Company’s Credit Agreement, originally dated September 20, 2019 (as amended by Amendment No. 1 to Credit Agreement dated as of May 6, 2020, Amendment No. 2 to Credit Agreement dated as of May 19, 2020, and Amendment No. 3 to Credit Agreement dated as of February 9, 2021).

Under the Amended Credit Agreement: (a) the maturity date of the Company’s existing Term Loans has been extended to September 20, 2024, (b) the revolving credit facility has been increased from $250.0 million to $750.0 million, (c) the Company may request further increases to the revolving credit facility in an aggregate amount not to exceed $350.0 million, (d) the amount of cash and cash equivalents permitted to be netted in the definition of “Consolidated Funded Indebtedness” has been increased to up to the greater of (i) $250.0 million and (ii) 50% of Consolidated EBITDA as of the most recent measurement period, and (e) the floor on Eurocurrency rate loans applicable to the revolving credit facility and the Term Loan has been reduced to zero, in each case subject to and in accordance with the terms and conditions of the Amended Credit Agreement. The Company paid fees aggregating approximately $2.1 million in connection with the Amended Credit Agreement.

The revolving credit facility includes an aggregate available borrowing capacity of $750.0 million with a $20.0 million sublimit for the issuance of standby letters of credit and can be used for working capital and other general corporate purposes. As of December 31, 2022 and December 31, 2021, there were no borrowings outstanding under the revolving credit facility.
Under the Senior Credit Facilities, borrowings bear interest as follows: (1) Eurocurrency Rate Loans (as defined in the Amended Credit Agreement) bear interest at a variable rate equal to the London inter-bank offered (“LIBOR”) rate plus a margin of between 0.785% and 1.625%, depending on the Company’s Consolidated Leverage Ratio (as defined in the Amended Credit Agreement) as of the last day of the immediately preceding fiscal quarter; and (2) Base Rate Loans (as defined in the Amended Credit Agreement) bear interest at a variable rate equal to (a) the highest of (i) the Federal funds rate (as published by the Federal Reserve Bank of New York from time to time) plus 0.50%, (ii) Bank of America’s “prime rate” as publicly announced from time to time and (iii) the Eurocurrency Rate (as defined in the Amended Credit Agreement) plus 1.0%, plus (b) a margin of between 0.00% and 0.625%, depending on the Company’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter. In no event will Eurocurrency Rate Loans or Base Rate Loans bear interest at a rate lower than 0.0%. The Amended Credit Agreement provides for the use of Secured Overnight Financing Rate (“SOFR”) as a replacement rate upon a LIBOR cessation event. In addition, the Company is required to pay a per annum facility fee of between 0.09% and 0.225% depending on the Company’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter and based on the aggregate commitments under the revolving credit facility, whether drawn or not.
The interest rates for borrowings under the Term Loan were 5.98% and 1.25% as of December 31, 2022 and 2021, respectively. The interest rate for borrowings under the Euro Term Loan was 3.28% and 0.95% as of December 31, 2022 and 2021, respectively. Interest is payable quarterly for the Term Loans. The Amended Credit Agreement requires the Company to maintain a Consolidated Leverage Ratio of 3.75 to 1.00 or less and includes a provision that the maximum Consolidated Leverage Ratio will be increased to 4.25 to 1.00 for the four consecutive full fiscal quarters immediately following the consummation of any acquisition by the Company or any subsidiary of the Company in which the purchase price exceeds $100.0 million. The Amended Credit Agreement also requires the Company to maintain a Consolidated Interest Coverage Ratio (as defined in the Amended Credit Agreement) of at least 3.00 to 1.00. The Amended Credit Agreement contains customary representations, warranties, conditions precedent, events of default, indemnities and affirmative and negative covenants, including covenants that, among other things, limit or restrict the Company’s and/or the Company’s subsidiaries ability, subject to certain exceptions and qualifications, to incur liens or indebtedness, merge, consolidate or sell or otherwise transfer assets, make dividends or distributions, enter into transactions with the Company’s affiliates and use proceeds of the debt financing for other than permitted uses. The Amended Credit Agreement also contains customary events of default. Upon the occurrence and during the continuance of an event of default, the lenders may declare the outstanding advances and all other obligations under the Amended Credit Agreement immediately due and payable. The Company was in compliance with all of its debt covenants as of December 31, 2022.
Convertible Senior Notes (the “Notes”)

On May 21, 2020, the Company issued the Notes due on June 1, 2025, unless earlier repurchased, redeemed or converted. The aggregate principal amount, which includes the initial purchasers’ exercise in full of their option to purchase an additional $67.5 million principal amount of the Notes, was $517.5 million. The net proceeds from the issuance, after deducting purchasers’ discounts and estimated offering expenses, were $502.6 million. The Company used part of the net proceeds to pay for the capped call transactions (“Capped Calls”) as further described below. The Notes accrue interest at a rate of 2.375% per annum, payable semi-annually in arrears on June 1 and December 1 of each year, beginning on December 1, 2020. The Notes have an initial conversion rate of 47.5862 shares of the Company’s common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $21.01 per share of the Company’s common stock and is subject to adjustment upon the occurrence of specified events. The Notes are governed by an indenture dated as of May 21, 2020 (the “Indenture”) between the Company and Wilmington Trust, National Association, as trustee. The Indenture does not contain any financial covenants or any restrictions on the payment of dividends, the incurrence of senior debt or other indebtedness or the issuance or repurchase of the Company’s securities by the Company.

Prior to the adoption of ASU 2020-06, the Company separated the carrying amounts of the Notes and total issuance costs incurred into liability and equity components. For the Notes, the carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that did not have an associated convertible feature, while the carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the Notes. Total issuance costs incurred were then allocated to the liability and equity components of the Notes based on their relative values.

Due to the Company’s adoption of ASU 2020-06 on January 1, 2022, the Notes and related issuance costs incurred are no longer required to be bifurcated into separate liability and equity components. This resulted in a $75.0 million increase to the carrying value of the Notes due 2025, comprised of unamortized discount of $76.5 million and deferred debt issuance costs of $1.5 million and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption of ASU 2020-06 resulted in a $21.4 million increase to retained earnings and an $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs.

The Notes are the Company’s senior, unsecured obligations and are (i) equal in right of payment with the Company’s existing and future senior, unsecured indebtedness; (ii) senior in right of payment to the Company’s existing and future indebtedness that is expressly subordinated to the Notes; (iii) effectively subordinated to the Company’s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness; and (iv) structurally subordinated to all existing and future indebtedness and other liabilities, including trade payables, and (to the extent the Company is not a holder thereof) preferred equity, if any, of the Company’s subsidiaries.
Holders of the Notes may convert their Notes at any time on or after December 2, 2024 until the close of business on the second scheduled trading day preceding the maturity date. Holders of the Notes will also have the right to convert the Notes prior to December 2, 2024, but only upon the occurrence of specified events. In December 2021, the Company made the irrevocable election to settle all Notes conversions through combination settlement, satisfying the principal amount outstanding with cash and any Notes conversion value in excess of the principal amount in cash, shares of the Company’s common stock or a combination of both. If a fundamental change occurs prior to the maturity date, holders of the Notes may require the Company to repurchase all or a portion of their Notes for cash at a repurchase price equal to 100.0% of the principal amount plus any accrued and unpaid interest. In addition, if specific corporate events occur prior to the maturity date, the Company would increase the conversion rate for a holder who elects to convert its Notes in connection with such an event in certain circumstances. As of December 31, 2022 and 2021, the stock price exceeded 130% of the conversion price of $21.01 in 20 days of the final 30 trading days ended December 31, 2022 and 2021, which satisfied one of the conditions permitting early conversion by holders of the Notes, therefore, the Notes are classified as short-term debt.

The Notes will be redeemable, in whole or in part, at the Company’s option at any time, and from time to time, on or after June 1, 2023 and on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding the redemption date, but only if the last reported sale price per share of the Company’s common stock exceeds 130.0% of the conversion price on (i) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (ii) the trading day immediately before the date the Company sends such notice. In addition, calling any Note for redemption will constitute a “Make-Whole Fundamental Change” (as defined in the Indenture) with respect to that Note, in which case the conversion rate applicable to the conversion of that Note will be increased in certain circumstances if it is converted after it is called for redemption.

The following table sets forth total interest expense recognized related to the Notes ($ in millions):

Year Ended December 31,
20222021
Contractual interest expense
$12.3 $12.3 
Amortization of debt issuance costs
2.9 1.9 
Amortization of debt discount
— 19.0 
Total interest expense
$15.2 $33.2 

For the years ended December 31, 2022 and 2021, the debt discount and debt issuance costs were amortized using an annual effective interest rate of 3.0% and 7.3%, respectively, to interest expense over the term of the Notes.

As of December 31, 2022 and 2021, the if-converted value of the Notes exceeded the outstanding principal amount by $311.7 million and $592.1 million, respectively.
Debt Discount and Debt Issuance Costs

As of December 31, 2022 and 2021, remaining unamortized debt discount and debt issuance costs for the Term Loan, Euro Term Loan and Convertible Senior Notes are as follows ($ in millions):
20222021
Debt Issuance CostsDebt DiscountDebt Issuance CostsDebt Discount
Convertible Senior Notes$7.5 $— $8.9 $76.5 
Term Loan1.7 — 2.7 — 
Euro Term Loan0.3 — 0.5 — 
$9.5 $— $12.1 $76.5 

The above unamortized debt discount and debt issuance costs have been netted against their respective aggregate principal amounts of the related debt and are being amortized to interest expense over the term of the respective debt.
Capped Call Transactions
In connection with the offering of the Notes, the Company entered into Capped Calls with certain counterparties. The Capped Calls each have an initial strike price of approximately $21.01 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Notes. The Capped Calls have initial cap prices of $23.79 per share, subject to certain adjustments. The Capped Calls cover, subject to anti-dilution adjustments, 2.9 million shares of the Company's common stock. The Capped Calls are generally intended to reduce or offset the potential dilution from shares of common stock issued upon any conversion of the Notes with such reduction or offset, as the case may be, subject to a cap based on the cap price. As the Capped Call transactions are considered indexed to the Company's own stock and are considered equity classified, they are recorded in equity and are not accounted for as derivatives. The cost of $20.7 million incurred in connection with the Capped Calls was recorded as a reduction to additional paid-in capital.
XML 42 R25.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Transactions And Stock-Based Compensation
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Stock Transactions And Stock-Based Compensation STOCK TRANSACTIONS AND STOCK-BASED COMPENSATION
Capital Stock
Under the Company’s amended and restated certificate of incorporation, the Company’s authorized capital stock consists of 500.0 million shares of common stock with a par value of $0.01 per share and 15.0 million shares of preferred stock with a par value of $0.01 per share. No preferred shares were issued or outstanding as of December 31, 2022 and 2021.
Each share of the Company’s common stock entitles the holder to one vote on all matters to be voted upon by common stockholders. The Company’s Board of Directors (the “Board”) is authorized to issue shares of preferred stock in one or more series and has discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series of preferred stock. The Board’s authority to issue preferred stock with voting rights or conversion rights that, if exercised, could adversely affect the voting power of the holders of common stock, could potentially discourage attempts by third parties to obtain control of the Company through certain types of takeover practices.
The following table summarizes the Company’s stock activity (shares in millions):
Year Ended December 31,
202220212020
Common stock - shares issued:
Balance, beginning of period162.0 160.2 158.7 
Issuance of common stock 1.7 1.8 1.5 
Balance, end of period163.7 162.0 160.2 
Stock-Based Compensation
The Company adopted the 2019 Omnibus Incentive Plan (the “Stock Plan”) that provides for the grant of stock appreciation rights, restricted stock units (“RSUs”), and performance stock units (‘PSUs”) (collectively, “Stock Awards”), as well as stock options (“Options”). A total of 21.0 million shares of the Company’s common stock have been authorized for issuance under the Stock Plan. Under the Stock Plan, stock-based grants are awarded at a price equal to the fair market value at the date of grant based upon the closing price on that date. Options and Stock Awards generally vest over a period of three to five years. Options expire ten years after the date of grant.
RSUs issued under the Stock Plan provide for the issuance of a share of the Company’s common stock at no cost to the holder. The RSUs granted to employees provide for time-based vesting, generally over a three to five-year period. Prior to vesting, RSUs granted under the Stock Plan do not have dividend equivalent rights, do not have voting rights and the shares underlying the RSUs are not considered issued and outstanding. PSUs issued under the Stock Plan provide for the issuance of a share of the Company’s common stock based on the achievement of various financial performance metric targets and market conditions, which are set at the time of grant.

The Company accounts for stock-based compensation by measuring all RSUs, PSUs and Options at fair value as of the grant date. The Company recognizes the compensation expense over the requisite service period (which is generally the vesting period but may be shorter than the vesting period if the employee becomes retirement eligible before the end of the vesting period). The fair value for RSU awards is calculated using the closing price of the Company’s common stock on the date of grant. The fair value of the Options granted is calculated using a Black-Scholes option pricing model (“Black-Scholes”).
On December 23, 2021 and January 21, 2022, the Company entered into and finalized, respectively, an RSU agreement with Pacific Dental Services (“PDS”) which awarded PDS RSUs with a fair value of $12.5 million, or 273,522 RSUs, based on the Company’s stock price on December 23, 2021. The RSUs vest over approximately three years and contain performance milestones. All of the 273,522 RSUs remained unvested as of December 31, 2022.
The following summarizes the assumptions used in the Black-Scholes model to value Options granted during the years ended December 31:
202220212020
Risk-free interest rate
1.9 – 3.1%
1.0 – 1.3%
0.4 – 1.2%
Weighted average volatility33.6 %25.3 %25.3 %
Dividend yield— %— %— %
Expected years until exercise
6.0
6.0
6.0
The risk-free rate of interest for periods within the contractual life of the awards is based on a zero-coupon U.S. government instrument with a maturity period that approximates the award’s expected term. The weighted average volatility used in the Black-Scholes model to value Options was estimated based on an average historical stock price volatility of a peer group of companies. The dividend yield was 0.0% as the Company does not offer a dividend. To estimate the option exercise timing used in the valuation model, in addition to considering the vesting period and contractual term of the Option, the Company analyzes and considers actual historical exercise experience for previously granted awards.
The amount of stock-based compensation expense recognized during a period is also based on the portion of the awards that are ultimately expected to vest. The Company estimates pre-vesting forfeitures at the time of grant by analyzing historical data and revises those estimates in subsequent periods if actual forfeitures differ from those estimates. The Company has estimated an annual forfeiture rate of 6.0% for the years ended December 31, 2022, 2021 and 2020.
The following summarizes the components of the Company’s stock-based compensation expense for the years ended December 31 ($ in millions):
202220212020
RSUs / PSUs$19.3 $15.5 $13.3 
Options11.2 12.2 8.9 
Total stock-based compensation expense$30.5 $27.7 $22.2 
The Company’s stock-based compensation is primarily recognized as a component of selling, general and administrative expenses in the accompanying Consolidated Statements of Operations. As of December 31, 2022, $43.6 million of total unrecognized compensation cost related to Options and RSUs/PSUs is expected to be recognized over a weighted average period of approximately two years.

The following summarizes the Company’s Option activity (in millions; except price per share and numbers of years):
Number of Stock Options
Weighted
Average
Exercise Price
Weighted Average
Remaining
Contractual Term
(in years)
Aggregate
Intrinsic
Value
Outstanding as of December 31, 20198.0 $17.81 
Granted
2.2 $26.14 
Exercised
(1.0)$14.01 
Cancelled/forfeited
(1.1)$21.17 
Outstanding as of December 31, 20208.1 $20.08 
Granted
1.7 $38.15 
Exercised
(1.3)$15.74 
Cancelled/forfeited
(0.6)$26.74 
Outstanding as of December 31, 20217.9 $24.16 
Granted
0.5 $48.23 
Exercised
(1.2)$18.61 
Cancelled/forfeited
(0.7)$30.29 
Outstanding as of December 31, 20226.5 $26.24 6.3$59.7 
Vested and expected to vest as of December 31, 2022
6.3 $26.09 6.3$58.8 
Vested as of December 31, 2022
3.2 $22.01 5.4$39.3 

Options outstanding as of December 31, 2022 are summarized below (in millions; except price per share and numbers of years):
OutstandingExercisable
Exercise PriceNumber of Stock OptionsAverage
Exercise Price		Average
Remaining
Life
(in years)		Number of Stock OptionsAverage
Exercise Price
$9.74 to 12.65
0.4 $12.00 2.40.4 $12.00 
$12.66 to 19.22
1.6 $17.95 4.81.3 $17.66 
$19.23 to 26.50
2.7 $24.15 6.51.0 $24.10 
$26.51 to $41.95
1.4 $36.74 7.90.5 $35.85 
$41.96 to 48.52
0.4 $48.01 8.9— $43.30 
The intrinsic value of Options is calculated as the amount by which the market price of the Company’s stock exceeds the exercise price of the Option. The aggregate intrinsic value of Options exercised during the years ended December 31, 2022, 2021 and 2020 was $31 million, $33 million and $12 million, respectively.
The following summarizes information on unvested RSU and PSU activity related to the Company’s employees and non-employee directors (in millions; except weighted average grant-date fair value):
Number of
RSUs/PSUs		Weighted Average
Grant-Date Fair Value
Unvested at December 31, 20192.1 $19.60 
Granted0.7 $25.76 
Vested(0.5)$17.87 
Forfeited(0.4)$20.98 
Unvested at December 31, 20201.9 $22.01 
Granted0.5 $38.76 
Vested(0.5)$20.34 
Forfeited(0.2)$26.54 
Unvested at December 31, 20211.7 $26.82 
Granted0.6 $47.80 
Vested(0.5)$24.85 
Forfeited(0.3)$33.62 
Unvested at December 31, 20221.5 $34.85 

The Company recognizes tax benefits for stock compensation in certain jurisdictions, primarily the United States, where tax deductions are based on market value at exercise or release and may exceed the grant-date value. The Company realized such tax benefits of $4 million, $4 million and $1 million in 2022, 2021 and 2020, respectively, related to the exercise of Options and $1 million in each of the years ended December 31, 2022, 2021 and 2020, related to the vesting and release of RSUs and PSUs. For all periods presented, the tax benefits were included as a component of income tax expense and as an operating cash inflow in the accompanying Consolidated Financial Statements.
In connection with the exercise of certain Options and the vesting of RSUs and PSUs, a number of shares sufficient to fund statutory minimum tax withholding requirements has been withheld from the total shares issued or released to the award holders (though under the terms of the applicable plan, the shares are considered to have been issued and are not added back to the pool of shares available for grant). During the year ended December 31, 2022, 192.4 thousand shares with an aggregate value of $9 million were withheld to satisfy the requirement. During the year ended December 31, 2021, 181.7 thousand shares with an aggregate value of $7 million were withheld to satisfy the requirement.
XML 43 R26.htm IDEA: XBRL DOCUMENT v3.22.4
Accumulated Other Comprehensive Loss
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Accumulated Other Comprehensive Loss ACCUMULATED OTHER COMPREHENSIVE LOSS
The changes in accumulated other comprehensive loss by component are summarized below ($ in millions):
Foreign Currency Translation AdjustmentsUnrealized Gain (Loss) on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Balance, December 31, 2019$(116.4)$0.1 $(27.9)$(144.2)
Other comprehensive income (loss) before reclassifications:
Increase (decrease)26.0 (8.4)3.9 21.5 
Income tax impact27.9 2.0 (1.1)28.8 
Other comprehensive income (loss) before reclassifications, net of income taxes53.9 (6.4)2.8 50.3 
Amounts reclassified from accumulated other comprehensive (loss) income:
Increase— — 2.9 2.9 
Income tax impact— — (0.8)(0.8)
Amounts reclassified from accumulated other comprehensive (loss) income, net of income taxes— — 2.1 2.1 
Net current period other comprehensive income (loss), net of income taxes
53.9 (6.4)4.9 52.4 
Balance, December 31, 2020$(62.5)$(6.3)$(23.0)$(91.8)
Other comprehensive loss before reclassifications:
(Decrease) increase(72.7)6.1 21.9 (44.7)
Income tax impact(17.0)(1.5)(4.7)(23.2)
Other comprehensive (loss) income before reclassifications, net of income taxes(89.7)4.6 17.2 (67.9)
Amounts reclassified from accumulated other comprehensive loss income:
Increase15.9 — 5.0 20.9 
Income tax impact(3.3)— (1.4)(4.7)
Amounts reclassified from accumulated other comprehensive loss, net of income taxes12.6 — 3.6 16.2 
Net current period other comprehensive (loss) income, net of income taxes(77.1)4.6 20.8 (51.7)
Balance, December 31, 2021$(139.6)$(1.7)$(2.2)$(143.5)
Other comprehensive loss before reclassifications:
(Decrease) increase(80.5)2.2 24.6 (53.7)
Income tax impact(20.4)(0.5)(5.2)(26.1)
Other comprehensive (loss) income before reclassifications, net of income taxes(100.9)1.7 19.4 (79.8)
Amounts reclassified from accumulated other comprehensive loss income:
Increase— — (2.3)(2.3)
Income tax impact— — 0.5 0.5 
Amounts reclassified from accumulated other comprehensive loss, net of income taxes— — (1.8)(1.8)
Net current period other comprehensive (loss) income, net of income taxes(100.9)1.7 17.6 (81.6)
Balance, December 31, 2022$(240.5)$— $15.4 $(225.1)
XML 44 R27.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue
 12 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
Revenue REVENUE
The following table presents the Company’s revenues disaggregated by geographical region for the years ended December 31, 2022 and 2021 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenues. The Company has historically defined emerging markets as developing markets of the world, which prior to the COVID-19 pandemic, experienced extended periods of accelerated growth in gross domestic product and infrastructure, including Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets of the world that are not emerging markets.
Year Ended December 31, 2022
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Geographical region:
North America$711.1 $655.3 $1,366.4 
Western Europe388.9 121.1 510.0 
Other developed markets91.0 38.6 129.6 
Emerging markets407.6 155.5 563.1 
Total$1,598.6 $970.5 $2,569.1 

Year Ended December 31, 2021
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Geographical region:
North America$668.9 $659.3 $1,328.2 
Western Europe366.6 125.9 492.5 
Other developed markets98.2 41.2 139.4 
Emerging markets374.1 174.7 548.8 
Total$1,507.8 $1,001.1 $2,508.9 

Sales by Major Product Group:
Year Ended December 31,
($ in millions)202220212020
Consumables$2,147.5 $2,067.9 $1,590.7 
Equipment421.6 441.0 338.4 
Total$2,569.1 $2,508.9 $1,929.1 
Consumable products include implants, regenerative products, prosthetics, orthodontic brackets, aligners and lab products from our Specialty Products & Technologies business segment and traditional consumables such as bonding agents and cements, impression materials, infection prevention products and restorative products from the Company’s Equipment & Consumables business segment. The Company’s equipment products include digital imaging systems, software and other visualization and magnification systems.

Remaining Performance Obligations
ASC 606 requires disclosure of remaining performance obligations that represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. Remaining performance obligations include noncancelable purchase orders, extended warranty and service agreements and do not include revenue from contracts with customers with an original term of one year or less.
As of December 31, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was $52.7 million and the Company expects to recognize revenue on the majority of this amount over the next 12 months.
Contract Liabilities
The Company often receives cash payments from customers in advance of the Company’s performance resulting in contract liabilities. These contract liabilities are classified as either current or long-term in the Consolidated Balance Sheets based on the timing of when the Company expects to recognize revenue. As of December 31, 2022 and 2021, the contract liabilities were $87.5 million and $65.2 million, respectively, and are included within accrued expenses and other liabilities and other long-term liabilities in the accompanying Consolidated Balance Sheets. The increase in the contract liability balance during the years ended December 31, 2022 and 2021, is primarily due to cash payments received in advance of satisfying performance obligations, partially offset by revenue recognized during the period that was included in the contract liability balance at December 31, 2021 and 2020, respectively.
Revenue recognized during the years ended December 31, 2022 and 2021 that was included in the contract liability balance at December 31, 2021 and December 31, 2020 was $52.8 million and $38.4 million, respectively.
Significant Customers
Sales to the Company’s largest customer were 11%, 12%, and 11% of sales for the years ended December 31, 2022, 2021 and 2020, respectively.
XML 45 R28.htm IDEA: XBRL DOCUMENT v3.22.4
Restructuring Activities And Related Impairments
 12 Months Ended
Dec. 31, 2022
Restructuring and Related Activities [Abstract]  
Restructuring Activities And Related Impairments RESTRUCTURING ACTIVITIES AND RELATED IMPAIRMENTS
Restructuring Activities
The Company’s restructuring activities are undertaken as necessary to implement management’s strategy, streamline operations, take advantage of available capacity and resources, and ultimately achieve net cost reductions. These activities generally relate to the realignment of existing manufacturing capacity and closure of facilities and other exit or disposal activities, as it relates to executing the Company’s strategy, pursuant to significant restructuring programs.
The related liability which is included in accrued liabilities in the Consolidated Balance Sheets is summarized below ($ in millions):
Employee Severance
and Related		Facility Exit
and Related		Total
Balance, December 31, 2021$21.4 $0.5 21.9 
Costs incurred20.8 5.7 26.5 
Paid/settled(24.0)(5.5)(29.5)
Balance, December 31, 2022$18.2 $0.7 $18.9 

Restructuring related charges recorded for the years ended December 31 by segment were as follows ($ in millions): 
202220212020
Specialty Products & Technologies$14.7 $25.2 $43.8 
Equipment & Consumables19.7 32.1 34.6 
Other3.2 6.3 6.0 
Total$37.6 $63.6 $84.4 
The restructuring related charges incurred during the years ended December 31, are reflected in the following captions in the accompanying Consolidated Statements of Operations ($ in millions):
202220212020
Cost of sales$13.6 $35.9 $18.3 
Selling, general and administrative expenses24.0 27.7 66.1 
Total$37.6 $63.6 $84.4 
Impairments

During the year ended December 31, 2022 and 2021, the Company made the decision to consolidate certain facilities in an effort to improve its cost structure. For the year ended December 31, 2022, the Company recognized a non-cash loss of $11.1 million with the majority of this loss consisting of $4.8 million related to the impairment of certain fixed assets and leases, which are included in selling, general and administrative expense and cost of sales and $4.7 million of inventory write-offs, which is included in cost of sales. For the year ended December 31, 2021, the Company recognized a non-cash loss of $29.8 million with the majority of this loss consisting of $19.0 million related to the impairment of certain fixed assets and leases, which are included in selling, general and administrative expense and cost of sales and $10.8 million of inventory write-offs, which is included in cost of sales.
XML 46 R29.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Income Taxes INCOME TAXES
Income (loss) before income taxes for the years ended December 31 were as follows ($ in millions):
202220212020
United States$21.9 $35.0 $(64.3)
International262.0 219.5 44.3 
Total$283.9 $254.5 $(20.0)
The provision (benefit) for income taxes for the years ended December 31 were as follows ($ in millions):
202220212020
Current:
Federal U.S.$42.5 $17.7 $13.1 
Non-U.S.22.4 26.9 13.5 
State and local8.6 4.4 0.9 
Deferred:
Federal U.S.(31.3)(2.2)(13.1)
Non-U.S.11.3 (57.5)(72.7)
State and local(7.6)1.7 (4.2)
Income tax provision (benefit)$45.9 $(9.0)$(62.5)
Deferred tax assets and deferred tax liabilities are classified as long-term and are included in other long-term assets and other long-term liabilities, respectively, in the accompanying Consolidated Balance Sheets. Significant components of deferred tax assets and liabilities as of December 31 were as follows ($ in millions):
20222021
Deferred tax assets:
Inventories$15.4 $17.4 
Pension benefits6.2 11.5 
Other accruals and prepayments45.3 54.3 
Lease liabilities35.5 34.2 
Stock-based compensation expense7.5 6.8 
Interest expense36.0 8.7 
Capitalized research expenses15.1 3.8 
Tax credit and loss carryforwards38.2 117.3 
Valuation allowances(38.7)(90.0)
Total deferred tax asset160.5 164.0 
Deferred tax liabilities:
Property, plant and equipment(5.7)(9.6)
Unrealized gains and losses(6.2)(6.5)
Right-of-use assets(31.5)(30.3)
Goodwill and other intangible assets(92.2)(192.3)
Total deferred tax liability(135.6)(238.7)
Net deferred tax asset (liability)$24.9 $(74.7)
Deferred taxes associated with U.S. entities consist of net deferred tax liabilities of $15.1 million and $133.0 million as of December 31, 2022 and 2021, respectively. Deferred taxes associated with non-U.S. entities consist of net deferred tax assets of $40.0 million and $58.5 million as of December 31, 2022 and 2021, respectively. During 2022, the Company’s valuation allowance decreased by $51.3 million primarily due to a corresponding expiration of certain foreign net operating losses.

The Company’s intent is to permanently reinvest substantially all funds outside of the United States and current plans do not demonstrate a need to repatriate the cash to fund U.S. operations. However, if these funds were repatriated, they would likely not be subject to United States federal income tax under the previously taxed income or the dividend exemption rules. The Company would likely be required to accrue and pay United States state and local taxes and withholding taxes payable to various countries. It is not practicable to estimate the tax impact of the reversal of the outside basis difference, or the repatriation of cash due to the complexity of its hypothetical calculation.

The 2022 decrease in the deferred tax liability for goodwill and other intangible assets included an income tax benefit of approximately $100.2 million related primarily to the acquisition of amortizable deferred tax assets associated with the Intraoral Scanner Business acquisition partially offset with deferred tax liabilities established in connection with the Osteogenics acquisition.

Current tax law in the United States imposes tax on U.S. stockholders for global intangible low-taxed income (“GILTI”) earned by certain foreign subsidiaries. The Company is required to make an accounting policy election of either: (1) treating taxes due on future amounts included in the U.S. taxable income related to GILTI as a current period tax expense when incurred (“the period cost method”); or (2) factoring such amounts into the Company’s measurement of its deferred tax its deferred tax expense (the “deferred method”). In 2018, the Company elected the period cost method for its accounting for GILTI.
The effective income tax rate for the years ended December 31 varies from the U.S. statutory federal income tax rate as follows:
Percentage of Pretax Income
202220212020
Statutory federal income tax rate21.0 %21.0 %21.0 %
Increase (decrease) in tax rate resulting from:
State income taxes (net of federal income tax benefit)0.3 1.2 17.0 
Impact of foreign operations(5.0)(6.4)80.4 
Foreign-Derived Intangible Income (“FDII”)(0.7)— — 
Subpart F and GILTI, net of foreign tax credits6.7 6.4 (72.4)
Change in uncertain tax positions(0.5)— 3.4 
Research and experimentation credits and other(1.6)(1.6)13.2 
Permanent differences and other(0.9)2.7 (20.3)
Excess tax benefit from stock-based compensation(1.6)(1.9)11.6 
Valuation allowance release on certain Swiss NOLs— (8.1)— 
Impact of step-up of Swiss assets(1.5)(16.8)258.6 
Effective income tax rate16.2 %(3.5)%312.5 %
The Company realized tax benefits of $7.2 million, $6.7 million, and $4.2 million in 2022, 2021 and 2020 respectively, for tax deductions attributable to stock-based compensation, of which, the excess tax benefit over the amount recorded for financial reporting purposes was $4.6 million, $4.8 million and $2.3 million in 2022, 2021 and 2020, respectively. As required by ASU 2016-09, Compensation—Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”), the excess tax benefits for the years ended December 31, 2022, 2021 and 2020 have been included in the provision for income taxes.
The Company evaluates the future realizability of tax credits and loss carryforwards considering the anticipated future earnings of the Company’s subsidiaries as well as tax planning strategies in the associated jurisdictions. Included in deferred income taxes as of December 31, 2022 are tax benefits for U.S. and non-U.S. net operating loss carryforwards totaling $35.5 million ($29.1 million of which the Company does not expect to realize and has corresponding valuation allowances). Certain of the losses can be carried forward indefinitely and others can be carried forward to various dates from 2023 through 2042.
As of December 31, 2022, gross unrecognized tax benefits totaled $6.6 million ($9.2 million, including $2.6 million associated with potential interest and penalties). As of December 31, 2021, gross unrecognized tax benefits totaled $5.7 million ($7.6 million, including $1.9 million associated with potential interest and penalties). The Company recognized $0.6 million, $(0.1) million and $0.0 million in potential interest and penalties associated with uncertain tax positions during 2022, 2021 and 2020, respectively. To the extent unrecognized tax benefits (including interest and penalties) are recognized with respect to uncertain tax positions, the tax expense in future periods would be reduced by $9.2 million based upon the tax positions as of December 31, 2022. The Company recognized interest and penalties related to unrecognized tax benefits within income taxes in the accompanying Consolidated Statements of Operations. Unrecognized tax benefits and associated accrued interest and penalties are included in taxes, income and other accrued expenses as detailed in Note 10.
A reconciliation of the beginning and ending amount of unrecognized tax benefits, excluding amounts accrued for potential interest and penalties, is as follows ($ in millions):
202220212020
Unrecognized tax benefits, beginning of year$5.7 $7.1 $9.1 
Additions based on tax positions related to the current year0.3 0.3 0.3 
Additions for tax positions of prior years4.2 — 0.3 
Reductions for tax positions of prior years— (0.3)(1.7)
Lapse of statute of limitations(2.3)(1.0)(1.0)
Settlements(1.1)(0.4)— 
Effect of foreign currency translation(0.2)— 0.1 
Unrecognized tax benefits, end of year$6.6 $5.7 $7.1 
The Company is routinely examined by various domestic and international taxing authorities and operations in certain U.S. states and foreign jurisdictions remain subject to routine examination for tax years beginning with 2009.
The Company estimates that it is reasonably possible that the amount of unrecognized tax benefits may be reduced by approximately $2.7 million within twelve months through resolution of worldwide tax matters, payments of tax audit settlements and/or statute of limitations expirations.
The Company operates in various non-U.S. tax jurisdictions where “tax holiday” income tax incentives have been granted for a specific period. These tax benefits are not material to the Company’s financial statements.
XML 47 R30.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings Per Share
 12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Earnings Per Share EARNINGS PER SHARE
Earnings per share is calculated by dividing the applicable income by the weighted average number of shares of common stock outstanding for the applicable period. Diluted earnings per share is computed based on the weighted average number of common shares outstanding plus the effect of dilutive potential shares outstanding during the period using the treasury stock method. Dilutive potential common shares include employee equity options, non-vested shares and similar instruments granted by the Company and the assumed conversion impact of the Notes. The Company will settle any Notes conversions through a combination settlement by satisfying the principal amount outstanding with cash and any Notes conversion value in excess of the principal amount in cash or shares of the Company’s common stock or any combination thereof. As such, the Company uses the treasury stock method for the assumed conversion of the Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. As the Company will settle the principal amount of the Notes in cash upon conversion, the Notes do not have an impact on the Company's diluted earnings per share until the average share price of the Company’s common stock exceeds the conversion price of $21.01 per share in any applicable period. See the computation of earnings per share below for the dilutive impact of the Notes for the years ended December 31, 2022, 2021 and 2020.

In connection with the offering of the Notes, the Company entered into Capped Calls (see further discussion in Note 16), which are intended to reduce or offset the potential dilution from shares of common stock issued upon conversion of the Notes. However, this impact is not included when calculating potentially dilutive shares since their effect is anti-dilutive. The Capped Calls will mitigate dilution from the conversion of the Notes up to the Company’s common stock price of $23.79. If the Notes are converted at a price higher than $23.79 per share, the Capped Calls will no longer mitigate dilution from the conversion of the Notes.
The table below presents the computation of basic and diluted earnings per share ($ and shares in millions, except per share amounts):
Year Ended December 31,
202220212020
Numerator:
Income from continuing operations, net of tax$238.0 $263.5 42.5 
Income (loss) from discontinued operations, net of tax$5.1 $77.0 $(9.2)
Net income $243.1 $340.5 $33.3 
Denominator:
Weighted-average common shares outstanding used in basic earnings (loss) per share162.9 161.2 159.6 
Incremental common shares from:
Assumed exercise of dilutive options and vesting of dilutive restricted stock units3.2 4.4 2.2 
Assumed conversion of the Notes11.5 12.0 2.3 
Weighted average common shares outstanding used in diluted earnings (loss) per share177.6 177.6 164.1 
Earnings per share:
Earnings from continuing operations - basic$1.46 $1.63 $0.27 
Earnings from continuing operations - diluted$1.34 $1.48 $0.26 
Earnings (loss) from discontinued operations - basic$0.03 $0.48 $(0.06)
Earnings (loss) from discontinued operations - diluted$0.03 $0.43 $(0.06)
Earnings - basic$1.49 $2.11 $0.21 
Earnings - diluted$1.37 $1.92 *$0.20 
* Earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. The sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding.

The following table presents the number of outstanding securities not included in the computation of diluted income per share, because their effect was anti-dilutive (in millions):

Year Ended December 31,
202220212020
Stock-based awards1.5 1.2 4.1 
XML 48 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Segment Information SEGMENT INFORMATION
The Company operates and reports its results in two separate business segments, the Specialty Products & Technologies and Equipment & Consumables segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income (expense), interest expense and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. The identifiable assets by segment are those used in each segment’s operations. Inter-segment amounts are not significant and are eliminated to arrive at combined totals.

The Company’s Specialty Products & Technologies products include implants, regenerative products, prosthetics, orthodontic brackets, aligners and lab products. The Company’s Equipment & Consumables products include traditional consumables such as bonding agents and cements, impression materials, infection prevention products and restorative
products, while the Company’s equipment products include digital imaging systems, software and other visualization and magnification systems.

On December 31, 2021, the Company completed the sale of its KaVo Treatment Unit and Instrument Business, which is part of the Company’s Equipment & Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business. Refer to Note 4 for more information on the Company’s discontinued operations.

Detailed segment data as of and for the years ended December 31 is as follows ($ in millions):
202220212020
Sales:
Specialty Products & Technologies$1,598.6 $1,507.8 $1,117.3 
Equipment & Consumables970.5 1,001.1 811.8 
Total$2,569.1 $2,508.9 $1,929.1 
Operating profit and reconciliation to income (loss) before taxes:
Specialty Products & Technologies$268.6 $272.3 $65.8 
Equipment & Consumables172.4 153.8 53.6 
Other(121.8)(119.9)(75.9)
Operating profit319.2 306.2 43.5 
Nonoperating income (expense):
   Other income (expense)3.1 2.4 (1.0)
   Interest expense, net(38.4)(54.1)(62.5)
Income (loss) before taxes$283.9 $254.5 $(20.0)
Depreciation and amortization:
Specialty Products & Technologies$80.7 $84.0 $80.6 
Equipment & Consumables54.6 31.4 38.7 
Other2.5 2.4 2.4 
Total$137.8 $117.8 $121.7 
Capital expenditures, gross:
Specialty Products & Technologies$48.8 $37.2 $36.4 
Equipment & Consumables20.6 10.6 5.8 
Other2.7 1.3 1.7 
Total$72.1 $49.1 $43.9 
Identifiable assets:December 31, 2022December 31, 2021
Specialty Products & Technologies$3,475.7 $3,498.2 
Equipment & Consumables2,455.3 1,946.1 
Held for sale— 12.2 
Other656.0 1,117.7 
Total$6,587.0 $6,574.2 
Operations in Geographical Areas: 
Year Ended December 31,
($ in millions)202220212020
Sales:
United States$1,261.9 $1,223.4 $960.1 
China222.2 236.7 198.2 
All other (each country individually less than 5% of total sales)1,085.0 1,048.8 770.8 
Total$2,569.1 $2,508.9 $1,929.1 
Property, plant and equipment, net:December 31, 2022December 31, 2021
United States$183.4 $157.1 
Sweden41.4 49.0 
Mexico15.2 8.8 
All other (each country individually less than 5% of total long-lived assets)53.6 49.2 
Total$293.6 $264.1 
XML 49 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule II - Valuation and Qualifying Accounts
 12 Months Ended
Dec. 31, 2022
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II - of Valuation and Qualifying Accounts
Classification
Balance at
Beginning of
Period (a)
Charged to
Costs &
Expenses		Impact of
Currency		Write Offs,
Write Downs  &
Deductions		Recoveries
Balance at End of Period (a)
Year ended December 31, 2022:
Allowances deducted from asset account— — — — — — 
Allowance for credit losses$20.7 $4.8 $(0.8)$(4.1)$(4.4)$16.2 
Year ended December 31, 2021:
Allowances deducted from asset account— — — — — — 
Allowance for credit losses$30.5 $4.7 $(1.5)$(7.3)$(5.7)$20.7 
Year ended December 31, 2020:
Allowances deducted from asset account— — — — — — 
Allowance for credit losses$18.7 $19.2 $0.3 $(7.7)$— $30.5 
______________
(a)Amounts include allowance for credit losses classified as current.
XML 50 R33.htm IDEA: XBRL DOCUMENT v3.22.4
Summary Of Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Accounting Principles
Basis of Presentation
The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP").

As discussed in Note 4, Discontinued Operations, on December 31, 2021, the Company sold its KaVo dental treatment unit and instrument business (the "KaVo Treatment Unit and Instrument Business"), which was part of the Company’s Equipment and Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.
Accounting Principles
The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The Consolidated Financial Statements include the accounts of the Company and its subsidiaries. The Consolidated Financial Statements also reflect the impact of noncontrolling interests. Noncontrolling interests do not have a significant impact on the Company’s consolidated results of operations, therefore income attributable to noncontrolling interests are not presented separately in the Company’s Consolidated Statements of Operations. Income attributable to noncontrolling interests have been reflected in selling, general and administrative expenses and were insignificant in all periods presented. Reclassifications of certain prior year amounts have been made to conform to the current year presentation.
Use of Estimates Use of EstimatesThe preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The Company bases these estimates on historical experience, the current economic environment and on various other assumptions that are believed to be reasonable under the circumstances. However, uncertainties associated with these estimates exist and actual results may differ materially from these estimates.
Acquisitions
Acquisitions
The Company continually evaluates potential acquisitions that either strategically fit with the Company’s existing portfolio or expand the Company’s portfolio into new and attractive business areas. Among other things, goodwill arises because the purchase prices for these businesses reflect a number of factors including the future earnings and cash flow potential of these businesses, the multiple to earnings, cash flow and other factors at which similar businesses have been purchased by other acquirers, the competitive nature of the processes by which the Company acquired the businesses, avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance the Company’s existing product offerings to key target markets and enter into new and profitable businesses and the complementary strategic fit and resulting synergies these businesses bring to existing operations.
We account for acquisitions under Accounting Standards Codification (“ASC“) 805 Business Combinations and use the acquisition method of accounting. The consideration transferred for the acquisition of a subsidiary comprises (i) fair values of the assets transferred; (ii) liabilities assumed of the acquired business; and (iii) fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired, and liabilities and contingent liabilities assumed in a business combination are, with limited exceptions, measured initially at their fair values at the acquisition date.
The Company makes an initial allocation of the purchase price at the date of acquisition based upon its estimation of the fair value of the acquired assets and assumed liabilities. The Company obtains the information used to estimate the fair values during due diligence and through other sources. In the months after closing, up to 12 months, as the Company obtains additional information that existed at the acquisition date about these assets and liabilities, it is able to refine the estimates of fair value and more accurately allocate the purchase price. Only items that existed as of the acquisition date are considered for subsequent adjustment. The Company makes the appropriate adjustments to the purchase price allocation prior to completion of the measurement period, as required.
Cash and Equivalents
Cash and Cash Equivalents
The Company considers all highly liquid investments with a maturity of three months or less at the date of purchase to be cash equivalents.
Accounts Receivable and Allowances for Credit Losses
Accounts Receivable and Allowances for Credit Losses
All trade accounts receivable are reported on the accompanying Consolidated Balance Sheets adjusted for any write-offs and net of allowances for credit losses. The allowances for credit losses represent management’s best estimate of the credit losses expected from the Company’s trade accounts receivable portfolio. Determination of the allowances requires management to exercise judgment about the timing, frequency and severity of credit losses that could materially affect the provision for credit losses and, therefore, net income. The Company regularly performs detailed reviews of its portfolios to determine if an impairment has occurred and evaluates the collectability of receivables based on a combination of various financial and qualitative factors that may affect customers’ ability to pay, including customers’ financial condition, debt-servicing ability, past payment experience and credit bureau information and forecasts. In circumstances where the Company is aware of a
specific customer’s inability to meet its financial obligations, a specific reserve is recorded against amounts due to reduce the recognized receivable to the amount reasonably expected to be collected.
Inventory Valuation
Inventory Valuation
Inventories include the costs of material, labor and overhead. Inventories are stated at the lower of cost or net realizable value primarily using the first-in, first-out method. Market value for raw materials is based on replacement costs and for other inventory classifications is based on net realizable value. The Company periodically evaluates the quantities on hand relative to current and historical selling prices and historical and projected sales volume. Based on this evaluation, provisions are made to write inventory down to its net realizable value.
Property, Plant and Equipment
Property, Plant and Equipment
Property, plant and equipment are carried at cost. The provision for depreciation has been computed principally by the straight-line method based on the estimated useful lives of the depreciable assets as follows:
CategoryUseful Life
Buildings
30 years
Leased assets and leasehold improvementsAmortized over the lesser of the economic life of the asset or the term of the lease
Machinery, equipment and other assets
3 – 10 years
Estimated useful lives are periodically reviewed and, when appropriate, changes to estimates are made prospectively.
Leases LeasesThe Company determines if an arrangement is a lease at inception and evaluates each lease agreement to determine whether the lease is an operating or finance lease. For leases where the Company is the lessee, right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The ROU asset also consists of any prepaid lease payments, lease incentives received, costs which will be incurred in exiting a lease and the amount of any asset or liability recognized on business combinations relating to favorable or unfavorable lease terms. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense using the accelerated interest method of recognition. In certain of the Company’s lease agreements, the rental payments are adjusted periodically to reflect actual charges incurred for common area maintenance, utilities, inflation and/or changes in other indexes.
Investments InvestmentsInvestments over which the Company has a significant influence but not a controlling interest, are accounted for using the equity method of accounting which requires the Company to record its initial investment at cost and adjust the balance each period for the Company’s share of the investee’s income or loss and dividends paid.
Fair Value of Financial Instruments Fair Value of Financial InstrumentsThe Company’s financial instruments consist primarily of cash and cash equivalents, trade accounts receivable, nonqualified deferred compensation plans, contingent consideration, derivatives, trade accounts payable and long-term debt. Due to their short-term nature, the carrying values for cash and cash equivalents, trade accounts receivable and trade accounts payable approximate fair value.
Goodwill and Other Intangible Assets
Goodwill and Other Intangible Assets
Goodwill and other intangible assets result from the Company’s acquisition of existing businesses. In accordance with accounting standards related to business combinations, goodwill is not amortized; however, certain finite-lived identifiable intangible assets, primarily customer relationships and acquired technology, are amortized over their estimated useful lives. Goodwill and indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. The Company first assessed qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount or performed a quantitative impairment test. When tested quantitatively, the Company uses a combination of techniques, including an income approach and a market-based approach to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. In making this assessment, management relies on a number of factors, including expected future operating results, business plans, economic projections, anticipated future cash flows, business trends and the Company’s market capitalization. The Company’s reporting units are the financial components of operating segments which constitute businesses for which discrete financial information is available and is regularly reviewed by segment management. The Company did not record any impairment loss for goodwill or indefinite-lived intangible assets in 2022, 2021 and 2020.
Management reviews the carrying amounts of other finite-lived intangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable based on undiscounted estimated cash flows, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities.
Revenue Recognition
Revenue Recognition
The Company derives revenues primarily from the sale of Specialty Products & Technologies and Equipment & Consumables products and services. Revenue is recognized when control of the promised products or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services (the transaction price). A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606. For equipment, consumables and spare parts sold by the Company, control transfers to the customer at a point in time. To indicate the transfer of control, the Company must have a present right to payment, legal title must have passed to the customer, the customer must have the significant risks and rewards of ownership, and where acceptance is not a formality, the customer must have accepted the product or service. The Company’s principal terms of sale are FOB Shipping Point, or equivalent, and, as such, the Company primarily transfers control and records revenue for product sales upon shipment. Sales arrangements with delivery terms that are not FOB Shipping Point are not recognized upon shipment and the transfer of control for revenue recognition is evaluated based on the associated shipping terms and customer obligations. If a performance obligation to the customer with respect to a sales transaction remains to be fulfilled following shipment (typically installation or acceptance by the customer), revenue recognition for that performance obligation is deferred until such commitments have been fulfilled. Returns for products sold are estimated and recorded as a reduction of revenue at the time of sale. Customer allowances and rebates, consisting primarily of volume discounts and other short-term incentive programs, are recorded as a reduction of revenue at the time of sale because these allowances reflect a reduction in the transaction price. Product returns, customer allowances and rebates are estimated based on historical experience and known trends. For extended warranty and service, control transfers to the customer over the term of the arrangement. Revenue for extended warranty and service is recognized based upon the period of time elapsed under the arrangement.
For a contract with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation on a relative standalone selling price basis using the Company’s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers; however, when prices in standalone sales are not available the Company may use third-party pricing for similar products or services or estimate the standalone selling price. Allocation of the transaction price is determined at the contracts’ inception. The Company does not adjust transaction price for the effects of a significant financing component when the period between the transfer of the promised good or service to the customer and payment for that good or service by the customer is expected to be one year or less.
Shipping and Handling Shipping and HandlingShipping and handling costs are considered a fulfillment cost and are included as a component of cost of sales. Revenue derived from shipping and handling costs billed to customers is included in sales.
Advertising AdvertisingAdvertising costs are expensed as incurred.
Research and Development Research and DevelopmentThe Company conducts research and development activities for the purpose of developing new products, enhancing the functionality, effectiveness, ease of use and reliability of the Company’s existing products and expanding the applications for which uses of the Company’s products are appropriate. Research and development costs are expensed as incurred.
Income Taxes
Income Taxes
Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted rates expected to be in effect during the year in which the differences reverse. Deferred tax assets generally represent items that can be used as a tax deduction or credit in the Company’s tax return in future years for which the tax benefit has already been reflected on the Company’s Consolidated Statements of Operations. The Company establishes valuation allowances for its deferred tax assets if it is more likely than not that some or all of the deferred tax assets will not be realized. Deferred tax liabilities generally represent items that have already been taken as a deduction on the Company’s tax return but have not yet been recognized as an expense in the Company’s Consolidated Statements of Operations. The effect on deferred tax assets and liabilities due to a change in tax rates is recognized in income tax expense in the period that includes the enactment date. The Company provides for unrecognized tax benefits when, based upon the technical merits, it is “more likely than not” that an uncertain tax position will not be sustained upon examination. Judgment is required in evaluating tax positions and determining income tax provisions. The Company re-evaluates the technical merits of its tax positions and may recognize an uncertain tax benefit in certain circumstances, including when: (1) a tax audit is completed; (2) applicable tax laws change, including a tax case ruling or legislative guidance; or (3) the applicable statute of limitations expires. The Company recognizes potential accrued interest and penalties associated with unrecognized tax positions in income tax expense.
On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on the Company’s current analysis of the provisions, the Company does not believe this legislation will have a material impact on its Consolidated Financial Statements.
Restructuring RestructuringThe Company periodically initiates restructuring activities to appropriately position the Company’s cost base relative to prevailing economic conditions and associated customer demand as well as in connection with certain acquisitions. Costs associated with productivity improvement and restructuring actions can include termination benefits and related charges in addition to facility closure, contract termination and other related activities. The Company records the cost of the restructuring activities when impairment is identified or when the associated liability is incurred.
Foreign Currency Translation Foreign Currency TranslationExchange rate adjustments resulting from foreign currency transactions are recognized in net income, whereas effects resulting from the translation of financial statements are reflected as a component of accumulated other comprehensive loss within equity. Assets and liabilities of subsidiaries operating outside the United States with a functional currency other than U.S. dollars are translated into U.S. dollars using year-end exchange rates and income statement accounts are translated at weighted average rates. Net foreign currency transaction gains or losses were not material in any of the years presented.
Derivative Financial Instruments
Derivative Financial Instruments
The Company is neither a dealer nor a trader in derivative instruments. The Company has generally accepted the exposure to transactional exchange rate movements without using derivative instruments to manage this risk, although the Company from time to time partially hedges its net investments in foreign operations against adverse movements in exchange rates through foreign currency-denominated debt and cross-currency swaps. The Company may at times also enter into interest rate swaps to mitigate a portion of its interest rate risk related to the Company’s debt. The derivative instruments are recorded on the Consolidated Balance Sheets as either an asset or liability measured at fair value. To the extent the interest rate swap qualifies as an effective hedge, changes in fair value are recognized in accumulated other comprehensive loss within equity.
Changes in the value of the foreign currency denominated debt and cross-currency swaps designated as hedges of the Company’s net investment in foreign operations based on spot rates are recognized in accumulated other comprehensive loss within equity and offset changes in the value of the Company’s foreign currency denominated operations.
Loss Contingencies
Loss Contingencies
The Company records a reserve for loss contingencies when it is both probable that a loss will be incurred and the amount of the loss is reasonably estimable. The Company evaluates pending litigation and other contingencies at least quarterly and adjusts the reserve for such contingencies for changes in probable and reasonably estimable losses.
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Foreign currency translation adjustments are generally not adjusted for income taxes as they relate to indefinite investments in non-U.S. subsidiaries. Foreign currency translation adjustments related to the Company’s cross-currency swap arrangements and foreign currency denominated debt that are designated as net investment hedges are adjusted for income taxes as those arrangements are not indefinite. Changes in the funded status of the pension plans, net of taxes, are recognized in the year in which the changes occur and reported in other comprehensive loss.
Stock-Based Compensation Stock-Based CompensationThe Company accounts for stock-based compensation by measuring the cost of employee services received in exchange for all equity awards granted, including stock options, restricted stock units (“RSUs”) and performance stock units (“PSUs”), based on the fair value of the award as of the grant date. Equity-based compensation expense is recognized net of an estimated forfeiture rate on a straight-line basis over the requisite service period of the award, except that in the case of RSUs compensation expense is recognized using an accelerated attribution method.
Pension Plans Pension PlansThe Company measures its pension assets and obligations that determine the funded status as of the end of the Company’s fiscal year, and recognizes an asset for an over funded status or a liability for an underfunded status in its Consolidated Balance Sheets. Changes in the funded status of the pension plans are recognized in the year in which the changes occur and reported in other comprehensive loss.
Accounting Standards Recently Adopted
Accounting Standards Recently Adopted

In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2021-08, Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805), which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts, rather than at fair value. This standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The Company adopted this guidance on January 1, 2022, which did not have a significant impact on the Company’s Consolidated Financial Statements.

In August 2020, the FASB issued ASU 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40),” (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. This guidance is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU 2020-06 was effective for public entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Effective January 1, 2022, the Company adopted ASU 2020-06 using the modified retrospective adoption approach. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption. The comparative prior year information has not been restated and continues to be presented according to accounting standards in effect for those periods.
The adoption of ASU 2020-06 resulted in a $75.0 million increase to the carrying value of the convertible notes due 2025, net of deferred debt issuance costs and unamortized discount and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption resulted in a $21.4 million increase to retained earnings and an $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs. Refer to Note 16 for a further discussion of the impact of adopting ASU 2020-06.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. ASU 2020-04 is effective for public entities through December 31, 2022. However, in December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 to defer the effective date of ASU 2020-04 from December 31, 2022 to December 31, 2024. The Company adopted ASU 2020-04 as of December 31, 2022 and its adoption did not have an impact on the Company’s Consolidated Financial Statements.
XML 51 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Summary Of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Estimated Useful Lives of Depreciable Assets The provision for depreciation has been computed principally by the straight-line method based on the estimated useful lives of the depreciable assets as follows:
CategoryUseful Life
Buildings
30 years
Leased assets and leasehold improvementsAmortized over the lesser of the economic life of the asset or the term of the lease
Machinery, equipment and other assets
3 – 10 years
The classes of property, plant and equipment as of December 31 are summarized as follows ($ in millions):
20222021
Land and improvements$10.0 $10.7 
Buildings and improvements154.5 168.7 
Machinery, equipment and other assets370.2 354.5 
Construction in progress71.2 45.6 
Gross property, plant and equipment605.9 579.5 
Less: accumulated depreciation(312.3)(315.4)
Property, plant and equipment, net$293.6 $264.1 
XML 52 R35.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisitions (Tables)
 12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
Fair Values of Assets Acquired and Liabilities Assumed
The following table summarizes the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates ($ in millions):

Osteogenics
July 5, 2022		Intraoral Scanner Business
April 20, 2022
Assets acquired:
   Cash$2.1 $2.7 
   Accounts receivable2.5 0.1 
   Inventories13.3 6.1 
   Intangible assets53.0 129.8 
   Property, plant and equipment— 0.3 
   Prepaids and Other Current Assets1.3 — 
   Goodwill77.3 373.1 
   Non-current deferred tax asset— 96.0 
   Operating lease right-of-use assets2.6 0.9 
   Other long-term assets4.9 0.2 
       Total assets acquired157.0 609.2 
Liabilities assumed:
   Accounts payable (4.1)(0.5)
   Accrued expenses and other liabilities (2.5)(27.9)
   Non-current deferred tax liability(14.3)— 
   Other long-term liabilities(5.8)— 
   Operating lease liabilities(2.1)(0.5)
       Total liabilities assumed(28.8)(28.9)
Total net assets acquired$128.2 $580.3 
XML 53 R36.htm IDEA: XBRL DOCUMENT v3.22.4
Discontinued Operations (Tables)
 12 Months Ended
Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Discontinued Operations The carrying amounts of the assets and liabilities of the Divestiture held for sale are as follows ($ in millions):
December 31, 2021
ASSETS
Current assets:
Assets for Relevant Jurisdictions$12.2 
Current assets held for sale$12.2 
LIABILITIES AND EQUITY
Current liabilities:
Liabilities for Relevant Jurisdictions$4.0 
Current liabilities held for sale$4.0 
The operating results of the Divestiture are reflected in the Consolidated Statements of Operations within income from discontinued operations, net of tax as follows ($ in millions):
 Year Ended December 31
 202220212020
Sales$11.7 $413.5 $352.9 
Cost of sales9.1 234.6 249.6 
Gross profit2.6 178.9 103.3 
Operating expenses:
Selling, general and administrative3.2 75.6 99.3 
Research and development— 16.1 14.1 
Operating (loss) profit(0.6)87.2 (10.1)
Income tax expense— 21.9 (0.9)
(Loss) income from discontinued operations(0.6)65.3 (9.2)
Gain on sale of discontinued operations, net of tax5.7 11.7 — 
Net income (loss) from discontinued operations$5.1 $77.0 $(9.2)
Significant non-cash operating items and capital expenditures for the Divestiture are reflected in the cash flows from operations as follows ($ in millions):
Year Ended December 31
202220212020
Cash flows from operating activities
Non-cash restructuring charges$— $— $9.6 
Impairment charges$— $— $10.5 
Depreciation and amortization1
$— $5.8 $10.9 
Cash flows from investing activities:
Capital expenditures$— $6.7 $3.8 
1 Depreciation and amortization were no longer recognized once the business was classified as discontinued operations as of August 27, 2021.
XML 54 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Credit Losses (Tables)
 12 Months Ended
Dec. 31, 2022
Credit Loss [Abstract]  
Allowance for Credit Loss
The rollforward of the allowance for credit losses is summarized as follows ($ in millions):

Balance at December 31, 2021$20.7 
Foreign currency translation(0.8)
Provision for credit losses4.8 
Write-offs charged against the allowance(4.1)
Recoveries(4.4)
Balance at December 31, 2022$16.2 
XML 55 R38.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories (Tables)
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
Schedule of Inventory
The classes of inventory as of December 31 are summarized as follows ($ in millions):
20222021
Finished goods$229.2 $214.3 
Work in process23.9 22.0 
Raw materials103.4 88.3 
Reserve for inventory obsolescence(55.7)(60.8)
Total$300.8 $263.8 
XML 56 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Property, Plant And Equipment (Tables)
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment The provision for depreciation has been computed principally by the straight-line method based on the estimated useful lives of the depreciable assets as follows:
CategoryUseful Life
Buildings
30 years
Leased assets and leasehold improvementsAmortized over the lesser of the economic life of the asset or the term of the lease
Machinery, equipment and other assets
3 – 10 years
The classes of property, plant and equipment as of December 31 are summarized as follows ($ in millions):
20222021
Land and improvements$10.0 $10.7 
Buildings and improvements154.5 168.7 
Machinery, equipment and other assets370.2 354.5 
Construction in progress71.2 45.6 
Gross property, plant and equipment605.9 579.5 
Less: accumulated depreciation(312.3)(315.4)
Property, plant and equipment, net$293.6 $264.1 
XML 57 R40.htm IDEA: XBRL DOCUMENT v3.22.4
Leases (Tables)
 12 Months Ended
Dec. 31, 2022
Leases [Abstract]  
Components of Operating Lease Expense
The components of operating lease expense for the years ended December 31 were as follows ($ in millions):
20222021
Fixed operating lease expense (a)
$31.7 $32.4 
Variable operating lease expense7.2 6.1 
Total operating lease expense$38.9 $38.5 
______________
(a)    Includes short-term leases and sublease income, both of which were not significant.
Schedule of Weighted Average Remaining Lease Term and Discount Rate
The following table presents the weighted average remaining lease term and weighted average discount rates related to the Company’s operating leases as of December 31:
20222021
Weighted average remaining lease term8 years9 years
Weighted average discount rate4.1 %3.5 %
Schedule of Maturity Of Operating Lease Liabilities
The following table presents the maturity of the Company’s operating lease liabilities as of December 31, 2022 ($ in millions):
2023$32.2 
202428.7 
202523.9 
202619.8 
202716.8 
Thereafter50.3 
Total operating lease payments171.7 
Less: imputed interest(23.3)
Total operating lease liabilities$148.4 
XML 58 R41.htm IDEA: XBRL DOCUMENT v3.22.4
Goodwill And Other Intangible Assets (Tables)
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Rollforward and Carrying Value Of Goodwill
The following is a rollforward of the Company’s goodwill by segment ($ in millions):
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Balance, December 31, 2021$2,029.7 $1,102.3 $3,132.0 
Acquisitions77.3 373.1 450.4 
Foreign currency translation(59.2)(26.6)(85.8)
Balance, December 31, 2022$2,047.8 $1,448.8 $3,496.6 
Schedule of Acquired Indefinite-Lived Intangible Assets by Major Class The following summarizes the gross carrying value and accumulated amortization for each major category of intangible asset as of December 31 ($ in millions): 
20222021
Gross
Carrying
Amount		Accumulated
Amortization		Gross
Carrying
Amount		Accumulated
Amortization
Finite-lived intangibles:
Patents and technology$432.2 $(236.4)$313.8 $(215.3)
Customer relationships and other intangibles924.1 (648.7)907.4 (610.9)
Trademarks and trade names224.8 (100.2)216.3 (75.4)
Total finite-lived intangibles1,581.1 (985.3)1,437.5 (901.6)
Indefinite-lived intangibles:
Trademarks and trade names490.9 — 510.5 — 
Total intangibles$2,072.0 $(985.3)$1,948.0 $(901.6)
Schedule of Acquired Finite-Lived Intangible Assets by Major Class The following summarizes the gross carrying value and accumulated amortization for each major category of intangible asset as of December 31 ($ in millions): 
20222021
Gross
Carrying
Amount		Accumulated
Amortization		Gross
Carrying
Amount		Accumulated
Amortization
Finite-lived intangibles:
Patents and technology$432.2 $(236.4)$313.8 $(215.3)
Customer relationships and other intangibles924.1 (648.7)907.4 (610.9)
Trademarks and trade names224.8 (100.2)216.3 (75.4)
Total finite-lived intangibles1,581.1 (985.3)1,437.5 (901.6)
Indefinite-lived intangibles:
Trademarks and trade names490.9 — 510.5 — 
Total intangibles$2,072.0 $(985.3)$1,948.0 $(901.6)
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Based on the intangible assets recorded as of December 31, 2022, amortization expense is estimated as follows for the next five years and thereafter:
Years Ending December 31,
2023$99.3 
202489.6
202589.1
202681.1
202776.5
Thereafter160.2 
$595.8 
XML 59 R42.htm IDEA: XBRL DOCUMENT v3.22.4
Accrued Expenses And Other Liabilities (Tables)
 12 Months Ended
Dec. 31, 2022
Accrued expenses and other [Abstract]  
The components of accrued expenses and other liabilities
Accrued expenses and other liabilities as of December 31 were as follows ($ in millions):
20222021
CurrentNoncurrentCurrentNoncurrent
Compensation and benefits$148.0 $17.5 $188.9 $17.9 
Sales and product allowances85.1 1.3 75.4 1.2 
Contract liabilities78.9 8.6 60.1 5.1 
Taxes, income and other42.1 68.6 48.1 201.4 
Restructuring-related employee severance, benefits and other18.9 — 21.9 — 
Pension benefits5.6 17.5 5.6 41.7 
Loss contingencies8.1 27.6 8.4 30.3 
Derivative financial instruments— — 19.6 — 
Other84.7 10.2 134.3 6.6 
Total$471.4 $151.3 $562.3 $304.2 
XML 60 R43.htm IDEA: XBRL DOCUMENT v3.22.4
Hedging Transactions And Derivative Financial Instruments (Tables)
 12 Months Ended
Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative instruments, gain (loss)
The following table summarizes the notional values as of December 31, 2022 and 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the years ended December 31, 2022 and 2021 ($ in millions):
Notional AmountGain Recognized in OCI
Year Ended December 31, 2022
Foreign currency denominated debt$222.7 $13.8 
Interest rate contract— 2.2 
Foreign currency contracts— 68.5 
Total$222.7 $84.5 
Notional AmountGain Recognized in OCI
Year Ended December 31, 2021
Foreign currency denominated debt$236.5 $32.5 
Interest rate contracts250.0 6.1 
Foreign currency contracts650.0 49.7 
Total$1,136.5 $88.3 
Schedule of notional amounts of outstanding derivative positions
The following table summarizes the notional values as of December 31, 2022 and 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the years ended December 31, 2022 and 2021 ($ in millions):
Notional AmountGain Recognized in OCI
Year Ended December 31, 2022
Foreign currency denominated debt$222.7 $13.8 
Interest rate contract— 2.2 
Foreign currency contracts— 68.5 
Total$222.7 $84.5 
Notional AmountGain Recognized in OCI
Year Ended December 31, 2021
Foreign currency denominated debt$236.5 $32.5 
Interest rate contracts250.0 6.1 
Foreign currency contracts650.0 49.7 
Total$1,136.5 $88.3 
Schedule of derivative instruments in statement of financial position, fair value
The Company’s derivative instruments, as well as its non-derivative debt instruments designated and qualifying as net investment hedges, were classified as of December 31, 2022 and 2021, in the Company’s Consolidated Balance Sheets as follows ($ in millions):
20222021
Derivative liabilities:
Accrued expenses and other liabilities$— $19.6 
Nonderivative hedging instruments:
Long-term debt$222.7 $236.5 
XML 61 R44.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements (Tables)
 12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of financial assets and liabilities at carrying and fair value
A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions):
Quoted Prices in
Active Market
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total
December 31, 2022:
Liabilities:
Deferred compensation plans$— $15.8 $— $15.8 
Contingent consideration$— $— $6.0 $6.0 
December 31, 2021:
Liabilities:
Interest rate swap derivative contracts$— $2.2 $— $2.2 
Cross-currency swap derivative contracts$— $17.4 $— $17.4 
Deferred compensation plans$— $16.5 $— $16.5 
The carrying amounts and fair values of the Company’s financial instruments as of December 31, were as follows ($ in millions):
20222021
 Carrying AmountFair ValueCarrying AmountFair Value
Liabilities:
Contingent consideration$6.0 $6.0 $— $— 
Interest rate swap derivative contracts$— $— $2.2 $2.2 
Cross-currency swap derivative contracts$— $— $17.4 $17.4 
Convertible senior notes due 2025$510.0 $873.0 $432.1 $1,162.5 
Long-term debt$870.7 $870.7 $883.4 $883.4 
XML 62 R45.htm IDEA: XBRL DOCUMENT v3.22.4
Pension And Other Benefit Plans (Tables)
 12 Months Ended
Dec. 31, 2022
Retirement Benefits [Abstract]  
Schedule of Net Funded Status
The following sets forth the funded status of the Company’s plans as of the most recent actuarial valuations using measurement dates of December 31 ($ in millions):
Pension Benefits
20222021
Change in pension benefit obligation:
Benefit obligation at beginning of year$(129.1)$(171.6)
Service cost(5.5)(7.3)
Interest cost(1.8)(1.2)
Employee contributions(2.5)(3.1)
Benefits and other expenses paid3.0 3.3 
Actuarial gain 27.3 13.0 
Amendments, settlements and curtailments7.7 33.2 
Foreign exchange rate impact3.4 4.6 
Benefit obligation at end of year(97.5)(129.1)
Change in plan assets:
Fair value of plan assets at beginning of year80.6 104.1 
Actual return on plan assets(1.7)5.8 
Employer contributions5.5 6.0 
Employee contributions2.5 3.1 
Amendments and settlements(6.6)(32.8)
Benefits and other expenses paid(3.1)(3.3)
Foreign exchange rate impact(2.8)(2.3)
Fair value of plan assets at end of year74.4 80.6 
Funded status$(23.1)$(48.5)
Defined Benefit Plan, Assumptions
Weighted average assumptions used to determine benefit obligations at date of measurement:
December 31,
20222021
Discount rate3.9 %1.5 %
Rate of compensation increase2.8 %2.2 %
Weighted average assumptions used to determine net periodic pension cost at date of measurement: 
Year Ended December 31,
20222021
Discount rate2.4 %1.0 %
Expected long-term return on plan assets3.3 %3.2 %
Rate of compensation increase2.2 %1.3 %
Schedule of Net Benefit Costs
Components of net periodic pension cost:
Year Ended December 31,
($ in millions)202220212020
Service cost$(5.5)$(7.3)$(9.7)
Interest cost(1.8)(1.2)(1.6)
Expected return on plan assets2.6 3.3 3.7 
Amortization of prior service credit and initial net obligation0.3 0.4 0.4 
Amortization of actuarial gain (loss)0.1 (0.7)(1.4)
Net settlement and curtailment gain (loss)1.9 0.8 (1.4)
Net periodic pension cost$(2.4)$(4.7)$(10.0)
Schedule of Defined Benefit Plans Disclosures The following table represents the service cost and other net periodic benefit costs of the defined benefit pension plans incurred during the years ended December 31, 2022, 2021 and 2020 ($ in millions):
202220212020
Service cost:
    Cost of goods sold$(0.8)$(0.8)$(1.2)
    Selling, general and administrative(4.7)(6.5)(8.5)
Other net periodic pension costs:
Other income (expense)3.1 2.6 (0.3)
Total$(2.4)$(4.7)$(10.0)
Schedule of Allocation of Plan Assets
The fair values of the Company’s pension plan assets as of December 31, 2022, by asset category, were as follows ($ in millions):
Quoted Prices in
Active Market
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total
Cash and cash equivalents$8.4 $— $— $8.4 
Insurance contracts— — 49.7 49.7 
Total$8.4 $— $49.7 $58.1 
Investments measured at NAV (a):
Mutual funds16.3 
Total assets at fair value$74.4 
______________
(a)The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the total plan assets.
The fair values of the Company’s pension plan assets as of December 31, 2021, by asset category, were as follows ($ in millions):
Quoted Prices in
Active Market
(Level 1)		Significant
Other
Observable
Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Total
Cash and cash equivalents$0.3 $— $— $0.3 
Insurance contracts— — 50.1 50.1 
Total$0.3 $— $50.1 $50.4 
Investments measured at NAV (a):
Mutual funds30.2 
Total assets at fair value$80.6 
______________
(a)The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the total plan assets.
Summary of Changes in Level 3 Pension Plan Assets
The following table summarizes the changes in Level 3 pension plan assets measured at fair value on a recurring basis for the year ended December 31, 2022 (in millions):
Fair Value at January 1Return on Plan AssetsNet Purchases/(Settlements)Transfers Into/(Out of) Level 3Fair Value at December 31
Insurance contracts$50.1 $(0.1)$(0.3)$— $49.7 
The following table summarizes the changes in Level 3 pension plan assets measured at fair value on a recurring basis for the year ended December 31, 2021 (in millions):
Fair Value at January 1Return on Plan AssetsNet Purchases/(Settlements)Transfers Into/(Out of) Level 3Fair Value at December 31
Insurance contracts$77.2 $(0.6)$(26.5)$— $50.1 
Schedule of Expected Benefit Payments
The following sets forth benefit payments, which reflect expected future service, as appropriate, at December 31, 2022, are expected to be paid by the plans in the periods indicated ($ in millions):
2023$5.6 
2024$5.1 
2025$5.1 
2026$4.8 
2027$4.8 
2028 - 2032$24.1 
XML 63 R46.htm IDEA: XBRL DOCUMENT v3.22.4
Warranty (Tables)
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Warranty accrual
The following is a rollforward of the Company’s accrued warranty liability ($ in millions):
Balance at December 31, 2021$9.4 
Accruals for warranties issued during the year15.3 
Settlements made(15.1)
Divestiture(0.1)
Effect of foreign currency translation(0.3)
Balance at December 31, 2022$9.2 
XML 64 R47.htm IDEA: XBRL DOCUMENT v3.22.4
Debt And Credit Facilities (Tables)
 12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
Components of debt
The components of the Company’s debt as of December 31, were as follows, net of debt discount and debt issuance costs ($ in millions):
20222021
Senior term loan facility due 2024 (the “Term Loan”)
$648.3 $647.3 
Senior euro term loan facility due 2024 (the “Euro Term Loan”)222.4 236.1 
Convertible senior notes due 2025
510.0 432.1 
Other— 0.3 
Total debt1,380.7 1,315.8 
Less: current portion(510.0)(432.4)
Long-term debt$870.7 $883.4 
Contractual Minimum Principal Payments on Debt
The Company’s contractual minimum principal payments are as follows ($ in millions):

2023$— 
2024872.7 
2025517.5 
Total$1,390.2 
Components of note interest expense
The following table sets forth total interest expense recognized related to the Notes ($ in millions):

Year Ended December 31,
20222021
Contractual interest expense
$12.3 $12.3 
Amortization of debt issuance costs
2.9 1.9 
Amortization of debt discount
— 19.0 
Total interest expense
$15.2 $33.2 
Components of unamortized debt discount and issuance costs
As of December 31, 2022 and 2021, remaining unamortized debt discount and debt issuance costs for the Term Loan, Euro Term Loan and Convertible Senior Notes are as follows ($ in millions):
20222021
Debt Issuance CostsDebt DiscountDebt Issuance CostsDebt Discount
Convertible Senior Notes$7.5 $— $8.9 $76.5 
Term Loan1.7 — 2.7 — 
Euro Term Loan0.3 — 0.5 — 
$9.5 $— $12.1 $76.5 
XML 65 R48.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Transactions And Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of Share Activity
The following table summarizes the Company’s stock activity (shares in millions):
Year Ended December 31,
202220212020
Common stock - shares issued:
Balance, beginning of period162.0 160.2 158.7 
Issuance of common stock 1.7 1.8 1.5 
Balance, end of period163.7 162.0 160.2 
Summary of Assumption Used in the Black-Scholes Value Options Granted
The following summarizes the assumptions used in the Black-Scholes model to value Options granted during the years ended December 31:
202220212020
Risk-free interest rate
1.9 – 3.1%
1.0 – 1.3%
0.4 – 1.2%
Weighted average volatility33.6 %25.3 %25.3 %
Dividend yield— %— %— %
Expected years until exercise
6.0
6.0
6.0
Components Of Stock-Based Compensation Program
The following summarizes the components of the Company’s stock-based compensation expense for the years ended December 31 ($ in millions):
202220212020
RSUs / PSUs$19.3 $15.5 $13.3 
Options11.2 12.2 8.9 
Total stock-based compensation expense$30.5 $27.7 $22.2 
Schedule of Option Activity
The following summarizes the Company’s Option activity (in millions; except price per share and numbers of years):
Number of Stock Options
Weighted
Average
Exercise Price
Weighted Average
Remaining
Contractual Term
(in years)
Aggregate
Intrinsic
Value
Outstanding as of December 31, 20198.0 $17.81 
Granted
2.2 $26.14 
Exercised
(1.0)$14.01 
Cancelled/forfeited
(1.1)$21.17 
Outstanding as of December 31, 20208.1 $20.08 
Granted
1.7 $38.15 
Exercised
(1.3)$15.74 
Cancelled/forfeited
(0.6)$26.74 
Outstanding as of December 31, 20217.9 $24.16 
Granted
0.5 $48.23 
Exercised
(1.2)$18.61 
Cancelled/forfeited
(0.7)$30.29 
Outstanding as of December 31, 20226.5 $26.24 6.3$59.7 
Vested and expected to vest as of December 31, 2022
6.3 $26.09 6.3$58.8 
Vested as of December 31, 2022
3.2 $22.01 5.4$39.3 
Schedule of Options Outstanding
Options outstanding as of December 31, 2022 are summarized below (in millions; except price per share and numbers of years):
OutstandingExercisable
Exercise PriceNumber of Stock OptionsAverage
Exercise Price		Average
Remaining
Life
(in years)		Number of Stock OptionsAverage
Exercise Price
$9.74 to 12.65
0.4 $12.00 2.40.4 $12.00 
$12.66 to 19.22
1.6 $17.95 4.81.3 $17.66 
$19.23 to 26.50
2.7 $24.15 6.51.0 $24.10 
$26.51 to $41.95
1.4 $36.74 7.90.5 $35.85 
$41.96 to 48.52
0.4 $48.01 8.9— $43.30 
Summary Information of Unvested RSUs and PSUs Activity
The following summarizes information on unvested RSU and PSU activity related to the Company’s employees and non-employee directors (in millions; except weighted average grant-date fair value):
Number of
RSUs/PSUs		Weighted Average
Grant-Date Fair Value
Unvested at December 31, 20192.1 $19.60 
Granted0.7 $25.76 
Vested(0.5)$17.87 
Forfeited(0.4)$20.98 
Unvested at December 31, 20201.9 $22.01 
Granted0.5 $38.76 
Vested(0.5)$20.34 
Forfeited(0.2)$26.54 
Unvested at December 31, 20211.7 $26.82 
Granted0.6 $47.80 
Vested(0.5)$24.85 
Forfeited(0.3)$33.62 
Unvested at December 31, 20221.5 $34.85 
XML 66 R49.htm IDEA: XBRL DOCUMENT v3.22.4
Accumulated Other Comprehensive Loss (Tables)
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule of accumulated other comprehensive income (loss)
The changes in accumulated other comprehensive loss by component are summarized below ($ in millions):
Foreign Currency Translation AdjustmentsUnrealized Gain (Loss) on Cash Flow HedgesUnrealized Pension CostsTotal Accumulated Other Comprehensive Loss
Balance, December 31, 2019$(116.4)$0.1 $(27.9)$(144.2)
Other comprehensive income (loss) before reclassifications:
Increase (decrease)26.0 (8.4)3.9 21.5 
Income tax impact27.9 2.0 (1.1)28.8 
Other comprehensive income (loss) before reclassifications, net of income taxes53.9 (6.4)2.8 50.3 
Amounts reclassified from accumulated other comprehensive (loss) income:
Increase— — 2.9 2.9 
Income tax impact— — (0.8)(0.8)
Amounts reclassified from accumulated other comprehensive (loss) income, net of income taxes— — 2.1 2.1 
Net current period other comprehensive income (loss), net of income taxes
53.9 (6.4)4.9 52.4 
Balance, December 31, 2020$(62.5)$(6.3)$(23.0)$(91.8)
Other comprehensive loss before reclassifications:
(Decrease) increase(72.7)6.1 21.9 (44.7)
Income tax impact(17.0)(1.5)(4.7)(23.2)
Other comprehensive (loss) income before reclassifications, net of income taxes(89.7)4.6 17.2 (67.9)
Amounts reclassified from accumulated other comprehensive loss income:
Increase15.9 — 5.0 20.9 
Income tax impact(3.3)— (1.4)(4.7)
Amounts reclassified from accumulated other comprehensive loss, net of income taxes12.6 — 3.6 16.2 
Net current period other comprehensive (loss) income, net of income taxes(77.1)4.6 20.8 (51.7)
Balance, December 31, 2021$(139.6)$(1.7)$(2.2)$(143.5)
Other comprehensive loss before reclassifications:
(Decrease) increase(80.5)2.2 24.6 (53.7)
Income tax impact(20.4)(0.5)(5.2)(26.1)
Other comprehensive (loss) income before reclassifications, net of income taxes(100.9)1.7 19.4 (79.8)
Amounts reclassified from accumulated other comprehensive loss income:
Increase— — (2.3)(2.3)
Income tax impact— — 0.5 0.5 
Amounts reclassified from accumulated other comprehensive loss, net of income taxes— — (1.8)(1.8)
Net current period other comprehensive (loss) income, net of income taxes(100.9)1.7 17.6 (81.6)
Balance, December 31, 2022$(240.5)$— $15.4 $(225.1)
XML 67 R50.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue (Tables)
 12 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
Schedule of disaggregation of revenue by geographical region and type
The following table presents the Company’s revenues disaggregated by geographical region for the years ended December 31, 2022 and 2021 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenues. The Company has historically defined emerging markets as developing markets of the world, which prior to the COVID-19 pandemic, experienced extended periods of accelerated growth in gross domestic product and infrastructure, including Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets of the world that are not emerging markets.
Year Ended December 31, 2022
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Geographical region:
North America$711.1 $655.3 $1,366.4 
Western Europe388.9 121.1 510.0 
Other developed markets91.0 38.6 129.6 
Emerging markets407.6 155.5 563.1 
Total$1,598.6 $970.5 $2,569.1 

Year Ended December 31, 2021
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Geographical region:
North America$668.9 $659.3 $1,328.2 
Western Europe366.6 125.9 492.5 
Other developed markets98.2 41.2 139.4 
Emerging markets374.1 174.7 548.8 
Total$1,507.8 $1,001.1 $2,508.9 

Sales by Major Product Group:
Year Ended December 31,
($ in millions)202220212020
Consumables$2,147.5 $2,067.9 $1,590.7 
Equipment421.6 441.0 338.4 
Total$2,569.1 $2,508.9 $1,929.1 
XML 68 R51.htm IDEA: XBRL DOCUMENT v3.22.4
Restructuring Activities And Related Impairments (Tables)
 12 Months Ended
Dec. 31, 2022
Restructuring and Related Activities [Abstract]  
Restructuring and related costs
The related liability which is included in accrued liabilities in the Consolidated Balance Sheets is summarized below ($ in millions):
Employee Severance
and Related		Facility Exit
and Related		Total
Balance, December 31, 2021$21.4 $0.5 21.9 
Costs incurred20.8 5.7 26.5 
Paid/settled(24.0)(5.5)(29.5)
Balance, December 31, 2022$18.2 $0.7 $18.9 
Schedule of restructuring reserve by type of cost
Restructuring related charges recorded for the years ended December 31 by segment were as follows ($ in millions): 
202220212020
Specialty Products & Technologies$14.7 $25.2 $43.8 
Equipment & Consumables19.7 32.1 34.6 
Other3.2 6.3 6.0 
Total$37.6 $63.6 $84.4 
The restructuring related charges incurred during the years ended December 31, are reflected in the following captions in the accompanying Consolidated Statements of Operations ($ in millions):
202220212020
Cost of sales$13.6 $35.9 $18.3 
Selling, general and administrative expenses24.0 27.7 66.1 
Total$37.6 $63.6 $84.4 
XML 69 R52.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign
Income (loss) before income taxes for the years ended December 31 were as follows ($ in millions):
202220212020
United States$21.9 $35.0 $(64.3)
International262.0 219.5 44.3 
Total$283.9 $254.5 $(20.0)
Schedule of Components of Income Tax Expense (Benefit)
The provision (benefit) for income taxes for the years ended December 31 were as follows ($ in millions):
202220212020
Current:
Federal U.S.$42.5 $17.7 $13.1 
Non-U.S.22.4 26.9 13.5 
State and local8.6 4.4 0.9 
Deferred:
Federal U.S.(31.3)(2.2)(13.1)
Non-U.S.11.3 (57.5)(72.7)
State and local(7.6)1.7 (4.2)
Income tax provision (benefit)$45.9 $(9.0)$(62.5)
Schedule of Deferred Tax Assets and Liabilities Significant components of deferred tax assets and liabilities as of December 31 were as follows ($ in millions):
20222021
Deferred tax assets:
Inventories$15.4 $17.4 
Pension benefits6.2 11.5 
Other accruals and prepayments45.3 54.3 
Lease liabilities35.5 34.2 
Stock-based compensation expense7.5 6.8 
Interest expense36.0 8.7 
Capitalized research expenses15.1 3.8 
Tax credit and loss carryforwards38.2 117.3 
Valuation allowances(38.7)(90.0)
Total deferred tax asset160.5 164.0 
Deferred tax liabilities:
Property, plant and equipment(5.7)(9.6)
Unrealized gains and losses(6.2)(6.5)
Right-of-use assets(31.5)(30.3)
Goodwill and other intangible assets(92.2)(192.3)
Total deferred tax liability(135.6)(238.7)
Net deferred tax asset (liability)$24.9 $(74.7)
Summary Of Effective Income Tax Rate
The effective income tax rate for the years ended December 31 varies from the U.S. statutory federal income tax rate as follows:
Percentage of Pretax Income
202220212020
Statutory federal income tax rate21.0 %21.0 %21.0 %
Increase (decrease) in tax rate resulting from:
State income taxes (net of federal income tax benefit)0.3 1.2 17.0 
Impact of foreign operations(5.0)(6.4)80.4 
Foreign-Derived Intangible Income (“FDII”)(0.7)— — 
Subpart F and GILTI, net of foreign tax credits6.7 6.4 (72.4)
Change in uncertain tax positions(0.5)— 3.4 
Research and experimentation credits and other(1.6)(1.6)13.2 
Permanent differences and other(0.9)2.7 (20.3)
Excess tax benefit from stock-based compensation(1.6)(1.9)11.6 
Valuation allowance release on certain Swiss NOLs— (8.1)— 
Impact of step-up of Swiss assets(1.5)(16.8)258.6 
Effective income tax rate16.2 %(3.5)%312.5 %
Schedule of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Roll Forward
A reconciliation of the beginning and ending amount of unrecognized tax benefits, excluding amounts accrued for potential interest and penalties, is as follows ($ in millions):
202220212020
Unrecognized tax benefits, beginning of year$5.7 $7.1 $9.1 
Additions based on tax positions related to the current year0.3 0.3 0.3 
Additions for tax positions of prior years4.2 — 0.3 
Reductions for tax positions of prior years— (0.3)(1.7)
Lapse of statute of limitations(2.3)(1.0)(1.0)
Settlements(1.1)(0.4)— 
Effect of foreign currency translation(0.2)— 0.1 
Unrecognized tax benefits, end of year$6.6 $5.7 $7.1 
XML 70 R53.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings Per Share (Tables)
 12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Schedule of earnings per share, basic and diluted
The table below presents the computation of basic and diluted earnings per share ($ and shares in millions, except per share amounts):
Year Ended December 31,
202220212020
Numerator:
Income from continuing operations, net of tax$238.0 $263.5 42.5 
Income (loss) from discontinued operations, net of tax$5.1 $77.0 $(9.2)
Net income $243.1 $340.5 $33.3 
Denominator:
Weighted-average common shares outstanding used in basic earnings (loss) per share162.9 161.2 159.6 
Incremental common shares from:
Assumed exercise of dilutive options and vesting of dilutive restricted stock units3.2 4.4 2.2 
Assumed conversion of the Notes11.5 12.0 2.3 
Weighted average common shares outstanding used in diluted earnings (loss) per share177.6 177.6 164.1 
Earnings per share:
Earnings from continuing operations - basic$1.46 $1.63 $0.27 
Earnings from continuing operations - diluted$1.34 $1.48 $0.26 
Earnings (loss) from discontinued operations - basic$0.03 $0.48 $(0.06)
Earnings (loss) from discontinued operations - diluted$0.03 $0.43 $(0.06)
Earnings - basic$1.49 $2.11 $0.21 
Earnings - diluted$1.37 $1.92 *$0.20 
* Earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. The sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding.
Schedule of antidilutive securities excluded from computation of earnings per share
The following table presents the number of outstanding securities not included in the computation of diluted income per share, because their effect was anti-dilutive (in millions):

Year Ended December 31,
202220212020
Stock-based awards1.5 1.2 4.1 
XML 71 R54.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information (Tables)
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Segment results
Detailed segment data as of and for the years ended December 31 is as follows ($ in millions):
202220212020
Sales:
Specialty Products & Technologies$1,598.6 $1,507.8 $1,117.3 
Equipment & Consumables970.5 1,001.1 811.8 
Total$2,569.1 $2,508.9 $1,929.1 
Operating profit and reconciliation to income (loss) before taxes:
Specialty Products & Technologies$268.6 $272.3 $65.8 
Equipment & Consumables172.4 153.8 53.6 
Other(121.8)(119.9)(75.9)
Operating profit319.2 306.2 43.5 
Nonoperating income (expense):
   Other income (expense)3.1 2.4 (1.0)
   Interest expense, net(38.4)(54.1)(62.5)
Income (loss) before taxes$283.9 $254.5 $(20.0)
Depreciation and amortization:
Specialty Products & Technologies$80.7 $84.0 $80.6 
Equipment & Consumables54.6 31.4 38.7 
Other2.5 2.4 2.4 
Total$137.8 $117.8 $121.7 
Capital expenditures, gross:
Specialty Products & Technologies$48.8 $37.2 $36.4 
Equipment & Consumables20.6 10.6 5.8 
Other2.7 1.3 1.7 
Total$72.1 $49.1 $43.9 
Identifiable assets:December 31, 2022December 31, 2021
Specialty Products & Technologies$3,475.7 $3,498.2 
Equipment & Consumables2,455.3 1,946.1 
Held for sale— 12.2 
Other656.0 1,117.7 
Total$6,587.0 $6,574.2 
Operations in Geographical Areas: 
Year Ended December 31,
($ in millions)202220212020
Sales:
United States$1,261.9 $1,223.4 $960.1 
China222.2 236.7 198.2 
All other (each country individually less than 5% of total sales)1,085.0 1,048.8 770.8 
Total$2,569.1 $2,508.9 $1,929.1 
Property, plant and equipment, net:December 31, 2022December 31, 2021
United States$183.4 $157.1 
Sweden41.4 49.0 
Mexico15.2 8.8 
All other (each country individually less than 5% of total long-lived assets)53.6 49.2 
Total$293.6 $264.1 
XML 72 R55.htm IDEA: XBRL DOCUMENT v3.22.4
Business And Basis Of Presentation - Narrative (Details)
 12 Months Ended
Dec. 31, 2022
segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Number of business segments (in segments) 2
XML 73 R56.htm IDEA: XBRL DOCUMENT v3.22.4
Summary Of Significant Accounting Policies - Estimated Useful Lives of Depreciable Assets (Details)
 12 Months Ended
Dec. 31, 2022
Buildings  
Property, Plant and Equipment [Line Items]  
Estimated useful life of depreciable asset 30 years
Machinery, equipment and other assets | Minimum  
Property, Plant and Equipment [Line Items]  
Estimated useful life of depreciable asset 3 years
Machinery, equipment and other assets | Maximum  
Property, Plant and Equipment [Line Items]  
Estimated useful life of depreciable asset 10 years
XML 74 R57.htm IDEA: XBRL DOCUMENT v3.22.4
Summary Of Significant Accounting Policies - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Accounting Policies [Abstract]        
Impairment loss $ 0 $ 0 $ 0  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Long-term debt 1,380,700,000 1,315,800,000    
Increase (decrease) in stockholders' equity 4,206,900,000 4,058,000,000    
Additional Paid-in Capital        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Increase (decrease) in stockholders' equity 3,699,000,000 3,732,600,000 3,684,400,000 $ 3,589,700,000
Retained Earnings        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Increase (decrease) in stockholders' equity $ 731,400,000 466,900,000 $ 126,400,000 $ 93,100,000
Adjustment        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Net deferred tax liability   18,600,000    
Adjustment | Additional Paid-in Capital        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Increase (decrease) in stockholders' equity   (77,800,000)    
Adjustment | Retained Earnings        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Increase (decrease) in stockholders' equity   21,400,000    
Adjustment | Convertible Debt        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Long-term debt   $ 75,000,000    
XML 75 R58.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisitions - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jul. 05, 2022
Apr. 20, 2022
Dec. 31, 2022
Business Acquisition [Line Items]      
Contingent consideration     $ 6,000
Osteogenics Biomedical Inc      
Business Acquisition [Line Items]      
Consideration transferred $ 128,200    
Weighted-average useful life of acquired intangible assets     10 years
Carestream Dental Technology      
Business Acquisition [Line Items]      
Consideration transferred   $ 580,300  
Contingent consideration   $ 7,500  
Weighted-average useful life of acquired intangible assets     8 years
Osteogenics Biomedical Inc & Carestream Dental Technology      
Business Acquisition [Line Items]      
Acquisition costs     $ 14,500
XML 76 R59.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisitions - Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
Dec. 31, 2022
Jul. 05, 2022
Apr. 20, 2022
Dec. 31, 2021
Assets acquired:        
Goodwill $ 3,496.6     $ 3,132.0
Osteogenics Biomedical Inc        
Assets acquired:        
Cash   $ 2.1    
Accounts receivable   2.5    
Inventories   13.3    
Intangible assets   53.0    
Property, plant and equipment   0.0    
Prepaids and Other Current Assets   1.3    
Goodwill   77.3    
Non-current deferred tax asset   0.0    
Operating lease right-of-use assets   2.6    
Other long-term assets   4.9    
Total assets acquired   157.0    
Liabilities assumed:        
Accounts payable   (4.1)    
Accrued expenses and other liabilities   (2.5)    
Non-current deferred tax liability   (14.3)    
Other long-term liabilities   (5.8)    
Operating lease liabilities   (2.1)    
Total liabilities assumed   (28.8)    
Total net assets acquired   $ 128.2    
Carestream Dental Technology        
Assets acquired:        
Cash     $ 2.7  
Accounts receivable     0.1  
Inventories     6.1  
Intangible assets     129.8  
Property, plant and equipment     0.3  
Prepaids and Other Current Assets     0.0  
Goodwill     373.1  
Non-current deferred tax asset     96.0  
Operating lease right-of-use assets     0.9  
Other long-term assets     0.2  
Total assets acquired     609.2  
Liabilities assumed:        
Accounts payable     (0.5)  
Accrued expenses and other liabilities     (27.9)  
Non-current deferred tax liability     0.0  
Other long-term liabilities     0.0  
Operating lease liabilities     (0.5)  
Total liabilities assumed     (28.9)  
Total net assets acquired     $ 580.3  
XML 77 R60.htm IDEA: XBRL DOCUMENT v3.22.4
Discontinued Operations - Narrative (Details) - Discontinued operations disposed of by sale - Plamenca
$ in Millions
Dec. 31, 2021
USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Liability for proceeds related to the Relevant Jurisdictions $ 10.8
Consideration $ 386.4
XML 78 R61.htm IDEA: XBRL DOCUMENT v3.22.4
Discontinued Operations - Carrying Amount of Assets and Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Current assets held for sale $ 0.0 $ 12.2
Current liabilities:    
Current liabilities held for sale $ 0.0 4.0
Discontinued operations disposed of by sale | Plamenca    
Current assets:    
Assets for Relevant Jurisdictions   12.2
Current assets held for sale   12.2
Current liabilities:    
Liabilities for Relevant Jurisdictions   4.0
Current liabilities held for sale   $ 4.0
XML 79 R62.htm IDEA: XBRL DOCUMENT v3.22.4
Discontinued Operations - Operating Results (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating expenses:      
Income (loss) from discontinued operations, net of tax $ 5.1 $ 77.0 $ (9.2)
Discontinued operations disposed of by sale | Plamenca      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Sales 11.7 413.5 352.9
Cost of sales 9.1 234.6 249.6
Gross profit 2.6 178.9 103.3
Operating expenses:      
Selling, general and administrative 3.2 75.6 99.3
Research and development 0.0 16.1 14.1
Operating (loss) profit (0.6) 87.2 (10.1)
Income tax expense 0.0 21.9 (0.9)
(Loss) income from discontinued operations (0.6) 65.3 (9.2)
Gain on sale of discontinued operations, net of tax 5.7 11.7 0.0
Income (loss) from discontinued operations, net of tax $ 5.1 $ 77.0 $ (9.2)
XML 80 R63.htm IDEA: XBRL DOCUMENT v3.22.4
Discontinued Operations - Significant Non-Cash Operating Items and Capital Expenditures (Details) - Discontinued operations disposed of by sale - Plamenca - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities      
Non-cash restructuring charges $ 0.0 $ 0.0 $ 9.6
Impairment charges 0.0 0.0 10.5
Depreciation and amortization 0.0 5.8 10.9
Cash flows from investing activities:      
Capital expenditures $ 0.0 $ 6.7 $ 3.8
XML 81 R64.htm IDEA: XBRL DOCUMENT v3.22.4
Credit Losses - Narrative (Details)
 12 Months Ended
Dec. 31, 2022
segment
Credit Loss [Abstract]  
Number of portfolio segments (in segments) 1
XML 82 R65.htm IDEA: XBRL DOCUMENT v3.22.4
Credit Losses - Allowance for Credit Losses (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2022
USD ($)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]  
Beginning balance $ 20.7
Foreign currency translation (0.8)
Provision for credit losses 4.8
Write-offs charged against the allowance (4.1)
Recoveries (4.4)
Ending balance $ 16.2
XML 83 R66.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories - Summary (Details) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Inventory Disclosure [Abstract]    
Finished goods $ 229.2 $ 214.3
Work in process 23.9 22.0
Raw materials 103.4 88.3
Reserve for inventory obsolescence (55.7) (60.8)
Total $ 300.8 $ 263.8
XML 84 R67.htm IDEA: XBRL DOCUMENT v3.22.4
Property, Plant And Equipment (Details) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment $ 605.9 $ 579.5
Less: accumulated depreciation (312.3) (315.4)
Property, plant and equipment, net 293.6 264.1
Land and improvements    
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment 10.0 10.7
Buildings and improvements    
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment 154.5 168.7
Machinery, equipment and other assets    
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment 370.2 354.5
Construction in progress    
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment $ 71.2 $ 45.6
XML 85 R68.htm IDEA: XBRL DOCUMENT v3.22.4
Leases - Narrative (Details)
 12 Months Ended
Dec. 31, 2022
Lessee, Lease, Description [Line Items]  
Duration of option to terminate lease (in days) 30 days
Maximum  
Lessee, Lease, Description [Line Items]  
Lease renewal term (in years) 20 years
XML 86 R69.htm IDEA: XBRL DOCUMENT v3.22.4
Leases - Components of Lease Expense (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Leases [Abstract]    
Fixed operating lease expense $ 31.7 $ 32.4
Variable operating lease expense 7.2 6.1
Total operating lease expense $ 38.9 $ 38.5
XML 87 R70.htm IDEA: XBRL DOCUMENT v3.22.4
Leases - Weighted Average Remaining Lease Term and Discount Rate (Details)
Dec. 31, 2022
Dec. 31, 2021
Leases [Abstract]    
Weighted average remaining lease term 8 years 9 years
Weighted average discount rate 4.10% 3.50%
XML 88 R71.htm IDEA: XBRL DOCUMENT v3.22.4
Leases - Maturities of Lease Liabilities (Details)
$ in Millions
Dec. 31, 2022
USD ($)
Lessee, Operating Lease, Liability, Payment, Due [Abstract]  
2023 $ 32.2
2024 28.7
2025 23.9
2026 19.8
2027 16.8
Thereafter 50.3
Total operating lease payments 171.7
Less: imputed interest (23.3)
Total operating lease liabilities $ 148.4
XML 89 R72.htm IDEA: XBRL DOCUMENT v3.22.4
Goodwill And Other Intangible Assets - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]      
Impairment loss $ 0 $ 0 $ 0
Total intangible amortization expense $ 106,000,000 $ 81,500,000 $ 87,300,000
XML 90 R73.htm IDEA: XBRL DOCUMENT v3.22.4
Goodwill And Other Intangible Assets - Rollforward (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2022
USD ($)
Goodwill [Roll Forward]  
Beginning balance $ 3,132.0
Acquisitions 450.4
Foreign currency translation (85.8)
Ending balance 3,496.6
Specialty Products & Technologies  
Goodwill [Roll Forward]  
Beginning balance 2,029.7
Acquisitions 77.3
Foreign currency translation (59.2)
Ending balance 2,047.8
Equipment & Consumables  
Goodwill [Roll Forward]  
Beginning balance 1,102.3
Acquisitions 373.1
Foreign currency translation (26.6)
Ending balance $ 1,448.8
XML 91 R74.htm IDEA: XBRL DOCUMENT v3.22.4
Goodwill And Other Intangible Assets - Intangible Assets by Major Class (Details) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Intangible Assets, Gross (Excluding Goodwill) [Abstract]    
Gross Carrying Amount $ 1,581.1 $ 1,437.5
Accumulated Amortization (985.3) (901.6)
Gross carrying amount of total intangibles 2,072.0 1,948.0
Trademarks and trade names    
Intangible Assets, Gross (Excluding Goodwill) [Abstract]    
Trademarks and trade names of indefinite-live intangibles 490.9 510.5
Patents and technology    
Intangible Assets, Gross (Excluding Goodwill) [Abstract]    
Gross Carrying Amount 432.2 313.8
Accumulated Amortization (236.4) (215.3)
Customer relationships and other intangibles    
Intangible Assets, Gross (Excluding Goodwill) [Abstract]    
Gross Carrying Amount 924.1 907.4
Accumulated Amortization (648.7) (610.9)
Trademarks and trade names    
Intangible Assets, Gross (Excluding Goodwill) [Abstract]    
Gross Carrying Amount 224.8 216.3
Accumulated Amortization $ (100.2) $ (75.4)
XML 92 R75.htm IDEA: XBRL DOCUMENT v3.22.4
Intangible Assets, Goodwill and Other - Intangible Assets Future Amortization Expense (Details)
$ in Millions
Dec. 31, 2022
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2023 $ 99.3
2024 89.6
2025 89.1
2026 81.1
2027 76.5
Thereafter 160.2
Total amortization $ 595.8
XML 93 R76.htm IDEA: XBRL DOCUMENT v3.22.4
Accrued Expenses And Other Liabilities - Summary (Details) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current    
Compensation and benefits $ 148.0 $ 188.9
Sales and product allowances 85.1 75.4
Contract liabilities 78.9 60.1
Taxes, income and other 42.1 48.1
Restructuring-related employee severance, benefits and other 18.9 21.9
Pension benefits 5.6 5.6
Loss contingencies 8.1 8.4
Derivative financial instruments 0.0 19.6
Other 84.7 134.3
Total 471.4 562.3
Noncurrent    
Compensation and benefits 17.5 17.9
Sales and product allowances 1.3 1.2
Contract liabilities 8.6 5.1
Taxes, income and other 68.6 201.4
Restructuring-related employee severance, benefits and other 0.0 0.0
Pension benefits 17.5 41.7
Loss contingencies 27.6 30.3
Derivative financial instruments 0.0 0.0
Other 10.2 6.6
Total $ 151.3 $ 304.2
XML 94 R77.htm IDEA: XBRL DOCUMENT v3.22.4
Hedging Transactions And Derivative Financial Instruments - Narrative (Details)
 12 Months Ended
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2022
EUR (€)
Sep. 20, 2019
USD ($)
Sep. 20, 2019
EUR (€)
Derivative [Line Items]          
Total debt $ 1,380,700,000 $ 1,315,800,000      
Amounts reclassified from accumulated other comprehensive loss, net of income taxes 0 10,200,000      
Euro term loan due 2024          
Derivative [Line Items]          
Term loan | €     € 208,000,000.0   € 600,000,000.0
Total debt 222,400,000 236,100,000      
US term loan due 2024          
Derivative [Line Items]          
Term loan       $ 650,000,000.0  
Total debt $ 648,300,000 $ 647,300,000   $ 650,000,000.0  
XML 95 R78.htm IDEA: XBRL DOCUMENT v3.22.4
Hedging Transactions And Derivative Financial Instruments - Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Derivative Instruments, Gain (Loss) [Line Items]    
Notional Amount $ 222.7 $ 1,136.5
Gain Recognized in OCI 84.5 88.3
Net investment hedging | Foreign currency denominated debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional Amount 222.7 236.5
Gain Recognized in OCI 13.8 32.5
Net investment hedging | Interest rate contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional Amount 0.0 250.0
Gain Recognized in OCI 2.2 6.1
Net investment hedging | Foreign currency contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Notional Amount 0.0 650.0
Gain Recognized in OCI $ 68.5 $ 49.7
XML 96 R79.htm IDEA: XBRL DOCUMENT v3.22.4
Hedging Transactions And Derivative Financial Instruments - Derivative and Nonderivative Debt Instruments (Details) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Derivatives, Fair Value [Line Items]    
Accrued expenses and other liabilities $ 0.0 $ 19.6
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Accrued expenses and other liabilities  
Long-term debt    
Derivatives, Fair Value [Line Items]    
Long-term debt $ 222.7 $ 236.5
XML 97 R80.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Liabilities:    
Swap derivative contracts $ 0.0 $ 19.6
Deferred compensation plans 15.8 16.5
Contingent consideration 6.0  
Quoted Prices in Active Market (Level 1)    
Liabilities:    
Deferred compensation plans 0.0 0.0
Contingent consideration 0.0  
Significant Other Observable Inputs (Level 2)    
Liabilities:    
Deferred compensation plans 15.8 16.5
Contingent consideration 0.0  
Significant Unobservable Inputs (Level 3)    
Liabilities:    
Deferred compensation plans 0.0 0.0
Contingent consideration $ 6.0  
Interest rate swap derivative contracts    
Liabilities:    
Swap derivative contracts   2.2
Interest rate swap derivative contracts | Quoted Prices in Active Market (Level 1)    
Liabilities:    
Swap derivative contracts   0.0
Interest rate swap derivative contracts | Significant Other Observable Inputs (Level 2)    
Liabilities:    
Swap derivative contracts   2.2
Interest rate swap derivative contracts | Significant Unobservable Inputs (Level 3)    
Liabilities:    
Swap derivative contracts   0.0
Cross-currency swap derivative contracts    
Liabilities:    
Swap derivative contracts   17.4
Cross-currency swap derivative contracts | Quoted Prices in Active Market (Level 1)    
Liabilities:    
Swap derivative contracts   0.0
Cross-currency swap derivative contracts | Significant Other Observable Inputs (Level 2)    
Liabilities:    
Swap derivative contracts   17.4
Cross-currency swap derivative contracts | Significant Unobservable Inputs (Level 3)    
Liabilities:    
Swap derivative contracts   $ 0.0
XML 98 R81.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements - Fair Value of Financial Instruments (Details) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration $ 6.0  
Swap derivative contracts 0.0 $ 19.6
Carrying Amount    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration 6.0 0.0
Convertible senior notes due 2025 510.0 432.1
Long-term debt 870.7 883.4
Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration 6.0 0.0
Convertible senior notes due 2025 873.0 1,162.5
Long-term debt 870.7 883.4
Interest rate swap derivative contracts    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Swap derivative contracts   2.2
Interest rate swap derivative contracts | Carrying Amount    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Swap derivative contracts 0.0 2.2
Interest rate swap derivative contracts | Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Swap derivative contracts 0.0 2.2
Cross-currency swap derivative contracts    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Swap derivative contracts   17.4
Cross-currency swap derivative contracts | Carrying Amount    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Swap derivative contracts 0.0 17.4
Cross-currency swap derivative contracts | Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Swap derivative contracts $ 0.0 $ 17.4
XML 99 R82.htm IDEA: XBRL DOCUMENT v3.22.4
Pension And Other Benefit Plans - Funded Status Of Pension Plans (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Change in plan assets:      
Funded status $ (23.1) $ (48.5)  
Defined benefit pension plans      
Change in pension benefit obligation:      
Benefit obligation at beginning of year (129.1) (171.6)  
Service cost (5.5) (7.3) $ (9.7)
Interest cost (1.8) (1.2) (1.6)
Employee contributions (2.5) (3.1)  
Benefits and other expenses paid 3.0 3.3  
Actuarial gain 27.3 13.0  
Amendments, settlements and curtailments 7.7 33.2  
Foreign exchange rate impact 3.4 4.6  
Benefit obligation at end of year (97.5) (129.1) (171.6)
Change in plan assets:      
Fair value of plan assets at beginning of year 80.6 104.1  
Actual return on plan assets (1.7) 5.8  
Employer contributions 5.5 6.0  
Employee contributions 2.5 3.1  
Amendments and settlements (6.6) (32.8)  
Benefits and other expenses paid (3.1) (3.3)  
Foreign exchange rate impact (2.8) (2.3)  
Fair value of plan assets at end of year $ 74.4 $ 80.6 $ 104.1
XML 100 R83.htm IDEA: XBRL DOCUMENT v3.22.4
Pension And Other Benefit Plans - Weighted Average Assumptions Used To Determine Benefit Obligations (Details)
Dec. 31, 2022
Dec. 31, 2021
Retirement Benefits [Abstract]    
Discount rate 3.90% 1.50%
Rate of compensation increase 2.80% 2.20%
XML 101 R84.htm IDEA: XBRL DOCUMENT v3.22.4
Pension And Other Benefit Plans - Components of Net Periodic Benefit Cost of Defined Benefit Pension Plans (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]      
Net periodic pension cost $ (2.4) $ (4.7) $ (10.0)
Defined benefit pension plans      
Defined Benefit Plan Disclosure [Line Items]      
Service cost (5.5) (7.3) (9.7)
Interest cost (1.8) (1.2) (1.6)
Expected return on plan assets 2.6 3.3 3.7
Amortization of prior service credit and initial net obligation 0.3 0.4 0.4
Amortization of actuarial loss 0.1 (0.7) (1.4)
Net settlement and curtailment gain (loss) 1.9 0.8 (1.4)
Net periodic pension cost $ (2.4) $ (4.7) $ (10.0)
XML 102 R85.htm IDEA: XBRL DOCUMENT v3.22.4
Pension And Other Benefit Plans - Components of Net Periodic Benefit Cost Reflected in the Consolidated Condensed Statement of Earnings (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Other net periodic pension costs:      
Other income (expense) $ 3.1 $ 2.6 $ (0.3)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] Other income (expense)    
Net periodic pension cost $ (2.4) (4.7) (10.0)
Cost of sales      
Service cost:      
Service costs (0.8) (0.8) (1.2)
Selling, general and administrative expenses      
Service cost:      
Service costs $ (4.7) $ (6.5) $ (8.5)
XML 103 R86.htm IDEA: XBRL DOCUMENT v3.22.4
Pension And Other Benefit Plans - Weighted Average Assumptions Used To Determine Net Periodic Pension Cost (Details)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Retirement Benefits [Abstract]    
Discount rate 2.40% 1.00%
Expected long-term return on plan assets 3.30% 3.20%
Rate of compensation increase 2.20% 1.30%
XML 104 R87.htm IDEA: XBRL DOCUMENT v3.22.4
Pension And Other Benefit Plans - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]        
Long-term rate of return on asset assumptions   3.30% 3.20%  
NAV per share, investment redemption, notice period   90 days    
Expense for all defined benefit and defined contributions pension plans   $ 19.1 $ 18.0 $ 11.0
Multiemployer plan, employer contribution cost   1.6 3.9 $ 8.2
Defined benefit pension plans        
Defined Benefit Plan Disclosure [Line Items]        
Unrecognized prior service credits, before tax   2.3    
Unrecognized prior service credits, net of tax   1.8    
Unrecognized actuarial gain, before tax   17.5    
Unrecognized actuarial gain, net of tax   13.6    
Employer contributions   5.5 $ 6.0  
Expected employer contributions within the next year   $ 5.5    
Defined benefit pension plans | Forecast        
Defined Benefit Plan Disclosure [Line Items]        
Future amortization of prior service cost (credit) $ 0.4      
Future amortization of prior service cost (credit), net of tax 0.3      
Future amortization of gain (loss) 1.4      
Future amortization of gain (loss), net of tax $ 1.1      
Minimum | Defined benefit pension plans        
Defined Benefit Plan Disclosure [Line Items]        
Long-term rate of return on asset assumptions   2.30% 1.80%  
Maximum | Defined benefit pension plans        
Defined Benefit Plan Disclosure [Line Items]        
Long-term rate of return on asset assumptions   5.30% 5.30%  
Weighted Average | Defined benefit pension plans        
Defined Benefit Plan Disclosure [Line Items]        
Long-term rate of return on asset assumptions   3.30% 3.20%  
XML 105 R88.htm IDEA: XBRL DOCUMENT v3.22.4
Pension And Other Benefit Plans - Fair Values Of Pension Plan Assets (Details) - Defined benefit pension plans - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]      
Defined benefit plan, plan assets $ 74.4 $ 80.6 $ 104.1
Quoted Prices in Active Market (Level 1)      
Defined Benefit Plan Disclosure [Line Items]      
Defined benefit plan, plan assets 8.4 0.3  
Significant Other Observable Inputs (Level 2)      
Defined Benefit Plan Disclosure [Line Items]      
Defined benefit plan, plan assets 0.0 0.0  
Significant Unobservable Inputs (Level 3)      
Defined Benefit Plan Disclosure [Line Items]      
Defined benefit plan, plan assets 49.7 50.1 $ 77.2
Total      
Defined Benefit Plan Disclosure [Line Items]      
Defined benefit plan, plan assets 58.1 50.4  
Cash and cash equivalents | Quoted Prices in Active Market (Level 1)      
Defined Benefit Plan Disclosure [Line Items]      
Defined benefit plan, plan assets 8.4 0.3  
Cash and cash equivalents | Significant Other Observable Inputs (Level 2)      
Defined Benefit Plan Disclosure [Line Items]      
Defined benefit plan, plan assets 0.0 0.0  
Cash and cash equivalents | Significant Unobservable Inputs (Level 3)      
Defined Benefit Plan Disclosure [Line Items]      
Defined benefit plan, plan assets 0.0 0.0  
Cash and cash equivalents | Total      
Defined Benefit Plan Disclosure [Line Items]      
Defined benefit plan, plan assets 8.4 0.3  
Insurance contracts | Quoted Prices in Active Market (Level 1)      
Defined Benefit Plan Disclosure [Line Items]      
Defined benefit plan, plan assets 0.0 0.0  
Insurance contracts | Significant Other Observable Inputs (Level 2)      
Defined Benefit Plan Disclosure [Line Items]      
Defined benefit plan, plan assets 0.0 0.0  
Insurance contracts | Significant Unobservable Inputs (Level 3)      
Defined Benefit Plan Disclosure [Line Items]      
Defined benefit plan, plan assets 49.7 50.1  
Insurance contracts | Total      
Defined Benefit Plan Disclosure [Line Items]      
Defined benefit plan, plan assets 49.7 50.1  
Mutual funds | Mutual funds      
Defined Benefit Plan Disclosure [Line Items]      
Defined benefit plan, plan assets $ 16.3 $ 30.2  
XML 106 R89.htm IDEA: XBRL DOCUMENT v3.22.4
Pension And Other Benefit Plans - Changes in Fair Value of Plan Assets (Details) - Defined benefit pension plans - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Fair Value, Plan Assets Measured on Recurring Basis [Roll Forward]    
Fair value of plan assets at beginning of year $ 80.6 $ 104.1
Fair value of plan assets at end of year 74.4 80.6
Significant Unobservable Inputs (Level 3)    
Fair Value, Plan Assets Measured on Recurring Basis [Roll Forward]    
Fair value of plan assets at beginning of year 50.1 77.2
Return on Plan Assets (0.1) (0.6)
Net Purchases/(Settlements) (0.3) (26.5)
Transfers Into/(Out of) Level 3 0.0 0.0
Fair value of plan assets at end of year $ 49.7 $ 50.1
XML 107 R90.htm IDEA: XBRL DOCUMENT v3.22.4
Pension And Other Benefit Plans - Benefit Payments That Reflect Expected Future Service (Details) - Defined benefit pension plans
$ in Millions
Dec. 31, 2022
USD ($)
Defined Benefit Plan Disclosure [Line Items]  
2023 $ 5.6
2024 5.1
2025 5.1
2026 4.8
2027 4.8
2028 - 2032 $ 24.1
XML 108 R91.htm IDEA: XBRL DOCUMENT v3.22.4
Warranty - Narrative (Details)
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Product warranty period 90 days
XML 109 R92.htm IDEA: XBRL DOCUMENT v3.22.4
Warranty - Warranty Accrual (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2022
USD ($)
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]  
Beginning balance $ 9.4
Accruals for warranties issued during the year 15.3
Settlements made (15.1)
Divestiture (0.1)
Effect of foreign currency translation (0.3)
Ending balance $ 9.2
XML 110 R93.htm IDEA: XBRL DOCUMENT v3.22.4
Litigation And Contingencies - Narrative (Details) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]    
Accrual for legal matters $ 35.7 $ 38.7
Guarantees $ 19.0  
XML 111 R94.htm IDEA: XBRL DOCUMENT v3.22.4
Debt And Credit Facilities - Components Of Debt (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Sep. 20, 2019
Debt Instrument [Line Items]      
Total debt $ 1,380,700,000 $ 1,315,800,000  
Less: current portion (510,000,000.0) (432,400,000)  
Long-term debt 870,700,000 883,400,000  
US term loan due 2024      
Debt Instrument [Line Items]      
Total debt 648,300,000 647,300,000 $ 650,000,000.0
Euro term loan due 2024      
Debt Instrument [Line Items]      
Total debt 222,400,000 236,100,000  
Other      
Debt Instrument [Line Items]      
Total debt 0 300,000  
Convertible Debt | Convertible senior notes due 2025      
Debt Instrument [Line Items]      
Total debt $ 510,000,000.0 $ 432,100,000  
XML 112 R95.htm IDEA: XBRL DOCUMENT v3.22.4
Debt And Credit Facilities - Debt Payments (Details)
$ in Millions
Dec. 31, 2022
USD ($)
Debt Disclosure [Abstract]  
2023 $ 0.0
2024 872.7
2025 517.5
Total $ 1,390.2
XML 113 R96.htm IDEA: XBRL DOCUMENT v3.22.4
Debt And Credit Facilities - Narrative (Details)
$ / shares in Units, shares in Millions
 12 Months Ended
Jun. 15, 2021
USD ($)
Feb. 09, 2021
USD ($)
May 21, 2020
USD ($)
tradingDay
$ / shares
shares
Sep. 20, 2019
USD ($)
Dec. 31, 2022
USD ($)
tradingDay
$ / shares
Dec. 31, 2021
USD ($)
tradingDay
$ / shares
Dec. 31, 2020
USD ($)
Dec. 31, 2022
EUR (€)
Dec. 31, 2019
USD ($)
Sep. 20, 2019
EUR (€)
Debt Instrument [Line Items]                    
Total borrowings under term loan       $ 1,300,000,000            
Senior unsecured revolving credit facility       $ 250,000,000.0            
Rate in excess of Federal funds rate         0.0050     0.0050    
Rate in excess of Eurocurrency rate         0.010     0.010    
Leverage ratio         3.75     3.75    
Contingency provision on the ratio of indebtedness to net capital         4.25     4.25    
Contingency provision, purchase price in excess of $100 million         $ 100,000,000.0          
Interest coverage ratio (at least)         3.00     3.00    
Proceeds from issuance of convertible senior notes         $ 0 $ 0 $ 517,500,000      
Conversion ratio         0.0475862          
Conversion price (in USD per share) | $ / shares         $ 21.01 $ 21.01        
Total debt         $ 1,380,700,000 $ 1,315,800,000        
Debt Issuance Costs         9,500,000 12,100,000        
Increase (decrease) in stockholders' equity         (4,206,900,000) (4,058,000,000)        
Additional Paid-in Capital                    
Debt Instrument [Line Items]                    
Increase (decrease) in stockholders' equity         (3,699,000,000) (3,732,600,000) (3,684,400,000)   $ (3,589,700,000)  
Retained Earnings                    
Debt Instrument [Line Items]                    
Increase (decrease) in stockholders' equity         (731,400,000) (466,900,000) $ (126,400,000)   $ (93,100,000)  
Adjustment                    
Debt Instrument [Line Items]                    
Net deferred tax liability           18,600,000        
Adjustment | Additional Paid-in Capital                    
Debt Instrument [Line Items]                    
Increase (decrease) in stockholders' equity           77,800,000        
Adjustment | Retained Earnings                    
Debt Instrument [Line Items]                    
Increase (decrease) in stockholders' equity           (21,400,000)        
Fair Value                    
Debt Instrument [Line Items]                    
Convertible debt, fair value         $ 873,000,000.0 $ 1,162,500,000        
US term loan due 2024                    
Debt Instrument [Line Items]                    
Debt instrument, term       3 years            
Term loan       $ 650,000,000.0            
Loan facility interest rates         5.98% 1.25%        
Total debt       $ 650,000,000.0 $ 648,300,000 $ 647,300,000        
Debt Issuance Costs         $ 1,700,000 $ 2,700,000        
Euro term loan due 2024                    
Debt Instrument [Line Items]                    
Debt instrument, term       3 years            
Term loan | €               € 208,000,000.0   € 600,000,000.0
Repayment of debt   $ 472,000,000.0                
Loan facility interest rates         3.28% 0.95%        
Total debt         $ 222,400,000 $ 236,100,000        
Debt Issuance Costs         300,000 500,000        
Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Senior unsecured revolving credit facility $ 750,000,000.0     $ 250,000,000.0            
Increase limit of revolving credit facility 350,000,000.0                  
Cash and cash equivalent threshold $ 250,000,000.0                  
EBITDA threshold 0.50                  
Payments of debt restructuring costs $ 2,100,000                  
Revolving credit facility maximum borrowing capacity         750,000,000.0          
Line of credit facility, outstanding borrowings         0 0        
Revolving Credit Facility | Standby letters of credit                    
Debt Instrument [Line Items]                    
Revolving credit facility maximum borrowing capacity         $ 20,000,000.0          
Minimum                    
Debt Instrument [Line Items]                    
Facility fee         0.09%          
Maximum                    
Debt Instrument [Line Items]                    
Facility fee         0.225%          
LIBOR | Minimum | Credit facility                    
Debt Instrument [Line Items]                    
Margin spread of variable interest rate         0.785%          
LIBOR | Maximum | Credit facility                    
Debt Instrument [Line Items]                    
Margin spread of variable interest rate         1.625%          
Base Rate | Minimum                    
Debt Instrument [Line Items]                    
Margin spread of variable interest rate         0.00%          
Base Rate | Maximum                    
Debt Instrument [Line Items]                    
Margin spread of variable interest rate         0.625%          
Revolving credit facility due 2024 | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Debt instrument, term       5 years            
Convertible Debt | Adjustment                    
Debt Instrument [Line Items]                    
Total debt           75,000,000        
Unamortized discount (premium), net           76,500,000        
Debt Issuance Costs           1,500,000        
Convertible Debt | 2.375% convertible senior notes over allotment option                    
Debt Instrument [Line Items]                    
Term loan     $ 67,500,000              
Convertible Debt | 2.375% convertible senior notes                    
Debt Instrument [Line Items]                    
Term loan     517,500,000              
Proceeds from issuance of convertible senior notes     $ 502,600,000              
Interest rate     2.375%              
Conversion price (in USD per share) | $ / shares     $ 21.01              
Total debt         $ 510,000,000.0 432,100,000        
Debt Issuance Costs         $ 7,500,000 $ 8,900,000        
Redemption price     100.00%              
Threshold percentage of stock price trigger     130.00%   130.00% 130.00%        
Convertible debt, trading days (in trading days) | tradingDay     20   20 20        
Convertible debt, consecutive trading days (in trading days) | tradingDay     30   30 30        
Effective interest rate         3.00% 7.30%   3.00%    
If-converted value in excess of principal         $ 311,700,000 $ 592,100,000        
Convertible Debt | 2.375% convertible senior notes, capped calls                    
Debt Instrument [Line Items]                    
Conversion price (in USD per share) | $ / shares     $ 23.79              
Convertible debt, stock price trigger (in USD per share) | $ / shares     $ 21.01              
Convertible debt, capped calls (in shares) | shares     2.9              
Convertible debt expense, capped calls     $ 20,700,000              
XML 114 R97.htm IDEA: XBRL DOCUMENT v3.22.4
Debt And Credit Facilities - Interest Expense (Details) - Convertible Debt - 2.375% convertible senior notes - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Debt Instrument [Line Items]    
Contractual interest expense $ 12.3 $ 12.3
Amortization of debt issuance costs 2.9 1.9
Amortization of debt discount 0.0 19.0
Total interest expense $ 15.2 $ 33.2
XML 115 R98.htm IDEA: XBRL DOCUMENT v3.22.4
Debt And Credit Facilities - Unamortized Debt Discount and Issuance Costs (Details) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Debt Instrument [Line Items]    
Debt Issuance Costs $ 9.5 $ 12.1
Debt Discount 0.0 76.5
Convertible senior notes due 2025 | Convertible Debt    
Debt Instrument [Line Items]    
Debt Issuance Costs 7.5 8.9
Debt Discount 0.0 76.5
Term Loan    
Debt Instrument [Line Items]    
Debt Issuance Costs 1.7 2.7
Debt Discount 0.0 0.0
Euro Term Loan    
Debt Instrument [Line Items]    
Debt Issuance Costs 0.3 0.5
Debt Discount $ 0.0 $ 0.0
XML 116 R99.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Transactions And Stock-Based Compensation (Details)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 23, 2021
USD ($)
shares
Sep. 30, 2019
shares
Dec. 31, 2022
USD ($)
vote
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2019
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Common stock, shares authorized (in shares)     500,000,000.0 500,000,000    
Common stock, par value (in USD per share) | $ / shares     $ 0.01 $ 0.01    
Preferred shares authorized (in shares)     15,000,000 15,000,000    
Preferred shares outstanding (in shares)     0 0    
Preferred shares issued (in shares)     0 0    
Common stock voting rights (in votes per share) | vote     1      
Total unrecognized compensation cost related to RSUs/PSUs | $     $ 43.6      
Granted (in shares)     600,000 500,000 700,000  
Unvested (in shares)     1,500,000 1,700,000 1,900,000 2,100,000
Expected forfeiture rate     6.00% 6.00% 6.00%  
Period of recognition     2 years      
Aggregate intrinsic value of options exercised | $     $ 31.0 $ 33.0 $ 12.0  
Employee service share-based compensation, tax benefit from exercise of stock options | $     $ 7.2 $ 6.7 4.2  
Share withheld (in shares)     192,400 181,700    
Tax withholding payment related to net settlement of equity awards | $     $ 9.1 $ 7.2 5.0  
RSUs / PSUs            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Employee service share-based compensation, tax benefit from exercise of stock options | $     $ 1.0 $ 1.0 $ 1.0  
RSUs / PSUs | Pacific Dental Services            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period 3 years          
Total unrecognized compensation cost related to RSUs/PSUs | $ $ 12.5          
Granted (in shares) 273,522          
Unvested (in shares)     273,522      
Stock options            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Dividend yield     0.00% 0.00% 0.00%  
Employee service share-based compensation, tax benefit from exercise of stock options | $     $ 4.0 $ 4.0 $ 1.0  
2019 Omnibus Incentive Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of shares authorized under the Stock Plan (in shares)   21,000,000        
Award expiration period   10 years        
2019 Omnibus Incentive Plan | Minimum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period   3 years        
2019 Omnibus Incentive Plan | Minimum | RSUs / PSUs            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period   3 years        
2019 Omnibus Incentive Plan | Maximum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period   5 years        
2019 Omnibus Incentive Plan | Maximum | RSUs / PSUs            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period   5 years        
XML 117 R100.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Transactions And Stock-Based Compensation - Summary of Share Activity (Details) - shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Beginning of period, common stock (in shares) 161,600,000    
End of period, common stock (in shares) 163,200,000 161,600,000  
Common Stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Beginning of period, common stock (in shares) 162,000,000.0 160,200,000 158,700,000
Issuance of common stock (in shares) 1,700,000 1,800,000 1,500,000
End of period, common stock (in shares) 163,700,000 162,000,000.0 160,200,000
XML 118 R101.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Transactions And Stock-Based Compensation - Assumptions Used To Value Options Granted (Details) - Stock options
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average volatility 33.60% 25.30% 25.30%
Dividend yield 0.00% 0.00% 0.00%
Expected years until exercise 6 years 6 years 6 years
Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Risk-free interest rate 1.90% 1.00% 0.40%
Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Risk-free interest rate 3.10% 1.30% 1.20%
XML 119 R102.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Transactions And Stock-Based Compensation - Components of Stock-Based Compensation Program (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense $ 30.5 $ 27.7 $ 22.2
RSUs / PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense 19.3 15.5 13.3
Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense $ 11.2 $ 12.2 $ 8.9
XML 120 R103.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Transactions And Stock-Based Compensation - Option Activity Under The Company's Stock Plans (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Number of Stock Options      
Outstanding at beginning of year (in shares) 7.9 8.1 8.0
Granted (in shares) 0.5 1.7 2.2
Exercised (in shares) (1.2) (1.3) (1.0)
Cancelled/forfeited (in shares) (0.7) (0.6) (1.1)
Outstanding at end of year (in shares) 6.5 7.9 8.1
Vested and expected to vest at end of year (in shares) 6.3    
Vested at end of year (in shares) 3.2    
Weighted Average Exercise Price      
Outstanding as of beginning of year (in USD per share) $ 24.16 $ 20.08 $ 17.81
Granted (in USD per share) 48.23 38.15 26.14
Exercised (in USD per share) 18.61 15.74 14.01
Cancelled/forfeited (in USD per share) 30.29 26.74 21.17
Outstanding as of end of year (in USD per share) 26.24 $ 24.16 $ 20.08
Vested and expected to vest at end of year (in USD per share) 26.09    
Vested at end of year (in USD per share) $ 22.01    
Weighted Average Remaining Contractual Term (in years)      
Outstanding at end of year 6 years 3 months 18 days    
Vested and expected to vest at end of year 6 years 3 months 18 days    
Vested at end of year 5 years 4 months 24 days    
Aggregate Intrinsic Value      
Outstanding at end of year $ 59.7    
Vested and expected to vest at end of year 58.8    
Vested at end of year $ 39.3    
XML 121 R104.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Transactions And Stock-Based Compensation - Summary Of Options Outstanding (Details)
shares in Millions
 12 Months Ended
Dec. 31, 2022
$ / shares
shares
$9.74 to 12.65  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Exercise price, lower limit (in USD per share) $ 9.74
Exercise price, upper limit (in USD per share) $ 12.65
Outstanding, shares (in shares) | shares 0.4
Outstanding, average exercise price (in USD per share) $ 12.00
Outstanding, average remaining life (in years) 2 years 4 months 24 days
Exercisable, shares (in shares) | shares 0.4
Exercisable, average exercise price (in USD per share) $ 12.00
$12.66 to 19.22  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Exercise price, lower limit (in USD per share) 12.66
Exercise price, upper limit (in USD per share) $ 19.22
Outstanding, shares (in shares) | shares 1.6
Outstanding, average exercise price (in USD per share) $ 17.95
Outstanding, average remaining life (in years) 4 years 9 months 18 days
Exercisable, shares (in shares) | shares 1.3
Exercisable, average exercise price (in USD per share) $ 17.66
$19.23 to 26.50  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Exercise price, lower limit (in USD per share) 19.23
Exercise price, upper limit (in USD per share) $ 26.50
Outstanding, shares (in shares) | shares 2.7
Outstanding, average exercise price (in USD per share) $ 24.15
Outstanding, average remaining life (in years) 6 years 6 months
Exercisable, shares (in shares) | shares 1.0
Exercisable, average exercise price (in USD per share) $ 24.10
$26.51 to $41.95  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Exercise price, lower limit (in USD per share) 26.51
Exercise price, upper limit (in USD per share) $ 41.95
Outstanding, shares (in shares) | shares 1.4
Outstanding, average exercise price (in USD per share) $ 36.74
Outstanding, average remaining life (in years) 7 years 10 months 24 days
Exercisable, shares (in shares) | shares 0.5
Exercisable, average exercise price (in USD per share) $ 35.85
$41.96 to 48.52  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Exercise price, lower limit (in USD per share) 41.96
Exercise price, upper limit (in USD per share) $ 48.52
Outstanding, shares (in shares) | shares 0.4
Outstanding, average exercise price (in USD per share) $ 48.01
Outstanding, average remaining life (in years) 8 years 10 months 24 days
Exercisable, shares (in shares) | shares 0.0
Exercisable, average exercise price (in USD per share) $ 43.30
XML 122 R105.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Transactions And Stock-Based Compensation - Summary Of Unrecognized RSU And PRU Activity (Details) - $ / shares
shares in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Number of RSUs/PSUs      
Unvested at beginning of year (in shares) 1.7 1.9 2.1
Granted (in shares) 0.6 0.5 0.7
Vested (in shares) (0.5) (0.5) (0.5)
Forfeited (in shares) (0.3) (0.2) (0.4)
Unvested at end of year (in shares) 1.5 1.7 1.9
Weighted Average Grant-Date Fair Value      
Unvested at beginning of year (in USD per share) $ 26.82 $ 22.01 $ 19.60
Grant (in USD per share) 47.80 38.76 25.76
Vested (in USD per share) 24.85 20.34 17.87
Forfeited (in USD per share) 33.62 26.54 20.98
Unvested at end of year (in USD per share) $ 34.85 $ 26.82 $ 22.01
XML 123 R106.htm IDEA: XBRL DOCUMENT v3.22.4
Accumulated Other Comprehensive Loss - Rollforward (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Balance, beginning of period $ 4,058.0    
Total other comprehensive (loss) income, net of income taxes (81.6) $ (51.7) $ 52.4
Balance, end of period 4,206.9 4,058.0  
Accumulated Other Comprehensive Loss      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Balance, beginning of period (143.5) (91.8) (144.2)
(Decrease) increase before reclassifications (53.7) (44.7) 21.5
Income tax impact (26.1) (23.2) 28.8
Other comprehensive (loss) income before reclassifications, net of income taxes (79.8) (67.9) 50.3
Increase (2.3) 20.9 2.9
Income tax impact 0.5 (4.7) (0.8)
Amounts reclassified from accumulated other comprehensive loss, net of income taxes (1.8) 16.2 2.1
Total other comprehensive (loss) income, net of income taxes (81.6) (51.7) 52.4
Balance, end of period (225.1) (143.5) (91.8)
Foreign Currency Translation Adjustments      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Balance, beginning of period (139.6) (62.5) (116.4)
(Decrease) increase before reclassifications (80.5) (72.7) 26.0
Income tax impact (20.4) (17.0) 27.9
Other comprehensive (loss) income before reclassifications, net of income taxes (100.9) (89.7) 53.9
Increase 0.0 15.9 0.0
Income tax impact 0.0 (3.3) 0.0
Amounts reclassified from accumulated other comprehensive loss, net of income taxes 0.0 12.6 0.0
Total other comprehensive (loss) income, net of income taxes (100.9) (77.1) 53.9
Balance, end of period (240.5) (139.6) (62.5)
Unrealized Loss on Cash Flow Hedges      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Balance, beginning of period (1.7) (6.3) 0.1
(Decrease) increase before reclassifications 2.2 6.1 (8.4)
Income tax impact (0.5) (1.5) 2.0
Other comprehensive (loss) income before reclassifications, net of income taxes 1.7 4.6 (6.4)
Increase 0.0 0.0 0.0
Income tax impact 0.0 0.0 0.0
Amounts reclassified from accumulated other comprehensive loss, net of income taxes 0.0 0.0 0.0
Total other comprehensive (loss) income, net of income taxes 1.7 4.6 (6.4)
Balance, end of period 0.0 (1.7) (6.3)
Unrealized Pension Costs      
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]      
Balance, beginning of period (2.2) (23.0) (27.9)
(Decrease) increase before reclassifications 24.6 21.9 3.9
Income tax impact (5.2) (4.7) (1.1)
Other comprehensive (loss) income before reclassifications, net of income taxes 19.4 17.2 2.8
Increase (2.3) 5.0 2.9
Income tax impact 0.5 (1.4) (0.8)
Amounts reclassified from accumulated other comprehensive loss, net of income taxes (1.8) 3.6 2.1
Total other comprehensive (loss) income, net of income taxes 17.6 20.8 4.9
Balance, end of period $ 15.4 $ (2.2) $ (23.0)
XML 124 R107.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue - Disaggregation by Revenue Type and Geographical Region (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disaggregation of Revenue [Line Items]      
Sales $ 2,569.1 $ 2,508.9 $ 1,929.1
Consumables      
Disaggregation of Revenue [Line Items]      
Sales 2,147.5 2,067.9 1,590.7
Equipment      
Disaggregation of Revenue [Line Items]      
Sales 421.6 441.0 338.4
North America      
Disaggregation of Revenue [Line Items]      
Sales 1,366.4 1,328.2  
Western Europe      
Disaggregation of Revenue [Line Items]      
Sales 510.0 492.5  
Other developed markets      
Disaggregation of Revenue [Line Items]      
Sales 129.6 139.4  
Emerging markets      
Disaggregation of Revenue [Line Items]      
Sales 563.1 548.8  
Specialty Products & Technologies      
Disaggregation of Revenue [Line Items]      
Sales 1,598.6 1,507.8 1,117.3
Specialty Products & Technologies | North America      
Disaggregation of Revenue [Line Items]      
Sales 711.1 668.9  
Specialty Products & Technologies | Western Europe      
Disaggregation of Revenue [Line Items]      
Sales 388.9 366.6  
Specialty Products & Technologies | Other developed markets      
Disaggregation of Revenue [Line Items]      
Sales 91.0 98.2  
Specialty Products & Technologies | Emerging markets      
Disaggregation of Revenue [Line Items]      
Sales 407.6 374.1  
Equipment & Consumables      
Disaggregation of Revenue [Line Items]      
Sales 970.5 1,001.1 $ 811.8
Equipment & Consumables | North America      
Disaggregation of Revenue [Line Items]      
Sales 655.3 659.3  
Equipment & Consumables | Western Europe      
Disaggregation of Revenue [Line Items]      
Sales 121.1 125.9  
Equipment & Consumables | Other developed markets      
Disaggregation of Revenue [Line Items]      
Sales 38.6 41.2  
Equipment & Consumables | Emerging markets      
Disaggregation of Revenue [Line Items]      
Sales $ 155.5 $ 174.7  
XML 125 R108.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue - Remaining Performance Obligations (Details)
$ in Millions
Dec. 31, 2022
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligation $ 52.7
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected timing of satisfaction 12 months
XML 126 R109.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disaggregation of Revenue [Line Items]      
Contract liability $ 87.5 $ 65.2  
Revenue recognized $ 52.8 $ 38.4  
Revenue Benchmark | Customer Concentration Risk | Largest customer      
Disaggregation of Revenue [Line Items]      
Concentration risk percentage 11.00% 12.00% 11.00%
XML 127 R110.htm IDEA: XBRL DOCUMENT v3.22.4
Restructuring Activities And Related Impairments - Schedule Of Restructuring And Related Costs (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2022
USD ($)
Restructuring Reserve [Roll Forward]  
Balance at beginning of year $ 21.9
Costs incurred 26.5
Paid/settled (29.5)
Balance at end of year 18.9
Employee Severance and Related  
Restructuring Reserve [Roll Forward]  
Balance at beginning of year 21.4
Costs incurred 20.8
Paid/settled (24.0)
Balance at end of year 18.2
Facility Exit and Related  
Restructuring Reserve [Roll Forward]  
Balance at beginning of year 0.5
Costs incurred 5.7
Paid/settled (5.5)
Balance at end of year $ 0.7
XML 128 R111.htm IDEA: XBRL DOCUMENT v3.22.4
Restructuring Activities And Related Impairments - Schedule Of Restructuring And Other Related Charges By Segment (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]      
Costs incurred $ 37.6 $ 63.6 $ 84.4
Specialty Products & Technologies      
Restructuring Cost and Reserve [Line Items]      
Costs incurred 14.7 25.2 43.8
Equipment & Consumables      
Restructuring Cost and Reserve [Line Items]      
Costs incurred 19.7 32.1 34.6
Other      
Restructuring Cost and Reserve [Line Items]      
Costs incurred $ 3.2 $ 6.3 $ 6.0
XML 129 R112.htm IDEA: XBRL DOCUMENT v3.22.4
Restructuring Activities And Related Impairments - Schedule Of Restructuring Reserve By Type Of Cost (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]      
Costs incurred $ 37.6 $ 63.6 $ 84.4
Cost of sales      
Restructuring Cost and Reserve [Line Items]      
Costs incurred 13.6 35.9 18.3
Selling, general and administrative expenses      
Restructuring Cost and Reserve [Line Items]      
Costs incurred $ 24.0 $ 27.7 $ 66.1
XML 130 R113.htm IDEA: XBRL DOCUMENT v3.22.4
Restructuring Activities And Related Impairments - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]      
Inventory write-off $ 4.7 $ 10.8 $ 11.1
Consolidation of facilities | Disposal by abandonment      
Restructuring Cost and Reserve [Line Items]      
Non-cash loss 11.1 29.8  
Asset impairment charges 4.8 19.0  
Inventory write-off $ 4.7 $ 10.8  
XML 131 R114.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Earnings From Continuing Operations Before Income Taxes (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Earnings from continuing operations before income taxes $ 283.9 $ 254.5 $ (20.0)
United States      
Earnings from continuing operations before income taxes 21.9 35.0 (64.3)
International      
Earnings from continuing operations before income taxes $ 262.0 $ 219.5 $ 44.3
XML 132 R115.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Provision For Income Taxes From Continuing Operations (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Current:      
Federal U.S. $ 42.5 $ 17.7 $ 13.1
Non-U.S. 22.4 26.9 13.5
State and local 8.6 4.4 0.9
Deferred:      
Federal U.S. (31.3) (2.2) (13.1)
Non-U.S. 11.3 (57.5) (72.7)
State and local (7.6) 1.7 (4.2)
Income tax provision (benefit) $ 45.9 $ (9.0) $ (62.5)
XML 133 R116.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Deferred Income Tax Assets And Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Deferred tax assets:    
Inventories $ 15.4 $ 17.4
Pension benefits 6.2 11.5
Other accruals and prepayments 45.3 54.3
Lease liabilities 35.5 34.2
Stock-based compensation expense 7.5 6.8
Interest expense 36.0 8.7
Capitalized research expenses 15.1 3.8
Tax credit and loss carryforwards 38.2 117.3
Valuation allowances (38.7) (90.0)
Total deferred tax asset 160.5 164.0
Deferred tax liabilities:    
Property, plant and equipment (5.7) (9.6)
Unrealized gains and losses (6.2) (6.5)
Right-of-use assets (31.5) (30.3)
Goodwill and other intangible assets (92.2) (192.3)
Total deferred tax liability (135.6) (238.7)
Net deferred tax assets $ 24.9  
Net deferred tax liabilities   $ (74.7)
XML 134 R117.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Tax Contingency [Line Items]        
Net deferred tax liabilities   $ 74.7    
Net deferred tax assets $ 24.9      
Decrease in valuation allowance 51.3      
Decrease in deferred tax liability 100.2      
Employee service share-based compensation, tax benefit from exercise of stock options 7.2 6.7 $ 4.2  
Excess tax benefit from share-based compensation, operating activities 4.6 4.8 2.3  
Net operating loss carryforwards 35.5      
Operating loss carryforwards, valuation allowances 29.1      
Gross unrecognized tax benefits 6.6 5.7 7.1 $ 9.1
Recognized potential interest and penalties 0.6 (0.1) $ 0.0  
Unrecognized tax benefits that would impact effective tax rate 9.2      
Estimated reduction in unrecognized tax benefits within twelve months 2.7      
Continuing operations        
Income Tax Contingency [Line Items]        
Gross unrecognized tax benefits 6.6 5.7    
Unrecognized tax benefits, net of offsetting indirect tax benefits 9.2 7.6    
Potential interest and penalties 2.6 1.9    
Danaher | United States        
Income Tax Contingency [Line Items]        
Net deferred tax liabilities 15.1 133.0    
Danaher | Foreign tax        
Income Tax Contingency [Line Items]        
Net deferred tax assets $ 40.0 $ 58.5    
XML 135 R118.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Reconciliation Of The Statutory Federal Income Tax Rate To The Effective Tax Rate (Details)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]      
Statutory federal income tax rate 21.00% 21.00% 21.00%
Increase (decrease) in tax rate resulting from:      
State income taxes (net of federal income tax benefit) 0.30% 1.20% 17.00%
Impact of foreign operations (5.00%) (6.40%) 80.40%
Foreign-Derived Intangible Income (“FDII”) (0.70%) 0.00% 0.00%
Subpart F and GILTI, net of foreign tax credits 6.70% 6.40% (72.40%)
Change in uncertain tax positions (0.50%) 0.00% 3.40%
Research and experimentation credits and other (1.60%) (1.60%) 13.20%
Permanent differences and other (0.90%) 2.70% (20.30%)
Excess tax benefit from stock-based compensation (1.60%) (1.90%) 11.60%
Valuation allowance release on certain Swiss NOLs 0.00% (8.10%) 0.00%
Impact of step-up of Swiss assets (1.50%) (16.80%) 258.60%
Effective income tax rate 16.20% (3.50%) 312.50%
XML 136 R119.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Reconciliation Of Unrecognized Tax Benefits (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Unrecognized tax benefits, beginning of year $ 5.7 $ 7.1 $ 9.1
Additions based on tax positions related to the current year 0.3 0.3 0.3
Additions for tax positions of prior years 4.2 0.0 0.3
Reductions for tax positions of prior years 0.0 (0.3) (1.7)
Lapse of statute of limitations (2.3) (1.0) (1.0)
Settlements (1.1) (0.4) 0.0
Effect of foreign currency translation (0.2) 0.0 0.1
Unrecognized tax benefits, end of year $ 6.6 $ 5.7 $ 7.1
XML 137 R120.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings Per Share - Narrative (Details) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
May 21, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]      
Conversion price (in USD per share) $ 21.01 $ 21.01  
2.375% convertible senior notes | Convertible Debt      
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]      
Conversion price (in USD per share)     $ 21.01
Dilution threshold (in USD per share) $ 23.79    
XML 138 R121.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings Per Share - Components of Basic and Diluted Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Numerator:      
Income from continuing operations, net of tax $ 238.0 $ 263.5 $ 42.5
Income (loss) from discontinued operations, net of tax 5.1 77.0 (9.2)
Net income $ 243.1 $ 340.5 $ 33.3
Denominator:      
Weighted-average common shares outstanding used in basic earnings per share (in shares) 162.9 161.2 159.6
Assumed exercise of dilutive options and vesting of dilutive restricted stock units (in shares) 3.2 4.4 2.2
Assumed conversion of the Notes (in shares) 11.5 12.0 2.3
Weighted average common shares outstanding used in diluted earnings (loss) per share (in shares) 177.6 177.6 164.1
Earnings per share:      
Earnings from continuing operations - basic (in USD per share) $ 1.46 $ 1.63 $ 0.27
Earnings from continuing operations - diluted (in USD per share) 1.34 1.48 0.26
Earnings (loss) from discontinued operations - basic (in USD per share) 0.03 0.48 (0.06)
Earnings (loss) from discontinued operations - diluted (in USD per share) 0.03 0.43 (0.06)
Earnings - basic (in USD per share) 1.49 2.11 0.21
Earnings - diluted (in USD per share) [1] $ 1.37 $ 1.92 $ 0.20
[1] * Earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. The sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding.
XML 139 R122.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings Per Share - Securities Not Included in the Computation of Diluted Loss Income per Share (Details) - shares
shares in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Stock-based awards      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of diluted (loss) income per share (in shares) 1.5 1.2 4.1
XML 140 R123.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information - Narrative (Details)
 12 Months Ended
Dec. 31, 2022
segment
Segment Reporting [Abstract]  
Number of reportable segments (in segments) 2
Number of operating segments (in segments) 2
XML 141 R124.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information - Segment Results (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Segment Reporting Information [Line Items]      
Sales $ 2,569.1 $ 2,508.9 $ 1,929.1
Operating profit (loss) 319.2 306.2 43.5
Other income (expense) 3.1 2.4 (1.0)
Interest expense, net (38.4) (54.1) (62.5)
Income (loss) before income taxes 283.9 254.5 (20.0)
Depreciation and amortization 137.8 117.8 121.7
Capital expenditures, gross 72.1 49.1 43.9
Identifiable assets 6,587.0 6,574.2  
Held for sale      
Segment Reporting Information [Line Items]      
Identifiable assets 0.0 12.2  
Other      
Segment Reporting Information [Line Items]      
Operating profit (loss) (121.8) (119.9) (75.9)
Depreciation and amortization 2.5 2.4 2.4
Capital expenditures, gross 2.7 1.3 1.7
Identifiable assets 656.0 1,117.7  
Specialty Products & Technologies      
Segment Reporting Information [Line Items]      
Sales 1,598.6 1,507.8 1,117.3
Specialty Products & Technologies | Operating segments      
Segment Reporting Information [Line Items]      
Operating profit (loss) 268.6 272.3 65.8
Depreciation and amortization 80.7 84.0 80.6
Capital expenditures, gross 48.8 37.2 36.4
Identifiable assets 3,475.7 3,498.2  
Equipment & Consumables      
Segment Reporting Information [Line Items]      
Sales 970.5 1,001.1 811.8
Equipment & Consumables | Operating segments      
Segment Reporting Information [Line Items]      
Operating profit (loss) 172.4 153.8 53.6
Depreciation and amortization 54.6 31.4 38.7
Capital expenditures, gross 20.6 10.6 $ 5.8
Identifiable assets $ 2,455.3 $ 1,946.1  
XML 142 R125.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Information - Schedule Of Operations In Geographical Areas (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Segment Reporting Information [Line Items]      
Sales $ 2,569.1 $ 2,508.9 $ 1,929.1
Property, plant and equipment, net 293.6 264.1  
United States      
Segment Reporting Information [Line Items]      
Sales 1,261.9 1,223.4 960.1
Property, plant and equipment, net 183.4 157.1  
China      
Segment Reporting Information [Line Items]      
Sales 222.2 236.7 198.2
Sweden      
Segment Reporting Information [Line Items]      
Property, plant and equipment, net 41.4 49.0  
Mexico      
Segment Reporting Information [Line Items]      
Property, plant and equipment, net 15.2 8.8  
All other (each country individually less than 5% of total long-lived assets)      
Segment Reporting Information [Line Items]      
Sales 1,085.0 1,048.8 $ 770.8
Property, plant and equipment, net $ 53.6 $ 49.2  
XML 143 R126.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period $ 20.7 $ 30.5 $ 18.7
Charged to Costs & Expenses 4.8 4.7 19.2
Impact of Currency (0.8) (1.5) 0.3
Write Offs, Write Downs  & Deductions (4.1) (7.3) (7.7)
Recoveries (4.4) (5.7) 0.0
Balance at End of Period $ 16.2 $ 20.7 $ 30.5
XML 144 nvst-20221231_htm.xml IDEA: XBRL DOCUMENT 0001757073 2022-01-01 2022-12-31 0001757073 2023-02-10 0001757073 2022-07-01 0001757073 2022-12-31 0001757073 2021-12-31 0001757073 2021-01-01 2021-12-31 0001757073 2020-01-01 2020-12-31 0001757073 us-gaap:CommonStockMember 2019-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001757073 us-gaap:RetainedEarningsMember 2019-12-31 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001757073 us-gaap:ParentMember 2019-12-31 0001757073 us-gaap:NoncontrollingInterestMember 2019-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001757073 us-gaap:ParentMember 2020-01-01 2020-12-31 0001757073 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001757073 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-12-31 0001757073 us-gaap:CommonStockMember 2020-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001757073 us-gaap:RetainedEarningsMember 2020-12-31 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001757073 us-gaap:ParentMember 2020-12-31 0001757073 us-gaap:NoncontrollingInterestMember 2020-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001757073 us-gaap:ParentMember 2021-01-01 2021-12-31 0001757073 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001757073 us-gaap:CommonStockMember 2021-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001757073 us-gaap:RetainedEarningsMember 2021-12-31 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001757073 us-gaap:ParentMember 2021-12-31 0001757073 us-gaap:NoncontrollingInterestMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:ParentMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:CommonStockMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:RetainedEarningsMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:ParentMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:NoncontrollingInterestMember 2021-12-31 0001757073 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001757073 us-gaap:ParentMember 2022-01-01 2022-12-31 0001757073 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001757073 us-gaap:CommonStockMember 2022-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001757073 us-gaap:RetainedEarningsMember 2022-12-31 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001757073 us-gaap:ParentMember 2022-12-31 0001757073 us-gaap:NoncontrollingInterestMember 2022-12-31 0001757073 2020-12-31 0001757073 2019-12-31 0001757073 us-gaap:BuildingMember 2022-01-01 2022-12-31 0001757073 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-12-31 0001757073 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:ConvertibleDebtMember 2021-12-31 0001757073 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2021-12-31 0001757073 nvst:OsteogenicsBiomedicalIncMember 2022-07-05 2022-07-05 0001757073 nvst:CarestreamDentalTechnologyMember 2022-04-20 2022-04-20 0001757073 nvst:CarestreamDentalTechnologyMember 2022-04-20 0001757073 nvst:OsteogenicsBiomedicalIncMember 2022-07-05 0001757073 nvst:CarestreamDentalTechnologyMember 2022-01-01 2022-12-31 0001757073 nvst:OsteogenicsBiomedicalIncMember 2022-01-01 2022-12-31 0001757073 nvst:OsteogenicsBiomedicalIncCarestreamDentalTechnologyMember 2022-01-01 2022-12-31 0001757073 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember nvst:PlamencaMember 2021-12-31 0001757073 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember nvst:PlamencaMember 2022-01-01 2022-12-31 0001757073 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember nvst:PlamencaMember 2021-01-01 2021-12-31 0001757073 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember nvst:PlamencaMember 2020-01-01 2020-12-31 0001757073 us-gaap:LandAndLandImprovementsMember 2022-12-31 0001757073 us-gaap:LandAndLandImprovementsMember 2021-12-31 0001757073 us-gaap:BuildingAndBuildingImprovementsMember 2022-12-31 0001757073 us-gaap:BuildingAndBuildingImprovementsMember 2021-12-31 0001757073 us-gaap:MachineryAndEquipmentMember 2022-12-31 0001757073 us-gaap:MachineryAndEquipmentMember 2021-12-31 0001757073 us-gaap:ConstructionInProgressMember 2022-12-31 0001757073 us-gaap:ConstructionInProgressMember 2021-12-31 0001757073 srt:MaximumMember 2022-12-31 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2021-12-31 0001757073 nvst:EquipmentandConsumablesMember 2021-12-31 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2022-01-01 2022-12-31 0001757073 nvst:EquipmentandConsumablesMember 2022-01-01 2022-12-31 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2022-12-31 0001757073 nvst:EquipmentandConsumablesMember 2022-12-31 0001757073 us-gaap:PatentedTechnologyMember 2022-12-31 0001757073 us-gaap:PatentedTechnologyMember 2021-12-31 0001757073 us-gaap:CustomerRelationshipsMember 2022-12-31 0001757073 us-gaap:CustomerRelationshipsMember 2021-12-31 0001757073 us-gaap:TrademarksAndTradeNamesMember 2022-12-31 0001757073 us-gaap:TrademarksAndTradeNamesMember 2021-12-31 0001757073 us-gaap:TrademarksAndTradeNamesMember 2022-12-31 0001757073 us-gaap:TrademarksAndTradeNamesMember 2021-12-31 0001757073 nvst:EuroTermLoanDue2024Member 2022-12-31 0001757073 nvst:USTermLoanDue2024Member 2019-09-20 0001757073 nvst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2022-12-31 0001757073 nvst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2022-01-01 2022-12-31 0001757073 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2022-12-31 0001757073 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2022-01-01 2022-12-31 0001757073 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2022-12-31 0001757073 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2022-01-01 2022-12-31 0001757073 nvst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2021-12-31 0001757073 nvst:ForeignCurrencyDenominatedDebtMember us-gaap:NetInvestmentHedgingMember 2021-01-01 2021-12-31 0001757073 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2021-12-31 0001757073 us-gaap:InterestRateContractMember us-gaap:NetInvestmentHedgingMember 2021-01-01 2021-12-31 0001757073 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2021-12-31 0001757073 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2021-01-01 2021-12-31 0001757073 us-gaap:LongTermDebtMember 2022-12-31 0001757073 us-gaap:LongTermDebtMember 2021-12-31 0001757073 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001757073 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001757073 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001757073 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001757073 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001757073 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001757073 us-gaap:InterestRateSwapMember 2021-12-31 0001757073 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001757073 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001757073 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001757073 us-gaap:CurrencySwapMember 2021-12-31 0001757073 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001757073 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001757073 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001757073 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-12-31 0001757073 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-12-31 0001757073 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0001757073 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0001757073 us-gaap:InterestRateSwapMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-12-31 0001757073 us-gaap:InterestRateSwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-12-31 0001757073 us-gaap:InterestRateSwapMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0001757073 us-gaap:InterestRateSwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0001757073 us-gaap:CurrencySwapMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-12-31 0001757073 us-gaap:CurrencySwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-12-31 0001757073 us-gaap:CurrencySwapMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0001757073 us-gaap:CurrencySwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0001757073 us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001757073 us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001757073 us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-12-31 0001757073 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001757073 us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001757073 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-12-31 0001757073 us-gaap:CostOfSalesMember 2022-01-01 2022-12-31 0001757073 us-gaap:CostOfSalesMember 2021-01-01 2021-12-31 0001757073 us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001757073 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-12-31 0001757073 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001757073 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001757073 srt:ScenarioForecastMember us-gaap:PensionPlansDefinedBenefitMember 2023-01-01 2023-12-31 0001757073 srt:MinimumMember us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-12-31 0001757073 srt:MaximumMember us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-12-31 0001757073 srt:MinimumMember us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001757073 srt:MaximumMember us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001757073 srt:WeightedAverageMember us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-12-31 0001757073 srt:WeightedAverageMember us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001757073 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001757073 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001757073 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001757073 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001757073 us-gaap:OtherContractMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001757073 us-gaap:OtherContractMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001757073 us-gaap:OtherContractMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001757073 us-gaap:OtherContractMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001757073 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001757073 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001757073 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001757073 us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001757073 us-gaap:MutualFundMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001757073 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001757073 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-12-31 0001757073 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001757073 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001757073 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001757073 us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001757073 us-gaap:OtherContractMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001757073 us-gaap:OtherContractMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001757073 us-gaap:OtherContractMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001757073 us-gaap:OtherContractMember us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001757073 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001757073 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001757073 us-gaap:FairValueInputsLevel12And3Member us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001757073 us-gaap:MutualFundMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001757073 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2020-12-31 0001757073 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-12-31 0001757073 nvst:USTermLoanDue2024Member 2022-12-31 0001757073 nvst:USTermLoanDue2024Member 2021-12-31 0001757073 nvst:EuroTermLoanDue2024Member 2021-12-31 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2022-12-31 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2021-12-31 0001757073 us-gaap:OtherDebtSecuritiesMember 2022-12-31 0001757073 us-gaap:OtherDebtSecuritiesMember 2021-12-31 0001757073 2019-09-20 2019-09-20 0001757073 nvst:USTermLoanDue2024Member 2019-09-20 2019-09-20 0001757073 nvst:EuroTermLoanDue2024Member 2019-09-20 2019-09-20 0001757073 nvst:EuroTermLoanDue2024Member 2019-09-20 0001757073 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-09-20 2019-09-20 0001757073 nvst:EuroTermLoanDue2024Member 2021-02-09 2021-02-09 0001757073 us-gaap:RevolvingCreditFacilityMember 2019-09-20 2019-09-20 0001757073 us-gaap:RevolvingCreditFacilityMember 2021-06-15 2021-06-15 0001757073 us-gaap:RevolvingCreditFacilityMember 2021-06-15 0001757073 us-gaap:RevolvingCreditFacilityMember 2022-12-31 0001757073 us-gaap:RevolvingCreditFacilityMember us-gaap:StandbyLettersOfCreditMember 2022-12-31 0001757073 us-gaap:RevolvingCreditFacilityMember 2021-12-31 0001757073 srt:MinimumMember nvst:CreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2022-01-01 2022-12-31 0001757073 srt:MaximumMember nvst:CreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2022-01-01 2022-12-31 0001757073 srt:MinimumMember us-gaap:BaseRateMember 2022-01-01 2022-12-31 0001757073 srt:MaximumMember us-gaap:BaseRateMember 2022-01-01 2022-12-31 0001757073 srt:MinimumMember 2022-01-01 2022-12-31 0001757073 srt:MaximumMember 2022-01-01 2022-12-31 0001757073 nvst:USTermLoanDue2024Member 2022-01-01 2022-12-31 0001757073 nvst:USTermLoanDue2024Member 2021-01-01 2021-12-31 0001757073 nvst:EuroTermLoanDue2024Member 2022-01-01 2022-12-31 0001757073 nvst:EuroTermLoanDue2024Member 2021-01-01 2021-12-31 0001757073 nvst:A2.375ConvertibleSeniorNotesOverAllotmentOptionMember us-gaap:ConvertibleDebtMember 2020-05-21 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2020-05-21 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2020-05-21 2020-05-21 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2021-01-01 2021-12-31 0001757073 nvst:A2.375ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2022-01-01 2022-12-31 0001757073 nvst:A2.375ConvertibleSeniorNotesCappedCallsMember us-gaap:ConvertibleDebtMember 2020-05-21 2020-05-21 0001757073 nvst:A2.375ConvertibleSeniorNotesCappedCallsMember us-gaap:ConvertibleDebtMember 2020-05-21 0001757073 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001757073 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001757073 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001757073 nvst:A2019OmnibusIncentivePlanMember 2019-09-30 0001757073 srt:MinimumMember nvst:A2019OmnibusIncentivePlanMember 2019-09-30 2019-09-30 0001757073 srt:MaximumMember nvst:A2019OmnibusIncentivePlanMember 2019-09-30 2019-09-30 0001757073 nvst:A2019OmnibusIncentivePlanMember 2019-09-30 2019-09-30 0001757073 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember nvst:A2019OmnibusIncentivePlanMember 2019-09-30 2019-09-30 0001757073 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember nvst:A2019OmnibusIncentivePlanMember 2019-09-30 2019-09-30 0001757073 nvst:PacificDentalServicesMember us-gaap:RestrictedStockUnitsRSUMember 2021-12-23 0001757073 nvst:PacificDentalServicesMember us-gaap:RestrictedStockUnitsRSUMember 2021-12-23 2021-12-23 0001757073 nvst:PacificDentalServicesMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001757073 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001757073 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001757073 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001757073 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001757073 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001757073 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001757073 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001757073 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001757073 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001757073 nvst:RestrictedStockUnitsAndPerformanceStockUnitsMember 2022-01-01 2022-12-31 0001757073 nvst:RestrictedStockUnitsAndPerformanceStockUnitsMember 2021-01-01 2021-12-31 0001757073 nvst:RestrictedStockUnitsAndPerformanceStockUnitsMember 2020-01-01 2020-12-31 0001757073 nvst:RangeOneMember 2022-01-01 2022-12-31 0001757073 nvst:RangeOneMember 2022-12-31 0001757073 nvst:RangeTwoMember 2022-01-01 2022-12-31 0001757073 nvst:RangeTwoMember 2022-12-31 0001757073 nvst:RangeThreeMember 2022-01-01 2022-12-31 0001757073 nvst:RangeThreeMember 2022-12-31 0001757073 nvst:RangeFourMember 2022-01-01 2022-12-31 0001757073 nvst:RangeFourMember 2022-12-31 0001757073 nvst:RangeFiveMember 2022-01-01 2022-12-31 0001757073 nvst:RangeFiveMember 2022-12-31 0001757073 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001757073 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001757073 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-12-31 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-12-31 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-12-31 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-12-31 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-12-31 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-12-31 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-12-31 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-12-31 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-12-31 0001757073 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001757073 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0001757073 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0001757073 srt:NorthAmericaMember nvst:SpecialtyProductsandTechnologiesMember 2022-01-01 2022-12-31 0001757073 srt:NorthAmericaMember nvst:EquipmentandConsumablesMember 2022-01-01 2022-12-31 0001757073 srt:NorthAmericaMember 2022-01-01 2022-12-31 0001757073 nvst:WesternEuropeMember nvst:SpecialtyProductsandTechnologiesMember 2022-01-01 2022-12-31 0001757073 nvst:WesternEuropeMember nvst:EquipmentandConsumablesMember 2022-01-01 2022-12-31 0001757073 nvst:WesternEuropeMember 2022-01-01 2022-12-31 0001757073 nvst:OtherDevelopedMarketsMember nvst:SpecialtyProductsandTechnologiesMember 2022-01-01 2022-12-31 0001757073 nvst:OtherDevelopedMarketsMember nvst:EquipmentandConsumablesMember 2022-01-01 2022-12-31 0001757073 nvst:OtherDevelopedMarketsMember 2022-01-01 2022-12-31 0001757073 nvst:HighGrowthMarketsMember nvst:SpecialtyProductsandTechnologiesMember 2022-01-01 2022-12-31 0001757073 nvst:HighGrowthMarketsMember nvst:EquipmentandConsumablesMember 2022-01-01 2022-12-31 0001757073 nvst:HighGrowthMarketsMember 2022-01-01 2022-12-31 0001757073 srt:NorthAmericaMember nvst:SpecialtyProductsandTechnologiesMember 2021-01-01 2021-12-31 0001757073 srt:NorthAmericaMember nvst:EquipmentandConsumablesMember 2021-01-01 2021-12-31 0001757073 srt:NorthAmericaMember 2021-01-01 2021-12-31 0001757073 nvst:WesternEuropeMember nvst:SpecialtyProductsandTechnologiesMember 2021-01-01 2021-12-31 0001757073 nvst:WesternEuropeMember nvst:EquipmentandConsumablesMember 2021-01-01 2021-12-31 0001757073 nvst:WesternEuropeMember 2021-01-01 2021-12-31 0001757073 nvst:OtherDevelopedMarketsMember nvst:SpecialtyProductsandTechnologiesMember 2021-01-01 2021-12-31 0001757073 nvst:OtherDevelopedMarketsMember nvst:EquipmentandConsumablesMember 2021-01-01 2021-12-31 0001757073 nvst:OtherDevelopedMarketsMember 2021-01-01 2021-12-31 0001757073 nvst:HighGrowthMarketsMember nvst:SpecialtyProductsandTechnologiesMember 2021-01-01 2021-12-31 0001757073 nvst:HighGrowthMarketsMember nvst:EquipmentandConsumablesMember 2021-01-01 2021-12-31 0001757073 nvst:HighGrowthMarketsMember 2021-01-01 2021-12-31 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2021-01-01 2021-12-31 0001757073 nvst:EquipmentandConsumablesMember 2021-01-01 2021-12-31 0001757073 nvst:ConsumablesMember 2022-01-01 2022-12-31 0001757073 nvst:ConsumablesMember 2021-01-01 2021-12-31 0001757073 nvst:ConsumablesMember 2020-01-01 2020-12-31 0001757073 nvst:EquipmentSalesMember 2022-01-01 2022-12-31 0001757073 nvst:EquipmentSalesMember 2021-01-01 2021-12-31 0001757073 nvst:EquipmentSalesMember 2020-01-01 2020-12-31 0001757073 2023-01-01 2022-12-31 0001757073 nvst:LargestCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001757073 nvst:LargestCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001757073 nvst:LargestCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001757073 us-gaap:EmployeeSeveranceMember 2021-12-31 0001757073 us-gaap:FacilityClosingMember 2021-12-31 0001757073 us-gaap:EmployeeSeveranceMember 2022-01-01 2022-12-31 0001757073 us-gaap:FacilityClosingMember 2022-01-01 2022-12-31 0001757073 us-gaap:EmployeeSeveranceMember 2022-12-31 0001757073 us-gaap:FacilityClosingMember 2022-12-31 0001757073 nvst:SpecialtyProductsandTechnologiesMember 2020-01-01 2020-12-31 0001757073 nvst:EquipmentandConsumablesMember 2020-01-01 2020-12-31 0001757073 us-gaap:AllOtherSegmentsMember 2022-01-01 2022-12-31 0001757073 us-gaap:AllOtherSegmentsMember 2021-01-01 2021-12-31 0001757073 us-gaap:AllOtherSegmentsMember 2020-01-01 2020-12-31 0001757073 us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember nvst:ConsolidationOfFacilitiesMember 2022-01-01 2022-12-31 0001757073 us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember nvst:ConsolidationOfFacilitiesMember 2021-01-01 2021-12-31 0001757073 country:US 2022-01-01 2022-12-31 0001757073 country:US 2021-01-01 2021-12-31 0001757073 country:US 2020-01-01 2020-12-31 0001757073 us-gaap:NonUsMember 2022-01-01 2022-12-31 0001757073 us-gaap:NonUsMember 2021-01-01 2021-12-31 0001757073 us-gaap:NonUsMember 2020-01-01 2020-12-31 0001757073 srt:AffiliatedEntityMember us-gaap:DomesticCountryMember 2022-12-31 0001757073 srt:AffiliatedEntityMember us-gaap:DomesticCountryMember 2021-12-31 0001757073 srt:AffiliatedEntityMember us-gaap:ForeignCountryMember 2022-12-31 0001757073 srt:AffiliatedEntityMember us-gaap:ForeignCountryMember 2021-12-31 0001757073 us-gaap:SegmentContinuingOperationsMember 2022-12-31 0001757073 us-gaap:SegmentContinuingOperationsMember 2021-12-31 0001757073 us-gaap:StockCompensationPlanMember 2022-01-01 2022-12-31 0001757073 us-gaap:StockCompensationPlanMember 2021-01-01 2021-12-31 0001757073 us-gaap:StockCompensationPlanMember 2020-01-01 2020-12-31 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2022-01-01 2022-12-31 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2021-01-01 2021-12-31 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2020-01-01 2020-12-31 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2022-01-01 2022-12-31 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2021-01-01 2021-12-31 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2020-01-01 2020-12-31 0001757073 us-gaap:CorporateNonSegmentMember 2022-01-01 2022-12-31 0001757073 us-gaap:CorporateNonSegmentMember 2021-01-01 2021-12-31 0001757073 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-12-31 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2022-12-31 0001757073 us-gaap:OperatingSegmentsMember nvst:SpecialtyProductsandTechnologiesMember 2021-12-31 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2022-12-31 0001757073 us-gaap:OperatingSegmentsMember nvst:EquipmentandConsumablesMember 2021-12-31 0001757073 us-gaap:MaterialReconcilingItemsMember 2022-12-31 0001757073 us-gaap:MaterialReconcilingItemsMember 2021-12-31 0001757073 us-gaap:CorporateNonSegmentMember 2022-12-31 0001757073 us-gaap:CorporateNonSegmentMember 2021-12-31 0001757073 country:CN 2022-01-01 2022-12-31 0001757073 country:CN 2021-01-01 2021-12-31 0001757073 country:CN 2020-01-01 2020-12-31 0001757073 nvst:AllOtherCountriesMember 2022-01-01 2022-12-31 0001757073 nvst:AllOtherCountriesMember 2021-01-01 2021-12-31 0001757073 nvst:AllOtherCountriesMember 2020-01-01 2020-12-31 0001757073 country:US 2022-12-31 0001757073 country:US 2021-12-31 0001757073 country:SE 2022-12-31 0001757073 country:SE 2021-12-31 0001757073 country:MX 2022-12-31 0001757073 country:MX 2021-12-31 0001757073 nvst:AllOtherCountriesMember 2022-12-31 0001757073 nvst:AllOtherCountriesMember 2021-12-31 shares iso4217:USD iso4217:USD shares nvst:segment pure iso4217:EUR nvst:tradingDay nvst:vote false 2022 FY 0001757073 http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense 0.0475862 P3Y P3Y 10-K true 2022-12-31 --12-31 false 001-39054 ENVISTA HOLDINGS CORPORATION DE 83-2206728 200 S. Kraemer Blvd., Building E 92821-6208 Brea CA 714 817-7000 Common stock, $0.01 par value NVST NYSE Yes No Yes Yes Large Accelerated Filer false false true false 163231502 4700000000 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Part III incorporates certain information by reference from the Registrant’s proxy statement for its 2023 annual meeting of stockholders to be filed pursuant to Regulation 14A within 120 days after Registrant’s fiscal year-end. With the exception of the sections of the 2023 Proxy Statement specifically incorporated herein by reference, the 2023 Proxy Statement is not deemed to be filed as part of this Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Annual Report, the terms “Envista” or the “Company” refer to Envista Holdings Corporation, Envista Holdings Corporation and its consolidated subsidiaries or the consolidated subsidiaries of Envista Holdings Corporation, as the context requires.</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">***</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own or have rights to trademarks, service marks or trade names that we use in connection with the operation of our business. In addition, our names, logos and website names and addresses are owned by us or licensed by us. We also own or have the rights to copyrights that protect the content of our solutions. Solely for convenience, the trademarks, service marks, trade names and copyrights referred to in this report are listed without the ©, ® and ™ symbols, but we will assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensors to these trademarks, service marks, trade names and copyrights.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report may include trademarks, service marks or trade names of other companies. Our use or display of other parties’ trademarks, service marks, trade names or products is not intended to, and does not imply a relationship with, or endorsement or sponsorship of us by, the trademark, service mark or trade name owners.</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">***</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Unless otherwise indicated, information contained in this report concerning our industry and the markets in which we operate is based on information from independent industry and research organizations, other third-party sources (including industry publications, surveys and forecasts), and management estimates. Management estimates are derived from publicly available information released by independent industry analysts and third-party sources, as well as data from our internal research, and are based on assumptions made by us upon reviewing such data and our knowledge of such industry and markets that we believe to be reasonable. Although we believe the data from these third-party sources is reliable, we have not independently verified any third-party information.</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">***</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Unless otherwise indicated, all financial data in this Annual Report refer to continuing operations only.</span></div> 42 Ernst & Young LLP Irvine, California 606900000 1073600000 16200000 20700000 393500000 331900000 300800000 263800000 123400000 154300000 0 12200000 1424600000 1835800000 293600000 264100000 131800000 128100000 153700000 167800000 3496600000 3132000000 1086700000 1046400000 6587000000 6574200000 510000000.0 432400000 228300000 185800000 471400000 562300000 27000000.0 23700000 0 4000000.0 1236700000 1208200000 121400000 120400000 151300000 304200000 870700000 883400000 0.01 0.01 15000000 15000000 0 0 0 0 0 0 0.01 0.01 500000000 500000000 163700000 163200000 162000000 161600000 1600000 1600000 3699000000 3732600000 731400000 466900000 -225100000 -143500000 4206900000 4057600000 0 400000 4206900000 4058000000 6587000000 6574200000 2569100000 2508900000 1929100000 1094300000 1082400000 874300000 1474800000 1426500000 1054800000 1055500000 1019800000 924600000 100100000 100500000 86700000 319200000 306200000 43500000 3100000 2400000 -1000000.0 38400000 54100000 62500000 283900000 254500000 -20000000.0 45900000 -9000000.0 -62500000 238000000.0 263500000 42500000 5100000 77000000.0 -9200000 243100000 340500000 33300000 1.46 1.63 0.27 1.34 1.48 0.26 0.03 0.48 -0.06 0.03 0.43 -0.06 1.49 2.11 0.21 1.37 1.92 0.20 162900000 161200000 159600000 177600000 177600000 164100000 243100000 340500000 33300000 -100900000 -77100000 53900000 1700000 4600000 -6400000 -17600000 -20800000 -4900000 -81600000 -51700000 52400000 161500000 288800000 85700000 1600000 3589700000 93100000 -144200000 3540200000 2600000 32200000 32200000 77900000 77900000 15700000 15700000 300000 300000 33300000 33300000 52400000 52400000 -2200000 1600000 3684400000 126400000 -91800000 3720600000 400000 41400000 41400000 6800000 6800000 340500000 340500000 -51700000 -51700000 1600000 3732600000 466900000 -143500000 4057600000 400000 -77800000 21400000 -56400000 1600000 3654800000 488300000 -143500000 4001200000 400000 -400000 44200000 44200000 243100000 243100000 -81600000 -81600000 1600000 3699000000 731400000 -225100000 4206900000 0 243100000 340500000 33300000 31800000 40800000 42400000 106000000.0 82800000 90200000 4800000 5600000 23000000.0 30500000 28200000 22600000 1900000 2200000 0 8900000 11700000 0 4700000 10800000 11100000 6400000 18400000 32600000 9500000 0 0 24300000 28300000 30500000 4100000 23300000 13400000 29000000.0 59000000.0 91400000 71000000.0 43200000 -71900000 39900000 66000000.0 -11900000 44500000 -20300000 21600000 11700000 11500000 2500000 -133000000.0 34300000 10000000.0 31600000 37500000 36700000 182700000 361600000 283900000 696200000 2100000 40700000 75700000 54700000 47700000 3300000 11600000 5300000 73900000 312500000 0 56000000.0 11400000 14000000.0 18600000 16000000.0 0 -657300000 262700000 -69100000 124000000.0 0 249800000 124000000.0 0 250000000.0 300000 300000 0 0 500000 500000 475700000 0 0 0 517500000 0 2300000 17200000 0 0 20700000 21800000 19500000 13800000 9100000 7200000 5000000.0 0 100000 4300000 12500000 -465600000 492500000 -4600000 26000000.0 -29600000 -466700000 184700000 677700000 1073600000 888900000 211200000 606900000 1073600000 888900000 38400000 35700000 56700000 119200000 84000000.0 28600000 36000000.0 24700000 28100000 BUSINESS AND BASIS OF PRESENTATION <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. The Company is a worldwide provider of a broad range of dental implants, orthodontic appliances, general dental consumables, equipment and services and is dedicated to driving technological innovations that help dental professionals improve clinical outcomes and enhance productivity. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company was formed in 2018, as a wholly-owned subsidiary of Danaher Corporation (“Danaher”), to serve as the ultimate parent company of the dental platform of Danaher. On September 20, 2019, the Company completed its initial public offering and on December 18, 2019, Danaher completed the disposition of its ownership interest in the Company referred to herein as the “Separation”. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company operates in two business segments: Specialty Products &amp; Technologies and Equipment &amp; Consumables. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s Specialty Products &amp; Technologies segment develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Company’s Equipment &amp; Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP").</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 4, Discontinued Operations, on December 31, 2021, the Company sold its KaVo dental treatment unit and instrument business (the "KaVo Treatment Unit and Instrument Business"), which was part of the Company’s Equipment and Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to risks and uncertainties as a result of the novel coronavirus (“COVID-19”) pandemic. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The extent of the impact of the COVID-19 pandemic on the Company remains uncertain and difficult to predict because of the dynamic and evolving nature of the situation. The global impact of the outbreak continues to adversely affect many industries, and different geographies continue to reflect the effects of public health restrictions in various ways. The economic recovery following the impact of the COVID-19 pandemic is only partially underway and has been gradual, uneven and characterized by meaningful dispersion across sectors and regions with uncertainty regarding its ultimate length and trajectory. During the year ended December 31, 2022, notwithstanding improvement in many markets in which the Company operates due to a return to more normalized business operations, certain markets continued to be adversely impacted by COVID-19. In particular, sales decreased in China due to lockdowns early in the year and a subsequent relaxing of restrictions, which resulted in increased infection rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Russia’s invasion of Ukraine and the global response to this invasion, including sanctions imposed by the U.S. and other countries, could have an adverse impact on the Company’s business, including impacting the Company’s ability to market and sell products in the affected regions, potentially heightening our risk of cyber security attacks, impacting its ability to enforce its intellectual property rights in Russia, creating disruptions in the global supply chain, and by potentially having an adverse impact on the global economy, financial markets, energy markets, currency rates and otherwise.</span></div>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Principles</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The Consolidated Financial Statements include the accounts of the Company and its subsidiaries. The Consolidated Financial Statements also reflect the impact of noncontrolling interests. Noncontrolling interests do not have a significant impact on the Company’s consolidated results of operations, therefore income attributable to noncontrolling interests are not presented separately in the Company’s Consolidated Statements of Operations. Income attributable to noncontrolling interests have been reflected in selling, general and administrative expenses and were insignificant in all periods presented. Reclassifications of certain prior year amounts have been made to conform to the current year presentation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The Company bases these estimates on historical experience, the current economic environment and on various other assumptions that are believed to be reasonable under the circumstances. However, uncertainties associated with these estimates exist and actual results may differ materially from these estimates. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates potential acquisitions that either strategically fit with the Company’s existing portfolio or expand the Company’s portfolio into new and attractive business areas. Among other things, goodwill arises because the purchase prices for these businesses reflect a number of factors including the future earnings and cash flow potential of these businesses, the multiple to earnings, cash flow and other factors at which similar businesses have been purchased by other acquirers, the competitive nature of the processes by which the Company acquired the businesses, avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance the Company’s existing product offerings to key target markets and enter into new and profitable businesses and the complementary strategic fit and resulting synergies these businesses bring to existing operations.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We account for acquisitions under Accounting Standards Codification (“ASC“) 805 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Business Combinations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and use the acquisition method of accounting. The consideration transferred for the acquisition of a subsidiary comprises (i) fair values of the assets transferred; (ii) liabilities assumed of the acquired business; and (iii) fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired, and liabilities and contingent liabilities assumed in a business combination are, with limited exceptions, measured initially at their fair values at the acquisition date. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes an initial allocation of the purchase price at the date of acquisition based upon its estimation of the fair value of the acquired assets and assumed liabilities. The Company obtains the information used to estimate the fair values during due diligence and through other sources. In the months after closing, up to 12 months, as the Company obtains additional information that existed at the acquisition date about these assets and liabilities, it is able to refine the estimates of fair value and more accurately allocate the purchase price. Only items that existed as of the acquisition date are considered for subsequent adjustment. The Company makes the appropriate adjustments to the purchase price allocation prior to completion of the measurement period, as required.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with a maturity of three months or less at the date of purchase to be cash equivalents.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowances for Credit Losses</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All trade accounts receivable are reported on the accompanying Consolidated Balance Sheets adjusted for any write-offs and net of allowances for credit losses. The allowances for credit losses represent management’s best estimate of the credit losses expected from the Company’s trade accounts receivable portfolio. Determination of the allowances requires management to exercise judgment about the timing, frequency and severity of credit losses that could materially affect the provision for credit losses and, therefore, net income. The Company regularly performs detailed reviews of its portfolios to determine if an impairment has occurred and evaluates the collectability of receivables based on a combination of various financial and qualitative factors that may affect customers’ ability to pay, including customers’ financial condition, debt-servicing ability, past payment experience and credit bureau information and forecasts. In circumstances where the Company is aware of a </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">specific customer’s inability to meet its financial obligations, a specific reserve is recorded against amounts due to reduce the recognized receivable to the amount reasonably expected to be collected. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory Valuation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories include the costs of material, labor and overhead. Inventories are stated at the lower of cost or net realizable value primarily using the first-in, first-out method. Market value for raw materials is based on replacement costs and for other inventory classifications is based on net realizable value. The Company periodically evaluates the quantities on hand relative to current and historical selling prices and historical and projected sales volume. Based on this evaluation, provisions are made to write inventory down to its net realizable value.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are carried at cost. The provision for depreciation has been computed principally by the straight-line method based on the estimated useful lives of the depreciable assets as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"/><td style="width:48.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.528%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets and leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized over the lesser of the economic life of the asset or the term of the lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 – 10 years</span></div></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated useful lives are periodically reviewed and, when appropriate, changes to estimates are made prospectively. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception and evaluates each lease agreement to determine whether the lease is an operating or finance lease. For leases where the Company is the lessee, right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The ROU asset also consists of any prepaid lease payments, lease incentives received, costs which will be incurred in exiting a lease and the amount of any asset or liability recognized on business combinations relating to favorable or unfavorable lease terms. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense using the accelerated interest method of recognition. In certain of the Company’s lease agreements, the rental payments are adjusted periodically to reflect actual charges incurred for common area maintenance, utilities, inflation and/or changes in other indexes. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments over which the Company has a significant influence but not a controlling interest, are accounted for using the equity method of accounting which requires the Company to record its initial investment at cost and adjust the balance each period for the Company’s share of the investee’s income or loss and dividends paid. No significant realized or unrealized gains or losses were recorded during the three years ended December 31, 2022, 2021 and 2020 with respect to these investments.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial instruments consist primarily of cash and cash equivalents, trade accounts receivable, nonqualified deferred compensation plans, contingent consideration, derivatives, trade accounts payable and long-term debt. Due to their short-term nature, the carrying values for cash and cash equivalents, trade accounts receivable and trade accounts payable approximate fair value. Refer to Note 12 for the fair values of the Company’s other financial instruments. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other intangible assets result from the Company’s acquisition of existing businesses. In accordance with accounting standards related to business combinations, goodwill is not amortized; however, certain finite-lived identifiable intangible assets, primarily customer relationships and acquired technology, are amortized over their estimated useful lives. Goodwill and indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. The Company first assessed qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount or performed a quantitative impairment test. When tested quantitatively, the Company uses a combination of techniques, including an income approach and a market-based approach to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. In making this assessment, management relies on a number of factors, including expected future operating results, business plans, economic projections, anticipated future cash flows, business trends and the Company’s market capitalization. The Company’s reporting units are the financial components of operating segments which constitute businesses for which discrete financial information is available and is regularly reviewed by segment management. The Company did not record any impairment loss for goodwill or indefinite-lived intangible assets in 2022, 2021 and 2020. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management reviews the carrying amounts of other finite-lived intangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable based on undiscounted estimated cash flows, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 9 for additional information about the Company’s goodwill and other intangible assets. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company derives revenues primarily from the sale of Specialty Products &amp; Technologies and Equipment &amp; Consumables products and services. Revenue is recognized when control of the promised products or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services (the transaction price). A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606. For equipment, consumables and spare parts sold by the Company, control transfers to the customer at a point in time. To indicate the transfer of control, the Company must have a present right to payment, legal title must have passed to the customer, the customer must have the significant risks and rewards of ownership, and where acceptance is not a formality, the customer must have accepted the product or service. The Company’s principal terms of sale are FOB Shipping Point, or equivalent, and, as such, the Company primarily transfers control and records revenue for product sales upon shipment. Sales arrangements with delivery terms that are not FOB Shipping Point are not recognized upon shipment and the transfer of control for revenue recognition is evaluated based on the associated shipping terms and customer obligations. If a performance obligation to the customer with respect to a sales transaction remains to be fulfilled following shipment (typically installation or acceptance by the customer), revenue recognition for that performance obligation is deferred until such commitments have been fulfilled. Returns for products sold are estimated and recorded as a reduction of revenue at the time of sale. Customer allowances and rebates, consisting primarily of volume discounts and other short-term incentive programs, are recorded as a reduction of revenue at the time of sale because these allowances reflect a reduction in the transaction price. Product returns, customer allowances and rebates are estimated based on historical experience and known trends. For extended warranty and service, control transfers to the customer over the term of the arrangement. Revenue for extended warranty and service is recognized based upon the period of time elapsed under the arrangement. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a contract with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation on a relative standalone selling price basis using the Company’s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers; however, when prices in standalone sales are not available the Company may use third-party pricing for similar products or services or estimate the standalone selling price. Allocation of the transaction price is determined at the contracts’ inception. The Company does not adjust transaction price for the effects of a significant financing component when the period between the transfer of the promised good or service to the customer and payment for that good or service by the customer is expected to be one year or less.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipping and Handling</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs are considered a fulfillment cost and are included as a component of cost of sales. Revenue derived from shipping and handling costs billed to customers is included in sales. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are expensed as incurred. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts research and development activities for the purpose of developing new products, enhancing the functionality, effectiveness, ease of use and reliability of the Company’s existing products and expanding the applications for which uses of the Company’s products are appropriate. Research and development costs are expensed as incurred. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted rates expected to be in effect during the year in which the differences reverse. Deferred tax assets generally represent items that can be used as a tax deduction or credit in the Company’s tax return in future years for which the tax benefit has already been reflected on the Company’s Consolidated Statements of Operations. The Company establishes valuation allowances for its deferred tax assets if it is more likely than not that some or all of the deferred tax assets will not be realized. Deferred tax liabilities generally represent items that have already been taken as a deduction on the Company’s tax return but have not yet been recognized as an expense in the Company’s Consolidated Statements of Operations. The effect on deferred tax assets and liabilities due to a change in tax rates is recognized in income tax expense in the period that includes the enactment date. The Company provides for unrecognized tax benefits when, based upon the technical merits, it is “more likely than not” that an uncertain tax position will not be sustained upon examination. Judgment is required in evaluating tax positions and determining income tax provisions. The Company re-evaluates the technical merits of its tax positions and may recognize an uncertain tax benefit in certain circumstances, including when: (1) a tax audit is completed; (2) applicable tax laws change, including a tax case ruling or legislative guidance; or (3) the applicable statute of limitations expires. The Company recognizes potential accrued interest and penalties associated with unrecognized tax positions in income tax expense. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on the Company’s current analysis of the provisions, the Company does not believe this legislation will have a material impact on its Consolidated Financial Statements.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically initiates restructuring activities to appropriately position the Company’s cost base relative to prevailing economic conditions and associated customer demand as well as in connection with certain acquisitions. Costs associated with productivity improvement and restructuring actions can include termination benefits and related charges in addition to facility closure, contract termination and other related activities. The Company records the cost of the restructuring activities when impairment is identified or when the associated liability is incurred. Refer to Note 20 for additional information. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exchange rate adjustments resulting from foreign currency transactions are recognized in net income, whereas effects resulting from the translation of financial statements are reflected as a component of accumulated other comprehensive loss within equity. Assets and liabilities of subsidiaries operating outside the United States with a functional currency other than U.S. dollars are translated into U.S. dollars using year-end exchange rates and income statement accounts are translated at weighted average rates. Net foreign currency transaction gains or losses were not material in any of the years presented. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is neither a dealer nor a trader in derivative instruments. The Company has generally accepted the exposure to transactional exchange rate movements without using derivative instruments to manage this risk, although the Company from time to time partially hedges its net investments in foreign operations against adverse movements in exchange rates through foreign currency-denominated debt and cross-currency swaps. The Company may at times also enter into interest rate swaps to mitigate a portion of its interest rate risk related to the Company’s debt. The derivative instruments are recorded on the Consolidated Balance Sheets as either an asset or liability measured at fair value. To the extent the interest rate swap qualifies as an effective hedge, changes in fair value are recognized in accumulated other comprehensive loss within equity. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the value of the foreign currency denominated debt and cross-currency swaps designated as hedges of the Company’s net investment in foreign operations based on spot rates are recognized in accumulated other comprehensive loss within equity and offset changes in the value of the Company’s foreign currency denominated operations. Refer to Note 11 for additional information on derivative financial instruments. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss Contingencies</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a reserve for loss contingencies when it is both probable that a loss will be incurred and the amount of the loss is reasonably estimable. The Company evaluates pending litigation and other contingencies at least quarterly and adjusts the reserve for such contingencies for changes in probable and reasonably estimable losses.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency translation adjustments are generally not adjusted for income taxes as they relate to indefinite investments in non-U.S. subsidiaries. Foreign currency translation adjustments related to the Company’s cross-currency swap arrangements and foreign currency denominated debt that are designated as net investment hedges are adjusted for income taxes as those arrangements are not indefinite. Changes in the funded status of the pension plans, net of taxes, are recognized in the year in which the changes occur and reported in other comprehensive loss.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company accounts for stock-based compensation by measuring the cost of employee services received in exchange for all equity awards granted, including stock options, restricted stock units (“RSUs”) and performance stock units (“PSUs”), based on the fair value of the award as of the grant date. Equity-based compensation expense is recognized net of an estimated forfeiture rate on a straight-line basis over the requisite service period of the award, except that in the case of RSUs compensation expense is recognized using an accelerated attribution method. Refer to Note 17 for additional information on the stock-based compensation plan in which certain employees of the Company participate.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pension Plans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures its pension assets and obligations that determine the funded status as of the end of the Company’s fiscal year, and recognizes an asset for an over funded status or a liability for an underfunded status in its Consolidated Balance Sheets. Changes in the funded status of the pension plans are recognized in the year in which the changes occur and reported in other comprehensive loss. Refer to Note 13 for additional information on the Company’s pension plans including a discussion of the actuarial assumptions, the Company’s policy for recognizing the associated gains and losses and the method used to estimate service and interest cost components.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts, rather than at fair value. This standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The Company adopted this guidance on January 1, 2022, which did not have a significant impact on the Company’s Consolidated Financial Statements. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB issued ASU </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">“Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40),” </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. This guidance is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU 2020-06 was effective for public entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Effective January 1, 2022, the Company adopted ASU 2020-06 using the modified retrospective adoption approach. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption. The comparative prior year information has not been restated and continues to be presented according to accounting standards in effect for those periods.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The adoption of ASU 2020-06 resulted in a $75.0 million increase to the carrying value of the convertible notes due 2025, net of deferred debt issuance costs and unamortized discount and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption resulted in a $21.4 million increase to retained earnings and an $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs. Refer to Note 16 for a further discussion of the impact of adopting ASU 2020-06.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. ASU 2020-04 is effective for public entities through December 31, 2022. However, in December 2022, the FASB issued ASU 2022-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to defer the effective date of ASU 2020-04 from December 31, 2022 to December 31, 2024. The Company adopted ASU 2020-04 as of December 31, 2022 and its adoption did not have an impact on the Company’s Consolidated Financial Statements.</span></div> 2 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP").</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 4, Discontinued Operations, on December 31, 2021, the Company sold its KaVo dental treatment unit and instrument business (the "KaVo Treatment Unit and Instrument Business"), which was part of the Company’s Equipment and Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Principles</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The Consolidated Financial Statements include the accounts of the Company and its subsidiaries. The Consolidated Financial Statements also reflect the impact of noncontrolling interests. Noncontrolling interests do not have a significant impact on the Company’s consolidated results of operations, therefore income attributable to noncontrolling interests are not presented separately in the Company’s Consolidated Statements of Operations. Income attributable to noncontrolling interests have been reflected in selling, general and administrative expenses and were insignificant in all periods presented. Reclassifications of certain prior year amounts have been made to conform to the current year presentation.</span></div> Use of EstimatesThe preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The Company bases these estimates on historical experience, the current economic environment and on various other assumptions that are believed to be reasonable under the circumstances. However, uncertainties associated with these estimates exist and actual results may differ materially from these estimates. <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates potential acquisitions that either strategically fit with the Company’s existing portfolio or expand the Company’s portfolio into new and attractive business areas. Among other things, goodwill arises because the purchase prices for these businesses reflect a number of factors including the future earnings and cash flow potential of these businesses, the multiple to earnings, cash flow and other factors at which similar businesses have been purchased by other acquirers, the competitive nature of the processes by which the Company acquired the businesses, avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance the Company’s existing product offerings to key target markets and enter into new and profitable businesses and the complementary strategic fit and resulting synergies these businesses bring to existing operations.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We account for acquisitions under Accounting Standards Codification (“ASC“) 805 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Business Combinations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and use the acquisition method of accounting. The consideration transferred for the acquisition of a subsidiary comprises (i) fair values of the assets transferred; (ii) liabilities assumed of the acquired business; and (iii) fair value of any asset or liability resulting from a contingent consideration arrangement. Identifiable assets acquired, and liabilities and contingent liabilities assumed in a business combination are, with limited exceptions, measured initially at their fair values at the acquisition date. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes an initial allocation of the purchase price at the date of acquisition based upon its estimation of the fair value of the acquired assets and assumed liabilities. The Company obtains the information used to estimate the fair values during due diligence and through other sources. In the months after closing, up to 12 months, as the Company obtains additional information that existed at the acquisition date about these assets and liabilities, it is able to refine the estimates of fair value and more accurately allocate the purchase price. Only items that existed as of the acquisition date are considered for subsequent adjustment. The Company makes the appropriate adjustments to the purchase price allocation prior to completion of the measurement period, as required.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with a maturity of three months or less at the date of purchase to be cash equivalents.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowances for Credit Losses</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All trade accounts receivable are reported on the accompanying Consolidated Balance Sheets adjusted for any write-offs and net of allowances for credit losses. The allowances for credit losses represent management’s best estimate of the credit losses expected from the Company’s trade accounts receivable portfolio. Determination of the allowances requires management to exercise judgment about the timing, frequency and severity of credit losses that could materially affect the provision for credit losses and, therefore, net income. The Company regularly performs detailed reviews of its portfolios to determine if an impairment has occurred and evaluates the collectability of receivables based on a combination of various financial and qualitative factors that may affect customers’ ability to pay, including customers’ financial condition, debt-servicing ability, past payment experience and credit bureau information and forecasts. In circumstances where the Company is aware of a </span></div>specific customer’s inability to meet its financial obligations, a specific reserve is recorded against amounts due to reduce the recognized receivable to the amount reasonably expected to be collected. <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory Valuation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories include the costs of material, labor and overhead. Inventories are stated at the lower of cost or net realizable value primarily using the first-in, first-out method. Market value for raw materials is based on replacement costs and for other inventory classifications is based on net realizable value. The Company periodically evaluates the quantities on hand relative to current and historical selling prices and historical and projected sales volume. Based on this evaluation, provisions are made to write inventory down to its net realizable value.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are carried at cost. The provision for depreciation has been computed principally by the straight-line method based on the estimated useful lives of the depreciable assets as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"/><td style="width:48.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.528%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets and leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized over the lesser of the economic life of the asset or the term of the lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 – 10 years</span></div></td></tr></table></div>Estimated useful lives are periodically reviewed and, when appropriate, changes to estimates are made prospectively. The provision for depreciation has been computed principally by the straight-line method based on the estimated useful lives of the depreciable assets as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"/><td style="width:48.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.528%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets and leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized over the lesser of the economic life of the asset or the term of the lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 – 10 years</span></div></td></tr></table><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classes of property, plant and equipment as of December 31 are summarized as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(312.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(315.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> P30Y P3Y P10Y LeasesThe Company determines if an arrangement is a lease at inception and evaluates each lease agreement to determine whether the lease is an operating or finance lease. For leases where the Company is the lessee, right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The ROU asset also consists of any prepaid lease payments, lease incentives received, costs which will be incurred in exiting a lease and the amount of any asset or liability recognized on business combinations relating to favorable or unfavorable lease terms. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense using the accelerated interest method of recognition. In certain of the Company’s lease agreements, the rental payments are adjusted periodically to reflect actual charges incurred for common area maintenance, utilities, inflation and/or changes in other indexes. InvestmentsInvestments over which the Company has a significant influence but not a controlling interest, are accounted for using the equity method of accounting which requires the Company to record its initial investment at cost and adjust the balance each period for the Company’s share of the investee’s income or loss and dividends paid. Fair Value of Financial InstrumentsThe Company’s financial instruments consist primarily of cash and cash equivalents, trade accounts receivable, nonqualified deferred compensation plans, contingent consideration, derivatives, trade accounts payable and long-term debt. Due to their short-term nature, the carrying values for cash and cash equivalents, trade accounts receivable and trade accounts payable approximate fair value. <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other intangible assets result from the Company’s acquisition of existing businesses. In accordance with accounting standards related to business combinations, goodwill is not amortized; however, certain finite-lived identifiable intangible assets, primarily customer relationships and acquired technology, are amortized over their estimated useful lives. Goodwill and indefinite-lived intangible assets are reviewed for impairment annually in the fourth quarter of each fiscal year or whenever an event occurs or circumstances change that would indicate that the carrying amount may be impaired. The Company first assessed qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount or performed a quantitative impairment test. When tested quantitatively, the Company uses a combination of techniques, including an income approach and a market-based approach to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. In making this assessment, management relies on a number of factors, including expected future operating results, business plans, economic projections, anticipated future cash flows, business trends and the Company’s market capitalization. The Company’s reporting units are the financial components of operating segments which constitute businesses for which discrete financial information is available and is regularly reviewed by segment management. The Company did not record any impairment loss for goodwill or indefinite-lived intangible assets in 2022, 2021 and 2020. </span></div>Management reviews the carrying amounts of other finite-lived intangible assets whenever events or circumstances indicate that the carrying amounts of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit, and adverse legal or regulatory developments. If it is determined that such indicators are present and the review indicates that the assets will not be fully recoverable based on undiscounted estimated cash flows, their carrying values are reduced to estimated fair market value. Estimated fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. For the purposes of identifying and measuring impairment, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. 0 0 0 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company derives revenues primarily from the sale of Specialty Products &amp; Technologies and Equipment &amp; Consumables products and services. Revenue is recognized when control of the promised products or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services (the transaction price). A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606. For equipment, consumables and spare parts sold by the Company, control transfers to the customer at a point in time. To indicate the transfer of control, the Company must have a present right to payment, legal title must have passed to the customer, the customer must have the significant risks and rewards of ownership, and where acceptance is not a formality, the customer must have accepted the product or service. The Company’s principal terms of sale are FOB Shipping Point, or equivalent, and, as such, the Company primarily transfers control and records revenue for product sales upon shipment. Sales arrangements with delivery terms that are not FOB Shipping Point are not recognized upon shipment and the transfer of control for revenue recognition is evaluated based on the associated shipping terms and customer obligations. If a performance obligation to the customer with respect to a sales transaction remains to be fulfilled following shipment (typically installation or acceptance by the customer), revenue recognition for that performance obligation is deferred until such commitments have been fulfilled. Returns for products sold are estimated and recorded as a reduction of revenue at the time of sale. Customer allowances and rebates, consisting primarily of volume discounts and other short-term incentive programs, are recorded as a reduction of revenue at the time of sale because these allowances reflect a reduction in the transaction price. Product returns, customer allowances and rebates are estimated based on historical experience and known trends. For extended warranty and service, control transfers to the customer over the term of the arrangement. Revenue for extended warranty and service is recognized based upon the period of time elapsed under the arrangement. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a contract with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation on a relative standalone selling price basis using the Company’s best estimate of the standalone selling price of each distinct product or service in the contract. The primary method used to estimate standalone selling price is the price observed in standalone sales to customers; however, when prices in standalone sales are not available the Company may use third-party pricing for similar products or services or estimate the standalone selling price. Allocation of the transaction price is determined at the contracts’ inception. The Company does not adjust transaction price for the effects of a significant financing component when the period between the transfer of the promised good or service to the customer and payment for that good or service by the customer is expected to be one year or less.</span></div> Shipping and HandlingShipping and handling costs are considered a fulfillment cost and are included as a component of cost of sales. Revenue derived from shipping and handling costs billed to customers is included in sales. AdvertisingAdvertising costs are expensed as incurred. Research and DevelopmentThe Company conducts research and development activities for the purpose of developing new products, enhancing the functionality, effectiveness, ease of use and reliability of the Company’s existing products and expanding the applications for which uses of the Company’s products are appropriate. Research and development costs are expensed as incurred. <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted rates expected to be in effect during the year in which the differences reverse. Deferred tax assets generally represent items that can be used as a tax deduction or credit in the Company’s tax return in future years for which the tax benefit has already been reflected on the Company’s Consolidated Statements of Operations. The Company establishes valuation allowances for its deferred tax assets if it is more likely than not that some or all of the deferred tax assets will not be realized. Deferred tax liabilities generally represent items that have already been taken as a deduction on the Company’s tax return but have not yet been recognized as an expense in the Company’s Consolidated Statements of Operations. The effect on deferred tax assets and liabilities due to a change in tax rates is recognized in income tax expense in the period that includes the enactment date. The Company provides for unrecognized tax benefits when, based upon the technical merits, it is “more likely than not” that an uncertain tax position will not be sustained upon examination. Judgment is required in evaluating tax positions and determining income tax provisions. The Company re-evaluates the technical merits of its tax positions and may recognize an uncertain tax benefit in certain circumstances, including when: (1) a tax audit is completed; (2) applicable tax laws change, including a tax case ruling or legislative guidance; or (3) the applicable statute of limitations expires. The Company recognizes potential accrued interest and penalties associated with unrecognized tax positions in income tax expense. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on the Company’s current analysis of the provisions, the Company does not believe this legislation will have a material impact on its Consolidated Financial Statements.</span></div> RestructuringThe Company periodically initiates restructuring activities to appropriately position the Company’s cost base relative to prevailing economic conditions and associated customer demand as well as in connection with certain acquisitions. Costs associated with productivity improvement and restructuring actions can include termination benefits and related charges in addition to facility closure, contract termination and other related activities. The Company records the cost of the restructuring activities when impairment is identified or when the associated liability is incurred. Foreign Currency TranslationExchange rate adjustments resulting from foreign currency transactions are recognized in net income, whereas effects resulting from the translation of financial statements are reflected as a component of accumulated other comprehensive loss within equity. Assets and liabilities of subsidiaries operating outside the United States with a functional currency other than U.S. dollars are translated into U.S. dollars using year-end exchange rates and income statement accounts are translated at weighted average rates. Net foreign currency transaction gains or losses were not material in any of the years presented. <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is neither a dealer nor a trader in derivative instruments. The Company has generally accepted the exposure to transactional exchange rate movements without using derivative instruments to manage this risk, although the Company from time to time partially hedges its net investments in foreign operations against adverse movements in exchange rates through foreign currency-denominated debt and cross-currency swaps. The Company may at times also enter into interest rate swaps to mitigate a portion of its interest rate risk related to the Company’s debt. The derivative instruments are recorded on the Consolidated Balance Sheets as either an asset or liability measured at fair value. To the extent the interest rate swap qualifies as an effective hedge, changes in fair value are recognized in accumulated other comprehensive loss within equity. </span></div>Changes in the value of the foreign currency denominated debt and cross-currency swaps designated as hedges of the Company’s net investment in foreign operations based on spot rates are recognized in accumulated other comprehensive loss within equity and offset changes in the value of the Company’s foreign currency denominated operations. <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss Contingencies</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a reserve for loss contingencies when it is both probable that a loss will be incurred and the amount of the loss is reasonably estimable. The Company evaluates pending litigation and other contingencies at least quarterly and adjusts the reserve for such contingencies for changes in probable and reasonably estimable losses.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency translation adjustments are generally not adjusted for income taxes as they relate to indefinite investments in non-U.S. subsidiaries. Foreign currency translation adjustments related to the Company’s cross-currency swap arrangements and foreign currency denominated debt that are designated as net investment hedges are adjusted for income taxes as those arrangements are not indefinite. Changes in the funded status of the pension plans, net of taxes, are recognized in the year in which the changes occur and reported in other comprehensive loss.</span></div> Stock-Based CompensationThe Company accounts for stock-based compensation by measuring the cost of employee services received in exchange for all equity awards granted, including stock options, restricted stock units (“RSUs”) and performance stock units (“PSUs”), based on the fair value of the award as of the grant date. Equity-based compensation expense is recognized net of an estimated forfeiture rate on a straight-line basis over the requisite service period of the award, except that in the case of RSUs compensation expense is recognized using an accelerated attribution method. Pension PlansThe Company measures its pension assets and obligations that determine the funded status as of the end of the Company’s fiscal year, and recognizes an asset for an over funded status or a liability for an underfunded status in its Consolidated Balance Sheets. Changes in the funded status of the pension plans are recognized in the year in which the changes occur and reported in other comprehensive loss. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts, rather than at fair value. This standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, and early adoption is permitted. The Company adopted this guidance on January 1, 2022, which did not have a significant impact on the Company’s Consolidated Financial Statements. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB issued ASU </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">“Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815 – 40),” </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. This guidance is part of the FASB’s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU 2020-06 was effective for public entities for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. Effective January 1, 2022, the Company adopted ASU 2020-06 using the modified retrospective adoption approach. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption. The comparative prior year information has not been restated and continues to be presented according to accounting standards in effect for those periods.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The adoption of ASU 2020-06 resulted in a $75.0 million increase to the carrying value of the convertible notes due 2025, net of deferred debt issuance costs and unamortized discount and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption resulted in a $21.4 million increase to retained earnings and an $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs. Refer to Note 16 for a further discussion of the impact of adopting ASU 2020-06.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions that reference London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. ASU 2020-04 is effective for public entities through December 31, 2022. However, in December 2022, the FASB issued ASU 2022-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to defer the effective date of ASU 2020-04 from December 31, 2022 to December 31, 2024. The Company adopted ASU 2020-04 as of December 31, 2022 and its adoption did not have an impact on the Company’s Consolidated Financial Statements.</span></div> 75000000 -77800000 21400000 -18600000 ACQUISITIONS <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company completed the following acquisitions, using the acquisition method of accounting during, the year ended December 31, 2022:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Osteogenics Biomedical Inc., Allotech LLC and OBI Biologics, Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On July 5, 2022, the Company acquired all of the equity of Osteogenics Biomedical Inc., Allotech LLC and OBI Biologics, Inc. (together "Osteogenics") for total consideration of approximately $128.2 million, subject to certain customary adjustments as provided in the Equity Purchase Agreement dated May 17, 2022. Osteogenics develops innovative regenerative solutions for periodontists, oral and maxillofacial surgeons, and clinicians involved in implant dentistry throughout the world, and is part of the Company’s Specialty Products &amp; Technologies segment. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Carestream Dental Technology Parent Limited’s Intraoral Scanner Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 20, 2022, the Company completed the acquisition of Carestream Dental Technology Parent Limited’s (“Carestream Dental”) intraoral scanner business (the “Intraoral Scanner Business”) for total consideration of $580.3 million, including contingent consideration of $7.5 million, and subject to certain customary adjustments as provided in the Stock and Asset Purchase Agreement dated December 21, 2021 and as subsequently amended by the closing agreement dated as of April 20, 2022. The Intraoral Scanner Business manufactures, markets, sells, commercializes, distributes, services, trains, supports, and maintains operations of intraoral scanners and software, and is part of the Company’s Equipment &amp; Consumables segment. The Company purchased the Intraoral Scanner Business through the acquisition of certain assets and the assumption of certain liabilities as well as the acquisition of all of the equity of certain subsidiaries of Carestream Dental.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table summarizes the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates ($ in millions):</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.275%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.841%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Osteogenics<br/>July 5, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intraoral Scanner Business<br/>April 20, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets acquired:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Prepaids and Other Current Assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">373.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Non-current deferred tax asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">       Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">609.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Accounts payable </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Accrued expenses and other liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Non-current deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">       Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company may up to 12 months after closing refine the estimates of fair value and more accurately allocate the purchase price. Only items that existed as of the acquisition date are considered for subsequent adjustment. The finalization of the acquisition valuation assessment for these acquisitions may result in a change in the valuation of deferred taxes and goodwill, which could have a material impact on the Company’s financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The intangible assets acquired consist of trade name, developed technology, and customer relationships. The weighted average amortization period of the acquired intangible assets in the aggregate is </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">8 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">and 10 years for the Intraoral Scanner Business and Osteogenics, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The excess of the purchase price over the fair value assigned to the assets acquired and liabilities assumed represents the goodwill resulting from the acquisitions. Goodwill attributable to the acquisitions has been recorded as a non-current asset and is not amortized, but is subject to review at least on an annual basis for impairment. Goodwill recognized was primarily attributable to expected operating efficiencies and expansion opportunities in the businesses acquired. Goodwill is not deductible for income tax purposes. The pro forma impact of the acquisitions is not presented as the acquisitions were not considered material to the Company's Consolidated Financial Statements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Legal, accounting, and other professional service costs associated with the acquisitions were $14.5 million for the year ended December 31, 2022, and have been recorded as selling, general and administrative expense in the Consolidated Statements of Operations.</span></div> 128200000 580300000 7500000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The following table summarizes the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates ($ in millions):</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.275%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.841%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Osteogenics<br/>July 5, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intraoral Scanner Business<br/>April 20, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets acquired:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Prepaids and Other Current Assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">373.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Non-current deferred tax asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">       Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">609.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Accounts payable </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Accrued expenses and other liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Non-current deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">       Total liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 2100000 2700000 2500000 100000 13300000 6100000 53000000.0 129800000 0 300000 1300000 0 77300000 373100000 0 96000000.0 2600000 900000 4900000 200000 157000000.0 609200000 4100000 500000 2500000 27900000 14300000 0 5800000 0 2100000 500000 28800000 28900000 128200000 580300000 P8Y P10Y 14500000 DISCONTINUED OPERATIONS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2021, the Company sold substantially all of the KaVo Treatment Unit and Instrument Business (the “Divestiture”) to planmeca Verwaltungs Gmbh, Germany (“Planmeca”), pursuant to the master sale and purchase agreement (the “Purchase Agreement”) among the Company, Planmeca, and Planmeca Oy, as guarantor. On December 30, 2021, the Company entered into an amendment to the Purchase Agreement (the "Amendment"), providing that the transfer of net assets in Russia, China and Brazil (the "Relevant Jurisdictions") would be deferred until the purchaser had formed entities for such transfer of assets in each such Relevant Jurisdiction and the applicable asset transfer agreement could be executed and consummated (each such asset transfer, a "Deferred Local Closing"). Except for the implementation of the Deferred Local Closings and related matters regarding the assets in the Relevant Jurisdictions, the provisions, terms and conditions of the Purchase Agreement were not materially amended by the Amendment. The Amendment did not alter the preliminary purchase price that Planmeca paid to the Company upon the closing of the Divestiture and the Company recognized the applicable gain or loss at the time of each Relevant Jurisdiction’s applicable closing. At December 31, 2021, the Company recorded a liability of $10.8 million for the proceeds related to the Relevant Jurisdictions. At December 31, 2022, all three Relevant Jurisdictions have closed and the related liability associated with the proceeds released. In accordance with the terms of the Purchase Agreement, the Company received total net cash consideration of $386.4 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">The results of the Divestiture are presented as discontinued operations for all periods presented in the accompanying Consolidated Financial Statements, with the exception of the Consolidated Statements of Cash Flows which include the financial results of the KaVo Treatment Unit and Instrument Business for all periods presented.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of the assets and liabilities of the Divestiture held for sale are as follows ($ in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.614%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets for Relevant Jurisdictions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets held for sale</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities for Relevant Jurisdictions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities held for sale</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2021 and 2020, the amounts represent activity for the entire Divestiture, while amounts for the year ended December 31, 2022, represent activity for the remaining Relevant Jurisdictions prior to closing. The operating results of the Divestiture are reflected in the Consolidated Statements of Operations within income from discontinued operations, net of tax as follows ($ in millions): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.465%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.443%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) profit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of discontinued operations, net of tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant non-cash operating items and capital expenditures for the Divestiture are reflected in the cash flows from operations as follows ($ in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.655%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.253%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization were no longer recognized once the business was classified as discontinued operations as of August 27, 2021.</span></div></td></tr></table> 10800000 386400000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of the assets and liabilities of the Divestiture held for sale are as follows ($ in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.614%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets for Relevant Jurisdictions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets held for sale</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities for Relevant Jurisdictions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities held for sale</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>The operating results of the Divestiture are reflected in the Consolidated Statements of Operations within income from discontinued operations, net of tax as follows ($ in millions): <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.465%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.443%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) profit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from discontinued operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of discontinued operations, net of tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from discontinued operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant non-cash operating items and capital expenditures for the Divestiture are reflected in the cash flows from operations as follows ($ in millions):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.655%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.253%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization were no longer recognized once the business was classified as discontinued operations as of August 27, 2021.</span></div></td></tr></table> 12200000 12200000 4000000.0 4000000.0 11700000 413500000 352900000 9100000 234600000 249600000 2600000 178900000 103300000 3200000 75600000 99300000 0 16100000 14100000 -600000 87200000 -10100000 0 21900000 -900000 -600000 65300000 -9200000 5700000 11700000 0 5100000 77000000.0 -9200000 0 0 9600000 0 0 10500000 0 5800000 10900000 0 6700000 3800000 CREDIT LOSSES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for credit losses is a valuation account deducted from accounts receivable to present the net amount expected to be collected. Accounts receivable are charged off against the allowance when management believes the uncollectibility of an accounts receivable balance is confirmed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management estimates the adequacy of the allowance by using relevant available information, from internal and external sources, relating to past events, current conditions and forecasts. Historical credit loss experience provides the basis for estimation of expected credit losses and is adjusted as necessary using the relevant information available. The allowance for credit losses is measured on a collective basis when similar risk characteristics exist. The Company has identified one portfolio segment based on the following risk characteristics: geographic regions, product lines, default rates and customer specific factors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The factors used by management in its credit loss analysis are inherently subject to uncertainty. If actual results are not consistent with management’s estimates and assumptions, the allowance for credit losses may be overstated or understated and a charge or credit to net income (loss) may be required. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rollforward of the allowance for credit losses is summarized as follows ($ in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs charged against the allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rollforward of the allowance for credit losses is summarized as follows ($ in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs charged against the allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 20700000 800000 4800000 4100000 4400000 16200000 INVENTORIES<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classes of inventory as of December 31 are summarized as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for inventory obsolescence</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classes of inventory as of December 31 are summarized as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for inventory obsolescence</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 229200000 214300000 23900000 22000000.0 103400000 88300000 55700000 60800000 300800000 263800000 PROPERTY, PLANT AND EQUIPMENT <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classes of property, plant and equipment as of December 31 are summarized as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.733%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(312.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(315.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 10000000.0 10700000 154500000 168700000 370200000 354500000 71200000 45600000 605900000 579500000 312300000 315400000 293600000 264100000 LEASES <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for office space, warehouses, distribution centers, research and development and manufacturing facilities, equipment and vehicles. Many leases include one or more options to renew, some of which include options to extend the lease for up to 20 years and some leases include options to terminate the lease within 30 days. The Company regularly evaluates the renewal options and, when the options are reasonably certain of being exercised, they are included in the lease term. In certain of the Company’s lease agreements, the rental payments are adjusted periodically to reflect actual charges incurred for common area maintenance, utilities, inflation and/or changes in other indexes. The Company has elected to combine lease and non-lease components for leases of all asset classes where the Company is the lessee. At inception, the Company determines whether an agreement represents a lease and, at commencement, evaluates each lease agreement to determine whether the lease is an operating or finance lease.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease costs consist primarily of taxes, insurance, and common area or other maintenance costs for leased facilities and vehicles, which are paid based on actual costs incurred. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of operating lease expense for the years ended December 31 were as follows ($ in millions)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed operating lease expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable operating lease expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(a)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Includes short-term leases and sublease income, both of which were not significant.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and weighted average discount rates related to the Company’s operating leases as of December 31:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"/><td style="width:72.183%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.886%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 years</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturity of the Company’s operating lease liabilities as of December 31, 2022 ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.953%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company had no additional significant operating or finance leases that had not yet commenced.</span></div> P20Y P30D <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of operating lease expense for the years ended December 31 were as follows ($ in millions)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed operating lease expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable operating lease expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(a)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Includes short-term leases and sublease income, both of which were not significant.</span></div> 31700000 32400000 7200000 6100000 38900000 38500000 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and weighted average discount rates related to the Company’s operating leases as of December 31:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.702%"><tr><td style="width:1.0%"/><td style="width:72.183%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.886%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 years</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> P8Y P9Y 0.041 0.035 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturity of the Company’s operating lease liabilities as of December 31, 2022 ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.953%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 32200000 28700000 23900000 19800000 16800000 50300000 171700000 23300000 148400000 GOODWILL AND OTHER INTANGIBLE ASSETS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performed its annual goodwill impairment test on the first business day of the fourth quarter of 2022. The Company used a combination of techniques, including an income approach and a market-based approach in performing its annual goodwill impairment test to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value amount. The Company’s reporting units are the financial components of operating segments which constitute businesses for which discrete financial information is available and regularly reviewed by segment management.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No goodwill impairment charges were recorded for the years ended December 31, 2022, 2021 and 2020 and no “triggering” events have occurred subsequent to the performance of the 2022 annual impairment test. The factors used by management in its impairment analysis are inherently subject to uncertainty. If actual results are not consistent with management’s estimates and assumptions, goodwill and other intangible assets may be overstated and a charge to net income may be required. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the Company’s goodwill by segment ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,029.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,132.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,047.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,448.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,496.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangible assets are amortized over the shorter of their legal or estimated useful life. The following summarizes the gross carrying value and accumulated amortization for each major category of intangible asset as of December 31 ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived intangibles:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships and other intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(648.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(610.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finite-lived intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,581.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(985.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(901.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangibles:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangibles</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,072.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(985.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(901.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible amortization expense in 2022, 2021 and 2020 was $106.0 million, $81.5 million and $87.3 million, respectively. Based on the intangible assets recorded as of December 31, 2022, amortization expense is estimated as follows for the next five years and thereafter:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.335%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ending December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.6</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 0 0 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the Company’s goodwill by segment ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,029.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,132.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,047.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,448.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,496.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2029700000 1102300000 3132000000 77300000 373100000 450400000 -59200000 -26600000 -85800000 2047800000 1448800000 3496600000 The following summarizes the gross carrying value and accumulated amortization for each major category of intangible asset as of December 31 ($ in millions): <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived intangibles:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships and other intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(648.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(610.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finite-lived intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,581.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(985.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(901.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangibles:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangibles</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,072.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(985.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(901.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> The following summarizes the gross carrying value and accumulated amortization for each major category of intangible asset as of December 31 ($ in millions): <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived intangibles:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships and other intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(648.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(610.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finite-lived intangibles</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,581.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(985.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(901.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangibles:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangibles</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,072.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(985.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948.0 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(901.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 432200000 236400000 313800000 215300000 924100000 648700000 907400000 610900000 224800000 100200000 216300000 75400000 1581100000 985300000 1437500000 901600000 490900000 510500000 2072000000 985300000 1948000000 901600000 106000000 81500000 87300000 Based on the intangible assets recorded as of December 31, 2022, amortization expense is estimated as follows for the next five years and thereafter:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.335%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ending December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.6</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 99300000 89600000 89100000 81100000 76500000 160200000 595800000 ACCRUED EXPENSES AND OTHER LIABILITIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other liabilities as of December 31 were as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncurrent</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncurrent</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and product allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes, income and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring-related employee severance, benefits and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss contingencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other liabilities as of December 31 were as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncurrent</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncurrent</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and product allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes, income and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring-related employee severance, benefits and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss contingencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562.3 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 148000000.0 17500000 188900000 17900000 85100000 1300000 75400000 1200000 78900000 8600000 60100000 5100000 42100000 68600000 48100000 201400000 18900000 0 21900000 0 5600000 17500000 5600000 41700000 8100000 27600000 8400000 30300000 0 0 19600000 0 84700000 10200000 134300000 6600000 471400000 151300000 562300000 304200000 HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has foreign currency denominated long-term debt in the amount of €208.0 million. This senior unsecured term loan facility represents a partial hedge of the Company’s net investment in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The euro senior unsecured term loan facility is designated and qualifies as a non-derivative hedging instrument. Accordingly, the foreign currency translation of the euro senior unsecured term loan facility is recorded in accumulated other comprehensive loss in equity in the accompanying Consolidated Balance Sheets, offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated other comprehensive loss in equity (see Note 18). Any ineffective portions of net investment hedges are reclassified from accumulated other comprehensive loss into income during the period of change. The euro senior unsecured term loan facility matures in September 2024. Refer to Note 16 for a further discussion of the above loan facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has used cross-currency swap derivative contracts to partially hedge its net investments in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. The cross-currency swap derivative contracts were agreements to exchange fixed-rate payments in one currency for fixed-rate payments in another currency. The Company maintained cross-currency swap derivative contracts with respect to its $650.0 million senior unsecured term loan facility. These contracts effectively converted the $650.0 million senior unsecured term loan facility to an obligation denominated in euros and partially offset the impact of changes in currency rates on foreign currency denominated net investments. During the year ended December 31, 2022, the Company settled all of its cross-currency swap derivative contracts and as of December 31, 2022 did not have any cross-currency swap derivative contracts outstanding. The changes in the fair value of these instruments were recorded in accumulated other comprehensive loss in equity, in the accompanying Consolidated Balance Sheets, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that was also recorded in accumulated other comprehensive loss as reflected in Note 18. Any ineffective portions of net investment hedges were reclassified from accumulated other comprehensive loss into income during the period of change. The interest income or expense from these swaps was recorded in interest expense, net in the Company’s Consolidated Statements of Operations consistent with the classification of interest expense attributable to the underlying debt. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also used interest rate swap derivative contracts to reduce its variability of cash flows related to interest payments with respect to its senior unsecured term loans. The interest rate swap contracts exchanged interest payments based on variable rates for interest payments based on fixed rates. During the year ended December 31, 2022, the existing interest rate swap matured. As of December 31, 2022, the Company did not have any outstanding interest rate swap contracts. The changes in the fair value of these instruments were recorded in accumulated other comprehensive loss in equity (see Note 18). Any ineffective portions of the cash flow hedges were reclassified from accumulated other comprehensive loss into income during the period of change. The interest income or expense from these swaps was recorded in interest expense in the Company’s Consolidated Statements of Operations consistent with the classification of interest expense attributable to the underlying debt. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the notional values as of December 31, 2022 and 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the years ended December 31, 2022 and 2021 ($ in millions):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses related to the foreign currency contracts and foreign currency denominated debt were classified as foreign currency translation adjustments in the schedule of changes in OCI in Note 18, as these items were attributable to the Company’s hedges of its net investment in foreign operations. Gains or losses related to the interest rate contracts were classified as cash flow hedge adjustments in the schedule of changes in OCI in Note 18. The Company did not reclassify any deferred gains or losses related to net investment and cash flow hedges from accumulated other comprehensive loss to income during the year ended December 31, 2022. The Company reclassified $10.2 million, net of tax, of certain deferred losses related to its net investment hedges from accumulated other comprehensive loss to income during the year ended December 31, 2021 related to the Divestiture. In addition, the Company did not have any ineffectiveness related to net investment and cash flow hedges during the years ended December 31, 2022 and 2021. The cash inflows and outflows associated with the Company’s derivative contracts designated as net investment hedges are classified in investing activities in the accompanying Consolidated Statements of Cash Flows. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s derivative instruments, as well as its non-derivative debt instruments designated and qualifying as net investment hedges, were classified as of December 31, 2022 and 2021, in the Company’s Consolidated Balance Sheets as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjMxNmE1ZmMxNWNiYTQ0NDZiNmQ1MGJlZTU3YTk5YWZjL3NlYzozMTZhNWZjMTVjYmE0NDQ2YjZkNTBiZWU1N2E5OWFmY183MC9mcmFnOjFhYjk0NDY1NmFjNDRhNzk5MDk3MDhiNTMxYmY1NGQ2L3RhYmxlOjU4MDU4MDRiMTYyOTQ5MjRiNjU0M2JlOTcyMDAwMmJiL3RhYmxlcmFuZ2U6NTgwNTgwNGIxNjI5NDkyNGI2NTQzYmU5NzIwMDAyYmJfNi0wLTEtMS04Mzc0Nw_b46ea4c4-d17d-474b-a081-fe621c36266a">Accrued expenses and other liabilities</span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonderivative hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts related to the Company’s derivatives expected to be reclassified from accumulated other comprehensive loss to net income during the next 12 months are not significant.</span></div> 208000000.0 650000000.0 650000000.0 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the notional values as of December 31, 2022 and 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the years ended December 31, 2022 and 2021 ($ in millions):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the notional values as of December 31, 2022 and 2021 and pretax impact of changes in the fair values of instruments designated as net investment hedges and cash flow hedges in accumulated other comprehensive loss (“OCI”) for the years ended December 31, 2022 and 2021 ($ in millions):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain Recognized in OCI</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 222700000 13800000 0 2200000 0 68500000 222700000 84500000 236500000 32500000 250000000.0 6100000 650000000.0 49700000 1136500000 88300000 0 -10200000 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s derivative instruments, as well as its non-derivative debt instruments designated and qualifying as net investment hedges, were classified as of December 31, 2022 and 2021, in the Company’s Consolidated Balance Sheets as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjMxNmE1ZmMxNWNiYTQ0NDZiNmQ1MGJlZTU3YTk5YWZjL3NlYzozMTZhNWZjMTVjYmE0NDQ2YjZkNTBiZWU1N2E5OWFmY183MC9mcmFnOjFhYjk0NDY1NmFjNDRhNzk5MDk3MDhiNTMxYmY1NGQ2L3RhYmxlOjU4MDU4MDRiMTYyOTQ5MjRiNjU0M2JlOTcyMDAwMmJiL3RhYmxlcmFuZ2U6NTgwNTgwNGIxNjI5NDkyNGI2NTQzYmU5NzIwMDAyYmJfNi0wLTEtMS04Mzc0Nw_b46ea4c4-d17d-474b-a081-fe621c36266a">Accrued expenses and other liabilities</span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonderivative hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 19600000 222700000 236500000 FAIR VALUE MEASUREMENTS Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value where the Company’s assets and liabilities are required to be carried at fair value and provide for certain disclosures related to the valuation methods used within a valuation hierarchy as established within the accounting standards. This hierarchy prioritizes the inputs into three broad levels as follows: Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, or other observable characteristics for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation; and Level 3 inputs are unobservable inputs based on the Company’s assumptions. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in<br/>Active Market<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap derivative contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap derivative contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The cross-currency and interest rate swap derivative contracts were classified as Level 2 in the fair value hierarchy as they are measured using the income approach with the relevant interest rates, foreign currency current exchange rates and forward curves as inputs. Refer to Note 11 for additional information.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Compensation Plans</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain management employees of the Company participate in nonqualified deferred compensation programs that permit such employees to defer a portion of their compensation, on a pretax basis. All amounts deferred under this plan are unfunded, unsecured obligations and are presented as a component of the Company’s compensation and benefits accrual included in accrued expenses in the accompanying Consolidated Balance Sheets (refer to Note 10). Participants may choose among alternative earnings rates for the amounts they defer, which are primarily based on investment options within the Company’s 401(k) program. Changes in the deferred compensation liability under these programs are recognized based on changes in the fair value of the participants’ accounts, which are based on the applicable earnings rates on investment options within the Company’s 401(k) program. Amounts voluntarily deferred by employees into the Company stock fund and amounts contributed to participant accounts by the Company are deemed invested in the Company’s common stock and future distributions of such contributions will be made solely in shares of Company common stock, and therefore are not reflected in the above amounts.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration represents a cash hold back intended to be used for certain liabilities related to the Company’s acquisition of the Intraoral Scanner Business (as further discussed in Note 3). Contingent consideration was classified as Level 3 in the fair value hierarchy as the estimated fair value was measured using a probability weighted discounted cash flow model. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and fair values of the Company’s financial instruments as of December 31, were as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.809%"><tr><td style="width:1.0%"/><td style="width:45.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap derivative contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap derivative contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes due 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of long-term debt approximates the carrying value as these borrowings are based on variable market rates. The fair value of the convertible senior notes due 2025 was determined based on the quoted bid price of the convertible senior notes in an over-the-counter market on December 31, 2022 and 2021. The convertible senior notes are considered as Level 2 of the fair value hierarchy. The fair values of cash and cash equivalents, which consist primarily of money market funds, time and demand deposits, trade accounts receivable, net and trade accounts payable approximate their carrying amounts due to the short-term maturities of these instruments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 13 for information related to the fair value of the Company sponsored defined benefit pension plan assets.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in<br/>Active Market<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap derivative contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap derivative contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plans</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and fair values of the Company’s financial instruments as of December 31, were as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.809%"><tr><td style="width:1.0%"/><td style="width:45.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.701%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap derivative contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap derivative contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes due 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 15800000 0 15800000 0 0 6000000.0 6000000.0 0 2200000 0 2200000 0 17400000 0 17400000 0 16500000 0 16500000 6000000.0 6000000.0 0 0 0 0 2200000 2200000 0 0 17400000 17400000 510000000.0 873000000.0 432100000 1162500000 870700000 870700000 883400000 883400000 PENSION AND OTHER BENEFIT PLANS <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company’s employees participate in defined benefit pension plans and under certain of these plans, benefit accruals continue. In general, the Company’s policy is to fund these plans based on considerations relating to legal requirements, underlying asset returns, the plan’s funded status, the anticipated deductibility of the contribution, local practices, market conditions, interest rates and other factors.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company’s restructuring activities (see Note 20), the Company had a reduction in participants in certain plans, which contributed to the change in the funded status through plan settlements and curtailments.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the funded status of the Company’s plans as of the most recent actuarial valuations using measurement dates of December 31 ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in pension benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits and other expenses paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendments, settlements and curtailments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange rate impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendments and settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits and other expenses paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange rate impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Weighted average assumptions used to determine benefit obligations at date of measurement:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Components of net periodic pension cost:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit and initial net obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net settlement and curtailment gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the service cost and other net periodic benefit costs of the defined benefit pension plans incurred during the years ended December 31, 2022, 2021 and 2020 ($ in millions):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Cost of goods sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other net periodic pension costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjMxNmE1ZmMxNWNiYTQ0NDZiNmQ1MGJlZTU3YTk5YWZjL3NlYzozMTZhNWZjMTVjYmE0NDQ2YjZkNTBiZWU1N2E5OWFmY183Ni9mcmFnOmJhNGEwNmE4N2QyOTQ3Yzg5MjU3NzIyNTU0YTBjNzc2L3RhYmxlOjc1ZmVkYmQ3ZGY4ZDQwZWQ4MTE1NDhjYjlhMjkwZTI0L3RhYmxlcmFuZ2U6NzVmZWRiZDdkZjhkNDBlZDgxMTU0OGNiOWEyOTBlMjRfNC0wLTEtMS04Mzc0Nw_7d04a4bf-3c4c-4358-aa04-fbdc84326c71">Other income (expense)</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Weighted average assumptions used to determine net periodic pension cost at date of measurement: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate reflects the market rate on December 31 of the prior year for high-quality fixed-income investments with maturities corresponding to the Company’s benefit obligations and is subject to change each year. The rates appropriate for each plan are determined based on investment grade instruments with maturities approximately equal to the average expected benefit payout under the plan. The Company periodically updates the mortality assumptions used to estimate the projected benefit obligation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in accumulated other comprehensive loss as of December 31, 2022 are the following amounts that have not yet been recognized in net periodic pension cost: unrecognized prior service credits of $2.3 million ($1.8 million, net of tax) and unrecognized actuarial gain of $17.5 million ($13.6 million, net of tax). The unrecognized actuarial gain and prior service credits, net, are calculated as the difference between the actuarially determined projected benefit obligation and the value of the plan assets less accrued pension costs as of December 31, 2022. The amounts included in accumulated comprehensive income (loss) and expected to be recognized in net periodic pension costs during the year ending December 31, 2023 is a prior service credit of $0.4 million ($0.3 million, net of tax) and an actuarial gain of $1.4 million ($1.1 million, net of tax), respectively. No plan assets are expected to be returned to the Company during the year ending December 31, 2023.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selection of Expected Rate of Return on Assets</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected rate of return reflects the asset allocation of the plans and is based primarily on contractual earnings rates included in existing insurance contracts as well as on broad, publicly-traded equity and fixed-income indices and forward-looking estimates of active portfolio and investment management. Long-term rate of return on asset assumptions for the plans were determined on a plan-by-plan basis based on the composition of assets and ranged from 2.3% to 5.3% in 2022 and 1.8% to 5.3% in 2021, with a weighted average rate of return assumption of 3.3% and 3.2% in 2022 and 2021, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan Assets</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan assets are invested in various insurance contracts, equity and debt securities as determined by the administrator of each plan. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has some investments that are valued using Net Asset Value (“NAV”) as a practical expedient. In addition, some of the investments valued using NAV may only allow redemption monthly, quarterly, semiannually or annually and require up to 90 days prior written notice. These investments valued using NAV primarily consist of mutual funds which allow the Company to diversify the portfolio.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company’s pension plan assets as of December 31, 2022, by asset category, were as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in<br/>Active Market<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at NAV </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="18" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12.24pt">The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the total plan assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in Level 3 pension plan assets measured at fair value on a recurring basis for the year ended December 31, 2022 (in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.849%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at January 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Return on Plan Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Purchases/(Settlements)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transfers Into/(Out of) Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at December 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company’s pension plan assets as of December 31, 2021, by asset category, were as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in<br/>Active Market<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at NAV </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="18" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12.24pt">The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the total plan assets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in Level 3 pension plan assets measured at fair value on a recurring basis for the year ended December 31, 2021 (in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.849%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at January 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Return on Plan Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Purchases/(Settlements)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transfers Into/(Out of) Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at December 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance contracts are valued based upon the quoted prices of the underlying investments of the insurance company. Mutual funds are valued using the NAV based on the information provided by the asset fund managers, which reflects the plan’s share of the fair value of the net assets of the investment.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The methods described above may produce a fair value estimate that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes the valuation methods are appropriate and consistent with the methods used by other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expected Contributions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the Company contributed $5.5 million to its defined benefit pension plans. During 2023, the Company’s cash contribution requirements for its defined benefit pension plans are expected to be approximately $5.5 million.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth benefit payments, which reflect expected future service, as appropriate, at December 31, 2022, are expected to be paid by the plans in the periods indicated ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.953%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 - 2032</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Matters</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. employees not covered by defined benefit plans are generally covered by defined contribution plans, which provide for Company funding based on a percentage of compensation. The Company provides eligible employees the opportunity to participate in defined contribution savings plans (commonly known as 401(k) plans), which permit contributions on a before-tax basis. Employees may contribute to various investment alternatives. In most of these plans, the Company matches a portion of the employees’ contributions. The Company’s contributions to these plans amounted to $19.1 million, $18.0 million and $11.0 million for the years ended December 31, 2022, 2021 and 2020, respectively. </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited number of the Company’s subsidiaries, primarily outside of the United States, participate in multiemployer defined benefit plans that require the Company to periodically contribute funds to the plan. Multi-employer pension plans are designed to cover employees from multiple employers. These plans allow multiple employers to pool their pension resources and realize efficiencies associated with the daily administration of the plan. The risks of participating in a multiemployer plan differ from the risks of participating in a single-employer plan in the following respects: (1) assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers, (2) if a participating employer ceases contributing to the plan, the unfunded obligations of the plan may be required to be borne by the remaining participating employers and (3) if the Company elects to stop participating in the plan, the Company may be required to pay the plan an amount based on the unfunded status of the plan.</span></div>The Company’s expense for multiemployer pension plans totaled $1.6 million, $3.9 million and $8.2 million for the years ended December 31, 2022, 2021 and 2020, respectively. <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the funded status of the Company’s plans as of the most recent actuarial valuations using measurement dates of December 31 ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in pension benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits and other expenses paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendments, settlements and curtailments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange rate impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendments and settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits and other expenses paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange rate impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 129100000 171600000 5500000 7300000 1800000 1200000 2500000 3100000 3000000.0 3300000 27300000 13000000.0 7700000 33200000 3400000 4600000 97500000 129100000 80600000 104100000 -1700000 5800000 5500000 6000000.0 2500000 3100000 6600000 32800000 3100000 3300000 -2800000 -2300000 74400000 80600000 -23100000 -48500000 <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Weighted average assumptions used to determine benefit obligations at date of measurement:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Weighted average assumptions used to determine net periodic pension cost at date of measurement: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 0.039 0.015 0.028 0.022 <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Components of net periodic pension cost:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service credit and initial net obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial gain (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net settlement and curtailment gain (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 5500000 7300000 9700000 1800000 1200000 1600000 2600000 3300000 3700000 -300000 -400000 -400000 100000 -700000 -1400000 1900000 800000 -1400000 2400000 4700000 10000000.0 The following table represents the service cost and other net periodic benefit costs of the defined benefit pension plans incurred during the years ended December 31, 2022, 2021 and 2020 ($ in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Cost of goods sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other net periodic pension costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjMxNmE1ZmMxNWNiYTQ0NDZiNmQ1MGJlZTU3YTk5YWZjL3NlYzozMTZhNWZjMTVjYmE0NDQ2YjZkNTBiZWU1N2E5OWFmY183Ni9mcmFnOmJhNGEwNmE4N2QyOTQ3Yzg5MjU3NzIyNTU0YTBjNzc2L3RhYmxlOjc1ZmVkYmQ3ZGY4ZDQwZWQ4MTE1NDhjYjlhMjkwZTI0L3RhYmxlcmFuZ2U6NzVmZWRiZDdkZjhkNDBlZDgxMTU0OGNiOWEyOTBlMjRfNC0wLTEtMS04Mzc0Nw_7d04a4bf-3c4c-4358-aa04-fbdc84326c71">Other income (expense)</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 800000 800000 1200000 4700000 6500000 8500000 -3100000 -2600000 300000 2400000 4700000 10000000.0 0.024 0.010 0.033 0.032 0.022 0.013 -2300000 -1800000 17500000 13600000 -400000 -300000 1400000 1100000 0.023 0.053 0.018 0.053 0.033 0.032 P90D <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company’s pension plan assets as of December 31, 2022, by asset category, were as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in<br/>Active Market<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at NAV </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="18" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12.24pt">The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the total plan assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company’s pension plan assets as of December 31, 2021, by asset category, were as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices in<br/>Active Market<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at NAV </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="18" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12.24pt">The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the total plan assets.</span></div> 8400000 0 0 8400000 0 0 49700000 49700000 8400000 0 49700000 58100000 16300000 74400000 <div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in Level 3 pension plan assets measured at fair value on a recurring basis for the year ended December 31, 2022 (in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.849%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at January 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Return on Plan Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Purchases/(Settlements)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transfers Into/(Out of) Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at December 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in Level 3 pension plan assets measured at fair value on a recurring basis for the year ended December 31, 2021 (in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.849%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at January 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Return on Plan Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Purchases/(Settlements)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transfers Into/(Out of) Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at December 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 50100000 -100000 -300000 0 49700000 300000 0 0 300000 0 0 50100000 50100000 300000 0 50100000 50400000 30200000 80600000 77200000 -600000 -26500000 0 50100000 5500000 5500000 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth benefit payments, which reflect expected future service, as appropriate, at December 31, 2022, are expected to be paid by the plans in the periods indicated ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.953%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 - 2032</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 5600000 5100000 5100000 4800000 4800000 24100000 19100000 18000000.0 11000000.0 1600000 3900000 8200000 WARRANTY<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally accrues estimated warranty costs at the time of sale. In general, manufactured products are warranted against defects in material and workmanship when properly used for their intended purpose, installed correctly and appropriately maintained. Warranty periods depend on the nature of the product and range from 90 days up to the life of the product. The amount of the accrued warranty liability is determined based on historical information such as past experience, product failure rates or number of units repaired, estimated cost of material and labor and in certain instances estimated property damage. The accrued warranty liability is reviewed on a quarterly basis and may be adjusted as additional information regarding expected warranty costs becomes known. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the Company’s accrued warranty liability ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.953%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties issued during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> P90D <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the Company’s accrued warranty liability ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.953%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties issued during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements made</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 9400000 15300000 15100000 100000 300000 9200000 LITIGATION AND CONTINGENCIES <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accruals for loss contingencies associated with legal matters when it is probable that a liability will be incurred, and the amount of the loss can be reasonably estimated. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss does not meet the known or probable level but is reasonably possible, it is disclosed if deemed material and if such loss or range of loss can be reasonably estimated, the estimated loss or range of loss is disclosed. The Company’s reserves consist of specific reserves for individual claims and additional amounts for anticipated developments of these claims as well as for incurred but not yet reported claims. The specific reserves for individual known claims are quantified with the assistance of legal counsel and outside risk professionals where appropriate. In addition, outside risk professionals assist in the determination of reserves for certain incurred but not yet reported claims through evaluation of the Company’s specific loss history, actual claims reported and industry trends among statistical and other factors. The Company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated and has accrued $35.7 million and $38.7 million as of December 31, 2022 and 2021, respectively, which are included in accrued liabilities in the Consolidated Balance Sheets. The Company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with ASC 450-20-25. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions including timing of related payments. The ability to make such estimates and judgments can be affected by various factors including, among other things, whether damages sought in the proceedings are unsubstantiated or indeterminate; legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; procedural or jurisdictional issues; the uncertainty and unpredictability of the number of potential claims; or there are numerous parties involved. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated. In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's Consolidated Balance Sheets, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company’s results of operations and cash flows for that period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to various environmental laws and regulations both within and outside of the United States. The operations of the Company involve the use of substances regulated under environmental laws, primarily in manufacturing processes. While it is difficult to quantify the potential impact of continuing compliance with environmental protection laws or potential enforcement actions by regulatory agencies, management believes that such compliance or potential enforcement actions will not have a material impact on the Company’s financial position, results of operations, or liquidity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company had $19.0 million of guarantees consisting primarily of outstanding standby letters of credit and bank guarantees. These guarantees have been provided in connection with certain arrangements with vendors, customers, insurance providers, financing counterparties and governmental entities to secure the Company’s obligations and/or performance requirements related to specific transactions.</span></div> 35700000 38700000 19000000 DEBT AND CREDIT FACILITIES <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company’s debt as of December 31, were as follows, net of debt discount and debt issuance costs ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.691%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.078%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Senior term loan facility due 2024 (the “Term Loan”) </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior euro term loan facility due 2024 (the “Euro Term Loan”)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Convertible senior notes due 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,380.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(510.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s contractual minimum principal payments are as follows ($ in millions):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.959%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.841%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 20, 2019, the Company entered into a credit agreement (the “Credit Agreement”) with a syndicate of banks under which Envista borrowed approximately $1.3 billion, consisting of the three-year $650.0 million Term Loan and the three-year €600.0 million Euro Term Loan (together with the Term Loan, the “Term Loans”). The Credit Agreement also included the five-year, $250.0 million revolving credit facility (together with the Term Loans, the “Senior Credit Facilities”). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 9, 2021, in connection with an amendment to the Credit Agreement, the Company repaid $472.0 million of its Euro Term Loan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 15, 2021, the Company entered into an amended and restated credit agreement (the “Amended Credit Agreement”) with a syndicate of banks. The Amended Credit Agreement amends and restates the Company’s Credit Agreement, originally dated September 20, 2019 (as amended by Amendment No. 1 to Credit Agreement dated as of May 6, 2020, Amendment No. 2 to Credit Agreement dated as of May 19, 2020, and Amendment No. 3 to Credit Agreement dated as of February 9, 2021). </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the Amended Credit Agreement: (a) the maturity date of the Company’s existing Term Loans has been extended to September 20, 2024, (b) the revolving credit facility has been increased from $250.0 million to $750.0 million, (c) the Company may request further increases to the revolving credit facility in an aggregate amount not to exceed $350.0 million, (d) the amount of cash and cash equivalents permitted to be netted in the definition of “Consolidated Funded Indebtedness” has been increased to up to the greater of (i) $250.0 million and (ii) 50% of Consolidated EBITDA as of the most recent measurement period, and (e) the floor on Eurocurrency rate loans applicable to the revolving credit facility and the Term Loan has been reduced to zero, in each case subject to and in accordance with the terms and conditions of the Amended Credit Agreement. The Company paid fees aggregating approximately $2.1 million in connection with the Amended Credit Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revolving credit facility includes an aggregate available borrowing capacity of $750.0 million with a $20.0 million sublimit for the issuance of standby letters of credit and can be used for working capital and other general corporate purposes. As of December 31, 2022 and December 31, 2021, there were no borrowings outstanding under the revolving credit facility. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Senior Credit Facilities, borrowings bear interest as follows: (1) Eurocurrency Rate Loans (as defined in the Amended Credit Agreement) bear interest at a variable rate equal to the London inter-bank offered (“LIBOR”) rate plus a margin of between 0.785% and 1.625%, depending on the Company’s Consolidated Leverage Ratio (as defined in the Amended Credit Agreement) as of the last day of the immediately preceding fiscal quarter; and (2) Base Rate Loans (as defined in the Amended Credit Agreement) bear interest at a variable rate equal to (a) the highest of (i) the Federal funds rate (as published by the Federal Reserve Bank of New York from time to time) plus 0.50%, (ii) Bank of America’s “prime rate” as publicly announced from time to time and (iii) the Eurocurrency Rate (as defined in the Amended Credit Agreement) plus 1.0%, plus (b) a margin of between 0.00% and 0.625%, depending on the Company’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter. In no event will Eurocurrency Rate Loans or Base Rate Loans bear interest at a rate lower than 0.0%. The Amended Credit Agreement provides for the use of Secured Overnight Financing Rate (“SOFR”) as a replacement rate upon a LIBOR cessation event. In addition, the Company is required to pay a per annum facility fee of between 0.09% and 0.225% depending on the Company’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter and based on the aggregate commitments under the revolving credit facility, whether drawn or not. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rates for borrowings under the Term Loan were 5.98% and 1.25% as of December 31, 2022 and 2021, respectively. The interest rate for borrowings under the Euro Term Loan was 3.28% and 0.95% as of December 31, 2022 and 2021, respectively. Interest is payable quarterly for the Term Loans. The Amended Credit Agreement requires the Company to maintain a Consolidated Leverage Ratio of 3.75 to 1.00 or less and includes a provision that the maximum Consolidated Leverage Ratio will be increased to 4.25 to 1.00 for the four consecutive full fiscal quarters immediately following the consummation of any acquisition by the Company or any subsidiary of the Company in which the purchase price exceeds $100.0 million. The Amended Credit Agreement also requires the Company to maintain a Consolidated Interest Coverage Ratio (as defined in the Amended Credit Agreement) of at least 3.00 to 1.00. The Amended Credit Agreement contains customary representations, warranties, conditions precedent, events of default, indemnities and affirmative and negative covenants, including covenants that, among other things, limit or restrict the Company’s and/or the Company’s subsidiaries ability, subject to certain exceptions and qualifications, to incur liens or indebtedness, merge, consolidate or sell or otherwise transfer assets, make dividends or distributions, enter into transactions with the Company’s affiliates and use proceeds of the debt financing for other than permitted uses. The Amended Credit Agreement also contains customary events of default. Upon the occurrence and during the continuance of an event of default, the lenders may declare the outstanding advances and all other obligations under the Amended Credit Agreement immediately due and payable. The Company was in compliance with all of its debt covenants as of December 31, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes (the “Notes”)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 21, 2020, the Company issued the Notes due on June 1, 2025, unless earlier repurchased, redeemed or converted. The aggregate principal amount, which includes the initial purchasers’ exercise in full of their option to purchase an additional $67.5 million principal amount of the Notes, was $517.5 million. The net proceeds from the issuance, after deducting purchasers’ discounts and estimated offering expenses, were $502.6 million. The Company used part of the net proceeds to pay for the capped call transactions (“Capped Calls”) as further described below. The Notes accrue interest at a rate of 2.375% per annum, payable semi-annually in arrears on June 1 and December 1 of each year, beginning on December 1, 2020. The Notes have an initial conversion rate of 47.5862 shares of the Company’s common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $21.01 per share of the Company’s common stock and is subject to adjustment upon the occurrence of specified events. The Notes are governed by an indenture dated as of May 21, 2020 (the “Indenture”) between the Company and Wilmington Trust, National Association, as trustee. The Indenture does not contain any financial covenants or any restrictions on the payment of dividends, the incurrence of senior debt or other indebtedness or the issuance or repurchase of the Company’s securities by the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the adoption of ASU 2020-06, the Company separated the carrying amounts of the Notes and total issuance costs incurred into liability and equity components. For the Notes, the carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that did not have an associated convertible feature, while the carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the Notes. Total issuance costs incurred were then allocated to the liability and equity components of the Notes based on their relative values.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the Company’s adoption of ASU 2020-06 on January 1, 2022, the Notes and related issuance costs incurred are no longer required to be bifurcated into separate liability and equity components. This resulted in a $75.0 million increase to the carrying value of the Notes due 2025, comprised of unamortized discount of $76.5 million and deferred debt issuance costs of $1.5 million and a decrease to additional paid-in capital of $77.8 million. Additionally, the adoption of ASU 2020-06 resulted in a $21.4 million increase to retained earnings and an $18.6 million decrease to the related net deferred tax liability associated with the reduction of unamortized debt discount and deferred debt issuance costs. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notes are the Company’s senior, unsecured obligations and are (i) equal in right of payment with the Company’s existing and future senior, unsecured indebtedness; (ii) senior in right of payment to the Company’s existing and future indebtedness that is expressly subordinated to the Notes; (iii) effectively subordinated to the Company’s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness; and (iv) structurally subordinated to all existing and future indebtedness and other liabilities, including trade payables, and (to the extent the Company is not a holder thereof) preferred equity, if any, of the Company’s subsidiaries.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes may convert their Notes at any time on or after December 2, 2024 until the close of business on the second scheduled trading day preceding the maturity date. Holders of the Notes will also have the right to convert the Notes prior to December 2, 2024, but only upon the occurrence of specified events. In December 2021, the Company made the irrevocable election to settle all Notes conversions through combination settlement, satisfying the principal amount outstanding with cash and any Notes conversion value in excess of the principal amount in cash, shares of the Company’s common stock or a combination of both. If a fundamental change occurs prior to the maturity date, holders of the Notes may require the Company to repurchase all or a portion of their Notes for cash at a repurchase price equal to 100.0% of the principal amount plus any accrued and unpaid interest. In addition, if specific corporate events occur prior to the maturity date, the Company would increase the conversion rate for a holder who elects to convert its Notes in connection with such an event in certain circumstances. As of December 31, 2022 and 2021, the stock price exceeded 130% of the conversion price of $21.01 in 20 days of the final 30 trading days ended December 31, 2022 and 2021, which satisfied one of the conditions permitting early conversion by holders of the Notes, therefore, the Notes are classified as short-term debt. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notes will be redeemable, in whole or in part, at the Company’s option at any time, and from time to time, on or after June 1, 2023 and on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding the redemption date, but only if the last reported sale price per share of the Company’s common stock exceeds 130.0% of the conversion price on (i) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (ii) the trading day immediately before the date the Company sends such notice. In addition, calling any Note for redemption will constitute a “Make-Whole Fundamental Change” (as defined in the Indenture) with respect to that Note, in which case the conversion rate applicable to the conversion of that Note will be increased in certain circumstances if it is converted after it is called for redemption. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth total interest expense recognized related to the Notes ($ in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.733%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.334%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contractual interest expense</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortization of debt issuance costs</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortization of debt discount</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total interest expense</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">33.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2022 and 2021, the debt discount and debt issuance costs were amortized using an annual effective interest rate of 3.0% and 7.3%, respectively, to interest expense over the term of the Notes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022 and 2021, the if-converted value of the Notes exceeded the outstanding principal amount by $311.7 million and $592.1 million, respectively. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Discount and Debt Issuance Costs</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December 31, 2022 and 2021, remaining unamortized debt discount and debt issuance costs for the Term Loan, Euro Term Loan and Convertible Senior Notes are as follows ($ in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.304%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.757%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.611%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Issuance Costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Discount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Issuance Costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Discount</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Senior Notes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above unamortized debt discount and debt issuance costs have been netted against their respective aggregate principal amounts of the related debt and are being amortized to interest expense over the term of the respective debt.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capped Call Transactions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the Notes, the Company entered into Capped Calls with certain counterparties. The Capped Calls each have an initial strike price of approximately $21.01 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Notes. The Capped Calls have initial cap prices of $23.79 per share, subject to certain adjustments. The Capped Calls cover, subject to anti-dilution adjustments, 2.9 million shares of the Company's common stock. The Capped Calls are generally intended to reduce or offset the potential dilution from shares of common stock issued upon any conversion of the Notes with such reduction or offset, as the case may be, subject to a cap based on the cap price. As the Capped Call transactions are considered indexed to the Company's own stock and are considered equity classified, they are recorded in equity and are not accounted for as derivatives. The cost of $20.7 million incurred in connection with the Capped Calls was recorded as a reduction to additional paid-in capital.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the Company’s debt as of December 31, were as follows, net of debt discount and debt issuance costs ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.691%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.078%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.187%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Senior term loan facility due 2024 (the “Term Loan”) </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior euro term loan facility due 2024 (the “Euro Term Loan”)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Convertible senior notes due 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,380.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(510.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 648300000 647300000 222400000 236100000 510000000.0 432100000 0 300000 1380700000 1315800000 510000000.0 432400000 870700000 883400000 <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s contractual minimum principal payments are as follows ($ in millions):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.959%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.841%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 872700000 517500000 1390200000 1300000000 P3Y 650000000.0 P3Y 600000000.0 P5Y 250000000.0 472000000.0 250000000.0 750000000.0 350000000.0 250000000.0 0.50 2100000 750000000.0 20000000.0 0 0 0.00785 0.01625 0.0050 0.010 0.0000 0.00625 0.0009 0.00225 0.0598 0.0125 0.0328 0.0095 3.75 4.25 100000000.0 3.00 67500000 517500000 502600000 0.02375 21.01 75000000 76500000 1500000 -77800000 21400000 -18600000 1.000 1.30 1.30 21.01 21.01 20 20 30 30 1.300 20 30 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth total interest expense recognized related to the Notes ($ in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.733%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.334%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contractual interest expense</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortization of debt issuance costs</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortization of debt discount</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total interest expense</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">33.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 12300000 12300000 2900000 1900000 0 19000000.0 15200000 33200000 0.030 0.073 311700000 592100000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December 31, 2022 and 2021, remaining unamortized debt discount and debt issuance costs for the Term Loan, Euro Term Loan and Convertible Senior Notes are as follows ($ in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.304%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.757%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.611%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Issuance Costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Discount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Issuance Costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Discount</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Senior Notes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 7500000 0 8900000 76500000 1700000 0 2700000 0 300000 0 500000 0 9500000 0 12100000 76500000 21.01 23.79 2900000 20700000 STOCK TRANSACTIONS AND STOCK-BASED COMPENSATION <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital Stock</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Company’s amended and restated certificate of incorporation, the Company’s authorized capital stock consists of 500.0 million shares of common stock with a par value of $0.01 per share and 15.0 million shares of preferred stock with a par value of $0.01 per share. No preferred shares were issued or outstanding as of December 31, 2022 and 2021.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of the Company’s common stock entitles the holder to one vote on all matters to be voted upon by common stockholders. The Company’s Board of Directors (the “Board”) is authorized to issue shares of preferred stock in one or more series and has discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series of preferred stock. The Board’s authority to issue preferred stock with voting rights or conversion rights that, if exercised, could adversely affect the voting power of the holders of common stock, could potentially discourage attempts by third parties to obtain control of the Company through certain types of takeover practices. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s stock activity (shares in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.548%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.548%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.551%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common stock - shares issued:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, end of period</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted the 2019 Omnibus Incentive Plan (the “Stock Plan”) that provides for the grant of stock appreciation rights, restricted stock units (“RSUs”), and performance stock units (‘PSUs”) (collectively, “Stock Awards”), as well as stock options (“Options”). A total of 21.0 million shares of the Company’s common stock have been authorized for issuance under the Stock Plan. Under the Stock Plan, stock-based grants are awarded at a price equal to the fair market value at the date of grant based upon the closing price on that date. Options and Stock Awards generally vest over a period of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjMxNmE1ZmMxNWNiYTQ0NDZiNmQ1MGJlZTU3YTk5YWZjL3NlYzozMTZhNWZjMTVjYmE0NDQ2YjZkNTBiZWU1N2E5OWFmY18zNjc0L2ZyYWc6N2YxZDllNzg5OTMxNDBmM2JiMmFjYWExODRmZTAzMzcvdGV4dHJlZ2lvbjo3ZjFkOWU3ODk5MzE0MGYzYmIyYWNhYTE4NGZlMDMzN18xMDg3NQ_ed775962-d178-454c-9c39-af6415d8c134">three</span> to five years. Options expire ten years after the date of grant. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs issued under the Stock Plan provide for the issuance of a share of the Company’s common stock at no cost to the holder. The RSUs granted to employees provide for time-based vesting, generally over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjMxNmE1ZmMxNWNiYTQ0NDZiNmQ1MGJlZTU3YTk5YWZjL3NlYzozMTZhNWZjMTVjYmE0NDQ2YjZkNTBiZWU1N2E5OWFmY18zNjc0L2ZyYWc6N2YxZDllNzg5OTMxNDBmM2JiMmFjYWExODRmZTAzMzcvdGV4dHJlZ2lvbjo3ZjFkOWU3ODk5MzE0MGYzYmIyYWNhYTE4NGZlMDMzN18xMDg5MQ_943f625f-f5f7-41b1-8512-aeaef3711022">three</span> to five-year period. Prior to vesting, RSUs granted under the Stock Plan do not have dividend equivalent rights, do not have voting rights and the shares underlying the RSUs are not considered issued and outstanding. PSUs issued under the Stock Plan provide for the issuance of a share of the Company’s common stock based on the achievement of various financial performance metric targets and market conditions, which are </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">set at the time of grant. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for stock-based compensation by measuring all RSUs, PSUs and Options at fair value as of the grant date. The Company recognizes the compensation expense over the requisite service period (which is generally the vesting period but may be shorter than the vesting period if the employee becomes retirement eligible before the end of the vesting period). The fair value for RSU awards is calculated using the closing price of the Company’s common stock on the date of grant. The fair value of the Options granted is calculated using a Black-Scholes option pricing model (“Black-Scholes”).</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 23, 2021 and January 21, 2022, the Company entered into and finalized, respectively, an RSU agreement with Pacific Dental Services (“PDS”) which awarded PDS RSUs with a fair value of $12.5 million, or 273,522 RSUs, based on the Company’s stock price on December 23, 2021. The RSUs vest over approximately three years and contain performance milestones. All of the 273,522 RSUs remained unvested as of December 31, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the assumptions used in the Black-Scholes model to value Options granted during the years ended December 31:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 – 3.1%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 – 1.3%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 – 1.2%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected years until exercise</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></div></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk-free rate of interest for periods within the contractual life of the awards is based on a zero-coupon U.S. government instrument with a maturity period that approximates the award’s expected term. The weighted average volatility used in the Black-Scholes model to value Options was estimated based on an average historical stock price volatility of a peer group of companies. The dividend yield was 0.0% as the Company does not offer a dividend. To estimate the option exercise timing used in the valuation model, in addition to considering the vesting period and contractual term of the Option, the Company analyzes and considers actual historical exercise experience for previously granted awards. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of stock-based compensation expense recognized during a period is also based on the portion of the awards that are ultimately expected to vest. The Company estimates pre-vesting forfeitures at the time of grant by analyzing historical data and revises those estimates in subsequent periods if actual forfeitures differ from those estimates. The Company has estimated an annual forfeiture rate of 6.0% for the years ended December 31, 2022, 2021 and 2020.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the components of the Company’s stock-based compensation expense for the years ended December 31 ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs / PSUs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s stock-based compensation is primarily recognized as a component of selling, general and administrative expenses in the accompanying Consolidated Statements of Operations. As of December 31, 2022, $43.6 million of total unrecognized compensation cost related to Options and RSUs/PSUs is expected to be recognized over a weighted average period of approximately two years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the Company’s Option activity (in millions; except price per share and numbers of years):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.548%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Stock Options</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contractual Term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.81 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.01 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.08 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.74 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.61 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding as of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest as of December 31, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.09 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested as of December 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.01 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options outstanding as of December 31, 2022 are summarized below (in millions; except price per share and numbers of years):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.642%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>Remaining<br/>Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9.74 to 12.65</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.00 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.00 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12.66 to 19.22</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.66 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.23 to 26.50</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$26.51 to $41.95</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$41.96 to 48.52</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.01 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intrinsic value of Options is calculated as the amount by which the market price of the Company’s stock exceeds the exercise price of the Option. The aggregate intrinsic value of Options exercised during the years ended December 31, 2022, 2021 and 2020 was $31 million, $33 million and $12 million, respectively. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes information on unvested RSU and PSU activity related to the Company’s employees and non-employee directors (in millions; except weighted average grant-date fair value):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.548%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>RSUs/PSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.60 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.76 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.98 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.01 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.76 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.62 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes tax benefits for stock compensation in certain jurisdictions, primarily the United States, where tax deductions are based on market value at exercise or release and may exceed the grant-date value. The Company realized such tax benefits of $4 million, $4 million and $1 million in 2022, 2021 and 2020, respectively, related to the exercise of Options and $1 million in each of the years ended December 31, 2022, 2021 and 2020, related to the vesting and release of RSUs and PSUs. For all periods presented, the tax benefits were included as a component of income tax expense and as an operating cash inflow in the accompanying Consolidated Financial Statements. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the exercise of certain Options and the vesting of RSUs and PSUs, a number of shares sufficient to fund statutory minimum tax withholding requirements has been withheld from the total shares issued or released to the award holders (though under the terms of the applicable plan, the shares are considered to have been issued and are not added back to the pool of shares available for grant). During the year ended December 31, 2022, 192.4 thousand shares with an aggregate value of $9 million were withheld to satisfy the requirement. During the year ended December 31, 2021, 181.7 thousand shares with an aggregate value of $7 million were withheld to satisfy the requirement.</span></div> 500000000.0 0.01 15000000.0 0.01 0 0 0 0 1 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s stock activity (shares in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.548%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.548%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.551%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common stock - shares issued:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, end of period</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 162000000.0 160200000 158700000 1700000 1800000 1500000 163700000 162000000.0 160200000 21000000 P5Y P10Y P5Y 12500000 273522 P3Y 273522 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the assumptions used in the Black-Scholes model to value Options granted during the years ended December 31:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 – 3.1%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 – 1.3%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 – 1.2%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected years until exercise</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></div></td></tr></table></div> 0.019 0.031 0.010 0.013 0.004 0.012 0.336 0.253 0.253 0 0 0 P6Y P6Y P6Y 0.060 0.060 0.060 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the components of the Company’s stock-based compensation expense for the years ended December 31 ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs / PSUs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 19300000 15500000 13300000 11200000 12200000 8900000 30500000 27700000 22200000 43600000 P2Y <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the Company’s Option activity (in millions; except price per share and numbers of years):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.548%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Stock Options</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contractual Term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.81 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.01 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.08 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.74 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.61 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding as of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest as of December 31, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.09 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested as of December 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.01 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 8000000.0 17.81 2200000 26.14 1000000.0 14.01 1100000 21.17 8100000 20.08 1700000 38.15 1300000 15.74 600000 26.74 7900000 24.16 500000 48.23 1200000 18.61 700000 30.29 6500000 26.24 P6Y3M18D 59700000 6300000 26.09 P6Y3M18D 58800000 3200000 22.01 P5Y4M24D 39300000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options outstanding as of December 31, 2022 are summarized below (in millions; except price per share and numbers of years):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.642%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>Remaining<br/>Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9.74 to 12.65</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.00 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.00 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12.66 to 19.22</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.66 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.23 to 26.50</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$26.51 to $41.95</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$41.96 to 48.52</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.01 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 9.74 12.65 400000 12.00 P2Y4M24D 400000 12.00 12.66 19.22 1600000 17.95 P4Y9M18D 1300000 17.66 19.23 26.50 2700000 24.15 P6Y6M 1000000.0 24.10 26.51 41.95 1400000 36.74 P7Y10M24D 500000 35.85 41.96 48.52 400000 48.01 P8Y10M24D 0 43.30 31000000 33000000 12000000 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes information on unvested RSU and PSU activity related to the Company’s employees and non-employee directors (in millions; except weighted average grant-date fair value):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.548%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>RSUs/PSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.60 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.76 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.98 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.01 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.76 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.62 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.85 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2100000 19.60 700000 25.76 500000 17.87 400000 20.98 1900000 22.01 500000 38.76 500000 20.34 200000 26.54 1700000 26.82 600000 47.80 500000 24.85 300000 33.62 1500000 34.85 4000000 4000000 1000000 1000000 1000000 1000000 192400 9000000 181700 7000000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCUMULATED OTHER COMPREHENSIVE LOSS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in accumulated other comprehensive loss by component are summarized below ($ in millions):</span></div><div style="padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Pension Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) income, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss), net of income taxes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income, net of income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in accumulated other comprehensive loss by component are summarized below ($ in millions):</span></div><div style="padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.019%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.468%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Pension Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive (loss) income, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income (loss), net of income taxes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before reclassifications, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss, net of income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income, net of income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> -116400000 100000 -27900000 -144200000 26000000.0 -8400000 3900000 21500000 -27900000 -2000000.0 1100000 -28800000 53900000 -6400000 2800000 50300000 0 0 -2900000 -2900000 0 0 -800000 -800000 0 0 -2100000 -2100000 53900000 -6400000 4900000 52400000 -62500000 -6300000 -23000000.0 -91800000 -72700000 6100000 21900000 -44700000 17000000.0 1500000 4700000 23200000 -89700000 4600000 17200000 -67900000 -15900000 0 -5000000.0 -20900000 -3300000 0 -1400000 -4700000 -12600000 0 -3600000 -16200000 -77100000 4600000 20800000 -51700000 -139600000 -1700000 -2200000 -143500000 -80500000 2200000 24600000 -53700000 20400000 500000 5200000 26100000 -100900000 1700000 19400000 -79800000 0 0 2300000 2300000 0 0 500000 500000 0 0 1800000 1800000 -100900000 1700000 17600000 -81600000 -240500000 0 15400000 -225100000 REVENUE <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company’s revenues disaggregated by geographical region for the years ended December 31, 2022 and 2021 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenues. The Company has historically defined emerging markets as developing markets of the world, which prior to the COVID-19 pandemic, experienced extended periods of accelerated growth in gross domestic product and infrastructure, including Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets of the world that are not emerging markets.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.483%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographical region:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,366.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Western Europe</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other developed markets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging markets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.483%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographical region:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Western Europe</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other developed markets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging markets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,507.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,001.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales by Major Product Group:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,147.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,590.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,929.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Consumable products include implants, regenerative products, prosthetics, orthodontic brackets, aligners and lab products from our Specialty Products &amp; Technologies business segment and traditional consumables such as bonding agents and cements, impression materials, infection prevention products and restorative products from the Company’s Equipment &amp; Consumables business segment. The Company’s equipment products include digital imaging systems, software and other visualization and magnification systems.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 606 requires disclosure of remaining performance obligations that represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. Remaining performance obligations include noncancelable purchase orders, extended warranty and service agreements and do not include revenue from contracts with customers with an original term of one year or less.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was $52.7 million and the Company expects to recognize revenue on the majority of this amount over the next 12 months.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Liabilities</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company often receives cash payments from customers in advance of the Company’s performance resulting in contract liabilities. These contract liabilities are classified as either current or long-term in the Consolidated Balance Sheets based on the timing of when the Company expects to recognize revenue. As of December 31, 2022 and 2021, the contract liabilities were $87.5 million and $65.2 million, respectively, and are included within accrued expenses and other liabilities and other long-term liabilities in the accompanying Consolidated Balance Sheets. The increase in the contract liability balance during the years ended December 31, 2022 and 2021, is primarily due to cash payments received in advance of satisfying performance obligations, partially offset by revenue recognized during the period that was included in the contract liability balance at December 31, 2021 and 2020, respectively.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized during the years ended December 31, 2022 and 2021 that was included in the contract liability balance at December 31, 2021 and December 31, 2020 was $52.8 million and $38.4 million, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Customers</span></div>Sales to the Company’s largest customer were 11%, 12%, and 11% of sales for the years ended December 31, 2022, 2021 and 2020, respectively. <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company’s revenues disaggregated by geographical region for the years ended December 31, 2022 and 2021 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenues. The Company has historically defined emerging markets as developing markets of the world, which prior to the COVID-19 pandemic, experienced extended periods of accelerated growth in gross domestic product and infrastructure, including Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia). The Company defines developed markets as all markets of the world that are not emerging markets.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.483%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographical region:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,366.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Western Europe</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other developed markets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging markets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.483%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographical region:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Western Europe</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other developed markets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging markets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,507.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,001.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales by Major Product Group:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,147.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,590.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,929.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 711100000 655300000 1366400000 388900000 121100000 510000000.0 91000000.0 38600000 129600000 407600000 155500000 563100000 1598600000 970500000 2569100000 668900000 659300000 1328200000 366600000 125900000 492500000 98200000 41200000 139400000 374100000 174700000 548800000 1507800000 1001100000 2508900000 2147500000 2067900000 1590700000 421600000 441000000.0 338400000 2569100000 2508900000 1929100000 52700000 P12M 87500000 65200000 52800000 38400000 0.11 0.12 0.11 RESTRUCTURING ACTIVITIES AND RELATED IMPAIRMENTS <div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring Activities</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s restructuring activities are undertaken as necessary to implement management’s strategy, streamline operations, take advantage of available capacity and resources, and ultimately achieve net cost reductions. These activities generally relate to the realignment of existing manufacturing capacity and closure of facilities and other exit or disposal activities, as it relates to executing the Company’s strategy, pursuant to significant restructuring programs.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related liability which is included in accrued liabilities in the Consolidated Balance Sheets is summarized below ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Severance<br/>and Related</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Facility Exit<br/>and Related</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid/settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring related charges recorded for the years ended December 31 by segment were as follows ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The restructuring related charges incurred during the years ended December 31, are reflected in the following captions in the accompanying Consolidated Statements of Operations ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022 and 2021, the Company made the decision to consolidate certain facilities in an effort to improve its cost structure. For the year ended December 31, 2022, the Company recognized a non-cash loss of $11.1 million with the majority of this loss consisting of $4.8 million related to the impairment of certain fixed assets and leases, which are included in selling, general and administrative expense and cost of sales and $4.7 million of inventory write-offs, which is included in cost of sales. For the year ended December 31, 2021, the Company recognized a non-cash loss of $29.8 million with the majority of this loss consisting of $19.0 million related to the impairment of certain fixed assets and leases, which are included in selling, general and administrative expense and cost of sales and $10.8 million of inventory write-offs, which is included in cost of sales.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related liability which is included in accrued liabilities in the Consolidated Balance Sheets is summarized below ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Severance<br/>and Related</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Facility Exit<br/>and Related</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid/settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 21400000 500000 21900000 20800000 5700000 26500000 24000000.0 5500000 29500000 18200000 700000 18900000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring related charges recorded for the years ended December 31 by segment were as follows ($ in millions): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The restructuring related charges incurred during the years ended December 31, are reflected in the following captions in the accompanying Consolidated Statements of Operations ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 14700000 25200000 43800000 19700000 32100000 34600000 3200000 6300000 6000000.0 37600000 63600000 84400000 13600000 35900000 18300000 24000000.0 27700000 66100000 37600000 63600000 84400000 11100000 4800000 4700000 29800000 19000000 10800000 INCOME TAXES <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before income taxes for the years ended December 31 were as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision (benefit) for income taxes for the years ended December 31 were as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal U.S.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and deferred tax liabilities are classified as long-term and are included in other long-term assets and other long-term liabilities, respectively, in the accompanying Consolidated Balance Sheets. Significant components of deferred tax assets and liabilities as of December 31 were as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals and prepayments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized research expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit and loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax asset</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains and losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(238.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset (liability)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred taxes associated with U.S. entities consist of net deferred tax liabilities of $15.1 million and $133.0 million as of December 31, 2022 and 2021, respectively. Deferred taxes associated with non-U.S. entities consist of net deferred tax assets of $40.0 million and $58.5 million as of December 31, 2022 and 2021, respectively. During 2022, the Company’s valuation allowance decreased by $51.3 million primarily due to a corresponding expiration of certain foreign net operating losses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s intent is to permanently reinvest substantially all funds outside of the United States and current plans do not demonstrate a need to repatriate the cash to fund U.S. operations. However, if these funds were repatriated, they would likely not be subject to United States federal income tax under the previously taxed income or the dividend exemption rules. The Company would likely be required to accrue and pay United States state and local taxes and withholding taxes payable to various countries. It is not practicable to estimate the tax impact of the reversal of the outside basis difference, or the repatriation of cash due to the complexity of its hypothetical calculation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2022 decrease in the deferred tax liability for goodwill and other intangible assets included an income tax benefit of approximately $100.2 million related primarily to the acquisition of amortizable deferred tax assets associated with the Intraoral Scanner Business acquisition partially offset with deferred tax liabilities established in connection with the Osteogenics acquisition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current tax law in the United States imposes tax on U.S. stockholders for global intangible low-taxed income (“GILTI”) earned by certain foreign subsidiaries. The Company is required to make an accounting policy election of either: (1) treating taxes due on future amounts included in the U.S. taxable income related to GILTI as a current period tax expense when incurred (“the period cost method”); or (2) factoring such amounts into the Company’s measurement of its deferred tax its deferred tax expense (the “deferred method”). In 2018, the Company elected the period cost method for its accounting for GILTI.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate for the years ended December 31 varies from the U.S. statutory federal income tax rate as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Pretax Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in tax rate resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes (net of federal income tax benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-Derived Intangible Income (“FDII”)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subpart F and GILTI, net of foreign tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and experimentation credits and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess tax benefit from stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance release on certain Swiss NOLs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of step-up of Swiss assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company realized tax benefits of $7.2 million, $6.7 million, and $4.2 million in 2022, 2021 and 2020 respectively, for tax deductions attributable to stock-based compensation, of which, the excess tax benefit over the amount recorded for financial reporting purposes was $4.6 million, $4.8 million and $2.3 million in 2022, 2021 and 2020, respectively. As required by ASU 2016-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation—Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2016-09”), the excess tax benefits for the years ended December 31, 2022, 2021 and 2020 have been included in the provision for income taxes. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the future realizability of tax credits and loss carryforwards considering the anticipated future earnings of the Company’s subsidiaries as well as tax planning strategies in the associated jurisdictions. Included in deferred income taxes as of December 31, 2022 are tax benefits for U.S. and non-U.S. net operating loss carryforwards totaling $35.5 million ($29.1 million of which the Company does not expect to realize and has corresponding valuation allowances). Certain of the losses can be carried forward indefinitely and others can be carried forward to various dates from 2023 through 2042.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, gross unrecognized tax benefits totaled $6.6 million ($9.2 million, including $2.6 million associated with potential interest and penalties). As of December 31, 2021, gross unrecognized tax benefits totaled $5.7 million ($7.6 million, including $1.9 million associated with potential interest and penalties). The Company recognized $0.6 million, $(0.1) million and $0.0 million in potential interest and penalties associated with uncertain tax positions during 2022, 2021 and 2020, respectively. To the extent unrecognized tax benefits (including interest and penalties) are recognized with respect to uncertain tax positions, the tax expense in future periods would be reduced by $9.2 million based upon the tax positions as of December 31, 2022. The Company recognized interest and penalties related to unrecognized tax benefits within income taxes in the accompanying Consolidated Statements of Operations. Unrecognized tax benefits and associated accrued interest and penalties are included in taxes, income and other accrued expenses as detailed in Note 10.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits, excluding amounts accrued for potential interest and penalties, is as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits, beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is routinely examined by various domestic and international taxing authorities and operations in certain U.S. states and foreign jurisdictions remain subject to routine examination for tax years beginning with 2009.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates that it is reasonably possible that the amount of unrecognized tax benefits may be reduced by approximately $2.7 million within twelve months through resolution of worldwide tax matters, payments of tax audit settlements and/or statute of limitations expirations. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in various non-U.S. tax jurisdictions where “tax holiday” income tax incentives have been granted for a specific period. These tax benefits are not material to the Company’s financial statements.</span></div> <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before income taxes for the years ended December 31 were as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 21900000 35000000.0 -64300000 262000000.0 219500000 44300000 283900000 254500000 -20000000.0 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision (benefit) for income taxes for the years ended December 31 were as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal U.S.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 42500000 17700000 13100000 22400000 26900000 13500000 8600000 4400000 900000 -31300000 -2200000 -13100000 11300000 -57500000 -72700000 -7600000 1700000 -4200000 45900000 -9000000.0 -62500000 Significant components of deferred tax assets and liabilities as of December 31 were as follows ($ in millions):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals and prepayments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized research expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit and loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax asset</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains and losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(238.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset (liability)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 15400000 17400000 6200000 11500000 45300000 54300000 35500000 34200000 7500000 6800000 36000000.0 8700000 15100000 3800000 38200000 117300000 38700000 90000000.0 160500000 164000000.0 5700000 9600000 6200000 6500000 31500000 30300000 92200000 192300000 135600000 238700000 24900000 74700000 15100000 133000000 40000000 58500000 -51300000 -100200000 <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate for the years ended December 31 varies from the U.S. statutory federal income tax rate as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Pretax Income</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory federal income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in tax rate resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes (net of federal income tax benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign-Derived Intangible Income (“FDII”)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subpart F and GILTI, net of foreign tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and experimentation credits and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess tax benefit from stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance release on certain Swiss NOLs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of step-up of Swiss assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 0.210 0.210 0.210 0.003 0.012 0.170 -0.050 -0.064 0.804 0.007 0 0 0.067 0.064 -0.724 -0.005 0 0.034 0.016 0.016 -0.132 -0.009 0.027 -0.203 -0.016 -0.019 0.116 0 -0.081 0 -0.015 -0.168 2.586 0.162 -0.035 3.125 7200000 6700000 4200000 4600000 4800000 2300000 35500000 29100000 6600000 9200000 2600000 5700000 7600000 1900000 600000 -100000 0 9200000 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits, excluding amounts accrued for potential interest and penalties, is as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits, beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits, end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/></tr></table></div> 5700000 7100000 9100000 300000 300000 300000 4200000 0 300000 0 300000 1700000 2300000 1000000.0 1000000.0 1100000 400000 0 -200000 0 100000 6600000 5700000 7100000 2700000 EARNINGS PER SHARE <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is calculated by dividing the applicable income by the weighted average number of shares of common stock outstanding for the applicable period. Diluted earnings per share is computed based on the weighted average number of common shares outstanding plus the effect of dilutive potential shares outstanding during the period using the treasury stock method. Dilutive potential common shares include employee equity options, non-vested shares and similar instruments granted by the Company and the assumed conversion impact of the Notes. The Company will settle any Notes conversions through a combination settlement by satisfying the principal amount outstanding with cash and any Notes conversion value in excess of the principal amount in cash or shares of the Company’s common stock or any combination thereof. As such, the Company uses the treasury stock method for the assumed conversion of the Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. As the Company will settle the principal amount of the Notes in cash upon conversion, the Notes do not have an impact on the Company's diluted earnings per share until the average share price of the Company’s common stock exceeds the conversion price of $21.01 per share in any applicable period. See the computation of earnings per share below for the dilutive impact of the Notes for the years ended December 31, 2022, 2021 and 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the Notes, the Company entered into Capped Calls (see further discussion in Note 16), which are intended to reduce or offset the potential dilution from shares of common stock issued upon conversion of the Notes. However, this impact is not included when calculating potentially dilutive shares since their effect is anti-dilutive. The Capped Calls will mitigate dilution from the conversion of the Notes up to the Company’s common stock price of $23.79. If the Notes are converted at a price higher than $23.79 per share, the Capped Calls will no longer mitigate dilution from the conversion of the Notes.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share ($ and shares in millions, except per share amounts):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.303%"><tr><td style="width:1.0%"/><td style="width:57.751%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.916%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations, net of tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding used in basic earnings (loss) per share</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental common shares from:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed exercise of dilutive options and vesting of dilutive restricted stock units</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed conversion of the Notes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding used in diluted earnings (loss) per share</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from continuing operations - basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from continuing operations - diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from discontinued operations - basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from discontinued operations - diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings - basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings - diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">* Earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. The sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding.</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the number of outstanding securities not included in the computation of diluted income per share, because their effect was anti-dilutive (in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.102%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.104%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 21.01 23.79 23.79 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted earnings per share ($ and shares in millions, except per share amounts):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.303%"><tr><td style="width:1.0%"/><td style="width:57.751%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.916%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations, net of tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from discontinued operations, net of tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.3 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding used in basic earnings (loss) per share</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental common shares from:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed exercise of dilutive options and vesting of dilutive restricted stock units</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed conversion of the Notes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding used in diluted earnings (loss) per share</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.6 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from continuing operations - basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from continuing operations - diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from discontinued operations - basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) from discontinued operations - diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.43 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.06)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings - basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings - diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">* Earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. The sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding.</span></td></tr></table></div> 238000000.0 263500000 42500000 5100000 77000000.0 -9200000 243100000 340500000 33300000 162900000 161200000 159600000 3200000 4400000 2200000 11500000 12000000.0 2300000 177600000 177600000 164100000 1.46 1.63 0.27 1.34 1.48 0.26 0.03 0.48 -0.06 0.03 0.43 -0.06 1.49 2.11 0.21 1.37 1.92 0.20 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the number of outstanding securities not included in the computation of diluted income per share, because their effect was anti-dilutive (in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.102%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.104%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 1500000 1200000 4100000 SEGMENT INFORMATION <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates and reports its results in two separate business segments, the Specialty Products &amp; Technologies and Equipment &amp; Consumables segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income (expense), interest expense and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. The identifiable assets by segment are those used in each segment’s operations. Inter-segment amounts are not significant and are eliminated to arrive at combined totals. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s Specialty Products &amp; Technologies products include implants, regenerative products, prosthetics, orthodontic brackets, aligners and lab products. The Company’s Equipment &amp; Consumables products include traditional consumables such as bonding agents and cements, impression materials, infection prevention products and restorative </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products, while the Company’s equipment products include digital imaging systems, software and other visualization and magnification systems. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2021, the Company completed the sale of its KaVo Treatment Unit and Instrument Business, which is part of the Company’s Equipment &amp; Consumables segment. The previously reported amounts for the KaVo Treatment Unit and Instrument Business have been reclassified to discontinued operations for all periods presented. All segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business. Refer to Note 4 for more information on the Company’s discontinued operations.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Detailed segment data as of and for the years ended December 31 is as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,507.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,001.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,929.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating profit and reconciliation to income (loss) before taxes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonoperating income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Other income (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capital expenditures, gross:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,475.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,498.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,946.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,587.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,574.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operations in Geographical Areas:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (each country individually less than 5% of total sales)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,048.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,929.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sweden</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (each country individually less than 5% of total long-lived assets)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div> 2 2 <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Detailed segment data as of and for the years ended December 31 is as follows ($ in millions):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,507.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,001.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,929.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating profit and reconciliation to income (loss) before taxes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonoperating income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Other income (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before taxes</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.7 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capital expenditures, gross:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty Products &amp; Technologies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,475.7 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,498.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment &amp; Consumables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,455.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,946.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,587.0 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,574.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operations in Geographical Areas:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($ in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (each country individually less than 5% of total sales)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,048.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508.9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,929.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.4 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sweden</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other (each country individually less than 5% of total long-lived assets)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.1 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div> 1598600000 1507800000 1117300000 970500000 1001100000 811800000 2569100000 2508900000 1929100000 268600000 272300000 65800000 172400000 153800000 53600000 -121800000 -119900000 -75900000 319200000 306200000 43500000 3100000 2400000 -1000000.0 38400000 54100000 62500000 283900000 254500000 -20000000.0 80700000 84000000.0 80600000 54600000 31400000 38700000 2500000 2400000 2400000 137800000 117800000 121700000 48800000 37200000 36400000 20600000 10600000 5800000 2700000 1300000 1700000 72100000 49100000 43900000 3475700000 3498200000 2455300000 1946100000 0 12200000 656000000.0 1117700000 6587000000 6574200000 1261900000 1223400000 960100000 222200000 236700000 198200000 1085000000 1048800000 770800000 2569100000 2508900000 1929100000 183400000 157100000 41400000 49000000.0 15200000 8800000 53600000 49200000 293600000 264100000 <div style="padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.809%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beginning of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged to<br/>Costs &amp;<br/>Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact of<br/>Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write Offs,<br/>Write Downs  &amp;<br/>Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Recoveries</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at End of Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31, 2022:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances deducted from asset account</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31, 2021:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances deducted from asset account</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowances deducted from asset account</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12.24pt">Amounts include allowance for credit losses classified as current.</span></div> 20700000 4800000 -800000 4100000 4400000 16200000 30500000 4700000 -1500000 7300000 5700000 20700000 18700000 19200000 300000 7700000 0 30500000 * Earnings per share is computed independently for earnings per share from continuing operations and earnings per share from discontinued operations. The sum of earnings per share from continuing operations and earnings per share from discontinued operations does not equal earnings per share due to rounding. EXCEL 145 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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g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�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end XML 146 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 147 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 148 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 374 590 1 true 103 0 false 8 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.envistaco.com/role/CoverPage Cover Page Cover 1 false false R2.htm 0000002 - Document - Audit Information Sheet http://www.envistaco.com/role/AuditInformation Audit Information Cover 2 false false R3.htm 0000003 - Statement - Consolidated Balance Sheets Sheet http://www.envistaco.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 3 false false R4.htm 0000004 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.envistaco.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 4 false false R5.htm 0000005 - Statement - Consolidated Statements of Operations Sheet http://www.envistaco.com/role/ConsolidatedStatementsofOperations Consolidated Statements of Operations Statements 5 false false R6.htm 0000006 - Statement - Consolidated Statements of Comprehensive Income Sheet http://www.envistaco.com/role/ConsolidatedStatementsofComprehensiveIncome Consolidated Statements of Comprehensive Income Statements 6 false false R7.htm 0000007 - Statement - Consolidated Statements of Changes in Stockholders' Equity Sheet http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity Consolidated Statements of Changes in Stockholders' Equity Statements 7 false false R8.htm 0000008 - Statement - Consolidated Statements of Cash Flows Sheet http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 8 false false R9.htm 0000009 - Disclosure - Business And Basis Of Presentation Sheet http://www.envistaco.com/role/BusinessAndBasisOfPresentation Business And Basis Of Presentation Notes 9 false false R10.htm 0000010 - Disclosure - Summary Of Significant Accounting Policies Sheet http://www.envistaco.com/role/SummaryOfSignificantAccountingPolicies Summary Of Significant Accounting Policies Notes 10 false false R11.htm 0000011 - Disclosure - Acquisitions Sheet http://www.envistaco.com/role/Acquisitions Acquisitions Notes 11 false false R12.htm 0000012 - Disclosure - Discontinued Operations Sheet http://www.envistaco.com/role/DiscontinuedOperations Discontinued Operations Notes 12 false false R13.htm 0000013 - Disclosure - Credit Losses Sheet http://www.envistaco.com/role/CreditLosses Credit Losses Notes 13 false false R14.htm 0000014 - Disclosure - Inventories Sheet http://www.envistaco.com/role/Inventories Inventories Notes 14 false false R15.htm 0000015 - Disclosure - Property, Plant And Equipment Sheet http://www.envistaco.com/role/PropertyPlantAndEquipment Property, Plant And Equipment Notes 15 false false R16.htm 0000016 - Disclosure - Leases Sheet http://www.envistaco.com/role/Leases Leases Notes 16 false false R17.htm 0000017 - Disclosure - Goodwill And Other Intangible Assets Sheet http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssets Goodwill And Other Intangible Assets Notes 17 false false R18.htm 0000018 - Disclosure - Accrued Expenses And Other Liabilities Sheet http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilities Accrued Expenses And Other Liabilities Notes 18 false false R19.htm 0000019 - Disclosure - Hedging Transactions And Derivative Financial Instruments Sheet http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstruments Hedging Transactions And Derivative Financial Instruments Notes 19 false false R20.htm 0000020 - Disclosure - Fair Value Measurements Sheet http://www.envistaco.com/role/FairValueMeasurements Fair Value Measurements Notes 20 false false R21.htm 0000021 - Disclosure - Pension And Other Benefit Plans Sheet http://www.envistaco.com/role/PensionAndOtherBenefitPlans Pension And Other Benefit Plans Notes 21 false false R22.htm 0000022 - Disclosure - Warranty Sheet http://www.envistaco.com/role/Warranty Warranty Notes 22 false false R23.htm 0000023 - Disclosure - Litigation And Contingencies Sheet http://www.envistaco.com/role/LitigationAndContingencies Litigation And Contingencies Notes 23 false false R24.htm 0000024 - Disclosure - Debt And Credit Facilities Sheet http://www.envistaco.com/role/DebtAndCreditFacilities Debt And Credit Facilities Notes 24 false false R25.htm 0000025 - Disclosure - Stock Transactions And Stock-Based Compensation Sheet http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensation Stock Transactions And Stock-Based Compensation Notes 25 false false R26.htm 0000026 - Disclosure - Accumulated Other Comprehensive Loss Sheet http://www.envistaco.com/role/AccumulatedOtherComprehensiveLoss Accumulated Other Comprehensive Loss Notes 26 false false R27.htm 0000027 - Disclosure - Revenue Sheet http://www.envistaco.com/role/Revenue Revenue Notes 27 false false R28.htm 0000028 - Disclosure - Restructuring Activities And Related Impairments Sheet http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairments Restructuring Activities And Related Impairments Notes 28 false false R29.htm 0000029 - Disclosure - Income Taxes Sheet http://www.envistaco.com/role/IncomeTaxes Income Taxes Notes 29 false false R30.htm 0000030 - Disclosure - Earnings Per Share Sheet http://www.envistaco.com/role/EarningsPerShare Earnings Per Share Notes 30 false false R31.htm 0000031 - Disclosure - Segment Information Sheet http://www.envistaco.com/role/SegmentInformation Segment Information Notes 31 false false R32.htm 0000032 - Disclosure - Schedule II - Valuation and Qualifying Accounts Sheet http://www.envistaco.com/role/ScheduleIIValuationandQualifyingAccounts Schedule II - Valuation and Qualifying Accounts Notes 32 false false R33.htm 0000033 - Disclosure - Summary Of Significant Accounting Policies (Policies) Sheet http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary Of Significant Accounting Policies (Policies) Policies http://www.envistaco.com/role/SummaryOfSignificantAccountingPolicies 33 false false R34.htm 0000034 - Disclosure - Summary Of Significant Accounting Policies (Tables) Sheet http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesTables Summary Of Significant Accounting Policies (Tables) Tables http://www.envistaco.com/role/SummaryOfSignificantAccountingPolicies 34 false false R35.htm 0000035 - Disclosure - Acquisitions (Tables) Sheet http://www.envistaco.com/role/AcquisitionsTables Acquisitions (Tables) Tables http://www.envistaco.com/role/Acquisitions 35 false false R36.htm 0000036 - Disclosure - Discontinued Operations (Tables) Sheet http://www.envistaco.com/role/DiscontinuedOperationsTables Discontinued Operations (Tables) Tables http://www.envistaco.com/role/DiscontinuedOperations 36 false false R37.htm 0000037 - Disclosure - Credit Losses (Tables) Sheet http://www.envistaco.com/role/CreditLossesTables Credit Losses (Tables) Tables http://www.envistaco.com/role/CreditLosses 37 false false R38.htm 0000038 - Disclosure - Inventories (Tables) Sheet http://www.envistaco.com/role/InventoriesTables Inventories (Tables) Tables http://www.envistaco.com/role/Inventories 38 false false R39.htm 0000039 - Disclosure - Property, Plant And Equipment (Tables) Sheet http://www.envistaco.com/role/PropertyPlantAndEquipmentTables Property, Plant And Equipment (Tables) Tables http://www.envistaco.com/role/PropertyPlantAndEquipment 39 false false R40.htm 0000040 - Disclosure - Leases (Tables) Sheet http://www.envistaco.com/role/LeasesTables Leases (Tables) Tables http://www.envistaco.com/role/Leases 40 false false R41.htm 0000041 - Disclosure - Goodwill And Other Intangible Assets (Tables) Sheet http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsTables Goodwill And Other Intangible Assets (Tables) Tables http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssets 41 false false R42.htm 0000042 - Disclosure - Accrued Expenses And Other Liabilities (Tables) Sheet http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesTables Accrued Expenses And Other Liabilities (Tables) Tables http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilities 42 false false R43.htm 0000043 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Tables) Sheet http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables Hedging Transactions And Derivative Financial Instruments (Tables) Tables http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstruments 43 false false R44.htm 0000044 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.envistaco.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.envistaco.com/role/FairValueMeasurements 44 false false R45.htm 0000045 - Disclosure - Pension And Other Benefit Plans (Tables) Sheet http://www.envistaco.com/role/PensionAndOtherBenefitPlansTables Pension And Other Benefit Plans (Tables) Tables http://www.envistaco.com/role/PensionAndOtherBenefitPlans 45 false false R46.htm 0000046 - Disclosure - Warranty (Tables) Sheet http://www.envistaco.com/role/WarrantyTables Warranty (Tables) Tables http://www.envistaco.com/role/Warranty 46 false false R47.htm 0000047 - Disclosure - Debt And Credit Facilities (Tables) Sheet http://www.envistaco.com/role/DebtAndCreditFacilitiesTables Debt And Credit Facilities (Tables) Tables http://www.envistaco.com/role/DebtAndCreditFacilities 47 false false R48.htm 0000048 - Disclosure - Stock Transactions And Stock-Based Compensation (Tables) Sheet http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationTables Stock Transactions And Stock-Based Compensation (Tables) Tables http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensation 48 false false R49.htm 0000049 - Disclosure - Accumulated Other Comprehensive Loss (Tables) Sheet http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossTables Accumulated Other Comprehensive Loss (Tables) Tables http://www.envistaco.com/role/AccumulatedOtherComprehensiveLoss 49 false false R50.htm 0000050 - Disclosure - Revenue (Tables) Sheet http://www.envistaco.com/role/RevenueTables Revenue (Tables) Tables http://www.envistaco.com/role/Revenue 50 false false R51.htm 0000051 - Disclosure - Restructuring Activities And Related Impairments (Tables) Sheet http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsTables Restructuring Activities And Related Impairments (Tables) Tables http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairments 51 false false R52.htm 0000052 - Disclosure - Income Taxes (Tables) Sheet http://www.envistaco.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.envistaco.com/role/IncomeTaxes 52 false false R53.htm 0000053 - Disclosure - Earnings Per Share (Tables) Sheet http://www.envistaco.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.envistaco.com/role/EarningsPerShare 53 false false R54.htm 0000054 - Disclosure - Segment Information (Tables) Sheet http://www.envistaco.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.envistaco.com/role/SegmentInformation 54 false false R55.htm 0000055 - Disclosure - Business And Basis Of Presentation - Narrative (Details) Sheet http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails Business And Basis Of Presentation - Narrative (Details) Details 55 false false R56.htm 0000056 - Disclosure - Summary Of Significant Accounting Policies - Estimated Useful Lives of Depreciable Assets (Details) Sheet http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesofDepreciableAssetsDetails Summary Of Significant Accounting Policies - Estimated Useful Lives of Depreciable Assets (Details) Details 56 false false R57.htm 0000057 - Disclosure - Summary Of Significant Accounting Policies - Narrative (Details) Sheet http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails Summary Of Significant Accounting Policies - Narrative (Details) Details 57 false false R58.htm 0000058 - Disclosure - Acquisitions - Narrative (Details) Sheet http://www.envistaco.com/role/AcquisitionsNarrativeDetails Acquisitions - Narrative (Details) Details 58 false false R59.htm 0000059 - Disclosure - Acquisitions - Fair Values of Assets Acquired and Liabilities Assumed (Details) Sheet http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails Acquisitions - Fair Values of Assets Acquired and Liabilities Assumed (Details) Details 59 false false R60.htm 0000060 - Disclosure - Discontinued Operations - Narrative (Details) Sheet http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails Discontinued Operations - Narrative (Details) Details 60 false false R61.htm 0000061 - Disclosure - Discontinued Operations - Carrying Amount of Assets and Liabilities (Details) Sheet http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails Discontinued Operations - Carrying Amount of Assets and Liabilities (Details) Details 61 false false R62.htm 0000062 - Disclosure - Discontinued Operations - Operating Results (Details) Sheet http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails Discontinued Operations - Operating Results (Details) Details 62 false false R63.htm 0000063 - Disclosure - Discontinued Operations - Significant Non-Cash Operating Items and Capital Expenditures (Details) Sheet http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails Discontinued Operations - Significant Non-Cash Operating Items and Capital Expenditures (Details) Details 63 false false R64.htm 0000064 - Disclosure - Credit Losses - Narrative (Details) Sheet http://www.envistaco.com/role/CreditLossesNarrativeDetails Credit Losses - Narrative (Details) Details 64 false false R65.htm 0000065 - Disclosure - Credit Losses - Allowance for Credit Losses (Details) Sheet http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails Credit Losses - Allowance for Credit Losses (Details) Details 65 false false R66.htm 0000066 - Disclosure - Inventories - Summary (Details) Sheet http://www.envistaco.com/role/InventoriesSummaryDetails Inventories - Summary (Details) Details 66 false false R67.htm 0000067 - Disclosure - Property, Plant And Equipment (Details) Sheet http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails Property, Plant And Equipment (Details) Details http://www.envistaco.com/role/PropertyPlantAndEquipmentTables 67 false false R68.htm 0000068 - Disclosure - Leases - Narrative (Details) Sheet http://www.envistaco.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 68 false false R69.htm 0000069 - Disclosure - Leases - Components of Lease Expense (Details) Sheet http://www.envistaco.com/role/LeasesComponentsofLeaseExpenseDetails Leases - Components of Lease Expense (Details) Details 69 false false R70.htm 0000070 - Disclosure - Leases - Weighted Average Remaining Lease Term and Discount Rate (Details) Sheet http://www.envistaco.com/role/LeasesWeightedAverageRemainingLeaseTermandDiscountRateDetails Leases - Weighted Average Remaining Lease Term and Discount Rate (Details) Details 70 false false R71.htm 0000071 - Disclosure - Leases - Maturities of Lease Liabilities (Details) Sheet http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails Leases - Maturities of Lease Liabilities (Details) Details 71 false false R72.htm 0000072 - Disclosure - Goodwill And Other Intangible Assets - Narrative (Details) Sheet http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails Goodwill And Other Intangible Assets - Narrative (Details) Details 72 false false R73.htm 0000073 - Disclosure - Goodwill And Other Intangible Assets - Rollforward (Details) Sheet http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsRollforwardDetails Goodwill And Other Intangible Assets - Rollforward (Details) Details 73 false false R74.htm 0000074 - Disclosure - Goodwill And Other Intangible Assets - Intangible Assets by Major Class (Details) Sheet http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails Goodwill And Other Intangible Assets - Intangible Assets by Major Class (Details) Details 74 false false R75.htm 0000075 - Disclosure - Intangible Assets, Goodwill and Other - Intangible Assets Future Amortization Expense (Details) Sheet http://www.envistaco.com/role/IntangibleAssetsGoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails Intangible Assets, Goodwill and Other - Intangible Assets Future Amortization Expense (Details) Details 75 false false R76.htm 0000076 - Disclosure - Accrued Expenses And Other Liabilities - Summary (Details) Sheet http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails Accrued Expenses And Other Liabilities - Summary (Details) Details 76 false false R77.htm 0000077 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Narrative (Details) Sheet http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails Hedging Transactions And Derivative Financial Instruments - Narrative (Details) Details http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables 77 false false R78.htm 0000078 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges (Details) Sheet http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails Hedging Transactions And Derivative Financial Instruments - Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges (Details) Details 78 false false R79.htm 0000079 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Derivative and Nonderivative Debt Instruments (Details) Sheet http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails Hedging Transactions And Derivative Financial Instruments - Derivative and Nonderivative Debt Instruments (Details) Details 79 false false R80.htm 0000080 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details) Sheet http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details) Details 80 false false R81.htm 0000081 - Disclosure - Fair Value Measurements - Fair Value of Financial Instruments (Details) Sheet http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails Fair Value Measurements - Fair Value of Financial Instruments (Details) Details 81 false false R82.htm 0000082 - Disclosure - Pension And Other Benefit Plans - Funded Status Of Pension Plans (Details) Sheet http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails Pension And Other Benefit Plans - Funded Status Of Pension Plans (Details) Details 82 false false R83.htm 0000083 - Disclosure - Pension And Other Benefit Plans - Weighted Average Assumptions Used To Determine Benefit Obligations (Details) Sheet http://www.envistaco.com/role/PensionAndOtherBenefitPlansWeightedAverageAssumptionsUsedToDetermineBenefitObligationsDetails Pension And Other Benefit Plans - Weighted Average Assumptions Used To Determine Benefit Obligations (Details) Details 83 false false R84.htm 0000084 - Disclosure - Pension And Other Benefit Plans - Components of Net Periodic Benefit Cost of Defined Benefit Pension Plans (Details) Sheet http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails Pension And Other Benefit Plans - Components of Net Periodic Benefit Cost of Defined Benefit Pension Plans (Details) Details 84 false false R85.htm 0000085 - Disclosure - Pension And Other Benefit Plans - Components of Net Periodic Benefit Cost Reflected in the Consolidated Condensed Statement of Earnings (Details) Sheet http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostReflectedintheConsolidatedCondensedStatementofEarningsDetails Pension And Other Benefit Plans - Components of Net Periodic Benefit Cost Reflected in the Consolidated Condensed Statement of Earnings (Details) Details 85 false false R86.htm 0000086 - Disclosure - Pension And Other Benefit Plans - Weighted Average Assumptions Used To Determine Net Periodic Pension Cost (Details) Sheet http://www.envistaco.com/role/PensionAndOtherBenefitPlansWeightedAverageAssumptionsUsedToDetermineNetPeriodicPensionCostDetails Pension And Other Benefit Plans - Weighted Average Assumptions Used To Determine Net Periodic Pension Cost (Details) Details 86 false false R87.htm 0000087 - Disclosure - Pension And Other Benefit Plans - Narrative (Details) Sheet http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails Pension And Other Benefit Plans - Narrative (Details) Details 87 false false R88.htm 0000088 - Disclosure - Pension And Other Benefit Plans - Fair Values Of Pension Plan Assets (Details) Sheet http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails Pension And Other Benefit Plans - Fair Values Of Pension Plan Assets (Details) Details 88 false false R89.htm 0000089 - Disclosure - Pension And Other Benefit Plans - Changes in Fair Value of Plan Assets (Details) Sheet http://www.envistaco.com/role/PensionAndOtherBenefitPlansChangesinFairValueofPlanAssetsDetails Pension And Other Benefit Plans - Changes in Fair Value of Plan Assets (Details) Details 89 false false R90.htm 0000090 - Disclosure - Pension And Other Benefit Plans - Benefit Payments That Reflect Expected Future Service (Details) Sheet http://www.envistaco.com/role/PensionAndOtherBenefitPlansBenefitPaymentsThatReflectExpectedFutureServiceDetails Pension And Other Benefit Plans - Benefit Payments That Reflect Expected Future Service (Details) Details 90 false false R91.htm 0000091 - Disclosure - Warranty - Narrative (Details) Sheet http://www.envistaco.com/role/WarrantyNarrativeDetails Warranty - Narrative (Details) Details 91 false false R92.htm 0000092 - Disclosure - Warranty - Warranty Accrual (Details) Sheet http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails Warranty - Warranty Accrual (Details) Details 92 false false R93.htm 0000093 - Disclosure - Litigation And Contingencies - Narrative (Details) Sheet http://www.envistaco.com/role/LitigationAndContingenciesNarrativeDetails Litigation And Contingencies - Narrative (Details) Details 93 false false R94.htm 0000094 - Disclosure - Debt And Credit Facilities - Components Of Debt (Details) Sheet http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails Debt And Credit Facilities - Components Of Debt (Details) Details 94 false false R95.htm 0000095 - Disclosure - Debt And Credit Facilities - Debt Payments (Details) Sheet http://www.envistaco.com/role/DebtAndCreditFacilitiesDebtPaymentsDetails Debt And Credit Facilities - Debt Payments (Details) Details 95 false false R96.htm 0000096 - Disclosure - Debt And Credit Facilities - Narrative (Details) Sheet http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails Debt And Credit Facilities - Narrative (Details) Details 96 false false R97.htm 0000097 - Disclosure - Debt And Credit Facilities - Interest Expense (Details) Sheet http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails Debt And Credit Facilities - Interest Expense (Details) Details 97 false false R98.htm 0000098 - Disclosure - Debt And Credit Facilities - Unamortized Debt Discount and Issuance Costs (Details) Sheet http://www.envistaco.com/role/DebtAndCreditFacilitiesUnamortizedDebtDiscountandIssuanceCostsDetails Debt And Credit Facilities - Unamortized Debt Discount and Issuance Costs (Details) Details 98 false false R99.htm 0000099 - Disclosure - Stock Transactions And Stock-Based Compensation (Details) Sheet http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails Stock Transactions And Stock-Based Compensation (Details) Details http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationTables 99 false false R100.htm 0000100 - Disclosure - Stock Transactions And Stock-Based Compensation - Summary of Share Activity (Details) Sheet http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryofShareActivityDetails Stock Transactions And Stock-Based Compensation - Summary of Share Activity (Details) Details 100 false false R101.htm 0000101 - Disclosure - Stock Transactions And Stock-Based Compensation - Assumptions Used To Value Options Granted (Details) Sheet http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationAssumptionsUsedToValueOptionsGrantedDetails Stock Transactions And Stock-Based Compensation - Assumptions Used To Value Options Granted (Details) Details 101 false false R102.htm 0000102 - Disclosure - Stock Transactions And Stock-Based Compensation - Components of Stock-Based Compensation Program (Details) Sheet http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationComponentsofStockBasedCompensationProgramDetails Stock Transactions And Stock-Based Compensation - Components of Stock-Based Compensation Program (Details) Details 102 false false R103.htm 0000103 - Disclosure - Stock Transactions And Stock-Based Compensation - Option Activity Under The Company's Stock Plans (Details) Sheet http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails Stock Transactions And Stock-Based Compensation - Option Activity Under The Company's Stock Plans (Details) Details 103 false false R104.htm 0000104 - Disclosure - Stock Transactions And Stock-Based Compensation - Summary Of Options Outstanding (Details) Sheet http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfOptionsOutstandingDetails Stock Transactions And Stock-Based Compensation - Summary Of Options Outstanding (Details) Details 104 false false R105.htm 0000105 - Disclosure - Stock Transactions And Stock-Based Compensation - Summary Of Unrecognized RSU And PRU Activity (Details) Sheet http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfUnrecognizedRSUAndPRUActivityDetails Stock Transactions And Stock-Based Compensation - Summary Of Unrecognized RSU And PRU Activity (Details) Details 105 false false R106.htm 0000106 - Disclosure - Accumulated Other Comprehensive Loss - Rollforward (Details) Sheet http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails Accumulated Other Comprehensive Loss - Rollforward (Details) Details 106 false false R107.htm 0000107 - Disclosure - Revenue - Disaggregation by Revenue Type and Geographical Region (Details) Sheet http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails Revenue - Disaggregation by Revenue Type and Geographical Region (Details) Details 107 false false R108.htm 0000108 - Disclosure - Revenue - Remaining Performance Obligations (Details) Sheet http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails Revenue - Remaining Performance Obligations (Details) Details 108 false false R109.htm 0000109 - Disclosure - Revenue - Narrative (Details) Sheet http://www.envistaco.com/role/RevenueNarrativeDetails Revenue - Narrative (Details) Details 109 false false R110.htm 0000110 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring And Related Costs (Details) Sheet http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails Restructuring Activities And Related Impairments - Schedule Of Restructuring And Related Costs (Details) Details 110 false false R111.htm 0000111 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring And Other Related Charges By Segment (Details) Sheet http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails Restructuring Activities And Related Impairments - Schedule Of Restructuring And Other Related Charges By Segment (Details) Details 111 false false R112.htm 0000112 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring Reserve By Type Of Cost (Details) Sheet http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails Restructuring Activities And Related Impairments - Schedule Of Restructuring Reserve By Type Of Cost (Details) Details 112 false false R113.htm 0000113 - Disclosure - Restructuring Activities And Related Impairments - Narrative (Details) Sheet http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsNarrativeDetails Restructuring Activities And Related Impairments - Narrative (Details) Details http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsTables 113 false false R114.htm 0000114 - Disclosure - Income Taxes - Earnings From Continuing Operations Before Income Taxes (Details) Sheet http://www.envistaco.com/role/IncomeTaxesEarningsFromContinuingOperationsBeforeIncomeTaxesDetails Income Taxes - Earnings From Continuing Operations Before Income Taxes (Details) Details 114 false false R115.htm 0000115 - Disclosure - Income Taxes - Provision For Income Taxes From Continuing Operations (Details) Sheet http://www.envistaco.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetails Income Taxes - Provision For Income Taxes From Continuing Operations (Details) Details 115 false false R116.htm 0000116 - Disclosure - Income Taxes - Deferred Income Tax Assets And Liabilities (Details) Sheet http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails Income Taxes - Deferred Income Tax Assets And Liabilities (Details) Details 116 false false R117.htm 0000117 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.envistaco.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 117 false false R118.htm 0000118 - Disclosure - Income Taxes - Reconciliation Of The Statutory Federal Income Tax Rate To The Effective Tax Rate (Details) Sheet http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails Income Taxes - Reconciliation Of The Statutory Federal Income Tax Rate To The Effective Tax Rate (Details) Details 118 false false R119.htm 0000119 - Disclosure - Income Taxes - Reconciliation Of Unrecognized Tax Benefits (Details) Sheet http://www.envistaco.com/role/IncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetails Income Taxes - Reconciliation Of Unrecognized Tax Benefits (Details) Details 119 false false R120.htm 0000120 - Disclosure - Earnings Per Share - Narrative (Details) Sheet http://www.envistaco.com/role/EarningsPerShareNarrativeDetails Earnings Per Share - Narrative (Details) Details 120 false false R121.htm 0000121 - Disclosure - Earnings Per Share - Components of Basic and Diluted Earnings per Share (Details) Sheet http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails Earnings Per Share - Components of Basic and Diluted Earnings per Share (Details) Details 121 false false R122.htm 0000122 - Disclosure - Earnings Per Share - Securities Not Included in the Computation of Diluted Loss Income per Share (Details) Sheet http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails Earnings Per Share - Securities Not Included in the Computation of Diluted Loss Income per Share (Details) Details 122 false false R123.htm 0000123 - Disclosure - Segment Information - Narrative (Details) Sheet http://www.envistaco.com/role/SegmentInformationNarrativeDetails Segment Information - Narrative (Details) Details 123 false false R124.htm 0000124 - Disclosure - Segment Information - Segment Results (Details) Sheet http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails Segment Information - Segment Results (Details) Details 124 false false R125.htm 0000125 - Disclosure - Segment Information - Schedule Of Operations In Geographical Areas (Details) Sheet http://www.envistaco.com/role/SegmentInformationScheduleOfOperationsInGeographicalAreasDetails Segment Information - Schedule Of Operations In Geographical Areas (Details) Details 125 false false R126.htm 0000126 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details) Sheet http://www.envistaco.com/role/ScheduleIIValuationandQualifyingAccountsDetails Schedule II - Valuation and Qualifying Accounts (Details) Details http://www.envistaco.com/role/ScheduleIIValuationandQualifyingAccounts 126 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:DebtInstrumentConvertibleConversionRatio1, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 - nvst-20221231.htm 4 nvst-20221231.htm envista-november2022grantx.htm exhibit23112312022.htm exhibit31112312022.htm exhibit31212312022.htm exhibit32112312022.htm nvst-20221231.xsd nvst-20221231_cal.xml nvst-20221231_def.xml nvst-20221231_lab.xml nvst-20221231_pre.xml nvst-20221231_g1.jpg nvst-20221231_g2.jpg nvst-20221231_g3.jpg nvst-20221231_g4.jpg nvst-20221231_g5.jpg nvst-20221231_g6.gif http://fasb.org/srt/2022 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 151 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "nvst-20221231.htm": { "axisCustom": 0, "axisStandard": 39, "baseTaxonomies": { "http://fasb.org/srt/2022": 1, "http://fasb.org/us-gaap/2022": 1592, "http://xbrl.sec.gov/dei/2022": 37 }, "contextCount": 374, "dts": { "calculationLink": { "local": [ "nvst-20221231_cal.xml" ] }, "definitionLink": { "local": [ "nvst-20221231_def.xml" ] }, "inline": { "local": [ "nvst-20221231.htm" ] }, "labelLink": { "local": [ "nvst-20221231_lab.xml" ] }, "presentationLink": { "local": [ "nvst-20221231_pre.xml" ] }, "schema": { "local": [ "nvst-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 902, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 6, "http://xbrl.sec.gov/dei/2022": 4, "total": 10 }, "keyCustom": 46, "keyStandard": 544, "memberCustom": 29, "memberStandard": 73, "nsprefix": "nvst", "nsuri": "http://www.envistaco.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://www.envistaco.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - Summary Of Significant Accounting Policies", "menuCat": "Notes", "order": "10", "role": "http://www.envistaco.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary Of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": null }, "R100": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "idab97eea8c784339969bf9ad8992cd07_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000100 - Disclosure - Stock Transactions And Stock-Based Compensation - Summary of Share Activity (Details)", "menuCat": "Details", "order": "100", "role": "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryofShareActivityDetails", "shortName": "Stock Transactions And Stock-Based Compensation - Summary of Share Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockByClassTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i63a0774616394edeb58cf18999153fe3_I20191231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i79f3efe7e07f4db7960799b8672f8e22_D20220101-20221231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000101 - Disclosure - Stock Transactions And Stock-Based Compensation - Assumptions Used To Value Options Granted (Details)", "menuCat": "Details", "order": "101", "role": "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationAssumptionsUsedToValueOptionsGrantedDetails", "shortName": "Stock Transactions And Stock-Based Compensation - Assumptions Used To Value Options Granted (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i79f3efe7e07f4db7960799b8672f8e22_D20220101-20221231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000102 - Disclosure - Stock Transactions And Stock-Based Compensation - Components of Stock-Based Compensation Program (Details)", "menuCat": "Details", "order": "102", "role": "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationComponentsofStockBasedCompensationProgramDetails", "shortName": "Stock Transactions And Stock-Based Compensation - Components of Stock-Based Compensation Program (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "idab97eea8c784339969bf9ad8992cd07_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000103 - Disclosure - Stock Transactions And Stock-Based Compensation - Option Activity Under The Company's Stock Plans (Details)", "menuCat": "Details", "order": "103", "role": "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails", "shortName": "Stock Transactions And Stock-Based Compensation - Option Activity Under The Company's Stock Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i45d1cdcdd5434011b48899c912957fd2_I20191231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R104": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i21ce030a64044ba2994e5956719325db_D20220101-20221231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000104 - Disclosure - Stock Transactions And Stock-Based Compensation - Summary Of Options Outstanding (Details)", "menuCat": "Details", "order": "104", "role": "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfOptionsOutstandingDetails", "shortName": "Stock Transactions And Stock-Based Compensation - Summary Of Options Outstanding (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i21ce030a64044ba2994e5956719325db_D20220101-20221231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R105": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "idab97eea8c784339969bf9ad8992cd07_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000105 - Disclosure - Stock Transactions And Stock-Based Compensation - Summary Of Unrecognized RSU And PRU Activity (Details)", "menuCat": "Details", "order": "105", "role": "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfUnrecognizedRSUAndPRUActivityDetails", "shortName": "Stock Transactions And Stock-Based Compensation - Summary Of Unrecognized RSU And PRU Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R106": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "idab97eea8c784339969bf9ad8992cd07_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000106 - Disclosure - Accumulated Other Comprehensive Loss - Rollforward (Details)", "menuCat": "Details", "order": "106", "role": "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails", "shortName": "Accumulated Other Comprehensive Loss - Rollforward (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i35ca32da971d47f3a89a7f8733e26963_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R107": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000107 - Disclosure - Revenue - Disaggregation by Revenue Type and Geographical Region (Details)", "menuCat": "Details", "order": "107", "role": "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "shortName": "Revenue - Disaggregation by Revenue Type and Geographical Region (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "id20fc1cd3c3e4f709881e3c48a385d60_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R108": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000108 - Disclosure - Revenue - Remaining Performance Obligations (Details)", "menuCat": "Details", "order": "108", "role": "http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails", "shortName": "Revenue - Remaining Performance Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R109": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000109 - Disclosure - Revenue - Narrative (Details)", "menuCat": "Details", "order": "109", "role": "http://www.envistaco.com/role/RevenueNarrativeDetails", "shortName": "Revenue - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - Acquisitions", "menuCat": "Notes", "order": "11", "role": "http://www.envistaco.com/role/Acquisitions", "shortName": "Acquisitions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R110": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "idab97eea8c784339969bf9ad8992cd07_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000110 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring And Related Costs (Details)", "menuCat": "Details", "order": "110", "role": "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails", "shortName": "Restructuring Activities And Related Impairments - Schedule Of Restructuring And Related Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "idab97eea8c784339969bf9ad8992cd07_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R111": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000111 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring And Other Related Charges By Segment (Details)", "menuCat": "Details", "order": "111", "role": "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "shortName": "Restructuring Activities And Related Impairments - Schedule Of Restructuring And Other Related Charges By Segment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i508dddf278ac4593927cc01e4e92dca3_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R112": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000112 - Disclosure - Restructuring Activities And Related Impairments - Schedule Of Restructuring Reserve By Type Of Cost (Details)", "menuCat": "Details", "order": "112", "role": "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails", "shortName": "Restructuring Activities And Related Impairments - Schedule Of Restructuring Reserve By Type Of Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "ibfe978892ec047adbeffbe8461bb1613_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R113": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InventoryWriteDown", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000113 - Disclosure - Restructuring Activities And Related Impairments - Narrative (Details)", "menuCat": "Details", "order": "113", "role": "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsNarrativeDetails", "shortName": "Restructuring Activities And Related Impairments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "iadaf3c3708ca44b6aeae24f532037bb3_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R114": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000114 - Disclosure - Income Taxes - Earnings From Continuing Operations Before Income Taxes (Details)", "menuCat": "Details", "order": "114", "role": "http://www.envistaco.com/role/IncomeTaxesEarningsFromContinuingOperationsBeforeIncomeTaxesDetails", "shortName": "Income Taxes - Earnings From Continuing Operations Before Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i768820c7bdc84771b48bfb75e527acee_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R115": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000115 - Disclosure - Income Taxes - Provision For Income Taxes From Continuing Operations (Details)", "menuCat": "Details", "order": "115", "role": "http://www.envistaco.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetails", "shortName": "Income Taxes - Provision For Income Taxes From Continuing Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R116": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsInventory", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000116 - Disclosure - Income Taxes - Deferred Income Tax Assets And Liabilities (Details)", "menuCat": "Details", "order": "116", "role": "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails", "shortName": "Income Taxes - Deferred Income Tax Assets And Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsInventory", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R117": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "idab97eea8c784339969bf9ad8992cd07_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxLiabilities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000117 - Disclosure - Income Taxes - Narrative (Details)", "menuCat": "Details", "order": "117", "role": "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R118": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000118 - Disclosure - Income Taxes - Reconciliation Of The Statutory Federal Income Tax Rate To The Effective Tax Rate (Details)", "menuCat": "Details", "order": "118", "role": "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails", "shortName": "Income Taxes - Reconciliation Of The Statutory Federal Income Tax Rate To The Effective Tax Rate (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R119": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "idab97eea8c784339969bf9ad8992cd07_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000119 - Disclosure - Income Taxes - Reconciliation Of Unrecognized Tax Benefits (Details)", "menuCat": "Details", "order": "119", "role": "http://www.envistaco.com/role/IncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetails", "shortName": "Income Taxes - Reconciliation Of Unrecognized Tax Benefits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - Discontinued Operations", "menuCat": "Notes", "order": "12", "role": "http://www.envistaco.com/role/DiscontinuedOperations", "shortName": "Discontinued Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R120": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000120 - Disclosure - Earnings Per Share - Narrative (Details)", "menuCat": "Details", "order": "120", "role": "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails", "shortName": "Earnings Per Share - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i5f867e3b0a8746739f4401540276db80_I20221231", "decimals": "INF", "lang": "en-US", "name": "nvst:DerivativeCapPriceDilutionThreshold", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R121": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperations", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000121 - Disclosure - Earnings Per Share - Components of Basic and Diluted Earnings per Share (Details)", "menuCat": "Details", "order": "121", "role": "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails", "shortName": "Earnings Per Share - Components of Basic and Diluted Earnings per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R122": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "ic77a745462374d6c9e41984e42ace5e9_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000122 - Disclosure - Earnings Per Share - Securities Not Included in the Computation of Diluted Loss Income per Share (Details)", "menuCat": "Details", "order": "122", "role": "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails", "shortName": "Earnings Per Share - Securities Not Included in the Computation of Diluted Loss Income per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "ic77a745462374d6c9e41984e42ace5e9_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R123": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000123 - Disclosure - Segment Information - Narrative (Details)", "menuCat": "Details", "order": "123", "role": "http://www.envistaco.com/role/SegmentInformationNarrativeDetails", "shortName": "Segment Information - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R124": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000124 - Disclosure - Segment Information - Segment Results (Details)", "menuCat": "Details", "order": "124", "role": "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails", "shortName": "Segment Information - Segment Results (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R125": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000125 - Disclosure - Segment Information - Schedule Of Operations In Geographical Areas (Details)", "menuCat": "Details", "order": "125", "role": "http://www.envistaco.com/role/SegmentInformationScheduleOfOperationsInGeographicalAreasDetails", "shortName": "Segment Information - Schedule Of Operations In Geographical Areas (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R126": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "idab97eea8c784339969bf9ad8992cd07_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000126 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)", "menuCat": "Details", "order": "126", "role": "http://www.envistaco.com/role/ScheduleIIValuationandQualifyingAccountsDetails", "shortName": "Schedule II - Valuation and Qualifying Accounts (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i45d1cdcdd5434011b48899c912957fd2_I20191231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CreditLossFinancialInstrumentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - Credit Losses", "menuCat": "Notes", "order": "13", "role": "http://www.envistaco.com/role/CreditLosses", "shortName": "Credit Losses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CreditLossFinancialInstrumentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - Inventories", "menuCat": "Notes", "order": "14", "role": "http://www.envistaco.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - Property, Plant And Equipment", "menuCat": "Notes", "order": "15", "role": "http://www.envistaco.com/role/PropertyPlantAndEquipment", "shortName": "Property, Plant And Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - Leases", "menuCat": "Notes", "order": "16", "role": "http://www.envistaco.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - Goodwill And Other Intangible Assets", "menuCat": "Notes", "order": "17", "role": "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssets", "shortName": "Goodwill And Other Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - Accrued Expenses And Other Liabilities", "menuCat": "Notes", "order": "18", "role": "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilities", "shortName": "Accrued Expenses And Other Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - Hedging Transactions And Derivative Financial Instruments", "menuCat": "Notes", "order": "19", "role": "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstruments", "shortName": "Hedging Transactions And Derivative Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorFirmId", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "false", "longName": "0000002 - Document - Audit Information", "menuCat": "Cover", "order": "2", "role": "http://www.envistaco.com/role/AuditInformation", "shortName": "Audit Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorFirmId", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - Fair Value Measurements", "menuCat": "Notes", "order": "20", "role": "http://www.envistaco.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - Pension And Other Benefit Plans", "menuCat": "Notes", "order": "21", "role": "http://www.envistaco.com/role/PensionAndOtherBenefitPlans", "shortName": "Pension And Other Benefit Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - Warranty", "menuCat": "Notes", "order": "22", "role": "http://www.envistaco.com/role/Warranty", "shortName": "Warranty", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000023 - Disclosure - Litigation And Contingencies", "menuCat": "Notes", "order": "23", "role": "http://www.envistaco.com/role/LitigationAndContingencies", "shortName": "Litigation And Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000024 - Disclosure - Debt And Credit Facilities", "menuCat": "Notes", "order": "24", "role": "http://www.envistaco.com/role/DebtAndCreditFacilities", "shortName": "Debt And Credit Facilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000025 - Disclosure - Stock Transactions And Stock-Based Compensation", "menuCat": "Notes", "order": "25", "role": "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensation", "shortName": "Stock Transactions And Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000026 - Disclosure - Accumulated Other Comprehensive Loss", "menuCat": "Notes", "order": "26", "role": "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLoss", "shortName": "Accumulated Other Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000027 - Disclosure - Revenue", "menuCat": "Notes", "order": "27", "role": "http://www.envistaco.com/role/Revenue", "shortName": "Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000028 - Disclosure - Restructuring Activities And Related Impairments", "menuCat": "Notes", "order": "28", "role": "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairments", "shortName": "Restructuring Activities And Related Impairments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000029 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "29", "role": "http://www.envistaco.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "3", "role": "http://www.envistaco.com/role/ConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000030 - Disclosure - Earnings Per Share", "menuCat": "Notes", "order": "30", "role": "http://www.envistaco.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000031 - Disclosure - Segment Information", "menuCat": "Notes", "order": "31", "role": "http://www.envistaco.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000032 - Disclosure - Schedule II - Valuation and Qualifying Accounts", "menuCat": "Notes", "order": "32", "role": "http://www.envistaco.com/role/ScheduleIIValuationandQualifyingAccounts", "shortName": "Schedule II - Valuation and Qualifying Accounts", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000033 - Disclosure - Summary Of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "33", "role": "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary Of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000034 - Disclosure - Summary Of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "34", "role": "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary Of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": null }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000035 - Disclosure - Acquisitions (Tables)", "menuCat": "Tables", "order": "35", "role": "http://www.envistaco.com/role/AcquisitionsTables", "shortName": "Acquisitions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000036 - Disclosure - Discontinued Operations (Tables)", "menuCat": "Tables", "order": "36", "role": "http://www.envistaco.com/role/DiscontinuedOperationsTables", "shortName": "Discontinued Operations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000037 - Disclosure - Credit Losses (Tables)", "menuCat": "Tables", "order": "37", "role": "http://www.envistaco.com/role/CreditLossesTables", "shortName": "Credit Losses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000038 - Disclosure - Inventories (Tables)", "menuCat": "Tables", "order": "38", "role": "http://www.envistaco.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000039 - Disclosure - Property, Plant And Equipment (Tables)", "menuCat": "Tables", "order": "39", "role": "http://www.envistaco.com/role/PropertyPlantAndEquipmentTables", "shortName": "Property, Plant And Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": null }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "4", "role": "http://www.envistaco.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000040 - Disclosure - Leases (Tables)", "menuCat": "Tables", "order": "40", "role": "http://www.envistaco.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000041 - Disclosure - Goodwill And Other Intangible Assets (Tables)", "menuCat": "Tables", "order": "41", "role": "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsTables", "shortName": "Goodwill And Other Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000042 - Disclosure - Accrued Expenses And Other Liabilities (Tables)", "menuCat": "Tables", "order": "42", "role": "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesTables", "shortName": "Accrued Expenses And Other Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000043 - Disclosure - Hedging Transactions And Derivative Financial Instruments (Tables)", "menuCat": "Tables", "order": "43", "role": "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables", "shortName": "Hedging Transactions And Derivative Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000044 - Disclosure - Fair Value Measurements (Tables)", "menuCat": "Tables", "order": "44", "role": "http://www.envistaco.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetFundedStatusTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000045 - Disclosure - Pension And Other Benefit Plans (Tables)", "menuCat": "Tables", "order": "45", "role": "http://www.envistaco.com/role/PensionAndOtherBenefitPlansTables", "shortName": "Pension And Other Benefit Plans (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetFundedStatusTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000046 - Disclosure - Warranty (Tables)", "menuCat": "Tables", "order": "46", "role": "http://www.envistaco.com/role/WarrantyTables", "shortName": "Warranty (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000047 - Disclosure - Debt And Credit Facilities (Tables)", "menuCat": "Tables", "order": "47", "role": "http://www.envistaco.com/role/DebtAndCreditFacilitiesTables", "shortName": "Debt And Credit Facilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000048 - Disclosure - Stock Transactions And Stock-Based Compensation (Tables)", "menuCat": "Tables", "order": "48", "role": "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationTables", "shortName": "Stock Transactions And Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000049 - Disclosure - Accumulated Other Comprehensive Loss (Tables)", "menuCat": "Tables", "order": "49", "role": "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossTables", "shortName": "Accumulated Other Comprehensive Loss (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - Consolidated Statements of Operations", "menuCat": "Statements", "order": "5", "role": "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000050 - Disclosure - Revenue (Tables)", "menuCat": "Tables", "order": "50", "role": "http://www.envistaco.com/role/RevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000051 - Disclosure - Restructuring Activities And Related Impairments (Tables)", "menuCat": "Tables", "order": "51", "role": "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsTables", "shortName": "Restructuring Activities And Related Impairments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000052 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "52", "role": "http://www.envistaco.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000053 - Disclosure - Earnings Per Share (Tables)", "menuCat": "Tables", "order": "53", "role": "http://www.envistaco.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000054 - Disclosure - Segment Information (Tables)", "menuCat": "Tables", "order": "54", "role": "http://www.envistaco.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "us-gaap:NumberOfReportableSegments", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000055 - Disclosure - Business And Basis Of Presentation - Narrative (Details)", "menuCat": "Details", "order": "55", "role": "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "shortName": "Business And Basis Of Presentation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R56": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "ix:continuation", "div", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "ie266e9b0b34e475dbe0701e4317d83af_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000056 - Disclosure - Summary Of Significant Accounting Policies - Estimated Useful Lives of Depreciable Assets (Details)", "menuCat": "Details", "order": "56", "role": "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesofDepreciableAssetsDetails", "shortName": "Summary Of Significant Accounting Policies - Estimated Useful Lives of Depreciable Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "ix:continuation", "div", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "ie266e9b0b34e475dbe0701e4317d83af_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetImpairment", "us-gaap:GoodwillAndIntangibleAssetImpairment", "span", "div", "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetImpairment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000057 - Disclosure - Summary Of Significant Accounting Policies - Narrative (Details)", "menuCat": "Details", "order": "57", "role": "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails", "shortName": "Summary Of Significant Accounting Policies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetImpairment", "us-gaap:GoodwillAndIntangibleAssetImpairment", "span", "div", "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetImpairment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000058 - Disclosure - Acquisitions - Narrative (Details)", "menuCat": "Details", "order": "58", "role": "http://www.envistaco.com/role/AcquisitionsNarrativeDetails", "shortName": "Acquisitions - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "idd38dc9f9174474596838d52f9b54eea_D20220705-20220705", "decimals": "-5", "lang": "en-US", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000059 - Disclosure - Acquisitions - Fair Values of Assets Acquired and Liabilities Assumed (Details)", "menuCat": "Details", "order": "59", "role": "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "shortName": "Acquisitions - Fair Values of Assets Acquired and Liabilities Assumed (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i7b4af94cfd9f4b2ea64a276245d8709e_I20220705", "decimals": "-5", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - Consolidated Statements of Comprehensive Income", "menuCat": "Statements", "order": "6", "role": "http://www.envistaco.com/role/ConsolidatedStatementsofComprehensiveIncome", "shortName": "Consolidated Statements of Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "iec0b95ca865447b7b9e41d5d557a745a_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000060 - Disclosure - Discontinued Operations - Narrative (Details)", "menuCat": "Details", "order": "60", "role": "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "shortName": "Discontinued Operations - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "iec0b95ca865447b7b9e41d5d557a745a_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000061 - Disclosure - Discontinued Operations - Carrying Amount of Assets and Liabilities (Details)", "menuCat": "Details", "order": "61", "role": "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "shortName": "Discontinued Operations - Carrying Amount of Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "iec0b95ca865447b7b9e41d5d557a745a_I20211231", "decimals": "-5", "lang": "en-US", "name": "nvst:DisposalGroupIncludingDiscontinuedOperationAssetForRelevantJurisdictionProceedsCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000062 - Disclosure - Discontinued Operations - Operating Results (Details)", "menuCat": "Details", "order": "62", "role": "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "shortName": "Discontinued Operations - Operating Results (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i4ebd98de49d8402bb20b58d8c02fad65_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i4ebd98de49d8402bb20b58d8c02fad65_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "nvst:DisposalGroupIncludingDiscontinuedOperationsNonCashRestructuringCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000063 - Disclosure - Discontinued Operations - Significant Non-Cash Operating Items and Capital Expenditures (Details)", "menuCat": "Details", "order": "63", "role": "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails", "shortName": "Discontinued Operations - Significant Non-Cash Operating Items and Capital Expenditures (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i4ebd98de49d8402bb20b58d8c02fad65_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "nvst:DisposalGroupIncludingDiscontinuedOperationsNonCashRestructuringCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "nvst:NumberOfPortfolioSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000064 - Disclosure - Credit Losses - Narrative (Details)", "menuCat": "Details", "order": "64", "role": "http://www.envistaco.com/role/CreditLossesNarrativeDetails", "shortName": "Credit Losses - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "nvst:NumberOfPortfolioSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "idab97eea8c784339969bf9ad8992cd07_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000065 - Disclosure - Credit Losses - Allowance for Credit Losses (Details)", "menuCat": "Details", "order": "65", "role": "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails", "shortName": "Credit Losses - Allowance for Credit Losses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000066 - Disclosure - Inventories - Summary (Details)", "menuCat": "Details", "order": "66", "role": "http://www.envistaco.com/role/InventoriesSummaryDetails", "shortName": "Inventories - Summary (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000067 - Disclosure - Property, Plant And Equipment (Details)", "menuCat": "Details", "order": "67", "role": "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails", "shortName": "Property, Plant And Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "nvst:LesseeOperatingLeaseOptiontoTerminateTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000068 - Disclosure - Leases - Narrative (Details)", "menuCat": "Details", "order": "68", "role": "http://www.envistaco.com/role/LeasesNarrativeDetails", "shortName": "Leases - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "nvst:LesseeOperatingLeaseOptiontoTerminateTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000069 - Disclosure - Leases - Components of Lease Expense (Details)", "menuCat": "Details", "order": "69", "role": "http://www.envistaco.com/role/LeasesComponentsofLeaseExpenseDetails", "shortName": "Leases - Components of Lease Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i34b1515ce1314001b62fc00dc1d8f0b8_I20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000007 - Statement - Consolidated Statements of Changes in Stockholders' Equity", "menuCat": "Statements", "order": "7", "role": "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity", "shortName": "Consolidated Statements of Changes in Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i34b1515ce1314001b62fc00dc1d8f0b8_I20191231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "nvst:LesseeAssetsandLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000070 - Disclosure - Leases - Weighted Average Remaining Lease Term and Discount Rate (Details)", "menuCat": "Details", "order": "70", "role": "http://www.envistaco.com/role/LeasesWeightedAverageRemainingLeaseTermandDiscountRateDetails", "shortName": "Leases - Weighted Average Remaining Lease Term and Discount Rate (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "nvst:LesseeAssetsandLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000071 - Disclosure - Leases - Maturities of Lease Liabilities (Details)", "menuCat": "Details", "order": "71", "role": "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails", "shortName": "Leases - Maturities of Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:GoodwillImpairmentLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000072 - Disclosure - Goodwill And Other Intangible Assets - Narrative (Details)", "menuCat": "Details", "order": "72", "role": "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails", "shortName": "Goodwill And Other Intangible Assets - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:GoodwillImpairmentLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "idab97eea8c784339969bf9ad8992cd07_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000073 - Disclosure - Goodwill And Other Intangible Assets - Rollforward (Details)", "menuCat": "Details", "order": "73", "role": "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsRollforwardDetails", "shortName": "Goodwill And Other Intangible Assets - Rollforward (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:GoodwillAcquiredDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000074 - Disclosure - Goodwill And Other Intangible Assets - Intangible Assets by Major Class (Details)", "menuCat": "Details", "order": "74", "role": "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails", "shortName": "Goodwill And Other Intangible Assets - Intangible Assets by Major Class (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000075 - Disclosure - Intangible Assets, Goodwill and Other - Intangible Assets Future Amortization Expense (Details)", "menuCat": "Details", "order": "75", "role": "http://www.envistaco.com/role/IntangibleAssetsGoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails", "shortName": "Intangible Assets, Goodwill and Other - Intangible Assets Future Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000076 - Disclosure - Accrued Expenses And Other Liabilities - Summary (Details)", "menuCat": "Details", "order": "76", "role": "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails", "shortName": "Accrued Expenses And Other Liabilities - Summary (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000077 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Narrative (Details)", "menuCat": "Details", "order": "77", "role": "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails", "shortName": "Hedging Transactions And Derivative Financial Instruments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000078 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges (Details)", "menuCat": "Details", "order": "78", "role": "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails", "shortName": "Hedging Transactions And Derivative Financial Instruments - Summary of Notional Values and Pretax Impact in Fair Values of Net Investment Hedges (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000079 - Disclosure - Hedging Transactions And Derivative Financial Instruments - Derivative and Nonderivative Debt Instruments (Details)", "menuCat": "Details", "order": "79", "role": "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails", "shortName": "Hedging Transactions And Derivative Financial Instruments - Derivative and Nonderivative Debt Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "ie48967f0081c4cb6bde0bbbe5def6f98_I20221231", "decimals": "-5", "lang": "en-US", "name": "nvst:NonderivativeHedgingInstruments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000008 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "8", "role": "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000080 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details)", "menuCat": "Details", "order": "80", "role": "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "shortName": "Fair Value Measurements - Financial Assets and Liabilities Carried at Fair Value (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000081 - Disclosure - Fair Value Measurements - Fair Value of Financial Instruments (Details)", "menuCat": "Details", "order": "81", "role": "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "shortName": "Fair Value Measurements - Fair Value of Financial Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i864f0229613c4434a96730b5649e4df4_I20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetFundedStatusTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanFundedStatusOfPlan", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000082 - Disclosure - Pension And Other Benefit Plans - Funded Status Of Pension Plans (Details)", "menuCat": "Details", "order": "82", "role": "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails", "shortName": "Pension And Other Benefit Plans - Funded Status Of Pension Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetFundedStatusTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanFundedStatusOfPlan", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000083 - Disclosure - Pension And Other Benefit Plans - Weighted Average Assumptions Used To Determine Benefit Obligations (Details)", "menuCat": "Details", "order": "83", "role": "http://www.envistaco.com/role/PensionAndOtherBenefitPlansWeightedAverageAssumptionsUsedToDetermineBenefitObligationsDetails", "shortName": "Pension And Other Benefit Plans - Weighted Average Assumptions Used To Determine Benefit Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000084 - Disclosure - Pension And Other Benefit Plans - Components of Net Periodic Benefit Cost of Defined Benefit Pension Plans (Details)", "menuCat": "Details", "order": "84", "role": "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails", "shortName": "Pension And Other Benefit Plans - Components of Net Periodic Benefit Cost of Defined Benefit Pension Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i42e4d01daa70420cba1ce598dec49a4d_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000085 - Disclosure - Pension And Other Benefit Plans - Components of Net Periodic Benefit Cost Reflected in the Consolidated Condensed Statement of Earnings (Details)", "menuCat": "Details", "order": "85", "role": "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostReflectedintheConsolidatedCondensedStatementofEarningsDetails", "shortName": "Pension And Other Benefit Plans - Components of Net Periodic Benefit Cost Reflected in the Consolidated Condensed Statement of Earnings (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000086 - Disclosure - Pension And Other Benefit Plans - Weighted Average Assumptions Used To Determine Net Periodic Pension Cost (Details)", "menuCat": "Details", "order": "86", "role": "http://www.envistaco.com/role/PensionAndOtherBenefitPlansWeightedAverageAssumptionsUsedToDetermineNetPeriodicPensionCostDetails", "shortName": "Pension And Other Benefit Plans - Weighted Average Assumptions Used To Determine Net Periodic Pension Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000087 - Disclosure - Pension And Other Benefit Plans - Narrative (Details)", "menuCat": "Details", "order": "87", "role": "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails", "shortName": "Pension And Other Benefit Plans - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "lang": "en-US", "name": "us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "if3f6d368461a4e01a019dc9447f84d6b_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000088 - Disclosure - Pension And Other Benefit Plans - Fair Values Of Pension Plan Assets (Details)", "menuCat": "Details", "order": "88", "role": "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails", "shortName": "Pension And Other Benefit Plans - Fair Values Of Pension Plan Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i676472021b6142ecbbf7a5e36df8d1f8_I20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i2370d04e040949e4a54faa3d5b358e45_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000089 - Disclosure - Pension And Other Benefit Plans - Changes in Fair Value of Plan Assets (Details)", "menuCat": "Details", "order": "89", "role": "http://www.envistaco.com/role/PensionAndOtherBenefitPlansChangesinFairValueofPlanAssetsDetails", "shortName": "Pension And Other Benefit Plans - Changes in Fair Value of Plan Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i984dc7761a934ecb80abffa7cb2eebd2_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000009 - Disclosure - Business And Basis Of Presentation", "menuCat": "Notes", "order": "9", "role": "http://www.envistaco.com/role/BusinessAndBasisOfPresentation", "shortName": "Business And Basis Of Presentation", "subGroupType": "", "uniqueAnchor": null }, "R90": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "if3f6d368461a4e01a019dc9447f84d6b_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000090 - Disclosure - Pension And Other Benefit Plans - Benefit Payments That Reflect Expected Future Service (Details)", "menuCat": "Details", "order": "90", "role": "http://www.envistaco.com/role/PensionAndOtherBenefitPlansBenefitPaymentsThatReflectExpectedFutureServiceDetails", "shortName": "Pension And Other Benefit Plans - Benefit Payments That Reflect Expected Future Service (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "if3f6d368461a4e01a019dc9447f84d6b_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "nvst:ProductWarrantyPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000091 - Disclosure - Warranty - Narrative (Details)", "menuCat": "Details", "order": "91", "role": "http://www.envistaco.com/role/WarrantyNarrativeDetails", "shortName": "Warranty - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "nvst:ProductWarrantyPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "idab97eea8c784339969bf9ad8992cd07_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000092 - Disclosure - Warranty - Warranty Accrual (Details)", "menuCat": "Details", "order": "92", "role": "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails", "shortName": "Warranty - Warranty Accrual (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "idab97eea8c784339969bf9ad8992cd07_I20211231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000093 - Disclosure - Litigation And Contingencies - Narrative (Details)", "menuCat": "Details", "order": "93", "role": "http://www.envistaco.com/role/LitigationAndContingenciesNarrativeDetails", "shortName": "Litigation And Contingencies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyAccrualAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000094 - Disclosure - Debt And Credit Facilities - Components Of Debt (Details)", "menuCat": "Details", "order": "94", "role": "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "shortName": "Debt And Credit Facilities - Components Of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DebtCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000095 - Disclosure - Debt And Credit Facilities - Debt Payments (Details)", "menuCat": "Details", "order": "95", "role": "http://www.envistaco.com/role/DebtAndCreditFacilitiesDebtPaymentsDetails", "shortName": "Debt And Credit Facilities - Debt Payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i91844e4b76a84413a19d54ae35835d62_D20190920-20190920", "decimals": "-8", "first": true, "lang": "en-US", "name": "nvst:TotalBorrowingsunderTermLoan", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000096 - Disclosure - Debt And Credit Facilities - Narrative (Details)", "menuCat": "Details", "order": "96", "role": "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "shortName": "Debt And Credit Facilities - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i91844e4b76a84413a19d54ae35835d62_D20190920-20190920", "decimals": "-8", "first": true, "lang": "en-US", "name": "nvst:TotalBorrowingsunderTermLoan", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "ie1189a8f31054373a5defee8b29f8589_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebtExcludingAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000097 - Disclosure - Debt And Credit Facilities - Interest Expense (Details)", "menuCat": "Details", "order": "97", "role": "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "shortName": "Debt And Credit Facilities - Interest Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "ie1189a8f31054373a5defee8b29f8589_D20220101-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebtExcludingAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredFinanceCostsNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000098 - Disclosure - Debt And Credit Facilities - Unamortized Debt Discount and Issuance Costs (Details)", "menuCat": "Details", "order": "98", "role": "http://www.envistaco.com/role/DebtAndCreditFacilitiesUnamortizedDebtDiscountandIssuanceCostsDetails", "shortName": "Debt And Credit Facilities - Unamortized Debt Discount and Issuance Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i58dc82ac62e5470ea211c95bbb1fd427_I20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000099 - Disclosure - Stock Transactions And Stock-Based Compensation (Details)", "menuCat": "Details", "order": "99", "role": "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails", "shortName": "Stock Transactions And Stock-Based Compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "nvst-20221231.htm", "contextRef": "i0839dd4a8def44ae8e7a2047bec7ec5b_D20220101-20221231", "decimals": "INF", "lang": "en-US", "name": "nvst:CommonStockVoteperShare", "reportCount": 1, "unique": true, "unitRef": "vote", "xsiNil": "false" } } }, "segmentCount": 103, "tag": { "country_CN": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CHINA", "terseLabel": "China" } } }, "localname": "CN", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationScheduleOfOperationsInGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "country_MX": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MEXICO", "terseLabel": "Mexico" } } }, "localname": "MX", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationScheduleOfOperationsInGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "country_SE": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SWEDEN", "terseLabel": "Sweden" } } }, "localname": "SE", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationScheduleOfOperationsInGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesEarningsFromContinuingOperationsBeforeIncomeTaxesDetails", "http://www.envistaco.com/role/SegmentInformationScheduleOfOperationsInGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r971", "r972", "r973" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/AuditInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r971", "r972", "r973" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r971", "r972", "r973" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r971", "r972", "r973" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r974" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r969" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r968" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r968" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r968" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r975" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r968" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r968" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r968" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r968" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r976" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r971", "r972", "r973" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r967" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r970" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.envistaco.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "nvst_A2.375ConvertibleSeniorNotesCappedCallsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2.375% Convertible Senior Notes, Capped Calls [Member]", "label": "2.375% Convertible Senior Notes, Capped Calls [Member]", "terseLabel": "2.375% convertible senior notes, capped calls" } } }, "localname": "A2.375ConvertibleSeniorNotesCappedCallsMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_A2.375ConvertibleSeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2.375% Convertible Senior Notes [Member]", "label": "2.375% Convertible Senior Notes [Member]", "terseLabel": "2.375% convertible senior notes", "verboseLabel": "Convertible senior notes due 2025" } } }, "localname": "A2.375ConvertibleSeniorNotesMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesUnamortizedDebtDiscountandIssuanceCostsDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_A2.375ConvertibleSeniorNotesOverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2.375% Convertible Senior Notes Over Allotment Option [Member]", "label": "2.375% Convertible Senior Notes Over Allotment Option [Member]", "terseLabel": "2.375% convertible senior notes over allotment option" } } }, "localname": "A2.375ConvertibleSeniorNotesOverAllotmentOptionMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_A2019OmnibusIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2019 Omnibus Incentive Plan", "label": "2019 Omnibus Incentive Plan [Member]", "terseLabel": "2019 Omnibus Incentive Plan" } } }, "localname": "A2019OmnibusIncentivePlanMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "nvst_AccountsReceivableCreditLossExpenseReversalAdjustedForDiscontinuedOperations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accounts Receivable, Credit Loss Expense (Reversal), Adjusted for Discontinued Operations", "label": "Accounts Receivable, Credit Loss Expense (Reversal), Adjusted for Discontinued Operations", "verboseLabel": "Provision for credit losses" } } }, "localname": "AccountsReceivableCreditLossExpenseReversalAdjustedForDiscontinuedOperations", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "nvst_AccruedexpensesandotherAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued expenses and other [Abstract]", "label": "Accrued expenses and other [Abstract]", "terseLabel": "Accrued expenses and other [Abstract]" } } }, "localname": "AccruedexpensesandotherAbstract", "nsuri": "http://www.envistaco.com/20221231", "xbrltype": "stringItemType" }, "nvst_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallsRelatedToConvertibleDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments To Additional Paid In Capital, Purchase Of Capped Calls Related To Convertible Debt", "label": "Adjustments To Additional Paid In Capital, Purchase Of Capped Calls Related To Convertible Debt", "negatedTerseLabel": "Purchase of capped calls related to issuance of convertible senior notes, net of taxes" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallsRelatedToConvertibleDebt", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "nvst_AdjustmentstoAdditionalPaidinCapitalIncreaseDecreaseinSeparationAdjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments to Additional Paid in Capital, Increase (Decrease) in Separation Adjustments", "label": "Adjustments to Additional Paid in Capital, Increase (Decrease) in Separation Adjustments", "terseLabel": "Separation related adjustments" } } }, "localname": "AdjustmentstoAdditionalPaidinCapitalIncreaseDecreaseinSeparationAdjustments", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "nvst_AllOtherCountriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All other countries.", "label": "All Other Countries [Member]", "terseLabel": "All other (each country individually less than 5% of total long-lived assets)" } } }, "localname": "AllOtherCountriesMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/SegmentInformationScheduleOfOperationsInGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "nvst_AuditInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Audit Information", "label": "Audit Information [Abstract]" } } }, "localname": "AuditInformationAbstract", "nsuri": "http://www.envistaco.com/20221231", "xbrltype": "stringItemType" }, "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Including Goodwill", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Including Goodwill", "totalLabel": "Total assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 9.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right Of Use Asset", "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right Of Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "nvst_CarestreamDentalTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Carestream Dental Technology", "label": "Carestream Dental Technology [Member]", "terseLabel": "Carestream Dental Technology" } } }, "localname": "CarestreamDentalTechnologyMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_CommonStockVoteperShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock, Vote per Share", "label": "Common Stock, Vote per Share", "terseLabel": "Common stock voting rights (in votes per share)" } } }, "localname": "CommonStockVoteperShare", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "decimalItemType" }, "nvst_ConsolidationOfFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consolidation Of Facilities", "label": "Consolidation Of Facilities [Member]", "terseLabel": "Consolidation of facilities" } } }, "localname": "ConsolidationOfFacilitiesMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_ConsumablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consumables [Member]", "label": "Consumables [Member]", "terseLabel": "Consumables" } } }, "localname": "ConsumablesMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "nvst_ContingencyProvisionPurchasePriceinExcessof100million": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contingency Provision, Purchase Price in Excess of $100 million", "label": "Contingency Provision, Purchase Price in Excess of $100 million", "terseLabel": "Contingency provision, purchase price in excess of $100 million" } } }, "localname": "ContingencyProvisionPurchasePriceinExcessof100million", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_CreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit Facility [Member]", "label": "Credit Facility [Member]", "terseLabel": "Credit facility" } } }, "localname": "CreditFacilityMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_DebtInstrumentAccordionFeatureIncreaseLimit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Accordion Feature, Increase Limit", "label": "Debt Instrument, Accordion Feature, Increase Limit", "terseLabel": "Increase limit of revolving credit facility" } } }, "localname": "DebtInstrumentAccordionFeatureIncreaseLimit", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DebtInstrumentConvertibleCappedCallsExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Convertible, Capped Calls, Expense", "label": "Debt Instrument, Convertible, Capped Calls, Expense", "terseLabel": "Convertible debt expense, capped calls" } } }, "localname": "DebtInstrumentConvertibleCappedCallsExpense", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DebtInstrumentConvertibleCappedCallsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Convertible, Capped Calls, Shares", "label": "Debt Instrument, Convertible, Capped Calls, Shares", "terseLabel": "Convertible debt, capped calls (in shares)" } } }, "localname": "DebtInstrumentConvertibleCappedCallsShares", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "sharesItemType" }, "nvst_DebtInstrumentCovenantCashAndCashEquivalentThreshold": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenant, Cash and Cash Equivalent Threshold", "label": "Debt Instrument, Covenant, Cash and Cash Equivalent Threshold", "terseLabel": "Cash and cash equivalent threshold" } } }, "localname": "DebtInstrumentCovenantCashAndCashEquivalentThreshold", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DebtInstrumentCovenantPercentageOfEarningsBeforeTaxesThreshold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenant, Percentage Of Earnings Before Taxes, Threshold", "label": "Debt Instrument, Covenant, Percentage Of Earnings Before Taxes, Threshold", "terseLabel": "EBITDA threshold" } } }, "localname": "DebtInstrumentCovenantPercentageOfEarningsBeforeTaxesThreshold", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "nvst_DeferredTaxAssetsTaxCreditAndLossCarryforwards": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Tax credit and loss carryforwards", "label": "Deferred Tax Assets, Tax Credit And Loss Carryforwards", "terseLabel": "Tax credit and loss carryforwards" } } }, "localname": "DeferredTaxAssetsTaxCreditAndLossCarryforwards", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Tax Deferred Expense, Lease Liabilities", "label": "Deferred Tax Assets, Tax Deferred Expense, Lease Liabilities", "terseLabel": "Lease liabilities" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DeferredTaxLiabilitiesRightofUseAssets": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Liabilities, Right-of-Use Assets", "label": "Deferred Tax Liabilities, Right-of-Use Assets", "negatedTerseLabel": "Right-of-use assets" } } }, "localname": "DeferredTaxLiabilitiesRightofUseAssets", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DefinedBenefitPlanAmendmentsSettlementsAndCurtailments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Amendments, Settlements, and Other (e.g. curtailments).", "label": "Defined Benefit Plan, Amendments, Settlements, And Curtailments", "terseLabel": "Amendments, settlements and curtailments" } } }, "localname": "DefinedBenefitPlanAmendmentsSettlementsAndCurtailments", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DefinedBenefitPlanPlanAssetsPaymentForSettlementAndAmendment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Plan Assets, Payment For Settlement And Amendment", "label": "Defined Benefit Plan, Plan Assets, Payment For Settlement And Amendment", "negatedTerseLabel": "Amendments and settlements" } } }, "localname": "DefinedBenefitPlanPlanAssetsPaymentForSettlementAndAmendment", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DerivativeCapPriceDilutionThreshold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative, Cap Price, Dilution Threshold", "label": "Derivative, Cap Price, Dilution Threshold", "terseLabel": "Dilution threshold (in USD per share)" } } }, "localname": "DerivativeCapPriceDilutionThreshold", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "perShareItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationAssetForRelevantJurisdictionProceedsCurrent": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Asset For Relevant Jurisdiction Proceeds, Current", "label": "Disposal Group, Including Discontinued Operation, Asset For Relevant Jurisdiction Proceeds, Current", "terseLabel": "Assets for Relevant Jurisdictions" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAssetForRelevantJurisdictionProceedsCurrent", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationCashFlowsFromDiscontinuedOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Cash Flows from Discontinued Operations", "label": "Disposal Group, Including Discontinued Operation, Cash Flows from Discontinued Operations [Abstract]", "terseLabel": "Cash flows from operating activities" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCashFlowsFromDiscontinuedOperationsAbstract", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "stringItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationCashFlowsFromInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Cash Flows From Investing Activities", "label": "Disposal Group, Including Discontinued Operation, Cash Flows From Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCashFlowsFromInvestingActivitiesAbstract", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "stringItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Impairment Charges", "label": "Disposal Group, Including Discontinued Operation, Impairment Charges", "terseLabel": "Impairment charges" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationImpairmentCharges", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationOperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Operating Expenses", "label": "Disposal Group, Including Discontinued Operation, Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpensesAbstract", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "stringItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 3.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Research And Development Expense", "label": "Disposal Group, Including Discontinued Operation, Research And Development Expense", "terseLabel": "Research and development" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationsLiabilityForRelevantJurisdictionProceedsCurrent": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operations, Liability For Relevant Jurisdiction Proceeds, Current", "label": "Disposal Group, Including Discontinued Operations, Liability For Relevant Jurisdiction Proceeds, Current", "terseLabel": "Liabilities for Relevant Jurisdictions" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationsLiabilityForRelevantJurisdictionProceedsCurrent", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nvst_DisposalGroupIncludingDiscontinuedOperationsNonCashRestructuringCharges": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group Including Discontinued Operations, Non- Cash Restructuring Charges", "label": "Disposal Group Including Discontinued Operations, Non- Cash Restructuring Charges", "terseLabel": "Non-cash restructuring charges" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationsNonCashRestructuringCharges", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "monetaryItemType" }, "nvst_EffectiveIncomeTaxRateReconciliationChangesinPriorYearEstimatesUncertainTaxPositions": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails": { "order": 6.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Changes in Prior Year Estimates, Uncertain Tax Positions", "label": "Effective Income Tax Rate Reconciliation, Changes in Prior Year Estimates, Uncertain Tax Positions", "terseLabel": "Change in uncertain tax positions" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangesinPriorYearEstimatesUncertainTaxPositions", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "nvst_EffectiveIncomeTaxRateReconciliationSubpartFandGILTINetofForeignTaxCreditPercent": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails": { "order": 5.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Subpart F and GILTI, Net of Foreign Tax Credit, Percent", "label": "Effective Income Tax Rate Reconciliation, Subpart F and GILTI, Net of Foreign Tax Credit, Percent", "terseLabel": "Subpart F and GILTI, net of foreign tax credits" } } }, "localname": "EffectiveIncomeTaxRateReconciliationSubpartFandGILTINetofForeignTaxCreditPercent", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "nvst_EffectiveIncomeTaxReconciliationImpactOfStepUpAssetsPercent": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails": { "order": 11.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Reconciliation, Impact Of Step Up Assets, Percent", "label": "Effective Income Tax Reconciliation, Impact Of Step Up Assets, Percent", "terseLabel": "Impact of step-up of Swiss assets" } } }, "localname": "EffectiveIncomeTaxReconciliationImpactOfStepUpAssetsPercent", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "nvst_EffectiveIncomeTaxReconciliationReleaseOfValuationAllowanceOnForeignLossesPercent": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails": { "order": 9.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Reconciliation, Release Of Valuation Allowance On Foreign Losses, Percent", "label": "Effective Income Tax Reconciliation, Release Of Valuation Allowance On Foreign Losses, Percent", "verboseLabel": "Excess tax benefit from stock-based compensation" } } }, "localname": "EffectiveIncomeTaxReconciliationReleaseOfValuationAllowanceOnForeignLossesPercent", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "nvst_EquipmentSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment Sales [Member]", "label": "Equipment Sales [Member]", "terseLabel": "Equipment" } } }, "localname": "EquipmentSalesMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "nvst_EquipmentandConsumablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment and Consumables", "label": "Equipment and Consumables [Member]", "terseLabel": "Equipment & Consumables" } } }, "localname": "EquipmentandConsumablesMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsRollforwardDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "nvst_EuroTermLoanDue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Euro Term Loan Due 2024", "label": "Euro Term Loan Due 2024 [Member]", "terseLabel": "Euro Term Loan", "verboseLabel": "Euro term loan due 2024" } } }, "localname": "EuroTermLoanDue2024Member", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesUnamortizedDebtDiscountandIssuanceCostsDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_ForeignCurrencyDenominatedDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Currency Denominated debt [Member]", "label": "Foreign Currency Denominated Debt [Member]", "terseLabel": "Foreign currency denominated debt" } } }, "localname": "ForeignCurrencyDenominatedDebtMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "nvst_HighGrowthMarketsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Company defines high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which includes Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan and Australia).", "label": "High-Growth Markets [Member]", "terseLabel": "Emerging markets" } } }, "localname": "HighGrowthMarketsMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "nvst_IncreaseDecreaseInDeferredTaxLiabilitiesImpactOfStepUpAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) in Deferred Tax Liabilities, Impact Of Step Up Assets", "label": "Increase (Decrease) in Deferred Tax Liabilities, Impact Of Step Up Assets", "negatedTerseLabel": "Decrease in deferred tax liability" } } }, "localname": "IncreaseDecreaseInDeferredTaxLiabilitiesImpactOfStepUpAssets", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_InterestCoverageRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Coverage Ratio", "label": "Interest Coverage Ratio", "terseLabel": "Interest coverage ratio (at least)" } } }, "localname": "InterestCoverageRatio", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "nvst_LargestCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Largest Customer", "label": "Largest Customer [Member]", "terseLabel": "Largest customer" } } }, "localname": "LargestCustomerMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_LesseeAssetsandLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee, Assets and Liabilities[Table Text Block]", "label": "Lessee, Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of Weighted Average Remaining Lease Term and Discount Rate" } } }, "localname": "LesseeAssetsandLiabilitiesTableTextBlock", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "nvst_LesseeOperatingLeaseOptiontoTerminateTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Lease, Option to Terminate, Term", "label": "Lessee, Operating Lease, Option to Terminate, Term", "terseLabel": "Duration of option to terminate lease (in days)" } } }, "localname": "LesseeOperatingLeaseOptiontoTerminateTerm", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "nvst_NonderivativeHedgingInstruments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Nonderivative Hedging Instruments", "label": "Nonderivative Hedging Instruments", "terseLabel": "Long-term debt" } } }, "localname": "NonderivativeHedgingInstruments", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "nvst_NumberOfPortfolioSegments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Portfolio Segments", "label": "Number Of Portfolio Segments", "terseLabel": "Number of portfolio segments (in segments)" } } }, "localname": "NumberOfPortfolioSegments", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/CreditLossesNarrativeDetails" ], "xbrltype": "integerItemType" }, "nvst_OsteogenicsBiomedicalIncCarestreamDentalTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Osteogenics Biomedical Inc & Carestream Dental Technology", "label": "Osteogenics Biomedical Inc & Carestream Dental Technology [Member]", "terseLabel": "Osteogenics Biomedical Inc & Carestream Dental Technology" } } }, "localname": "OsteogenicsBiomedicalIncCarestreamDentalTechnologyMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_OsteogenicsBiomedicalIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Osteogenics Biomedical Inc", "label": "Osteogenics Biomedical Inc [Member]", "terseLabel": "Osteogenics Biomedical Inc" } } }, "localname": "OsteogenicsBiomedicalIncMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_OtherDevelopedMarketsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other developed markets [Member]", "label": "Other Developed Markets [Member]", "terseLabel": "Other developed markets" } } }, "localname": "OtherDevelopedMarketsMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "nvst_OtherNetPeriodicPensionCostsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Net Periodic Pension Costs [Abstract]", "label": "Other Net Periodic Pension Costs [Abstract]", "terseLabel": "Other net periodic pension costs:" } } }, "localname": "OtherNetPeriodicPensionCostsAbstract", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostReflectedintheConsolidatedCondensedStatementofEarningsDetails" ], "xbrltype": "stringItemType" }, "nvst_PacificDentalServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pacific Dental Services", "label": "Pacific Dental Services [Member]", "terseLabel": "Pacific Dental Services" } } }, "localname": "PacificDentalServicesMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "nvst_PaymentsForCappedCallsIssuanceOfConvertibleSeniorNotesFinancingActivities": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments For Capped Calls, Issuance Of Convertible Senior Notes, Financing Activities", "label": "Payments For Capped Calls, Issuance Of Convertible Senior Notes, Financing Activities", "negatedTerseLabel": "Purchase of capped calls related to issuance of convertible senior notes" } } }, "localname": "PaymentsForCappedCallsIssuanceOfConvertibleSeniorNotesFinancingActivities", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "nvst_PlamencaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plamenca", "label": "Plamenca [Member]", "terseLabel": "Plamenca" } } }, "localname": "PlamencaMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "domainItemType" }, "nvst_PrimeRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prime Rate", "label": "Prime Rate", "terseLabel": "Rate in excess of Federal funds rate" } } }, "localname": "PrimeRate", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "nvst_ProductWarrantyPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Product Warranty Period", "label": "Product Warranty Period", "terseLabel": "Product warranty period" } } }, "localname": "ProductWarrantyPeriod", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/WarrantyNarrativeDetails" ], "xbrltype": "durationItemType" }, "nvst_RangeFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range Five [Member]", "label": "Range Five [Member]", "terseLabel": "$41.96 to 48.52" } } }, "localname": "RangeFiveMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfOptionsOutstandingDetails" ], "xbrltype": "domainItemType" }, "nvst_RangeFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range Four [Member]", "label": "Range Four [Member]", "terseLabel": "$26.51 to $41.95" } } }, "localname": "RangeFourMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfOptionsOutstandingDetails" ], "xbrltype": "domainItemType" }, "nvst_RangeOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range One [Member]", "label": "Range One [Member]", "terseLabel": "$9.74 to 12.65" } } }, "localname": "RangeOneMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfOptionsOutstandingDetails" ], "xbrltype": "domainItemType" }, "nvst_RangeThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range Three [Member]", "label": "Range Three [Member]", "terseLabel": "$19.23 to 26.50" } } }, "localname": "RangeThreeMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfOptionsOutstandingDetails" ], "xbrltype": "domainItemType" }, "nvst_RangeTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range Two [Member]", "label": "Range Two [Member]", "terseLabel": "$12.66 to 19.22" } } }, "localname": "RangeTwoMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfOptionsOutstandingDetails" ], "xbrltype": "domainItemType" }, "nvst_RateinexcessofEurocurrencyrate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rate in excess of Eurocurrency rate", "label": "Rate in excess of Eurocurrency rate", "terseLabel": "Rate in excess of Eurocurrency rate" } } }, "localname": "RateinexcessofEurocurrencyrate", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "nvst_RatioofIndebtednesstoNetCapitalContingencyProvision": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ratio of Indebtedness to Net Capital, Contingency Provision", "label": "Ratio of Indebtedness to Net Capital, Contingency Provision", "terseLabel": "Contingency provision on the ratio of indebtedness to net capital" } } }, "localname": "RatioofIndebtednesstoNetCapitalContingencyProvision", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "nvst_RestrictedStockUnitsAndPerformanceStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock Units And Performance Stock Units", "label": "Restricted Stock Units And Performance Stock Units [Member]", "terseLabel": "RSUs / PSUs" } } }, "localname": "RestrictedStockUnitsAndPerformanceStockUnitsMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationComponentsofStockBasedCompensationProgramDetails" ], "xbrltype": "domainItemType" }, "nvst_SalesAndProductAllowancesCurrent": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sales And Product Allowances, Current", "label": "Sales And Product Allowances, Current", "terseLabel": "Sales and product allowances" } } }, "localname": "SalesAndProductAllowancesCurrent", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "nvst_SalesAndProductAllowancesNoncurrent": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 9.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sales And Product Allowances, Noncurrent", "label": "Sales And Product Allowances, Noncurrent", "terseLabel": "Sales and product allowances" } } }, "localname": "SalesAndProductAllowancesNoncurrent", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "nvst_SeniorUnsecuredRevolvingCreditFacility": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Revolving Credit Facility", "label": "Senior Unsecured Revolving Credit Facility", "terseLabel": "Senior unsecured revolving credit facility" } } }, "localname": "SeniorUnsecuredRevolvingCreditFacility", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Fair Value Assumptions, Expected Forfeiture Rate", "label": "Share Based Compensation Arrangement By Share Based Payment Award, Fair Value Assumptions, Expected Forfeiture Rate", "terseLabel": "Expected forfeiture rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "nvst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]", "label": "Share Based Compensation Arrangement By Share Based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]", "terseLabel": "Weighted\u00a0Average Remaining Contractual\u00a0Term (in years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "stringItemType" }, "nvst_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement by Share Based Payment Award Options, Aggregate Intrinsic Value [Abstract]", "label": "Share Based Compensation Arrangement by Share Based Payment Award Options, Aggregate Intrinsic Value [Abstract]", "terseLabel": "Aggregate Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "stringItemType" }, "nvst_SpecialtyProductsandTechnologiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specialty Products and Technologies", "label": "Specialty Products and Technologies [Member]", "terseLabel": "Specialty Products & Technologies" } } }, "localname": "SpecialtyProductsandTechnologiesMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsRollforwardDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "nvst_StandardProductWarrantyAccrualDecreaseFromDivestitureOfBusiness": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Standard Product Warranty Accrual, Decrease From Divestiture Of Business", "label": "Standard Product Warranty Accrual, Decrease From Divestiture Of Business", "negatedTerseLabel": "Divestiture" } } }, "localname": "StandardProductWarrantyAccrualDecreaseFromDivestitureOfBusiness", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "nvst_TotalBorrowingsunderTermLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total Borrowings under Term Loan", "label": "Total Borrowings under Term Loan", "terseLabel": "Total borrowings under term loan" } } }, "localname": "TotalBorrowingsunderTermLoan", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_USTermLoanDue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "US Term Loan Due 2024", "label": "US Term Loan Due 2024 [Member]", "terseLabel": "Term Loan", "verboseLabel": "US term loan due 2024" } } }, "localname": "USTermLoanDue2024Member", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesUnamortizedDebtDiscountandIssuanceCostsDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "nvst_UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation", "label": "Unrecognized Tax Benefits, Increase (Decrease) Resulting from Foreign Currency Translation", "terseLabel": "Effect of foreign currency translation" } } }, "localname": "UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromForeignCurrencyTranslation", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "nvst_UnrecognizedTaxBenefitsNetOfOffsettingIndirectTaxBenefits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unrecognized tax benefits, net of offsetting indirect tax benefits.", "label": "Unrecognized Tax Benefits Net Of Offsetting Indirect Tax Benefits", "terseLabel": "Unrecognized tax benefits, net of offsetting indirect tax benefits" } } }, "localname": "UnrecognizedTaxBenefitsNetOfOffsettingIndirectTaxBenefits", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "nvst_WesternEuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Western Europe [Member]", "label": "Western Europe [Member]", "terseLabel": "Western Europe" } } }, "localname": "WesternEuropeMember", "nsuri": "http://www.envistaco.com/20221231", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "srt_AffiliatedEntityMember": { "auth_ref": [ "r895", "r899", "r1056", "r1110", "r1111", "r1112" ], "lang": { "en-us": { "role": { "documentation": "An affiliate is a party that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with the entity.", "label": "Affiliated Entity [Member]", "terseLabel": "Danaher" } } }, "localname": "AffiliatedEntityMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r386", "r765", "r766", "r769", "r770", "r842", "r895", "r899", "r1043", "r1046", "r1047", "r1127", "r1130", "r1131" ], "lang": { "en-us": { "role": { "documentation": "Information by consolidated entity or group of entities.", "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r386", "r765", "r766", "r769", "r770", "r842", "r895", "r899", "r1043", "r1046", "r1047", "r1127", "r1130", "r1131" ], "lang": { "en-us": { "role": { "documentation": "Entity or group of entities consolidated into reporting entity.", "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r386", "r436", "r448", "r449", "r450", "r451", "r452", "r454", "r458", "r538", "r539", "r540", "r541", "r543", "r544", "r546", "r548", "r549", "r910", "r911", "r912", "r913", "r914", "r915", "r916", "r917", "r918", "r1044", "r1045", "r1128", "r1129" ], "lang": { "en-us": { "role": { "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r386", "r436", "r448", "r449", "r450", "r451", "r452", "r454", "r458", "r538", "r539", "r540", "r541", "r543", "r544", "r546", "r548", "r549", "r910", "r911", "r912", "r913", "r914", "r915", "r916", "r917", "r918", "r1044", "r1045", "r1128", "r1129" ], "lang": { "en-us": { "role": { "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r384", "r385", "r554", "r583", "r919", "r922", "r924" ], "lang": { "en-us": { "role": { "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": { "auth_ref": [ "r979", "r1006", "r1008", "r1021", "r1085", "r1086", "r1087", "r1093", "r1094", "r1099", "r1100", "r1101", "r1109" ], "lang": { "en-us": { "role": { "documentation": "Represents amount after cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]", "terseLabel": "Adjusted balance" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r331", "r395", "r402", "r408", "r476", "r717", "r718", "r719", "r748", "r749", "r777", "r780", "r782", "r783", "r839" ], "lang": { "en-us": { "role": { "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "terseLabel": "Adjustment" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r331", "r395", "r402", "r408", "r476", "r717", "r718", "r719", "r748", "r749", "r777", "r780", "r782", "r783", "r839" ], "lang": { "en-us": { "role": { "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r331", "r395", "r402", "r408", "r476", "r717", "r718", "r719", "r748", "r749", "r777", "r780", "r782", "r783", "r839" ], "lang": { "en-us": { "role": { "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r464", "r940", "r1050", "r1124" ], "lang": { "en-us": { "role": { "documentation": "Information by name or description of a single external customer or a group of external customers.", "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r533", "r534", "r535", "r536", "r677", "r847", "r866", "r896", "r897", "r937", "r955", "r966", "r1048", "r1115", "r1116", "r1117", "r1118", "r1119", "r1120" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/LeasesNarrativeDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationAssumptionsUsedToValueOptionsGrantedDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesofDepreciableAssetsDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r533", "r534", "r535", "r536", "r677", "r847", "r866", "r896", "r897", "r937", "r955", "r966", "r1048", "r1115", "r1116", "r1117", "r1118", "r1119", "r1120" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationAssumptionsUsedToValueOptionsGrantedDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesofDepreciableAssetsDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r464", "r940", "r1050", "r1124" ], "lang": { "en-us": { "role": { "documentation": "Single external customer or group of external customers.", "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Continent of North America.", "label": "North America [Member]", "terseLabel": "North America" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r460", "r849", "r938", "r964", "r1040", "r1041", "r1050", "r1123" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r460", "r849", "r938", "r964", "r1040", "r1041", "r1050", "r1123" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r533", "r534", "r535", "r536", "r626", "r677", "r710", "r711", "r712", "r846", "r847", "r866", "r896", "r897", "r937", "r955", "r966", "r1036", "r1048", "r1116", "r1117", "r1118", "r1119", "r1120" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/LeasesNarrativeDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationAssumptionsUsedToValueOptionsGrantedDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesofDepreciableAssetsDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r533", "r534", "r535", "r536", "r626", "r677", "r710", "r711", "r712", "r846", "r847", "r866", "r896", "r897", "r937", "r955", "r966", "r1036", "r1048", "r1116", "r1117", "r1118", "r1119", "r1120" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/LeasesNarrativeDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationAssumptionsUsedToValueOptionsGrantedDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesofDepreciableAssetsDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r384", "r385", "r554", "r583", "r923", "r924" ], "lang": { "en-us": { "role": { "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r678", "r1009", "r1126" ], "lang": { "en-us": { "role": { "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.", "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r408", "r678", "r977", "r1009" ], "lang": { "en-us": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": { "auth_ref": [ "r391", "r909" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]", "terseLabel": "Schedule II - of Valuation and Qualifying Accounts" } } }, "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/ScheduleIIValuationandQualifyingAccounts" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r461", "r462", "r886", "r887", "r888", "r889", "r890", "r891", "r892", "r893", "r894", "r898", "r901", "r902", "r903", "r904", "r905", "r906", "r907", "r908", "r939", "r965", "r1050" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesEarningsFromContinuingOperationsBeforeIncomeTaxesDetails", "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/SegmentInformationScheduleOfOperationsInGeographicalAreasDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r461", "r462", "r880", "r886", "r887", "r888", "r889", "r890", "r891", "r892", "r893", "r894", "r898", "r900", "r939", "r965", "r1050" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesEarningsFromContinuingOperationsBeforeIncomeTaxesDetails", "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/SegmentInformationScheduleOfOperationsInGeographicalAreasDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r408", "r678", "r977", "r978", "r1009" ], "lang": { "en-us": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]" } } }, "localname": "ValuationAndQualifyingAccountsAbstract", "nsuri": "http://fasb.org/srt/2022", "xbrltype": "stringItemType" }, "srt_WeightedAverageMember": { "auth_ref": [ "r896", "r897", "r1115", "r1117", "r1120" ], "lang": { "en-us": { "role": { "documentation": "Average of a range of values, calculated with consideration of proportional relevance.", "label": "Weighted Average [Member]", "terseLabel": "Weighted Average" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdateExtensibleList": { "auth_ref": [ "r329", "r330", "r331", "r332", "r333", "r396", "r397", "r398", "r469", "r470", "r473", "r474", "r475", "r476", "r477", "r478", "r717", "r718", "r719", "r748", "r749", "r761", "r762", "r763", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r813", "r814", "r818", "r819", "r820", "r836", "r837", "r838", "r839", "r840", "r841", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r877", "r878", "r1007" ], "lang": { "en-us": { "role": { "documentation": "Indicates amendment to accounting standards.", "label": "Accounting Standards Update [Extensible Enumeration]", "terseLabel": "Accounting Standards Update [Extensible List]" } } }, "localname": "AccountingStandardsUpdateExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r25", "r45" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "terseLabel": "Trade accounts payable" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "auth_ref": [ "r1022" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Allowance for Credit Loss" } } }, "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CreditLossesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r466", "r467" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Trade accounts receivable, less allowance for credit losses of $16.2 and $20.7, respectively" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r29", "r298", "r315" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 5.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Taxes, income and other" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesNoncurrent": { "auth_ref": [ "r31", "r298", "r315" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 8.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.", "label": "Accrued Income Taxes, Noncurrent", "terseLabel": "Taxes, income and other" } } }, "localname": "AccruedIncomeTaxesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r60", "r66", "r254", "r987", "r988", "r989" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Unrealized Pension Costs" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r140", "r343" ], "calculation": { "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r358", "r367", "r368", "r767", "r925", "r987" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "verboseLabel": "Unrealized Loss on Cash Flow Hedges" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r63", "r65", "r66", "r350", "r861", "r874", "r878" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r366", "r367", "r805", "r806", "r807", "r808", "r809", "r811" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r62", "r66", "r254", "r841", "r869", "r870", "r987", "r988", "r989", "r1003", "r1004", "r1005" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails", "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r59", "r66", "r254", "r367", "r368", "r806", "r807", "r808", "r809", "r811", "r987" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign Currency Translation Adjustments" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Weighted-average useful life of acquired intangible assets" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r37", "r963" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r717", "r718", "r719", "r1003", "r1004", "r1005", "r1100" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Noncash items:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": { "auth_ref": [ "r169" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.", "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt", "terseLabel": "Equity component of convertible senior notes, net of financing costs and taxes" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r214", "r215", "r682" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Common stock-based award activity" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r722" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Cost [Policy Text Block]", "terseLabel": "Advertising" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AllOtherSegmentsMember": { "auth_ref": [ "r432", "r448", "r449", "r450", "r451", "r452" ], "lang": { "en-us": { "role": { "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.", "label": "Other Segments [Member]", "terseLabel": "Other" } } }, "localname": "AllOtherSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r714" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-Based Payment Arrangement, Expense", "verboseLabel": "Stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationComponentsofStockBasedCompensationProgramDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r351", "r468", "r479", "r481", "r485" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Allowance for credit losses" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": { "auth_ref": [ "r484" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery.", "label": "Accounts Receivable, Allowance for Credit Loss, Recovery", "negatedTerseLabel": "Recoveries" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]", "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableRollforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "auth_ref": [ "r483" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.", "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "negatedLabel": "Write-offs charged against the allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r80", "r97", "r289", "r573" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r74", "r573", "r816", "r996" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of debt issuance costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r573", "r816", "r935", "r936", "r996" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of debt discount and issuance costs" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r97", "r120", "r128" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Total intangible amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of diluted (loss) income per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r104" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r104" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r97", "r135" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "terseLabel": "Asset impairment charges" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r296", "r314", "r347", "r381", "r444", "r450", "r456", "r472", "r538", "r539", "r541", "r542", "r543", "r545", "r547", "r549", "r550", "r765", "r769", "r794", "r963", "r1044", "r1045", "r1113" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets", "verboseLabel": "Identifiable assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r338", "r354", "r381", "r472", "r538", "r539", "r541", "r542", "r543", "r545", "r547", "r549", "r550", "r765", "r769", "r794", "r963", "r1044", "r1045", "r1113" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r0", "r1", "r17", "r137", "r143", "r336", "r337" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Assets, Current", "terseLabel": "Assets held for sale", "totalLabel": "Current assets held for sale" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets", "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r685", "r686", "r687", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r709", "r710", "r711", "r712", "r713" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationAssumptionsUsedToValueOptionsGrantedDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationComponentsofStockBasedCompensationProgramDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r264", "r267" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Accounting Principles" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingAndBuildingImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Building and Building Improvements [Member]", "terseLabel": "Buildings and improvements" } } }, "localname": "BuildingAndBuildingImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r139" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Buildings" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesofDepreciableAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r759", "r949", "r952" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r234", "r235", "r759", "r949", "r952" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r233" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Acquisition costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r244", "r245", "r247" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Consideration transferred" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r243", "r246", "r764" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "terseLabel": "Contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsNarrativeDetails", "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r248", "r760" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "verboseLabel": "Acquisitions" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/Acquisitions" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory": { "auth_ref": [ "r239" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory", "terseLabel": "Fair value adjustment of acquisition-related inventory" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]", "terseLabel": "Assets acquired:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": { "auth_ref": [ "r237" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lease obligation assumed in business combination.", "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation", "negatedTerseLabel": "Operating lease liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r237" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r237" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 7.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets", "terseLabel": "Prepaids and Other Current Assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r237" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Accounts receivable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r237" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "negatedTerseLabel": "Accounts payable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "auth_ref": [ "r237" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "negatedTerseLabel": "Accrued expenses and other liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": { "auth_ref": [ "r237" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets", "terseLabel": "Non-current deferred tax asset" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r237" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "negatedTerseLabel": "Non-current deferred tax liability" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r237" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r236", "r237" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 10.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventories" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r237" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "negatedTotalLabel": "Total liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]", "terseLabel": "Liabilities assumed:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r236", "r237" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "totalLabel": "Total net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "auth_ref": [ "r237" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "negatedTerseLabel": "Other long-term liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "auth_ref": [ "r237" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 8.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets", "terseLabel": "Other long-term assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r236", "r237" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 6.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property, plant and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r232" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Acquisitions" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalExpenditureDiscontinuedOperations": { "auth_ref": [ "r16" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of capital expenditure attributable to discontinued operations.", "label": "Capital Expenditure, Discontinued Operations", "terseLabel": "Capital expenditures" } } }, "localname": "CapitalExpenditureDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r284", "r285" ], "lang": { "en-us": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying Amount" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r99", "r341", "r920" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r93", "r99", "r102" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Ending balance of cash and cash equivalents", "periodStartLabel": "Beginning balance of cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r93", "r288" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r55", "r304", "r322" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r159", "r882" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "Commitments and Contingencies, Policy [Policy Text Block]", "terseLabel": "Loss Contingencies" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock": { "auth_ref": [ "r155", "r165", "r1042" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments, contingencies, and guarantees.", "label": "Commitments Contingencies and Guarantees [Text Block]", "terseLabel": "Litigation And Contingencies" } } }, "localname": "CommitmentsContingenciesAndGuaranteesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LitigationAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r1003", "r1004", "r1100" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryofShareActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in USD per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r36", "r176" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "End of period, common stock (in shares)", "periodStartLabel": "Beginning of period, common stock (in shares)", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryofShareActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r36", "r963" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock - $0.01 par value, 500.0 million shares authorized; 163.7 million shares issued and 163.2 million shares outstanding at December 31, 2022; 162.0 million shares issued and 161.6 million shares outstanding at December 31, 2021" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]", "terseLabel": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Compensation Related Costs, Policy [Policy Text Block]", "terseLabel": "Pension Plans" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r69", "r362", "r364", "r372", "r857", "r863" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r83", "r371", "r856", "r862" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLoss" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income, Policy [Policy Text Block]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r106", "r107", "r286", "r287", "r464", "r881" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r106", "r107", "r286", "r287", "r464", "r879", "r881" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r106", "r107", "r286", "r287", "r464", "r881", "r1125" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r106", "r107", "r286", "r287", "r464" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r106", "r107", "r286", "r287", "r464", "r881" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]", "terseLabel": "Construction in progress" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r585", "r586", "r599" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Contract liability" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r585", "r586", "r599" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r585", "r586", "r599" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "terseLabel": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r600" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtFairValueDisclosures": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt, Fair Value Disclosures", "terseLabel": "Convertible debt, fair value", "verboseLabel": "Convertible senior notes due 2025" } } }, "localname": "ConvertibleDebtFairValueDisclosures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r168", "r551", "r552", "r563", "r564", "r565", "r569", "r570", "r571", "r572", "r573", "r932", "r933", "r934", "r935", "r936" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible Debt" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesUnamortizedDebtDiscountandIssuanceCostsDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.", "label": "Convertible Debt [Table Text Block]", "terseLabel": "Components of note interest expense" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r115", "r449", "r450", "r451", "r452", "r458", "r1014" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Other" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r77", "r849" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostReflectedintheConsolidatedCondensedStatementofEarningsDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfSalesPolicyTextBlock": { "auth_ref": [ "r1051" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.", "label": "Cost of Goods and Service [Policy Text Block]", "terseLabel": "Shipping and Handling" } } }, "localname": "CostOfSalesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": { "auth_ref": [ "r150", "r151", "r154" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.", "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]", "terseLabel": "Restructuring" } } }, "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Credit Loss [Abstract]" } } }, "localname": "CreditLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CreditLossFinancialInstrumentTextBlock": { "auth_ref": [ "r480", "r486", "r487", "r488", "r489", "r490", "r491" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security.", "label": "Credit Loss, Financial Instrument [Text Block]", "terseLabel": "Credit Losses" } } }, "localname": "CreditLossFinancialInstrumentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CreditLosses" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrencySwapMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.", "label": "Currency Swap [Member]", "terseLabel": "Cross-currency swap derivative contracts", "verboseLabel": "Cross-currency swap derivative contracts" } } }, "localname": "CurrencySwapMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r999", "r1091", "r1095" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Federal U.S." } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r999", "r1091" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "terseLabel": "Non-U.S." } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Current:" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r999", "r1091", "r1095" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "State and local" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r105", "r464" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r241" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships and other intangibles" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r348" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of debt and lease obligation, classified as current.", "label": "Debt, Current", "negatedLabel": "Less: current portion" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r172", "r380", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r567", "r574", "r575", "r577" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "verboseLabel": "Debt And Credit Facilities" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r28", "r29", "r30", "r297", "r300", "r313", "r386", "r551", "r552", "r553", "r554", "r555", "r557", "r563", "r564", "r565", "r566", "r568", "r569", "r570", "r571", "r572", "r573", "r817", "r932", "r933", "r934", "r935", "r936", "r997" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesUnamortizedDebtDiscountandIssuanceCostsDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Margin spread of variable interest rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r30", "r300", "r313", "r578" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesDebtPaymentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-Term Debt, Gross", "totalLabel": "Total" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesDebtPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r170", "r553" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Conversion price (in USD per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleConversionRatio1": { "auth_ref": [ "r51", "r177", "r180", "r182", "r553" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.", "label": "Debt Instrument, Convertible, Conversion Ratio", "terseLabel": "Conversion ratio" } } }, "localname": "DebtInstrumentConvertibleConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal": { "auth_ref": [ "r171" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only.", "label": "Debt Instrument, Convertible, If-converted Value in Excess of Principal", "terseLabel": "If-converted value in excess of principal" } } }, "localname": "DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of the entity's common stock which would be required to be attained for the conversion feature embedded in the debt instrument to become effective.", "label": "Debt Instrument, Convertible, Stock Price Trigger", "terseLabel": "Convertible debt, stock price trigger (in USD per share)" } } }, "localname": "DebtInstrumentConvertibleStockPriceTrigger", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "terseLabel": "Convertible debt, consecutive trading days (in trading days)" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.", "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger", "terseLabel": "Threshold percentage of stock price trigger" } } }, "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Trading Days", "terseLabel": "Convertible debt, trading days (in trading days)" } } }, "localname": "DebtInstrumentConvertibleThresholdTradingDays", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r290", "r293", "r551", "r817", "r933", "r934" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Term loan" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r50", "r290", "r570" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt Instrument, Interest Rate During Period", "terseLabel": "Loan facility interest rates" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r50", "r290", "r580", "r817" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Effective interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r50", "r552" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesUnamortizedDebtDiscountandIssuanceCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r52", "r386", "r551", "r552", "r553", "r554", "r555", "r557", "r563", "r564", "r565", "r566", "r568", "r569", "r570", "r571", "r572", "r573", "r817", "r932", "r933", "r934", "r935", "r936", "r997" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesUnamortizedDebtDiscountandIssuanceCostsDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Redemption price" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r52", "r177", "r181", "r182", "r183", "r289", "r290", "r293", "r311", "r386", "r551", "r552", "r553", "r554", "r555", "r557", "r563", "r564", "r565", "r566", "r568", "r569", "r570", "r571", "r572", "r573", "r576", "r817", "r932", "r933", "r934", "r935", "r936", "r997" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesUnamortizedDebtDiscountandIssuanceCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt instrument, term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r289", "r293", "r1049" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "terseLabel": "Debt Discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesUnamortizedDebtDiscountandIssuanceCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": { "auth_ref": [ "r289", "r290", "r291", "r292", "r293", "r1049" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount (premium).", "label": "Debt Instrument, Unamortized Discount (Premium), Net", "terseLabel": "Unamortized discount (premium), net" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).", "label": "Deferred Compensation Liability, Classified, Noncurrent", "terseLabel": "Deferred compensation plans" } } }, "localname": "DeferredCompensationLiabilityClassifiedNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r999", "r1092", "r1095" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "Federal U.S." } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r291", "r1049" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "terseLabel": "Debt Issuance Costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesUnamortizedDebtDiscountandIssuanceCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r231", "r999", "r1092" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetails": { "order": 5.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "terseLabel": "Non-U.S." } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Deferred:" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r32", "r33", "r299", "r312", "r740" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total deferred tax liability" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r726", "r727" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "negatedLabel": "Net deferred tax liability", "negatedTerseLabel": "Net deferred tax liability" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r999", "r1092", "r1095" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetails": { "order": 6.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "State and local" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetInterestCarryforward": { "auth_ref": [ "r1090" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.", "label": "Deferred Tax Asset, Interest Carryforward", "terseLabel": "Interest expense" } } }, "localname": "DeferredTaxAssetInterestCarryforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": { "auth_ref": [ "r228", "r1090" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.", "label": "Deferred Tax Assets, in Process Research and Development", "terseLabel": "Capitalized research expenses" } } }, "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInventory": { "auth_ref": [ "r228", "r1090" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails": { "order": 9.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.", "label": "Deferred Tax Assets, Inventory", "terseLabel": "Inventories" } } }, "localname": "DeferredTaxAssetsInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r1089" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "terseLabel": "Net deferred tax assets", "totalLabel": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails", "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r1089" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Total deferred tax asset" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net of Valuation Allowance [Abstract]", "terseLabel": "Deferred tax assets:" } } }, "localname": "DeferredTaxAssetsNetOfValuationAllowanceAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": { "auth_ref": [ "r228", "r1090" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits", "terseLabel": "Pension benefits" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r228", "r1090" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost", "terseLabel": "Stock-based compensation expense" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": { "auth_ref": [ "r228", "r1090" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other", "terseLabel": "Other accruals and prepayments" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r741" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedTerseLabel": "Valuation allowances" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r218", "r1089" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Net deferred tax liabilities", "terseLabel": "Net deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails", "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Gross [Abstract]", "terseLabel": "Deferred tax liabilities:" } } }, "localname": "DeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilitiesFinancingArrangements": { "auth_ref": [ "r228", "r1090" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from financing arrangements.", "label": "Deferred Tax Liabilities, Financing Arrangements", "negatedTerseLabel": "Unrealized gains and losses" } } }, "localname": "DeferredTaxLiabilitiesFinancingArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": { "auth_ref": [ "r228", "r1090" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.", "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets", "negatedTerseLabel": "Goodwill and other intangible assets" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "auth_ref": [ "r228", "r1090" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "negatedTerseLabel": "Property, plant and equipment" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax": { "auth_ref": [ "r66", "r647" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Accumulated Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Tax", "verboseLabel": "Unrecognized actuarial gain, net of tax" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": { "auth_ref": [ "r66", "r647" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax", "verboseLabel": "Unrecognized actuarial gain, before tax" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax": { "auth_ref": [ "r66", "r647" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax", "negatedLabel": "Unrecognized prior service credits, net of tax" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditAfterTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": { "auth_ref": [ "r66", "r647" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax", "negatedLabel": "Unrecognized prior service credits, before tax" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": { "auth_ref": [ "r617", "r947" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.", "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)", "terseLabel": "Actual return on plan assets" } } }, "localname": "DefinedBenefitPlanActualReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld": { "auth_ref": [ "r631", "r947" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan from actual return (loss) on assets still held.", "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held", "terseLabel": "Return on Plan Assets" } } }, "localname": "DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansChangesinFairValueofPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActuarialGainLoss": { "auth_ref": [ "r610" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.", "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)", "terseLabel": "Actuarial gain" } } }, "localname": "DefinedBenefitPlanActuarialGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r604", "r642", "r665", "r947", "r948" ], "calculation": { "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails": { "order": 5.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "terseLabel": "Amortization of actuarial loss" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "auth_ref": [ "r604", "r643", "r666", "r947", "r948" ], "calculation": { "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "negatedTerseLabel": "Amortization of prior service credit and initial net obligation" } } }, "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": { "auth_ref": [ "r649" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate", "terseLabel": "Discount rate" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansWeightedAverageAssumptionsUsedToDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": { "auth_ref": [ "r650" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase", "terseLabel": "Rate of compensation increase" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansWeightedAverageAssumptionsUsedToDetermineBenefitObligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": { "auth_ref": [ "r649" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate", "terseLabel": "Discount rate" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansWeightedAverageAssumptionsUsedToDetermineNetPeriodicPensionCostDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": { "auth_ref": [ "r651", "r670" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets", "terseLabel": "Expected long-term return on plan assets", "verboseLabel": "Long-term rate of return on asset assumptions" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansWeightedAverageAssumptionsUsedToDetermineNetPeriodicPensionCostDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": { "auth_ref": [ "r650" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase", "terseLabel": "Rate of compensation increase" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansWeightedAverageAssumptionsUsedToDetermineNetPeriodicPensionCostDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligation": { "auth_ref": [ "r605" ], "calculation": { "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Benefit Obligation", "negatedPeriodEndLabel": "Benefit obligation at end of year", "negatedPeriodStartLabel": "Benefit obligation at beginning of year" } } }, "localname": "DefinedBenefitPlanBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": { "auth_ref": [ "r612", "r673" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.", "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid", "terseLabel": "Benefits and other expenses paid" } } }, "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": { "auth_ref": [ "r609" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.", "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant", "negatedTerseLabel": "Employee contributions" } } }, "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": { "auth_ref": [ "r626", "r627", "r629", "r630", "r631", "r632", "r633", "r634", "r654", "r945", "r946", "r947" ], "lang": { "en-us": { "role": { "documentation": "Information by defined benefit plan asset investment.", "label": "Defined Benefit Plan, Plan Assets, Category [Axis]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]" } } }, "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": { "auth_ref": [ "r945" ], "lang": { "en-us": { "role": { "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested.", "label": "Defined Benefit Plan, Cash and Cash Equivalents [Member]", "terseLabel": "Cash and cash equivalents" } } }, "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]", "terseLabel": "Change in pension benefit obligation:" } } }, "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]", "terseLabel": "Change in plan assets:" } } }, "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r619", "r629", "r669", "r945", "r946", "r947", "r948" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "terseLabel": "Employer contributions" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansBenefitPaymentsThatReflectExpectedFutureServiceDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": { "auth_ref": [ "r636" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years", "terseLabel": "2028 - 2032" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansBenefitPaymentsThatReflectExpectedFutureServiceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": { "auth_ref": [ "r636" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One", "terseLabel": "2023" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansBenefitPaymentsThatReflectExpectedFutureServiceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": { "auth_ref": [ "r636" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five", "terseLabel": "2027" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansBenefitPaymentsThatReflectExpectedFutureServiceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": { "auth_ref": [ "r636" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four", "terseLabel": "2026" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansBenefitPaymentsThatReflectExpectedFutureServiceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": { "auth_ref": [ "r636" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three", "terseLabel": "2025" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansBenefitPaymentsThatReflectExpectedFutureServiceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": { "auth_ref": [ "r636" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two", "terseLabel": "2024" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansBenefitPaymentsThatReflectExpectedFutureServiceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": { "auth_ref": [ "r637", "r948" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year", "terseLabel": "Expected employer contributions within the next year" } } }, "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r604", "r641", "r664", "r947", "r948" ], "calculation": { "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "terseLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": { "auth_ref": [ "r616", "r627", "r629", "r630", "r945", "r946", "r947" ], "calculation": { "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.", "label": "Defined Benefit Plan, Plan Assets, Amount", "periodEndLabel": "Fair value of plan assets at end of year", "periodStartLabel": "Fair value of plan assets at beginning of year", "terseLabel": "Defined benefit plan, plan assets" } } }, "localname": "DefinedBenefitPlanFairValueOfPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansChangesinFairValueofPlanAssetsDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": { "auth_ref": [ "r611" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign exchange rate impact" } } }, "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": { "auth_ref": [ "r603", "r625", "r947" ], "calculation": { "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.", "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan", "totalLabel": "Funded status" } } }, "localname": "DefinedBenefitPlanFundedStatusOfPlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r604", "r608", "r640", "r663", "r947", "r948" ], "calculation": { "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "negatedTerseLabel": "Interest cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r638", "r661", "r947", "r948" ], "calculation": { "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostReflectedintheConsolidatedCondensedStatementofEarningsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "negatedTotalLabel": "Net periodic pension cost" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostReflectedintheConsolidatedCondensedStatementofEarningsDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]", "terseLabel": "Service cost:" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostReflectedintheConsolidatedCondensedStatementofEarningsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList": { "auth_ref": [ "r638", "r661" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of income or comprehensive income that includes components of net periodic benefit cost (credit), excluding service cost component, for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]", "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostReflectedintheConsolidatedCondensedStatementofEarningsDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": { "auth_ref": [ "r621", "r1058" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.", "label": "Defined Benefit Plan, Plan Assets, Benefits Paid", "negatedLabel": "Benefits and other expenses paid" } } }, "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsCategoryLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan, Plan Assets, Category [Line Items]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Line Items]" } } }, "localname": "DefinedBenefitPlanPlanAssetsCategoryLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansChangesinFairValueofPlanAssetsDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostReflectedintheConsolidatedCondensedStatementofEarningsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsCategoryTable": { "auth_ref": [ "r627", "r629", "r634", "r947" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about defined benefit plan asset investment. Includes, but is not limited to, fair value of category of plan asset and its level within fair value hierarchy.", "label": "Defined Benefit Plan, Plan Assets, Category [Table]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Table]" } } }, "localname": "DefinedBenefitPlanPlanAssetsCategoryTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansChangesinFairValueofPlanAssetsDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostReflectedintheConsolidatedCondensedStatementofEarningsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": { "auth_ref": [ "r620" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant", "terseLabel": "Employee contributions" } } }, "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r618" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign exchange rate impact" } } }, "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements": { "auth_ref": [ "r632", "r947" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, measured using unobservable input, of increase (decrease) in plan asset of defined benefit plan from purchase, sale and settlement of trade associated with underlying investment.", "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement", "terseLabel": "Net Purchases/(Settlements)" } } }, "localname": "DefinedBenefitPlanPurchasesSalesAndSettlements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansChangesinFairValueofPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1": { "auth_ref": [ "r1052", "r1055", "r1057" ], "calculation": { "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails": { "order": 6.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment", "terseLabel": "Net settlement and curtailment gain (loss)" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r606", "r639", "r662", "r947", "r948" ], "calculation": { "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostReflectedintheConsolidatedCondensedStatementofEarningsDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 }, "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "negatedLabel": "Service costs", "negatedTerseLabel": "Service cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostReflectedintheConsolidatedCondensedStatementofEarningsDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels": { "auth_ref": [ "r633", "r947" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan, for assets transferred into (out of) Level 3 of fair value hierarchy. Includes, but is not limited to, transfer due to change in observability of significant inputs.", "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Assets Transferred into (out of) Level 3", "terseLabel": "Transfers Into/(Out of) Level 3" } } }, "localname": "DefinedBenefitPlanTransfersBetweenMeasurementLevels", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansChangesinFairValueofPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r97", "r138" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortizationDiscontinuedOperations": { "auth_ref": [ "r335", "r996" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deprecation and amortization expense attributable to property, plant and equipment and intangible assets of discontinued operations.", "label": "Depreciation and Amortization, Discontinued Operations", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortizationDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r97", "r439" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r265", "r266", "r270", "r271", "r924" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r276", "r773" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "Hedging Transactions and Derivative Financial Instruments" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r262", "r265", "r270" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r262", "r265", "r270", "r271", "r274", "r275", "r772" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r355", "r356", "r793", "r924" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Accrued expenses and other liabilities", "verboseLabel": "Swap derivative contracts" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r355" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Derivative financial instruments" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "auth_ref": [ "r355" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 6.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Noncurrent", "terseLabel": "Derivative financial instruments" } } }, "localname": "DerivativeLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r771" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative liability.", "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r1097", "r1098" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "verboseLabel": "Notional Amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r257", "r259", "r260", "r262", "r263", "r268", "r270", "r272", "r273", "r275", "r773" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]", "terseLabel": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesReportingOfDerivativeActivity": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for derivatives entered into for trading purposes and those entered into for purposes other than trading including where and when derivative financial instruments and derivative commodity instruments and their related gains or losses are reported in the entity's statements of financial position, cash flows, and results of operations.", "label": "Derivatives, Reporting of Derivative Activity [Policy Text Block]", "terseLabel": "Derivative Financial Instruments" } } }, "localname": "DerivativesReportingOfDerivativeActivity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r598", "r938", "r939", "r940", "r941", "r942", "r943", "r944" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r1050" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of disaggregation of revenue by geographical region and type" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]", "terseLabel": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "auth_ref": [ "r199", "r212" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of share-based payment arrangement.", "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]", "terseLabel": "Components Of Stock-Based Compensation Program" } } }, "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax": { "auth_ref": [ "r3", "r5", "r7", "r19" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.", "label": "Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax", "verboseLabel": "Gain on sale of discontinued operations, net of tax" } } }, "localname": "DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax": { "auth_ref": [ "r3", "r4", "r19" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until disposal.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax", "totalLabel": "(Loss) income from discontinued operations" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share", "terseLabel": "Earnings (loss) from discontinued operations - basic (in USD per share)" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share", "terseLabel": "Earnings (loss) from discontinued operations - diluted (in USD per share)" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": { "auth_ref": [ "r4", "r5", "r6", "r7", "r14", "r19", "r728", "r751", "r755" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 1.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.", "label": "Discontinued Operation, Tax Effect of Discontinued Operation", "terseLabel": "Income tax expense" } } }, "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued Operations and Disposal Groups [Abstract]", "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]" } } }, "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results.", "label": "Discontinued Operations, Disposed of by Sale [Member]", "terseLabel": "Discontinued operations disposed of by sale" } } }, "localname": "DiscontinuedOperationsDisposedOfBySaleMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]", "terseLabel": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsNarrativeDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]", "terseLabel": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsNarrativeDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember": { "auth_ref": [ "r134", "r136" ], "lang": { "en-us": { "role": { "documentation": "Disposal group that is disposed of by means of abandonment. Excludes disposals classified as discontinued operations.", "label": "Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Abandonment [Member]", "terseLabel": "Disposal by abandonment" } } }, "localname": "DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Consideration", "terseLabel": "Consideration" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": { "auth_ref": [ "r15", "r337" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 1.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold", "terseLabel": "Cost of sales" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": { "auth_ref": [ "r15" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 2.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, General and Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss": { "auth_ref": [ "r15", "r337" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 1.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Gross Profit (Loss)", "totalLabel": "Gross profit" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": { "auth_ref": [ "r15" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 2.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)", "totalLabel": "Operating (loss) profit" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "auth_ref": [ "r15", "r337" ], "calculation": { "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": 2.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Revenue", "terseLabel": "Sales" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown": { "auth_ref": [ "r97", "r136", "r142" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.", "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down", "verboseLabel": "Non-cash loss" } } }, "localname": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "auth_ref": [ "r23", "r146" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "terseLabel": "Discontinued Operations" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r949", "r952" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]", "terseLabel": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]", "terseLabel": "United States" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DueToEmployeesNoncurrent": { "auth_ref": [ "r53", "r294" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 7.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amounts due to Employee, not to include stockholders or officers, which are due after one year (or one business cycle).", "label": "Due to Employees, Noncurrent", "terseLabel": "Compensation and benefits" } } }, "localname": "DueToEmployeesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r373", "r400", "r401", "r402", "r403", "r404", "r409", "r411", "r418", "r419", "r420", "r424", "r783", "r784", "r858", "r864", "r929" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Earnings - basic (in USD per share)", "totalLabel": "Earnings - basic (in USD per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Earnings per share:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r373", "r400", "r401", "r402", "r403", "r404", "r411", "r418", "r419", "r420", "r424", "r783", "r784", "r858", "r864", "r929" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Earnings - diluted (in USD per share)", "totalLabel": "Earnings - diluted (in USD per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share Reconciliation [Abstract]", "terseLabel": "Numerator:" } } }, "localname": "EarningsPerShareReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r421", "r422", "r423", "r425" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r803" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Effect of exchange rate changes on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r729" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]", "terseLabel": "Increase (decrease) in tax rate resulting from:" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r382", "r729", "r752" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Statutory federal income tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r1088", "r1096" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails": { "order": 10.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "terseLabel": "Valuation allowance release on certain Swiss NOLs" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationFdiiPercent": { "auth_ref": [ "r1088" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails": { "order": 4.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of reported income tax benefit from difference to income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to foreign-derived intangible income (FDII).", "label": "Effective Income Tax Rate Reconciliation, FDII, Percent", "negatedTerseLabel": "Foreign-Derived Intangible Income (\u201cFDII\u201d)" } } }, "localname": "EffectiveIncomeTaxRateReconciliationFdiiPercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r1088", "r1096" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails": { "order": 3.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent", "terseLabel": "Impact of foreign operations" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": { "auth_ref": [ "r1088", "r1096" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails": { "order": 8.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent", "terseLabel": "Permanent differences and other" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r1088", "r1096" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "terseLabel": "State income taxes (net of federal income tax benefit)" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": { "auth_ref": [ "r1088", "r1096" ], "calculation": { "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails": { "order": 7.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent", "negatedTerseLabel": "Research and experimentation credits and other" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfTheStatutoryFederalIncomeTaxRateToTheEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r47" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 7.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Compensation and benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r715" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Total unrecognized compensation cost related to RSUs/PSUs" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r715" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Period of recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": { "auth_ref": [ "r716" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Exercise of Option, Tax Benefit", "terseLabel": "Employee service share-based compensation, tax benefit from exercise of stock options" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Employee Severance and Related" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]", "terseLabel": "Stock options", "verboseLabel": "Options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationAssumptionsUsedToValueOptionsGrantedDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationComponentsofStockBasedCompensationProgramDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r176", "r331", "r366", "r367", "r368", "r392", "r393", "r394", "r397", "r405", "r407", "r427", "r476", "r584", "r717", "r718", "r719", "r748", "r749", "r782", "r805", "r806", "r807", "r808", "r809", "r811", "r841", "r869", "r870", "r871" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails", "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryofShareActivityDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r565", "r793", "r933", "r934" ], "lang": { "en-us": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "terseLabel": "Fair\u00a0Value" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FacilityClosingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Facility Closing [Member]", "terseLabel": "Facility Exit and Related" } } }, "localname": "FacilityClosingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r787", "r788", "r790" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]", "verboseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "terseLabel": "Fair Value, Plan Assets Measured on Recurring Basis [Roll Forward]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansChangesinFairValueofPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r278", "r279" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of Changes in Level 3 Pension Plan Assets" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r565", "r629", "r630", "r631", "r632", "r633", "r634", "r788", "r843", "r844", "r845", "r933", "r934", "r945", "r946", "r947" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansChangesinFairValueofPlanAssetsDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r277", "r280", "r565", "r933", "r934" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [ "r565", "r933", "r934" ], "lang": { "en-us": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r789" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel12And3Member": { "auth_ref": [ "r1054" ], "lang": { "en-us": { "role": { "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3).", "label": "Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member]", "terseLabel": "Total" } } }, "localname": "FairValueInputsLevel12And3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r565", "r629", "r634", "r788", "r843", "r945", "r946", "r947" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Quoted\u00a0Prices\u00a0in Active\u00a0Market (Level 1)", "verboseLabel": "Quoted\u00a0Prices\u00a0in Active Market (Level 1)" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r565", "r629", "r634", "r788", "r844", "r933", "r934", "r945", "r946", "r947" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Significant\u00a0Other Observable\u00a0Inputs (Level 2)" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r565", "r629", "r630", "r631", "r632", "r633", "r634", "r788", "r845", "r933", "r934", "r945", "r946", "r947" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Significant Unobservable Inputs (Level 3)" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansChangesinFairValueofPlanAssetsDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "Notice period the entity is required to deliver before it can redeem an investment calculated using net asset value per share, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, investments calculated by per unit, per membership interest, other equity or ownership interest and alternative investments.", "label": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Investment Redemption, Notice Period", "terseLabel": "NAV per share, investment redemption, notice period" } } }, "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionNoticePeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": { "auth_ref": [ "r629", "r786", "r791" ], "lang": { "en-us": { "role": { "documentation": "Fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Measured at Net Asset Value Per Share [Member]", "terseLabel": "Mutual funds" } } }, "localname": "FairValueMeasuredAtNetAssetValuePerShareMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r565", "r629", "r630", "r631", "r632", "r633", "r634", "r843", "r844", "r845", "r933", "r934", "r945", "r946", "r947" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansChangesinFairValueofPlanAssetsDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r282", "r283" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r264", "r268", "r274" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation": { "auth_ref": [ "r1022" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) allowance for credit loss on financing receivable. Excludes net investment in lease.", "label": "Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation", "negatedLabel": "Foreign currency translation" } } }, "localname": "FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/CreditLossesAllowanceforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r345", "r514" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedTerseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://www.envistaco.com/role/IntangibleAssetsGoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IntangibleAssetsGoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r129" ], "calculation": { "http://www.envistaco.com/role/IntangibleAssetsGoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IntangibleAssetsGoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r129" ], "calculation": { "http://www.envistaco.com/role/IntangibleAssetsGoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IntangibleAssetsGoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r129" ], "calculation": { "http://www.envistaco.com/role/IntangibleAssetsGoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IntangibleAssetsGoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r129" ], "calculation": { "http://www.envistaco.com/role/IntangibleAssetsGoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IntangibleAssetsGoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r129" ], "calculation": { "http://www.envistaco.com/role/IntangibleAssetsGoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IntangibleAssetsGoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r511", "r513", "r514", "r516", "r850", "r854" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r127", "r854" ], "calculation": { "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r121", "r126" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r127", "r850" ], "calculation": { "http://www.envistaco.com/role/IntangibleAssetsGoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Total amortization" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IntangibleAssetsGoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]", "terseLabel": "Foreign tax" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r812" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r924", "r945", "r960" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign currency contracts" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnSaleOfBusiness": { "auth_ref": [ "r768", "r996" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.", "label": "Gain (Loss) on Disposition of Business", "negatedTerseLabel": "Gain on sale of KaVo treatment unit and instrument business" } } }, "localname": "GainLossOnSaleOfBusiness", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r97" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedTerseLabel": "Gain on sale of property, plant and equipment" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r344", "r496", "r855", "r931", "r963", "r1024", "r1031" ], "calculation": { "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "nvst_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0 }, "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.envistaco.com/role/ConsolidatedBalanceSheets", "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r499", "r931" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Acquisitions" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetImpairment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.", "label": "Goodwill and Intangible Asset Impairment", "terseLabel": "Impairment loss" } } }, "localname": "GoodwillAndIntangibleAssetImpairment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r118", "r124" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Goodwill and Other Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillDisclosureTextBlock": { "auth_ref": [ "r506", "r508", "r510", "r931" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill.", "label": "Goodwill Disclosure [Text Block]", "verboseLabel": "Goodwill and Other Intangible Assets" } } }, "localname": "GoodwillDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r503" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "verboseLabel": "Foreign currency translation" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r97", "r497", "r502", "r509", "r931" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "terseLabel": "Impairment loss" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r75", "r381", "r444", "r449", "r455", "r458", "r472", "r538", "r539", "r541", "r542", "r543", "r545", "r547", "r549", "r550", "r794", "r930", "r1044" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GuaranteeObligationsMaximumExposure": { "auth_ref": [ "r156" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.", "label": "Guarantor Obligations, Maximum Exposure, Undiscounted", "terseLabel": "Guarantees" } } }, "localname": "GuaranteeObligationsMaximumExposure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LitigationAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "auth_ref": [ "r996", "r1035" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.", "label": "Impairment of Intangible Assets, Finite-Lived", "terseLabel": "Impairment charges" } } }, "localname": "ImpairmentOfIntangibleAssetsFinitelived", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r76", "r98", "r252", "r400", "r401", "r402", "r403", "r417", "r420" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "terseLabel": "Income from continuing operations, net of tax", "totalLabel": "Income from continuing operations, net of tax" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r72", "r295", "r306", "r326", "r444", "r449", "r455", "r458", "r859", "r930" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Earnings from continuing operations before income taxes", "totalLabel": "Income (loss) before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "http://www.envistaco.com/role/IncomeTaxesEarningsFromContinuingOperationsBeforeIncomeTaxesDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "auth_ref": [ "r71", "r305", "r307", "r323", "r373", "r396", "r400", "r401", "r402", "r403", "r411", "r418", "r419", "r784", "r858" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "terseLabel": "Earnings from continuing operations - basic (in USD per share)" } } }, "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "auth_ref": [ "r71", "r323", "r325", "r373", "r396", "r400", "r401", "r402", "r403", "r411", "r418", "r419", "r420", "r784", "r858", "r864" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "terseLabel": "Earnings from continuing operations - diluted (in USD per share)" } } }, "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": { "auth_ref": [ "r3", "r4", "r5", "r6", "r7", "r14", "r19", "r253" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 }, "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent", "terseLabel": "Income (loss) from discontinued operations, net of tax", "totalLabel": "Income (loss) from discontinued operations, net of tax", "verboseLabel": "Income (loss) from discontinued operations, net of tax (Note 4)" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r949", "r952" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]", "terseLabel": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r1", "r8", "r9", "r10", "r11", "r12", "r13", "r18", "r20", "r21", "r22", "r144", "r145" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]", "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails", "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails", "http://www.envistaco.com/role/DiscontinuedOperationsOperatingResultsDetails", "http://www.envistaco.com/role/DiscontinuedOperationsSignificantNonCashOperatingItemsandCapitalExpendituresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r517", "r522" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostReflectedintheConsolidatedCondensedStatementofEarningsDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r522" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostReflectedintheConsolidatedCondensedStatementofEarningsDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Tax Contingency [Line Items]", "terseLabel": "Income Tax Contingency [Line Items]" } } }, "localname": "IncomeTaxContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxContingencyTable": { "auth_ref": [ "r222", "r223", "r224", "r230" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.", "label": "Income Tax Contingency [Table]", "terseLabel": "Income Tax Contingency [Table]" } } }, "localname": "IncomeTaxContingencyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r382", "r730", "r738", "r744", "r750", "r753", "r756", "r757", "r758" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r383", "r406", "r407", "r442", "r728", "r751", "r754", "r865" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0 }, "http://www.envistaco.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax expense (benefit)", "totalLabel": "Income tax provision (benefit)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "http://www.envistaco.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r365", "r724", "r725", "r738", "r739", "r743", "r745" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "auth_ref": [ "r1088" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount", "terseLabel": "Excess tax benefit from share-based compensation, operating activities" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r94", "r101" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r96" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Change in trade accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r96" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Change in trade accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": { "auth_ref": [ "r96" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.", "label": "Increase (Decrease) in Deferred Income Taxes", "negatedTerseLabel": "Change in deferred income taxes" } } }, "localname": "IncreaseDecreaseInDeferredIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1": { "auth_ref": [ "r265", "r269" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) related to the fair value of interest rate derivatives designated as fair value hedging instruments, as offset by the gain (loss) on the hedged item to the extent that the fair value hedge is determined to be effective.", "label": "Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments", "terseLabel": "Gain Recognized in OCI" } } }, "localname": "IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r96" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Change in inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r96" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "terseLabel": "Change in accrued expenses and other liabilities" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r96" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Change in prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": { "auth_ref": [ "r415", "r416", "r420" ], "calculation": { "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails": { "order": 3.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities", "terseLabel": "Assumed conversion of the Notes (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r412", "r413", "r414", "r420", "r684" ], "calculation": { "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "terseLabel": "Assumed exercise of dilutive options and vesting of dilutive restricted stock units (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r512", "r515" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Indefinite-Lived Intangible Assets [Line Items]", "terseLabel": "Indefinite-lived Intangible Assets [Line Items]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r130" ], "calculation": { "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "terseLabel": "Trademarks\u00a0and trade names of indefinite-live intangibles" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r123", "r130" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [ "r344" ], "calculation": { "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "totalLabel": "Gross carrying amount of total intangibles" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangible Assets, Gross (Excluding Goodwill) [Abstract]", "terseLabel": "Intangible Assets, Gross (Excluding Goodwill) [Abstract]" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwillAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r119", "r125" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Other intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r291", "r309", "r369", "r438", "r815" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedTerseLabel": "Interest expense, net" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r80", "r571", "r581", "r935", "r936" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "totalLabel": "Total interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [ "r82", "r572", "r935", "r936" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.", "label": "Interest Expense, Debt, Excluding Amortization", "terseLabel": "Contractual interest expense" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r376", "r378", "r379" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateContractMember": { "auth_ref": [ "r924", "r945", "r959" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.", "label": "Interest Rate Contract [Member]", "terseLabel": "Interest rate contracts" } } }, "localname": "InterestRateContractMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r959" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest rate swap derivative contracts", "verboseLabel": "Interest rate swap derivative contracts" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails", "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]", "terseLabel": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r495" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r981" ], "calculation": { "http://www.envistaco.com/role/InventoriesSummaryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory, Finished Goods, Gross", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/InventoriesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r353", "r921", "r963" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.envistaco.com/role/InventoriesSummaryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories, net", "totalLabel": "Total" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets", "http://www.envistaco.com/role/InventoriesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r340", "r352", "r426", "r492", "r494", "r495", "r848", "r926" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventory Valuation" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r983" ], "calculation": { "http://www.envistaco.com/role/InventoriesSummaryDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Raw Materials, Gross", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/InventoriesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r117", "r984" ], "calculation": { "http://www.envistaco.com/role/InventoriesSummaryDetails": { "order": 4.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves", "negatedTerseLabel": "Reserve for inventory obsolescence" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/InventoriesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r982" ], "calculation": { "http://www.envistaco.com/role/InventoriesSummaryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Inventory, Work in Process, Gross", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/InventoriesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r493" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write-down", "terseLabel": "Restructuring charges", "verboseLabel": "Inventory write-off" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r471", "r1122" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investments" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LandAndLandImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate held and assets that are an addition or improvement to real estate held.", "label": "Land and Land Improvements [Member]", "terseLabel": "Land and improvements" } } }, "localname": "LandAndLandImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r833", "r962" ], "calculation": { "http://www.envistaco.com/role/LeasesComponentsofLeaseExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total operating lease expense" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesComponentsofLeaseExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r1107" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Components of Operating Lease Expense" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r826" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r825" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r1108" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of Maturity Of Operating Lease Liabilities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r834" ], "calculation": { "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total operating lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r834" ], "calculation": { "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r834" ], "calculation": { "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r834" ], "calculation": { "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r834" ], "calculation": { "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r834" ], "calculation": { "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r834" ], "calculation": { "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r834" ], "calculation": { "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r1106" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Renewal Term", "terseLabel": "Lease renewal term (in years)" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r835" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r41", "r302", "r320", "r963", "r998", "r1020", "r1103" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r49", "r339", "r381", "r472", "r538", "r539", "r541", "r542", "r543", "r545", "r547", "r549", "r550", "r766", "r769", "r770", "r794", "r963", "r1044", "r1113", "r1114" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesCarriedatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r0", "r1", "r17", "r143", "r336", "r337" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Liabilities", "terseLabel": "Liability for proceeds related to the Relevant Jurisdictions" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]", "terseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r0", "r1", "r17", "r137", "r143", "r336", "r337" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current", "terseLabel": "Liabilities held for sale", "totalLabel": "Current liabilities held for sale" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets", "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsCarryingAmountofAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r30", "r300", "r313" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-Term Line of Credit", "terseLabel": "Line of credit facility, outstanding borrowings" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage", "terseLabel": "Facility fee" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r46" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Revolving credit facility maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Revolving credit facility due 2024" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "LIBOR" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r30", "r300", "r317", "r564", "r579", "r933", "r934" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "terseLabel": "Long-term debt", "totalLabel": "Total debt", "verboseLabel": "Total debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-Term Debt, Fair Value", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r166", "r386", "r569" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesDebtPaymentsDetails": { "order": 1.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesDebtPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r166", "r386", "r569" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesDebtPaymentsDetails": { "order": 3.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Three", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesDebtPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r166", "r386", "r569" ], "calculation": { "http://www.envistaco.com/role/DebtAndCreditFacilitiesDebtPaymentsDetails": { "order": 2.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesDebtPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.", "label": "Long-Term Debt [Member]", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsDerivativeandNonderivativeDebtInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r349" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 }, "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt", "verboseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets", "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesUnamortizedDebtDiscountandIssuanceCostsDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r52", "r167" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesInterestExpenseDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/DebtAndCreditFacilitiesUnamortizedDebtDiscountandIssuanceCostsDetails", "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "auth_ref": [ "r532", "r977" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability.", "label": "Loss Contingency Accrual", "terseLabel": "Accrual for legal matters" } } }, "localname": "LossContingencyAccrualAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LitigationAndContingenciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualCarryingValueCurrent": { "auth_ref": [ "r532" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.", "label": "Loss Contingency, Accrual, Current", "terseLabel": "Loss contingencies" } } }, "localname": "LossContingencyAccrualCarryingValueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualCarryingValueNoncurrent": { "auth_ref": [ "r532" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.", "label": "Loss Contingency, Accrual, Noncurrent", "terseLabel": "Loss contingencies" } } }, "localname": "LossContingencyAccrualCarryingValueNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery, equipment and other assets" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesofDepreciableAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MaterialReconcilingItemsMember": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.", "label": "Segment Reconciling Items [Member]", "terseLabel": "Held for sale" } } }, "localname": "MaterialReconcilingItemsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r57", "r301", "r319", "r381", "r472", "r538", "r541", "r542", "r543", "r549", "r550", "r794" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestPeriodIncreaseDecrease": { "auth_ref": [ "r251" ], "lang": { "en-us": { "role": { "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.", "label": "Noncontrolling Interest, Period Increase (Decrease)", "terseLabel": "Change in noncontrolling interest" } } }, "localname": "MinorityInterestPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]", "terseLabel": "Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]" } } }, "localname": "MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MovementInValuationAllowancesAndReservesRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]", "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]" } } }, "localname": "MovementInValuationAllowancesAndReservesRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MultiemployerPlanEmployerContributionCost": { "auth_ref": [ "r675", "r676", "r679", "r955" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for employer contribution to multiemployer plan. Multiemployer plan includes, but is not limited to, pension plan determined to be individually significant and insignificant and other postretirement benefit plan.", "label": "Multiemployer Plan, Employer Contribution, Cost", "terseLabel": "Multiemployer plan, employer contribution cost" } } }, "localname": "MultiemployerPlanEmployerContributionCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MutualFundMember": { "auth_ref": [ "r1053" ], "lang": { "en-us": { "role": { "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective.", "label": "Mutual Fund [Member]", "terseLabel": "Mutual funds" } } }, "localname": "MutualFundMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r377" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r377" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash (used in) provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r93", "r95", "r98" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r73", "r98", "r308", "r324", "r337", "r360", "r363", "r368", "r381", "r396", "r400", "r401", "r402", "r403", "r406", "r407", "r417", "r444", "r449", "r455", "r458", "r472", "r538", "r539", "r541", "r542", "r543", "r545", "r547", "r549", "r550", "r784", "r794", "r930", "r1044" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.envistaco.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net income", "verboseLabel": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows", "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity", "http://www.envistaco.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r261" ], "lang": { "en-us": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net investment hedging" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsSummaryofNotionalValuesandPretaxImpactinFairValuesofNetInvestmentHedgesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent": { "auth_ref": [ "r604" ], "calculation": { "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostReflectedintheConsolidatedCondensedStatementofEarningsDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.", "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component", "negatedTerseLabel": "Other income (expense)" } } }, "localname": "NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostReflectedintheConsolidatedCondensedStatementofEarningsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r103", "r329", "r330", "r331", "r332", "r333", "r395", "r396", "r397", "r398", "r399", "r402", "r408", "r424", "r469", "r470", "r473", "r474", "r475", "r476", "r477", "r478", "r717", "r718", "r719", "r746", "r747", "r748", "r749", "r761", "r762", "r763", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r813", "r814", "r818", "r819", "r820", "r821", "r836", "r837", "r838", "r839", "r840", "r841", "r851", "r852", "r853", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r876", "r877", "r878" ], "lang": { "en-us": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "Accounting Standards Update and Change in Accounting Principle [Table]", "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Accounting Standards Recently Adopted" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Countries excluding the United States of America (US).", "label": "Non-US [Member]", "terseLabel": "International" } } }, "localname": "NonUsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesEarningsFromContinuingOperationsBeforeIncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r250", "r584", "r1003", "r1004", "r1005" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interests" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Nonoperating income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r1013" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of business segments (in segments)", "verboseLabel": "Number of operating segments (in segments)" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentationNarrativeDetails", "http://www.envistaco.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r1013" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments (in segments)" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r444", "r449", "r455", "r458", "r930" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Operating profit (loss)", "totalLabel": "Operating profit" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r827", "r962" ], "calculation": { "http://www.envistaco.com/role/LeasesComponentsofLeaseExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Fixed operating lease expense" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesComponentsofLeaseExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]", "terseLabel": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r823" ], "calculation": { "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Total operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r823" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r823" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r824", "r829" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "negatedLabel": "Change in operating lease liabilities" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r822" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r996" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Operating Lease, Right-of-Use Asset, Amortization Expense", "terseLabel": "Amortization of right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r832", "r962" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesWeightedAverageRemainingLeaseTermandDiscountRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r831", "r962" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesWeightedAverageRemainingLeaseTermandDiscountRateDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r227" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "auth_ref": [ "r225" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.", "label": "Operating Loss Carryforwards, Valuation Allowance", "terseLabel": "Operating loss carryforwards, valuation allowances" } } }, "localname": "OperatingLossCarryforwardsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r448", "r449", "r450", "r451", "r452", "r458" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r24", "r256" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Summary of Significant Accounting Policies", "verboseLabel": "Business and Basis of Presentation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/BusinessAndBasisOfPresentation", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r47" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 8.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAccruedLiabilitiesNoncurrent": { "auth_ref": [ "r54" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 5.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Noncurrent", "terseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAmortizationOfDeferredCharges": { "auth_ref": [ "r78", "r97" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization of other deferred costs recognized in the income statement.", "label": "Amortization of Other Deferred Charges", "terseLabel": "Amortization" } } }, "localname": "OtherAmortizationOfDeferredCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r346" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other long-term assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": { "auth_ref": [ "r63", "r67", "r359", "r646" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax", "negatedLabel": "Future amortization of prior service cost (credit)" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax": { "auth_ref": [ "r63", "r67", "r359", "r646" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax", "negatedLabel": "Future amortization of prior service cost (credit), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "auth_ref": [ "r66", "r367", "r805", "r807", "r811", "r987" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "terseLabel": "(Decrease) increase before reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r66", "r70", "r367", "r805", "r807", "r811", "r987" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "totalLabel": "Other comprehensive (loss) income before reclassifications, net of income taxes" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": { "auth_ref": [ "r64", "r366" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax", "negatedLabel": "Income tax impact" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": { "auth_ref": [ "r357" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent", "verboseLabel": "Cash flow hedge adjustments" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r58" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "verboseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": { "auth_ref": [ "r63", "r67", "r68", "r359", "r804" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax", "negatedLabel": "Amounts reclassified from accumulated other comprehensive loss, net of income taxes" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r70", "r176", "r361", "r364", "r371", "r805", "r810", "r811", "r856", "r862", "r987", "r988" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.envistaco.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other comprehensive income (loss)", "totalLabel": "Total other comprehensive (loss) income, net of income taxes" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails", "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity", "http://www.envistaco.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]", "terseLabel": "Other comprehensive (loss) income, net of income taxes:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r61", "r63" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedTerseLabel": "Pension plan adjustments" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": { "auth_ref": [ "r63", "r67", "r359", "r646" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax", "terseLabel": "Future amortization of gain (loss)" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": { "auth_ref": [ "r63", "r67", "r359", "r646" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax", "terseLabel": "Future amortization of gain (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherContractMember": { "auth_ref": [ "r924", "r945", "r961" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is classified as other.", "label": "Other Contract [Member]", "terseLabel": "Insurance contracts" } } }, "localname": "OtherContractMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherDebtSecuritiesMember": { "auth_ref": [ "r1019", "r1023", "r1053", "r1102" ], "lang": { "en-us": { "role": { "documentation": "Investments in debt securities classified as other.", "label": "Other Debt Obligations [Member]", "terseLabel": "Other" } } }, "localname": "OtherDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesComponentsOfDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r47", "r963" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Accrued expenses and other liabilities", "totalLabel": "Total" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails", "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities, Current [Abstract]", "terseLabel": "Current" } } }, "localname": "OtherLiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other liabilities.", "label": "Other Liabilities Disclosure [Text Block]", "terseLabel": "Accrued Expenses and Other Liabilities" } } }, "localname": "OtherLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r54" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities", "totalLabel": "Total" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails", "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities, Noncurrent [Abstract]", "terseLabel": "Noncurrent" } } }, "localname": "OtherLiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other liabilities.", "label": "Other Liabilities [Table Text Block]", "terseLabel": "The components of accrued expenses and other liabilities" } } }, "localname": "OtherLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r81" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income (expense)" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.", "label": "Parent [Member]", "terseLabel": "Total Envista Equity" } } }, "localname": "ParentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PatentedTechnologyMember": { "auth_ref": [ "r242" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patented technology to exploit the technology for a period of time specified by law.", "label": "Patented Technology [Member]", "terseLabel": "Patents\u00a0and technology" } } }, "localname": "PatentedTechnologyMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r990", "r991" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedTerseLabel": "All other investing activities, net" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r521", "r995" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "negatedTerseLabel": "Paid/settled" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r91" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedTerseLabel": "Payment of debt issuance and other deferred financing costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtRestructuringCosts": { "auth_ref": [ "r92" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred in the modification of term of existing debt agreement in order for the entity to achieve some advantage.", "label": "Payments of Debt Restructuring Costs", "terseLabel": "Payments of debt restructuring costs" } } }, "localname": "PaymentsOfDebtRestructuringCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r375" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "negatedTerseLabel": "Tax withholding payment related to net settlement of equity awards", "terseLabel": "Tax withholding payment related to net settlement of equity awards" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r86" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Acquisitions, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r87" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Payments for additions to property, plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent": { "auth_ref": [ "r29", "r188", "r189", "r190" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 6.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as current.", "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Current", "terseLabel": "Pension benefits" } } }, "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r31", "r188", "r189", "r190" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as noncurrent.", "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent", "terseLabel": "Pension benefits" } } }, "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r626", "r628", "r634", "r653", "r655", "r656", "r657", "r658", "r659", "r671", "r672", "r674", "r680", "r947" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "Retirement Benefits [Text Block]", "terseLabel": "Pension and Other Benefit Plans" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r186", "r603", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r649", "r651", "r652", "r654", "r657", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r674", "r675", "r679", "r947", "r948", "r952", "r953", "r954" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Defined benefit pension plans" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansBenefitPaymentsThatReflectExpectedFutureServiceDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansChangesinFairValueofPlanAssetsDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanAssetCategoriesDomain": { "auth_ref": [ "r626", "r627", "r629", "r630", "r631", "r632", "r633", "r634", "r654", "r945", "r946", "r947" ], "lang": { "en-us": { "role": { "documentation": "Defined benefit plan asset investment.", "label": "Defined Benefit Plan, Plan Assets, Category [Domain]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]" } } }, "localname": "PlanAssetCategoriesDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r792" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/FairValueMeasurementsFairValueofFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PostemploymentBenefitsPeriodExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Period expense related to postemployment benefits.", "label": "Postemployment Benefits, Period Expense", "terseLabel": "Expense for all defined benefit and defined contributions pension plans" } } }, "localname": "PostemploymentBenefitsPeriodExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r35", "r582" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in USD per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r35" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r35", "r582" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r35" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r35", "r963" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.01 par value, 15.0 million shares authorized; no shares issued or outstanding at December 31, 2022 and December 31, 2021" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r985" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r89" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from Convertible Debt", "terseLabel": "Proceeds from issuance of convertible senior notes" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities": { "auth_ref": [ "r990" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow provided by derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.", "label": "Proceeds from Derivative Instrument, Investing Activities", "terseLabel": "Proceeds from the settlement of derivative financial instruments" } } }, "localname": "ProceedsFromDerivativeInstrumentInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": { "auth_ref": [ "r84" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.", "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested", "terseLabel": "Proceeds from sale of KaVo treatment unit and instrument business, net" } } }, "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLongTermLinesOfCredit": { "auth_ref": [ "r89" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Proceeds from Long-Term Lines of Credit", "terseLabel": "Proceeds from revolving line of credit" } } }, "localname": "ProceedsFromLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r992", "r994" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "All other financing activities" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r85" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from Sale of Property, Plant, and Equipment", "terseLabel": "Proceeds from sales of property, plant and equipment" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromShortTermDebtMaturingInThreeMonthsOrLess": { "auth_ref": [ "r89" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing having initial term of repayment within three months.", "label": "Proceeds from Short-Term Debt, Maturing in Three Months or Less", "terseLabel": "Proceeds from borrowing" } } }, "localname": "ProceedsFromShortTermDebtMaturingInThreeMonthsOrLess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r88", "r213" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from stock option exercises" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrual": { "auth_ref": [ "r161", "r162", "r303" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.", "label": "Standard and Extended Product Warranty Accrual", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "ProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPayments": { "auth_ref": [ "r157" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.", "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments", "negatedTerseLabel": "Settlements made" } } }, "localname": "ProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r158" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.", "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Accruals for warranties issued during the year" } } }, "localname": "ProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyDisclosureTextBlock": { "auth_ref": [ "r165" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.", "label": "Product Warranty Disclosure [Text Block]", "terseLabel": "Warranty" } } }, "localname": "ProductWarrantyDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/Warranty" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentAdditions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Additions", "terseLabel": "Capital expenditures, gross" } } }, "localname": "PropertyPlantAndEquipmentAdditions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesofDepreciableAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r146", "r883", "r884", "r885" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property, Plant And Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r139", "r342" ], "calculation": { "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Gross property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesofDepreciableAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r141", "r321", "r860", "r963" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant and equipment, net", "totalLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets", "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails", "http://www.envistaco.com/role/SegmentInformationScheduleOfOperationsInGeographicalAreasDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r141", "r883", "r884" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Estimated Useful Lives of Depreciable Assets", "verboseLabel": "Schedule of Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentTables", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r139" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesofDepreciableAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "verboseLabel": "Estimated useful life of depreciable asset" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesofDepreciableAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r374", "r482" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Allowance for credit losses" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RatioOfIndebtednessToNetCapital1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indebtedness divided by net capital.", "label": "Ratio of Indebtedness to Net Capital", "terseLabel": "Leverage ratio" } } }, "localname": "RatioOfIndebtednessToNetCapital1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "pureItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r1015", "r1016", "r1017", "r1018" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable and Allowances for Credit Losses" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]", "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]" } } }, "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r66", "r367", "r805", "r809", "r811", "r987" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": 1.0, "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "negatedLabel": "Increase" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r66", "r70", "r367", "r805", "r809", "r811", "r987" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "negatedTotalLabel": "Amounts reclassified from accumulated other comprehensive loss, net of income taxes" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]", "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodTax": { "auth_ref": [ "r64", "r359", "r366" ], "calculation": { "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails": { "order": 2.0, "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Reclassification from AOCI, Current Period, Tax", "terseLabel": "Income tax impact" } } }, "localname": "ReclassificationFromAociCurrentPeriodTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "auth_ref": [ "r368" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r993" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "terseLabel": "Repayment of debt" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermLinesOfCredit": { "auth_ref": [ "r90" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Repayments of Long-Term Lines of Credit", "negatedTerseLabel": "Repayment of revolving line of credit" } } }, "localname": "RepaymentsOfLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": { "auth_ref": [ "r90" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from a repayment of a borrowing having initial term of repayment within three months.", "label": "Repayments of Short-Term Debt, Maturing in Three Months or Less", "negatedTerseLabel": "Repayment of borrowing" } } }, "localname": "RepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r217", "r328", "r1121" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": { "auth_ref": [ "r132", "r133", "r328" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.", "label": "Research, Development, and Computer Software, Policy [Policy Text Block]", "terseLabel": "Research and Development" } } }, "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "RSUs / PSUs" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]", "terseLabel": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r519", "r521", "r524", "r530", "r531" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Restructuring Activities And Related Impairments" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairments" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r97", "r525", "r527", "r1037" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "terseLabel": "Costs incurred" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [ "r520", "r521", "r527", "r528" ], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsNarrativeDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostsAndAssetImpairmentCharges": { "auth_ref": [ "r97" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.", "label": "Restructuring Costs and Asset Impairment Charges", "terseLabel": "Costs incurred" } } }, "localname": "RestructuringCostsAndAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r521", "r526" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "periodEndLabel": "Balance at end of year", "periodStartLabel": "Balance at beginning of year" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r980", "r1038", "r1039" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 9.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Current", "terseLabel": "Restructuring-related employee severance, benefits and other" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveNoncurrent": { "auth_ref": [ "r986", "r1038", "r1039" ], "calculation": { "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Noncurrent", "terseLabel": "Restructuring-related employee severance, benefits and other" } } }, "localname": "RestructuringReserveNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccruedExpensesAndOtherLiabilitiesSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]", "terseLabel": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r38", "r184", "r318", "r873", "r878", "r963" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r331", "r392", "r393", "r394", "r397", "r405", "r407", "r476", "r717", "r718", "r719", "r748", "r749", "r782", "r869", "r871" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r186", "r187", "r603", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r649", "r651", "r652", "r654", "r657", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r674", "r675", "r676", "r679", "r947", "r948", "r949", "r950", "r951", "r952", "r953", "r954" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansBenefitPaymentsThatReflectExpectedFutureServiceDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansChangesinFairValueofPlanAssetsDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r186", "r187", "r603", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r649", "r651", "r652", "r654", "r657", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r674", "r675", "r676", "r679", "r947", "r948", "r949", "r950", "r951", "r952", "r953", "r954" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansBenefitPaymentsThatReflectExpectedFutureServiceDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansChangesinFairValueofPlanAssetsDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r435", "r436", "r448", "r453", "r454", "r460", "r461", "r464", "r597", "r598", "r849" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r587", "r588", "r589", "r590", "r591", "r592", "r595", "r596", "r601", "r602" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/Revenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r927", "r928" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r593" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Remaining performance obligation" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r594" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Expected timing of satisfaction" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r594" ], "lang": { "en-us": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r370", "r381", "r435", "r436", "r448", "r453", "r454", "r460", "r461", "r464", "r472", "r538", "r539", "r541", "r542", "r543", "r545", "r547", "r549", "r550", "r794", "r859", "r1044" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationScheduleOfOperationsInGeographicalAreasDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r830", "r962" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "ROU assets obtained in exchange for operating lease obligations" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r464", "r1012" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue Benchmark" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RevenueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r66", "r1104", "r1105" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of accumulated other comprehensive income (loss)" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock": { "auth_ref": [ "r121" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.", "label": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]", "terseLabel": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of acquired indefinite-lived intangible assets. Indefinite-lived intangible assets are assets that have no physical form, but have expected future economic benefit. Indefinite-lived assets are assets that are not subject to amortization. Acquired indefinite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the entity) and in total.", "label": "Schedule of Acquired Indefinite-Lived Intangible Assets by Major Class [Table Text Block]", "terseLabel": "Schedule of Acquired Indefinite-Lived Intangible Assets by Major Class" } } }, "localname": "ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": { "auth_ref": [ "r191" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.", "label": "Schedule of Allocation of Plan Assets [Table Text Block]", "terseLabel": "Schedule of Allocation of Plan Assets" } } }, "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r104" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r104" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of antidilutive securities excluded from computation of earnings per share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": { "auth_ref": [ "r648" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.", "label": "Defined Benefit Plan, Assumptions [Table Text Block]", "terseLabel": "Defined Benefit Plan, Assumptions" } } }, "localname": "ScheduleOfAssumptionsUsedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r234", "r235", "r759" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsFairValuesofAssetsAcquiredandLiabilitiesAssumedDetails", "http://www.envistaco.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r229" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r52", "r177", "r181", "r182", "r183", "r289", "r290", "r293", "r311", "r933", "r935", "r1000" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "terseLabel": "Components of debt" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Components of unamortized debt discount and issuance costs" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r226" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of Deferred Tax Assets and Liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r194", "r195", "r196", "r197", "r198" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansBenefitPaymentsThatReflectExpectedFutureServiceDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostofDefinedBenefitPensionPlansDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFairValuesOfPensionPlanAssetsDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansFundedStatusOfPensionPlansDetails", "http://www.envistaco.com/role/PensionAndOtherBenefitPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": { "auth_ref": [ "r194", "r195", "r196", "r197", "r198" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.", "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r265", "r270", "r772" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Derivative instruments, gain (loss)" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of derivative instruments in statement of financial position, fair value" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "auth_ref": [ "r1", "r8", "r9", "r10", "r11", "r12", "r13", "r18", "r20", "r21", "r22", "r144", "r145" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "terseLabel": "Schedule of Discontinued Operations" } } }, "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DiscontinuedOperationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r1010" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of earnings per share, basic and diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Summary Of Effective Income Tax Rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.", "label": "Schedule of Expected Benefit Payments [Table Text Block]", "terseLabel": "Schedule of Expected Benefit Payments" } } }, "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r787", "r788" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of financial assets and liabilities at carrying and fair value" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r509", "r931" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsRollforwardDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r931", "r1024", "r1025", "r1026", "r1027", "r1028", "r1029", "r1030", "r1031", "r1032", "r1033", "r1034" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Rollforward and Carrying Value Of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r999" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "terseLabel": "Schedule of Income before Income Tax, Domestic and Foreign" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r130", "r131" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r26", "r42", "r43", "r44" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "terseLabel": "Contractual Minimum Principal Payments on Debt" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r193" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of Net Benefit Costs [Table Text Block]", "terseLabel": "Schedule of Net Benefit Costs" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetFundedStatusTableTextBlock": { "auth_ref": [ "r190" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of net funded status of pension plans and/or other employee benefit plans.", "label": "Schedule of Net Funded Status [Table Text Block]", "terseLabel": "Schedule of Net Funded Status" } } }, "localname": "ScheduleOfNetFundedStatusTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [ "r204" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.", "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]", "terseLabel": "Summary Information of Unvested RSUs and PSUs Activity" } } }, "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "terseLabel": "Schedule of notional amounts of outstanding derivative positions" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/HedgingTransactionsAndDerivativeFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Warranty accrual" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/WarrantyTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PropertyPlantAndEquipmentDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLivesofDepreciableAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Fair Values of Assets Acquired and Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r520", "r521", "r522", "r523", "r527", "r528", "r529" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsNarrativeDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [ "r148", "r149", "r152" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.", "label": "Restructuring and Related Costs [Table Text Block]", "terseLabel": "Restructuring and related costs" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "auth_ref": [ "r147", "r153" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Schedule of restructuring reserve by type of cost" } } }, "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r111", "r112", "r113", "r118" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationScheduleOfOperationsInGeographicalAreasDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r111", "r112", "r113", "r118" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Segment results" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r681", "r683", "r685", "r686", "r687", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r709", "r710", "r711", "r712", "r713" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationAssumptionsUsedToValueOptionsGrantedDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationComponentsofStockBasedCompensationProgramDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfOptionsOutstandingDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryofShareActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r212" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "terseLabel": "Schedule of Options Outstanding" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r201", "r206", "r207" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r210" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Summary of Assumption Used in the Black-Scholes Value Options Granted" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTextBlock": { "auth_ref": [ "r34", "r35", "r36", "r173", "r174", "r175", "r177", "r178", "r179", "r181", "r182", "r183", "r184" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.", "label": "Schedule of Stock by Class [Table Text Block]", "terseLabel": "Summary of Share Activity" } } }, "localname": "ScheduleOfStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits, excluding amounts pertaining to examined tax returns.", "label": "Schedule of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Roll Forward [Table Text Block]", "terseLabel": "Schedule of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Roll Forward" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r126" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentContinuingOperationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component of an entity expected to operate in the foreseeable future.", "label": "Continuing Operations [Member]", "terseLabel": "Continuing operations" } } }, "localname": "SegmentContinuingOperationsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r432", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r458", "r464", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r523", "r529", "r931", "r1123" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsRollforwardDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentOperatingActivitiesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operations of an entity including continuing and discontinued operations.", "label": "Operating Activities [Domain]", "terseLabel": "Operating Activities [Domain]" } } }, "localname": "SegmentOperatingActivitiesDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r432", "r433", "r434", "r444", "r447", "r452", "r456", "r457", "r458", "r459", "r460", "r463", "r464", "r465" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "verboseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SegmentInformationScheduleOfOperationsInGeographicalAreasDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r79" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/PensionAndOtherBenefitPlansComponentsofNetPeriodicBenefitCostReflectedintheConsolidatedCondensedStatementofEarningsDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringReserveByTypeOfCostDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r96" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Noncash Expense [Abstract]", "terseLabel": "Share-based Payment Arrangement, Noncash Expense [Abstract]" } } }, "localname": "ShareBasedCompensationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r956" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Award vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r702" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfUnrecognizedRSUAndPRUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r702" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfUnrecognizedRSUAndPRUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfUnrecognizedRSUAndPRUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r700" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Grant (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfUnrecognizedRSUAndPRUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r697", "r698" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Unvested at end of year (in shares)", "periodStartLabel": "Unvested at beginning of year (in shares)", "terseLabel": "Unvested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfUnrecognizedRSUAndPRUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number\u00a0of RSUs/PSUs" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfUnrecognizedRSUAndPRUActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r697", "r698" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Unvested at end of year (in USD per share)", "periodStartLabel": "Unvested at beginning of year (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfUnrecognizedRSUAndPRUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Grant-Date Fair\u00a0Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfUnrecognizedRSUAndPRUActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r701" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfUnrecognizedRSUAndPRUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r701" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfUnrecognizedRSUAndPRUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r711" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationAssumptionsUsedToValueOptionsGrantedDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r712" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationAssumptionsUsedToValueOptionsGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": { "auth_ref": [ "r710" ], "lang": { "en-us": { "role": { "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate", "terseLabel": "Weighted average volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationAssumptionsUsedToValueOptionsGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationAssumptionsUsedToValueOptionsGrantedDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationComponentsofStockBasedCompensationProgramDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfOptionsOutstandingDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryofShareActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r958" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "terseLabel": "Number of shares authorized under the Stock Plan (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r691" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "terseLabel": "Vested at end of year (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r691" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Vested at end of year (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r704" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value", "terseLabel": "Aggregate intrinsic value of options exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r695" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedTerseLabel": "Cancelled/forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r693" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r212" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Outstanding at end of year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r689", "r690" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding at end of year (in shares)", "periodStartLabel": "Outstanding at beginning of year (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number of Stock Options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r689", "r690" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding as of end of year (in USD per share)", "periodStartLabel": "Outstanding as of beginning of year (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r705" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "terseLabel": "Vested and expected to vest at end of year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [ "r705" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "terseLabel": "Vested and expected to vest at end of year (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r705" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "terseLabel": "Vested and expected to vest at end of year (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r685", "r686", "r687", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r709", "r710", "r711", "r712", "r713" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationAssumptionsUsedToValueOptionsGrantedDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationComponentsofStockBasedCompensationProgramDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r694" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r695" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Cancelled/forfeited (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r693" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r688", "r707", "r708", "r709", "r710", "r713", "r720", "r721" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Payment Arrangement [Policy Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r209" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]", "terseLabel": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfOptionsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Exercise Price Range [Domain]", "terseLabel": "Exercise Price Range [Domain]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfOptionsOutstandingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit", "terseLabel": "Exercise price, lower limit (in USD per share)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfOptionsOutstandingDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r205" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "terseLabel": "Exercisable, shares (in shares)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfOptionsOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r202" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding", "terseLabel": "Outstanding, shares (in shares)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfOptionsOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit", "terseLabel": "Exercise price, upper limit (in USD per share)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfOptionsOutstandingDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r957" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "terseLabel": "Award expiration period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r709" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected years until exercise" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationAssumptionsUsedToValueOptionsGrantedDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r212" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "terseLabel": "Vested at end of year" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r212" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Vested at end of year" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Outstanding at end of year" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r705" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Vested and expected to vest at end of year" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r203" ], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price", "terseLabel": "Exercisable, average exercise price (in USD per share)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfOptionsOutstandingDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r202" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price", "terseLabel": "Outstanding, average exercise price (in USD per share)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfOptionsOutstandingDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Outstanding, average remaining life (in years)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryOfOptionsOutstandingDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "auth_ref": [ "r185", "r216" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).", "label": "Shareholders' Equity and Share-Based Payments [Text Block]", "terseLabel": "Stock Transactions And Stock-Based Compensation" } } }, "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "terseLabel": "Share withheld (in shares)" } } }, "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r27", "r297", "r316", "r963" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short-Term Debt", "verboseLabel": "Short-term debt" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit": { "auth_ref": [ "r220" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.", "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit", "terseLabel": "Estimated reduction in unrecognized tax benefits within twelve months" } } }, "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r160" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the standard and extended product warranty accrual.", "label": "Standard and Extended Product Warranty Accrual, Foreign Currency Translation Gain (Loss)", "negatedLabel": "Effect of foreign currency translation" } } }, "localname": "StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/WarrantyWarrantyAccrualDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandbyLettersOfCreditMember": { "auth_ref": [ "r164", "r249", "r327", "r537" ], "lang": { "en-us": { "role": { "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.", "label": "Standby Letters of Credit [Member]", "terseLabel": "Standby letters of credit" } } }, "localname": "StandbyLettersOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r334", "r432", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r458", "r464", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r518", "r523", "r529", "r931", "r1123" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsRollforwardDetails", "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndOtherRelatedChargesBySegmentDetails", "http://www.envistaco.com/role/RevenueDisaggregationbyRevenueTypeandGeographicalRegionDetails", "http://www.envistaco.com/role/SegmentInformationSegmentResultsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r56", "r176", "r331", "r366", "r367", "r368", "r392", "r393", "r394", "r397", "r405", "r407", "r427", "r476", "r584", "r717", "r718", "r719", "r748", "r749", "r782", "r805", "r806", "r807", "r808", "r809", "r811", "r841", "r869", "r870", "r871" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails", "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryofShareActivityDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity", "http://www.envistaco.com/role/IncomeTaxesEarningsFromContinuingOperationsBeforeIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOperatingActivitiesSegmentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by continuing and discontinuing operations.", "label": "Operating Activities [Axis]", "terseLabel": "Operating Activities [Axis]" } } }, "localname": "StatementOperatingActivitiesSegmentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r392", "r393", "r394", "r427", "r849" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity", "http://www.envistaco.com/role/IncomeTaxesEarningsFromContinuingOperationsBeforeIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockCompensationPlanMember": { "auth_ref": [ "r1011" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.", "label": "Share-Based Payment Arrangement [Member]", "terseLabel": "Stock-based awards" } } }, "localname": "StockCompensationPlanMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/EarningsPerShareSecuritiesNotIncludedintheComputationofDilutedLossIncomeperShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r35", "r36", "r176", "r184" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "verboseLabel": "Issuance of common stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationSummaryofShareActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r35", "r36", "r176", "r184", "r694" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedTerseLabel": "Exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/StockTransactionsAndStockBasedCompensationOptionActivityUnderTheCompanysStockPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r36", "r39", "r40", "r116", "r963", "r998", "r1020", "r1103" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Envista stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r250", "r251", "r255", "r331", "r332", "r367", "r392", "r393", "r394", "r397", "r405", "r476", "r584", "r717", "r718", "r719", "r748", "r749", "r782", "r805", "r806", "r811", "r841", "r870", "r871", "r998", "r1020", "r1103" ], "calculation": { "http://www.envistaco.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "negatedLabel": "Increase (decrease) in stockholders' equity", "periodEndLabel": "Balance, end of period", "periodStartLabel": "Balance, beginning of period", "terseLabel": "Increase (decrease) in stockholders' equity", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/AccumulatedOtherComprehensiveLossRollforwardDetails", "http://www.envistaco.com/role/ConsolidatedBalanceSheets", "http://www.envistaco.com/role/ConsolidatedStatementsofChangesinStockholdersEquity", "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails", "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental data:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TrademarksAndTradeNamesMember": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trademarks and Trade Names [Member]", "terseLabel": "Trademarks and trade names" } } }, "localname": "TrademarksAndTradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [ "r520", "r521", "r527", "r528" ], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/RestructuringActivitiesAndRelatedImpairmentsScheduleOfRestructuringAndRelatedCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r723", "r732" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Unrecognized tax benefits, end of year", "periodStartLabel": "Unrecognized tax benefits, beginning of year", "terseLabel": "Gross unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails", "http://www.envistaco.com/role/IncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r733" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "negatedTerseLabel": "Reductions for tax positions of prior years" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "auth_ref": [ "r735" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities", "negatedTerseLabel": "Settlements" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r731" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Potential interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": { "auth_ref": [ "r731" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense", "terseLabel": "Recognized potential interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r734" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Additions based on tax positions related to the current year" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r733" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "terseLabel": "Additions for tax positions of prior years" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r736" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations", "negatedTerseLabel": "Lapse of statute of limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r737" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "terseLabel": "Unrecognized tax benefits that would impact effective tax rate" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r108", "r109", "r110", "r428", "r429", "r430", "r431" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r742" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "negatedLabel": "Decrease in valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesAdjustments": { "auth_ref": [ "r1002" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment", "verboseLabel": "Impact\u00a0of Currency" } } }, "localname": "ValuationAllowancesAndReservesAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesBalance": { "auth_ref": [ "r387", "r390" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount", "periodEndLabel": "Balance at End\u00a0of Period", "periodStartLabel": "Balance at Beginning\u00a0of Period" } } }, "localname": "ValuationAllowancesAndReservesBalance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "auth_ref": [ "r388" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense", "verboseLabel": "Charged\u00a0to Costs & Expenses" } } }, "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDeductions": { "auth_ref": [ "r389" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction", "negatedTerseLabel": "Write\u00a0Offs, Write\u00a0Downs\u00a0 & Deductions" } } }, "localname": "ValuationAllowancesAndReservesDeductions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesRecoveries": { "auth_ref": [ "r1001" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from recovery of amount previously written off or reestablishment of reserve previously utilized.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery", "negatedTerseLabel": "Recoveries" } } }, "localname": "ValuationAllowancesAndReservesRecoveries", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableLeaseCost": { "auth_ref": [ "r828", "r962" ], "calculation": { "http://www.envistaco.com/role/LeasesComponentsofLeaseExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.", "label": "Variable Lease, Cost", "terseLabel": "Variable operating lease expense" } } }, "localname": "VariableLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/LeasesComponentsofLeaseExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/DebtAndCreditFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r410", "r420" ], "calculation": { "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average common shares outstanding used in diluted earnings (loss) per share (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Average common stock and common equivalent shares outstanding:", "verboseLabel": "Denominator:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r409", "r420" ], "calculation": { "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted-average common shares outstanding used in basic earnings per share (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.envistaco.com/role/ConsolidatedStatementsofOperations", "http://www.envistaco.com/role/EarningsPerShareComponentsofBasicandDilutedEarningsperShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 8 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1000": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1001": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1002": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1003": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1004": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1005": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1006": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1007": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1008": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1009": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1010": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1011": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1012": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1013": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1014": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1015": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1016": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1017": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1018": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1019": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1020": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1021": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1022": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1023": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1024": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1025": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1026": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1027": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1028": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1029": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1030": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1031": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1032": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1033": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1034": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1035": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1036": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1037": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1038": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1039": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1040": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1041": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1042": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1043": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1044": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1045": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1046": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1047": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1048": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1049": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1050": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1051": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "705", "URI": "https://asc.fasb.org/topic&trid=2122478", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1052": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1053": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1054": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1055": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1056": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1057": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1058": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1059": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1060": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1061": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1062": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1063": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1064": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1065": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1066": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1067": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1068": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1069": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1070": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1071": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1072": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1073": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1074": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1075": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1076": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1077": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1078": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1079": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1080": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1081": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1082": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1083": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1084": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1085": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1086": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1087": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1088": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1089": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1090": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1091": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1092": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1093": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1094": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1095": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1096": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1097": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1098": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1099": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1103": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1104": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1106": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1107": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1108": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1112": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1113": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1114": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1115": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1116": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1117": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1118": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1119": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1120": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1123": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1124": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1125": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1126": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "11", "Subsection": "03", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1127": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "01", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1128": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(ii)", "Subsection": "01", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1129": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)", "Subsection": "01", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1130": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "01", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1131": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "02", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "40", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(5)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907907&loc=d3e12803-110250", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "460", "URI": "https://asc.fasb.org/topic&trid=2155896", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466103&loc=SL6014347-161799", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r216": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r23": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=2122178", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=SL65897772-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r24": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r248": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r256": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r276": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org/topic&trid=2229140", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(20))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(21))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column D))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2029-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919269-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919272-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919236-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "3B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.23)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(e))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "https://asc.fasb.org/topic&trid=2175745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e709-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "https://asc.fasb.org/topic&trid=2235017", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(13))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r721": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r758": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "54B", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL7495116-110257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "40", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=116633155&loc=d3e31531-110899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r812": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "8", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "https://asc.fasb.org/topic&trid=2134417", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r835": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r872": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r876": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r877": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r878": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r879": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r880": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r881": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r882": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r883": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r884": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r885": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r886": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r887": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r888": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r889": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r890": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r891": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r892": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r893": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r894": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r895": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r896": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r897": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r898": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r899": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r900": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r901": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r902": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r903": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r904": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r905": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r906": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r907": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r908": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r909": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "09", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r910": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "01", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r911": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "02", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r912": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(A)", "Subsection": "01", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r913": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(A)", "Subsection": "02", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r914": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(B)", "Subsection": "01", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r915": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(B)", "Subsection": "02", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r916": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(C)", "Subsection": "02", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r917": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "01", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r918": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "02", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r919": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(m)", "Publisher": "SEC", "Section": "4", "Subparagraph": "(1)(iii)", "Subsection": "08", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r920": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r921": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r922": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r923": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r924": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r925": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r926": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r927": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r928": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r929": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r930": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r931": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r932": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r933": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r934": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r935": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r936": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r937": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r938": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r939": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r940": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r941": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r942": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r943": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r944": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r945": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r946": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r947": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r948": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r949": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r950": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r951": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r952": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r953": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r954": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r955": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r956": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r957": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r958": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r959": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r960": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r961": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(6)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r962": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r963": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r964": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r965": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r966": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r967": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r968": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r969": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r970": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r971": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r972": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r973": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r974": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r975": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r976": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r977": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r978": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r979": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r980": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r981": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r982": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r983": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r984": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r985": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r986": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "210-10-S99-1(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r987": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r988": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r989": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r990": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r991": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r992": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r993": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r994": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r995": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r996": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r997": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r998": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r999": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" } }, "version": "2.2" } ZIP 152 0001757073-23-000010-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001757073-23-000010-xbrl.zip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

P(V97AR M,UUYAXC)/]!B,PO1UUPA*%TB&Y2:*9K676C((NBUU4BBAV'9GMRL 9[@0]0M M1?!TL NGQE>4ADV]+J?\ O@3D'+&5.D2D=\)GU9(WU-#-!]IL=R4SGOC?9-I M'EK6<)3ZD&_,ZNP$(^H.A%(Q9ZBTCK P!#:U.W$L/345T4;0@X-6L*-*8 MOW0ER&&G4VF.B3WHA(AZ$%0'M@C [T@"V"9MQOSAPCL.S? I3R0>T7/( M+CNRBPY4VT9FN2;/K6#-/Y@BEOCS'2UERCUW-9);!+QI, M6WDP$/'4O=FW.$Q3\!XLWD0E*1G,4ZTKLZQ M=K(]L=$@,E[PVD9F&1&LE/"6GI]YX=I^FG:?>;O*$FRJ<'A=F.)&@RK0A#6% MMRXP+1TN^"(O0I9S1W.K.\??&.PFE$7<#WW;TIQET(JR$4KQPML,)!CI3$^2 MRJ_!,2XUHD\+KU=MAS\K'HT_!DPC-]R@<#=1#%:YB9=N[#LW#D!738&?;E('AF.V4-5T'7R QX&"29!:>&QM.]K'? M2;X#BRMSBPX';FZ3XX0G_YH%VSLK<>NF'.;VWL%L4H*")3"6HP-.&A6\5XS*LMJ M)O5*C8FA:(Q(B%@5T:U61:-<,?Q.(/T=T"$+8 A7U.HE(9#JVD3S5G4[F,WJ M)J=QE*2/X5^$G34@'VQN8PM!&^_^*9/]8INL-M9$:8:+KG 5('3'$\K3*) M0&R:'FP3"7'; ",&+ ./ ;B;V0J+K0-!N\55E1+4C*4EI+4,\[&.ZT)W5E6A MDO1MENWN>NB? N'H"ZBFW^JGFCOUFD\1WJU*MH3/@\\1-Z,7M%,C&6REE.2Y M TDXD%HTEZSW3UG VZ/FO!T6F#>:V7L8AH;)FSNEBAGUS@GPDXJN.QA(:5@[ M#*6!T_'\I=6+G(R(E67]*.FL7W*Q?$/Y=.F7WC:^'P9\P/,]H< BW6J M;HEWH+ E0*MB8'Z5XY]NKB K$D%5=,1VD]G<'Z30>V@LD8RI;RY*%F M9S/HYI^O4U7!*5=1@?BA,#(F;72Q]!)_/)Z*N@=[KNZD&YW;RO![N-?N2D#T MQ%V0WB8 ^H+[PA/0X"8KW72UF(%( @9.K87TFJHU>)6G(EUC0^9@/- ^YJS/FO24_T48@;<1!?+%.!_$D%XP:[55B M;E%+YU\\R1?AS&^T'^GL).**AWU"KGF5YKW4&(QYS[";BDV"AS^\=?@XX3:: MW^:DAT%R?IQI0&$U'E*K0!UD$/I:IA;\1MVVGF&5X2(Q+?L^C=KS^12&>&=7 M?2YYWT\*8GKV1L@7^LDV=IQT^@'4MA1%+DULLM-0IQ>'@ M",Y]G4O5NS>)3:+C)911 ?YJJ@$">U:5V,7H=VS[!UKUL#%>,L#M& M*C53O%/(E*NS!(N"2)K'9 G=VJ]-$-A.*6G F9\LPT66%FO8<1G4H'3J^YXK MMMQ,&Y8K7AF=LKM..N4W3>VSEUV5?$[9 @E?U:4'!>SQ%!F] @\TC.$@%*YU MEFC#MSC/2T11$3BK<@.NU#2:)!3&FQ!OW=U;IZUYA)4'19XEX^BU5(BL$1/; M:O((][,G=,3BF=F0@%G!0=1V83!>,7#6&?(7,?_7!)1V/:KNJ!&^@ZC^IU*& MT&W+A<- ^H$BKR^H:"7/'N'+1^4M&"E3ZN(W2I/R4OJ58F6]L(LU*NLHL0// M 6,%A03"S9CJM0-#WF@1&MJZI9HZKDB"LDMR"4U01I7/>[<$[9F9YLKHN_C^ M:>[(AL/('*:7&\F-[@@:)<=,&P1&_.%RQP/OT>VA;<0QZ$>Q$RT^.-=X[^#!G5\KIL=I/!OMQDE\><)O(C.N;A MIG.,6>KF&;K/)DXDI.E&=H.Q%7OK< MOPJ[I;TUXCUTS19:06 MPE:2G:P,G-69LP?=$O*)94_,WQ6+[-^[2$Z:HAI3V&X.MJ_ @0/)>DT%?7&"R:TFN2+6@6D*TE-3#_#DL@N8NX,;="?9.W.P M*0? 9TRAIO(C<'TE4,J%(2?<']TB8?J@1@X+X++ G)BTZ]$MNT5/R)D;6"\U MF&\F] CUJ#%P/>Z2.W2$/:2DM^)D0E"22J93W@6N@Y7"8&<"ZB!A*=5YJCOC M)8WN-+:EGAW:1ISM_I90YP&R];:/71++ML;44"@W)6)4$>U.)P(YN(E&G(_K M1J&VRRT1B,"1XUL O1:">RYXFM3$**/P(#C4:EC"'YHHS0+GN75LS>R=R3'P M YK5L387)ZM(VSBTTXF5:.(T+G0GDVHFD_K):A MVF6>;DPNN"6PE>9,C4@H80[A203*U!4DJ?<]A_-$J7UE]$F; ;BM003Q)CRK0F]93FMSL[T=DP^F>A-#)VO4JOX^$@>E4G M7%9\!'\76@VB0RPSR8L,Y-.+/3BP@T;="ARR [@!:!&2^!=,/"[PB("'!NMD M!/ZW$&JO1S\/$0T.DNBO.FOP(3<%>*L=9W-$YJEYQB0H85;*8CU8-X=B!T%W MM@LN@;8L*BO)T"Z41-:($%X5 <^PTWR:FM[V!&$L2\M:)WTRX'/D<40KVS*LH^S@,Z]LQ-IVZ\Q=/'X>/@7;*H$W0Q?RM./>A[/ MX$U3\2WL[E]5:CU^,7SR%>16]^EZ^/X(GR&W7@R?/E] ;!UZ^_%]N!\_E.K! M.WS=6Y[YXDS.4FE/DCBW=:G[R39G9B_CLGMDEDA*R\SJP2--1 IYKF^DTH@0JF"MEB?:Q]7D-O2FZRI6C$)>O MM_3P8HA@-/H:2 XPWQ3;^Y!]%<^ M>OPN"$!W@C.DPP MY;#-#5PF/::2++2W)'M-I7)H5)D*1P.MH0&C4U+=AJ#GT*L98">$,4P4_ 6V M9S$&9P;^Y,PY^SA>DX"DE'[',&9A6&*HD8CRD4(R06"Y[Z8&A["2\HJ#D9S1PP[R MIC"9:Q_('$+SV5.3SFNSJ]_W7F;K4(6\+0>@N-P2UJ M.MO8S7U-9#GS841M1>SFE3[M\0J?]KL-LS^$H [ZK(Z.?0)AF$7'4I'N]N-:T\TNH^!!Y]BRC0^MI=.)A M0]Z:PAN>Z-"50)>7"L!"P?1US:)@'MDZL>V(W"3R:)AK'!N)I MHA-^3#[#X%2=F8!ON]7-=^L#Y9%>87ETM_5!]L89EZF5$=A26U>(*"N3WE;4-YQ)T68) MR_L@+AWX;S:X/6"4D[D+!FU=>!BK&Y&.!C^5V#9SN)K+P1/6ENM(OK_>CF:I M&B.@A!GX&?"5>7X-7 97I3F"'(G"#0&WXN-0I)?I,:2239)V]YG?@5]+M'7M M3U.4)F7E! U&X@55PH%W;1N?S7(/]DEFBOV_*BMAA*6^=&CD%DNMD- MFV?-67^&])C8=H=2X.NZ2N%)R!.S4EO"_U1*%[7+&LX63EY>%V.B&D'=\471 MO,M$ CS^2E4-7R3O_ZGOQ^?G1Z^C5_^*WA[\.8C^ M/#C^X^@L.CCY5W1Z_.MOY]&[4[CX_='A^<'Y\;N3Z.#7@^,3N '>[!W\URG= M^?3XX"U>>?#Z/S^\/C[D2^&6!]%_?CC]5_3N#=WP\.W!\>^#Z/#@P]D177W( MMSP]/CL^^37Z\_C\M^CTZ P?9L9[>O;A#"^%!QU].'E]=#K ?]$W.+JS0?3Z MP_GQ$5WS]OC@U?';8_KGX>G1 ;X6_N[5OS:#_V'WR3H5(3DH[!D"E='V7O)Q MD* MLYPYQB'+MMP&\5I(LV1IKV%?Q(SFU*C)QIK;IC,]E+V1:Z-@WIPB'AZ5 ME-PJ8>9.[VX<=PQ*\*2\SB-C)U8# 1Y+/I2;7G)@U!)@IN,Z_^'SNHEGP0T[#/=;<%C/56Q?TFBT,O,"]&O6@;194V/34V$ (T..DG-4F' EV8:G["87: ME0]-J( IX1%,;5F/I(\8#L^$*>2.?H/+WMD9-,N/Z$B;=\@;#>#J<>6"L4@% MS*8R+N:A*JL4/0\PT[DLKAVQ' L*62>4TF'J-((WRP:P>9L1%2A6AG^&+N(9@2^3*3QGQE@>MQ[^ MLQT[5G CXJ;3OZ-1EW[1ONEYG(Y3)LW52)B>*2E>D3&OYUE0(@>U&O!=*X+=:RZH%]0C&>&$_O/R:XW7)@&P>M4KYS8A?BS8:19HC*A+5S.N#4*BB)#[]7NQ.H3>9L58]R?S4[;CL"T]JB6"K^)GF'D* \?N%X$< S!1*CML.R=! YL:B?0R\4\FB/, M(ON'OG;VZ PLT/DG:RUT^=ZS>5VR^JO/T4S'XE-VEYLNABQ%8V*9<7W@C'RQ MC!M5,XV"FXV?Y/XRX-[2@-YT-1PU>[HV?N+T/6201?](PV-'=.D,,'.-=!:5 MSMVQZQI?4H4%$>5;3""[S-$$F^!D2%J0Y&#R6,584 +Z)O >* M^L(& \"MGQ#\SO8-*BP -V@LQ+P2'(>61&2C0T\93MD$0:ST/'EYCX<7YP75 MN#M]C7[I[9.V*0 MW;)?7,K:7]M-68M>H739*Y3J+"5<1F5X-KP*60P2Q*U*XX$+N'UA58C+:;A M5&G/8GC\$JJ#SK0K@QZ(&&()T04\LT0))94#<.F?49";=R3[&]W/U4UB:MN% MP<^\W@"VO3!\B.$D1C2.528I,M@V&+0W.V:,/0WA<&[^K/XU=U:#Z6S)/J]) M,^&!>KJM"\0*V]R0=(NU_ VG@1ZP\9-\U3O)+! \26$Z5/G:AQKZ<&@=;:*, MBH)-(].F912KJ<)(J1 -8E!?T/(A)[9='OB-R#7,F\$EM7&G@M4WUWH[H;=+ M-W<-LQF9CB??;8-+GX*\+N]L2N"1YV\9BU":*B'+69D3SQFEL(0/#"YB]1MA M< N9>28AL]((KO 3G$%:[P83@2U9G9@WD,#E9=!XY11:/0Q,4Q\!)K=',JMZ@S"L(J M2;815MR $(-)M= $W+&<>(7_QG0KG/0VXQ$)G :%HI]-F,^.U->D/BF0=1XW MP:U)6_4N77@,B;6+C3>MKQ!-H6/GG[A9L>G4]69N(WFWE?;*M8ZFN[P*MI3? MMN"EZ[H:8=A%PLZ[J;:3B3L.9@.#J=S_CPK])FF-D5':2S[_9M?:,31S7!?8 M_-&51$G>_'N.P/8+6O\;4AG9HV]SMS@">XPPT4@>OV6I4HN\F&?:;426?H5:T-V=I7\+4JU^>"Z?^?GY>9R<\^FP M.PPC\&$G\$^/.O4HN\ T,AA9_*[,6H)S0-9%V;2?&EVP.^K +E5I/'?S>^[PY6_GO;5J@L;U,TO>R OT8U#L MNQ6M#A,3W]U?"+F/OC,B0PE-681@>@K(WMB:(J=6YMQVX!EVGBTFP^I ? ;Z M:K99V,F]M6K7="R=S\X+:MM$ 8C?57&EJ^A@A+C8M^IFR9#*5[?W1U3VF6PC M&[I)4\\8$\@[,^#8/+WE6)4YJGB.HED.]LA'M49_47;'RP UWR,HM_7*7Z>\_HK6 M'^.%ABFHX=_=01'$BS8P_M<@0OZGAA9%1'O.Z&OVUN J20C"'<2!([+) 2T[ ML8[+!(EVTVX3.AO^+9\UEUA?BJ M499K=LT6T=)._*9 ?N&W9\7Z$<,2:;3>4B2GN5ST:T70D0O*]G/W1A+XE\E( MF!*8VC*UD7,"H!K'.2_B#@(SKK[&9#L&H=K?YECCS-0YS2G HA7>SFA)M;?D MV&3QS1BQN1J>$0+2).4XS4LS<>V[FU:U'KV]OQ5-A?M$(^6Q1^IL 3.R=%4R MFY%PX_5RMTN8>A0K &044V]SHO574LV[VK#*B%C<\M)FYQ<04)\LH=JBU'82FL]FBRA!/$!. M"%"Q_JVA90N<-_]%75*ZHQJ]G&EUU1$E^LE[LHK!.$'1(M56W$=F(^R)M>JQ M]Y8\)5S,<_61-FB:H$3B#,%ASF8G_&C991KM4 MS0=#!#;)>@KB3P$>#?;$[ M.S5@,]J1ZLU);Q%&1L%)($ T]I"PF*@*/AW5E>'G\=/53EN/%09JNJ$[=S86 MAA.!_!>QPP))?1CJKH*"3I:4S(16FV'59JR6]70R#=5+ZDUJ*V*2!^W^$2P ]7(*S9;AJ2E"UT)38VI M^J!G^-P3/9BHP.%Q'3FWY+L-&P.4J#/Y3EY_+ENI,P&C$89OSR\?0>]5?'JG MKKKW]I1MM5()5F TCOFVQX7RL*O>32QVXIK2-'O2)*57^H=B'TW=MIO&$!Z+ M3^BPHT5C]WC(>6%!FM&=LO$N7#=+/;@4_P4+_6^OMDW;!AT43 M13THK&8(4$I4K:^OO>?0,$IKX_7.+/[-L0[?'IPZ]WF!P6*;5MAL.%29SBF2 M/\+\!VW_O@,];%IMYSO2XTO()BM.K8\>5 5T\\?SEMLGC9-B7$\Q%S_6Y4:86=U4=4NNKK^W_?5&',"# MLM0,@CP0FOU3ZMJ)0O^4-;E$!6 OO6' ME9T.VW:@L/-1-.?#>L\"I"C;4?MEVK5P.%=R@>Y.8["ED6-7:I!MO3J> C$6 MJT-A$Z^6U^LD%09F!*)NXC SA51JF4V'4-3%!F6:&/0Y89EP@-O<^&)4Y%=@ MS%QPWE=E5W9CF3#7]RVRX!:1T]L1/N^(3?"QE3:./.,4UH'S+>1$B*>R(2)6 M96)FLW?4X+;]ODP/M$PF$AN>.^>DUEGL(?(HS,N'$L_@]U59<%7Z20X\#^;[ M+"ZVMV'RB+Z-7&/A[3RK[I$)_+Y$"RY1 M.R,Z$@;SQ$962"L$N>(L_C[#=\QPT]6$CYQIBFUT L\ZFLIU1>O] M LLP6N_U,_"#]91!!%L3'U!=6@@2+83"/+,:7TKO["J'J?D='%"DKAUTM9PI M-+=O)SN5<-1\#0^#[5,"YE#&ETU>?A+/X)TS8&A,Z:6H- !1([<=$9XF19X? M-KZ9(;_&+V1 M*V*C]K&.;CJ,K)F1[,*GV-K\C1 *:\6T? J?UC- &++^7I=1MF MVXSX@NV!6YPU-2I!-HX$LA+/)^ MSU<%Z+R@I-*1X[?F2AYG&W:$/Z2IIOY?-']\[T*3#3K6I.P3TVXZ)N@**GO\ M.)\,6]T/@K/>SH][K%B4_,"!)!7^DR.E_]9A-VQ4"26R6214ZF00>W.4P4B# M#3\9&,O=Q/MT7TD1KMWID>!L.AC^!/\0'Z]J2[&_!EK@&KWXC-,-:5?>#,XTDBRN@%CRG M9R#,.U&TVQY,B>DU0E]42/*&[2#M<'92YF+@\2\?/B9*4&;P["_1L(MSF5Z26S>A0L>\EW1\483AVAK=SL0E R0]*#& MT9;!Z\TQ7GPQO>VOAR5@DI=EI;VUMSW/ZT#FXKX;=*UHZ\?$NB4=@Q1HTRG? MQWNI.4-T6;1@S%2MM1],UH"LF0"\;LV1!78P;R*8;.18XL [<55V(99D6=AM M](C5/FEQI@:QWDM$)AV$)NT7-.QJB[P?=[(7#U01/8&I7!U8KCR:AP);!U$4 ML+/U3B-_V:7')Z!/\=1Y"_L=8F@AAKO?(89?0B]UB8H^L];;D$83-'\^K^K: MEI?@M9/0+B=CELXO(ZG:X/F?2@\K+PV -\+:7"L*FK=8PF9$7A:]35:#CJ8K MH]0@SW!NBT6&ASFF#.OT"0Z$0$80W\EF2![92@)!#(%NRIO"V!!L=>L;T M,1/^P0ZM/^?LE;.\+K7INS+F_@0AFP=E72VEJV.+))6(W/$E.*56,0\,(7Y& MU+G$7FCH07U&:<_,0XY%>@EI&6HG"\O,)><+%K^\WTB[_FY>MQEGBW X8&IL MI3#$H,=UQ8 K>IBT$%0S-8:Q#V'!HZDV3=_QUZ]R8K@MO/60@%!CVLVL2,\Y M(A#V&66;A9M^T28'D+D]B^%!A?MLG1+;?=1K9"=*B:V5^#E MO#_)]E&/%0S3] H@5KLW&L16A64N28:.6"N.YC*-"QC-XB"-MA'EARDC"F9U MN:',N:=B+J=%@P.F%D2=$T0N;>H)]HH#F0/Z_27]/,IGB/NL,\'^Y".&7E'R M_5I:QV*FI=2VJ"C,%5(,V;",^[B[<]NXMOCCI-",^X\6E:EVS*<05(&H5=J(A7 MS>^76[9EK#7?_J=&QYYI-[B):E=)5LB^V"L">^1;A[U]?VJV^3?Y]MRIO4UQ MIQYH&A=3A7_[\<5N9]?-+S@ NN,O8(6GR7B!(1VW) _\ Q/$;.W-%#8JQIS: M@-&1NM*2UR$33))!2'A 1#Y>@]0E3?#^0KT==H9S-\;",H3O []B,A![TI'/ M"<&8J9J5^A?SQTLL-4W5[2])1F.G'[V4VXEX0/L$Z2>195Z&1J/DK]UQ&>[P MD:E@H%5LGBQ?#^FKGZNXX[OGPV?/=GN_AA?J_^D2;@M?/GNQ+J/=>S;OCDU_/HL-WI^_? MG1Z<'[\[">9%%K]A3NP^84GR:9.VZI=^^H9'"V"EUOG',ZKEJ O]X\-L][LG MSMU>= W9.F"]E]@/,,(Y>+EB4WI/P\3.\0)3?/<>HL\ M+_IQHJ9?1O ]\$QO_GE]7R0P#%R/[T)R(R;]&Y:2W^([/^A1_7[>O\QY/\?& M>P]TU'^F") 78OKD$/;G![&"4/C.4$*N7S>N]>+%\"F'>^X;UGKQ?/ABI__K M.T,OK7648>\.GP2+B>LI5U!D>L[W!6^B_@MH!3N^ON=Y@=O\T+6T\@9/,4D1 M!-.?#Y\]\3[D<>[QARM#;O9:CU/EFI"^5I6*B YTC/SJE*1=,JKDE>F6;8"L M7CE5:3RI:*33_(;A\9P Y-BZ5Q<1TYOJ%HW[3Z5/68Q?QC@)Q'U24O+,DG8C M*[3IQ(74C0S0X!9JN_N=/!# ,"65 MRY3@_)+,"RYY?]4S*ARY#U^T^>?V(*8U%9__VV#W?;._3HDBSO]8RO M>!F4((DZST-Z_ U[2$O?7 TK<:4=GD]*9JS) JR^N_D)$?= W2\'1]'=CK?O MOUM&QG<451>*:G\=452>&^F9C$^7 JOJA/C.H[1Z_?KHY/6'WZ.#N\S@A=YR MN;4XY^0F"$F7X7(J?:^SDS6(H+07R!KE$:48>H8.D&\'L]1-7EP%E>>F)1/X M,YU$4RFX8L(BE& OND,UHWC;O_&1-,@:"^5,YR/3CD^("+ADG&H%*R+2G=HV MUTB")+X4#WUJG+U?J9\!ESNS>QC4 QJ$Z9TU06NW$8A&&OL@F;9[?J,^5_K; M8J%VQ.ZFGE;J+I",@4"\3%/=W S"[XSM[?DF-49AEVX8252 M9X-^R037*5N!IW92<*O@]':)M1L__.-KM7[IGJX#5X,;1*A@'$6>75#G#R1; M(WKPSH(%YG%"E@/>QOX6Q]VK?*DG4:X\@^O+O"ZX""$\S*Y%?W$54RD0_' MG$FU#X3-MB_=1990Q#+S[@[ MI]>F&9E-4=L051ZU\T(];8BDMFD7.HK4BOMCJ4R$(-5+=AL@^!@L1T7UQ /@ MFEYKG:*Y2N5+.*;V.YAL1MG@:PV-VVS,''>9U)::S4'$W'C+KIZA=\EX<^Y' M09_I+B,\\TQ?E65>R]QER+B["U$_W4MLLU>/)OA_#\!>W0/;_G#Z[OW1P4GT MX>3XW4FT)51O1Q\LS1NW>K'7'1V^.WGW^_%A='!Z=."N/SHP/UB,I/N+O>;> MG>?[:S(>/1E^VG@Z8D"XA1[M#9^WTTGH';"+O_N5)_MN8=HSV03@/[5>F+H_1S=C;V8G.AM$_"P5S M4D2OTNMX.(A>U0G1@$9'\'>A570(#P)5FR4J>K$'EAE9Q:24F6&Q65I M99.6P_1G#@@Y8'7QLS)/J4?DN-!DZK5+[\4VE3Z0X?K[YH :H4/552??!';, MD HC\7OA+<7]_C9VXI;J5-C+&E"#LF)_N/M\/F4%B>%#V'$L5P8@DNU&PHW] MH507G7U#EC?EP^B]Q][FF<+F(%0B([G1=X<'(%QWQ!65$+^V"FGQQCPAY<"< M*RUDNS72V)J0I^.E>41^#-R,QM%]; -G$$D4C"?('=,=D7"?YY@IA ]=YE/+ M486D02I)S3_9M0>/=7:)/E!6(XG-P#(?CI*BNAR 2*)D&[CVVS!3U,P-_ MG]J9\<\\*AUY->FP(%]OZ>'%T'EP04MHOF2;VMP1EY#X?.5E,AM$?^6CJ$)8 M[,"G6D>N'*%"PLMPC5*K(P-Z_P0)-0>>J^G8ZXG#K'0=_3JX MF"Q.#;R _<S(,/%GG";4)DR'3762B*ZK+C M=/S4\Q:&FMC;)!2[/Y<8U'#TB[:Q$4DQK[UGW^)YW2Q=C%:'N9$##J,,D&*GMVUE6T1> MYVF=56#((/%V2 ND[0JALFBM$+*7W1/F&6 <)>GWC=@.H_6V';HAM+BF9[J@ M8.I[WMS%*KTF&A"^_^ B>C/O"- IA*/U!H9/Q\Q[67F[,GK[]A!U$M+5Z9FF M'1:5\NIRK@VM:X JCAA0;!0':-ZDK,J&_!96*BMH3?@^G&DK:T-.=NI&BW]) M?*D/[6R"3B"=CWTZYE"9H#0J-:D2Y?I/]4.HJ9, ZHK[20)Z9Q5!VTQ: MP5".HDQ@DZC"1#9I+7M'0FH@A[7!93)=<3L:[RQN+;EI>2Z]5Y?'KT5DS+&LRJO M&"M%/'\(1"CU#.NJ?([ WO"3TV%]XMDH0$X,VC96<[*G"QB]WXCM.%YMV_$. MT_$XDW:%9 10$.K#_TS:_K:CZ6AY1%&:LK)[4+N>- MJ.F;VV1+14A1 M,T:*YR"1Q3C3U2X)M5 M>I6F("$5:]!S"Q\?DA8*$U[,'Q_TF.3VF*E0SKN0G.N$?>R M;2RETWE>^'UC2C^L+6=7X+8.E$MA^F'TYZ4.@KW4Z05>$QO+:!VW"ISG3E1' M++30T_P:@WTH_#C-Z5UK/^!Y+\X*%A2YOHQD":/2%VQ[PT M07B=PM;>E^.BW%U^;#'3/C#-/8CBCM^(L-*K+:P6D55G3,!=1J=XGY4T?3I[ M>2F;)IIPER6CFT6Y,M7"HJ!)O\=YM-7H?NYP=F'[\VUN+JD_*A1ZK2"VB[7S M\+CC&+OFA.S$C_'(;B7;)-YT61&+>5ER4]U9POF/,##OBPF;&YS33FH ]_<> M@!DNETLCB#;L#?R4;D]7>Y?'<,K-E>;[:_]N8'8F8]LRQ7EA<"%##*A.MM9 MG9]*@;E>UG"0<9H)Q(^I$53-"W5+7V,4Y<&'L_/3@[?'ZU5IU_,N-?J"H*NC M=W@$HM?YN/:;*Z_%J_75CH5[VF]*83$4.;ZU$+58*Q*DBYN7I*2N#UG,]N3_ MU C&XIY"<+"F,TY#F\1YT'3$:_C.^N8P52"PWV$6/M M+-200A6["ZD]3=G8AQ1OPN0A-@1'#YQ:RJMFVYY2(E![.SNO'*K4]JD',W), MB-;=:.NPNMP.WO6^X,YO;U?W0(?51]\H7*LWFJ.513$I[I$%&H S*[#AL9,> M8/%,]IN/(("O;$D+82[A!;8: M>M#3?J3S%-UQ^].US[)Z,4B5^%*KII8)WC[,J3K^FWU_9H+8 -EPU. [P$(2 ML$D) >A%=2G"J,I+3NPHB2CHCV.MR2D^^-^[.P,TJPGZ&>3N)C7#901#)?ZZ MFF)D0#"?GN$[4MF5X)WPOJ[WGGLNAVLG22IQ&AIP%V;'QFT+S47,K0 M7KMU@S\@+^ MF9%JJ\@I/!#LUZG=_QU&P%+DW'H958L%!I(P8R1GF.@OG/M-)02#.T@>MM%C M8*G!*UAZ772C49%?Z0(36^;;;4+[Z5B27K;'J&?AO]+I15)/#:]&&(53659+ MM7FAJ[KH*MDB84$N!DF,1F:,FMPYH R_^Z#!]GMBQ.F:*AH7^*;3B9P+!B:[%98DF8]-69&)V!N/0C2N.![!G1(IYS$Q M*Y,VZ+U:"CJWA6K:'B)51C<:#U_ 7)8$&7+F[O .8U)1O0]G4M%::70BEO&W MCJ3,UR"ZN;D99J/1$*FC63JM5AO.?X+X272%IQ:L'W@2 U8/[;^Q"GE<_.W' MO?W]ES%FOI>I\,9JMD:L)W/-#$:!61M[\T(+!Q$WWK:T:03?$.\?G?[07:!Z M*@JZ*SX]G,KB$L'J$FS;BTM,'>?9(_,U=H7.I" 1P^B:HG,#D0@8T/@P/!N* MHA==W#$F5LG$O7.#0)*F41$F:"62AU@]4(IQ?U4V,M+4J:0HE4L%XR/).S"# M1_*@,B^8Q=U))ENKV)]<]5$A76QX[9>]S\FYUG8X)_>?KI?[8X/+2,L94 MA^.TX)LV.YDL_55[3E-FS$O/"K9F+>XIH4Z;J5LN))9^[#EH@NA:I;66J+'Y ML2F2=<>-]R Y/^V'+&IRL^-/H&PI=8;#JTL,9D=4(5H7KFJ"ZHMY[XJ;;;%) M+M@ )R?)8S IAAJ>_UJ/-:%']G<'T>^J@*..?_UGG>EHGX,,9WI6R34[4IU$ M(@'[.$A?"7/L8<+B6ILS9J<)_R&I11Q!QZSY5H?(@&4J1E_^+,9+\Y7W[\,( MQ169\I6<\86U1*]<"13&,FRD32;_>G5Z\-_';]?*SNM^D;=J!&?TK;J)WN?@ M MUV(476;"W>^'ZD MQ#9(A8H :_N3E+/&O"O;JE$<=3_Y4]:C:5(1SP0;XW'8A%+A+//&%BPY^:%^ M8HH>9E2)A&]=.)J^'9I:)75Q@;'[RM-\$C-K/@;>\,/9_X8)H P^O.$TQR)5 M;-6(Q0[$F^PNH/]'X)PW^BDL&KXNOR(Q+=(KIK>N=JHY'A-#N.^=P64O*E3> M&Z$_,20,K_G&^L3G?L1TZ_C=F^VU>LON8P7B0E5(J2Y;'3$A\':KE27!T-ZB0$.0) D!$@4N8@75=E#*]'\Y>RU6G;UL*D&G30U".2*L& M6F_NW@0Y0[*QH\#%0&0L$T.@T;-;7TG/W_^J2(@RHHLD[Z>Y35\6B==WW- / M5H;W6P0!#M!3QA-D&3#9\C4D MQEYG@H!%4$@X753%U+W8"A4'$P;95-P.%XXI+9;@^8IV\T0GU(_E Z+_SW4Q M33*K_8YL)>2*O]W]8F0M"O+'6VK[GB&R;P_,]'2-P4RKM2\_9!581(:C5QQ[ M)_T\XV;BSJ>((!9_LE>K\+BVS02_E/F&X,6-GWBM7["U(%M)3+,\I^^,([1 M^^<:6WLY4&!I."6-]RMX!A42.8&T(K^SSSV_;?O+<29Y> M!*'2+/;]]X'[Y6.0^US.) 63WM 'YC,S)$.V/"$2C<['2Y=[(F"48*DBT9X>,< M3#N[// 3VUBE5S9[S)?SR %A .@DZX]HTB;<-$A\_E%@Z:;(@)UZ["/A?L 9 MZQT++D -=CIO9NGQ ^>.2V1'' ++J";!!*&1I)G_PH7F9\PHI!VEB:[Q_O(# MX@9)R4&(U51=,-DV7,OI#HRFV\K1G&@U8[J8 V)J0"0/+'G3P"<_P3MX/ #8^@YF824CFSB\Y#JAM]YV@\(UP<7 MO9\Q$Z/TJG2C1R6GF$P)OXBE^G"@+Q/I9-=@B#;R$?DO*8>YQQG,<@:F5SZ9 M4-\$/>"6"*5MR3B'[43;O64"*8&N[M#18%B8S3.Z#>C\J&P9\R4<1S9M(' " MM\5XZ,COM(?BK!W<@%6"NJ'L&PS/O;LP4OT+M6AD9K6LU^-)VZVNR-,")9ES M$P5G3'@&IF=7=%@A3)689+6G:^*:NS!X4B.P'>Z@2D(I@;?R6K(2HP\UX*#D MO=WUTB:92+,M'4^JD+A(W9I_H]2=UM/^T8S:#5+X.:BLM"H(U(A**Z.V(;%T M36AH6,$+V$G X4T4=I%U71=U%L\[1KTCS R3>'.8C5%QZYB&FJE>^Z99S#&-+;JN0'' ML^C&#RQ]J4B,LX=HD+PX\WV>[J#Y%1'JT]D7,^*1,RPXI)-+QQ^QZSK\7]L, M3SK +N0B4QF0$Y;;8B/ZAF"JLHL:RP)M>("J"V9@V/%)1;=]CBU /4DF+L3I M\;LS^7+?ZM(N&[QRGF4J*6G;8E0+ M5RNYX ) $(Z1J044Q@5JCW*1PB_ >(2UX&_IU\0$HG U8?Z3Z'] 42.!9EZ7 M;D'AYOR+<5W)3^'Z:[P;C$,^B?*:5EF>7*/M^A=XNN-$D1U+C'#RA?;1?9[+KN%[B7U^#W:=E;!@O-WC-8TE^)>@I-R#?4 MD\?V'5KE5VGM3GJ5KXB[[GKKK\AA/'<:MJ;"G=;^[T4AV1[0@/I,H!D:$T?52T2C/ZK(S=CE#)\_<94ULH6^I M'?6]#MQ7:"6](KPDTOA5>(__K<.>:WVD[(5&2X=;L%WSH<$H<5V6!O,41_F( MZB05, MWM7J9U(7% 7LGI)!J[&URX?T-_61^4GSDINIFEN!L_-!?,BY@!ZT!^:L][8<:+]99N3 MW:(3M":*M$U0O5[I/U8@;@SW7G/G) 1 %9@[)O70.;ZC#,5$4"GAJTMX*0IZ M,QT&1F3R)*M:/S/Q>@JKN<;8YE=D9W(-30 VV1YX'-)4^[)@L4REKM#]1'B8 M7\\@ $7_'29JC+!A::V@FNP6 7S&5>YAFP!M:#K,6 J_Q2)?84K*<0'_E1=7 M44C0L@F'Y3NSW==]"3/?,VS^62#V(F3%8C=M_OE@FXG/H-3D>.UF2X'K3H09 MATX-UL&9#KA4)D2<.O8K&VRE^ID+G8%!F*92DH3;P"O1H;0^PDBFT?GN[OZ3 M:,N\DW _Z&]1AC4D@U=@.V0?62,&2PQ-R>-.;&U/H>VRDA2"Q4LAE]W)XSRA+9"SF>QFE>S1]Z_A*$L-CBF)3 M$PRMY57CA0(4:+V<=*;RI(Y9Y8&8#?1 -TPIFE Q;EP=\]?8$M!BT@X.7UDJ M99E2OCU;&_"U]'[*D9F-V[#K_R%:0A*A":*TBBM=A47/9HCL^]/4XZ;"T;+9 MRZG6C@!^?I.9UW>[,7 #. 4" T-H"?;CDLB!NB;Z1:_X$B^27_MWO)MC:4ZY M!L>(3<$&]E^!GQ2ZU13+RZ [ZAF/.F.CBSI^.WY[M%8"]]NS!CN;"6"HS6^' M@JX3=&IS\%0$<=-]0)JB\4<6QJ^LDZ+3FDBL3_)AM+__U,IVW$%@2[BN-^8; M5ZWW.ZL9H[@.?W]C%!=!,KZ1S31:F*V)84UOYRXX];W$ M4G)!C#G1TV'I?+=;E@$KZ98>;U4TT>-+)/* ]0%W#A(/)HUF% J\0UZEO:_&.H'7_ MB%J41"W9:VZ99X3)*2H4BFFDIQ0HBZDZ@2PUO ^+'K'FO)^RC$5%KDP*E/:I M+G.[ZWCK? 8R9JWVSH/;95] /!UYJX-[8Y;'A14*6,HU0L% .I>E6+#.I($+ M1;\L-16HA<*L\ 26>8IGL6$(=!/2:;9W@W2\NU^\<=5*S.Y&YI,,:,,*$Q,R M"'HV,:>7CFRO>\SQ,- )>\9U$UA%4O+D$2=:TD2\+YOST6^F-F:1>@*67 0E MTF,JZ@P'>!>IUMPQ&3P3MZPS00Y[RTJZ/)F'Q2&S'9/:M0IP,9O%Q7'L!!<^ M0YJ?$,>\'!B5=A]RQ UY>V@>ZBR#,9C=ZWAZ9Z_AU-]3 \^BE1)X,,D4(1W>X[2500IC>LG.@BB"8(2F.Q;BR] M8,+NI&'8YZHU/)]?OY._%O.>Q!8P*Q+.0?K5IEY*9Q.TXK='#'ON)42.N;\I M.FW7&BM3I>[">>W'IV$^PDHP^Y'@EI'1*9. M:7MB-6:VBU&1J]@!HFXY280 !FJ,-,:V7\BLC*4YE1U^PJ@.NM' D*1O&T 7 MG!\*Y)L@GZ-MEQ1]:9M)=*;0+5"#<^\FH#>Z-12N4GI^DQ<9%51+K:_F;^"Q M='8I6>FF9<1I!-, !@M/%;RT@8OHUOT$7\SQY\;-$/2V2O8[G:=IC=PM>;E, M0-9V!]VN3D'X%GD&3@%N2]\TP6UNFN3)+L5.>&62#,?I /8ASC[ABG9?[+T8 M(M.@X='L;[!KQ#,=@;#7KMMOL'>Y_Q%O9200Q'+F'44Y?J(7B)L$: MO !F2\&H]NF(UJ\FIP_@4U5<@K0YX)Z3-F$J=D.[:#*>^H2IQBGU*J:S?/$F M*=B_S,VDCRD2RCH\%C5Q)E+NSKJ1;=M7*'Z$^ ?";+.*1Q@+M M5E@ -SQA"ZI2N+C(A-0%QBF#8Q$=R(,]3KYCG[B1+/+@2GAR*?E(_^'6."?& M6CBA6]@0V@>5N\:/XTL=UT+<8OANL&E6$3M H6_CFQ_@M(L=TX3C#.BY9@F9 M]Z_@B<:J#9-?=^O:6D0*%OBX6$M@85# #4&A03SD-Q'94'#II*,D3'9!.'^) MB^1L@L?2BN.=^AKBP.L:TN!1OKG,:8U0IIL.P)M 'MT7#.23F)E>QV:WG!ZV M3;9YU<4U\AXC89TY'?CC=M]8;$2U"#\.DL&ND0;$J/=B-U':X]B.>WN ZYJN[44]K#5KSDAC1 M#RK*>8,T745!!\]079EQA(AT"B'3.&HB:H2CB5E3^!W$(D"O)7A(Q/01&M3RBYPQW+0HU>;6L G9FLJ3]NLR+= \=^VD@J' MD29*VB7@-&%3A%/F^WQT#)JA%,<\:(70$5HBI4<*#ROQRTE"-5&OF3MKDL*N MKD,3F&:2)]LG7\6OJ*OR:S#*,3=H7@H9U> !U8T6KDO3?>TUIP$PE##A \D! MA3;GL5I"@TENVX1FD>J&O#VPCFU^%S&")QXX[Q%ZHF$Z M@!8P;]=/$L],@_)VT)%UDO&$+]4HY^&450K1"@ M[AKMB4@2]0\C?&R'P[;XK?PWFF^$=B9FN@XW>FCU#':N+SI'V$?-K)$1%KZJ MIEL'5YE.U4T*YX8N-0*_S#MVIRQIK"E=*K1F8@>:UN/?,[0V0_OB>X;V(?W! M3SO?_:V!4<@IMFBL#/),FZA(RJO HJ2RU Y#D=FN+2;#C,XH!_NSX 5B5"/) MJ*ZZ0V16@^'9[)#4ZV4_W0O -"_D86*0IX=K]?Y?)<[1!U[P@DDHT*GO1:_? MKUQK/.3:X%BLZWS!$!Z&[%C+H\D8X)QER[E:&J?$5+0C ND)(9#F8B8F23%U M9X>9%]EC]5(<$^G5$A?J!B/ >('K.ABDC.U![^FRQU-/BO0NL 1-2FBVK=>A M7,RIZ6E^;(E9@I6@+2A60R/QY,5]R5>N38^CO(@Y)"3\*FC8-8OC.W:UG^*R M0F&C^=/4#D)6N M^C3,#QW[@>T#O!#D^.X3G!#>.VZ1-)^.D,V&M_)A M'NOM@:<"C9(8="<7!M:1E^REZ$:_N97IGDGH$JR,,0G*WM:R49Q32##H18*B M-,^\/&N7UI>$)F@S5=P:3GH3[I-F/\/H7'P_ZL#$3O>MZW9!1/74@"9NV RF MA0^1KWJ=@T#5CFNAOC;\H["][+P_U5DM*;S&;B>7!$%XRM_;R-W%GD;<^\7^_+\)R4^A#A MSO?J?U>LA[@MXSL!.TO:1=MZOMOHB.JN]')!?@UNAH'O;8]5)JM#)=O.;;:E M_G:)P*6 W4H@EE8?7PM*("E9U-SF:JJN&/SI5X6']=P# WH!K3K-;;MXRS<" M'\?U6-H;VX$\S'3N+6;1;*A@^KS"I]5]V_DL?A[:V6.ZU\DBT]$J24V3X+XT4<\H_)2/HR2TA5:8'S1[P1:.8=YKQOG#8$ ( M2;=W0;;>.-JJ2\;_SZUA<1&4[84Q'/X5'L@Z*5O9;8Y!H*BF03B=/#="L*D6 MVCUK73['PUV1>>@^LP>F.,754ESCWJ_J(FMLX@YS#B$M[R83C#QSTLSZ(]Q& MTCO/7H_3(!'0G:VEU"(?2VST9^DSPV[#PF:P780,= M<%T)76A?*D8,93+"T[E:PET/+X:#I89S$"27*8HR&F)SFOIM*_S^ LNNC#DV M[EJE,/M2;$)[P]TGK7,M'ZY^+/3T MW<'YYX1"5T2''^PQ_:VC3[JA/$UR^8OSDDS-[.QB)A5E0?_O?1X6_1Z='[ M#Z_>'J\7-.);4X$46T![3KNF!(?_UF!XAMIJ"[\P1?LGKUSY91>2V\!@1956 M01;0:$6\"59"&R7+K2=]73OPPIEBO=Q!MDDIG)+2+-P_($TE MVTA@19/;VC*:G!&,/5C8-H35)IA,9^-.$[DK\'#G+"'XT_8M&Y744YKZ6IBU MLL-;8"(%).%\OT-W@B;1Y M5 %@7G9,?+6+)R%>3@H-$XNHZ8.9=P"A[V<,&>JAON"4 M5? 6Y.2#6O@8=BIW3DQD.J'5\?$LF20-;=.L6POKQWAQ*]OH8%QM@/W22Q=@5+)+M38(!%B15'#Z([/9_-+JNLSS1=?ZPQK:-M=U423N*H0HW MJ;.Z]73;#> MFP?!9%^;C#X_.OQP\/K=Z;K98??-D&_(<>\N,@V#VRZM@H8366%D%0B#C]?Y MKAQ@$>)'?ER$HFM>Z--/NZ U9 MIXF%C/))>%4P=3KZV5O?WZYR^=5NSP/9V&UV/.;(O].X@'7\9>;];:[8R&-J?%! MC\H*I) "HUH*H4E9$.^<9VTAEEZHX3I(*Z33YR D(VB.(QP#V&UAG0?)/L.^ M]^;5N24RMK2!(*3TE%U*"J3?)*4V7)V,"@^"%\;*O,CA7P.A)L8>$;XIW.Y\ MVD'[X3B\^ZISVE:OQY/5X <)H^TL=R8LF!0@H)NYJD7DA;2 V.[O@TG@R<"2V:FFJ08[ )8[G)0-;/H0EI$I>_15H GRWFAB>I, KVBXH^P"(X"P M,7E6!^Z<75)>NZ3[:SYCG(F_U$%P&;>KAFTL)$/:[.?,WK0MK?CMQ6G4^(IT M[O/2?QGF1(073V^_@[1Q*/V976*8@L%>D2^3+JV/WZ CN"YOA1G%_A_H^3.$JQN=KSEZ,D2FLP MN>'+O\!V@>_(A"_JJ%0*/\T("$//T@D,W5Q%W4OAC=*K9(K\LAI5:82CB.%, MGNDTQ1M5=0IV.JBMR@P\ROAWL#[U*+I.DEAY(ZN(MPP>F6!X!$:^R?'3-\YZA&I+*;6;/ T.P&BK7)XFUPG]!6]*XFVS O M?V$049=Z?-7O&1;ZD:$]COTT S='$ZHCL:[S&_",R\MDYI-"HI%(1IU?96Z& MC.9C/L63.=X6ZO8"<6E,$DHI-%>/%%C\"1.6WD;@,^1,S9A[/,-=N9JINA*W MRG+SR^,(5];HS((9%W#)-#O==DUF:L90MZFE*>3<6R/$N=%RX?3@Y/!HK4)Q M/1!DL:)A(4\90Q D5C",Q";B6KWK5S&[772(V$P%ZSP(/76QIQ%@$R/18#WU MV[Y0 R^R?X7\C%W0TB%FR;I.LGL9\5_ WEZ7#'JOB3=WM\O*@ 3%.G;<]]9; S<(MCO^V\_[C[=>1D7.?4"JGE&E.EY M5%+C[RK!Z_;V'K\,.0JWL$?]KOL0254(*E1G>#?X]OFSEU%>1W(=17CXTVUD MS^\Z@F /T,*D-9JWJ(0+K/$T1R]5=.9L0"H6G7U067(@NC,5(R#)8H4_F172 MG1PW JQOIC_JZ-4 %WNL[4,J3)SBG.!QP0AAY1_/6^%LGH#X +,DPN7DNU;\ M/Z >P41(I)DV'$NL9J6=!*?S;=?AU/[38%>.\7_LV=0$*>,&*7>PEBYS'71T$FD2PE(A1*(YLD4]'MY!VO^N0X9[(E"FIZUK7 M&+ @=JTC)K>!!SEM##DF((;F+J?6P1.O#NTA33Y5/M,P9*DJ(;(G+O@?=$-= M7*M2<>,P/Z62%$M5POXV09D2*)2+"VRR:DL_;-<.TS4<;\1)F &\G,ZH&0)_ M)0YKXR4B25@8^@C.A5MF"$,N:-L FTZ7X&E-80-<6@^QT2]UD_VN7X].?S\X M^=>ZX=GZ*+.7&G+9 #'W*YA+Q.QGSIG/3# N\K*$MR"B8E?#.%6QYB0<0^:W MJ3S@(Y%F@UP"&W+_Z>.7NU3V9^(;JU6M_UJ#&!W#L%ZAY"X1';O,C32,SJ3S M2TL615.\#LP-3( 3#J6-.L%204Y 2ZRL>9UC\TIOF;A?$O+V9YZ[NAHKU%2_ M23FO"W&#K\#K_=7=#QLG:0&&BJB_I)-2]TZ=!.W"1UA#6A&[T7SULIPX\08K MM]\^G/QZQ&^ M D/O395-SI7I:^L%JNLXBX67T7398.B]/(Q $8V&62BKJ;S%U/& D$YRKXVQ MJ4XD"V5615LO=J)8W;++$38V-'7_<)?=Y]Y59NS6[B'/2*XDCXPS4O)HG 5\ MJ+*4#;:W%;]RH)/"KI.D;+A[BS(.K^$FR&U5@OQ LLF3*;W@ MA_I<@_,WQZZ;NIL^JA:ZH71BVZ?D>J.@3LF,KK^CR11625C]=(0/Q8GZ#DFQ MD)3]=82DK(%Y)(UQUVW(;YO.: MK:AY\CU(2Q%'UU)2 J =0?;(L1A]J=3XRCHV[TZ.SM;/N6G"PC= /!PT.3PZL-Z6*"Z1 MA!^;W:_4I2H5GFAPQ$M0_K#7J33#X_=HEX(/\P+.)['- MPT'062D)=XUE4U20(H)@08C-5K+]J>AVCQJ/TIS_K[TO;VX#7;Y2,A\X_0 MVXR$'S.,!(I5V*#)E1GS$59-8M:,(.\AES#:BPZ.\*&#_?US_%9C+G[(X\M! M](L>\]LRIARB"Q53I9^\**#'J9*"LZE,-,7C]$7Y#Y!7?C6Y.3MDB68S]>Z& M"<0=Z<9PL8!Q_][ \6 :\0*,N>L65O5=5+^+*:PN$,BXRE3<_$_R+UZCJSA# M8T1Q&:/U!Y,1,5\F*[(HNA)MZIW&H)AAEID ">TJ1H23>7,5?4$];QX#8:]2 M>*&ZHM8P:7$>PS^O@#JG\7KX&-=C9U9G:Q'B&N$N33'E.9O&L.ARNP9Z_9&; M3?EKW((K9FQQG0$9F]R0=3"&7<_C"3T6)[BCV"0>DFG[@(SX@.#YX /F#6#PVEF#:T;%IO %91< %X8Q9=Q!DL"(X4#"(\7 M"]CE*S&'_875@6489?,KK!2R&03LE;H%- &U(P2,D0OM+&1 VZ&J)[:Q&2L$ M=OH+5/IRP>9_[F+7^\QRF#4"TM55>7B6PW0F99RH3&8*3N"$_&:$!;]C%2D&6V8^[FR/,NZM)TEH^_'MWX8NCO$.:L=SRG[/0!23\-#L&- F>Q#H M^&DNLH,00Q2B-+.U$GM4"C3'!7U6SN2@4N_['&!B4CP-NZ9#JT#K:]>EMD*Y MG!=X=5J5Q9WE,@%9L&H'QP333.U8)6&UK$IK@/D_UJ!H"REJBR,K>3>MU%S0 M9<0UQ5T;V+J7;%?X?O'+9CFV.P1H5*S>J9WWRF!OBCQ["]%\'%C2I)QI[*RP M>CJ0KUQGXD:D/0^ZY;RLU)I=%?2951&JJ%H9Y.7O ,/X:'84_4CDX$Z4$7YZ;9X8G_-#/!!J,C:-= 4?V7Z)HA/>P M;/$35R&#WO$*N,\<'/,S:O?]GV5_'Z=VH1E,U,SA1^ M5X?P'0BM(*8"KTX6&MH2F.+U \7:;(/TG]H]&>>N<'HS*0>(44TP0QB08<$Y M6BB. X[E7\;10Y$L!NYKURJ%SBA>#65#TM% M;UN^(1C&CT\?WWXFU-E!]/6WZ%LR$6F3BUT=.T_0B7*.1B:636/WZ*"BT!4\ MZ4Q7XIQQ%;?Q%SK^XF@;?_$H%S1#YY^=\H\FZD9PH%!7?*R$Z\SKTF!V!F]Z MI)R[C)-')YOQ RBVH^MRT.-F+NCS.C;>*/:& MW];H.Y(R*B&TC:4_/X=/P'"0Z\@AZ+9;[=KE@UN8]L B"4O]ZZ^J<NH M:-'?XAGJYO3,.Y&0V<3&6]:JI)T JE#&.)H).PL@I=E\(JH(G^-.&73&?^_OGK^Y> M+OZ"73MM/"S0;')HH4:3O5^QL2=IG2\&)UI(DF,2/WR<,0=80==%_%L#@L_P MC.JEG ZBOT./7=6&23Z2][ U Z:!*FG%2:; *X&_4]LJCP/++8AHYW"7"(^V MD^$5*HQ575<[4,ET!52%>OL)]9$4 MK[>T>L6^6K*L\# A'";$9Y=Y7+=K[UT"QZM#D?CU_7]_?/MYHRYI5]3S"/89 M?1F>*W*CYG;_(B'# $3^"UB"!RL1V?)\FJ( ['+"$#8=4JW0H3PT<9 K$##4 M6(RX0F@R1\.'KO6AI*- 408)VZ RHXQSBR.-B4:F!L[-]L/*2!6[+B<7*\!Q M(FV<9W-$98Y5;6Q\83J+$42N,,$S(:A%IS3I9IV:CAB%,L^2A:GRN5%3ZJ8% M[7HN=MH=Q4Y=X3WQ) KE%"0_>K:$?(XTXVJ!')NMQI)Q8F4W)-R M!W$!"%/_(9OK5DN,)V\$?64Y\92KFRI 9#&G06W62>O>%KE6 R60768U+#4& M[X_A)J/]8(XAF]&WO>CO50P'LHK^DE^G(!W^IC,I,;XB*:>PJ"1_QL%]XL*2!AT\6@"F=/D-4&3NN7C^U7K$<+U.\=FJ4Q;0PHAKFL@> MH\\!ZTER$5?01VH@+[%OQ4M$:E23SNI\IC:1K004QFE!S(@U#=(RG-O=W2R5 M[!J3'.-5?[-9KRM)$O?57?6.&IJ_AFM>S.$]6PVZWG7ZXN*NM6'0F;"U,U<@ M(LNU@/%@VKKLS'&=V_)-OK!5R@UCP>%[\R$C=+WVK4#9?K0P>++!"Z'/D93Y MV?VHW$3BI#<2F>QE26KR8S)MGS,-/D M-D&551-6@/!59&CT&TJZ&;( J%)]'#+C6/99\&B60(M@-2&U7"E&=AL,+['EH^H;I09 MV/Q; 41UE'LD('ME!B)0^29>5<4C:.B')# MK',K4I-W) (YRQI]*;',X.'I&]BH^&5>G%]B/I:UQFI@*9G=,XW?23W;G%[04>,,G"T/J"]-U+LA4C;6I&L*KX#U'ASMN VR%#MW-N+1-(LH'VL,PNN M"T0A,$!\1SD47XN ZB1:PN3/^8<>;XA.")VFT3 MAZ"\;'2>S*G>DC1>+_!]O9:ES2;P-:.U\"APSI+WH%&O1':#WR/C$Y+!<5&G MN*:[5!.,K;9?QS7/"T> ]W0Z*Q-[)?'ZR-'HJZG7R^^(!V^->--OV9+2J-QP M6%UE^RY?9JFTB]R<^O3>0;R$10&7*&>1#[ND"VM68)!=5="R97=U^%EGNU*F0>,KWAM00R07#4A/FM61@4?- MT!+#;%/LK9,1QB*+A;Z56G*]V\4,7?Y1-PZ'(JY<$Z:B%@AJFHL1UES-!,9Q M'>>D(=$]U>Q=%![_1IF&N<[+O)ADQY67TK]Z;,-E 8"55R5 *VDWMFY(J4_D M#%_"8G<5[ :L/3Z9BBD!?__K^Z]8&/[;9ES!5UVLY%)E3%DYD'>?:I^PZ52 M.-G92ZX8N\YE^C74!@/H A,:P=JFLDQ!GLOPX7:B]:[.N/CRRZ?HU&1?;M1A MVJ 2D)NUL$O>4LY/JDLGN9CNP!AA#@CR40$QQDYB$AYU=:$L8$-XK=(%6548 M:(UPURX2H3J\L8JHH6@U&!BA]>S(&K5PK=__^!H-"55P%P-50Q.PQU[/"7]1 MPVUC)7!!%=:=LK(ZX="Y[Q2,8-5Y&F.A)[>&!.T?ZO#8\IJL(QG.0Y>6SCM=E39=# MKI#19"9$LC^N# ,M*5Y+1V0JH<)M AO8Z,NV58O%?2G$M^-C&-9KE@:[.SD[G9R8BDL1K>9Q>E: 9D ML8.S#?>HB;#\VC5#GV#>C\CF)7Z)80%EE<*_X>&HY 1#-+?S#<+VR5YV=/Q& MR*LDR&C.%EZ\2&5$IL@+:B?:,"AUU/)OKUQ[?[E(Q:)P;Z MLO.INW*"B75E;4P5E='(R$*HQ5B!Y%U5<4DDC:A6A0YR=S)WG8S;=KRVPH:" M&<"R47P[(:-PC=BFL/+M=-8Q<+:O38W8]ZM0SUOWIGVSQO2_)[M9/_:^[7&0 M*RMCCW@.GW"N'1Y9 TO(-9>X+-DUD%W"IK R?SGW>T0!)G H*I-O_IPBKWV( M0^-X]A6VK!X^_HJ1(K_-R^2*;_*%R:\%LAB0)'\49"&D5/-:(I]M=Z!G@)A/ MX=-1N99KLFYKN6PZ?[E];D,GD?WWD_)& &V@%#04TZ@^,C$7>_&9TFRIQ^T# MM'P:-2Z>79*=H-38K(_I4)6T5&XI](H#-'+,EIC>OEB!IP(55 42P+;F9 6[J7>"L*?GU7EM&0K>:V)!_3' M9YX?+$#OO(QSBLXC1QA5'TX56O) VURVN[KBKM8"J'9+[>B2#E/X.9DS\OIM M^Z.]+ML+M]36=&Y+6>0+!4J-W?U/65U)65*[/@DZ"I\S@JC#MR5[WY"XMBW$ M\RK5[$WQ$#9SEC.!(1&#*,E+19T5=M=8@4#+1\=.77O'8XN@K/)RVXB1*K4Y M*V03A81[U"TNU3_\DU^P R "",^(NN-[G.6$%;+:2,"N<1 (HAPPU+(.Q- Q M%N%9:G1I75YYU_7R6E!M7CNJ":N2#&%@JAK:X<4;1)RR/N+4<\+2'(;1-)79 M&M?$WP(;[19Q^^3!]TIZ6QYZ-1^U'J'5J.T>[X^Q[Z!D\M[46/>)0NLS @;M M0.QVL/?ICJO%#B)JKJ6W@?_[G%SO@L*0_A9C7MLB&B**\L%^ .00[UJ;C-2\C-+,=)@4PZ<&^@JP5H&5N+TE*5X4^,A6>@ MCB7 B%,:\38WP>[]"R6P-!^DXZ;L 8DA];S*$K]20A=&7I)5P)YJJ@31_O HBPX MGIDLD)EP#!1RVSQ&&5O#E!V&*XJNNBG^#E!"G;GF6(<:]?0\GM7BS^H?;S ! M,X\7?\X*F@2]],8]JL?0 UFMDCB76T\=\L_FKNSM\WV9PX&:IZIG^?,>_?0? M\[3]V_'>V?%)YZ\PQ<[?^EH]/-L[W^_^^:[-/LY@CX[VSL_.EFKV/VAY>8EA M%VO@%?_G#R=_\#::"-3^'FP=:#=D'U%G7C[ IR?PNR1Q?SZ8_3,:AB^\?QC* MV:-S@/"%'SI:@_W?+TT%#$UPO#&5+:EKRR[W1?%L)!GZHLFEO\>J$B[;@Z\[ M=NLO.E^^/ZS&81SV=;!W>FQ]QT.77SZ!-'O?'8;_[I\>.XXU%/E.B\]X>O]=X/]SIO[8M?D[#$\3/",9*NTZYTH#0.F!J[2IL" MHY04D"2I'[.F2B:(VUA+ _J8H+RQL@%:S5_Q>C_)&=QRC@>^#Q8)5[2?*;DD MP8J$G]LL0+&'(YNA* YPK-B#_)*Y!/]X/K3YRKG3H>0K;A=G1Y)+G3X?E[&Y MI+M2!X$9G[O\L+?1TT!KIVK&>CJ1W9=/#?[><6$]&W \23& M8[1>7!N'W01\WQF,*\F$ MQJ2$A..0S*;^[ >FYHUIR,V<./U[2^,($"TYQ"5H%H?VW"\'1VQ\?5PZMX]' M^ _+7"GEW^GI[2F'LVE3?P""XPQX:[VU_'>=MKV.)&=9<4)Y4M!HT;+L:F\L M.5]RK/Z61B.1ES=;,^_Z2BK=1\%BAYGU7 _GYL&>1U5@=840-)VA/Z5M -8$S=Q[/M[OK MI:F_:HHQ#)E-7I6UI M[OIY'13P5@VB<5?K?B,A9%HMIE@QDZ"X%( \8;8G* MCV%< O+145;A#Y<8_84AOI>(1YRF"(0PB))L#H.ADJ(#']E-I T72R:H^WF< MS'7D\LZDG K5RHZH=P0G"P6Q2M\7T5W4BEK@KZZJ$KP,M!1NPDMSQRI=X.:OQ(] ME"@3:,F2DR*;OY\XHD"WZ<.:N&O]5U^;6=*G\X#X8T8RL WXRG5TYHW:72U7 MD'+'ZTH7O8LO?W7=#+?,VY/K;A?S7%'R*#1(;0*1PPI9>SS?EK/GCBAF!NG* M8FZC9_:9#UEDJ)D=>TM.0J^N ,^/Q-NV/SHG/;EEB&L$7/NY#>F;&ICB=%AR<2,O1IU:#/ M7'BTW(6+:"##0.O>V3L+]>5NX3#D*CQWSO7YN;M*9EA[\EBXDW(TO3!=\/;8 M-S!NU8OG5B\.MNI%1WZ)$?E)R"Y4%?U(*Y#]5[6#,SXV^@!K""3QU4Y&#\JV!@$#E1/>&"H*I[:XZ M!PT"R]I@H@EF!W,N,7Q**X2(J*,<])*BINQ#RMXPMD4UI750-[:W=!-\C.NP M2^NDWDB;[DK2K2,7>PY&5P)S6:UC8FUI+4HG",E1;L!0*.#'E7S/U2"5K;HG MUBP<1F0+BYXO5L5A*0G:$<[.@[*-W2$*;@-GLNY E.WY%M.M8X%UK](AI#MZF3I5SC&\ MLY_[-+A]SEE2BW76TUK(P-XQF=/0&ZYCO4=X#B_-\BL<4C7-3;__.>T3RSU% MUO7#[-_UG/MZC'M*E*D@K(6['I2>X ZMLW@.G=M=.'"6@D:0$[OY)8[OF:.^ M*))T/ZK7.=>!IW3971V'QM%'&L-NGY4)OCV/K>*V3B+AX59QNU5Q0U^-!7GK M)LICT 2!SC2^7[X%'9.T0!5R!=8JY/7+3>"\P5AEB3@RH(&(VR[%,VR*" MV23R>UT/16-DJ7STB)!,2$-CA\\ZZ%QKZ.(YW+IX-DT'DB+M?6S@MO3EBEU! M7NQR?25&.,*K=N3T"0'=6H9Q%*B^W!", YLE>SX!CQ=+4>[L]BZ#RH5CPU:S M\B)7;U6:++_'_1T6@\G(96R1.'E@CM63Y<]U"U?7\W M5<#PKH*1Y2;TM^,,Q)5AU2ZZ?E,_4=AJU=.KPL+BD7V(5'*0(Q%W:33NFO5$ M3@4%B1C$]5]GRO&%_\HF&K5JV:H0PO?[\G^][8"\WH)S$?K(3"_ MBCU82C3O0H*JXQS%9B[\UQ*SY:\,&LF(B;J^,SV3%5I(5Y4J,.9+%N$$*?VR MBJ?\XJ@L" 9L%F=I2.K>GI.7WLOX&ROIA V*'42V4L[6$2-@;)N&$FWMA M$G?)B7_NP.Y0T%J70R(89:4MO(&="&;.NY;FI]F>06CH2NOHRUGP!GO4HXJX MH8HK;)3G=G ]&T[;OC@IH[=I,O[JTN/8K^Z.I)X6V_,V!#8"/; M.LR#2_9/DJJXIJSJV02*XY4%BN?:IG4WJ%,,T3R;.I%'D[*I0'!/)B)M5W-[MA+[4TCL=XE0ZI/173GB MV..TCLD\Q(9;7=[5RNX)CB'1(RRMN9;$L+#59UY<(KB@WP*YXJKZH!6K+*XK MYKK-GH0FX">V' 06(@RDU9$$8L>OA/,J>EH+@UH%XW*"\FV??\2/^7F2_>B5 M+/^#4(NWD.C DVI"?3&@]V?I[ULO?,ROGF/:"97P$9;I/ MLAGA[\KJ/9C.!^7G'];IK(\'L5B&;B_W-3-V7J$7NIMWNJ7FZ%?NAI8*)KEU%7$@K%" M'5%/2HVQ%8APZ%% '^HU.NN )D>Y)C O%*+E*6MA3H_\Z>K:[NI[W3FN]KM_-U0^= M0^N,V==DO?$H%^&9LZX]L8KA0Q/._G+3--QTD>>'D(R\O]TWXYZ@G3Z8V%.A M==K95]L0KW42$DZW(O]ZB?Q=(5Z8!%_/XWE31SOBGR#JSSDQ7M4%ES]*Z"NZ M9@^/LKS=VN>_7EL9_"ED\(>.R@H$)[7-YD&.&V@QS^8YE6K%A-6.+NE- MD0ZB!*VN>8[_!)FN2K(:_WDM$)M\$#4%_PN[*)LY%GK&U5X?\^I+OV];46NS M1"TI(;23/)^@7)<5!NN8<5R.KA G@K;0#L26'MM;T-KF8>BH@?2(?MYBZ[8W M5I#TH]GE)R>ZY-P>73C<^5GPO, $?/\8% MMCFT3T0XF#PH?3]I[;Q5;??ZVKB#[*TI>#?#OB]TG[O0IMZDA]XX N)[03@;34$P#;AJV1#>3+)E$TW@1C42"]1P*@?69,"]9 MEJ7&:I*H2&6$'EL( @ R$2FSIIJ5F'EGW(.ZO >JXNN041])64&I0:SD.ZD6=C/FH+ M!JZO6XODQT>V1!%V_8>F832*D*IWJHMVT"=MQ'6B)CS9,X@6%'3,]Q#I@U9JX^BH;=J+#@/BFA$4EY;,6E7\ME+!DU,/Y.#HRC[8 MUY;+YV!/7Q1.^[MX'C]G 61:B^%M5MQ'.;DOEU4^(V?T&)NKA1)[.CL8_KR7;GAVNG3PV2NMO7NX-URU^JXLNUM3W5U1H=:G M$&/'99Z7-U2%=R83"6JCTSGD^$]_/#[KSFK?EN)]=MVN[V0055G%4?#<'H)0 M?,6:%N/M\?@H/6B9 !@57_V0M-\ P2R[]-X;SU8I>/E :CL$'"C4-N3E=BKQ MH$5%MU1Z)2&G7?C>X;(V! TF2+.9=1#5BWHNT%C[+VFPC9.DF3:Y_%3/RXJJ M_5[CJ%05KIU*%.(FSK%B<*J_WAU$32T(T;T6( G(9RTH>0GI#@]F4U4Z*_L7 M_#2(1GF97%%/J:CG59-L$PK7B/T_0F7MQQ'3U@X2RF;AP7JKP>PT;49[>-9] M)Q#$U2%ES@.S@Y&[!;N6Q_5S4ME9PEV1*.'+W65C"70B85!J#4"@6\,+%5H. M!N3T59-::D4?KLY97]ZK?S%V0V%)7G!VL#Z1&Q'6NXCJD+@7[L"9T.W!(QU' MV"LB$(H9/W7UO; J\GQJ7QLZ;XM N<;RQNI%/+<;]?2^'13G>>E,M::0[H'V M07G'R1A88B7=$C%,4I7Y.!=5E<$/"VQ@7%;03T&9C:+>BZ)N^^,XJZ8UM!#C ME]%-7$=%.>V[U*P"U)G@KH97+MC,*A5Q]U;/;WAN^?5!W!;!R.EPH6"W:G:'NV-@:TUF',ZA M/>X(KK?5BR#@D0T=,FSKN4Z6=4N=ZQW9$CD-W7 G^N _.U58)NC-G8X;W^9D M"?7&MYT>K><]=N?FIQYTZ]RNB2'H=7):[Z^Z[@)KN90C%$3HKY\JN>@:M=RN MO,STCGP>V[:V?-J6E_:U?DKZ%LQ7BZ+[6S#?+9CO%LQWJZWV:JNKUSO?FA6> MG)8;M[AK@1E=BD)45/DE3LBK3Q2R;*I$!"Q*EHM=(5I0F7:8?P4O1Z.R MO*H->._N (L\)NVNI2U.)F1I!+(;,8*9H?%+/O 166 AYGO1-N_JU5[W5V2< M6L;]W>?W>FY548OV;C:^(^CWY;)[H%G!*/"@+S_H\_8P=]? MO)0KN&0Y]K# M 5AJ008!O=*#\3@/3$6/(^C2U9\B^Z^"]L*\J]V0.SX8-. EF*WEH0]'TZHW MG= ,O]KC'=/Y/$7:3^=S\=_D^GL8.$&;[+'W_M[M?NQ7F\-PT!FI_C.+5!A> MF%393'GI4)XA(>.:8 MWSS:$8YM635"2AGHG' WCX;=DQ)!HSOVP'6@W&Z(7SF MOPWBO_4*;8/XG\\H\-M$%#8G"H3QPU?/F48:/6$7]W\FR+% E!7%(=D M0^F4U658P&%2.9)RMJ#L#CWH,G\E)WSYU=-5CQJP8#//=9\P#VP]"//;:PX.IXN2[ZDZ-J>;"0CDTN M&,]S-KR]\>7MH-JR=.#,W!SE!TRAP(-QKUP>T\!#)HI8PPKF5]V]N<=."3+8 M7<]W?;29UZ$Y3KZ:E[SNW[6^,3SH1>R8WRI)]$M8+;?JY1-(BMTVLN?4;%9V M)#]7Q,+:2;%?^O/^/?LU5J8 /6LD%& /S+K1IH8N0S@EO[F'O#L7P8=5!&LV:4 M9PE&1%S'64XA8SZ,D'R9@&2GLSQS2QN#J@IO9?4$IER)?S191>4Z2*6EN:E5 MJ$4"'WAJ3J#%0*80N>]2^A)HOA2C >N9Q?CB*"MA]:HL\6(U2#67+Z&&#J?D M,I.ZN01;P-?K)IGP"U@ !-;;:\;"V)40#ITEG8.EFK2RXB'70>EE. P$OL#@N\7/.8!_47=AL^S#Q M;>?KLF+.1,-T+4B7W/S,)5;Q/*C.NT-T3#DK0/.MC+ON#7'HF=Q6);)A4]"! MDZ/HW30W^=8U2/4EPCU_K,/@498\E-%VZI_')>?CI29[_'4_U(7#_#4>IULD M*63/2.^5T/K^CX_/UT/1R[X(\RUL+T3@PMM_!0]@ MJ[+( /HQX"_C")?:G1%'-U4&RU80[EY2*NYU$!@YPOHIWS_=THC1=L M'D^OR38N?19 6;"T7*K[L*A."G,)((_%EY70*&"6RT#7II/#F,$ZEJE;WXZP MR:)R!'LER F0P$!%Y (W>QF9%8?8E8N 9T=Y7LSPNJWZ&T0_X>06N;GYL"^J>4ND&#ZTJD%FRGR,U>GI#O^6L.XBKKPZNBY,3- =T!/2< MAZF^7)R-A6MR$7K<&@?[(0:E'O49E'E$6U^]D3_=@3QS]J%#57('UQ=[THU? M?._R>C!$+_UEUQ$C7)>!&]:XU.'=<3=]US:?W073RIW[CCW(H1J[IR'WQ'^I M9[R[WE+-HO-]F0'K7&.W_&"OJ>M$#N[T)# ,C6^DER!@PO26*9 ]I<]-R.;N MWC2O1_>(G)^O(AG>[ZJ%J=RR-PX;W5C2=_MJB.1?.D%^;M[HQO MY5J6=^)J=R9MBNJ$"8)M$?=JAYJQ>TV$KJ(RUKAC.6V/S'"D.P;-GP_7Y,QZ M_H_E W;#R_&0T_&EP9[IZ!R$58B&?2:?<1\"QKM.\+=;;2-/8/(8+F'RX'&D M(BFY#-Z?*8D+G_K#?W[C2#.,__HEOHD^D>[H6B/6?,9=Y@!/:TZNBO(F%^FE MTIU1<;U 71KM!1Q7=UG%;#K #U^__:CYZR]Y7%#4',8M6TV#)KYVH#:CMEK1>J/Y-]K2IB;S6U[ TX*AE4W^9S-$07;$\AF,A+S&R$< M!*90P[Q\9!>9SG(A0&CE$Q(S\RKF+81(QIU MPV2;:>09D:-F:(<1]X_-R3U.&@[6Q-,AQTJ;BB#Q%6%A\2L<8AHE697( EB1 MW=]'-#)%XAIWJ_.2OCY,RN$F8E)N !%5EV:9.PD_I"*'$U8)'5YL$PW[&%^X MS<8)A3.WFJ3NH=UIG!5S^'^NU3 2DS@?!TR/.DX9?K)NJ/N,32UFHI)T ,9; M8_(OW$6B[S=9+4Q!"?M^$[A=OL W8DTK80!Z1BR72&!I?CTO8UBI*N* M#N\5A7P+C51E_G*$AQ]T#H'/5DAH-2=(Y#R!RTCB[/#@UHFO5: ^';!* /<' MF0$87H(I])@C$->3*)Z6#;(&*32D'#8/1V@FL&Q(:?BV!;)(%GN1REQULO_' MN>;R?%AW\64>'&:UUR5RN+; G=+%"E=[@9/_:2$_SHC8[_) IA3AZV FO M?D+PDS@,=*N@M-+ "M,U8A&<7'EDA4DZUQQA88 BV"-0*^ONV4+57!EW%0D MVE7"$ 4U&.PJF-W0DA;4&4$I!X>$8A#\.B,43"S@TE")&4Y.D7DE..)X!&+2 M3[B,\"6EA\C3@L]438Y0!K@G<)^0M,#L9G&F:]=(ZI0P':9?7$IE3P0IU*@J MKP1E>JCE+6>B4(L$C30\.?W;]]%.Y\MF .'@ M,/\M+AH$EQ@.HH/]X=G@3^2FI97@?ZI[P)]Z+@.)>O&BXY"XM2AE7;_D&DA.@%NQTA6.G!_IO/,F/YK7%V).?T\?#.@ M30+%H50[Q4-_G.V2J\Y=F,7]3 <]E(V.7LK086PRJD[ M>H=.%&+&" I-5F,_I"80642]J(7=>D=>$90]1Z#P70)-*=*?)-<8C?'_WCP- MWP3%^N.GGR^^?/[Z?J/X8<=<7K"1H*7S(]\>"+KA(:P[AP\7?12/%_9*@!"V2RM@EBG$;8#2 MZ8'B?'YEN<8ER;Z[X\?/T;O0!*I<1&'(/:-4O5I MYP@.*!\/V(+"+/79_JZUUG+WE :(6;TL;B,+K.+4U.7#N_X_9745?2,FK;2. M070SR6#:F57(S^A_SAHII1+V] H78S$=@80F+]&G__KV75U5M?^WZ*528*S+ M/-6"*_$U)4!LOM[WA_]\.\G$&%8;R!-E[GX>CX'H5RS928AWX@2Z)/M7DY7\ M0)S]>;G#Q[:%(6/UJ6MM=BP&\?;]9T6S.\9C&P>6:[:# MNNTR9:Z%@KTOZ^4U*6T,MUVH7)Z<$OPC& M7$C/IKJE77[;6_V_]A,R IL,H=WN6A1_4,O1UL28($:U.P*>"2@F1(/J>5RD M5N>:>T/[2"R!$*% 4">58)Z"_31%AG1>5N*!SF&N\R:;$YF,4I&0:0KK]= : M$"7T*![\F!5D-VS087TS*94$*]ESD,?@B#2KRFC12-(%(9L>O2FK/)53Q6'0 M443V'>79E,R\^EOE+R9RQR2]9#K.*@8;1T$H:EC7H'G"=C!OY=?)-8N3TPJE MD(9'6AG'<3/*BC3$,F&2K5E1;_#?RQ(/TRBNLWJ/,P!F:BV3]L%H M+_VS(L6-7\7P AACBWMUL3M&46+-&AB60/Z)NAD\@^WPUI(L3B9I+$&^(S(2 MVK2&??OZL&'![HON"1PZ'-S6!:U=T =;%_2CT/H8:%61QF2F'HE"C#/014"$ M1/'9\TLY#K):7 /11#\-"LBBJ(F4[^JCSJX>[ @(8CRO2WQ^[S&Y8UNP&]/_ M'D&P"R_E!W9P#=CB9BB1I"H!)BK-2X:R2EH-!#?D%;'(22WF^ O0&RP$H M*Z28:38U+UDR0KWUDN'!4=N=2YV4D,.A)UA//'/P89K5-7DU?F]2F48UDN[ M)&[0/WK;&V0 3,!:T+ M/(H@NAT-U;._E=45B BR?"%%N0$3PU.5J^0^[]7]VUY53Q[?^F19>8T/]_<. M20TJ%YBW)T"^A"\/SPY(L1V>GQU+,0[N+[F^1;=(RI) *OC."1H(YBD&;0ZZ M?*.U9"C3Z@O+U$.3;XOV;)8%=;D0U*#G]=D)]:=2T6;C&3-K(+U0'!4[T&X:C+,=4SP@4[IO:*BN)QB&P5HS M'T4*JXUT\"]Z[_@K*9.HUX >07\R0 &.:B&-*%I/(HIDW)P#5Z*QQ4YR UVD M&*'33'>U5L?BI@D#%A3$DW3:+W2$6#[3O4(-T1< Z3U=F?_GAP=/BF MB#[%"1>+244>_2JJ) ;6G(KHOV(8GZC74K!@KW:A8X@P6,[LJXGB)ZY*6H\M5]%;74J8.EHN7'KIM&[GTZB<9:S\U2NHNQ"_3XP5=H' MVD''[T@/'=(IA#VGP \9##)7@PPL-*PI#+>DN<<%J [_2TU%+F0\0V(?L!=[ M+?T[AJJHR& *,,1H93C5AR=';X:#X_V#P?'A_JU>5+93VV'4(H=S5Y6%-/SJ MK>+%_ L%3(YY=^G@JE!*&3CI&(E:897 > 5*KO!#C$Y!NX&LP$)C3.>M-F[Q MI@ZT##"WKP;=(^ B/RD91'G-04Y/Q4RBS$@;\BC.T4)"P3]T_O1HY^6E<$VZ MUW'>&/AV>\QQS8E6B9B.X(U#K:V"5BJN<;47(N9 !&JHS.%%>F:Y@=M@-$Z3 M+X'9*?IV4=<8R@MZ\X4,Q/TJD#[@Q#\:0/S'@5!?CGN]! _?=Q5]-B<+H$<5 M)F4.M(3T0G+[Q[@IM0H0H##YTLG:H4M-(0:= =6[3O0840\5,TDW*J,8?QG] M(LG8\?X E@&CG:/Y8D9OLK*JQA2X<\03\59$._@4.[;FL';V]:'?<004X1:. MY-#A%&PXH>ON]KZ[3$H*,E.[DD-96$U)MQ0O;]FR[_P[*EK_1%MI4W$R +U* M=UYE8]B-F:WR,S-P&")5Q2W4A;+"@$@#*HM)\*FD)YU-JB#S: M86Y W[,FH]=,8ME]B+.\839(6;D+Q1%HQ]6"6J%6,D^9HO@Q[U2 'J8$&D+;5-MV6>,%]XJRD[!H*@I>]O3A)Y27PSO9T.Y)VLLHD MZB =Q[/C).R8ND0B5,[(?C]$M'LHQNN+#SA\L?$!:QK%^-O[=^\W*XRQRT!> M/% ^P;INU,?O_^_]UU\N/KW;J-U:#__-DYU"&3I& J6R=Y-OPK@W#"8.4W*& MR=4N#8P)]^SC)NF+\ZKE*S$[KNOH\#@2*"3_8T\;U&XR4,%4VBTFR8'D85** MOXGJ.D/Y8^=/?SP\>@,_?+N@?^W*D',IX^E*?BD:5;-1,R?<7#N(4,H]K8I_ MF,D '/!?HLIE(3T2G(@11E;>$Z9]R_#*J)6OH8/-T5F%R7+:2^48\ :H[53E M-8>,U,T,IUH<"T#P ;3R-FM/[#A MSHF$*YP?O]@J14XS[A!2?95:<=A*K6"UV^"RRRPEM"1@YE+86?*>N4/5-D00 M(Y !EAS,39F&&%+/U7%ISS5D/'F#)*=5C:I.5)\[#J?6D&]L=-*)#[C*OA5$ MQG9V-+S;2F? M2 #N3=-:CB%;J-"X.JC3Q &78XH-=$8,IPI$E8<_!P**I-P M%H-(BB9P6LC*QI:(,>71M[']_7/2A0U%O-[)!!%.'DC F#<&$8%59MXNF2:> M3/1.E=;2;Y8Y[75)NWAH=#A2=RX09KMHN9",TV.3\]I.JB&(!B^_@@_H+ M;<$$9B4]_F@C;:@](I- J%2[S0S)UH]O_W:,G@[M[2 WE(I+YU620='HMY=A MT<;D*O'"R)>B,7"KD?T.FFSMO=81@U,T(1Q[KR!)] JP0$_Q1 MLS[&[>(LKN+JMA'B9.\\P+:C0'-KZ5T "0+3,J5-5"G,.J6=-V2>U6,Y,&W@ M=N;P@LT^W_]Z\?&%V'Q>+FWZ/HDSRX\ PG:>_0M/)]V>92Y/&Y_0.#LILI<= M3OB#0;9#%UL'0T!!T6;JK=7^I?(.I):[&7V)V_*:"; U6J_1,#WZA@]B&R ?EE"(!XUPC M&>H)R>BMPY-]#:E@ P*B=]W(EFXS*@PL;?*%@Y:X<'R6NBMR\5S&EUJ\G345 MG&=,8]*@AFI(:17?))+FB1@O)*'0J^%+LPL61A+ECFM[C2] -H9 MD.O24M02[-T+T3!.TTYIPTIG,\$:&'Y2U]W[ =?R+X(S"GM1;!74>:514=0F ME9PM"?RL/3+/KQR[WF,8-.XKQ;A8L0O=+F6%MVL-#*4XC;H4,@(@3"[FHX^R M'(W/7OA+$)75)K0RFE\[-XRRIEP;T*G4W&W<'FFIA]&CZJ?RF# EA3B;V2". ML,'I:T88FL8X'+Z#L4Y !K$/PI-]P?+@CT\?O[]_%_W]XZ>?WWW^=:/N?X> M&_\S^FQB(39J1O?'G^F GWD!J_";)(J4/JX5NNYYM\DFD!J!IAJKCF? F#3 M%J V>)R^,N373Q_G8LI2K&PJ*:^!XFCLF@6]0=)AZS7._D?BCM*OM% ;!F)[ M*#.4R0G_4\W"F*PYZ?^O0#1_C7^'%A::E'W%ZA0-YK(E=-:0Y;^ M]=>O;W5JBVN4IA D@_3IX#2H("W]^V[;LDOY%=[:$O*-F!:(PH:3OA)BIK_" M6JF>?6[0.^GX,L8P-1I8>S_41BY:^@ON2,F6% Q=IM6C!#^&\):>7WP*G\8E MNM?2!")U]>YP\827(%^!DHT+2J9\)?RCO$% /L$D(C*K:7!%M-1J ,=2 CAZ M%ML=A7,W$92>(S%XC"=HYTHG:&F%XR()15Y;A5^4:\$+ )Z08MD]W4Y@#K8I08'-VD2R%!A2J)E&JU G+'&O=&.0$GV+Y M_4=41D@)(?,=Q@)I('Q"Z%_@?>VJ)$-F8*F"2&YM0F&Q'WA?!5=;(T@Q\EDN M@C5&-26[& "Q ^,>!6UJ_!.K?5.I+&'R",$WT+5?:.C*6PB*DR9QZW+TCWA@ MI:IT]2L+HV$U,!6_)$DG9S[:V!66N[TM43T&]^J/2KJW>O54-^]_D["2-X[Q@ M<-=-'PA)O#L^=WR.=U+_W>CS=Q,./6\T'L&G M\1_GT'+] ,:2<,4T$YP4GG=RT8#&5.LJ]KS%8N$N0E?(B3>^\HRIEE<(H:B; MZ:PQZ)LW.%*2#7[IOW,<&(ET5E*N(964:)K!3#$^@9N,JF_@."NIH:B6DDVF M&II^,X0;(;^Q.:GG-=,%':SM]+WZN>_91?J)R):#?L;FP++C!HN"=AJ0I!N1 M-&_1=A[E"4W3I-M)4AIVD\Z? 8+T4+S647I9T.-&R;@SI6;]N-5T.^U*]Q8L MT],X\/U?&U9TT,\%U[B>1/WZMC:S84S36^V0@DUX;%UJU*KKZ5040L9[OKUZ M9L;)2R5PK3';3,*H_;UVU'N3RVMG M*Y)E&#.GH+F.PR,$;G>>V3#'3A!5NR?WT^'Y$!RL4?_XW>E]%YN$SQ$^@4^B,+XI M/)+OV=;T@RY\+CE+9@I3S20]FU.X+ @_?%E[9(AJLG$H2LQ15;]]I?(UF=MW MM3CAV=R8,?+_X,%[=S[#Q0! MK&MB)O&@1W>T@LSV3Z.$ MIXP4Z,&Z+-CXJ71*LUE!30E]+H[WF4?S'%?![.=4*:/&3 . ?:)944M1@)A3 M^6#%&KW9X1?6,!6NF&4(U]8SIN CYS.T<&4MK%@4^,[O!R^:RH6T:)>42#!M M089,2&F9(+0PL'%KNF]D@"8)!FI%@43(C$H'F5"02M%X?=/+F*H*LHP9M_MI ME7HED1-L,1.AM2ACTUYBC#1+2;%JH^R94D^O.L]NU^WX'=-\:D2CL_7"J[[4 MM7VII[,GYB(W:@5;IWUW^]R_8!;W(?*W3_]D:(.V&W0ZKS+KV7VK]P[9H2K" MCQMAXU%=B7T(; 59V]NQZ-&&:+.Z-<*]!TV].=,?,[0FYX\O=98;^WNM3D_9 M$4XD5QKV]\*H!U^QJY_ ^?GE7;K>1=ZSF;?MXV55OL-FZZY\O^'@WWEI/Y-8 MY^@A##'V>)1Q1N G0;91?;8V3H^^IRM1_U"()2V(J1\;7]CW1ZL])?U[%9)@ M*9OI3947/LI78_V+P/ZL&/P-4$L#!!0 ( '"!4%9@9I?Z@P@ $PM 6 M 97AH:6)I=#,Q,3$R,S$R,#(R+FAT;>U:;5/C.!+^?K]"&^IFH2IO3L); M8*C*).:@;@XH"#NSGZX46XY5R)97DA.RO_ZZ)8_]"Z[_=^O?!*;1)"KVP\?S[ND5*G5/C6[M5JOWR-G_?]\)*UJW2-] M15/-#9#/&&I(8%BU+"0Y)JG0_(I9/J.5"J%5%=F$\6'L2&->J-) M/DEUQT?4M1MN!#N9ZCFNN>?CFAWD>"##R$A^]+?/^P.6BV!E[CL$%; M>RPX\/8\MGOHM?8:S2C:H__UP,@:B+L^VDP$>U]*>%J)&8[?;C6J^[N9.1KS MT,1MKU[_9\F*GAQ',C4PGH+^[JM3LZ3,L'M3H8(/T[:=4LEUG38'4DC5WJK; MOR-LJ40TX6+2_K7/$Z;)!1N3:YG0]->RAFVH:*9XY 0U_Y.!36">?1P[D_=! MC^ IFT[!:Z#1_GW,!]R0IE?U%BU>;6L B\M4:>T\-^CU5T^QZU_WST_/NYW^ M^>4%N3PEW;-S_Y3XG_WN;?_\-Q]>0:M__>PGB3_N6SM]7_W#WK M7/S+)YUNGUS??O1OB->D%:^U37=(YZ)'O-W0/96?_5PZ-Z33N[SJ^SWRDK;@ MQN]:Q#?K#41]_\PG-YWK#YT+_Z9R^?FC_[O=&VAIU.N-)SK[/WNFK94S/2^3 M3L(5Z0SCD#)>)@%3AD<38F)JWFWM'ARMG5Y"U1#M5;V_8EK7O0N+^^^7O5 M-AO5UO[!1FIK=B'<8L!RZXRF[TO-TK1#1L,0N$*[D=T3;W$+!8N65UQF/_T\ M+J'4\@.ONG!DBFD_S&CO>V?DX/,W3>JB ;Q21"; 3XUT+0X."=4,8LX0!!' MU@O(($PCF>4Z1G$42\"!HQ/'9Z"]@9 ZAW[HVA4LFI7)E Q8"*\UV0:DA0R@ MZ^#DWP,=,!K7N<")&QFN+O-=FQ7FQGBDWOD2,-3!WG43]"USIT$ATRT M9>.!HH6!(A@(Y_GX?( $SK1#4_D M6O4_#O>Y]*I044'YMG>0_?PRU^K3@%6''M-@)F##1OBO [>,Y".@N=Z\"[* M 0,0%B,Y7B%SP$H.OA78KO78(,52JP<3U)FOGX\7B@EJ45T0BQDRRT4LP48. M?A]LT5+PT-9-=3[0/.14<9P =_3'1K 4->4:*8EU MKR%^O?I69@D(%X@ITR MBMN:"XIA":9EC9A1&^CAB-(\OX-O X:"$#F@/PL7(X4K@;ZA+>\U5@(*HF9;5@+J&[P:1E09!+G"'9T+7RNT)E(;>(^57M"E83') M'SE$/U"]O:9+!- $?_-(NC <\BUFBQA8W[#5+V?7CK,JIOHAUJ.GLE!FH77A M=CT*]SHA@M\Q450T'LF7?WB)-H#ODU+;94A_#U]]]AGD[EL&B1FD+0>'T\-> MGCE1].GS!V[F3_'(? /A62+$#Z91(,5&*OW ,>P+4)DDW!C&OA"Q!A)8#+:' M'.RS2K;A6$* T!B X#]2\ZDO87_D',RW?B-/ UMQV7&)XN,2_UM 6)..=010 M/3"4 WHPW\;,/> ,MKM@!P]IT9C1.PSWCOK9@&])JRT.3RM>WP2B(H-QU8X5 M7I>&T%&S!Z>[%G %U84N@!I@I&7'.300#ITG":1A?S([F2+8K:P-OO&)[\B7 M.D ;(@4'O R;R:Q/ CC8"GV!F[*+NCP=23%B&'I3.BQ^:%"%&V-))N2$0>LX MELYWT054 HJ>A)=4-PZVA\^XC/0R UD/ &&=,SEE Y7C;T7>7MG>(5L;LG]R MD>V'1%_"FK_;:L'YL)\+=S.>-#:^U*7!G[]?[N<&9Z:X)8.W:F WB"U/DNG* MOJ2]^@NA^\I0?J6 HX6L^"&E&W,6$?^>!3D6;\BERQF6E[1F+TXMW2C[\DW3 M1Y=R,^EN);==#7W$EJ[ISG!J+V;59UWH ,":F^4N7[G96WRZ>\;VQO/)_P!0 M2P,$% @ <(%05O0 W+>8" A2T !8 !E>&AI8FET,S$R,3(S,3(P M,C(N:'1M[5IM4QLY$OY^OT)KZK)0Y7<;#(90Y1ASN(X#"IS-YM.5/-+8*C2C M64ECX_WUURV-W["=. G9!0X^&,^H);6DI[N?;NODE[/K=N_S38<,;23)S< MCXOC6E'I0:EW6\*AZB6IE.%%9EGN] 3?P">G[/0?)[\4"N1,!6G$8TL"S:GE MC*1&Q /RB7%S3PJ%3*JMDHD6@Z$EU7*U1CXI?2]&U+=;824_G8YS4O+/)R4W MR4E?LJ,?'C586.8'A[5:^:!6J[/_5D#) M$HC[/L9.)'^?BT1<&'*"V:'S4JY_,^<$ST]"55L83X-_?U7 M/\S*8)8_V *58A WW9)RONNT.5!2Z>9.V?T=8TLAI)&0D^:O/1%Q0Z[XF-RJ MB,:_Y@T<0\%P+4(O:,2?''0"]=SCV*O<@'&DB/ET"94J*MUY&(J^L*16*5:7 M-5ZO:P";RW5NXSJWZ/57+['=N>UUS[OM5J][?46NSTG[HMLY)^?=J]95N]NZ MA%?0VKE]]@NY^7A[][%UU2.]ZV>O:^?W]D7KZE\=TFKWR.W'R\X=J=1HH5+? MI7ND=75&*OO,/^6?_5I:=Z1U=GW3ZYR1EW0$=YVV0WRM7$74]RXZY*YU^Z%U MU;DK7/]^V?GLS@9:JN7R4]G^SUYI?>U*NWERH<94,W)1))_3/ FXMB*<$#ND M]MW._N'QQN5%5 _ K5N5--&?KUNMI7W)I_)]I1G7!5B9I(GAS>F78R9,(NFD M*6*GG^MTG(W>5]:JR$TP0LT"*K-)W'R^.8LE1T?%1KF!X<3"_EHVG3B+-$47 M:4J6K;;5BI7]ZL;6U+HQY 8V-S\_<.6ZL6ZXW#K88MN8WPFP';;1(: MO\_5%1B_(_\ "4HB>-("D!/2 M %YIHB+@IU9YN16!F ?<&*HG*!+1>P[S+HQIX!T#96!*Z3('F ,% J$A4P"Q M&+J#)N#4R7@H@B$Q*7[,^X^YYMD@N(!(& DI!68G8V&'L$"3\, IB.,FH)K" M$X4#@DWI3Q:WX?5BNO9_@VE.0A$#:A" R!3 M!F,"$A<@D0<4"RTG) $@H0V@;4@Y!WF&+_-H:K CYE+O/$JD$@0 V0K@YZ8S M3I^ FB$)I1J;*>PU'X#'A;S=$HHOO=Z@97X!O6:JS(JVKQ? ]=<&X-[2:;_; M.:Q6&L. MST![ ZE,"OW0M6O8-">3:!5P!J\-V06D,0[0]7#J/ 1#&@\X:8'7O$TE2+C, M<'^7[[FN+C/$)_\HD(;''O(X/D'7NF )'IFHR]83A4L3A3 1KO.Q?8 $@)F##1?BO S>/Y".@J=F^"[* /@<09C-Y7J%2P$H*OA78KO/8 M(,5C-PXFJ'-?OQ@O-)?4H3HC%G-DYK-8@HT"_#[H8I04S-5-3=HW@@FJ!2Y M>/KC(EB,(Z4&*8ES L;Q%^??E>&@D(5X@IT2BL>:2HIA"9;EE)A3&^CAB=(B MOX-O?8Z"$#F@/V?+D<*70-_0N0F=_W>Y-58!WR/!$(+4J-A5 M0Z@!^")W1EQ2S:88 =0*VA=2V E2CG73HL4X.#FD>+ OB2YP;Q=^'K(%)2DD MAP9V'2E2$"C-G *.A0]X#,Q' F"AA2=H"2@"&88')5B,2" "O,'R6V 9[)'. MB,K4>18\,QZ&P$7%"';;K.&4,Y:QA:?TC^MIID,A= 0O9SR9[:O4;M9@&U]. M9](R>=_>(NV M@.^34MM52'\/7WWV&>3^6P:)&:0K![.IL>?G3A1]^J+!S?TIFLPW$)X50CQ3 MC0(IMDJ;&<=P+V#(*!+6*"H /9AO8^8>" ['G;AHT MYO0>P[VG?B[@.]+JBL/3BMZ-?CS]\O]W,)FLELR>*L&3H.X\B29[NQ+.JN_$+JO#.5W/!809G^#U(#< M:.!KC&<_JK2'@H?D?!8CK[/\8??&E^G@U;P1.[3FE;Q,=F_U+$KNQM7*5;0O M7U%]=)LW4?XZ<],7WT=\Y7[O'.#N1E=YWH7V >6I7>WRE2O!V:>_H.RN2I_^ M#U!+ P04 " !P@5!6410SG=,$ !'0 %@ &5X:&EB:70S,C$Q,C,Q M,C R,BYH=&WM65EOVS@0?M]?,76Q/0#KM',Y;@!5EA%CLW9@*SV>%K1(V40E M4:6H.-Y?OT/):IPF;=KM'DD:/P@69X;SS0PY_"#VGPPF?OC^-("E2A,X/7M] M,O*A95C6VXYO68-P ,?A[R?0-6T'0DFR@BLN,I)85C!N06NI5-ZSK-5J9:XZ MII +*YQ:>JJNE0A1,),JVCKJZQ%\,D*/?ND_,0P8B*A,6:8@DHPH1J$L>+: MMY05'\ P-EJ^R->2+Y8*7-OMP%LA/_!S4LL55PD[:N;I6_5[WZJ<].>"KH_Z ME)\#IZ]:G.S:\]B.]Y@3=[H1Z^[O=-VN0SJ[GV?VU5JD?]6&0*_4FTK__6TUR;3+$+99"$ M+[)>%5*K-FW$D4B$[#VUJ]^AEA@Q27FR[CT/>1*>L28$Q]6@@XLEGW,%'==TKB*^&6N$R66R]<4X MO\'JOP[1#Z;A:#CRO7 T&<]@,@3_>!0,(7@7^&?AZ$V 0R@.IN"-!QO9<#3V MQO[(.VED=S[*T[/I[,P;AQ!.[CQ69Q_.S)GIFS +?%T5<#H[=OO.X_9FX TF MIV$P@/N4[B;)!_:N7OWA<0 S;_K:&P-9A:TR.DR)7& _G0NE1-K3O?2<2<4CDFR< M5/YJ\:;-'NR9KNOJ3JNP[2C:.-XT8;-JPI:B-\CVS0/[RV+;=+YL^CCM/S:M M5=6MKAVNCB(GV:N6L]-J+')"*1[[/3>_ =7Q-:22UA\;874B^-?WU3=SS=5 M%>VH#5[*)7B+)26,MR'2X.(UY*4L2H* E("M1LD $)%KHG.MGJC MI#>JB$$M&A?9X&>P+\A+0@[/S@K[\%!*+ M2HFT$6<(+J(ER1:LB(+JUQ1E@0@D6@. I%&2V_%G1,N$2@ MN62%AM36-B1) .?"8J,1"G+$6+0WL6J$5H:U H%:9U!&)G-4)*V[- M**E4M'V36[3E@A8-GCH&+:BQFY]:[M8>:99SL^:P0;9NW3>VWC4/<;,-L'#/ MGN[L'\*0S65)Y!JA]R_NQI=^^PJ)Y7.MV5A']' M1NYZ;3;T18F\A[I0B(13:-)\GPKW,Q3K/M7C%-L^I_KCACX4_"5G>()EX\T\I%&/M+(1QKY M<$Z_;1JYW>D>*C-Y,#3R9RC6?:K'C&4<3X(WR!;A)DHY_'3\;"@EO#B5'$=R M'+H4:@,OBD29*7W#MM%]^4,5MJI/NEO?C+_E>NBSF[1)/717U!+ P04 " !P@5!6'YWD MO>S;! JN#$ $0 &YVO-HUL M:0K3T2#-.35?8U3FR'ID_NW_OAT.[KSFR;0_'OW]KOY)W;WS?W_^V_^SL?'/ MA\^>WMD:Y],ACV9W-B=,,RYWWO1G1W=>%IZ^NE,GX^&=E^/)J_YKVMB8_V9S M?'(VZ1\>S>X89>QG.R?WH>@<=,T;(26S 9#K!D:T&X Y%"(/.I3_/+P?K$]@ MO=N S'H#HHD;&%3>B&"\B]$$BO4_RWVK/;F:M/9K.3^_?NO7GSYB<>O>Y/9Y3'/^7Q\)[?'/XV308_C2>''/'N_R-R;!Z>M' M_SN0C-I09D._?^;3Z<8AT?^6+GIV_T[1\]C[8? MW>;\\/L#&AW^_2Z/-EX\ORMT9RH__VW(,[K3SK#!_W/:?_WWNYOCT4P:\<;> MV8F\B'S^[>]W9_QV=F_^,N_]_!__\1]_F_5G _ZYM9.-R];PMWOG&_]V[_S4 M:5S.?OY;Z;^^,YV=#?CO=TM_>C*@L_NC\8CE!OIO[[<#>7+^L5\*C^8?97]/ M+,FDG\^O_W;VC.O?[_85VE@*$!:N ,3(@8R"D#@'SB[]:ZO=BM)*;WQHH2,: MMDMS__X#,4ZE&:A' SJ\>Z=?Y)3%_GZ6ML:OGYIGK_?MSFDYWGY]\#@>[Q[O MO.T-M_7!4/Y]V>OO[_VF>EL'_=[P-[WS^)?!P=X+N[_WRNV_/#A^:GN#_7?C M=SM[!T<]^;ZS]_OQ_G!;CO_-[!\?O.KM/>P?O'RA>V;;[;Y\--S7>-;;VWE] M,/KEZ.#=6!V\_.W-[LN#X;[YS>X?[ZN=K=[1[M8K.-AZY7:VCH:]Q[WA_'QG M4>V__&5ZL'=RM&]>O.D]?F+V7SZQ.T/YS;LG(.;23CPH9F7\!4 MHRH)M)4&4_[;O4^@O$YD+SW/H_XTTV"?:?)(MDQO,;X"QCM?8.RU59B*$R,& M:@.*+1NH2&U0A:A0(P'1W9\;#DN#^%=P0G94VV&M"U@&\KG=_?K1_@Q!OC\1_G&T*R!,:/!D5?OO??'8+[Q7@??$E MO$A<@RL;K N*>HY!%''$C> ]BI8.F&J^^[,231=<4,%^"\Q<719#4+!DA* , M<=0J@2.RUJBBYC#K2YCUQS!?:)[[#_)1SFX:.1@-'O'?_^JO?NE3DXWE;SZ[R3\[Y[-.@=/WNU\[(W MZ+U[8 \>[[Q[:I\=[0_?"H!"E./]=T(. 7]?"/+LN'>\ [W'^P*B$.+XE^/] MO1W9_D!?_D:N=7I@7G@!6*[7>[4K]WIP_$H(M&-VWAVJ@^.!G/.@OS/L'>V\ M>_5F9^OWNK.W/]O9_!1\RB56Q4I"!2VA4T+:P!S-AL\N0[5%S'BX^_._TZ/_ MZP\!:@)7^1T>)IY\"VE<8XNA[ T[(0V3$"-'EU+2591#^->3STW")5>VY&2O M15V_%DI0Z@_$1L@]S;AY@]WZJ#\2R=X7ES">]IL$_\"@[5&[D;DN7RZ1K+3N M&]K6='C4@[6Z^L6)"^6)NW^_*+WN/?S'LB';^ G:WV M_[.^@'VVN_>;VSE^)@1YH7;,+X/=O7PF)'JS,_RE_SF1>GN';^;_/W[RMG?\ MQ/6V7ITU:]3;^^W=_O"%ZXGUD-^>[0]_J;V^>M-())8$Q+*HWIM_)?!,D&&C M2*R] 0'2!HD V*CLC<[6&^_I3WBT.SOBR25N?9YNGDXF@ML->94/%*H2")6' M/)(/LU\E#NKQ[%Q#]//%ULWQ=+8YX=*?;;_-@]/2J,^3U_W,;<]'C'LRRN,A M[TXVQ\.3"1\ULKWF\XVK9+ULKW]IO7XYZCW>?B/7@I[YK1'([K\[%!*]L$( M<7$OQ*(]/.Z]RQ^1+LM]_?YJ?_B;6+5]<7&_O1'W!SM[V[JW=72\?SPXVA'+ M=+#W1'U!NG>_BVM[UC_8*J\.CH]>];8>#@ZV#M_NR'5V'_?ZNR^WY1X>#H3$ MM;?Y!>E"44"0ZH;-D#? .MP@4K!14W,WUO@<]%5(UQN/QB?SYC\ZO$3G1-#Y MH[CDT81R,Q5W3D?]<^:)^1 C=WMF?-A,E9FO"57ZKE\NI=[]VV>6H.SO9?9O%4SUZ)C'&]QI.M MP[/>UJ'9V7NEFH':V7HXW'V\_TY\X*N#K>W7Y?&C?GK\PHO7.^N].X2=XZ/! MP*_%NL#]\-!1NJM[>OO!,[NGE;W;W\9.+W_PNUW*C)J=$[MA=N<[NX]\' M(L/4_KNCOGA7N?9ONG?\4+;]?G2PE6%_@)>\:I[QC=R3WOGM7Q6C(6_=!K"M M&Z Q;PJU<-1O$0+JIHI\$3X?^?7AS28U_KXJ"]:2]]B%)G%0CJI =6F-" MC2%JVXBAHXI6;5Q^^)P+SX]HP@]IRJ79%N'JW'<]F$QH=#@W/@_//ASR*YVU M30_>B&^>__4[3QO7S\V:7C9)CK.Z)$G/[+\]V!J(1#ITHG7?BD$0%?N+R)A' MQ_LOM]_N;CT;BM9])P9 /\=RC_D^F;P.AV/[<'QHU>[+U\(Z.(EWVVKG4:H MX1,Y;^]H?T\,VN.#@6CH=SV-HJ4/;>^W?W$)P45OFM<2Z>O$BL1LHX2O'K0K MF+6%NS__:K\IM,DV*5 @B&8)?PTCQHHI@+,";D5SB^X-H.ND"4>PU1M7-ZJK M09IPTAOH1.422\!C@]:M<_2KZ-[[M)-QPI5%BF2>?J5OM/6'WY_.>[H%_SOS M_O'[L[,3@7/:'YX,6A?Q?-O19.XI/NX&_>GMM,@I[GUZCO/K?[CHQ3U,QZ>3 M^;=YW_3]"\Z=H_M77,WEB7@>2U]^ZY?VO?9YG].7O/NQ[?YOEPZ&"HM4?+G&^Y_+[ MY47N??*BOOK>?!5MBD$T:B%@ ])44[80; A0?=;S4,.V$'4%7M?YF,.LO0$[ M'SA0[T]TL>=J;Z"IEOGC3YL-F;Y_LB'3]'3"/U\ ,-]Y>8K+?9??VSF^^D:C M(UV\L86CO>0,?\TG<^-S7OW^\TG\MM_7QH;WSSHOQY"]2[XO?MXU;/!H/^Z.O MG?:J!N*34]S[].[_C/E_I>=P^03XQ*/IJWLTO3"/YG2 [)6-" RURELC7T": MD#07X\(\MFCC\^?O3:WB>U-7?V]J<4K D@IM*,/;"%PXB7RO6JQ,U,Y6MLW. MZ'@3K^OBJ?FPJ?KSKT4N]O9DT,_]V7EWZIW2'[;NHS:WYGW0<-GOM/T_IVUP M1"*'\4B^3A^\[8N3OSQ,M@_'H^>S<7YUV37[U4N\?VOO[^2;#*"."W,!/@.1 M5VT==IFUU2"O-'E3LU(EZX)5 M)5P;R'ZE-M33$50PYNJLJ39Y &:,-;(5;4608V2.:X-*;SQJ#SX9#P;SD9$9 MB^#O"DI.6Y6]*^R5DK:3$ED'EF*)$+3S80E">%WDP_+5>J@ZBQ^3%I@(Q(O% M:HICEZPK2:>JUP_2BJO>!JH)-7APXN1,TJP)76!6O'Y87K^ 7#ZJ M08OP%[=H7=(@@@63JX9-T#6O#31+Z!1;($P5$0* B38:8(E"3*W*>!52 M\3ZM40NZR4ZQ!>*C3&$3P:NJ%6B+6!0I+!1UXAA-7!M\EMPIMDC(0@S:$Z-- M"0)Z4EQ]M12\LC;4LC:077^GV )1R49A2B$QEPH)2A*41/U[#CXD5W!M4+GY M3K$%H@02C,42(KF8@ LE-H08J2ATT12WA%'U=9$/RQ_ZIXI1FIY#T8/ 61.1 M38R^2B.LT?'Z@7LCG6)+P;+H(BTS1FFJ#-[KZ",93SYC]BIFNWY8WG"GV%)0 MS=$'Q2ESL@ 2J;5INMF8@L%$G[1>/U27WRFV%* ANF"SU1%K!AL;F[6XC7C>U,=)]\UG?(3:!)["I550 W@7960G%FSO$)E@HUN;:!91L?) MXF RP5G+I&I):C[_TU]-O@LN^-D<9 AEV(Y*Y80$"HG3"@O5:>$(2EKU@>R&^@X62 J(2@+ MJ3CK,Z!545F)Q24VUU&))DQK@\H2.DX6AY(3"]?F=I6+K J[]4$9G\S7M\YOY$I'EN/3Z6S8 MG4:NR1D/EHM%"\RA6=QJM7<4K-,I*9&5\=I&6VPI8FQTM(0!&#B84EFOCY.Z>J_#4GC*Y2$- M6G;8CO FL=@4S@B.#*!72:E$U%;"I\3I?$+[6O"F0^*F:QS*HF2"Y52--A"* M0]) WEJ#-2L-9FTX](U*XI8\5Y''REABK7U+N,Y5Y'$V)8).A0RKDM>&/-_? MF73+IROPR7/RP6.MP2F 2&AKAE)RR[M5&=?'&%U)GMY2YBH:*+ (Y\@290$4 MIN2ULQ*D*VLX:7V#>4:NF3)_J1ONED)7D4!9G)ARA3")E*XN"L8U&V-]"I6! MEI"$:Q6Y]+T#^DM)%.8N' MY0U/G%L*JJT A36%8M %0K6$4>PQ!FO9^.CM^J&Z_(ESR_&S.@C0IJ4Z0:B: M)'83&)S@[15%1S>7\/":\;VIB7.+R\3(F%P0[>,*.B@221O,G&-IJ82L3GEM MH%G&Q+G%P:2T8>] _* F$%L9D_&D<\PV.:>571N8;G1(=W'X2%PH[<>'(GB MCA:U$:]FC/->)^/2VN"S[(ESBX,LM"2\59%-&, I@UJA$F=4T$25^ :S\'8T M++@65+2E4!AK0)7%+8E$2! 9CS'(56%AB"*XE;0GD&JT,1IM4.A8._ M3EKIH=E9JS0U>S JS12#]M436_$HD*M*#L'H-G7 IU;:LJ/4H;>WU+GVCL7*(6N#N18&]#5E-B3J M/G@#X'('IDP^'8\.11$.6W6X+X'<_% EKAVPBL.\'9K&G\$$0&@):"P JJ20 M\/#EPI%DN.->H (#%\]"@;G*DQ.6"^')H/RFUGYZ/1># ^/+M^6$'>W15A_?C0[\F=P)0X0M15B9K+.5&HRMOH%'/.Q!<5 MQ&[1_-8NG4\ ^I[NT 14HPCM$BLDP]+ZR#3!Y H&%2\!NK6AWPC/QV;Q>_I% M8YN^DCFWU1Q:NPB&0$)H5!)*"UP=B(96KR$M/U))T8#RN61#$6SR%*.S#F.. MRA1CX]K NCP)<_.@BE*)R#I4GZH$%#41"L[,Z'*2AIO7'M0?JPVS!(O194+O M) Q)(44&75QQ+I!$);2Z\>/[&O3]Z: IE,Y8:8/:']T8'OT M_NB4R^Y)*R\IATS/?RY;ZL.SYS3X[L4NEU<['TY^/YYV,6_\^1%SZ^KZ,*&C MW=5@W 89I@_//GF6J9QB<-HZU[]^YQ]Q^=A=_26?3?!ON7;1Z1@VE!>$S60:D&3*N<0K;: G+N4P?26JC=& MU:5D>%0VV\#&^JH36 327@QKY,2Y>DVJ0V5/;JEZ8U1=2A67[),K.8-UK,!P M2)5JD2OX:)(/J@,3I;YI[/(I"3M&I?WS9'@R&;^>TZLA2T3M 5F" F8$A5KL,W+0(4: M2DV6V;I04HYKUM)N:/[-M;0O'[%6\$:TWJD4R8+)-@$6$1RLC,BR;HI'2!%"S%5)7)F8,3J&Q9 MW7;UE^>A+K&9O%]K,#IM]_+%4H.+<\C'RQ-<>:%!"3E8;;C$P. MQRH&TJ/) M%-E7TX%&]Z'_Y&)\[OGY*3[N_'A^PKE/ VF9DW&1)C>5:.S]0%R?N]+J#&&; M!)Z<*1*"Y9S$0)(.G'1M?E.QQ-R=3)1 XKU;*6/XB3P++7;=&Y!:!:HWTV>RWQ@KA IK;:M,W/3 XH*&]" M ?;.U5J[M&A]%5K?M6"$X(RTI)RT8&1]B-Z7F*TW2)A<[ !&C_HBG?EI_S67 M)PV$P[;2Z,%TRK/IP[,=.AY/Y@.*GZ<9F,E5N-S8S.>%+2-)H8W[VD1D6C6/ M6*O56#)G(]&YZ+!;*@V0P'O(HGLUQ"KL05 ^W5M97L3*CRDR:OI Q&([4N/AIV1'D47%M]E MN14+;U)>4;4&M'7%9\I^3=O9,D!;7$NC4B J$X)VMHVP4R M(SX9%:Y= 6YQK2TA8!L3Y40!LO=R^]J@87G)*M(JU_'J)' +]&U,.4:,7+P& M4@Y])8^M@#1KC=B!N7,M[<.3^5A:^^''H?/I9+S'D^'3,8VV3EF> U:W-;T? MX^'3+P=X^M,Q&!WN;[]X]NTC/ Y+XNA4! LZ^X28JK,1*B4 7\ZS86P/SK\6.M_EO&/!='7?)YBX^+H14VK_MJ]/>M/7WU$ MG$?C"?E^04JP>6J753"ZJFAUX M*]%*EY96WM*I8P,E4!TJT!2]E4"812<$BU8IPVQ*=2L\_Z/[E/L@6,_SI#X3 M##=;^E3*73%=F24*5Q(KQ*J@5(7!D,_(CH(KFCNU8O.61QVQ6:@J" >*2%\/ M8(K(8A+"<6%40;[?VJSKY]J%I]Q^FX_:'+R.F2V.&C7E!"$5L!XP*0F;(>64 M, 3N4HVL6RIUR7(5HU0M&&IJ(P^%JK*B\6L.)E1OC>+&@NR.Y!V[IU*UD @[98 R>4-PF68W5)A\ LR83 M,79@T+N[E%M:O+C VL6%@JXMNT])D#W$4%5V\I]6F4/4MZ9K[7BT?)OE(2,X MJ@Y$=AG@F$FAMA6I9&N[,!>N^UQ;1KRXP%5RED* +*C:)/P1C16]UBF"]]HY MRK=F:QVIM'S+Q8#1BXL4D23XZ>\JO>?"9*;P\Z,GHY'0V MG1^A.]*(D&.UQMOB2Y3X$G-=4*'I2*]*Z*O#*Q%JT=16+EA:?4KSE2M>]P"+7SQ!S"&0"&PB: MDJ<<4JQLQ7JQ7N&J8C?I!99+W%7ABM8V&8/!I]0R=OFHG8LI,&02D5X[P)6U MAB>;ZAQS!A4R,"%%K%XB)TI4*<+:2(3+L;E5,_E=D0?5JJ@EH(ZA!' L'Z05 M>V<\(J/A#J0JZC9/NB(-C(56#MNF%LZ7JLC6@LX$U%RU,1T8&.Z@-/@&TJX* M3XHSN>7%A>PI23"H*2DOH[K$D/8>I M%(^M5N(/TK:NM_]T<6BAAZJ,B5[;/"]M$7VP*CD/D47<0*=ZNW?.%QBW$SRD M:?_S="XTF9S-1_Q/QI,9EP?#\>EH]O[G'TK6=*3KNR:NKE*-P2OPL2;?2EZ( MZ@!"V=.!);E7AFY[.NL/:<:[]?U/NHN;M[YFS"Q@>:!04!L1AIYR*R]J8@?& MU#O6Y!:H&S&ZBDD%B@E23$FGFJ+*T@Q3CJ4#*4.ZU.06&+(CJ1Q5B+IZ$2:8 MV I@.5GV*EG7@=E%*S/RTX4&OSA;K2T5BXRD)99/1$E[2!+3HR&N!M,M<=;' MW"RPFI401@R-C>@SU!S$V2N5R#G@RI>E)E;:372$-:MA;A99NXZQ>J-C= 4X M8TJ(05=74JJLZ4<=25Q+<[/ CF;C,FJHL52&D'U*JCKV)KM27*O?L/).ZL8; M_(+Y?&-=X O,Z:M4+@J,MMC*%W!4N!E/2/ M. BZEF9FD=,K@A+'Q I4;(,0Y,3BD"VN==1P%XIM/^-9_QRK5E7QRS**OY[_ MH.V<;K4$OEP>\D@^=&7Y$958E&7GGB;(5*+ MBR0-0U&Z$ 41>2HGTIE=Q,(9(D'I4-ZG5<)J^8F5E--6*U43>(14?!2G"D4# M2MC7JF]W:('VR@*[E!7054QGL0*JUR3>3Y/2L>0($"I"\1WH:EXE/*\G K+. M,OJ6D$K$K$N4JK?.N500K*$P;WOJLNW=.L"_TO;4U=N>6EC;2Y5C0(R&LX(@ M82W7FK@U18E1O.Y2!=0GHSP>\OLR?5]?\KXYGLYVZW-:TYJ8U1927+2MT8)3 M&EOV$LXE)88*T*7<2RL&YU(\HRG*58'15@6052+V% -72SYDIM@AL[MB<"[% MV.:6T3'ZS.PKU$!$-1@))E%T#RG/ZV9LG_-@T!\=/A;W.:'!@U%Y4(;]47\Z MF\Q[E;;?GLAIU],0QRSMU >3K1*H58H:+6I(T5)5D+5@'I)1EIKL171B/-%C$ M'*N38!HJ^F1!13$7"JSG M'F-N,I/&E6_FTT=L3_WPK/T]+^B^*2PY'$_Z_-GTOR]_M$G3HP>CTO[9_I_3 M_FL:R N^WO+NBQME+YB+T@PVE5;L21/'&EJ*3I=0J7I+ZA5).')+ZF\@=2B> MM!)#;:LHQ5 H4> JTE VL[5Z]4F]4DG#EM_";DE]MR]:HT2KO1/5"J5@"JS! M5)65*J)$.D#JY?-H(?+#"(46F)#OEME>)ZI&AZS%7">O, 1K2F[E*+&0[4!N MG35A]E))O3L[XDG'"CY['5)0WH#Q8I,](#DJC#82BXA.?,O<'T$]=Y&Y+ &> M]H$\@@.37:J&<@K:>V)&IM5G[JU$_C&9F\ASKN X&@,YIYAUM):=,EE%]FKU MF;M\LJR)#NXB?7WP$%J_=/(2OG%.J09R;'UIM7%J![*CK0E].\*7RC8Y:ZVB M),%1P5B10#OY%J@X[D#JD/7@2U'YU>?+ MCR'L5H4O;#)5,%B-=J"]Q2CNR04CP.JV\'GU^;(>]N5*TR"Q)?T&1[YS. M3FGPZ'14.L)DXTS(M27I*!YTMNE\ZFH,1L)*Q6;U$^#WQ%G968H9.+3I"D#)@PH& Y;Y9(8B@5_J0LFD M#OO7E1D16XEAW@66?,P!Q$):7TT K16)8K0E./2I@K;JEM2KT9-Q2^IOT0- M)OKL6JY62#I'!:YXC-4S*9]Y]4G]8\B 6U)_2\K):'6RT4N07T'4+44RUOA@ M*'((6J\^J9?/HS498ELS9@=5G8\!J$( !H4A%A-CRE"Y*.UOF?TC".N;&S=> M8&YO3-CJZ,: $73F!-EF1JL(8NGRQKHH.[2-\V MYP.-A&\B#T#KE+"R:>EV"RMA]&V'VXJ(W57A2]!1NYR,0H, )@MW6 +^R$8E MJWT'"NZN!U^N=ZK9 NU+5<$X7W+T$9CEGXQB5DP(Q147.U"C:CWX<@-3AQ98 MU=N#\2Y7G6I+I6&2"Q@2>T65Y#JW<>SMU*&.,+DB%PD'3V?W7SS?X\GPZ9A& M6Z<2DQCHS!Q3*J;8"AP]<.!6R95KRZX4VPS"#DB>%8%D@3U[3AI(RX*=784$ ME3CF((&,9<<4+'48DNW3R;BCH @@00R5(@S@@XT50&D'$E'ZDK #*WO_$)0' MYB<;W.9X])HGLWX:\',>]<>3WGCVIU4+KGSQI^/1X4R ;S?QI1?\Z-KM@(Z8 MSJ H^*R5R^S!FH*9LTNAE-)6)]4.=$G=4F+1,^Z\12U_6J4Q<#I2538C! 3_JQ_'55-KB>3I+ 9-;*$-FW]::04BTTZ$,M& MYSHPVK!*N"RPO;1VPI"";PN;M"4=BP-BZ]"ZXN%0.KS0[\CD I4,42+AH3/3GG45A<27CN;:@IY">^MB_)]^4 Z(7^. M0G^?,VCM$Z.W*8%SVBOG81V O!'1OWPH$2T;1%^RUY E0I P&D/!%D^+.IS+ MP5L$K^)@/@?E>S).I-:)D4$I&P!BIJ!960W1QQ#4>3W?CK2O?Z^7G_9'O%LW M)UP6-Y1S?K9'E/L#>1&?7N\9OQX/7O='AY\>M(X-NU0O4MY'M($ALXT$UGI4 M/D72I.Q%W[B97^_\PZIR:'5L=.N -@+1U3J@/SGT>VQT4(5L,\G&B/ ,T3$3 MH@G@I6-!H?&Q2XD9%HU;!;8QY5899^IBOT#[Q6J&MAQE6VI M6M6!Y(V+Q^:[A-'EON>"2$EG3WDF\GMZ19&]*JRH$#EJI<#7MAP\86J]1DD8 MXJP%[$#/YZJUV,7U?BJ'(0;K8R* X@QIL:Z64,L'L:^E0_EZ?J=)G]* GXG3 M_RPP'8_*>/1$'GN2:/1JMU86K-IQ3Y\\W'WVO0WX+]R0B-"#!DG#69M6%NMS77_YT:=2_)6A?0T;B'"$Q ^J(I0T@N>14 M+LD5W0&"_CF-'M)TOG5IIK*3U# YLS65(GH-X$W,"<&30]5F^+LN.-=EVJXK MDJZ3U A):U<@6F\,E%"2$J=FL1K06&WJ*C76MRVS<:'6:%F9"-89#!I#+L6" MTL3GP]T=!.Q*;;F3@)%OQ=*,@FPLY**3"E7[-G1B5$O8U ' 5FU^PI* K)HQ M.Y]2F[B/"7-220F4:%(QV79H75!6X39W1 M5ERLO.Y(H66Z2,%XGYU-ZR F?C0B+6=MM]9BD%#4C')")$NN<&7&9&)%AW$= M HP?C4@W%=Z)X6YAR B_U;='9YILO=E]_;J;X> M-67.4=BB546)FFHJ1!ZU]MD8QN@ZY#&[H[DWZ>2$RR8-!M>P(FWYSE-94M'D MP.0KN&(18R:T3$9SU1967YC?4FFA&OV](7LMM_QU$];V?+/QRD(F=*W DFWK M_42E*0"*E%4 I6,7!D ^FDTWFR?$:0GZ9V>;X^')>"1?IY]3;S@)7ZKT>L<))2G"![(Y@[)[I4#="GR5X,A Y 0DQ<(1? 6 MCIP5E(I:6;B0%Q> KG3FM94#5%T=4+6X7G;CBD^I).=X>C?CJ=/AGE=HW7W(Z[3I=ZOMK'+F(Y)P?K M27OMQ61"K!%5R ZM,:'&$#\LY[27Z[=^"'3^])K+FBWR.?)_NB3,+F))6'18 M6"D3"Q($=$FGB.A0$^5(H72 )-<_\VNYQF'Y)!'QQ<:'Z"5@ PG1HBJIEA): MB3S&G#M DELH+X(CFQ0H$$>0"J?/GK]81VHZM@6+2@05@:N/WB3KW6JRP] JMNF 8'5)-E)26*R-#/YBN:C6QMA59.3F^+0MJSF1-W7V M&7=^I2PGSEMR,AH\Y\EK>=2%C?KT,T'][H]ZP<)O2A" >B ELY H<0 M<_"8G0WQO.]B3H6-6TZL'B<^Z_SZA!5_VOGUX=#OL"6>BT17EDU-'K#4F#AI M=M51;3/T:767GO_(O+F6]>:,),:D>J_!"_8V,2> PB5$,CIT:>;_'^"S/3P9 MC,^8Y^A<:1[A]4GQ3HY]B!Z.+I>@46E0K*.NBI*ERCE)-(X=H,CUB^*%D:^3 M%('HD#5J[3R 2CXYTA+0&P9E,9HNE2/Y :S( MVT*UQ@Y0Y >R(DNA2 12I"#$F#5HGY-8CAJ"JQ9TC5P[-";[ UB1I8SR*E4K M^29-B2";@%X3ZQ*L-\E[11V@R ]D199"D1"KYB4411Q-,138_ M9$3325&IG*50B['D+$0JF%T,U@4)49V)WG5 ,:P6=1AM:4C%O"+#X8D.N4+&$+B1B^0,@Y[V' M7^O)>S JO_*DCB=#&F7^L'T=#6[*D#UQ\MHH,)31BM*"6BQ:9)=BA@MIG7+2Q:0"KF47Y=:6E4VU>*M2=\WPJL&[%.-L=&9E%7E0 (E,C, N M.A]TM,:5U"'C/"\@WC*:E3:96?92\ZCSK=,'I[.C\:3_CLN+4>')1QYW7I3W MX=GV6Y[D_I1_%3+P1X'6.4G:]]W16J9)4^1*L=XY00,LE$U4@H13EK@!JP MIB@?G8= A8R_;<^7J#X:GT[6L3F'&*0Y2X-6I@72ED)4N1A 84;4(?SPS?EZ M@+^>*CRLP,;4 M?L.DE&K)RO@<"(*MF$E9-(6LSPS%='9#SZ?!T(,>6O8FXR\'5KBZW2+.B[0+9+%F-"X:L"UA:NI.E/% M9(*$K&C6$:_'U!\]'4^G/9YMTO3HT6#\YA]<#OE7446= FJ:Z\I5R^&U35V*1L;DE*H65VMPDR%ZZV!JC4I?GJJV]?EP]WT<Y8M<+ MY!O7N)_C]1TNMZ4.4Z;D9$T$71"UJTDBS.HI9?'MZXC7\C3N H&S#HS%5OVS M*/"Y4$ 3=2HB<*4->KV.P"U-XRX0MQQSL$JA):6AHD=43B,)C":'JKHT6WAE M+>7R^^T"1@DU$Z18+:AI<9>T)E^:<)NT@M8 DY4(-BM#BJ.()T!]F5-LG4"^ M>8VK%^9RH5I#"!@-:]!5@',VBUT.XG8UHUU'O):H<1<'G"7PR4D8$K"5"\#( M6CQH-$%)FPMY+8%;GL9='&XQ&6.(7'7% I9 7BM"+%'["M(&.S2?8&4MY?(G M&JA$+9%$: 7UH.2:@B9?=1;IX[2J;JU17JK&7<[T3>.4=SX&;S4( EB+2=YD M\.P=JBXEB%AYJ[Q\M)5Q[%S1#JD R05M/>>(K::A[S"N2Y7WG)?RQ2^&KS. MH)%"\, "4+7>YE)C(+0J=6%R]L19&5-<,HZDZU= M1^"6IW$7AQL$J"95I7-%,)XP:!O9AYRJRP6Z4 BVY=!Z#]YC'A].Z.2HGVGP M(<56;SR9'3T8RFO)M*@\6^\O^?!T*C283I^?W_'THQG4ST\X]VDP._MU,BZG M>3:E4=GC?#0:#\:'_3]-3MQ)E^M#R^H8M5#(@RL%(^D8K:JD3J((FFJL MUJ6V!KHDD05.14U%MY1\ *$#*-Z@Q?]>1LWOX25/9SP9;9].QB=KN6@K*>?0 M8,DB+ &J%IM04 >"6!.;BX33J\VI1>-XZV3^8MXD7T"WRA>A&D!$(L;(Z'R. M/H70A16@MR9A/@%,@6EU(V/+^VISA$J1BE<9='70R5[<%7F9&=!E(H2(LI*$X3J3)16]%A2:;.Y'SX;KPO'4[?S4I;@B6?"RV M5)# )K*5&#F@CE7HD[I25>761%RZ'\T5K4=MVFIEK5*0@*=B\3YJ1'_K?A;O M?O[1/SQZ/!F_F1VM,:],4JRHJF"*!A5!!$YPT8+6/HL)Z>04A(5[@%LZ77F4 M)B>MB+Q7-8*OL:6N,DBV6%/L98V5U:;3+9:7TS?!.U&?RM@8("D="6W!7+4- MS-%T86[V"O>S+WGD9CG3OQ7$0A1U#1F4$OF25-$&3#&83>U"R8T59M1RHIOE M$*FX$I!#!;M.5TZ8(W*G"KUUQZ.C2-!($N@XM.SG\]8[E6>V*^[GIKMG MEV,G)-*)*04+/HK7B4C@K"M5<;2^HPE2;D=NED8GJ@:M\B#8BDJ6>!E+:>8J M,H&$SKX#=+K%\G)=>0YHJ5C6N@*6&K4!#DS>ZHI!=2%RO1U*^9/T6,2@,)LB MN@)4<009 @NZD$/56J\9Q#^0_B]&U:QSL=DRU* BHF:; $1D2B9_TWB>K6NLKBKLP MJ>U/ 'SO#Y_3FEI1=A$TEP0")*A4HR?E IM6%,1QKMVWHC>*X7)BRL0!07*N.A:G5(R)6NPU=CN&](;Q7 IMC044VVSGB$%(/:$C$YKM-8ZXUU:=MZ- MV5GK/O[#X.(9O^;1*3_C(?5'_='AKSRIX\F01IEWTZ!_.,]BL_U6(LB6V*8_ ME$-VZW/9.JV4YW7N+M_R.>I_NYX3_U3&[3P-.GN)\O5>Z3U+/WJ!?XFBUU-I MSZ>,D*L+FH$P1/'FOE@@(!+7WH4549?PB=;*\HO)'*9G_>FKAV92/AC1Y M]6GFE[D-N4"[QW^6X.5[;N#+\F*;I]/9>,B3+PY>1 ?K#AV/)Y=7^#BL?TJ3 M0Y[.+G>MHXX1>VF#]8;;)#?R,5IBFX3)M2VY\%V817W+Y%5C\G+FT:!GXJ2< M=P$D#DZQ) -.JV @B,#K@)J[9?*J,7DIFM8%*HR<45%;U)^Q5/"M-C<&E3&F MU<^7/*\&*C')Z434WN9X.GLP*K)-XI//.+0]/!F,SYB?"X4G33(N'L_KR46N M3'4ZDQB8!$8%3%6!A(ZQQ"SQOULCB!Y1[@]:0L#!>"J'=@2@'%S16@+YX#6D MXB@%GVWF[$7C$.4.*?15:DS+%ZRF2=.$+'\L6+*((=6DO4<%G"[6UJP9L-?> M!)2Z='MBE4L *!MZ!-F]SE M&(O#&HM-'M<(HIOT>8L#*&5=35)1S&.&:"M!]8JK=021L1,#@QV:5[.<*JQ4 MB@J*; PD[H[)6DNIU%Q:/7-KU@SBYC$]/-@3 \R]<=NO#LQVF MT70.^=X1C5HW;/S$TX?)/'.XU&[Q47U/S\9Y?&0/W"3 M!BU.>G[$W"3[@U+Z[/:%0. MJ62$(+X9,-766^%,H'R1&F&U+?F?+!;*X]/1;')V_\7S]3)/QBI=JN-J4DOV MZ##X%%6,F2*''*$#YFGYR"VES247LT+M6V<@./818U"%*Z!%"72H YIX^<@M M1?=6A2KD'"V H]B*\D5V^IAH>@$UX6>AS]![M+C]L:C%VNIZFI2*.$HQA03 M5"NJ#I!*2,HQ4J0U6!U[DQ NIQH]941"53,4*.SB/"MZM8FM\F2[,AE]12!< MSKP=7W.NWNNJ*U3-9(DSR59#%FM>X>*=#;D/$0*7[79;$AQ\2/;XH%8)&-[O M.UML$+1';Q^(8,X+QO95QMQ81):(!$ ML1*5%:YX?\N$QE*";5Q4=W:A&]GPJ/QA/N'HVZ9 M!%O95PT&/1 $"6^S@ Y5J!%K";7>FH25)L+B+$(ME )KFW52$!015;)&,U:? MG4&WNA;ABS&CBY[&T>&#/.N_GI/B8H#HLUGJYQLWSWLHVP*P]UV4'6F]3=+E MX)4S.@/7BNAM("36H95A[,"4[,Z ML@YP($"./#&!B@^1P8=$1@,97; M[\=?Y0RE/S@5Q/@YY]/)'+?MMZW[G\NCR7C8ZK6?SBZZ][=ITI9B3G_ER?,C MFO##LZ^?X#/$9^/\JIU'KCX_42OIOH[=)>)WJ\8HJCQDL,:DI'4*MA@@";95 M%]*BKCTQEC-PE"A#]L5[+D"MR&%,P)1E>T&V75I#MK;$6$K7#LY[E2RIGXQ(/Y%;^HQ;[W7*6L\/%"\4:N.5(G M&1>T M9$"^VFP;6<[+N(-8G@#6VMAE?BRT+U46=;V3J35(<K=T6AUGYST6 MRZ0*YPJZ&'1&96LX1\&;0Q>"OJO0:7,\.1D+H;@W'ET OHZ^)E;1PS55ZU,5 MRP"$*CN=K(4F@N)]N3:ZG*='59!$3*)9*(!RS998*6='Y-3/W- MH[F<+)Y4+":%!F*"$DC""I-TUFC1VD K/$OB-DK]@D[7,@#;JG!;"1,,D09M M7$M;J$M2-6G6;#N0<.F6(=<[VELX.7 U$:D*P":*=[#HDP^, &&%TY/<:OYK M-1VJ)8,T+4^&R/@@\B\RNY0=1 H1"JRNZ;@EQK5:C,@QL"H!3,M]:Y,(RL00 MM6^S?&I>8=5Q%6+L"'P3<2;/6!ZZK?8<'B 0HY1,2?$ M'"!!RX?2Z5:[%' 6F/XR5 2M.%-6@*Y(5$UM.APIGY I=KOEW$C0=3UYZ=ES ME)93L*4EU8@8"X/+:"*RR9U9=[ :N"QR)F+-SJN2Y.5#KBIFB6V=(RK1Z1R[ MD+3RBHMC-WOKU6O(QEFO2XR((A@C$VK#8&J,L21R:[0@_1J16\X4".M$]U/0 MI68)!T.,AJRRU;:,$ A=&0Q:+G++2847O4T2R">O Z".*0&03SHZLFVPN/O6 M;4.E^^LJ;YABKHBE7 R@7!&9>(8@C*B)ROK69H]^WG4K!<3KTT0 7) M<1 DH0I\0<<0O:XM3V6$T'V+NA0LEV)C=;8EI&)-2"3M$E,HI;8:$P9]Y;+B M:]5O/$O+M41KV(I'4D3C/$$1."2DSI'%R^E6)'O%.R:7B<'B(K.D%-<6G043 MH:5FS=G6K%5PD4W"%4=QJ2 M#N(8(E!P&'+*$K9VOAU<&P8+[*G3&C%6+;%)%)_L8V:LBKRS)L44EEY/=N6E M[?5XB*#(B:=V6DN+*(9$'A4O346%$F/NKH=8 BI_L:WTW]Z?\.!\_?]1_^0. M3?)D//CT/;:?_#2>'-Z3*-#>NSCB7BOSNU''X]EH/..[=^ID/'S&=3I/1OS[ M6=H:OWYJGKW>MSNGY7C[]<'C>+Q[O/.V-]S6!T/Y]V6OO[_WF^IM'?1[P]_T MSN-?!@=[+^S^WBNW__+@^*GM#?;?C=_M[!T<]>3[SM[OQ_O#;3G^-[-_?/"J MM_>P?_#RA>Z9;;?[\M%P7^/;W>=QF(>/1KO'O^F#O1W3&_X^W'F\XW;WGAT= M[#WK[^S],MQ_MP,]LV]V7O[2W]W;@:?VV='^\.U@=_CDS<%6MCM#N;MWAV][ M[YX-=X:]H]V]%V]WCA_(+WZ3^]K6.\_D6N='I@7?O_XX:O>NWQV(&?? MW=JVOB[.=Q[_7G>,7L]Z9>OMT;WNVN[5C M>UOY7XBLP!?>R%#"!H"/&TDS;[04<55"N%0JW+E]JW_R5G>??_I68U7>4O4; M27F] 2:%C124WV /5@&T=9CE]JW^*5<_>ZN:T:OBTP87*L)5MALI6=J(ND:P MX+U38@P&_=&K9__>C,QM2#ON[IW9^-9P7 &,5[.=S4_!<,IBLCIMJ*K9^;^L14YOZH]%__ M_#?YZV+@17MRM:W#201BI)(O3B5F%RA&JOE?QJF['_]J.CMK#!CV1QM'W#\\ MFMT'=S+[KS?],CNZKY7Z?^]^>AQ-#N70-)[-QL/[_F0FNZY/,?_U=S;QLTZ!^.[K_JOC#C4K# M_N#L_O_>$S\_O=/C-W>>C8'SCMOV-Y KG*_.N;\Z<+ M]!YOW]G!Q_J)0G[1X>S\>@_[VS]M/G3':,GL/7A^, M?CDZ>#>&G:W!\>Y65@=;C_J]O5?R[^%;^0[[9A_VCP_?'!R_@AWSZ'B_']7! M/X]4'OX^HI?Q=%?V[;X4__3NV:N=ET^T^*U7XD_D^]'QP?%1?W?KX7!W[_#= MOMS_/]_)]?>V_V53R=F(^W;@E,@C2AL(P6YX+#G:"-62N?NS5AO_/7<*'X#X M^<[5";6D5O%_=FCRZL[NB/^_;^#^Q9;9^.2^F]_YK$UZO3P^S;WHACS!@$ZF M?/_RPW^5_O1D0&<2<,WO8_ZC__KT[,WKO>;)K,6'%ZUKWM#.=U\XQ @_B5=M M/G$FOG=6+B]\X2Y_FKO+>[/RY3[S4_#Q#_>JG_0?[OMW9XWN)V7_^* M_([/[UK>2WOC?[]K[U[^X(3*_\_>ES8WD6QI_Y4*3_>\,"&IM2\P0X3!ANM[ MVS87FZ;I+QVIJI144*K2K<6V^/7O67(K+<8R&,M&$S&WL53*RN7D<_9SL)?) ML^;LRFN402:2H^6M268W)YM]C+;TWL>AGP32.SZ[-=VP.'+WB+,?QP7&A\Z2 M- >E.4FG(H?1K_)GH_!*!M4\+1XJ(GW\\,_LK_-D_M>'CZV_IN\;QU_VZS!6 M_>.7SU\^XEP_O6\=?_HGS/>H?7+P\>JO,_6;/_\Y&4Z#Z/03S/U3,(7Y?SD^ M@+4@[K^W+8/#GWY\?3?TZ./XWK)Y]>1W]^V5^2AF6O/Q)MT$J"7G-4 M;8M64!WTVGY5#H?]8-@?],2HO??BO_\+/NP^7P0U Q2*V'\P'7\O[DEDO']R M\G[_=^_=X=O3=^?>V_?OSM[OGYQ[YZ<>"'/G(+%YC99W^LYK=)X$3[W3U][Y M/PX]1\XS,M[^JW/\NC%HM4O[0Q?^-X*ZAR56)*F73Z0W"C,X)V\N1>K).)#! MCY UWI(%[I!]^^6KC_5WJU-XYP1_5@W$O(ISJ\KX@4+![843N.K[?_>[K=;( MEWZU.6QTJ^W!H%X=],6@VO#KW=9@T.KW^JT[1>M719K"D;TF.OD(1W'38_M9 M3TPT!Z+;;0'LM@(?I,G.L#J0(%R..OU&H]V4@W[?WWMQ('VVI*.=NHR_%0_/ MX1M$S:T!F=-W.Z%S)W1NE=!YGL+\J.W@>L%S)*+L84N>L\GQP;A]>@!S^'+4 M.'GS'J3/]U]./[R_^MA\!Z!U#!+E4?VO\S\F?X4+DN?T\/(4?GMR'GPZ_O0> MGODWZ,C'G;_.7W_ZZ\U1^_C+^\OC3^^B$YCG*LFSUY+USJ YJ';\UK#:;LA> M54C1J-9;@\Z@C;%WP5!)GNU'+7F>O]L_.3LB$?..I<\\U6M3$V@Q?%Z[?W7< MO;T;;77IT1MBS0;#W]])#FYTD%I2S@UR>.Q!)C^O]]__U>C6G]_\?_-DW3>W MUBM:6\3R7R73:9AA9(#W.@3V#5<;I)QG=ZE5'%)4 +Z-7_9 D?N;K)B O+ S M8B3\H-K$_VD/@T%5M%K-:F_H]WJP?:.F;&+L1Z/:&M0[[=O*E^N(+9R.O2SU M_V\/ S[,.?T];M0^S<9[GHCR=5^5P:L'>' ;^:W9Z\RN]GY[4/+QG5^*=W(< M9@A<^0E\\S->C$^'?P<-Z?N==JO:J L!*K1?KXJ@)ZJ=8:O5&(W:PTY#[KTX M//GCZ.Q\W_O'Z>\'1R=OSKQ7I^^ ;>^?DUOOX>MB3PZOA)\3A7C)R$L-97@B M\S*LRC,*9>"%L1?FF>=/1 IS?4A.@T&M5^_=2G_KU)J#YG=7X)K-6H?_AKI>]#C(8M(42OV@]&W6J[6Z]7!X-1N^K[C4YSU.OUA>RA_2T2ER*5 MWZ""?IN.\]-=AG-Q=:3"C'VZ$ ]:6O_A5+X0*"N:3;_>:/6KG5YG6&W[?5D= M-EM!53:&PU&G!4)-&ZB\WZK"N71[S?ZU=/X (+U_(R)^0B#K@<:>8+BY]ZE( MPRP(?=+:0>H)74"FQ]*QB,,O]/?3>[[[+,[X706)7/8N?)5 M56K\TUL9GY8):>WN?>71U6]LM&_PRGL^A6T!X?T@2&66J?_\#A-H[ #X!@!\ MO!QBT?6Q^750K3<&H%7Z&/@]%(/JJ#4"P:/?\OO=SMZ+9KWNP;7Z5RHD'*GW M,KH(:A7O91%&2)7>X1V)'VERR?]NWOXB3,,@B.0COPAO$Q"ZH[_"&4ODNYMP MDYNP((IT_*#5'[3KU78C@)O0J\NJ$/ _G0$>PFC4:30:>R\&S7ZS4>TVZS<2 M118AOGD[B%_E2# [U@SML!(\T/)_A7\\S0]3RYW2N9-:/[?B^A_$;SYHQW\ M ];?C"Z&GV93_/WQ^3_#XT__;IX>C.NGYWX'?C_YZ_SD\_&7R>>3@TGTUZ>C MSO'K_M7QP6=,:[DZ^734.CTX_/)WJQ7(?F,@J[V@"1IKRV]6![XOJGY=!HW. M:!3X]<'>BY>I%,NA(C^*8DBP/DW?ILD%"-$[X\76T]5^\V^_'@Q'H@N:8:<) MZ.S7AVCX[E>[O7ZS/NCY -R@([X"W(/#C,,EZEI(-/H>GN('J52J*X *Y-L4 MJ#^@)LGLOM7'^]L?$)\\E)]6J(Q_>](#%U&_+TAG_W0K: MO69]V*XV1W5 ,R%DM>^#U G;)64]Z'>:O?K>BUYCR;-=O<-S^3V!"_@62>-! M6S._+?9@_'='-/K=OFA6V]UA4&TW@TYUT!L%55$?--K--EH@FWLO^HU>%>Y< M_3&X4VV_<(\!0Z8R\-X6:5:@3S5//'@"36<1K==9.-O6LMCJU3OL./*N=6K?1^>[#TFQOYEJ]?<3M%AH=S\,\HI@ *?R) MYTJ, ..D1YY4]$/(8/8N]R$L(G MJ0&IKWM^MG\+?GCXN(+[>:,YI.OR0/F\SDL\/?]X>?(%GIF^@W?O@WK[&<>& MW[^_(K7R''C\A^/FLGI[U#GYM-\"62#\Z\T?GXX/_OWEE-9QA)G47T[?X/H^ M=CY^0?7V<,EHWNQW>G (LEH?]D%.\$?UZK IA]5F@$U(@Z CZTV.(4V0>A+_ M<\7[!=A/PYN)U+L04?$M#ON?GHH5"C(([DCX9B2\4/6G%?2ZHYX_K*+" ?)N MLU,=UAOMJNAU.]U>OS%L^Q+0^(^S\QVE?CO>'BI&QN&KBS9'9'./P=SXXX@Y M7'#=P!$,AAU9[=9[C6H;%+7J4 9!=0#ZG.PTNR/X$H@9R.5CDG[VSA"1/7TF M7_?C/$#KCZ/769')FUVCUXUOJ]=MRY)/3D\.OX<*OJHZE3.06_AJEG FC:K M=2'7EL)2[ZW;GXAAED1%OOXGWS9C]W\GJ07FL:P.4RD^5\4(!G@FHDLQSS#? MX-[K>]U399FC.,#H(.D-YYX_D0 ,4RPU$_)=<.++P\P3WJ6,HNKG.+F$>4J1 M)3'&FF=9@<94D7G )<*8P\_?%:"-MNL=?:N<&PD7K+;U%7?NW"/W ;;R7[B3 M9VHCCV@?'R@+_#:S\,>_A[(#>D,PJOJ--J@4@]ZP.O2;S:KH^(, V%J[-1SM MO?@HLT5VY:;>&?C[T6G/1#&F#LM&<_BN1'M]SN))LBI/\?[VJOU\ZU%@$W2, MDQP^^4\1HJ@!$L8($R=32D_/KA$]6AC 6OZ(\HBM-++]8 GW# M07/H@\2<7,=,[I^&NP\6'R\GD@+W$<"L(]Y[TGC*>SL!61'A,?!$%!F,=,%S M*-4#,/ *O"Q!I"-::J4681._QE(+7@#?QF-Z=)9*7Y(+H='TJ-!1YCV!\4;P M_UGA3[QLDF#&I*X-D$]$OKB*2Y$MXSS]6"WDJ2?BP'O2=!8[E!+.IAA^@J7@ M;^CQ$;53UF-1RW*:"$U49+DWJ'L!J">UM=4)[AQ.5-DH+K*"-L=A"@>WPGH]Z2-^[$T[N 7T=& M12 "#)J&>0[()2/ HC2)T0P=S3UY(=.Y=X1F%>%30-R!R 57_U@ 9CN&*]6Z M"C^@9<$UV;VSZOEW >!T/0#S? RFRNSI/2*FLX.X@0I ?TK$//Z[W9%RT!RU MJG6!7I9.MUX5HU&CZL/F]IM]*;N#8(>8.\3<5L0DFV<$4Y>>\'U S%0@["'( MH,$S7OFI!W1<7?E%-@6HA;>D6IP"_)G")LPK*-/"<)A=-L;/QVERF4_TUS4/ M9%Q)DR,+*UG0*9 98UN;L,XU4Z2O&\_U8U]]8.T$]7,HV*IGU\Q5/ZE-P(WF ML-K4DKHKGF]@U;COV+G!H-;OM&Y9E*1=7__U;:N'-&N=_NU^>6WD7*_6Z=RN M*,GUDVWVOW]A38P>'-S%9$&VOX=RG8\U L!6=4M? >Z,DW2^(@" 'B)$\M5# M#ST6X K^AC'?38\/#N'7\YMWTY%,4'B_% M AR"" 7S?_/Q\OC\J/[QT[^O3LX_=DZF'SL?SX\O/YX?7L)WS=,/1U>KZJ8T M1G4?Q*MA578ZH*3V^IWJL-T85OOUQJ#>:S>"?JN[]^+WU0SC[BMY;DKGW[ZOXR%=_W^NZ :MLK"HO^T)*QMWQT M@[(AWZ=F[4,@V9-5&L+/0+8[L-W6-=WP4,_6:8CWO\X'4\2>96+:R9=%!F_. MLL=9O_Y'2<%'2TU=6Z/!P)>B66U*,:BV9<.O#H)!4 U:W6Z[V1@,AD+>K'[] M@V&T]_+H(^+)AZOM63MD;$7 &XL=WE;TE=T1Q??AG"J^&U7@QK2U!LNP@S4CAB M$?N(*Z"&8#%C?#C+11R(-,@\+ 4!JLS)KQ&ZXEXNM*BO_7>J(?@F_Z'@1>2ZQ/A,> IP'%GB'N8DQA0Z9*BX<+M*E8HSC(#].-0W"M,IN_MG\&Z!#P'!4G)!0#,6 M11#F:EXU[WZ]PG?(18_\4;J/2TW2?7O@KR,Q7C:<#Y,D&H(:D>3#Y.J!LM)O MBS'8_[O?J_O]YLBOPG^":KLWD%6LBU5M#?Q1M]=L-8%#?KU):ADAUN1 _7#X M:#29GV0VPA$NQE=2VKS%*B5K>8Z+0/;F4PDXCD9,EN/AKXFL0O;C)Q06!EPFFF=AIHIOH[_N0E:' D4)%#9D MG#%;PN@N^(K"=LW;70(R;$J:PFL)%5Y+,S=,+ 7!YP+IS4Q!B3JU1/Z@V@/9K#Y" MDZ*W3Q0)IO(*-*"KO=D13Y@*1@$D.GI+K5E M6\0.993$(WRD.OOM!0U8W?GX[UZG5V_WFR!>!%W0N1O#015DCT%U,&PW08X= MC?Q>XZLZ]RY^\&$GO.P3#WPMAVDATKE*2:E3K^=6A6"-:TOB4]D$.*P1HE84 MI/2="CE>4N2D@)/:#MBI[OIK"B:&IXHXY)O.P^Z5;W]WY+>Z_5ZWV0A$6S;; M_<%HZ+?:O5:OUQYU_<;?1SC#>K-1WP-4]L,I7.3_VSLZ>;TBYX-F144BSNA5 MIW9F94R I5:#)*^J ?<\;"X.8]5_.H0X:AX?'&//HH[H#(;542O !)&.J X& M/5GM](-VO=4*>K(]VGO1Z+8J +Z53MUT!]>'_ )DWW.@%3$> W-%[HM,5^9< M,TE34IEL%JG+ P@G^8O"4$ M!S\?O<)[/O[=:0Z:H^X 2+7K]['7:+W:EZ.@.ARU@VZCU0.MNK_WHEWK+=&I M-PRC" _T"2L!Q2QA?="/D@P1; 9,CPCVE]:@UF@OD]7_6X _RNE TP[:?7BL M-05K\&O*]0B KC>1(.^A5,MU#/GO&_S?5B]N=1V:@]-7[X\/3\[/O*,3W7SS M\,![^=%[=_CZ\-WAR:O#\JKNOEM\9COXR>#E',:6J00U]AQ>]#("VOKI[C^: MSM[_W>C4N\->T*NVVGVX_\T!-K^A/]O]=@/$"+]59Y0.XT(&^PBCPJ_7!4@: MLMYHMEN=UF#4$QW9'+6Z8BC\7F?/DX"J,SB!/"WDS0KF_.C[]Q98E'=T=.0T M$H/!?9GF ANGQLPS$-Z C:::6KA1^!KF.$N3J[DU8I$;!HW6*'5Y(HX+8(U3 M*[CISJ6,.IM%UVCODR\G1.L>9P5[5,%HU5P4)YY+D59E M'(!,\0'=0.PX\N5,F^;P@TP;@]3?--^WM)@SLQC55Y83!9T]"T#62&58WJ;* M^G%4D8Q PI_E+&] _QD>"LT"'GL-)^ UZM5_+&+[?)2<$,U+A5.8 M9CHKYC"^@.,0.@M&97.K+U^54V1HRW ;U(^\?R343RKS7MGV=I5KOR6_$'7Z MA3-,HC"@4\F*818&H4C18*RF<,T#HZ],0&1Z!$1F;2#,UG/>Y7J']$D88S>Z M9XW^O5W\__F?_UDHR[6@I>\*G7V?0F>PK8IM,)D2>_TJZ[C'^_T!Q,I+ZB4Y M$1?22_$K0F: UD"B%I95 "S3"Q1KZ4^Z6/@E"1S*>'XIR4-0_P!2,>^,+A5S1HQ8N2<9+1+;^4<&=S_3;R!W-#$^44 M@NFSW;V@J8$&).-,?U+S8(&@,"6E59(1UZS43V9S_1>[89/<^G2 #-FCC),C MBD:V4?/.DD@"5^"P@_A"QJ%E FOWKE+:.5R+\W*"197:'2K858YP7&>$KJ^ M-C4I<@6OC>[@>07_VVN;),5VO_G0BYR0N^$?5A%%$G0 M;2FJ(E?^;C&;P192FF$D+OE,U 05HNJ_F'&ZS]/6)\S9X;OLECNQ+;QON:KD M_0'B^YRH D^2#7X8GZ-*_E]JOB&1FMC< MDI2U%%),\)1FDHZJ/"KP"- $8"2W2S+0;*(<>6$:5)'207V!&?FP5T]L7R0S M$@?LZ-]F17HAYPQ8, _IBRS/GC)MVY@D4 7S<(K*5#4X1;/IP#B*Z8P5IBE>*V:W9/W"V 9Y27%TRC@E: <&RNF@IHS)HL8?5TZ M(7WF6H08RBB4R)])0TJI/BCN1EI[ L@%F*XCSD[#S%W@Q0M3)XGEI'.<@'A:$4).9[8"0SE<@!,NAV9@8.M5PE>9I M=4:/$2C?W1O+:LZK@R^4-7=G!04BM:C:[HC/Q&QQ^*=KO='7:#3GTH M9:C[L,IVO$- M#:\&M7[_=D4[KANU7VOVOO^HW4&MU[U='8SKANW50%&_?1V,6[=U_@'M+W]L MMN:#7M"]M2A=O:2W^V\.2PM:TV:\LY2=-[A-#HJ"* 0P>-8C\ZFG%WGS=+CE M=V]$.M?)*:/1G27$\>0"Z2LS\#,RB^!3>R^.3EZ?OCO>/S\Z/?'>'?X._SAY MXYV?>O#IA_UW!]7?3T__A1^=G>^?'QXOLXWO?;MNUP+^GC;O?\76S,6;I.AF M_:^;B%"#O1>-__U-+(HR&]W"!Y%?]MVR6;?V^K[=?W?N'7U;6_ [/8 'GVQ] M0T+Z_O4N[H UWS"O^"B74Z]1NRL!:@NOT<,$\FYG[X6N.K$&SW><^=[GLN&! M-J_GS#\;#JFP[/T=&FT]\?;W7KP+L\_>:^'G2;I#I,=RJ,T=)"V(1B]W:+3M MA-MKHWCD8?I,!A#O(.F1W+"G?H.FDK0U-PAT];3;6_OQ=L4 M';P8D+2#HD=RI#LH6H"BU@Z*MIUN^_6]%[_+L8@PO<.7U,QIATB/Y61WB+2 M2.T=(FT]W;;V7AS#;[PS,9+YW#L(,TQ#+M*=I/1HSO=KN/1HG,^/9B&/'2O1 MB\Z.AJ.=+_W^R>G1"1Z=G>"Q]8QI (('%^C!_,<5J?A<2\D[_$\1YO,*/!%1 M_O693?_WCK&L;\H9*T=8%3/UWA:I/Q&9RLVFWSI-SG2]T/T/939)DN MC;/O%*Y^;?(J7R4QE]J@9P#.BH@+.9R:#,H=MCT2&NFT=MA6QK9=6.2V$VZK M!]K!O[$,7)A3!C;A%'P0Z;\=$[>W/\0Z.$H/Q6#*'78]$A+H#G;85<*N_@ZZ MMIUN^Z!/6$GKS#8700@[*V:SB/X6Z=P[$+G88=4C.?,=5BU@U6"'5=M.MX/V MWHM75%.=H(98L?X3"^[@#RS669EL!VJ/A#@: MC1VJ+:#:3GO[0Z95R/3J#I#)I>P=_7X7^FWMO;!J' 9T MB93*(+].4G@7=E!+PRP(5<\4JM?[-I476(/X*,8V*7?N/-S!V8\EAV^&LXOC%'?2>U;CX0#9(S8.3Y)LXIW:)JWG^KF[6AGT%VCI/<& MF[:C871G"WTLQ]]H[E)#%X!K5^YPZRFWT=Q[8=$*&_#).+MSF\,.F'[@\>Z M:0F8=A5]MI]R.WLO5$[7W#NEQERJK=H$;3_E]O=>:"A[YW0WS$JX=9["-(6OVLIQ! ZKF=Z1 M:4NVTR(?#47LL&P)RW85AK:>ZO M6"OV%7J&=;(<=Q8/VQ\U_=.SD]-@:NFDWLRO5L/ZSWT!8\"8=AOA"Z M;]*4O#-_(H,BVC'R1W/BC>:NS,Z"QK&KL[/UE-NJ[[UXG:08'5']EW=63*\PZ9&<[%JT_OV67\>7N[M3 _!%V=Q_LZ5_MNKMOU-W]6_OXWF"' M?B"#HR5IBW-F$\_#V(^*0 9>DN*_=8Q2X WG'MQ:F:*!&?,_\TF8>?MQ7(!$ M^$["4R FIM+#VD)-G'-Z*=*@&B7)9PP)MF^@!QK/*5N4AI'>5(H8'TI&].?[ MVEG-&TE "Q@Z,Y4I C3WDCX..G.#GSQ\GHLK#S=6_1.^O@@SMNO[(IMXHRBYQ)_#,+KTTI! /A\!LN*L4_F?(DSU:I(BA?G#)P'Z3#4JX;'RCJFIP\F.C&0/!T%5 M4I[#/)>*1HR+'^._$E(-RM[*T;XBA\%F>>%BM!>V# M^'[U0_@"_D''!20&VY!D.?PF*+2_ R:6I_ 7T .F$\/'%T08%2^&ZP#KP4=Y M@FQ?] (XCRB9J1WQ,9XE#RFV!4:2\3B?9+@A4ZX&H_>H F/#OO$?O&(DRQ"P M9\PKQ+]3F8PJ'EQJF%6(&P!OR&9PJY/1B/X9A3G]VVYY@ 5/PV&AUJ.WT8<= MP/M3Q&HY#LW# !*72X\G_F?8A)FN=TIO#P,9!SQ):2)W?"=RY[DW3I/+? )/ M2Q\A@!]6UR:E7\,]Y#W(O$O8&QGAQ(+.+LDG7MBAJ0J(KLO.5P2 M/%3>DN= >#D<.I.D'XEP"A.-J 4&GI'N@<%D+X!(5+4+D<&2,EO]@B?H)Y0\ MCLIF%(IA&-&VF(F-5*8![!<"TQSVP*<4=;Y;?#TBI!EU7PAQDDQ]_YP6X-*B M6@S<91'/-2#A6\8)?/X<9UE,9SP6"S1SSFU?^3 N"[^AI3@W@5(A0.($HLD\ M2H@@*G')E9\YC $5\-X"4YS*% MU0 O&<^]K/ G,'N-SVJ4BD9C];'=BL5O,@#$*%C\U%_U(4]V\5.<[N)G""F+ MGR%T^OG2IW#)IBNFI5!L\>,<8%8N?0H[M?3[),M"$!^7/X6:(?XI^ ?#"!*]O*M49(PTF'M[J/!S-K^57 M(D(N-9YX<0+4!,2P_F%Z@? 1%X#5,CZ8AB1(X!CPAR]GAHDZ7)SAJ:*N=XYHP*4( M,V:QS+YX*TN7QP+(B%NEXIOG^N[@#@\E0]DL#6&E>%DF,KM./J!]R(HADAMQ M,"\NID-X _+],/O,+RU@4213,9);/@BH3^=$(@4?,M[5-;\$#*8JV?F$44:3 M&%LD]FN>VP964]M*H:RV]4+H5T@/-VU<""P4+KG&M[T[6EA@4F2)+U4%*A$6 M@Q#9IX? <<<17"?TF3*&\^/59;I9JCZ?2._9)&,N)">W(U^P6SA+H!Z:(K!C% M^AEH=# TK%MDFC\%F'% _UXB%<\[O,*;J(D3%"^\=4JNI)7#G8G@:@)BHCA> M07$A2!B $!DD\SLCH.)(Q8Q?B1 (W(P?6;M&&'(BZ>;"E(4Z)IPORGB.-%_1 M9*#8)YY';F>3>\PO8Y M24#@\EZ&B0^,O.*=IE,_J7@'AW\>G1%>_TNFJ8=:K^(MP"4%\AG0< 'JY#/D M'C.1YC%P RHNAD842?6J40%%.7F*VBCP(E3#<8P@' -$?H&WH^TDS?!)^E,Q MB&GBHPI/GR1H7\*IU;P/$GAF-"/&[L.JDBE&D <2QTV)%PY! _&TM@"S BD- M!5)!^Y&2&!X"2P>=?EZ-I&#;!X(T2ZNY]">DB9%8Z-@H@*>?%BG9$=(L'*%L MCKQXE$1A@CMNQ@#V?D%A[;#1B0A @44U%YX@52'+L__GH7I/1[)8D 4BE1.T7J&UQ2P"SBPKR-J! X/ZEU=9M\@3X-9HW4#I2)NP M0/Y- K0 ^#QY]3D=,AKWIF)LCI87BC.#^_\!M>"4U6[U.I)]]$*G4R2[.5/5 MTG&A)(W&)O)<7."!@1JB)H)VJ 0+JBI)C!P:ZYT6MDA/NY M[K!1EY(-*5,X!5AXL][H5UCXNIPD(#-7DTN4*4'UR4+8Y92 X #T.]Q=G<2* M2W^BE!3UG5)+GE;HT+$'!HZ*QP 2'2GS>+E9K4.UU%A0U"FAN(W3V<@HDI2O9KU"LYW0'(HCA)),BB2+21$]1VP!(11W]C16#.,O0/I\Q"X6!Y" M+\F.0Y,),VL['7EHK4I,_@FJ[$@HN&\%T-UF)[YMBM@'O P"2 %T$SY1NL4A MJ?Y\-(2VL3%+O=2JTMD\0\U44\#ARS-]^MY4TB5&(Q0"CZ/\!W3SU%;F4DP9 MF-!/F29H/ 0Z00E_G.*,F#K9'E@DA08FI33@E0X)'X@MQ'%RH=0$QGTY,[@. M"X1_$LD@>A/.H88SF[%:/I62T0(N?35/JO ?!:@*;)&J2HSH,DFC .1(!D < M-(FEWK((35% (HJ7V@'06IUYVB2#$\+]ST!"!#;@8[SL@EV:<"F#)>BAIV@A M%WF>DBT<#;=CI?N4+Y)^EV90#)!\)2U'%Q[05(3'KCD*O@^9CM=HUSV*XDW1 M-J'YW8I%XC'(E'P)23J&=7UQ[:[K9Z2,R6I;%O M1@$S!I 8:+*HXI(IGKDTLVS$*YK3IN"^=5==P?ZP"*/<;#PQ>.OZH#6[7@_8 M'"*'9L?P3"W[*2!0&\6B(#^,@P+MI)DL"Y"-CC>7@HX6!2 ?OUC V\"# /4 MCQC)A\TF\!KX7P#L+KT('R K!8D9:C+TA43KJ,]V545C"V9'H*.)@%\QA39GUBVN:+LAJ#7*G'3X@I< >R[ERF> MCZ/I\T,3$,R'A'\T0<+P<"9QI82H[$]B2<<<6)50E04YY1PB;P_1!/DRV!A' M5G6<<*'-GC# +$33;Y&67'0BN(#)PAZQ<5:;GC0EXCSQ^/6FH+MPP8#'G/R* MF@F.4BEQ.XL9BG;P+E_/2Q])&*,KC]F,ZP DQR-0JC]9-#*1A.WZ'LO?^3B/ M,9+/UT7=52(ML)7/Z 9V]0BR(,A4Z1"K)5 KN^-)T11(P\!,,05S\,-4.)0E ML1H76TAA]3"IE&:AG8)/&$;U3ED+/3P?R!'9'$6FE^_^4O$'XI 5A<8@4L"^ M*1OCJ],_C@ZJC0'<*:"$:>A7O)*(0+<;F;]VE:!KSO=EI!B (D:8-?P+C;; M'U$+*/F#%Y=K5=1#^%BF(-$4*5RY"DWI. P"T/'PJXJW/\*%5KS?\39Z^[ S M\"=W2\I" 3N#$,#&4N7$P!G^4R"HTU.(/7!JXNG3[3?%XS4[8!!5LD>8,6^O M.')&Q4"OZP-!IS7ZN8*45%ESM[3/A=R56AE3IX;W)R,DC)@9(%7 K84KS^X8 M%8VB)'%2[0T &%D"9X6WF24LM+@SG<'<#CF MS9)9$2F\)0ZJ/&",ZC.0?_)T>2=TX>*O7>B*H]7C9=J' MW2$TLX8,GY;B"MKN(*AG4S09Z(U/YQ43/* V"%4\7H1*#?-.2^*C M42W/3C.K5RKA#IT VAD(DZ7==*?B[A8[BLR*\;>:;% 0L08'9B4*N$$*0]5@J2U+4J" M1%9(HRO(;JT47Y;/?^ET6UH702.0UVS^2L(\LC'F7R3MK!@>)4G-]#(@4!6I MAE"B.9*1*>VMLX$X+ /H2#@EG*BSA7F:ZT.@P-%8QJ-8OO(F@ =8XD?TN^) M60"MJN@82XC:,,7RJIIQ"E,"XM]^ML'R^TK-3R.X4@9:E7I)RJ8-8>U<@6NE MQ+B-"$0B08[>P\M)PG87@'W^O378X@7W H'&:A"U0F4))#J-LL0A5J6,&V)% MM4^C.YQU&"ODE_&$W+/:WFM/; +KK_Z'FHS-W>-#:5'X$Y*Z6%>JTYI7&@X$ MN5]1'E<:F%6/VO0K,Q>*[X)MX4U5/D]TOI)4A\9YWG3BG%:-UB9Z:YMGO+Z0 M9IM-A!F]HVRW-283I09;_05N"6C(83:1@3;7I*6R!08%Z8@^RSGIU1@I!PBW M$!N!J%[1.Z08%S+HBH*(R+!L;AL% MBA<[E$'##+P1(LS#T6":@ M7<^ D1D4VWF/UR--<[WW^&'X@>]IWXZ,G,:Z/5E;T(IAV"JS0!9:\(.U.J\6 MQ=[]MYC.GA\8.R^%/ <4"6MY[ )C;_9[-[*#<*D,M'KRSL5F*6!,_L$B8UX3 AA@0!K&N'+@7"@C:]\- ME8W4!=(%P4!-T.*A4FQ01D#O!LC1:PT#[)E0CB4=EHF(=7#^)ZCZH_R2(\W" M7.FC)R9FXKN23K?6N0'MK$":/)D]J[;HUXOEM@'M.-OH_/A.YGQ#1 M7X*YQAG0^^?=3FZXDSZ(3*EC=D+AQAK60U2BJ8*:OH2[**GI-5])VUBM*E=31R[\SXYZV[@:_V=AW*(3H3 M:05\%J^L0^D^#\(QBZTX"C8[\80/3"R%L^>XSX> 4O- S+6QQI[#]M_S<\K- MB"(V#E#.J#*XY,Q^7W$4@LEW4LE_$*8R>)0]G1%_,!ZB5Q]@AQ$U=*A%1FA/P6U MM@I[&XE9)I_I?SS'<(9(S)^%,>T0_>AY>?05W(C$?_Y:RC>D=OP-%W^WB#?3S':)W2CFU\J7U?RNN7?8\]S5:O M^B-J4&6)P-/"P*W(1^V!8O(H L 68)1 &'AZ.=]$6PN;_"UC/-))?BLS>@AT M^V99S'VV+7#W:,=X7("XNJ[6"26VJEB:18K:9*%U[R$L]Y=O6J*[M!1'W:JU M]4 [:+!^^RVK1-3=<+7?DU?L:.XAT5RWTZFU=C2WH[D?N+9&I=7MUMKW1W6/ M2^!J]_?(?T,&MPIU[/CJ!8;&'LKR+ZIO+-]A#9H;$QGVR>'/O(S M:O5KW=T9;?<9-9J#^SRDGT&T/ES(E?C)A.MVO;WDMA\- YU.K;,[I.T^ MI$ZW=9\:T,\@7"][R6_ "&_DPGS$ML2;KW^[[U>CTAG<6F2]\29LN>U[1\R/ M@Y@'O?K&''U'RCM2WD)2;E8ZW<%M7=UW3LQKNJRVKVF+>:>A+[BM/H=G<>VFT_ MI$:S\YAB5+\-/[;O>-J#9JWSB--K=[&(U[A:[I4][^+<;G0_&X_IC+X-1K;O M=!JM0:W];>CY (7.GSPPL-5K[Q(ZMOV0&G!(O<=S2(]-[.RT^[7^3R=V?DN4 MGJJTML*=NPL7^6X;M-V7IE'IU'NU_C?%DWR'7=IR*_#NONSNB[XO]?JM2XWL M[LONOOQD]Z4)_.76ONG[OR\D0?Y&Y6E?W*!W.X\>QEB^_UFC?Y=%AFG$5<6@ M5[=WWZP8Y[863\8BZ3=:B:Z4KNVQ6<6#EQ M'_RJRW13^6C5 8OJ38=VP[FCK=/DT>VVE6Q\?K8YUR\-VU.7&OT)ZHR;2E4] M&P\*JUY7L=]1%?^EILC]A+"7A>HYJ=OAC+QNK?XK?3^H-7ZE!IO8OPU.F=JP MF6FW.[]R:T&>$X^SW+JW%%!5\9KM7_GSLD.UXG75Y\EJCP%O=[/SZ]KV8F<; M]0AVRJP/VBL6$O(RJ=.(@=$4A5O/YI-1!4>1GJIJ#>*S$]FZLY@QU\QQ4Y0M+_9S;O8;36 WZ3V M[S;#]C7SOP582S,:$7N!/7FILP[W_U!/):,17@@7RA<;W!IP+>$SW\R+,,/& M:@R"O\$/N/$6M2]2OWN.2*JI77U&(U!O%1D8]'V.X)(GBH=@(Z(40!#Q*\E% M.H?[D:IVF-R6S7UDF*@^?6-J$D!XQ@U[GZ]OO^OPAA+\WN0<2J!;7P)==\AN M_S;0V&BN@<;V3:"QT5T/C1^0^61Y&@ZI9?8-%VQX), =C!4ZK?"(+TY$' -$ MZ3;P"UQGH:T[\TF#K27N:+#V!E#[C:TPEG'V7S)-*]ZQ!*'DJN(='/YY= 8D M5WVU?\[[BHV?5@+HKA7<>FQK/?16<-O+\O:=[N=,H-BL+*?>;@^#Z8VY#Z/I M:H?-(+'K*'6>5[T:Q>(J+TW32!+FY86("OB!V\K5_0DUN)8A :;I($N_Q+:P MU#,2\41> 2R&U-(YS4>@*"?8TI:;P')G2/,Y]:/#MG&DS)A^V[8]%742KE&7 M6VY39>8.!U-$*'+"?@]A;:,1]T,>S@F!<';<0Q3;J>>HB:CFR0BA (#TO5W= M0H=+8L\7(HP0O2O\8(JC.Z"'79CIK23%4XO6L>KNBZM!1AW.Z.]L'B/[0$F: MFD,C]\)6U.H]_@1[> 8U[Z# OJ2FJ\ZZ$OH5/CCL74V:WV52.J=-NNK<%\7& MWC\+V+..LR"SQ]B?$%@3M9B'CT!]@[].@7LG("V@Y@LB^50&E*5T%/LUE-2C M!!5=[_??7[&<_O((GZ*FW\J*94+M;&'WL#NNZ3.^ MT,VQ84."3;?FK!A^0@T4FVO+-!? =[EC(\I:(OA4Z":*(M,=5@/='OV0E_>V M2('O@YZX/TXEJSM(0/ZESI%%.I9D;B#!C]H#AW#*V LRB2YXWMIX8?I&:ODE*7)N.)^D M4UD7Y>V[3GV2O _F$:?F,WP)LK=/=WE?8!SB(@DM7H,%G MN9'W2J"& ,@ZU;*L6]_ CD5=+# MRH,)LL64SQLE?.FMW]:2AENQ^DTF(U3YK"4.B XMC4:G<0P]%>[+3>U;B4\J MC)C"A[AOF81"*-&2+VM)-VOZ.@OM!0&M% MF:^"O>>7\M 9?(!ZU?$$5H[6Y_PO\4?BG1MK]7N0N.@ CF+8C8(^>[D*.!R1 M7",%:N$H=5(O8>=-^CQ1,DJESWWLK8!4<01?B;=_*C[+4KMSN.WCE/O> [VR MU!J!GEH%C6KJC1/!YPP:; 9@-<6K2H*M:GYL!5S^?>9-8!>ED=)Q?NH3/EK3 M;G6A(_,&[1&W5K=ZAU1>(/S@-NVCN$QW:>NI'; &A1W"7Q3B'?I(2VL29DWP MSS0!LDF<%KN2NGG+*^EK.Y%6TBH>WW]\M0.@ +9(CR*X@%>!.D_(HG41T'=F M(*WEDR>\16GVF@R7C= MZBH>[ ;RN%2.)+)H[P3$;KCW^$_\H0 NC%N%O!<=I,2S1F$L8I8O<_A =Q0G M:Q&H9U$F+R=HQ=,&K/T8U5$T]L,MV@ 3M_<&O#K]X^B@VAB@AP%V+J>ACX#O$C:0P91X?Q$;?@I4&(1H"P?='*EB MEJ*BEH.&[HN"/6'$%N:QP!%)04?= @DM%II-X". U041)\LWXR@9LNO4F2*H M'&3J,F">\1VX ($#%38V"J A.IY4*!DHSLHXS1ERC9H5?9"9B6N %0>D7@X MT8H^P?.L&,*Q>Q,)FLN$[TKHL^0#.W !_#TI0$H0\XQG+F',!!<+G @=AG.W M*>\-=AT[=,>P&)250K*V%/!-"B]@/@*BR%#*&'B+".#B5.!K-,VS#C<1:%(! M OG"PN54BAA>/"HB%/0 ,B7KZF6Q=J->7JL34!$)H.I4-,?$Z\C?J4:NB>H(,! M@A=I1=GB \F.7](67DT /7\(M :@N02-A9V@XQ&=F](+W#4 O+L7!$HCTIT MIOM:LPE,J>6Q?:7VT>#&K.A3O=Z$NX5,^.T"Q]%:)# 2K[%?\]Z%V6?OM2#" MK5;QKPQ8!WO$X'$T'"[HE[3/[C"]FGHZV\MKU^#A87P M#X,R,&9:S!2=&,4&F#G*K'I6ROQC63._39EXX5I-Q 5R![0;2;C\M)?(SA^\ M2$JL[QUNNJB^_XQ*+=JEXA'\<)DQ;]MEX'D;$@WC"Z&)1Z]%G[CBEQAG I1 MV$/2E?Z-:S6!*6D&-IV1ZJ;,$.]K9S7'2^TG1:PX*/PS"IA*8!L42!J:+LZ*%X4/D6T U6KC'56X:*SZBAU5[ 4!\.2]D;&16Q$+4..>(V\! M;@;,!P7E/!?^9_9YHS"[/ V)HK#/PCF:\2/D^P7'6\$50*Z';Z)I\1G #J & MRWY^<^'TM-7F4[# ')EPJ"Q.I=F3"V#U]CF#\,4&7<%>5F/"07/O>&[_A@6# M1.//&?GMR5V&&=S<&U!/$ ;(B=7!FLB A8.U,]%N5?1KI!;]7%<-?4!@0_%; MU\L!WT'$3[B3=B:0VMO> 7Z+9PK%0P8"!GDO4I>')APC7OPP2D4%:ME&W6\%^< ME?:@P+;' -191M%CJ(CF(1EQ6!6,2*525F_]"AE?A&D2HT1M=2P[.O%[%4-* M(J=R*Y!$#!H*CP/&%*!V!$^-[UPL3*E^C MBMD]SUJ+G*"Z&2O81PGIVTQQI"-VGV_HX/YN/&C5I)Z7]JC1KG7T+@5PNUBZ M>T:&*/SEWHL#/B)YQVNX=AMK'NG[PS01@1M\- (",D&-Y7A>#G) 65T'Y=K M"0G*T"6Z+M=1K!O]XXN9<3WI:%ZIH1(^%7 GY^@@M(8_$V!!RC4'=*B0)?85 MV(BB"KX+GB4X)46"[:KD$;"9'QB9L3(*_9:B\1;=$T*6;;LG,*E-[\E; U_W M=55H)]554< *'/XR23^/@#B![&.F*C33,U':VY),IT6L ]/1%FY7$RS3X8>) MC-%2,$-;EPD/I/@@('Z192:8B#15)YO#R7RZE$8X*$4DP>0BN'JI"OL8@:02 M^Y*YC9)/!&7ZV:"DC8Q7.]K_[K1_8/CT-M"^$Z]IB5\+(RN+EV*)(M_4R\)ERG3\((=C$2(,JYX/: MMIA\D4]2*;W/$G1,CC(PGAT\H"%Y HI;[ MQD:8P)=P];))./M!DO!WW<#__J]!K]Z\:[S;!-W:1$W*<[1-.+SWXC!#U @S M.'B\(IA1\QJO-Q'%?6*M\GX]HW0ILBJ3KSHK")/0#:U,YC.1D:,W2,,+&\E9 MH"O=<06;##V,F:*, K)@ER+],$'/2BAP<0#O7\*UB6,V_7C->J.K0\!LF$IB M4PSH]1BJ3*X.=,CF0EOM :(+7SUN RO)WA/F[!EQ!LU4^JQ*#K3A/CS .XIT M/%B1 HV&W53)50D):I3FS(E6Z@\TBX#*01*7.X)*3LM0N I'H5Q,NABJ56@] M)"[(!J],0#I=4:=GD3X2TJ9$J XIZ]%OZA"LT:YFSQ@8D(EX"C@0B=Y(AQ)B MB@69R=5/W)B+69%F!;H>G$G%XX3VU\"?,X(;<+7B]-AN2 M-K KE4= 4.U^" M,GEQJ(%SJO@$5HVH\B%J691X.[-?H= ]B4O)-#PL#J$,&A4MLOAWP?::A2[M/5T33J, A!2ULWL;P)!*# M 0B*C,.JK->PP-":"P[;(H"\("47SJ_49&28X,GY63E MMFC"J(!PU"8R/8"6":)3I=#KJL@%E[O@ M1%&&]:4\/KT;MYQ@2)QRD'!>'@:MV+0\$7P2%$VMHZ6JG&O'(=;7 MA.)33I:3OE3.1,1$NBN!H;;*D8 )RSJ1$:,*?8X#5)H0;G"L,=UF%1I3'J4J M:.Q&:A2*[XQ28>)A\OB= MSG+0P\IX(M D88R 1@_#V&]CYW:4,EKB$+B$9!4TDP[M8)@?Z'^I=;H72U;( MJ>1B+'!V,L@T2^>D%LHFM[%J$8=X( _"O3HX.[47@940HD%8$BLM":RRCXB.WK+D^#MF:9QCEL8QQQ99+7@[&.E^1B9-*3\3 MTW-D7VVO*7%7\F\1>[ 1GKX 10]9(6DQ&*7'26QEK+>PD!E'MQ*< MH"-6EG%BT<[%VH5U'"^SVX7D")64H'0[&^_,A@L3O*NA[C($A)C(:*:6:E-M M5(!89 [QV7<0CWO-'WOC-R3K!V+I53X_8%T?E&1VGQ?,L3#86BY(U$X]$Z1J MFWCV5HL19R8K\>#\SPJ%)6HVJKEC(*>D#:-4I\53'P5!Q_!;D@=\>6TUJ"4& MM LZN^$Y=\J;L_5!9_<*/%\3-;KM.QL&3'I^L)U'F8)6:/H" ; F%GC'*#WH.# :=J!D]3#)1?)&$9OC]SB M4-*F49^%J)B )EJON-'^@J)RC<:+:,=*-'!AT*\H2<6M# FGA2B+T\5JQ75: M+%:=2>:2E?JOKU9YX[0I%*49C-FB:"^U75^K!6B%)2.R!$O^:T!HG-U"[4VT M1$\P2/FDP6(-B2(EJ&+ (;T9F? M"17&41J<.I-^^Z6O&8'7-\.7*;5 MS'&YUXXY;9UK7*040KE0\$X9M]0UK9C?3$WF5*645Y?* M<0%R29)2%J8($;YLD50>U 3P:<5#!X4Z*H0V"K ?-)/E GSL42K"".Z.A0$R M?-G*@I'Z+/9^:=5U!1!<*,80?3#35$*-\ Z4.I06*S1*U9%9S;K;>"_&I2E2E9>N\0DTY2_+TV MXII27>,$33I*VRI;RBJTP40O1)A8P0*8 Y%#E*#!S1P?6YU4^F@1:5H@.YSV M4#+=8?4F.IN$E-4J.[LM,5D*N"9HYY;(MDWQ#$GE5*XH+1UA05Z5*57*)/*W:9(U;012)^*W*=;YF*60BL M&5,*" 8H=5S)1TSR?)'UI%6Y/'4%=E1N.9=. MX!]( 7O-E0RHJ#8_A(=AY\(Y(.2?+A\[%1@QUTX=:Z;R XFLX:!B=2J6G2U: M\8GOQRI-G7Q&'.Z@^( 5TYF84-Y75Y"\)' A@TIIL_#\59XTSIR$]]AX42[@ MJD]E^<)2_HPWQ6($5>0K8Q0[G+)7J9()U(:BK+ <([[^](BU,I)0'@S0;!6. M#%BA4]'7#J;J)@,ICJFR@"VY@'=3HK/HHE3>1:E[(4("J589K\BUR-JK$\W9 M>@QX]AE_'DB,]]-S5J$GNE!U:JI=L-'*5NT30<*5KMCO"J\,X\_D8[K$"!U; M'F,Q)W>5WTL3C3KZAW)K38ZSN9_H[BH5@H)#==+S;\+Z; 0,A3HY JR1H]PW MD(-K%;P#B;]-L20KQ36S][G$,$R\-446ZARR/&3$QBO#4LK<;T"SA8I9DHL,(Y$"V(ZS=9T##,2^D2GFUE)_ M$>6D/H*EJ)?0+"LJA<# /#4XN) 4GY*0@IT1NJL-H]T)W1E>$B-;-4_X%4X5 M9"10A@RG<_!\A:VR#-]EEH!Q*Q8KRSK2*O:U X@?"A KK>S/O$VK)G_7W3M/ MA2DW>!GJ!BNJVU1F;/"NV6RHLVJPX!.FGON3!'4AK,VK-%L<8YX4J/4&6&;. M%Q1\I[1<%J15;(.)";/I-'CW5,":\JHL.#94E#I)*25M&&NPD4*?.JEN2H@F M"6I!Y[56B')2_DAD%,9E[1'.-H&.O7*S8.*O%APP:,J5JAT8B654G5&;1_32 M\7,,*XG5[IIP,=Q2,HTJP%';R/H[K'Y(8>H#G=._1?=!^;4WW&P MNQ%Q5_O"G-" 8,EJI^*C@W(D%?6#RG+' )7/ M9S)S%'*UEM_6%G70F;VX+QRJC14WN=1Z.4G=A(G;CW62CE,(@OB""19749IJ M,C9UF$+'I0BL$*K<\&)DO EFH?Z@;G^CQ4@.X_O0A3Y(>RV;)6VS(H[2,60[U M-2;XN+0()QN#A2Y*.S2Y'2MWTW& /R0:L0=CKS!QEF4#L[&DD(%DM>U9R<$K MO)!4BUHR)IN::Z9"VG(@]4ZZ^5[Y$M<5P=A?=@[?RA5 M" '?VFC]NN!?L5N#B#2'5W;J%097!3K \4KN96[6CJEQI8Y=S=KRM+B.#55A M\)I-\VJ:ERF.ZGKNM6?%N5ICE4H>*:B:AD$0R:KR;9@ZN37;GH1_8JH\V]'+ MQC_M5A5K&ND1JFIJP\A(7R^F-94J4Y8=$I9U)VJE@!T@DF6 0QMR#@SG!X/\!T M_MT#5+8-U]XP87-156:J!TZ$\ =55.>MF&% <[VNK^M+N$^?2>K 'D5A7B@L MI':ZV'1HJB*.16[\Y\UZHT-O:-9;=3;S,TBHRE?.[5H5JF?#F!!N%C"MO8!I M%>Y1W'0:*,.*V_8YW7!]*C[1Y9NJAA>^ETW"$2U#MPY$?8@1KT+!'":V#R/T M6)M:I1)>=Z%!7DSC=&];>82[0*FL^%('T3+,.9695ATW3A6% M:AV8:Z.U4#K7^<.8I&22 NW> P>9AL5TY1FXEU4+V-CM$71U51=CHDVIAO>I M++\=#-\+#!]][YB^>T;A\TG)5N\&(E'936UD06,34EZ\4' G++MK%A;NB!4( M@08$N"SLBMLW2E+GMTZ)-W*VJ 1[I6T:VXX*?E\VN7%,2,G@AN7SJ5_/(I#H MQO/#(N?+OCKFYV#=!NER DI8I9F5@(]WP(F*U07G..<'0SA ]:;:/KQ.]UFJ MT9'9P73_'+>Z %>OTW!$P=X5F$&.S89R51T(0VZL&<%Y0V7]T1N;0LF-,I0X M52YU76H]6RDY?%0;M#Q1C6^7#7R:^YF"2!GYNLH&0*Y61'R%;1;$VHUTD\I( M8KP>T0_P19DZM)99"IB3Z*M88C7[S :\I=OK^MFU;="6_R-_^PY_[TT_OVD M]#TCZY&5PXQD8#NYD0N2E4JJR:+ZE5''5AD+'5/HK-5$ZSGUK!:7O* *8DDR M#)ET8ER7$U?6V[4P%GBE[];CF#L'#;J6*P[OE!1=^=1J_+X)TV;]?ML"7 MAJVJ88TNBW&V#!#N/EF9D_5O-\9YX8[G4L(#6)D/[V:'4K<"TJ\^=Y9#VZPJ78 W#N^E 48/:W*&H L9R^P1*=NE*ZEP%L& M0"33F-FUZRR< V?-4;0A.0CVM2Q#I=(-IJ;#*,?A>MQ(U&ZJBEAV?96:&9>" M>W6=0))R%A-K/64WP(7;-EW6_6'F2%+6"A&! MK F".AAB,W/VI;)=AIJ^1?;594@K.W]*24S9NOUF)#(2R5NFK+L2DK%"@4E&7D7"W/-Q>L]Z%B8^\VF?.7DUV#!0FQ)^J#\QSI]Q/7UNDE#F5[4 MC1QYVU?"_F&$(EW'^ _C"Q"$A2UM>$9!K/?,JAT2(O>^E+,J.H%DH.K&DW * MW ;KB+.&RK()%:7@8LQ.8KY3;ZO<*SFD3+%B,1?,D>?Q!3(FFRH5H33F$!@2 MS=))Y!@FN6JF,8B K@&Z@#*=JCK0;FZJ4R_73A!7;[-5\/6C5$PELC5R4VU< M4=@M&9RY54]7]@^V*83:O."KV=J*QZB#8#%4^HSJ>>J*),847K&&=F#K>+C& M(L].0K9(K6K(P75(C%5\NYE6KYLFA;(H8-E83]3 M5_,T8(["+DSND"K!L632H )-Z=1/Z!T4R=&M*UL\!9U2 M 9$BS+#H%6_>7*DYY>#^3/AJI0D4U(BI5:QCEM.ET8PJ6A<)(F<=6Z1 M";0!*@>9C68W/K(:%=X) M&&!$%R*05;K*WG]"!U-?+["%TUY5B!W=\S0<"EV[)(#BAW2H-"3 M+%^HWF&=?]EBKSB=JG"Q3K8^5!&H?'*IYKIK$K8];YS9408@S$Z7ES55DA8*MM.D=R;^;8'D-TO% M'U,LP+,%O>Q6M;YAPK1BCC!E[-Q0*2[>V:[;H%631;#B.FG"K&(,$1(NE23* M)28L?4VPX31]'AJ;?"!LR8KU#,)0QE!>6[)H\./JA=CJ.9919GZ]K,T:>#22]/"&OWW)=S'6U1M?6&-5]571QR*TJ M-LK1J]R91A?&O%S(_%+B#(D&^F39$VS:0PPJ9VSS)3UW+5PE<]"6 M\GRN/;;"/(=U9=R>B]:H#C\A01=)E7S,I$AAZ/="=6!56(]$BU %(H843"EG M*E7GU!H='"%IH?&2BC1DEIL,J8&+LGDC@,"'13R56M,0N:H'8C4Z@)0+&:FT M7=C'2+7BG?*OU^B M=2K> 68TZSH>-&NL[J&*G[!9O/IJ_]QK'=@L;?I.S=@I(%^V_W.6<*BBI=@? M/V5X'LZIO5<:DY'>M#LL!:I:68QU'R5ZD7()BD[,)@;J:!DIU=F6\W7;4L&_ MD^B"@\G#-*CBKS%B,H--PD!*FS,!/RYBDN34O!V? 'DWX9?58F8)>@>%VP*% MAU>8-\:1=DZ99A3]F6U3.[G,O0'&HFE^N@6HJ>)\V>@$W#_E)2 $+*V # L4 M-JGL]$L+XB N4V!G 7&Q%2VU[D.O9&XZHGK<^=!Q/Y))0\LS\.)Q KH%3/@] M.0P89ZW5SU:9I//)Q6<,A2S%#)C2#J8%P6+ON)(OA(OH<(\GOI/ECD]*HZ*+ M.YH["H0G-U3@6QN-!?(#,_#8>2+<* *4B+@DW25EL3,?KOM8Z4LZ5$J!1J M*BJM[0K&,HFBC_X&A^;F]>PWDU2AZT#ZDD(L6HV*5@-?)ZFK\X H:$ )E#;! MJ7XTC8HCT#(4,!21L6H4TN0PI(3[&)A6E53S#'6X$3>U.TD 8)LMC1^B@'?+ M4FGDP!N%&/^.HBE('+FI,8OQ5)@3%&62 TEU;95]WJUW$HW8FX@DZI,\F3WK MK$$(WG6#0]B;KTH"URR3S_0_GF/]W$C,GX4Q40#]Z'GY??@".",*957M>6T,<-]ZK; M_/5;=F*#>_-3[&9]MYO?;S<[_5^_#;M&]'\/"KL.35@,0]8K&SUS*\KZ^A9L MX<&W^K>[1@N+O=4U>I ;UKXE[OR\&]9< 2V_DG98CBZJN/OOBB5.GT%_3HZ MBK'B^!1-"74RH6>4TTIITZ9^1Z;ZLJM,>K?CF)-KZ]8"T4XV,Z%2M^)(#!>" MN96[5+DL@S#%MAAL+8;9FGP'-R3/]9NIH)LDY3(+-M2J66G5Z[81,N=2HD*G,)HH*!:9#BN&U[1'_S*K4"X6K.-97#B?)S@T8I3:PL?PGI6Y,3+3*G# MP!NTE\&B]E%;?T9LVZ]E:D#'1.]\KB<1&U H*+"ZWWK.E@"B,AF*^9:D6D4HJ\Z@: MB*SR"U200R#&2D.O#QZ*KE"45E+[914J'?>(_E1#DHE^*4 ME?5Z/32/BQ!7DA785W!N/Q^&"5;'P^1>71\TE2,Q3%4,EHV8JG(2E0/=*LP+ MPR!I(K#^\C0Q Y*-_?"K<8KEUW5<.45$JM,IQ4/B-M4;,)8]2WN4"KNQ!/?K75N5&MER2^+&GFU55OAPD \4;%8Q_<:/; Q M9*])I_KATV\T5W@)510F=;LLIK"$N7( MM?S.>/&72Q7<,O5LE2_! ]Z+NHA.4+-'C040GWJ^Y]]7HQT.J9;'+M,9A'I=%[$_84&8BZ2:-@,JSQ[G'G =/TJ= M(7G0)+6\3A*64P_28NSM!X /86:Z8-)(#27K"5 4DE3WVT&-,U/=EW5Q9&X; MBB)F')B4@:4N)KK;QD*S:"65VIDU!ILB\GS+^+P/X4L9?AG M(940DZ#(\WRY/@KM&3?M#A8D6#II5$46&R&;.B;2:5@4<+:4^TJWD&JID]ZY MS@FS<*2$2_I=2?SDS%,KNIK$>PI<+*D+3H>2Q5M*6A,EMR[GU@+58P(5PH*) M#-2U%A9G9UZ7*?4DDKE[ =SL:A<=^=Z>'>^_.T]HT4V%9WK9XH TZ2IC.ERYS"W M)YD.]\=Y+P__NQA>,W0)CE?7+\;E+:^#ZP->&E[&1V"T:M@PXF7Z=\343+%* M57&9B9T3F"]73/T5Z=UZ\HMS,*J L90NYU=3[A2,6'%U>$!,8D4H#YA!I9\H M[D@0CT/)\GVR1:7#."]2 MV1$F_4,W@E:*?9*62@U0N'=LFKWA^W*T7M3*Y41"5811&;]*%>"T2<24_39U MRW46!=F>30%IZC*QV/GV,1A65S8YOG\=F^;V6C6E:C1*(0\6 M>]DZE>MO5CN'RGBI#"!M?2,S%-6%ZBVXB MK1.JL$-=,5378:@*6Z3^1'U7+@)MB]&O:SZ<2DQ,HT=MKT_W87/%3:\_]2AN M&PLCIF K;C4YV79FM\WNE,J>VVW;IMMV%!,#V=EY-]ZY_=/]W:9MMFD$>V<@ M%GW>[=R&.\>FNPT<:4H\7N%'6W:H<%7(O:/9C6FVXV$(PM0)V#,J(4XHE:,0_ZV+W5<,!P*F.$(MEB8D,L38 M84)V>N)?29$S29-AV\QSL#!/N$[Y/FB&:J853. 7.3N^(CCIM JO#54U%*U" MEK169:-QK%E:E:4*) (S3,-LPH4^R)/I?0*^" >6N#HIV>KI5AK;$AR%S6Z_ M(8F] B(=IN$W2B+>?1+VD?'2. =EH>Y]A"2Z0XL-C_1,N=H$4-J%DB)0,EG! M=52%&EEJ94=@KSQX["+.TT)RS)V\PFC5S!%)2W>8*ERF)=.DCPVW^6+0[3RV MOD3N*401LDL4L#O[6YW]/Y+D,_M"J/M"*JMZ&01=$_BZ!&D96B$1?;C[0N)C M7=SK"@;N8EI>-.J[H)9;;=P_N.:8*K7/+?T<_^ JV^ZE=$J*83L15\8L&7>= M^ H= 6+:+)O\A!-4.;U]& ]>7S&]6?&%U#P:*)\,&BQ&KQR_A'>P28';J1<$ MJL2'EQ% :AR=@MC/BO9Y6KPY/#$^97@K?^+]^L$6_&9VJ?Q/'3< M+@HZ-+Y[GW7 -*KJ.&<0/T2H9DLU#U'@T4$0"VUP!;L9N,P:=[B.*:< '\#G MC2"7F7VRF1:Z,JJ9#:UXED34(J#B97C>L-L@P@5CG011+HFJY#RT_>N*:\"S MIYB-4Q%(XU+GZ95/<']&%9M2?0#&_^CNH&J8POYD73/2*?U$ MRQIAD(4C)O.#)L!$:OWH*#9E4&CF:X+&T0.K)ZE_[% M$,F[).$FM+2NDK#M M[>LSX-YQ$=6#823G2M7H2\VQE GV!C*1$V47ZG-KS3/!*4?6O8Q\):NH(NW& M^^1V]".GK# E7Y#3**=, ; 3PQ;E6)K6L7DIAZHF%9-_HEU/N%E"A5/[6/DW M=4H>"J[+;4IGE]H=3<5G#G%AE[031H;A86(:@0BSV-,W\31[3S;/B;/5^W9 C M"J4*]K!=1;CZ7"EG3KLDRU4@,;G+381C3^1%F!6FZ=-O\(/8=)[2OWN.N66: M*MW81Q+2G+*6STMA7TXV"%H5X!H."X1;A$,E\#N/:/4;9!Q=FU\%+3Y70:$C M[E^"&L"%8CE.],Y;Z]J1UT&S@H^_7*M#G=@ACOV[I* M5R.ANGWLGD.%GDAP4(Z_+?OM:BYT'@ MP@TZ#=GZA*4(-W6%*]Z?U53,=O @2U,*A@NR69X KI)B8D\ MXTF:F5QR UIU:21&!K/H9>@;;X,;5 6T^ 8OQA438;U-[WL+(NS!X=5.\]Y0 M\WX#FSSS3N=J,P=.@T,3;6?\/H0F,79=3PH=2.8<38D_K#BV5P*A&V-[75E- MD=F9(C.WAJ8JRT>54 V?LLU]ET-72C&Z.I'2SNG@\,^CLXHBGXJM9KS.B??( M_'0;(,2S95/*#TA^:J_WX[57)C^U&M_+CW?_N%V"1#?7%R_"P6\PNX3=$'C$ M3OEM'7I\LWY""SBLPEX7.UFI^%CJMM*I5V 3EG[AZPP2[6!S60)GKOHZ97^" MHI$-SG/;2#@+<0&?BXQ3F@3>61MY<&Z^?/W[G]X?C9XV^>KMTZ&_RA@!X[]Z M^>KC&5N%:6164W6Q#]4VR^$4H+S.GGY>P[A.W08(;X,CQOYGQ3F+>."(; M=9_A1CQD;,'T:OP9-G)010E4/\=+#S51HL"3 M2ESJ,E4Q;[-IO1A:K&*-;9BC"--+,:<,*MS=EQ).(F;E$YU1O64?Q^G;UL&. MRV[(97E4]&V@/8D0?@H8#?=T07^J.,THG5,W\2ZN!0=[#[#Y2,?+6)HW=\J) M:J5[0O7 N;D1QM "(;/?5(=FH^5 Q]?:2XPXY5Q$LC/&9=,' Y45&_^LOA-S MHR5F,LY8\R&7L+93Y)=)-8"=CC-5<;=TA:A2@KKS_/9SE=^W(\ -"5 E]HTB M,:9,-SX/UH 9R[*58+:,3(;?&$=Y4*1,T5K19K/45'P&J&:P(Y].1&61F9@6 M)$,\[651\*4C"NZ#DA"Q]JNSE!84E+*YP%@AE&%5<]EKJ9,5';7) M1&9J_X:"@B>R-JY54!1M'?QV='KVVRQDL^)3RN("Z9-RDSB0!<2/81@+*]WD M*]>N\MCTXM=FHZW;G>R>DK2V-4=KEZ2UL?5OL?/VPS+ZK>L;;LS\^H(;_0=N M.#MHHZ7FE^R(@U._C8'OVRQZ9W.89FS.0%4,#+6EN=XM7:5K3%"+&5B;&XG^ M)=-T)U]N&NIY+ '.=N;7C??MG#JR[_+&--_%TEH?HV]OMW*8[ M]P^13I,8?K+;NDVW[@SVS1^!?+7;NHVWCKG]81SL10T)^X"#^$,WDW M39[])(Z^=5K!_7CU.NN]>IV5V7G]P9UGY]VCRF8.C4IIJ"K6;%9WSI0: MV&/6@W9PH ME;[<2:6;LSBJ_$:%TTK-L \M.3O1JKI8FJ/3&PK6=@P\%2>\T-B\V!F%/M8% M%VN4X/6J8-=[#+3'>&PV%!)!83PR&AO9^&'B@CE$&AWC1$6XHLP)@EPH"J.* MV:V*4J0(1KA&T5BH(,A+<85!F62^T/?4N,0/^(58@G A=Y *^IU-1+ 3[S>6 M485N_BUR]L'3ME%.L6-,A.0C](J>%+F1A8!G+*?5,O1"8KD>7$\V)<&]& M\)Z I!TJA;C]U0+=^I%LV.+;9GM9+Y32U $MR'W("WY-'/%B75L\("/0&_'^ M5;B[M!LS#BT;X5>9*6]%5F.G9!< MW3_>5G1A0HS"F$J=)U,^85ZZ$^N(#BR\4)&? M3)*H.D($FLR#%&MY8G7^Y J#*M 55$2JESH*/>33'^D4$)S-X=M]$X)Y.)4I M^1'_"''Y;T4^H?'\2(33ZW(JMZ45-N;[I+&N*'"J.]-OOP/'E-C@QO2F-@UE M"\V7/!EN53KZW84(.9:(^IY@))LJ_T8_ WP)9TXZ(:8QA0IOJ!*QX*;1.IMP M/PL%$_!Q& 0PZB%2)8[W.Q;ZT.F'94:CTUI=P7:5)=MI_?:!&26$MB"!A."%NZT)G0 M$?/QDF-W++%%R0PXB1<06)AJVBCVDE+/QFGT%NS;A&NB$6EBHPP;)B M#1!C*M6<.B6Z50"-G59E\3U4\PF0*IF&'+R%06[NH'Q"+-V8Z* Y"]X@760 ML^KW5-80R\,;7V2&OL 1UX0*0>V"$3$GT+[/J:%>4%B:S7JCR:M(!TQ6U/2C MJMAJY6(QW;&474=A4P5%>ZJLND#.I&IOPKE\JGF[W2_304K1HANEX33&FB:! MU-%264'35&6R,'XW7Z+[[2=DJKK.P5NP.ZK\R[4@1EE32] 4A'R@6,Q':WJD M>,]5R7,X-:K(L @!<1)7:00#%>3_Q1*<;!K#5E[ =@7%4;":M_Q^A$$2 '4% M\ Q%"&Z&ALG?I8+N5$1EZ;W:UXUJ*7JJ3;\T$J8R%75B<\(\$B\Q"QQ[+E$\ M;L6\4T"WEXTFN7=V06\ MW;A0#LJB*FQTB 6/R!)#H>O$*.!K>#Y6R028KQ\5F//-[$\!JYNUAJQB1%(% M7!4489OUYT>HRO9JWK%1AHUL>Q!F?L$&%BK\#P+B/*.(.N]U&&/%0'2^HS7/ MA(*](U6>'K&B9(U>U7CN>5@W6>#5T>/"!\M+EE>8 MO3E&?DFUX[&B%&9@)Z7U-?9KWCMXC_=:4(H\+;'Y_!V]^IU]-8J,+YU4")RT M#JN#L?CY\AAOE.)#W^F5;KW4?V::D!QH' MM[,367HGS^6RA["65!S-]-15# M6ZH@[<9L84R@:4Z:<:Q4Z;/)?!S*N/11*7[0K1&-CTL1Y9-RM&@I;>[LM-S% MU*G573'Z,NG0F#(43U5J>9S;O (06M.@BO+2O,QX=+L NR'^)$DRN12=QLT: ME4 [8@IV.MO8VM69LKW0^S'Y2=&^>RV [%^!FB6YO=Z&1'^?@&I5+[.+2QG; M[<:O2W1D8^_6GL,KF6+5%1VPSTX5WSF"BHE/7=>WT2TY3AV(,$-@!1'.%^H. ME#+4U870XV 26UI8YXM-,Z#P?KY/*.^@)&ED-"HJLR((F@2?Y2NQ_:(U=@C5 M=Z3B_4/&L(EG/CP28_ULO^8]463N?J7H^FD%M2 4'U4!H#*]-!H+NC0^PG36 M6%3'U5<-VLAU/ZS75&](ZB]<*5-3GIMM3-Q@>P''DLN@7'J@HFKP MF3?>U%!UCVK^!&WO:#K^PM9PN"Y*A+!;R(5]4NHA18I&N7+$U-%Z6-?04>W0H2$"Y%&F3:(;:&YZA(?\MJ+#^Y&>M@AK'$2DOKO5AJY9HI&ULTUS;0 MS-V!%56=;E0_^BA60^G7_"F)W9T.*:'(L^34>Q9T(F;+'VAFOM):]OK^_;C2!!MD6 MT(WM1I/&?/I?G9.955F-!O482B+W8B,VQ@*!?M0C*Q\GST'^A*COF+3PZD4% M_X44C 3-0^\XA;( WS]+'']\4U?+7/BT19"C=P> ,)=8-NPMWNW?__715Y\] MV7]!^=R2^RK7/IE2>X<>AD_DZ/[D)9R?R=S@-+S[YJYBI;+?>OWTU#-7%8MY6]BQS9\T&)6J6@E=K8V+M:60M2=7OT> M-J7/'9ZJB-N!\5"3&6.&6@HC*,J&4;+,SU1'$M^^RW9 KB7F9D_/=2G$9:[LBX<6R>ETXHB^P#AY)"5DX\7D(^NI9X2B M8+/?,V)6^U8_1H4R;CNEE!)A)IUQTF]:]))7B\.C?2T^7#97F1L?O?@[?QJC MV+P"%!=%J)=TSK:[^[#1(5 <^^:$01[,F*"/@+TB9:X M]HC,1\O51//.AKYF9S&EO)A[+_=:^5NQJ5;>";2_ M:SO;I*DR12*9R];(#;)]&<\U"\;"7[<2C6&H2+%3?//99[/@)C,&UKF!R6"= M"<@/W#'\+]^^:B[8%][,0-NA=.ABQ'#=&X96)O> +9I,8D]>YT-:E:G]_K MHM>G.R%^H,;\F2QBE)/"1II/<,M^FFE]RG3/'J6H6!9)6XS3R8\>%^%-@2_K M:8'#[X.Q6X^^]3E9PJZKSEU'S;Z@C9KQ=;_A9?-?6"5>G2/^D@QB0,8@7M&T MR7F8;,OW=*3O2@GBH8D=#J62M8&IZWF=>K][:UMH-4J[FO8SL9"7O'7M^/EUCC$)@(KYF M'U=3;CFE1>87B_9I&..PW612XFBB9*0)I7Y3"QF0@(ZR20UG"=<40*&RRAD0 MZ:$3$YO$83Q-!-Z:1+0\Y36;>913/.RN=K'3>"#1S6]V2<.LW@5UQ4ST+X""AK]=E'/9\-FP>8A$%?+"(D4C"1K, M)&>_;3E[?D#(Y3N=;3>?S3SF=FA&] 6YUG,6W MFL6?/N4LBH=XG,)[;%>E6H'#\[E4(&XL#!]G]*UF].^?=%-:_'"S,/8^D^*= M]VE'0>ZW%N2^%+?O/GBZ+ZR\-PYQ-*Y6ONS96)Q-\Q8IY0 <5_!M+1R2. Y1 M)O'R#2K3TE:E+4>FS00YX1@SGB;NCH/I!.-)3>A9;6L-86PY[D3&=X!"*TT M($2U SMBNQH%NWE7449 (KA=IA)BWYV7_:5_$?P=CWM5"2G]NF;(C%0(X6KK M*D\T:',9<:.CGIC4_L+4AZ1?,-2"TBA!<&]X,CQUF$[@6#?ESC7PID:OE/^A M]J+0ZU1-#0ABBB6[EIU:Y8[BKQC?50BG3T+LN&^$J!H0EPS0)0+N MJ@M--TI&(E6+[1H NI)310!I_="EZG=7K26#&6>ZL'43HOI\[3B,1[I01(/( MHVE># 4I)AH7\4Y6V0X???/-'X 00)$M#*.]U#BMBV]!CO>/U1:(87SEP+>C MILOS]*% YE+.RWB/37U&06,/%%X2(2>B8G)%$7!0$(>7E+??E/5"RF9A<^@_ MJ0=)T&^(4RL1&=[6715I?K7&N:RL-*"_*J31/41XD>\L7_24 MH#YN0K6QM$4@!$ZISS;:%3+N:_^ ##F91\(Z.CFOE#DV S:J3 M;5U-RN\> M*=7?LMCVQ3TIMMT5=^)9EBU];MG2>^1$.-W/ ZE?VYD"UQYC [,M?-E>SX:- M9-EF('X3L0\P=@WA?T54L5K)(8P.;^QG:_7>5PG=5N4:A:S"P/@HM6^7 PH$ MYR1&B@3A< E:(4V:AS/T7"R3'2USS2J+%Q13U'* Q]>.U8J"='A-E#6*#\^Q ML3+*0JXO#M*AL3L/+DS)T9)OH*>V6=3(WL]ZZJ0(^TV6QQ"NF#EP"PGZ-5#('%O/LP3.><<\?SLZDGE@8I%'- ML58;C';&I?U38[XV5Y1.]K?3%D<#;Q]J-898A0^!(+B.?==(7$%ST2JI^'=55V4G0AQ8[)>M^G$M&*]J.+U?YZ1+B'RY+N5SYTJW^^ (_SIPP>U1[TL70 MY8KBX<0-+C;<'GJM(WB+JH'Z+<9YB_P-(VZ:2U0+]3E1XM,U<4+2!UU3]BBV M!EQHDKAB1H2P6UDY'(LFR,@$3W-:#\D[1$T8K0-7% M?6*+H-'?99KKWZZ":R@@@(N)CI+9@Q^^/?NE?\@__%##M$/:#F0#8:R?.]1R M^.:KY^&+(.(:.J&0%S&;?%C=QM -<'I/*TI_MP4XZB&8O?"V_XZ\VQNI4NJU M8B;:ZSV_F]@\&CXQ,-"X$J4Z,=WCX,B\WWB%J$4"Q(#U!$!TC9?D:4VR5;M@ M9LG# 1("^^H$C5LG:I7CH5?O*7(KKZ>#.$+VR\3"YA9(0M\#(3%1>N:> M,M@*VGO,+399I!AQIN4-)">;O)8[X7;;M$PME#Y"P'5S_I,1NE<>T\9Q#UE! M_&]VIYS$%JHW*4FO9EQ8-\]^TK 8N'_]VRT< K(7_77"'H2=I1 MKX3J[I1N.1B:[^0KLCP\DSJJ:<&QVHD:VM\" .Y]?@J1%([6PRE9^BTWJ MKSOL1>_;RX9FT:&[!)Y=0^Y+W#I,],-B]EM[3F%K=Z!9N=0E*6R(?/>4&.7$ MZ6I=6%'U-S? 'JS@""J9,R"<(4MU\;"O?S_AN62HH\2_D)F8E[$:3T7#W/7- MQM:VWD%(2E(+5U5.X%7T[4L5Y29&L[#D#F:--I?"(Q^\^@/BNM# MYPC,(WVEJ-;.ZVG3S]=_8G,Q(H^6R71R],!!@3&M*LI^*FX*("&83:ZK/SW^ M@S)$::-7;0G#3C*_QO/I)#I/";CI$K6(>QY&;U7L(>&;L_%7 -CE<#&HAF?X M,G.^Z*%BKK&J%N?PB8R0".E;?JT72#L03D*,P.%#W"6MNYE%$S\8C.2PID5T M9*4-8-I0YY:-YV@P:!::Z3'E;^/G5:9<$79ZMMASL\F'&+VPI<^#%;Y$PMIZ M3"_8E4?0/!-\VA=#%?M66N,XPISA>) :T*0GC@E,!SX8H)CE5O-M797P1?%Y M??2C[G7,+I]]]P(0ST$[7+/L&F!:X2RNQGC#FK0X"LUS[4?[@7CZ36Q?1B#= MOY[(5(/^6LAJ[HA=>'L#1T[\,X,VWI''?V,29[2#2E8&-&0Q'FJE^#3OB.M5 M>1;AO*/B$M7JL)Y'DYB&1O,+ _LNE*Z!! 35I)QGJA M.+T-:0'DGEV>W5VB&5I)@LUS>K4&2T$XM7]C1J:$2#T2J3@OG M,?%2',;QA6.&0"&.D^\4@WFM1$'EB=(HP N.S0![O6KO\V+7=0\FR)T4KR^7LAS0!K+K,N?9W$$MEV] MZ5V"Q1)\3;6E%D7;I$C(/[ZZDP79KC!0-1JD+H+5_4=IE7S*SXTY)UU?25-OVJ8RT_ MUX!-^Z"1EA"3#YZ1$RE'QDNGO)9_>?B6%[0_)SH.2_[?DX\U*FX2\W-+7]$H MC[[[X94Q'64]QJ#L=ZQ5X7F&)45+F#9>.-ZXXG#S,B\B&6>-^%4-D_2EPO/FQPH*XG/F8EP0(M--RH,+L\H#4J]X>/%\NXV< M5T3F8^"B+TEGU#,\:(DC' E-+]7PL&KB\-*M5-(+FG[0^:///*6$+LK-/QL] M?\H%11\SI:[5"??U_E MO_B)LS][$)EI&]5&OZ(:!&+&<]A[,P[7U3D7U_7U]6DE/L&\/0TK4/B5TH-J M\DR_/Y:LF7P*RI^$5T:O]3D 3=6:CQ^7G?+Q,ALZU^PH ]OO 8)Y]-G)W]X; M$W!7FCE_-+*Y.]_B_X+L6<[ >>)1,?2H9L$V.*D<<(0[Z9FT*M;!\UN%0U=/ M"BJ@-,(90*A4!TFG[./Y9;5&FIJMBV6_-:%@5;^IH#=5#6N]H!,M9UK48"]M MK4R2R/H@CUDRBZ+14J\5JV7'5Y<:T!:+EOGR7TD -+]DWZ1_,Y5.4 O>#*;, M !@EF@UIYV6K3WG<_QDYZV#O5S7HK?MX=4#6E.< SZ9@-1L8@55U%6EN7-=I M)#8WLMO.=!H2$U%%\NH==E^Y]P0T\)"SPD9,KV1_UQM#$[U#0BI*3E1R'J8G ME)P21O$?N$^ZE)/5;NOB@^VH>=/D.>;4GDMX(49> M^<[TG ^F;_Z:PRQ"#U>59X$,]\U&CD0.5OO4N^KD9FI)6BPM%^ D],L%&;EN MR]P_QU"2B_&OE:[(G)TXMOJ:3_:&EE_"K;*7<&M&E\LBEF<] \:'8E^X\\;8 M,;;>>7,+_(M*8QOEAA7/8I7.:2*@Y1"V-GQ9 8T0D8Y>KEZ4!E20)?[ #Q*I$V&C6Q.J4-H2TI=>5R:QXJQ^G%@S1_',,I*=!]=6O#P[,(._4+DLVSSM M,1IU=QQ("KV[2LHJ4IJ1I+O-'SK\QL.LZ%=0UK37)W/FSS-7A>YN*G'JXT@U MO.G;5;V((.O]L0P+ZF]5OGN,'OH*V2MM@,[WH6>4V5O-T.#;9@)=487$KNPH M264V%,)&9 +ZR8TOB"LVDA1GD'EZ/<5,J46+$?Z_6M6$\X7+LG/?DQ3&I&X> MQ>)P;9IJI;G2(KZ5ZQ\H'-.>#K9U\X77AJL@"5H=G-$UVN7VFL46U813]#+5 M2T',XV5+WY;\PBVYVSO+$--TNWMSN+TBD#+LT/\LK8W?#N@[?]A]:^!V MAVCC$H4^8#72)6'B2BRF\3DK:SO*P2'B7$;X.]!@B[#1!?X&FVI=%G77;P]_ MU_$ZRC>5W,%MQ/ 44:^UI5Z;/(U>#E?!037Q8I$3]'S8D1N"1!+-6'[EP&L" M)[F]3 ^D+P7(ICC/]A?W(-H,-#9_Y[M$DD#>0W&FB8*)[.K2)7&6^-7-, F7 M26Z]*; ARU [-_1_B9B[[:5EJZ"KP)71]2!#DRZCOS/#'Y@:AK2 M$TMSASKD4NIVWP1^$FN?/[WMP'D,8V/?O5 MH@"$:W$1N(["X00^--)[\K'BB!NX<*Y"E7DX6)O6K9..P!%+=I'.+.]0:AEM MV:+9C+4R$8U(BA(Q*/4)Y:QM1PYD$+GOT12>JJB%K%\!%[0-.[_2!:*\F'-+ MUF@:(DY&6O#2&9K+P4^&DV^ZN"2LSW\3-^5VSMJ_ERI*^U.Z^1O/W&-I[R^/ MOKHGI;V#9O+)@4;DCUD%/)"T52+J9Q4=5[[]: MGG3I[)FW"S8!U!V]# -O $/FHF6)D&#:+ ,)@Q+M^?=M&T*69]V@E:JSME]7 M>*:GX;$?X&MJ:[Y_=O;42G=JD_&1)<#Z)*\0M9.K1J1>:M]"*LX%TH72-6+0 M.R.&KX7+E&"7P>(_C3W4U.Z9T'*!*AB(UZ32D;V=(.G#"\Z>ZM=4JCM_._=R M\FY/[1::Z!3D3)&?>!:[P_&JHD($_Q/!7;<@I,T@Y\PE.]Y^$Q'*UVZ^RND4VC!P: 7# MQ[,T6+QF;@@8TU";:(0-@[W=Y'9QWD5!FK3S^9#3;7"2';@%9DP3;[RUMI*-?WDNLANUM,;, M7JF@UI>//GOP^B'6I)((A/V?LNYS(."EB:9C*X1]BZR?5^'R5JY_^6/<%F'7 MPD1E;T.N 75IG*:F[* 0P54IZ\>7'[:7(0SX1P1SIA@LC/OKY!Z9<4U5 G4U M:W90V?Z,-GC? /.Q-&$J0"I^&;U'9_B/V?-B]OPYWO_Y\^ MZ>ILCF/NU@(D4RNQUJG29L52G]*72.BR,]H8OY75:)L*Z1_DOCR/@+UKA(EI M=24SF"P(W(<=]&)\=NIRS8]0G19,B?[G;CF/6'\GQF])1F%'!V@7CF=Q9 MAAM%S:'K!^4M3YOE)*W5N$=ZM^!H#JN&/3F]9[#PAQ%R^%VLUR>$T/][TH%J M 5V5^*,]EG$Y:.\36"W=)@KC1BPEWNGF(D[IEF?+_Z+RQ)8]*H1R*OY I@[V;-O_R0"1>*J MX-W,^CS%1PMNV[9S[\C8K-/^Z?C*^"Y5F.SW=@>7T2G4F-GTZ:0)33**RASK MQ9X4CZT- Q )QSZ/YO N%Y().DSB@3H82/#5+]N%'+/1Y: <3O; MPHHCP 9Q-?9>./PFG/;)!6#910AYU G!*H4(&[I9U"C:F:C@+)Z,L76E8]11 MYN,3_,,0$4P-T WGWGBX!*55Z_8%)5BJTSO':Q"%O:NR7G%7X 4NAGJ!]WTR M0R_/%10:S4+((+'[4H0*LI?#^6S$N"[^P)D>3,EVB EI>=W*%:VV7#"Q#<9/ MQMXSLW4[ZNHZ#OUVOWCR?T%(^%[*@=[0'=RV7^;3912MQ MG0U?GF.LQB%X./*NRM[PE4Y R"= TXGA?0I,<8IXHA1NJ@_*5*_43:>C9@5J MR[&FR--;>#MEV4D5W@.)>]P+3U WHCYHO<$*VDDKKYP;=I_GR2@Z\ NKL&I_ MNX<^TYO6>WE'=W_1D>K:$'0VE4A'N:$Z-1:1B(8A"DG(OV1CGFEK]U\1D?^8 MW?]E)%.RL&/^UQ]?QK@C'ZQRI"R.:_^7*CY* W'OTDCQBO_UZJ>DL"H#KM?- M(O$<9^ 5>$=? B$!,])DD@\V.KR:F><8\*NO7T3)DT2)$2M(0O5A51,YTQ=4 MQ5+J"4S;YI*N5XR#K52G\@E MPCSV,5OP$9%-#9D?G_U4Y,Y4-O&.KXTV7\RL$&RUS@B@BJ:([YC2R-*!L.>B M>E$.JI7'F5?%9_512_ACA&6P)[QN?ALZ:1)-0Z&W?^,]Z;NLRY7I%@*QL93W M<9_.KGG6KNK7%=O'F4[PSW;CH^&*]59$/YB^# '*W5]9?]?6I0;K\\3QN[.YSSD;'R"]G;V M3E(\)MS^EX;IT[W$OEL9PK.761B.AMKA2.\@ CUT$>)Q+FR7%M+'_%*I(@UP M0O0R\8G\ IK]X+W3[W[ACB\7[69K/:"_S X63[+,-K[X+!Y^%M*OH;W:SZ0D M09_"F4F+LG(7E$5((QPWRC@3"$BPN,@_AEU&"4.0Q%355MUX]^(V(QPRZ3X/1Q,AAU9VD+\E M1\<'-_UA8?-C'?4OC[Z^)W743S,\BDRP'>'H G1S%'G"T9H@W"EE![]B,^,: M%9*ND22K>4&FDP-[QRX"D3@7 B8G2".IB#N3<7['0O,+OL,/[$MD/SK0$/<[ M#'84R3-?@_E>"\EG;8>>#Q=>/05(E-_[V^Q;(&>"E_?44+5U>,02S6[;.NP_ M^:/4HA4=30_5G8YV_'FI>(.Y\)@TAP$A9E<.L@[+G;Q MB+=:?2IV*FPW!'&E[M#S<#!$P@FV1^GI/>E0V?"C-J_-PR[G+N#$&&@"BEB\ MX04$R!N!S\3^\E4^CN; K:[T?__7;[[^[/%'4A^8>H0]]8$ON.U_=C' 4^R; MO]7SUZ3Y>86,H#!+T$_N39-1VMO@KZ-';!=-\W)8L?=I!095"6 5MUUHDEIE MSA-327!:AD9A; 9,):?Y@[3(\=EK?2A@QL.29FAL)T9'DMB'P!3 *UWM)'5L M_RHD"82B_8R]Z4)B?JE(M$Z$V*.Z[J;<,<\JZ);20PPOD^6-4GF6\A8_5M+6 M\M_UHI ' ??WT#71([6>06?^@9%DTVED0CI,^!:$&Y4H9IL0N&QXT>'%/*^J16J9Z75=M-VH MM" 6M6Y7[#/:"@/,0O+!JJAI_+RE?@]QPON=8,>=_CX[79P'T)-JKNXE6@\= M6>_3G+\7)VN8]D???/-53$/^\/SETX2H2-;AD$%X\.BA$1]K4@MX8Z!0!($K M?R-+?H^NWDJ*L7;<[K)UK SW:0,ZU<1.)"["#F;K5+C1@\:>8_ 5.VV09>AB>0K68>)%$9J.]WS8Q*_B49LE<28-. ;VG]SR MSO+)M)@-J$&QMQ8=5+% 7!V?V#;LQX]':_%>?@'6.C H]9J.=TRYK.K(#R]G M]M[Z0AYW) 8*.<:PG).94(9RV:K",*8(AZAXC+7+'3?:97,\$_>,[9]S\ V8 M%SEQ\OD;AYT-#UA(JD:W7B,-*K@U=W>%(K:=V]_18# #?? I^7:C>\?OIZOA M(E&P4+ENCU?*3$+RX#ECH19NRQLLO=/3H#6N$.8/-N6:_&\ M8J/G=FJ.*8A#T(B84T=?BQ&2>H[6\U!KK'P[S?X#X'K5A00K$5.SA$_32 F MB![=^#(H,KGZ7OM7+ Q-VU]JPRM-M+&'8:I@7\<"/+B8>RPJ"H7@@E(DQ#O* M;5TB,&;SHK,E6!<)!LGP$"U5)B%^LS\-D O)P=TZ.+BZATYVG/6=A:E8[5B%*9CWF[^5U M(8N%:%.F@@IU#.8U\9:VI=3^PLR(JW#)LAG^#="$EL\8""U7 _ES\#-WK017 M(>&*+NDRHQ")7"#+Z4>SV&G?8SDNT ^\0%]LJF;V4K7':,+3HG3[$?3:2P.)4FS0^L?I]7&TWM2C$61ZKII;E:GFT, M/JSRU&$[G'=MN4CT#7DX#JJ9\ N7-R#7?+]5B88MVN0I@]'V[&*-31E6+R=< MBB#2Q)707C=*ZIWHT>1QR55>@2'HLEK%0NCFC4S:J@4P MV\4.B?HMJQ^E9!\QJ,'"S1TUF&"(" J7F?/#@BM1+[QZDP M*#T_%<7W3!R)>D=:.4 MA+/\N(_OIUK 4NM2WE TE727_%J5K(T^4=C5[8JI26=1]A-M756OSR&4P,U. M,*2#5C'I,)6-H%(@A_1[86JB(Z#-YFY4,]ZN&S!P_50?F3 "EYVT-H7HC CZ MH4:NP>AR).,9=BXQN?G7#+:U'E87UB1U0U#!D"8A-ZPK,-ER1?'L8D"%*'_* M7#O&MLCS%=.R6AU\)Q0 E0[ES.$^0)-6B%9E27#6?6P/G/F@R[J MY39',CJWC:>$+!T[NO1E%_MC,.)Y9N1&4)"["8I)ZC+*A3G5 MKRM=N:TPTPHC6Y))8Z7*)6(]$1>6EDC$9][2B&RP@NPZ3' MMO7P[$@+RO)C'@E[9>AUM(!;NW(G\-F1"-X"N M)WI,D?$5'((Y1T4TS7NP:.SP==4GQE-U)#\AD<(]:LIW*(F?T&YU2/#[$R'X MHIAQA+UH-?ZW8(7[16T0&'$5Z###&Y?E L*YWS?:;4*IKQ$LYIPY_^2+(P'7 MKQ(KLV_E%$2,A1[N@!+$#J$8X78E$OU[SX-[5!V .,RE!QI3$8 M9J#D4JY\F5<#&I.!JQVHI8Z@6,&/;,K?*CLJT[W-[#^")S%[]'5AZAI@'V#D MS9\ST$PIGQ6$L\-Y"Y]ZCL;CJ(<)#Q%';'H!UAX;^+4EA!PJ>&P,1;FM 2;"0RHOB??#9XJ2*\C"RT;.X>5"JWQ M>VW23"Q->S8^?$JJ^LX1,ZQ^\3,L#*,ND"!=7;Q&3K< UE]S?4?,-OQV8=Y) M3EL%!TMD[$A)JSC8/@T)[KXJU3F/OE<68]_SWJ4?@ZUJKU(D$_M5Y5L5H/PI M6( C;^ATD5*2=K%&_$+Q&W//'2%]-!6ZL[:A M@),1L--]3ER,R*LOU/&6%$XUQRZ,1UTBW45N8J>%U/,]\+<.T%V*(*A4.ME6">='TG2RL3 0: MS],.%EQ8UJ;N4T%S(+E2IF>U4Z0]?A"KP'D?6I\)]1AIP-[H9#&SG GVWOD+ MS:4]NV;)$(X9O"A1$$NL-&V*5&+OHDCYY+$>:4%37FR6JQ7,D90K>_8P61]% MPK*A914'9[!SJ,2F2C[!5750DV"#7+A09&]/VN7)IIV3XX N4OR^J(W[W-#< MCTV^I"$&9ZV]EK6B.R=$\85Q,!9V2K*-?BLMRC!^GA!'?GE>Q83^^42.RN7K M-+%3N'R#N:$WHMZ$EC@X?J3X3>Z!FB]*;+E?90I-*>!QQ")^1,8L/],O 6;U MX$GT$V05.D),0;MQ#S9\D(_S^QG@0),T0K"QJ*3/!1JM)^>[$^JLLV$T=LWN M/Y/2+SL+V57*,9/=D7. M7&BK6Q$FNQUL4[F17N"7V6\2"D%/A/2R^]-% (C.EK('RM0(*&-OI(2CL)7Y M$1EC_E;:ZCEHE55O9D-O,VB'PJ):ZU*UMBW\^G^%%7V&\M-+EY9[96FY&Z#^ M']%>BJH-'&+5N<^\E:F^*B6^36IZ:ELI*"V$VTMSIPLM8TL0^4*+99 MF*LM4L#RLSYP*QI$C+^K/=*+>6 )[)@,?:C5/+^W> /-B!8I'F)AB,N*'QP0EYT-L5$X0@;I M<1V5!GK#ZTI*R?>MT0AU)G ;,\GN;<.:\1Q#-U\.7"VAXVRJ: M@N@TY66H4G8T9D"%P^S179&4A[#(M;%V\L.KPLIO'HGA27D 9 J;MJM!#B.V ML734DE?<>^8+1YB3FJ&LB<\+R"5EN 17[-&%[TDU6 X1=CMF5E!:89H/E'51 MQ6#>=M9D+!N7WI@8MO""?*%JNUU5@C T72.="9(YIE+1Z>&N5E>H^6T(UF.Y MNZ%:\3W6YGY.X E;>=V$CMFLE8SVSSF7]7<+O__S=V0\1,8+4)SC* M+ M2DB=2.BHQR#*0YU]( E(['V9-=0$7P,BY+=-.9SVLL[7RD28QE/%9=64. M2-3;I+\;"^5"%I=C7K2N;I&@V_WI*$W;&7,2K5C:/*?[R-E7" >(,,"7PO:K M^VQ/*Q,?_K=N%UB!,$:]8X3<6R /$B)J8DT58CZ1[*["=4EEM:3HD.LS>+B' MA' TZ5.+RD&59$V]KE;U)>A\% 0L/TJ6G0.I%IQ(XPF/XEA_OJG^_,T]JS_? M^?. 0=A$X[2%.;;N'4)KC62G.E#,Y](()=S1#;[<'CHDA2 Q.,D=EH;R=773 MQE_(C:O?-^P,I5B84(X=,- FUS%O-[$%*3QLS+TX1 MB 06=($7+7TCI7>R2 MNF5BTY%>B( S>V=_71H67F;U:01Y%$GYI^:Z>B44/L>P)/ MJ'QX&BFJY3UZ0^)T9>-/H6!-,;L2(JN5G<>UH[NY9K8BO\%)GP3*MS^LRAW7>&#/+HI-F M(H8Q$,X2R"Y<0)[!HWX77L-8%N$T:RNRQ<5<$3$4C&4,3)2ZWOZ)U!7I@J_4 M9^JT5G&MN\FA9JV)K8$[5P0OYSK@Q 6"\$@]BOB<$^[G';0IKU#@D)$\.'/$ M;%)5C+.G@&<-()Q4ZV1,-=NG%;X8] -A\YU8W!%=VM)YB1<6>(-65,I&H*9S M4-4B0]!1G) I7_WBZ>R_?;PF[_D.\7(T-VH>LDT5NX^2;]7FWQ!(1&R<&[E8 M&45CKY7Z0T_G5[*DH)Q0PG($UYB=0:NT[9JP0\\,7&PI1L(>]D$4[B?VS9_$ M.D7V#8TESLY>.F"$4YIC@.QVY\3WS5_C-&.&T.C=YPBC,'P_%5S2)JMCXG<"J#)Q)49<=TVX?1^F)T&0N-^ MR,01],1]SLILY)<'6( %*E3AO9\EKI^4(_*#7F[$-&'7G@\9/J!7%A&[3"&- M+S&)P+%4>R?(S8)DR8*_QZ,=\HC"I4:IC1!HP_W6J1?1.BR901M!L^,Q&^J- M'".* 5/O.A+C;_IJ6+3-#D[/8O:@/JU.4><39Q]LS ]U",: "E[!=66IGEID MFI-CR6?\Z$==5Y(P+AE9N")@G.A#' FN0#1>"4+^R*7)3N5^O*S[A*E#]FL5]7/G,YV4_ ANL$D:>D<-WW0W7#*6L2W)Q&QR;I7@%IYV )B]EY'9PL M#.XL\3W(:QVNX4SR^W$$A(7;DA.2L$5N>:.PX,^_^N+)X\^*8"GQ_VQKYY^^ M^(-=9ML"^Y!:M,JF8:?WT#6LSD:9Y&I>\3Q.:225OD3U"X@KI&A$;O%T)DQE MHWQR?[R[V.*Z&W;OG8B\O\9II4C]DAN+?L)/TR$ MF@86D!+14M MMIHGXR+I>]'34GYNA1,-WM&MCQ.)+&(Q!I^\5FI3"WY\!Y9X M9&S-ZLA(H1G,$2KQ!)+;'>2 JE]:#ZBR;N5>T[>J&8').Q=-B M+Y0)+_&2HU95W"YUE(I5B8HBUL9DZ-#T8@\LPI2510 ;6C[*,JI--%*1Q>%S=7O4?_)G4S9>9N=QK=8QWKC[^YDP\VX\N)A&WE\ M*)'QFWIELF:9DY-)<6\3QC[8'_,>Z.T[#4/ZKKFJN];0VU.M0G<>U/DB!S$8 MYAL"A?OLZ9.>H-_7538@R1G)N3BQBU.')=JU*^7"!DH(;$%?U&1&9/:C& ;&6@UDSR,F.Y\;KTO<4'8\ZAW;918 MW7GYD*D-RZ1K=HO#;;LYT*0X!(7,Y\JE.K+;2 N(/MS^OO_/\)ZS1U]:ISFK MDQ7KO."K7'"8DFL;:9EZRVFI &CP<9_*B?^3U@5RO)(;#&%]\*MH(4]:KLO@ MXJT/#. ;+5[^VAB.O57BQGQ\-::NP#9$F7(VA*LL!\L,S,MIN OPWC]"9(VT ME2: YE-#>]1Q_GAF[?%G]ZR:>I]./2K/_O&Y:-&>Q6UWY\^Z"=TBGT&PU#/- MO\CK_E$%=ZTGA\4;RRR&1]'4SZBX8,0#;Y8LSAEL?N[82K,K9B^62W;X+"/! M]]/@L@]:JRE"4=I!T_=136=J@O"B!>=>RK3AT,AF&3@F%4L1!N M"WT,YJ;E\(N)A^A)9C&$ZV#001Q)66GHZOG@SH)?W6KWUK=">YD.WG .2*@E M-X[%'_\" O!W7)L6/SFUY-&49O7_!%%6F;H1QM/8R PAFR>\@R.3M26_[6L]3!=FN\^"Q5=">O+Z^/H7C&V9GWI[.48&*F1#_R."< MNN@ TS[1IU_R_YY\U'=!G2&.MV)5G[,W 36/L"LVY47L7[&W?)#2X! 2-]/W MO39Q_7NYWCS1-=BG'.]25;XEJA0IJ)B3%-ZC\ #? YKYZ+.3OU&MJ OCR^ZT MO;__5V%J1'M__1-^G.CP1G_N9Y\7LR^X1;\4!%BS$U2!2^VU?2)C(J!#Y%;A M'80#]WP5:_K"FD*E6W!=1%2)$'"#TXD13(BS>^V M,O&DLFK[\Y.)U?(QTQ MQ)4LR]C"3"]]LH140[4QE>U0 %NBS8O;8+;VI1?>2&F:F$?;!6 M<:[?G?3N#1FL8_SUE\>/#L=?>(%Z\?_\2_WYHZ_*+Y?S1U_.S\LOOOCBJ_.O M%E]^=EY57WY=?O--N9S_?X^_^M._W*^H[1.=6L]__NY'\?N>O_K;[/NG9S^_ M^.G57?"(#H:6T\OF_[2#4?("J"^Z"!962%A%+Q8F8F@TJ2==%+F(#YA3+T2: M.IJZG*=-LU75JJ\$H#KMQ?A#P3EA)O)*46):VMRBLF#VEL]*JR56WU1*)8Z) M> -V92F+>L&2GADZ,F)!+/W0O:#W"^4&.'PO/'5DW>]A=JSGZ]"U!/HO@9'0 MV6GI"R@H!I-6(5)%/P R:@VM8BCC/[RHVD2(1 PJX+S: %);XZ@/I1%/"5Z1 M_>(#I&MUHCO2PP-*"WPYJ4)O'?G*:$X!K" MQR','#IRU_3(/LO/=/;K'FI;U@LB)%,.M>/>$0RAK@GLP,AB*I.\H2A\A@D9 ME"Y'%H53F*Q6=74EQUV]COSZD2PT1)+(JN==ORD]@<\%#2%4:RZUO*K_9Z@7 M!F=/WGY\H8G#\BUM^=>/_N4=+.B=H_B9-KP^SIZ]&M: K-V1: $62&2K2=F) M9O1>'C"!51 ?;D9-PX+^7Z#L"BYTEPA):VE4,7+=Q[*L_OR_3ZLH!!)?W25* M\R\Q%F?1SABJ0/D&Q-KN@MDERH0! 4^HCA]$B*9CK5?2#%@:5MVC'WY%-+AG M&DOS;3]BRNRF-3-:)RE[<#\UZN[D:GB>$378@5LDSL%"DT>N5"8\2SI'2S5D M8@,:-@M?C2;T.(_/?S9R>/OIF!"[*"SX1V&F@;I_8LS^0G\)ZD MLZ,;T8'9]G;BY/%_G,9;F\97OLTB*9[V*NWN7#^0AZZC4LZ6ZO+6 ? VA_%Q MTFYMTA ?773M-<, #'P_2,/D4KD8Y:QC"DDJ13PK5ZL1IL2C,A85A-&KXRS= MZBSM.9QC],LX(I2&W5XJ@)YT12@9UJ _Q78\SM/M>2-+!JUE@^"V7 SR7V2 MJ+#8?E)NRCGG(1=]=:P)PB0X_J$7Z4#W\1+9;Y\[V,M!R.G)$C-B>+*C%;9U MEW74\H0O*SO_!A3I<3F\UW)0B[IJA>2,#F4)>NFMYH^(> ^S6#=]KE6B/-N] M: 6G3-XV,;O8-Y1?9%YNR_#[=G-9I=2-)9E&A7VQ]^<,?0 "4:67:G$T"+?J MVCH>/-+@J2A&=GXR58$.F17Z7['/K3D384OUNR'GCU-S:U/S-.\+CNG-L-,( M=]1V/+8%1(8+V41OV(O6T.<)=")[7M:;^U:)IT2%=TPH?/AE\>S&IH%Q1T>P MF,UB=0-'@1>=BW_?IS9Y2&>N,K&IR* M_3PV"J/J4ZA=B<\2GF[^6A[AN(UO=QNGU0!CFZ@M"C^CQ>RW%MRMB,^BN("Q MS'!"T6CM5$$FRA1N>H^>X0>/Y3 ZZR81/[&GO#=0A)_U2%C; XP74Z=2MS!2 ML @CH7.'I)' ?XQ_;E!Q5B2 M>%:3QEW,I0Y4ZKF:X#.SX!OV^1S"[%=M1T@ZB&_" M$B/]=-L%J04I]S,MQCF^(G%5#$]'+T@H7/B=',.NMFZ M[E/*0GO!ZYN7@=%29YB3C!(WM8%R,3!T1@E5W+Y5/0?C:;B7_57YN3=DVV+; M)@P^D"J'&+^.:^;VO/(*OJZA_'UD!-I85J_-QGA!CC$Z-RN)>FXV5T3IV^7V M.JS!AZ)LX^1=$ E4*-%]^*K:L=OM+X\?WS.VD>.F?J^P*OAK@\!T3PJX5Y2W@MI),EZ@Z43)^=V@S6PJ/$\[ 0YY)Q1T53J550IXXKPO;UUT,G0&]&^)&&E6YT!"*G!+MJF4GG%2;9]_1+U23*I MY]0[!/G2Y1+0,GI,BV$N[6/'T^Y632B!.]B 35^EZL?15[S-_$A:U(DHMZ)PTMX%%K;J\")S92Y&W0+O+EH\\>O'XXFX<9[:5+=FW ,<)_Q6PX,WRVEDRJO&/"BZ54Y7HI@2 ME7#PX^.LW>:LO=LY>!S\6XV\V!ICIY7/*PDNIDU\1._M'U2NST*[ MWY*84N(E909P.7M6K2#O+-*"F"@%!;$Q._R-2NRC#ITA*B&(+[*HU-MGQV57 MJF[@@>5PW':WV_\Z,;>F#EC]/E\-M'HA8(,88UH9K.+H@MGN-I53%WI71];S#YL2GE;_D['TC/!K(=5^,\R8A-$A\-A)2?G M#%("M'.\\UP:LZ2^0*>Z.W, ?#4MN'1>%I[E9 MM&\F3#?W11P5P2&$_V9/$<%:83+QF:/6J]:;5;NKR*UR833$\4: K#23(<91 M[>@M^S\^OV?]'W=%M^A&&?FW%/]X]/@.:>/^KQ9DN"M*FF,=HQZI?W;-.A&C M";VAT]GLU=!KSWS=+%=J@#LIQ(Y5@_I5>QU,:C:!X7I"'%58QIM]>(ZVUHL# MC02.6*(095QI!$73GD./+:IEB:(O$@+(^C'Z 7"M\%-NWI=%12SQAW.@WMKD M%\K%)>?!$CI2(+H#I6IP[JZJE<*@Y%A8:S:8L"CWT0,BJ.# 8XFVUM6AJ6!] MBN"2-&A?7&B[8[B$?;!I-UJ(>5@HO&3A;C\O-]A5VMXL)"9)^\F/C";3-NVV M4B:**4R+4.>#M[>@4""A98"Y(!%O)]V!O@?P^/9 MA*8;AND*%]S*NT4?^GQ87%1;4*ZTVUH>?K%KPC:88TF%VU2DLY*3?X"P%#FG MJ?S,5=?RKN$1TL(9&JS+PL24Z;G)QM^7BD@N8'C-U:KBFWKEKGVC)-@Y% :4 M^M@*U;ZHLV=,AH0R]DP&A6.=8%%T(!$!>)!X^T:HR4D>V"FCFBS<$'5M8 MW1?!/K8Y^;X9P["7GS?"'QQ7_<*@3?7Z'*$)9ZF&9')W@0=OAZTLI#F(P9?* M.![WBIC7\%H#=IH4[375, ]&[@J+R.$%23O)M8M2?3,V$.$!?[V$,-PDQS&" M,M.U RE$[- (CAN6/-=A"+_*;K%2V"*>-=[#%:&+F.>?+F1G3'EH..XJQN;= MS@:,L=V"+$+J6_9##X+,6AM*W(:9-JM(J8: XZI*$C)AQ+BL^-AZ_"SW=:$. M.W=W.:[XYNO/'M^EN.(+'L8T1*P4'4#Q9>OBP:3@89&T4IGKGOXM=Z]J*/:^ M#9TL)TI[8#840)BH\JNXF@,VHK #1B!3$'V<(TV_6CD(C<2G"0O M["0^SL>'G \--ABMI$ CPVM(!"(:YRFY)*:\RHZ$XU1]1!MHYLR5&,._)JJ* M)))8D4U/JHI%;A*M\V6B*ULX4U'.O%+%Y-@I*->6"T:E7K!XSBI&_W(/A$W\ MRG%I?.RE8?JKUD>HVD:"$VA(@ Y'K>PZN.,J/XV5HV51H9H" 0D#!OA$15@; MP5[CN.S!Z"BA/E?"-9K$4]-X6#A+7$LNXN_7GJ]JXQ6BF2G8(J6\"])#M_^DC$J>SC=^LP-S8]9J+90I*@@WN1$FU M)=6J=$F]&E%X"Q_^8+L$-[=;\-E,*?[P-F/NH&J,HWXRDRQM6%;EF4J1, :: M9):$QM6B$)(P)E SM4JDI+1D?_C6/#_LCN'?UWA>EJ&NU#)-_U3Y%I4D>O*Y MB[?+4R?-KOW>W+==NG>J=O"V\KW%1]3OO2L[_7D#-J#'Q>S+1W_(&%'#JB'; M:D=OB3R'*;< /B+L1*RR7TY?2<[0#JXBR\SEXH*^/20F)T0BQDJI3.&MVCDS M]_LW>E4WZFKK)C95BBDEFY&COAPZNFKA>Q5_E3;:^#Y"CN3@V7BBF+S'Z6(ZGB M,47Y8=W>%+7:0B$-!G*/<=&:DG6OA[,> 75_&680\5*_ET<\1BL?<#\\>HEWU.P#0 M'GW]A YR5UT$ZQ8_2<5=4'SO%]6*F*%A]KQ"%B>5PA-(1&$ QRSX!YY>H@N, M$1[3D"KVU?H\#'"K.R_$0)0D(R\&_HNTL?7_+C3)K3A'+;D]JELB,- MW>RGQ)]G\SVH^PTS=@1"_N7Q%_<:"'G<9>]U\FF*C :/ _]1 M]H-(D"$.7?'P4*[N">D2ZM)!_F_%DAZJ2EUUJ3Q*YV5?'Z?L(^T5EU< /FA* M+.PX%1]R*B["(1&XGXH*15&;\J311B3"&!=KZL.9=3Z'[775,/? M%(Z_5/Z"W\*NZQ>: ?+9A7'_ER5M$Q#,I2BHGW)5KH[ F ^^&&3LK9A^7NW: MR*;/"%=SLY=(SE9=UX;I71>SZ[(K$$4-Z#Y;U'V)WA[UV+4Y)YM]DV/US8)] M=27]0%QL0Q=#L<.]/@D-GR4:00,;$136W2T@4: &)YI9SG>:H[Z!;>:NP &> M1M1+;W"S=\4\%$[_3DOT*+47F0JGY>2*Z:;X$38E9N\/=5)_Q&%Z]/@/9% ) MYJN$)\!R?Y3LR<68'GT6,16E]()(T9]HBK^J9:1:].EL]I1 IK#>5KLTH1&WP1WLA@UY<$TN(E!6$ U3'7 M*!FO-B][C>'Q"T'=58L]J(,.]=.H;(6AYH>Q?.3:$ VY(>TZ9/3+Q6+;%9_" M/''1Y@*)/K H8:NT&UY': 3:WGV!E,.Q;9+5C6W4G>[-',X(-+RV#@MH(SS+HRU=X!>;:NR76WQ:HSA+0K=SGZ?_58RP8\J[-LJ$P7_>Q%U2F66X# M2]N" 3:FT(P[13$N<*0%F#)>)QDH3WHK!NT_M3R0#$RC^=5^6 -EB/<5C% 1 MNPB)/G3N2QB-NH]-A ;-31*%49I0.PM_#R/9:U]@G!VQ;_W/]#ZI'1G-Z#=T HYADT8Y_?'/Q0,,(Y_FT,P@ M@C\-?5^G%5$W5Z61._[RN@.30.S,4*"K-,OWE1 ZU.DW?DF'Y[,S!28W[::X MSD?L_ 5MQV6YF.S--JE+6W/3DI?^ =6=E-MM.7_=%S?>U1*H;Q)-'ST%3EE>SM$NC*#'GIU! M3K'QTY=7DCJ<&, I"H\]MHW@F02'X\*UHD=V!ND?CS.*IHN[L@O>$9[\\V0( MXI>EV*W]A7F34=PS;V_)/G4'#0?9>F6IC$PA%E&3"?/%5U:_VX[X"%W.Z.YDYV SG*\R $-#/6:?3TL26U75>O=K4G*DBSEDAKE.XX07X'K!S MX*F.($=[4WTZ^[F=+7@4Q+_I[!<'K5)QV"QY]"V!QFZ;RGM$6@E8W'X7XNFU MNJ&T,>"Q'O2538/&V[CP;*5U&\&+%.+K6HET-M!=&(P)P= \UEI73,Y*H68Y M\=#+XR1'H5?2@_)U%>)H$:Q*@4"DFM!C.<7N#+7HH-5+L8Y+0+E?+]KKIN

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

6V5)(E)V5=0&TO[5O^KMJ\2W7+CZ*Q:UEJDK*,':?GRY4=^H\*N,['K M'],'=:B7#&$!CN;&E29XR!LB$(.8M8@(Z\G6#J'J%I.H.(PW&NY+""P5N,\* M]ZDC/H)$[CW0@)/^"4D$&8,Q:!QLP"+I(9>/^(A5.>I?X+ZZA3P*W&N'^Z1V M(M%C'X0 *X@#9@D&RR@#K6)B A:,%FEW9[=IIR:B??..#-W,[ZL45I(G5R(K M^+LTUC_;_5%HL1(06GG.7;"BVK^QF+ZQ;CN,CN.I^;0[&@TZ]G)D;#><]E^& MB_X@']H\2!\8?2[4/!,U_SDEO!@-!'-O@8G\@A4"JX@ 3Y!%:<*%4GQKAY<2 M[NN,[P5+J(+O1\3WA-)R7! ;.08(PH2D1NP*')"8L!6YNY5M]1&7>4 5:.5 M4UKX5P>A5E4$+= -U;C9^L=BW PS */A=F+M.C#AHY3/?> &\&HZB*:B!"2,X(1;093:VB&LOGIW*^%5+Q16*&QQ4K=0V%P4-AD8M)(X MA@+8:!.%:2_ >NXA(N6"21K6BF3#4E9#>[)"887"FO/4RXR %@J;A\(F9;A2 MA'CK)%B26[0Y14!A%2%2H7B:+X-9KCE,M^E*,-@F'&<[,(->NM=AZR(,6L,S M,P@;T;K@QL*A:77X_J7MAN]7SK*[":SA+=::F(U6!5EWYV6WH&7-L.-6%7&S MS-N:6F!K8F>]"(.33/[U>KW([ EGZ49^RY"XNILK@PP5@^P>!MG;Z10'AW , M'$,N/0(LQ%Q/7F@0+DT@ET)8416D9F+]"LH7FI*N3TR.0TZ*]U,:.^8R5(QR4-@G,]:F34(A MKD%SR:.RR 6!LAE+YV[:UKPTXT)/:TY/2]'8A9[FH:?)4Q""D&@"@31?B9X$ M!8VDVTPI9Z4[D 5:&G0D\K1D]+4=F%GN:@IZF4$8H(TTEG$^T2/1GJ M0"D=000L)352*V4JG3UWA*+^\QO7WW6]BGE%/G47Q&BX0EW0LV[N-3;3B7./ M"@MKFRU1K)'UL$;J]N7<>J+T'H=.K\^,),HJX@ MP3IJ #'LM20*&^TR=14?4*&N!A?V6)@3Z([Z'H7$EDEBDYXB:D-$WG)(EE:R MOZ2G8"5/+\%9$I")UOK*_IKV%*URD8^5U/$_D?'KFI11DO<:N*6LAY O08<' M;R73O9QI3(+=.@."40N,XB3E*4Z3Z7&TP2-D;4U2OF0>%_(J4KZ0USSD]7FR M\R$FTF@$0LB8Q+SFH"*AX*1RE@L:B4>5F"_D5((^OFEO/UGZV8+^=C]MH+C13 "WK6S;W&IG4L_.HN M6M>4CF*/-- >:8 GZ'KA7W]=%1\HML1,ML1T"T7-)!>>$\#">TBSI4%IK0 ) MFO2OQ%9K4>6XS]T,ODBB0D$K[L\I%%0+!4VVM=<8BQ@Q!(1BKM[*06MDP5-D MTUO&*F&V=L@VKJO^=*&@0D&K>LRF4% =%#3I46&(<6HT Q\L!Q:" \64 TL4 M]S%-&0I5@@1I$@5M6D/)&\IW7;,@2F+=>K#^HK7OE3N]\/Y,O#_=QQ(')9 7 M%H(W2?VR0,%::D#CJ!EE0G 4J@(4+/T?$!,^ MY 9,,I&0T&!Q"! H$E%9:7UDF83T= N^E2.AE6B1^;_GXI%"E:M'E8M6Z84J M'T:5DSI=1R2HB0(L$A@8L1*L1 *"8!0Q1GA@8YW>I+[$F]"R=#?=C'D;TO.= MG_?SM_?=^Y;I^>M?A/]>=CZDI=\;C3NE#%O]R]%PE/XB/^&JZO@Z/,#E&HLJ MX+$"+JW?5CF#X^M?KF>C]#O-B#&!+;K)[=_5O01_Q:SMRW,;!L>Q,B>&Q]_( M\_L 0&F_=A_#PDT[@E2(ALH ,DTC,!=<,C$X R4Y1=@H$DA.@Q!D>^X\B.6+ ML#MINP!Y :U>"Y 7"N3)5K">%I ?(B@3PI]8ET+#AMP1*!@(GTDR8JY"0A9I@AE-GL%>5ZNX'E M+3)LJ4%#+8FT"MR"<;J 6F86D7Q!$Q 0W M1!FA,I0%VVY\!@,6+(H1@3&UV/\GYA=;P\KS5CXO_MI;OI[6>1B.'STWWMH_[ MR] :]5L5$--;VQ6#7(_ASG?$42'ZEY&QW?R&[WS8^9_T<@VYJZ3ANMDE'YQGFY]N/UU("8?^^J;.$NW'28.VL88\(* MSY$-@4NCM8GN#2%;UQ\Z^UKIXR+9%V 'P;P'$],3/C7=C^;S<.N7[X;CW$%X-V,[_V,$O.[<]Q(T//_YHRUM'^Z#]U^')Z6[KW\>_[Q^VGY^T]HY? MOCA^N7MZ>-R^;WCMLGQ[\?[N^>'NRWTE.<'AP=M$]/6L?/TF,MPW;Z[X,[G^?[F=1+ %;3+3?F.,@0^#;"IUS<4P/+W^X==KQV2G5]U,]:%?O[]Z]@%/6$W5 M<(W?_@:7;32&S)75=O7-5V]O5V]-6)#C][C:5O+NM]$V_E_-<]C>]XS5SQ\? MXVW%Q'T??X;WJ.8/^N1ZW:RZUV5_$C=92M4GS*>^_Q91,Z:KQY$UZF<<5A' MJV0GM@Z27>Q;^\&%+.];%#^9-@8;-MX+3LP<,W#FYZR)*X.QE>?B1XJU>9.; M(R_WB+;]_&GOD[NY-D.&RY#-.F1H%KY8BQSV=A@EXR]7M5S5?:=7I(CKZTW[W^^XBUG_]UEC[S M^=6[L[-7YT?\Z.^7[X__/F!'[QP[3K__YCH]^'CT_&6G_?O7OY M[NC+L[/VN\-/;9*^[_P/\CI]Y]'?_WD_Y3H]W?WX^ODA?KW_)W_]KMUI/S_Z M/3_\].K\93SJ()S=ID(QNU]44Y-X(6')AN$;SSO'H M+ RJ7(!!. N]8>=#N&J@=Z7AG[1Z2<_WX]5_MD;F4QBN]TGS52C7WY1K;-I! MC6?]0?K/7LM=#@:AYSZW1H-TM6Z5:-(R_MWE<%2E2JP\0-8S9_2'_8#J=_S< MT0BH(MV]FYQ[HPO0>('M7:VOT[R\QO>ZV_.GWQ;;[M>U=MT>J!@P,Q@P[;TI M5Q+22"A##2CCL@$CTD^1.0@RBV9,! JYB"%"MYQ=7TH_H)(F7C?D:_"4%,@W M&/*3OA?J'57<"" <>V!<4[">(I BTJ"=,-;1K1TI;W$>%\0W%O'+="D4G#1\]-IY=_N9LSYU\&US7#82>F M(;PF7O/IA4F$/"HD.PO)GDSI)TZ4B8$A0-;DKM"<@Z5" :)INGEP;GQL?GL- M:\ 7G"\LUEQPOFR<3XHF[IV-6"D0G@1@U"31Q T#AGPRE7UB]%P:C#6JGE#! M>=VNDAJ4TP-<)07QCX'X2?DD#6>.2 =6Y= N<0&4(1J(Q@%1A8//S4W%-IO# M2U**AST8MB\R2A):DP(I,:CFLVSC0U!7ZRDQ:/57+_K#T2",.H/J$/AOH1=B M9_0BK;5A<53-Q[33ZC;55@O[ZP7XZD M*K!_--A/ZBH7$.$^!+"!YO"S$Y!H7T(D5BN7:Q>*F#TI:QB5:K2@.NV/3+?5 M?U!J[%J+KJNYG./T6/,(NODI@85N'T*WGZ<3_)R1N?H6F"@8L$A\/BOJP D; MTJ1):R3>VE'X%G$ULQ^K&6>L:G1G;RSFER/&"N8?AODI9>4BPQXAX-3QI*R8 M!&.( "61MEAHNGE'$%>P7M!WH+C64JLJH^YY:/6J)"5- MR\+W+W.!R^MQ+I4Y:AB=M=F&:D^;O&4'*KO/ W:?X^GS8Y)@;TB,X)FPP(BB MH(U$X!$U6EJ*)37CEHDU%_*8%RZK4>FC4&:AS*5DH!;*K(TR)]6YQL[2G$5* MJ7))G9,(1NL 6 :6"%$8J=S6#E&JML#G:E'F3^_V\3FUT.JL [0VS%J[3Z0P M:VW,.I6RRPGA6".0-$1@P6C02CK0(2+,,;-&Z:T=Q><_C5,[8.;RE93&/*4Q MSV1C'E%+8QZ^M;.*C7EN^W #6^*L;3^??^^VGQ^YRF//)XDWAPFY]TURO3UX>(;4Q)_5U=T#;E]^OJ M,MM[G+%RL\N^V07&%NXU ((_K _19L[63#^]*Z9:>AVT[UFTS\)C1>FXR%M]'OFHC,RW3*0 M,PWDRS RZ9?^:Q_>QQJ_TO[K[L7MW.7Y9;<2U%5F3J62OL]$R)DY9:G/-*Q5 MXGPUE >]#YWAR(Q__N]E9_2Y#.5,0]GN][+S=9"$4/8''>;["\.)0]V;D![T MF^F:G@M/OFO"V"((Z\6U3%CKF,8FA2P$-4A*)K"@F@4?+%];MI_(9C.COLN>YE'K$7_4%5;V0T&G3L9>6@..U_C]YK\#8F MJ-$^N0IJG#_KM-_]];[]Y3UY_>X 5=_S)5WWR[-N^]W+]T=_M[OM+[OT]?.C M+]^"&J_/7[U[]>7U_GORZN]7_&C_Y;OVNQP4><5?GQ^F[_S/NU>G1^GWNW@R MJ/'Z/#W#N_;[XW2OK]^]_]A^?D2.OKQ%K]]UTS5?=X[.VV='7]Y_/-K_*[>8 M^#01U(C2<>P, 8F# N8D \4" 6>T098XKFU58:RNP_$+#UD\;@9-(;X-(C[' MC!%(V>@HLX1I[P6.@>F(A&+,/C;QQ?[@W(S2C7T:/>U=GH/OC^#J>PLKSL:* M7R9;(#*/4+0*3)ID8)03,-QPB"(0$P5E7J.M'?J$*UUWM+L!&(D991"S:2F@S= LKKK>Y6:BQ4.,$ M-2KM(JX#P*A=#%K#>6,&NTUDY@+.?,!Q6\E;X>G_6\)D3D? M\K!WE0UY/"B_3P??\RN/[;7G65 MOTSW,I1-:99-Z?-4Z(L;S&U(%CF5+ +6(-"0H 4E$MJN;#<)XNOO-G9Z59T(DAW0JUH. M)'JM;K$Z0QUZG?Z@UMUM(F MI[G&Q%)4_AB#>]<0/(Y[WP"X'VQQ+\]B,+3WII2\T,@SYAP@P0TPA"-H9SEP M)(WPV 7DD@*2LE&]< JT-Y*!2ZO3C9WZ]9RFIBOYLOG6N_E.J74<#2>$"LAG M)8%)S=+NFS=CIJ/F&B&>JP66W7<%L;UT"MZT,/N+RX$[,\-0J71S<1'28YMN M=]BJJBZF_QKU6YWA\#(?:K^7DG^X:B\^IN(*;,Q!@=ID>^_#<'0OL^$:B MJ'"XEV'X:P(4ZF!#R.$2''*%!A+# A*)A@.&"E17HK1!OEU@Z^ MK>#PS(W6"L +#Y,FU\A)3L C%M =;#]83 M"H$*&H@P6");]N!50_C2B7@3JLR=A LSJ!*$ONIT\XW?2LR\N/::-TU-$-^C MB9V_<[WS'_;<(*2=?S^,_]WI?8/8C<^7/7^6/7^Z^)-GV$G)$02BJD;' 2RF M&**@-DVPP [QK1VT38OC?L70O78D7,+F&SOUZSE-35#>9?]]W/UW2G-;[_.Y M: W>(0G,6@TZS1Z@B+ VTC 1==F 5Q'>2V?A38N:JV MJV'$"2(9$"D\L* #6&$<("NIP]@:S,76#J7SVU8-QF@)6!=Z7JMI6F:R>:'G M.>AY2OHR$D+Z)P+QD0&3!H$*SH%6R#J)TB8JR-KS\WJ"=.E5ICZ-8MD0MTZX?N=*(VP3(PK( Z88#1]&(C)Z!4=!3Y M]&ZNI5VPNX+87;K%M6E1X[TSTWN;+M?IM7K?]TSOW-HSO3AOBH^M3%.9IHV= MIA)1W-BI+]-4IFDE3BJ+?'B5>D2]IHQQI20SWE+O<%*UE*A[R-H[VHL>=7K] M0=5#:FPX6%:D(DN*D:W,"3VX,"YI@#YHAR1DVT0B1 MNT7-TSVT>>'&1@NEWTPWUYQZTDJ+/)S;,&A1_*25X3-/B'&^QG[-8ZD92(HI M0SAFR"//6=3.\,"IH40'C!SA/#>XNX_+K32X>_R6!:>[HTFG'*&:$^+3 F>Y>L+J-+A;@L-N@]F 6!\%#8Q+@AGSW@I.74R;78S: M*AP>FPU*)^ :J6+"NL$T!,H4!Q.Y V:- $58^HDP2H1T:5_(F6]/A&*UN? + M7:P5742EF&2,:*H)"\A:$B,B DGKA;#%>&@X([0GC ?C#;>:1\ 1);VC$4W* M)U#@2E@4A)'")+V#B=A44\"B39GB;9'QIOJSG< M*ZO*,_-PPBH2PBQ\(+7$P@1%K652"8-"%)&FW0E1*J,O&F5U.>)HG!Z8>.+M ME_:7/^@;I),5PB*'8"P"EC.-+"(6:' XS3(7T>$L4B1!B_=IK!U3K#]9.(*4 MM=*&X".SS-M$'I1DO[Z0EGM5%$K#^>#H>SY0)$BO0P1OK0#F2025%"A0A866 MG+&@;:Y4LS("I:9,MT8';?;ZY^?]_*T)0U U,VZ9CV:07M/4?$A8*KEM)=;? MO&F:)8IF,=->:L.U9<$;&XA12AN/%-?$\RK4CZ]#_;CT!E^QG>C@AO?\%4OW M]88%)9/\B( U3^K5,0'&> (>>>N#1-0RM;7#\/P[4<%]H>>2+%FFOB#T0=6Q MHM))^''%F&?!86,,M4&)F"1@U#R4G7GE=^9)GY%0EM@L"JT0$I@D :RS!(0C ME#(GJ?"L;,TK"?RE\_,FY%B6-B)-.@I93JPV5:N7,N9+W?D/IS+:2,#!4&,A M:J& 44/ "&4 6^;2WJ^D8DG+B%L"R@7>S8;WVK%P*0&TL5._GM.T#$E>-N!E M;\"3TENB-)N.RGQ.+G?R\@$T<0-K1F<,CI3K]PPVJHQLGJXM4,9VN9K',LH\>M"T&LU3" MGH>@IQ0OY0XAS7)7)^F!^8#!A&#!*8Z]1_E0K%Q_AEY/F"Z=33-"@+9.W+T1N1,3TPT<$PX,!<,&"(\>(2-#LA)K]S6#L?;UU(E8 MPL;RYU09W$ 8$0HIR"G>P')S.:NB A(M,@DO :M82QG4!F\L< MQH"DPHP)'JTE:;$$+#DBDFK^V#Q0BDO52!*3Y?U16LJ")KL3>P:,4 U*)J6@ M>23:<6.X%%5M*4H*412BF*B4+3FEP:#H+6(2$2,B\H%8G5:52)*S& R-YH+) MTK=:NZ $9>!43(00B(FN'";&M-Y()EI2"LU;L,HMC*Q@I M*4_\PJ5FWB&%TSKT* ;*J,86WTTOI>AMDWAFLNBM$5A@Q!/%(.. .6G "B>! M<,JY1SK8D+""&;TE763FID*K13&;1@<3G'6\#[VG9?W_Y?GEUTSRIFC:;4$-VKUXXV215^K&(WZ M+7=F>F]#J]-K&>?22ANE9=6Z&'1ZKG/1#=NM?[;[H]#"XINM7;)02X"]:=,T MBR>!.Z1TLAV],ZW=J2LHWU.078#37UL.!&,!D\592'([ N(% MN-$6.E A$L_$\ M&8%PPI&@=*Z:$CFPM'3!Y&;C,@U0VJH6MI@4)**,V0]X8RSJ*DR@2)I/N![Z98:DUB]FF/KF>26>$ 1>%S-IH#S;V% M* Q/ZI:G39QL[?#;VJH64ZVQT%XZ V]4EO-_3._2##ZWQCG.I.0X/Z 7'B(" M4TT]]3Y1#M;4*,D""Y+X&/ // %E6UGZMN*F8C 264!<-UL%2H8(DH.G1C MHZB2&E7)I$?<1(64$AYD8@I@) K0BEI0A@:/A;6.RRK'&>%MLI'&2&&*N_T7 M,FCJ=6#(,^:#L0)S:E%$E 2+L2RRI.%D,)'CS(RS)+ (5&J;R(#'I$N\ 4>M M\<:%X*(L.URS:WG>82+\9@Z*DS9:(;9FF,DUEFDI6VT9/?9FF,DTK MX8QUCIJ N#?**L8CUY++Z BAPLH8F*DJJ9+K2JID!J_L4:?7'U3B:FP;OD@/ MT_>3+3F+C)I)1KV=EE%IWARWR(.(EN:S<@2T9A0\-,URNI ;&;7.CKB8 MZR4:+CV1V16'HZ?(WF/;^'ZWN-&.^72BG?/A=3OGDS,S"!6<=H:=43@)@P\=%\;[S,O@^F][U57^,MW+LL_,M,^\NR6C"$=&7!0@*9; MO-)@J*&@!&/);*"2H%PIC=7FMR^X+_2\6AD=9>J7/_7K.4VS%"BE+"#C6"[[ MPR362FD:K36"*:F9Y&5G7OF=>3*J[BRW.@@*@N=>E"[]9!G!('W:EJ7P7B-5 MMN:5!/[2^7D3PIKM,&IUJBX_)7Y9_+EEFLHT+=Q(XTH$*M-\RF2IY;JNSB.E MN)>.*D7$S$9:Z>[]<(OJ[=2)"6&9\3PJ8-3C]$(]6!SR.:J(B'9.>X^W=@BC MV[@492GAZT+0JS%-RU31A:#G(>@IR2NX"4)' M+IQ-#>,-">(A!:<,$=39(W MK#]#KR=,E\ZFFQ"BKOK[T>BVU4W45"+3Q0U6IJE,4YFF$DA<5,XAYP=&^OW?A^/W7.VV%-;:01C,N9(#0?\49" M ,G%983RTF;;6]U6@6KF8]Y-)(4"X!K4<0'PXP%X2CU+A)V3B@#AA S'(/U MU(-':;9HE 0%7A"\:@A>NO6U";'BKX5)]X,+YS9I:'I':=*?/?75<>3QTSRE M:6^JW66"TCUQ9BJU[;"HMQ:9JY-F) RN1 M*IQV1PI$$@Z," $V1 %4>(D\)M+2<0EU( M6E^CLC4@TT4$D@I!%X*NQXT?N4YFL) ^,3+#.ME+1$M,"!<"6\+MW0Q="C$W MB:HG W268>.%%D ")< X\F"09B 5UU9*SB5.EF^:YUN2XV:N";(&+%T8M3!J M+2:O]$Z1B RU2B;8$8610DF#>D4TLD$6]\+JDNQT"G*03H=HP.'>G2E9Y>AF?3MRO/^6OI$T6B,(!AQ"8E]7-_RN1F\[?2N[TQ\3W$NY-5X!=V= M_[W:^/OG/+W3UF_Q8_ ?7?41*()D23D)HC"X^W^*'W# MJ%^]L]?O57-@1L&WGG5ZINTP=S9W@Q)6>)XLY<"ET=I$]X:HK>L/G0VN'^'"O U@!\&\!Q/3 M$SXUW8_F\W#KE^^')HW+S7FX]Q#^8(JG)OKQ1UO>.MH'[;\.3TYW6_\^_GW_ ML/W\I+5W_/+%\XO3@Z*!]>M(Z M?M;:VSWY=^O9[\=_G]P3PWHI$+C]N?[YC]PK(5VXF[ \_->#62C=?K4??..) M:@-*C]$U%\/P]/J'7Z]=QIU>=3/5AW[]_NJ9U";VGVJXQF]_ \DV&@/E*I_O MZINOWMZNWIK833];+S:S2[YYSM@E=X4F\X5JXR\R^Q=)N]@3?EAX\RP//$E]9QG\1,O_>'W< M!U@U!/^7=Y.S?T%-51#&KEBR1-MBYBJ K7D.SZR;[_FV1UP;'S)25'O/C/(A M,F:""M(0Q*0-3@;'9R]CW\PR/\=[5[[?=R_?M\_3M_Q]1(_V'6F?_D';7_Y@ MQW__Y]WK_??\Z/DA>?W.?6Q_>?OIJ^_WW?LO1\___'+\]R$Z.GW6/3I]^:Z] M_R<_^O+GEU>G!^GO_\2O_S[X^/KYRW>3OM_CTZ./KT^/^*MW?WPZ^OO/3^WG M1ZA]^OY+^[1]EN[_O'WZ5_?5Z6_O7S]OQ^OTW:,3Q(Z^.-3^^ 8I3Y@4$21G M!I@T'E2T&$(((FK' J&RIB(_S3NL6#AG33DG1.YT6MK*.\4D(B9HC"SCQE!* MD$<5Y^!KSKE'/]O".7-PSI<)SA$J]Z0E!C3W$9C/36DQUN IHL1'YIWQ6SN4 MH5N:V"^5H\,5"^0)- M\(41U@4C!&"#*#!%&2C,$3@>6(B*>4Q0X@NZ31M$%S7Y%59'VO5[+KL9.J-P M/I\SH2G^@H5=HT[53_BV;/K2V \7@\255;^2#:M]N$R=?'/8RQ8TPQ9T?2SK M.Y/5<42\!N.%!,:(!&V] Q&Q5RR9#-[&M 7A;=6@+:B4]&FZK"P0?3A$)U6E MI4)K8RU8E7OT&JI!!QN JFB0\49[R[=VDJAL*D0W'EZUJ[ "KX?#:U*$B2&BK!5L+1WSW,V_9>'6]JK6]%^ MF99V55'SYM@?Q_T0PV 0_-Z9&;P-Q04T$_MTINQO@[CP05B@+E$0<\:"D2ZD METQ*R"!MT=8.1J*V,C,-.LY5D+LP [P@MV[D3IKE/#H2E4@3$A !%HR$9"MH MX-YJI#V)7M*M'47F-\L7!-R-!UWM9GD!7=V@FS36>>2&:>U !,. 22[ ..DA MR& $$U$:9[9V-)J_6W'S6@*MCK'>[?8_YD+'^5AKRZ75WQE5_8'"IG4(6J;M M_F+0_] 9IF]]UA_L]R_M*%YV=YU+ SLJ-#03#4TGE^%C8DH+#0#"QWO35GIEB(1-%6@A0[)2MNDTD)L[= :LK&+ M:[VY8*W=3"]@K0.LDP:Z4HP1(1D@AWR":#(>-,4!!#5,42>PIBZ9#*I1GKT" MM$5:Z 5H=0!MTC;W6GED@H-(>=H++=>@&,ZG([$-!GLD9%7@N;8>4L6%/COL MGIM.KY7@-DPKO=6/K8M!+FTP^ORD==$UO5'+]'PK_/>R29J:X_CB:F)>Y&DYN)Z1PE&S<-1T5KJV::9$M"!9L,"(H:!) M9* UY9)3Z;"QN<+L(W$ZEJ@>N/',2,+=)<1/MP;H@ M(>;BRDF%*^MYLBUNL>&7CMOUQ-PRS??[0J[AM:]7!(J39CZEBCO#*'A+-# N MLO.+Q63P.^24XU1'7%OEZ^*%K\W2_[_FKWYK- AFE-%1 ;:R]CN]X6AP6?W. M7@[3988/2Z9975=$H^S^WZ[FH-#4+"40OK9!^=9OBE 1E=$(")44F$PF@\9" M@Z3<4(UM,OC]UHZ:R]0O[OD&0W7AIGZ!ZD.A.M$4F3H:A4THU1(C8$X+2"3K M0"-"G1,L*">2*L?;LGE874^<-Z(ICYB#L;S9*)39L$B;<%P[ZUVC(N==".AV_D0 M?&&BF9CH:,HP1Y923:F#D"8-&-,$M)(&,%*:Y!.J*+*M'3%_[:KB0F\N>NLW MS MZ%X/>26L]8I3HE@/2@N32LF04#K9$:JQ\-UXZ-5OK1?H M+01Z4R:\-UXPZ\ 0:A/T1 0=M0&BK Q$"T9(/AM6LN"7"<1G"0JM#Z9[&5K& MO[L9*YQ97^Z.9^=WTJN,Y7X_5 MF^YA;QP)3/]QF&ZJ8Z[/UZ<1KIJ(7'3#*.Q^G=FOGHK";C.QVQ]3LH"&&$Q. MF"<6J7S&1X%5& %.)J(@B ?-K M7'_="?[W8(;A9;ZKX_CG<.Q)N3E5!^-B1X6F9J*I/Z^X'C!.)Y,\K?("J0T8$5X/H^3 M\_N- ^43(Q-NF0VTJL/35!QO/ ;K+VM?,+A8#$X&)XB)7CBJP N3,.BE J.P M2+NJ<13%-&,^-JYPW4_L?=\97G3-YWRSX'?]879B$-WUZ>AMV>W[^:I'+8<38. M=M,A%)Z$C$(!B(@.&/&)@R4/8 F-Q#CB(R/YR$.34CQ+"*7I@K W?3S"6T61 M!(]U=0@I@(I5KPUAD(_4\YA,:TS7MJ,N)MNDZ3;^WIGIO0VM3B]A9MRB+OWL M^N>A-3*?-NZLQ%)K"QWVW"![5O;#^-^'O>NN@57$-9SF"2FL-!,KO9T^PRQD MH$0P<-HI8"ZQDI5&0& A8(TEBDHDBT#?TI-DZ=5+2FRBD96&"G 7 MS)-"8; M T)"@*')GF>&YC/-P@&G6,B(I4ZSNK7#&PG< KH%G&XUML^*6 KDX7_6J9[Z.!\:%EKCK7M0;!A\Y 4R$$ M(HK&F$-IM+0%6$\W_# ];_JI8.\1L#=EQT?%,24>O,EV/!,6-.<6*)9>.$>% MI[[:,Z?K:Q=?_.,;\]>'F#O% []<\_WPVT04#IJ%@][M3MGMCA./& K@(W+ M!-=@@^;@5$C_BTB2G%),=:GQOZZ ?02[O0!V#L!.&.Q*2NRUHX <2P:[U0K2 M?'G@5@>DE+4AMP@5HGC<-]Q@+Z![..@F+76/=="*8/ A&>F,B@ :!0'!"!>1 M(D+C<7>-N2WUXG:OW^U^83YOH,^]63;[M?O@Q7@N"B/-Q$C3K;FP +A!\(X4E+/LT']UR ME90#BYZ!Y1B!#-RI-)?.,;VU0] M:?#%];[L+?,14F<*WN;#VZ01'Y@5WCH$ M0J@(::X4*,LM>!,,"I$FLRK$=)M(_;$DWK]:4CN:#P$:S]@L(%H'!2 @C#!65<0B6S;4$"!Y? M(_2O2]^VNADI9:#=%*#=B2) MR]DB#ZW*Y5-\2H6E#UB1?Z"L@>B;.JP+!8V<** &B:!$2= !^6!:RUR M0?Y@23ZH)IH2"J_)=]]H6[P=1BUGAF>MB]RDS@??LI]OF.5Y^#_,[:BW_8$/ M QCU+Y[FN1CVNQW?RL^VBLRT3$,]S=9>FJP75W/UV^<_A[DNUU>^VOTZ786L M9B*KZ89;E@2K/0V0[+5$5FDB04FC !NEF0B&2X:W=K BM[#5PUP)]T/)"KGQ M-Q7VM5O]!?:+@_UD,1UFI.4* 8K9G\]RD@\C&(1#- :LM159"8CZ4HP?#_;S M0';]45N[BBBH71AJ)Y5%@J:D,DAP,9)\+H#E1-':ZO#< M&RA+#@HT6GQD>+1BM_]QV(J#_GE5GFWBD\ZG!1KOHU-BV];-?]][(S M[&3@#I^T>DF\]N-8OYK\SB#XDE#V>'+TVC-VVM\=C_YOE\-TA\-A&*;-[SAF M?%^]X\L>-],>-]TQS:4YT]'GND[4 ./(@U4X@K.&*LU=M#CM<4*+)M9Y+(EC MC0PG%0 O$L"3TE(+*XD6(+W0P)#5H(R/()03Q#-&D2 Y'2X5N@5[LZ M+-!;(/0F]:&F$L>@!"C&);#X_]C[\J8VDFW/KZ)@WKSHCB"YM6159;5GB*"] M].-- VZ#;X_['R)7*%M(3)5D&W_Z.2B7M>G,G"K6W&KY59J(DA2&H: $02P M+*JT(!P[JU$C)<=#BSC=V,Z2=?&3#W%C3P_H#]1[;]2[ /-%IH(LS"4)$VR$ M*&A$A(XD28(@S3,A4A8"]29T':EWH+R'Q_D#Y=T7Y2VB_$!E+$V!U 15DH!" MG1(1"44RGLJ4JE E00(H/UL7RGMNQGNX^;!YRCM[*KCK%9KO[Q_B/UV3Q*,B M?'\\;^!T#N%P#LS JNZ'52WW6@LC'5!J&(G#( .('PB2IUE(PC2/$Q6G"1S@ MQG:\MEFC@SU_'>/$!@I^0 I>3!EA,DD-SXE)!59O#E/"(B5(FJH@52+77$2V M&M0ZE:(8E\+$5ODGW^>";O!TG^[;*#ZO*4ZX',3][0GQ0K>#FA&BFY1F?P7R^SGXSQ5>MR#==3@<" MO26!+JH--!!Q(@)&TCB+".6!)H)BMDADLC#4(D]TO@&DR MO5@C$GW>KH+9 MJ1Y5>C8;:ZL>@!*A8-C/? ;D,C+%A$]DP<<=#>*YE95=&Z6A.9;=YBQVZZ2> M(=_M.]G8(\4C(*$IFE&]O)J@ZRZV%\'/P' M:Z\S#*3\,*2\H#*$5 >&1I2$$M7_0(+*H(&>59(J$:"8@!"EL@P4V&BN*9I F1(UTJB/C>' MPLYX[#M(K,H4?X[>@K5("7@S+;LLRU:['GC477G4BE9RPK (> W)8YT3FBL, M&HHIX5*(6,=1EBIL0,6&>K(_*PD_6%[ 0,(/1,(+:%\IPYC4 8D8HGV:A M)%3PF'">9P#^C> <$!*-Q$_L%5AKS-\4J/UE7FF,$OJU5ZIVE2(PE*I=JVYS ME]3!&^#%71G9*'Y1HV MH_0IEJE^AO5J?W"J\B"Q?S3]+@4D*9Y+@?0;:PQ(PG:P:1X30TT:)M(H8W*L MZG?I^+-M>0C?M.5K2ZV*RQU7=]/G MUT_$K4NLVI_3R[-7/WX$Z,]&B0\:,#:(M?N@N"4U+8E5$NF8!'!& MA*8T)\)@I2FC)$W20$@LOA[1?(M=+=:>6\C6.WWNG)R(=&^-?7].E_.C!FTU M!P+,8> 5=^<5RXT:M$Z5#)*$9 8 #]5)1D06"I)1H4*6,9;EZC((_.A!'D.< MUCI"[1L0[0"U[X>8%Z"VC#,FPB@C2C& VIHK(@+X57(5288H7 7K&!KR\]/C MHU9U':3H?1/>4DQ6D&59'B=$"F$(Q=:[C,9P;[62'$Y.A!2[I23!NDC1YVW6 M%M.RG'Z!=0R9UX]3L/5T6LZ0"[W28K;'9_,2-G)W"!1!]+B\2T_D_'5)A( MQ"PG>2AC(%&E2&X8(X)*IB.3&\/NSWPS9/;?CYOH;KKD\[!H/:A?:- :'H0] M+;IM#!H;CVA1\&NOX1='VQF.PA&:=93(*( MAH3F,B-YGC$2&)[+0*1YC!W@Z7IV=OTYB7!=G(B#IOB#C3F+FF*0=K N.Y=69#)WM&'XR2B"7:V)5&:WZ,WJ)IS @AGO@7_NOEOM'2I%'<9)S$NLT(91) M2G(11(1G/(V8,$:D:]G2:G 2K+V3X$IR'LCV=F2[X M(52#C*&(DY:' _O$Y M$2PTF&"03#93V( #?6O9C9>"<3$ZT"3FA88C% MUC)&0I;&<9B)@*%E'_!]M!ZD]NPL^O-2GO+*V?#Y^3D@>)C9N!J5>LQG\-ML M.MCYUP/G3SY7LV[5^I?VN%[B:=4\Z\!T#!2']GCV\73>U$K94,_^GK'%,!8F(>"@LH?W"GZ[\?Y&%11G8_Y!,2'_5I2RJ[]2?GJZ]9UWBI [Q, [L652O_5FH@=?> MBM0XL$L,,=8P-,"4G0D0I";(XYEG&>)PAT<5K)2V?KWJR?A,> MEO8,'7='_.OH2S$[/9V.SL:ZC]_3_FQ>SBQ'_PDOU MW%QVCUK@H;8#OG.G7T[%Q/*HZ3'(3KK83K M1SG &MY1E@4)"3A)@M20$L,CF[[7CJ\#4ZX=23E!XO+&TCY MH4EYL>*;3$Q,$\#),D+'NJ(D-TE$@/WRG*9*!R+>V+Y;)-'@5EMWM]I AC^4 M##_T(_J.7@,9IE)%)B*91D.121/":2A(J$2H\R"A02@VMI,[508?I=W$R^@ZU;W?-JTOZ@/JA.C, !'MP0L_-0S&RY)$BC"5/!;WGK]S8SIZ0IZL9\P;'M3-=2/>,/" V_& !;TB MX%H)EF<$;K<"0!/EA+,H(+D,C,FEB;6B6/!OV43P!.C_CK3[\Y/O@SK,!O*] M?_)==)^9,&<\SRG)XRPFE,H<*3D*!%LZG58&+^P".<9<::8[.[T_WWM*QG<\Y/-!&E MYI\ U<%D?^/C+_RBVOA7?Y6PQ.Z6WG@W_-JW_YU+ZO8F)WQ3[THC\ZJJ@+U\N>F_NX7=]6X-;H MM6/_9O_QEOUH@2C<9TFV%<7QI1^#I+STLZN&#>.M/,J_:]BK/TLHO?_)AEN, MI@\S++O1L/?D\%QK8\:^GHTDKTY'Y^7TGX7#;XTG M.B3)9Z7"W+MY \[M)1S;6W]JOU^\AR/;G0SPYZ[P9[E<.:B8L3%90!25MI1! M1O(HX"05H(ZF81()GF##XWLKH'0S(GE"#M"?BNI_L&NT@@7#3P/]_SCZ7[!> MQ+G1H*\&1&89)30.(\)UK($=Q"9A69R%40KJ3YILI7=WR/PXVK\+W3Y1TGU, MH\5 L ]&L(OV"A&P'*YO0+2&?RBP7Y)+&I(@!;S%>:8"3$2D^0^0V/=JKKB[ MCW6M59'70&;2!5%^E:=\ R!#5%Y;@EW42*3, BD9)Y2*!+LO*9*'FA,=9C$U6:84P](H^;J(Y6?C M^7!J1G'?FL5SMWL^G,YQ)S[V%E8^5;L366I>Z5?:_1=^'\_Q-+H'$A8ZCC>V0T15<8]U=KH/; MY8>Z70;*7VO*7U24\CBC.HQ3PB@#O&#B@' E%-'PD\YUJBE7&]MIECT\Y0^N MFYM3^._ZI)A,,$Q,\'%3R'YPUMR6_2DN@-=ISF3&:!SG>9H+DW,%$C"2*LB. M=W\ WNFGPDWF9T1-9\2_;N!PM^)PNTL:D=!,AE0!1GF2&14A(8;Y0(CK18B+FD-@0I6F&2-Y%.6$ M:I,3%O&(2)"W,C1:Z)!A1>1P1?6:M2WR^%,X6EY/U/=J!@]H(%V[;?J/!UK\ M3\.G$S0'1URFD4YH%F@.Q"QS0$XB-(I&3CFZ0>K,P*=_')]>KEP?IT;%6:2Q M:'U$J+3)Q#0C22"E,1$-(IYN;*=!>G? ])3<0@.G&SC=8 ;ZB=G@@MXH4\XS M%H2@+08)H8GAA,4T(DF:2:YEFAAV?V:@'\4(!R8V,+'!OO6D^=124S=N,I8' M*4F )Q%*64!8'F=$!$FH8ZI2&L3W9-_Z(5S**]P+A5Y"ZNJ#W+.-^P9C=%8; MPY+4=(XE2GK+O@]7D<'Y^[MH*\/%(\1G_[5*WZ7U$HSWU M,9Z#E_VEK=/"@1T",A\56!P*Y-Y=S)8_&]1:M<2?!U#==PV977^#WL*5VM=# M\-+ML-*'Y=S+/&4ISQ1). ^Q4(PF7!F&;>KCV/ @HB+9V([9%ETC#\0] 8J! MZ_RD7.?>8[$'KG-'KK-@23(R"ZA4DF J&:&!3DG.(T9,JGG&>2"BE '72>X> M,7F_7&?@&#\IQ[CW&.Z!8]R-8RP%60>)R*5@)).!)#2+M2O''>B8!5)D@":C MC>UD54[6$"GQXQ2\&?^Z7&SS-LO]V;CFJB7^-%SS ;0[.3W31WB)D'$.7/-6 M7'.YSZ&A.J)9&A%!14"H82$161X2%IF0RB")\R#?V [#_.X!9JM9USJ')PQL M9YW6]KCJWQ2S4A.I0$A9P1;(\S3EG1B<9J'>,WKW6 MS_URG8%C_*0XHB%+]F9$]N[@_8A7E9Y5HZF8ZY+/,%Y^C+GF M\$68MVVK>G-5<#"@/6T.>^^JX#NG"M<>!0/Y!#+?:WB+EA$2B7DWBT,_JO@S]?[>[_<3AZ>?#N[<&[ MG:/=@_U+;VE_Y?FC7)[5R]D_.'I].#HZ@&7L'Q[\N?MJY^CUJ]&;W?V=_9>[ M.W^.8*E'K_=>[Q\=+B_NAA>+;MQD1QYQ_:-P:S3R4&!_?@8#R7NP??2E_4%Y MPB?%-VLT:]D=_+(S46]+76%*!?YZ8!K^U[*_5T4EQ]-J7NHCF-/OXZG\]+B" M_]M^(_AWX@\?=[Y]^'9"_SG[<'$ S^Q]^^_3 Q#L^Q\_!7O1?K$?O0\__/TZ M!B$^UO_U[N*?O]6YB&BZ]TH5>Z_V/QZ\.CW[Y^,NW7_UX=O>V6L*@CTZ./KK MVX=H-_[GZ-^G'XZ4V?^V<[%WD-HKI@40@>")0ZW M%9.Y5CN8)YSH.,IY8%(1Q!2.CT5&1A'(>![&<9#%&R,-:.H<64PYUQO;O[\_ MW-U_?7@XVME_-?I]YW#W<'3P9O3VW>M#H )+YJ,:%/C+LL"ZX#,_ WNB[J"N MGT5_UBQ(5$I-E@8:+EH6"FXRD68\#&2B@RQWG/7!:,:.^%LQ PXE;T!%O\\K M^%M5C0X P7PN])/!_/0#F=P;[!-8=C].B\OFKU00"4QFEU7@:-2I]@A1[OZZ=W?TW2WU%YWB8 M!Z:Q7QRZ%_?K=\"R)=;P *ZE U5HW@N8&;H[WX6*82A'P0$"%I3&@B,\*2 M,"(BB)*4FX!K$V]LS[Y,ERP2(U%+7W^\U6^CPW.-$')V,7I;"[3_Y&?G+T9' M#0OVS/-UP\;=%UZV//Y2(OC1&F[GGB-]AMF+ZH8K]#L"M_6S'D_/06S!9.8& M=@[ M-L T$0^H?>[+Q1'U44%[ T>*.K*ZL!&G#Q$T\+(F@M0=FUV1%8CKBT0 MJ*HI3-%R+D0,=B+5U,R^(*S ;\PZ4^WA@*X\%G#.,,%V0E9K!(YGAQAST6"6 MK=&JC;KB@+]C>Q:D/N:#XSY;D 2:HX*=S^\A/\O5E.;T>F M,V3YGXMJ#JMTVM*_X(%)81!-("_SS[T J:_J+?)_LR-8VX]67:SRPG]0S:;^ M\%#LE04B"PM7)A5 ?TLYFZ-R.D/A*N8E3A]PAT,A[2.;"-OLDOB)Q7FV9J!3 MU/QP6'4?G_'PT/WHS^@6554!V9'RND<-8^3MZ"3R@OW[[/6,[\< M*\WB2,8)R7+ENZOGJ4DPARU-5$9%+MFBQA8RE>2!RF-!$ M"Q4MZIDWL8RM@6:'MP215M=(L49BH6=4EET[LFGLR%5C2!F=\!7\9@TV=K-V M+,GRT2\;?^SLO-WX]394_VC;N5,ANI;SRO-R--&/* !Q^&-]TT<>T5FYU\7M M<8BX/0K[.@"UH+AU88(BY=X, MF/D%!]JP#QXU3[ROG]AMGZB- M#QN@XWPY+>2I5:7@<&>U*G.Y2,2A5@A$)TF1?1?3>35�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»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ɬ<*@J)D_**-B%)%J]^1Z;T!>7ONUU8D8'' EC)(^8^\1Q.T.,R*JM[&0+UT6.<(W>O/ M2)X2A)*JVH3.XI6OC;;IRU&;N4H#MBX8S2[2E(M_$D<^P8M7AO8A:G(HOKL=)PBN\,(NO-V"T Y?]H]0COU8M>D4 (5I24L48LGO=!$>]@1GV_DS@NCQH,_HWY4U_XL&'57NH9^XB&L2)9\\( MWNX+':N%><0K&7%L_1#:8(GX?PG6V!O3BT&J^X>@VXR-1^KURI\M]C"+T^ATZL MLA=OZ>C3"*M&GKXC%AL\,=H*EH#\>XX+,E,\4'7IB)M@RW6::?^B+]>U;0*V M=KAYWMPM*UZ$!:%7"Z8T,F.I5UYM9]UCF<7QL S0K>V?! MB5FAC.^+P;1PE(79@,30G_"H4ED:OA5.)UF>HXEG MS2W EG8,]OV3%]'6'6/)%H;0BYE+-<9[G:3C5(/YV56HHH7M5Z&8$,6<6HFW M;4JKA)-KT);^&Q.^LX")S* RQ8H7EARQQ?'<#8U1:-$^]"U)5BW^/%9#=);Q M-Y&Y6.9_NH^W3S?DX/-TSFPL<#E]4UM@;+('$PYP[86#\Y.5])/-K74RT:61 M8'B^289M'IY]]K95F4,8;B/R=%'G),3#3G5%_/8E45=D8C7+EH0?!O3OW90= M!83];]]3&#/JMD?+5;S(D3/U^D&./L\I11ZYX4[<4G[=;#,K@P+";$-/Q@M !GNOZD0\U4_:;P)-TVIY86XF]PT6B8AZ-"NS3G1&X*\(+KXM M7?G\^I6ZZN'G =*[S,'Z%;2DLR[-FB8,OW<;:Z]C&A'>?;H6#[W^54P]9+H1NF[[Y=23@AU77Q ?PC,?G9QXN.YA.2@87KGD:7PE42XCVZ4 M/Y@P2?"P'U2^KZ"#[9R N2PU4UNN_[JV8669MH 2[$L9M4[?B+03ITC9CFIY MFT% Q='^]IH$3F"3Y2SL=<.\BL_N#LN;87\0DEB.17:T%PHSF])ZX)WG/(*/@+JNW;XL8O4F1Y*EM M;XF#PY\6K\+AA1EA@FV1T'_K_+E4JP*U^"3]L/[>UY?T^V6L=M( 5%7I:&K< M!UNM;Y=*&$&C63Q0H8W=QJ\27U.+.S]J@SUHT^H)Z-UMO_=:#MI$/L=*B&<3 M:ZSBB5^'K&7M?1]T@0:+W3'G!_-RN0=AW$8] :(IGXH<4GW=WGX]5>1/J9!V M%H'/HRZWC$,6L#F4FZEN( /+WJO6M734[Z[O@MQ]:)X E\C11X)=TC;U=<%Y M#NJ.MOJXBX%KG1O$&<_PGI0&.*Q4H=&2@J_'PWC^GLI M*Z8-C*!?5C <-Y%ZL$N8G7J_-WY-J"N/ W[T"P8,(1%^T6#)I>@N7A+Z6+S? MM*_K7).> [R%J,X0T^1<5OE#2I,C2WD!OO+-OUL-/=0-!^.;3NS%;IA"OSJ MT?M/+8CMS0XJ?K_36G7JO"KLC]WRU'PX!F:-D*O5SB%&-9*&R=_SR60W [7' M=3('4EW7#X1(;/211047U$LUT.$V%.V8DVX)9V7@>FQ, MC1 Z>G$ON]Y+9GB#YK67SVK$=QR#PM>7\NMUUE[(#Q;'2PHJ]:@%":F7-0UQ M7UL:E3@2X!$>'[N1QK*RMJM @_[*,-$OVVJ[YAM$*N3CPCZKWAAD#8TE_$QG M3 I\ A(\.8_069/189/A/4R(YOH>5)L;C2W4U'82CQ(PR]G2+#$%Z:^U.)>T M%0BL7Z3V9LM%!(M)J+PX'=V_'B_?]U6JFUWQ:&EMBAYKI(_3=>[%=9DEWZKZ M1*=FDY"IT<#!?NA&P\UI8CVXC$7>#&UV*K"[K&:Y3?7#F;NZ-P9IM]8GT]2* M"F08M3*,IDOYRTD?I^W1-"$R?R8&'\J1#K8P]2MOI>K$+5P)@-(RI@Z$\%XN MF%.-T6GHO42 XO2WM3BA^:_8PZ4KMB MZ1/@)!!7#RU*_#8L7Y%0&$&U9HM]/#02W!:\=F'I ?CII.;MB]*^;.5,M2YA MG^S4M'=*0"&;;PQ).@%)R9_:O,]ST/5-+OJH46J\JB:V/H9+DCKN>A32&U;' M%)(ST3ZIU;G@KB(ANZ(^+X"RF:DT W'ZWC9GS8&S5^!2(84J&*+Y-6AIX*%=3@H M82&FQJ?%UULSY%\S))2.[7R0K^Z:UVW&%]LG 1J'(E=U67?H^31AAO8^RG]H MD_O9J*]'N!(V(?*Z9P33/<+?9[8HK-$;B22 M(0*Y96]U#4SQP14%,.'6.H,73S^X,!R1#O[W3+ EQ!Q:$TB.8GO*#DW^_OWX M^_SJC:QB:VOB*U@-5F9M"UG@,](HHDM2DHEMT:JIG1369?S1VFO-&)-;\;76 MS!'4(78W0]9ZLRS%\.1W(S%G6=EV<-\XP!SNA\S'CI6;]0TA@D/XS#ATFDLP MW029SROHLH3B1*[8.^;B=\ JS?9XSR6KZ# M]P&=GZ;1@\E=02,G.:]JP#IV'L=VG3G%]@8?)6V*V%BR]?5>ZJN8EU^-'N1G0P_?2F%]I17/+9Q/@V3(,0MV%\=9&& M<3WP@EIC.Q>#Y$$H3U3?SM.&0A0ZH]WY.%JCEZ\<.DRB0FUTA L$&EG%*>_K M0NJ_854UV'X^T#$PFQ="\U,9BRRXN,'NIQ4AJXM]@#O\::(F608R%P4EK1U, M:S"])>]KT[))OAX+U5P".Q-A['YDG.*^3A>=4C)*-FF7Y%0MT=@ MURKW=O3HD#=-Y':9IL'ZE)N81E0[63>LF_$AN"6^V6,2$4TT M^ 09\MP/J#"%3@HLM)F#G%O?UJ1E\D3. V:\,!; 87V0NQG)5II!XMS*ML,- M\S/6 :[ZNXJQ% 6XAD=ZE48^5KDOVARRFRVE*2]>#?B Q%-1$+[R2M0=?=*2 M5E6K%UR ._E4@8EE@>5[UA8]KJLTZT3;L""@SW'"+\%Z]^A3;96BA'-"XE2L M0)_6Y4[\*0TMII2XJF#S:PH'4RR50F?BW>2]MBJ1AO-L*I5ET]Y7"Y6XGO#^&NYS1EY.IHP3&2ZYC+0WAB'AG['J?]=3#;U M N[)I.H4?20+,-5]'(_OU_5L M)OWX")+EO]U#GG6Z0,;<"6NC*[:#6V*N1III",*!WNI,G/3IS',U8+SH315R M33\QL=P=$$>NI?W0HZ=(]WO^5R1\A)/:H9K%Z8]%58$="":%P:A8>3F&Z^[- M40)OCM!O@6EB%G/,XPI5\V\,,L3 U:T'6'3KY]$74^B82SI28A)+T-H'JN]( M4BS62%,)V0T" VL=N3%K&OBT^H3,7^.(_&JZ-;,+KRD.>QT]-@NK\C@S/SN\ MM@^R7>3$5>)4WY?.7E+DO$;')!C!_3!DSS'A(]_YG =.$MUE4O .]9,:3:M@ M13I!J&.I6+\V\3K:R(XJ>NB@PTP\[\_,U;2G.M45Z]YWR#\]A ,7K#N,U7L: M5-Y_1R;^Y5//@WP);Z?C/>I+-A[MC]D,2=#1EB M3+AUG&'Z40X9-X4U. \>6UUF4!JI:F5M9>T]1L69*FU"_H?!S4;1+ +A'XHN MT*)JK+F&H-J&A6S;#!0G@0 =I>X%ZUF+A 4YU+Q-A41]UR> _@5,IV.H[-9C M]!;]'-TTTQDD\F<%?0"62HZ:X")GK)\;H^J.7,[9^O8HO:W(B]A8T\_2]& L ML(:43A)V5?*G^")FEBMV::6'M"0JXO*0?=$.!2R? -V1WCANF)-D@OGYCMC" M)MVZ(0@$E2C%WHA6(=>JQK(;\!+8 56 (&>4WM;SM$WM:B9ZG8-WE3V)*C0D M4(3$_E>9B#9=(B#KPR_ M;RF@(\)AM9-E!0<@(ELCJ,OLX*Q'%>4WU/T0Q#"7@H+5Z@-5>RV%TC(5R'SH M.Q7/<)4/,]JD$? U_R'D79'B+J#-+CS]_=:W9&#&V9,KE)]>23L,S5K?J+4, M:=YO[,5%?*:*#D1#/8(6'I3A>Z&/EQ@%T[B%9S)*7]#.V". -4$[97=\2LQ]N2!M 3P0L ML9C5WKURH%^@WX8LUL@[;][P[,RQ+":RLB\H/!!D900 M#MVM!XX\&_3^"7C+U-^Z7K:MAFVX MTW2"FPL.IHYAV\IXVC'4=>TC$Z6KE) MM:=0=^8R>> ^(T]-/2:_L_X>?MWF5ZI6;+3Z\H.1(K\FN\(K[!.[==X59%:W M.4II)%.?,[%>06X9_KN">B_2H.LL,$+6AQ>T6OSA0DC7.[!HN,[(ROA4Z MS45(J)5T/AA;1"*FIC@)WS+FZO^PJERH09]CDSJ2+5*Y$ZJ4 _-EA+8<$UD\ MSLV@8=!?^#2[;)--0F'E5IN*-+BOEC)4/^LOA[N$2!$31 MO49FN+U#TV/BL!ZZ/KC^<3(VY:FPL*%-0V2(E>R,*=-H.VL>W:5 LD!)\N?U M%[9^'BY@\GYY%W+@5\&BI\C=0GA#J8T\I7\M'U!./\KK-@OLY;P$KKFP"G%N M T? #/9YYR'ZQ.?+.SD3]0Z-&4=WCNC7WZPLPKB#)J4-7 M?52:.N<9V['T/.;:9P/XOGR*>:LX1SG_TT0D,LC&T+AYU' "_MU]Z;:]5#K! MMJX)5;8(8[C++@LK&J9DPQC639GI+^W.FZ"IZ2< P[#E.V_J[$_EK)WB/83X M]>ZM-JJ(1TE!@XZ4C(5I5A6N5/[I/5ZBDZ&6"3:#[1[/5 /=90_"!*?VM;-1 MO._D9J$!!_TY6'1-9X)1=W)30R \.A7232OC$A>F^^4K@BH6^:D2$[,9& M#'FNW&:A[HGS>5>>H78JO^U[L$<_+(X"%")$KSR;'FA_*>D<_9;&=,$4>;HI0M'N@S#@IL M0K/;G^3&*?HBO0A6B1E-4R@07<;=,O9"&W[BF'@GO0$K_%1ML:=58UV0JFMW MY?B"*WVB3Y+*E^K(1M-#LENVYAW4[R5T[I--X4.FM7@Y#CZ!;F%=\LD9 M[JT:PVO$YGTL)R<_E99 _*8]S<%_+] T5Y$X?ZRZ4'F=S$:/7,!9F)/^AH"A M!8Z.*2-"BMC;QIC]0-,[6MD/X6.O4\H='_8'SO/,&TMGTTR2"9$J7"XD[ZA9 MC3-:QARP\\(79SJ&?F*UT15G?$K4K$1,0()T>T"2JGZ&>K[J:DT0 M0W0SM,^'80>$7KBS:?2I\*$D[RB U4=@G)'"@8,2K#XAH>[^C2#)B#I#ODA@[!_XP;""N%KI>&3M18EL:9NEAUYBRQ;RE53%)!$5Y@:.-#%N;#%]L M"%"LW/;)4S(V3E%W1!R^RE",4P)_5P19E)K>Y J^IE$7WJU:!4'EBVL0DSP^ M+[\H,^*\==QIEL_0WDN6]<(Y;Y)YGA1"KC?$L.8,Z]UQE;NJ3(&) ^[8Y_1\ M-M')7=[:4O OAHC34>YN2^<=.Y"O8#53G%8 EVKSO?B-H.OJ.'W*S+)JC3#[ M#'W8A+*FS)+%+R_D$2D_@,)^L3[$,15)NQ9;='B,I5FM@FXR368"V8AB/4VD MBD]C\0$#O#U,/=. ..]! MY+J%HQO#?2T0Q+%TYQJQ/SP2G;].DFF!C?Q,(; MR6>,RL /UELYU(PN;GTWUBQ$:\HT1G;CU@S7SHA"H:"TNB#.5_4[2S"]V'#B MS%MOB?ZUCVI$P-FG3+UC)E279L=A$N%3E?LU+TJQV7?\FGM7D^*OK+*D-&568Z!T(97JHL%V&7H-XW-P3!N@=W[YHQ#[X6@4CW&V:Z2FM@7VK M8CS/Q=@1)M=>TSAW.>)8-,N_DDFU5J=&E\2G1H: ZQ.2U=<8,YJIQ,^T6U>NP.*;X6 M7W-_J0N8=VM#U3#S78"\O\S\Q1^ X,A1U)FD-@>V31%(%ZIE?$$Q\89G3Z)N MDJ(\*;ZGD[KVM/H=*3(73=O,%=O*^XW9]:E5<(9R8RM)GYPZN2T]1<7JCEFP M+\'-^TL,3C%E 0DWM3J5S=;Y*L[M&"-,$5FEM9O48M]X@SRB^';^N^)J2\%* M>Q!C F^?ZPT13_X)SZ\LBK5@,[<8?,@+$X]R;[8!T*;4D0231EL46RPF"#RM M9G'"D/#=$J,_GEA2#S-/#A5@B'"&TZE_Q%O8.W/DD_PP[B#0(:7)QU]#\"9J MN'\5LM9B!9=[@LR4!;C?&4EBS?F_:H(ZU1"6?$:&GC!W-5JUXM ]%.MMVI.\ MPEYYP1H,9^;L8O#EMKQOD9#/9.40:M7XY25-AGM[;*(("D#'+8RN#,!-TK:? M4+V[6\V0[\@P*(J99&RM=J;76$,K#F*8F%$>9G;F54"4'M"61%BLKF]!OW/* MGWT"^JO6"N8X'67KG8W9XW XIM\,1K>A'S>'*O2LPM6'#5!BS%QE"LYZH"GO MGEE?L*X:FM#7C/&[@$?$3H5CZ7KCVT=Y4L;=16W:"D%JPM,-AAS2*XTCX46] M*M^%Q 5GG+W%J5YN?#]M;,"*EJK'>RE$6#* 9WRDO&VT,E8<'2240JQ)(Q;\ MZRR1H.W &TEYOGXEG?"N]V!B%(V9 UPP1[F@G[]D>.,RAL2%3.9L_6MD1$(- M>-E%(,Z^&$K4%2?\N"81D\JKAAW!]!XMQ?/;>1D<<",1[K3N7=X'#>CX>'-W MD@["N/M9E^@W/.VD"^SR:DQPCPU/KE,V#"S?FNI1BM>V-,\LZ4,/%YL&OQ=% MEL4];RBC0D[#3LC4.(LE A,'DAAG[T_?75.D9/+3@G'])!9BK?CHE%EPU,\C M7 @7U/(Y7<<3V[%A?C2VIKYKU]PZ+///0X(\+Q^MD M/?IIPS)CWA3'KM+/QZ9U(*2U)F;$"VA5N_XAPGZ85;KCZJ*7C3\K0"'6G_'0 MM,#[ F&_(8,D)J$VL7%Z<%C:HB>,YCC&$GX1K_36UK!NRJJI=58\TMTPP&(+ M_&J 2@OD/N48$E/TO1 M# L5 J09VZ%^CC\-&6MV 2WK>Y[8!O&!]R%8..BC>I63_D7;6:1=')(5- M0AZ]-"P"DM#$R7<3P7/ -DG6G7'DZ2LK4_0Y,X!+-M1:V8(X$?KS:UK B6>5 MNB_ELH#3GOP95E2]FCN(DK*K9N&*380F I09K=/8&.U,"Y5(;#-OC)VP_#5) M#^"\@6L_G;M#^X%=$EX-YKP<,[-0YG!Z>X"\\_W<=74G45EDY% ?RM0OA76X MD'\R>(YC1WA [O:;YK:X].S@V/8,VNZQIFV-TJF6<=4.%@4"%: MR&?*S_8$X(E4DBJ>3\6N<+Q2*-A%^_2UGWGX%:(/\0-)U8>:=3N^<8)"WZ]6 M##L\]8-^/ZIHO#-=>EA1R+K)DC""9:@IXQZY3N<,Q'WKLVEFDM12-%C%!CMB M9'].CE)YSGB+VXJ3-MY-I!)GC909,#>]\8E6+QC5O0]OV1"R\+VN%@<3]0>9 M&>[7CQM7/W[C_[ *'2E1+&4'P]NG3\77*3?G&84UTPY\\V0YH"0X$Q<4C#O5!P9QM$ $/.O8$'K(8,LQ@X\/I2FS!#J8#YF42#^ES_7Z M1(P=H^PA'+;9>%E^(Z#8B^0_%OQ]W$"6QD% HVQ@?T(K3Y9C$4.XEK@*UP2? M!:M!T&-P*Z8?/X10E:25,NZQ+*"WIWPT,Z_]<5NJ30A1&BM%E^;E$T!,KAU/ MY:VBN^@O.[NT%)UI$Z81&ZT43,7YH$)-$[E/S/0M=V0K6%2Y/6BS]*>[BK< M2*6FE#0[4OK-D02"_24\_W\;Q-]W!LO MU177-SZ4=/%F(RPX/M!X0"HZYLMF+E'J-[U*39;E;3GU45"^*Y#W/YIXJ7=7 MG;S '0R6T!>WW?1A)[V3PK7'L"M$;"::)NX1^X+F-'0J]/L\ $-IG>WTP &Q MY^HW!X202W@E<[@_5"+SYGC"\^A7W2SY9377S%;J$"5;RZ*[,2>/5>MZ.G], M$_9+Y% 6N,;;M82HD_AP&VKP#QDX'0C6;?'AD$XJGMZJ8@D4=.S72&>34HD2 MNZVO"S=I'^C?>8[$$>S=C628>WLA=X:92EEDZYR@+Y#0X5/2_!;9$GUTI=M5 MUVDV46$ZK@5>:Z#\5G)"N5V#LJYH,".?GB,0,CN:]:(+M<(0,M9R$>>[5^2S M5AWB_Q**4,&[#R9/(=4NY(!/ZI=?65GW&<>FB>S+[>8(NLT<YM'40]C2FD;R7ESI0%+=')'-(_I7Y0 MNB\,8,O[;_MS]E\EDU&\9+5M<#9YT,OO=1F9F/JJ+;E-L&30F:R"OZ$7QV Z M829YB(&8?2'S*$_,L69(%MZ W0_/LXY^&DKH!.[AXX?--#Y9J1<*4L$//K";-61F-*,RIZ-PDZ88>GG8R"5KOA4(/9\@NV>IY/R@ MC#ZL.7<#;]$>_^8)B#)]1>KUWHN>9""[6)>%U5.7K@!KH2.NW-3^.N-3)M2! M\&QU99A[>K0MI,)A6IO]ITVC7?/8Q_--QGB)EHL&%1D4$O:DDMM%H2T-"CU# M^YQE2LK4B?O1BYT/P5=0OZ1?NN" 4ZY>72\U=MB3*:&'NBC(QP!>#-/I1VQO M%66S8ZN;&+T;X_Z] DTOUKO:0C \Q/'J43 M(FP0$C,LQX1N*H,C?ZS3UX-P_7?J#54"C9\P8E>%)%\H=RJ@4%LTF\ ('V9? M76HW5'9\1,/(PNG!_3WW'K;T 4'%.$+FCV/XFR3]F9T%^AFZN4HRK3@I@:,4 M#SY:EPO\B0T1\NWF\H9!J#_GZ>_4_L-X"EFG)Z#!";LLM@B1@$$V%2UF)R1. M+TZ#@AMF65,>'V9,8_N83V.NP1!L)I&O=\"]/]5N=]$P5VM(O\%*FXA)7$J^ M4UT&^[Z3_M8 S= >^NAEF%:[ZAM3-T,' ([PX3SQQI'.M3[W M3"BR@8U#87U=+-.GJZ9;UF!FUUV&/XXG5*@WAB?I8B2[/5A*^[8\;]FN]IO> M0( /_6L#.D/)'#?T3$X&Y%H$NR:"P2UD8HL\F3'4^=JSJB27W[FROAC674N1W<$9CML5QD9G>FT:LT]DUD*P;:M2O]I2\C=O6;6W_FM(4 MZ/-U)L^LBJ^W"O\)0-G);/J&X2&V9&%:O]0_Z["8:(J5_C NN6O*JR0#E71K M0**CL(.K,"6[#;@"!0A 3(^)*/54H:-T.@E"A1#&M83AL5"<2,N$(3INT+IP M[>G/*/;Z2EF4!;)HM/)]IP42?6HEV*1/I3+#[!KBY@J\AUEDD^^:DKP7MBZ1 M.=U7QE]BR'^]*]HB-N"A?&,PV,N"^>-C>0V9V^B75YCQ<>TLG[VCSDG<&^OA M[IDT9PN)>&O!0BS$BF2:=1'Q\"Y]MHW(",N=-+<.ZQ/K!Z"5R,WFF*\Q"T1P MCM+!-BYU+(1*O[?-L5ZYZ'"*@W*AARI%XUY,4-41&*N&Y"U](T0EJ/9KTA9X M[*(0L=0X!1\(MK_X'.2$HZ3>CI.DWNZR+:UPGO-HVS@\,@D;9X_K)SGQBI,T ML?5(:0,6P(B MG-A_5N7/U6%$#9[7R=">Z*/H0;EU>P,K-R/#-?OHTCY?F@]T+(X(W[DQ17="L485 M0$1RIQB_XUH*#Y(8/K7UE*ZN&P\VW0@Y]1RWO_U]^+'RD%^ &A,?T3W/" M&B!8#E#'BXZLJ;X2%5MG+5WT"EO[-Z4L$<3"(FSQOL"RI,CI^>%D0>8>4(319#_!8U1(2;K8$(3GG3A^G%<_77)&47F_IFJEG_6"HBT$ MUQ%Z,(EM?#_X+3-BWX!0$G6A/I9(VH_I2_/<)6AEY"'=UGLC0V3=*'8310=6 M7F1)08;B0IK4Q5]ANG@1X;/(XZ2H\GQ0_:@2#4Y86 I+O9FKLA/66,S\DK]; MKD;19&"J&[OG>2'O"X:L$>&$;N9\1!D:=F("&'5%U47*0.*#(55!#3^;P/G" M2;"+,&>G=G\JX@:^JO_93XOVVBPLWPZNL';Y@,\J6VR31\U7'NWUV6C$5?0@ M3SVZ9.Y9XC[8=?]WM'PQS'M)TF1-5-CM?"![L)M@_A;;VT1IG04;'GI(K<)' M^*^LU>%W(E/69< MLRQL;MY ,S8FG=.2J"N4DY\)]::-#G>O][U*K9(M&]1.-+?%E).3K).A#Z($.: KU=BHV\CG.)F+ _>C)Y"&;=YIK&ZUL_S/<!M6+T^E\[6,QX82BM/AFL>WHC+ MG9<[FTARNS:M&1ZUZ3!4INMH:FY(1I.;@:7S;B(/%Z9GS1(:3P@=1^O3S3#M M+9?", H(W3K'8-=O3B/]6#4561^MZ6 MLG.T%XV-S>$J>A7,21I1O7NLFRD+*A8THJ5627 MV:)DF3G+_%#P4>EZYQN;$U8_S'F2BU%T:Z,FJ- 891CJ)+[B@UUAE_F)#V8" M\<2;,GZ&W]AM #J_WA1@E>&H5FZ@3O=!@\1N*V2Z\5<-75(Z(AHM9JX5\!5F MS>Z1:UK@?M_QLGPPPVYJ6$B&'L2+"#5AM$9C==IV)311%(^92AIJ]2AYWW#, MI1D'TG,W%.;\WN9MQ;PENVWWBUMC-$\VT:@&E;>"+?NTI(\MEN/X^"JL]9M& MC:#@C>?=VKT&ZXDJ;YF'X2LYY1:Z590-[ +$P;H-#(7M-W,YJMEX$('B[(5J M'R_V1+1,L7?)N+(]T0KWW5S-7X;6'( ?09LB4U*U*4_ \>NT]1TH.^RHF[,- M'*,4G6UF,_-:;,O*A?ON%X\G(%K4,[%VI 2J7&882WY08\2<0)?@]?GXV_=D M$Q3ZI!XRI9'2V9Y.VGA]26:JY=C*SN)%L/EU.L*72&AE8X]0:IOGG.[:]VWZ M*JFHVI^/Q*!:.]I>Z)YZBF$LZ^[,KC*]]X)(<0L1B31.$^/6V @2L?AE+M:+ MZ7;%8M"^N_N(M6?=!WEQ-T-E],B!%UB)\CH].O#D9M>,7_B[WM]Q?(O8FK]" M/CF26_02G%Z)9GMO'<2PRO=6[^88FI=VW(M7_ZFWD;^#=&MLP/>DA*W??"YP M\CMK4HM_/:N72UQ)#)[1IW=AXFIYXZ"@HN=4P,_:I6P WXO(M5!K94UCK^)M MY'ME@M R:6*K=R#^ MLO?+T0,1F_K0!1SQ[ORNCS^^.O,J>))C^L;Y+5AEHRQ&M!+B%3\!UHQ=C%\8 M[7VKT] ?+CG M\HWBVO)BIR]J\R/_5)(1J8KQ**?JX*K4LO6Y:AYZ!(_@-_;F5^IKRQLQME&[ M[4RGT #!+- MP-2!D.Z7<0CX<\.J!F.9:W>WI95>>*-XH37&S:"*V4[5MC0%NBF.OX!@+&(Y MPOQJ8RK]+T0)P>_99O@\[C&*'1]@>3<(D$)EMLKMGP#<>M DSOH^'Y^L17O$ MPL(FKK)%\X6Y,G8Z@:!B6^ \^C=!XC"?@W640JDIQD,W:009C,F,Z MOQ 1KCS<.YPDVN;8S(CP0*T"FG@Z\NH'ZM:O[U[Y968B95R8S'KP3B/%"AI& M!W$CT#0FF@>4IVQ4&58"[@8ET=0S[9:%/_@,5=4+(.*[.PJ/1K0<'7HL)E[D MB7U.B(&GIL3^,W)18TIO-.2GJ)LS+QL&^',Q,_OT?D@ MPEN=PW[1SAQV7MG&C[=M[42,A4G9/;&,3 MC->O$GLN0.(0AWTR$5R:>%?R\%^&D-&!QX.DU[=L6XCIVQ*BXQOZ') J]L2S M8_HX:0)UF&4ZVHH\O6,&M["> 8NF4(]?5TH-8V'%57FOW4GLSD'&IV\] =E38,6[09.&WC*"S M-P'Y&K\N,R\T'EF#F?)S[^5R+O:%=G,>M*GLDAX#&!]FG\^,N2C_0VF$@X@> MA,-T%RSG+Y?HB-27FU=W(/NA8I[ECU2GL0,II8L&\8G3D:/LEKMK.4;Q#@>! M?T;MS#/S/]>2_QX:N*BY3OJ1HJY(Z^99#LO:Z9]TLS-;8&G%/2,E&I8VED;A M[E3V[W&P.VRVL(TY9^I@&Q4V#CR5+UUS3EQ.[*L]G]_5*T0)I/I.U"0>:+Z3 M&W8L([=IW#L-_WA]UV\C(4^FTQ'WNTC9 @LB#B)6C+F&6BCT.<'OB2 1))?> M,KUIF7<7BP;;ZGVS='E&$/^IP(15##5.W@MD(W2")2(2X54W:8+*1SKC51.C M;T/H]O:4\?#'MEX>^#@K$TY%$5H77S;?E#!E$X73;T!G AG&J@SZ,)-*](P/ MW!SP]!5HYFZ6FY)Q1V?0PB,3V_2E^WU676)@>Y4#R?;5(/B>?3H-WC2-<23Y M&83N=DR@MZE[JR1?8Y1747->IE#!]( [0:!C5PF9:H-;!TKK.M7:=A7\-/0B MP2^O7B934[7B(P!P4KJW39!\!U/+.<>C8X:FN+7JRJH&I9GOI*]'^["1)I/8Q+I+%D592(2[]2M7X?J#?,F\V;\JGX,).R_T99<_^/%5DY(^/+3D*'U06 MCOG)=!;9+X?:FUN[M%,.WQ#6*'U9XP>A.YFCSEQIOVYRS;7H3B2:FTMY7F%Z MJ[(#*=8MPV[-)\!VU?[4(>.!D$AKC7^AC*,F=KO9]5P^XD7XZF0$53O,\+=@ MGD5%.GE<18JL'AS9TM4LF"< -A>-_\V_A$#!/P,&1H( Z5\CX)\A VC(R_PS MS/XE8J3QIE_],\[B_R4L7\%?_D7SGT^3*$)RT[@D MFRG6%!53%_!K":WQ W,9(E+SK5WW)?P/BQEVYVK\F6^K/W@YN\1?_&8KC;O; M5(#_*KV=E*'+.J28P:>'I-4&]QYI*[\H6K/9EBSG":# -](1K).G_L$BS_./ M^1!,&M]NR]?-5UTND'X:F$]B->+(3O!RK:FC;4;8?I\JIJ_.M]Z*8#9*; MO M967VJ!!,&%56Y)#BNYX *MMW\[GVP;]#-[43 M7%)77P'OJ)'HV2AA!+K^4-(Q:LQ6#V)]FU @Z:A&PJ". A,\?&G>0QXJK_(\ M,Y,+O+$(0N.'K^T_S+W$F@AD0OF.*LK M*W8O&&9WL8VJ9L2;F*L0E?:^>XB0D-_M!G-,OUI?ERE9,C)9ETJ%@/%4V#8^ ME1;0;[AZ4WRN'&PK,5C9OYATJ950T-ML ,?X#SF_C$,B :X& +N_,?]-WK3. MLQ]5'U6IU$ M0-G.2/X]#$"5,S9$E\AM>7836BVNMA6/'5!BO-WZRY4NKR,U C)&'899Z'YV3C*BW MX1OL<>JO=%KT53>Q[_,NFXI/5?9K"&OAEX$$^@0>(]7RL"02\]DY[1=GD!YS MX\PWG[1IXS;3ZP\_P',ZUUD-/99FBT^VHI"(QYQ7GC;U>W62U\T(H%5R$,E- M<]6/B]HQ?,ALS,9#;1]]?2/-K*6MFI4T"9!X2(5GK)UDEAL.>)2\ZSCMJ(HG ML:>"M7O//K1SGW7J>X\*G'"*NVT>&KNXIU>;'JOQKH2FU+:;N#%>18[BY[JV MO^5HWG$9K@B@VQIZU\!!TX 6WEFKTYDQ@4PYZ)7A1NFJ(R [!*,LC 11Z-EJ M:7L"(B@9.LX^%1>X2*9[(10WV >()5;\Y)&;]*RBN:Z8$,10\/[HB)G9=' MMK'P5GSXX,Q('1.7A![@4OXVOKBG_/ ZHP)LCYG@ [;%KT%J]FMABC66E8O4 MRVKD%K(EV6J5(#*8?7A1V%?VXX9V=\;QZ /+ZP\O/V@'L\K 8TM31UT$O-XT MOBX4E^6JY#?6PE"_&_W.P;F7S:U%#*\NOM1MER/"VBT\!.\V9+^A1J1W^@2\ MK;Q\ G <:@]2:]IC;%,L^5CK$DNMK%\SPL"YP$D&F[U"DI<1)N'7!HUDT)/A M"YX@\\.P?2W/2;/VC?K:V6;_P4>$#BEV+I;ML_6<^\AUQ4IY 7P-GSSC O%Z MH1E6R:;^J$+">XJM7]/YQA#X; (RX>WU4J'EZ6&4"\0#Y+TI-RTUB5G8:1^[ MRC%(H/RK#_IM_$U"Q,F1VG2Q!3^$*UHS,J V%8=.F#\YO"P/X_<-%UIGU$)H MMYE@4KLVC0Q5$+KN:C.!^YX1:G<2 L_Y]:4\$B\F&/S+\I@,6DW5D[M9PY.< M(M[E:*CL5^X!_(3] 8G._3N=8J9T;U>S^R;;68)YXKG\Y&V!OA^X/JJ(7MC] M9JA'&TGNMA+"0PVT(X(?Q,[4@_&8[Q9%@C8/VS*'LK%P#W0VXW'*,0J64*NQ M0K-U6+@B!1#7%D\V'C_"[&L9O4"F=)\>RLY,0Y_=2F:,$5>O99D@45=$(M@^ M/C4T\43W=]P(^T X@"AE<%F-:K.T40R5NQK_Q^__8 MMWT<8UU*_&7.C)I(%3:_WB;@VETN\8PL7QFM.E@&_XO!46MZV@I'N5?UAFJ;%%U)Q_E)@M[(> M@9W/4$TT[V]6:86.GF#I_ZN]KPRJ*UK6/ 0"P26XA>#N[NX6W)W X>#N%MS= MW=T/#H'@[G:0P,&"'-P2")G<5U/SWDS=6S,U55,UK^K]Z%^]]NY5J[[5NWMW MKV_M\;9V9.5^4OA,!R EEMK_BAG/RG0)5K7,V8-EX+7D;2&KXYR:(1\QP"F1 M5@T,_I HPB2)_?8K\872%[T.HOQP)56$:ELB2EYP:A@@+C^J$\><_!.GF2,] MNU^S+7_7JB"%#66[HBN@=J9L2Z%F#%J+&/.S7CYI\R?O"57.B'\+VE\\M<338''^3.&+WZ\B1F"AAG_XJHD0__SK/N3ME?7)\-?=^L ME'MV+[0W3&^S-Y@ZK)L.64'K\7PS*DRZG\AZ[JC2$F M[]Y==#UKCAJ8RCZ[ [?7WTG4%8UU:9:ZOEI8H&&J_JS;I-"&IU=0VNLQAV7) MO[EOYL GT=*9BP0\3O4D5:D(PTSTYV5EHQ3\ F^#>ZOPL3U-=@KSUR7+ RRM M4O:=WI=!//2Q82 M+M^)=N%MI.UQH=DIILDE_+RXPXOZ7EEV3"6"^Z9%]9#.]GEEQJANG8W,Z=E3;-BL@A$M""7YNFB1>#L+V9V&IOQ]?GART)"AD M;C%4C%EP9#B250QA="3*"D0;G92J$8H6Q PJQY:E#\ROAP?DO<$[),1CVD+6F4RK^7*H2+$ MXW1I3,:S:Q(+P275#2;H BZ(!I? 7@\CE"XO-TXCUZ.-BC<_ 0QFL. M7,!-BGDNR7-/F$-\^ 7T"V!T-5GOS['2^3A^45S4C(Y!;N\59LG,/CJKBB/X MKJE5OT@L,8//5"CG1;:GUZ"CG[''DR5W-.5=6+\E#-F^A1O?GN6(B9F#>D4< M=30_JSQ,7!2U9[_$^D6;1ZF%$ &5%;'U\A"="W;=B]"(N*O?0],Z>(FM4DV4 M/&?7O RTJFFZ?V=5N??IW!Q$?I1+DA"P<+FYGJB,O(??ZRI>;$.77;UWAT?L MG[.F)/DM-1M7^T;NEY25$5]63\0:Z*M$IMHR; M,%9UI0[SCW(4?$A?OHP8]ZVUP?B&;D"^87,@H" EF9>RLJY[/YN!C MK?S=6>8:C!M43_YJ;4IH_-U(. .'I[D] S6^SFIT%&D:1585$PDIYOBN\&\$ MY6UXOII#!NOEL/54/\6?LKKF^59^7N^!$X=^OI"Q:^/MR-6I6[/I+W,ULE.2 MP6&JVL'BW#XJ8&^3.)4\0-^@#U#9C0]O^O#D%I/V]#AD ;VAJF+G=5'C3B$! M2MLW_0$TW'QWW%!T-PN/$L86)_>QW+.]5\,]:?X+>@%.;P5P;;:#/6L=,7]) M[+DBLJV^7$:\,VE-)Q$=A2N7!CKB$8D8)DD^SLWIP^(JB9\?:)L6F(XO5+EY M8%0*;T-AW.6U6Q5+! $M6#[E[@G0Z*U]RL+WSF2Q=*Y!B,,70,4=B(\&R =* M%1!GE_C++'H8Z]RJ='VW\7*JVEJG8*"28Y)4(W<<")FL#F(3"CY.G@%([>>_ M]7#"\18\ "9O]Q544[5=VE/CGST HS[S"^E.8W]X#'T<\:#N<\L0&7XX0>\TXD_F S0N6Z'<>[]2/UDXL&Y^"CV] M ?D5S3@= C-5;TIJ6N6KJ+;4$8TZ220HWA U7!-8;1CP9"UFB*%PXTU%?:L]7.&,NZ25M]Q^L#O&CA=9(OZ8D!+FOZ^Q$ M'2:^,@K8)\\Z>W_ E'(PA[+!XIGDOT;*-%^K++!OGBQQ#216#,?XAVM2-OP! M9-J:9E)@=0[/XZ4-H_S%&R95G>$OE7>,![3F<0 MSO)7"]/5>=M=+#T+?6MFJ0?W6NC!4@9A5!Q=%M3Q^KB<'%M>K!(B/XLPF2/% MUZRN;I 6[A'B@.P!+1M%#C??NF,GA &8O4=DWRFHF_B)MN@+);++^U.5Y\O; MKC9!KRZMO?,VG=&ESVCR"?;+I=W(\ " D"KRIXY$C6N^.)87MAK;U;6,FRG\ M:NYFHH]RR?L,1"[MW#HVU'%FOL=@FK7$%QX; 8C4DQ&#AV3^ H0Z.)\]9,C_Y%9XJL3WRSH[%M6<>B!*H(BGM M+5X9.U^&A;:G?55)U9^=UYK+>O-U'3[*9/=7= MCE,+ V7W^&+W&*G'NC[B@O-[1N&O'!*;R3&?GL3T,Y66G7A^ MTT(O35N7N"U![@M$5DIAU),6+GF='[TX"[92F%; C22VY!_Z>7/ 9T.,)<+A M+.7)E!@CFGXEZ2K39?06?-@A.?$O/GL'H+V'VDA>O@]6N5/-^;>BL'X-!ZDC M41](-O\QX5$POZ$QJO8?0'C)FJ[+9&9LO8+@MDS)Y.R#]3LMT!)[[.1F^$U[ M!AKG>S$>I>L@U9Y55JO6CGF-GPG)_.#.3(6;@)T!MZ_VU4:R3Y&2WR:&@&[.72?B/H-5W7%B]3" MW[![K-,O5O]R-U23Q$!5 S$W3(%F'0^5#[6SX3P4:9H3;G!DK[;+ [3MJ$)\ M N: BM#*LQZT!W%+'$+JSLOBPL>R2.]V+YY[]>;==3NN=R(>!GQZ\$.R'0)]SUQ)+ M4L?!>X>0+7!WUHAGNZK+N;EM$E4><4%"IQ,_=ED!&"U-D$ 3-1\XIC:#EC\F M]O)5LCJ"$0'"IZ-"^E8WPVR'DS"PZOK"J^;';U]V@OG1>6<=."^E5C0E,KXK M+X$GRMPJ;-=X]_93!DMO=88O4SX>\7X##&&9?N#@B?;8@UD<2R]%E%<8C=E# M B 2:!#2M25#(_!R?)K>H1JE1@5G2\0OVFU_ .1/3EK+Z/D%1:/*RE)3#LR?^%)QMXA%$23PQ5#G$R%;PIF6NJH?<_'GZ5$61J0+8Y\(_^K71' MX,9)D>A&3Z;WINA*7EB[\OIKY.+%ZI9I6Z&=O(G 7D>*/" +RK+$F+7D0V7[ M&>' LJH(_1=31N]3>/&0396"@UNW$K]U%DD67021#B_*>8J/M'S-\!M+S+C$ M3SH.+QY[9_5>S^2H&\2W,$X#-Q!]XIRX?LFMXOD.GI+#=@J[^" NW/PGH^$@ M[%X6YB7I[M2("&1'!3^%=*L87I0Y$MSAV*[@M\A;@1<@4[DU9IYUVDQ5'[5D MNG1NSLEYUG&5J Z/C6!NF\P MB(\DH]PRYG4.E*5\.X/3G-<4:0L48=_CG:+#8 M#AC&DH! QNDYHD4J[X:#&!G&Z_'!$#*!ADGD('=V58Y48YK5R,H=1>N,;>G* MNNB;YE^_5GBO(%64J!& O+UPR@;K'K9)M7H5U)<73Q[NG+?'V3>]]IWWEQHR MI<9,_H/B]]OB,_>'"J7>SMZ^+&Z0.(S+U'2Q<_>I<_*$,9U$P,C M.R\=)>2="Z*,[:^^8KZ#I1:" %)74''L ''8FVO*G&DYMBA[,'^P#8EY"(6. M9I*\TS8OHOR!=?=:T2=Q<@U1O%/)G8O O?>.Y&A-%I2VJDJ#2U$.I MD(]H4U_Y][0*6+U[!@*IUMJ6EUB7@9T[55S-D\P<;<5Y+H6 SMW$Z"LN\ MJ<*(0,IE8=YN[>W1S \/G\,@O/G4&N.!BW77@0]&E1>SZ^\/C5]:W8*YSG#5 M$6DS2XWTO1N-EP^]XP03-U[*-;S8,L)5+SB6KT-!,5_V*IKQD^L-P#,)SW\ MF$8G+MA4>]8I?M%XN8?/G=FNLJH2^Q4!DC$ J/T+#Y2,3GW9X6ZI?*+2KH/! MPT5D.H6HV-R)5(58E@!D]:U,P*7#Y:>AT\P@6;PR0$NZ[>]>H6Q(L?/^"UTC;B(M_6Q/1G,+D GI/1D6;?^I*F^1-/5S&4,]#7.X1Q_EMJTF:8[ MF,7PWJ?KQ#MU5T=*A:R?1HYE$(ODI[6G M6-1\VFJBV 6H>/:S+GA\P/477>8.QV^'A,/ZIXFR2^3&Z8[7D4D](*+I"POB MI*SEN_&*MP8KC90%RW)^]4#?,//\%JIV#B*XGX'7-YOPQ>,3>!'_1R 0,?B; M#_1<1OZJG[2#"L5R/&S3J;8DNG5@.E&UIM[-+LY=1Y5+([T':'3"YU>_<.CO3KOA3P,(_]JS0!\U5!<,>-B?KQU(J@= M@YL^&0E&$* SXQ?I_ 7MD_T[L5JG2*_V5\:4O?XYD>@5VN72G'V-WH!XVH=U MYJ%W$AC'QQ.3UQUTE,>1W %^W^:W5&CJR"640-[N4RJR1T=XHI]7DX67IU'P M(BC5U1&(S!#EW&0 KJ],"QZQ,+>A7^UA[9Q397/%Z?#T-&:J7?O>$'JOP T)P,J54\[&VW+O M_B@:JJ1_T9L-X_[I2-/>%:!QHT\RLP7 G]Y1EF9J8N9S'(-S&RM>$"?7W.\1 MT0;#3%47F,MZ7[_C2\J"E/(,VYPF<-[%,9>[Y"]^-'H?.6ZPT7D5%$4Y?T_B M('CQ-N76)/63]WY_SMILAV4A_1SQ97QKJ.*7):)!GIV_KP25^0NLU)6V)QR= M+D=]U_IL+MS*R]JD>>2L'Y,7JG>P2YKB3-UR91-MEBK+V.T1MYKQX+QELF&G MRSAB3B'(+83@!9>$1?20=HL!!T&^^^NTZ']W&%S![NBF%QV/GE7:-(J9%\QW MN-.L& [>NMSO)D_LO[#L?L6R#:3OZ)=>O.MCFKRYN,L7O-")T&\WVXX;_2KP MK5KRW2OG2*3H7]RX!-)>65\T0Y$OZQHH8@3LY3]1\6IV?"]^<97@V!UE,54ZY>)2T9P8Z'B;C4=NP+E6L"+T":6@PM@X#K<=$H__" M,/=%9!7&EK.FDJJ6JI2IM<2#5.!3II]F$(671"%9Z?S%V6$HM>/#B*;$%?3G MG0B;2E]WAU:H@]:6,.OP>0^7_48ZD1D-T:P $E&C;$DP_W>4IZ!A?(-?=L1_ M \6S,3*!O8@:^8$*_KA;(P#XY[61\Y-E\=<'N4G(>-8XP0AKZ5<>14?<*&@ M@BGL [M0R493(]JTU,5).$2 Y_M?[VQ6B [V,T5[DB4LC]A7GZ^C;BF@!QO6 M$A[B(-!DV,J^$M/\5-P+$1A\4[_I_5YWR;&MZBZYCX&<3X('J$-]* M[>"H5/ZMY4(;^,$U&E.CJ%#ZK\>:?!X@_]BW=-]#2-VT!&MD8:60__BU,P4U MFCI9G^;&6''3 >ZF.0/-2D",?C8M$'$9(3FS8,WNJ<#!N E62+.?+)F8>7DX M1B9X:[R-"P?=(5_@R=?Q$^'@'K=J6N!&C>=$!I,H]7A?= B+FEPS?VII9:83 M-;F*S,L+;U2XBDBM >+S*=3.]8>]Q?]&_1,TUO(A^>;H*<:7N.@.=N@RXD_ &B- M[W].C9R'S!0I"B#2>NWE(?+UI?"5,?[?1^I=6":W?_ERJ:F.0,+Z];A-[/'@ M#^!:R_X?U+#S?P#?4_\ 1K3N0VJ>QI06/6B:"HRV<.",@A'] GP#W>&:6\Y> M_:3^ +5_@#P9*<:?\(P?_\4>]%VRTF,IVY*PEVLZ HK,*!4^'2WF;A:_\.$ M.=)HF;K5D*06B,-%P46+EX;%+Q8OA'(T^N^/_H=):(O@1DC\"PO_X#3^+]5_ MJ?X3J31D:8AN\TF6[/#&3H%W_TO=V2=SV G'+I#TNCQ]MM#YF:57I&;G=_IV M;[95-'92]QL^LU?A/&P]KT)<8:"E9971> YJ+ O*FB%C>RM:7=D71/^=ON$\ M]]&AO&!,8$EOJ<93)I1)H%>I:@0QR[T0\[N!Y ,,(0(*%0@S;-I[J&7+'IL< MN!L850VH3/"8X0W"VEC?KC\JY8MQ*F[KZ$Y0JKRAC*!EP'&*U];J5P!B:]G M1;\)%BF(N:Y\:H:"MFDAETH=BPZ;K]C(_A+LG:$*<"ET* L-&P0H/J.NCHO M/8L\P+@^>)DSJLD3]ZYT6?E7ZD 45(M(I-9U]G ZEG3X0K22)SG(N?V$-.K+ MS#:XB7$VE\K(1-:OD>Y$?Q#,9+0(Y-_::2SH=6$(BO+-)9O^]D"M$>E$X?(' M\(8\?R0 U93WJ3[ZNJ%.@?H/P"%DM7MA M>'*^I. ]E>C10]07T+ROW\+NMZ!FLX/?W\]T'TJ>6OC>\4V Z&TNPVV;Q*[W M55+B#>A+RII*8N@!#;Q+T,3(RT Z(V]\O)[7E0[)4=FH=WKA:.J\;DD8/NK\ MPG=SUEJILHO[J]0K^TL.!!HI8@R7.F_?"[K<9(Y"^4EMFHI0V_Y1"NR(]9C# M.O$]JF6&Y#_$@YR(13,I3Z9<*E7?A'X'I5OZ4)),Z C$(<"%T-&6)8[^V@Z_ MC+5>WE]4:2BLVC2$\(Q6M3]S><(>N^%)R<=];RI[S#4%PP)C=<)/!:YU$[8MZV&SW_X-;PN^J! M7><7_%9FAY9/V#N-/8R;EU&0]*,O'FY[AH!F0XB^T9P7\REU)(S0 M6BNJ%.D;EEXK*[Q_3]2(T\E7C+MZSBNC$:\@Y@+M ^D9QO; %2 3L$8"$ MWS6]GO<*-T.]^RK.5E\+M6^W"#0]O!Q'I*5Z@VA=G.;VEH&1*R9T#$K>6GM" MK+3^%+CA=.\@JJ+*+]86C06I&;O%YW#[Z"..'$=JU7U7SW5U-' J>7":4QS- M@^Q!6"\\_E)5D<:?E)CJ@C0=2)3 =0,M$\-LNUMT!S&QR'UJ":"<7I?Q<**V MT'>8K&ESU$=)VL0Z $BH:\4 J@IHEDN?/EA"$?.M5EFY#7V2LQ%MNE)H(#4Q M[,;YP=KP&106=2_"UP@YEY$=.Z;@F;%LJC(O$XT=:G++$I_KX3>E%W)& -$+ MS&GBQL)W^IA(P%>RA*,+>O?UHH354P%<%1))@BE_&,3PD.BM8H$$(7_5B\#N ME!JZG=>O\+[?]RNKY1%]*8>E(\/!>?+:V))-FAV'*._@*0ILX05OQ_BN-D&" MZ06A'0:RZ0]5.\>P8AK.S5+\:6O^N.XT-*)<:K)<5VF#RF'+2NZH;BNKAGSK M@*,9C\.A#Q#K%+&=_J'F]U-;IDA?YBUYRNE"[,MZ>_YFS9EJO3[EN4H)SADP MZAH=61HM>;>NA,5#5U<""HOZPJ'..@/]DFO:;B<3R,X*&UI39 P_63;@#468 M__D[:S.Y3W\G1A[TX=0%E$,#&]9A_Z$!-$B'G8#[#=.3#-N\4_CT7JT')V_* M?L9W,HBCK7W N4<7W=;5O(+*!/&MEW5TQ*KC,(VXL4?AO.I!3L?2!\G8QU)X MUO8N,KMG*KIZ\XL,APNG.9)]6<>!PT6TB$?J@2I9HTBD6M@O7$O*=FP>*CJO MMCM+DP5'>E-C9&VA\E 2=?2>2.I06(%A!8#>X$5VN;Q?*4!./&:1JDJM;$*8 M.#)'YY2_+,U!$VN;2/H#QR":_$9("DQL%'+03H[+^TNF_FF-A:7"E$N3\@<5 M)?>2($M3HIW3A,,D,@4 E7%URON]L@]?]L7M[WK:^L>UWV[?YM.?O[J!4I", M]@M6U.2?W'/0ESE/3&A6B_3JZ^N%*PSUX:7>($AOS>.C..N%F_$)88?:PM.N M[?,FLY9SJC*/Y(QX47_>_*30D&;(Q$5D!O Q3R=+NW ,)BN#@H6YH"Q^VM=E MJY"9/(. 5MN'QR3($'^^E'#*FY$'ANW@HD8*RU"WG*^@71 3D"X:C*X8P*J= M+YO*//5@]?[]D7,-6]&["=-0VB\- ;B"KD MT1??>C?KF1QS1K"W'7I:Z_.[NCIK?]EZN;B-4^Y01CAD.,P_-TK4TGG:I3 3 M3V-N3S;>J22?]4Q]A0=5:\E4&4S 1>OP,:#GI27J*Q>N5,9V?!$:6B@<072O M99T$E-^]'F<5X5FTWMK!A7F-\+8TFR@FY+!=T%)@1JOC*;]N!YS5<@7NB9=A M,YB?J(%-@%/M"VPN$N9](+)053@44?,V47)#[M0M(Y O>.3NT?,QWH]*HE?A MW4?V$HI@!WXJ)Q'?@^QS?_CRDS^ C7[EQ_C?.1VQ&(^:G<:B/_G\>W?O1CF^ M<\/-F+X %\]7%UWP=W/O,#V,5_VD M>[31$J\O'YPVX23(MDD5;"'&T>ZH,RIA.XF#(81F$#E(;(^SV:WFKM+?RMO2 MY7$$U)&Q%F/;&JX/60N9N( ;>W*#FC2X!Z$/UAD ;[Z?ZB1-+QG9*=FO^1TR MM&\KFUNG 8A*)^'Z '2>H.6S^(XG)Y!3A>%)="-(3B4:AZX%:,XQ0RS@(?7< MV\ 5/ZZ=!=<5#4B8#$:A+_F_%@$U0D-O.AC[EO?JK5I;!D@IEM[@X0_@?,>* M,[B5\7!-X*VK'!45PN<,-L0G,W8UUFFO1W66+EE]"Y'V$->JQ=/8(N>:(Z161S('7C7*F+ZW M@_27=S_"'IV-QISZY?<3)V6T=-6?/P\:#_GFX3@+4._T/WGM,?0^Y_; 8X.Z M&@_SG6BCHFG$4YJMG25;Z-&Z(.(G)EY[C5AV2V<0;.*1NU?:@E^_Q+" *L(I M8T#[GH?FCN?FMY1D<<5*&:.&+G@3,E6GOIFA+];E=K[@HQ[&'YA>-+",6N[V MO11)%V9..)K>K;RQFV)M,;I)%8"?<>(780REDPPLP_%K6UB%2+>I4+?>M)(] ME0\%!Q+F6@(Z2-];3F8)',6C1*)/T1,ZPZR=CV)CT>((>9H88J?;Z?U@ MV*F$^:3(Z-P'M-JRW'.;R-^QN M"3!F;D@UC"!1$O @">?2R[K98]Z/3EY.Y(@;B1@UT9>\@3M7J05.N*!A5AG4 M+4W.CQ!E2RE0QK70SS$#J$/&:SUNY\(NZ18.%KA_8ZIW$]@,0\IT/54"J YJ ME"T5L+/V:20.7'T$A%TI* M>5H9F(LU'7'Q(9X' +]TO*,_ ,1[OWHYY56'1KJ,Z[I&';%VVBH/5(7H> 7> M6UY3)]>X::UVKF5,^7\[Q(/2X24J62 .L$K5UYA\-(0@_!')JYUWQ M&V8_V.&:TDJO&7=;J'J_Y*VI:?ALQ-,RQ,JI>&>W?V[? (Y>=)#BQ-L+-()[ MTO4K T)GV27WXU!6<[RZ\F7K+37Z7:_M65^Y5W+H2=D>!BS'U/E9[F8"2$SY MO-LOC(7&-0O/W\79^"!EDF&K^"?!MP7F^">G@W7H_W65_2P_K M&B!Q8%X2A,L"P8D]_P?2M#=3W&O:!OT=X_^(G-^,01,W [E,O)&>$4_%6L6M M7^?9!K_56E7L8%T,.(S1D;J-!V\\+&!/0KKG>.B)SFZ\G/9F$^86WY'UR#@^&F/I<5""[#N'_;CH@65L=SDK$/^N%:R7D] MA,)/A+OR%BCN7I^"JE9ZR4K.O&:\ ISX"^3#N'C !ZNO_I;\"M*.)3)$PJ)R MTW)NVCQ?$9]4]V:+ZPQI>C^5<8S+;&5GSO9RT7^^V0S$JL%R'7SDE9L4:%AE>_N#_;N1,4U>> -" M<8E?M@GNK0)G6E2S_!2.J[:$4&+UC-O5\Y#R:OBY=9*!'*Y\BXGR%*7TYKZ^ MA+\B=IA&&L;\#M*?>E02D62KU]JC+IW3PR& 2]B&%VH4+FQ[]9E37 M#+[ "PV&MN3O5'VJN-9J?/)+N;IXT,U%>'[.[5TJ[+WLWD>9"0'3O..Q\PX.A?CO?0 $;.T-'9P52)C_9+#L_<#$.Z\5W.-0D)&E!U[G&C.N5JWL*TLQ4C7;G M/W>PI^GJZ%3 /U<00!MO0?Q$/B!^J->\):H*[FO8>!%;6OVN?$W;AY<_#'<0 M]=T[QK8AG9K0_*CMFRE+>UP#K-)V/V9AN??]'LG/NOV^UAB1^3&'M[U\:F^4 MDZWWU5B(=,2SF(N^=! 1%J&2TZSRH K]IE)CKH5L/O$?B=Y2E7J6IMY(3:905+MR+$U3Y#E>S]-"FC!)\'BA)_D M&!S[E+JDPA;N;P>SQJ@$5AD!;YS$-B#1^C#3MPK?42/CDO35J"B2_&(BYB2N M',(3FM'+=%#M6%;GM*1$#Q+X%Q(V)"P(4*EP5)&W4PO:X"+I$GCZ,/4SAH9- M-UI'+)D_WURL$H3[9YME[W_4WP0AFZ^[RG]&5@ M<6C,D"_CJ+LUR74F.$( -/>8';R,^SK[TLS[8X/V%'3TZPOE5\K""RZ.-7P" M5X>+GFYS^M=W-[I:I1ZT4A+ MM">(:L@?S"-QL,4)JV?P8>.VW9[SZ-9!BC/PMV9+O:$RP>&DQHMXH."8,5;P)F_EVT1,B%*1W7'G.< ,_7AFN\3-= EP\1,!'V7S1C>X_H&GR M2V.W\I^^9(P.:+%E$(3,7N[A[3Z%-VR>"#KVU,A8NX@<1]BL4(6NJZ'9CL"T ML=/&)[6$&Z!PT1C;G<,< 3K8<2_;LK@?+T)CY+P^V3WSR4K0.8L:N+IZGTT48=![ M?QDA-HV]1V<\^C6Z_ZF_IZD5G#N>>=[D&.-C_/*%==?SVU0('1T(!^D-W5,J ME"Z"A'"O-5'K]IXFQ=8]M^='%+CSYI.T>LJ^"T4F'6I"6!.\;Q"<[6,WVM2> M813VQ7&, ML%*ZL341Q-*"S=$4?&0XQU]P6@%>=,MQ1(_&-UA[1MB0=>9'GU M9DO9$79!"TYJNS#11B>)?*< ;VZ95)LR_#F8OC&>YX0GGJ:ASG+!WJFT3\RIRK@^(MO#&X93W\O& #RXV8>3$/@\ M".$_V-WUY$G] W@G%SE:[.1%%A)='R;)3]F9(A2T;2:MC/*-ER$%)1DP[?\'=I[*I'GHPVXH\Q?MTZ$G+E:+ZIGVG#\DQ#>ZH\*JU5PJO[TY< MSWA;NALTQ)VCLAWZH6TK2X_PR.$<0(3!CN'K+&-O^#0V[$4<=?6K/:.[:96V M";0/_-AQL]^N% _]P.<)I=8>RU[/>ZC_T4_V]!G/Z8ZH_/.-E_#CTB3L8.)( M)L.+&F:>G+J4D*==.X?XPVO*Y=A OM'%EVU'S]$Z1J9P2N]EV-ULW)/>-"U8 M-D!57&#F_? :1&[0APQM?&I]MEN M2;IKF=F\MW65&:T#WW.QS MKMC&,WGI\2'8W=)@=XGV@ZP?V*84I8K4X !=#=R):4'UM[C^0'WNVXN-%- M(@*V@SDY_N: 85?'"3S;J$.K:]W33:>^_O.GMR7)=)"T3?D+>,5IJ39 M@9 _V$&.X7L=4XTT=(DNX3C/$I9"Q8W$ MM:/"1!_^,IZLOY4N8YX4''XV1AO\?MAWM+84V"U2WY;A:M>=?ZY#>0C[/AX? MP]5;H!ZPODEB[G5/Q6+$4QG?*U4IZUXL.%,]5V67TK<$7/.-LTV:Q;:4+Z99 M44AV5OCV=HPZYA[=5+9YS5YTK/K;XDB?E48*MQ-)-5I=0QAG$U5H&?&X&&8O MW^]<]!3].31G)>J%B;=WU]/$:O>%_;HX6-MZ^(,4.,AO@@48 BF]"V1Z^Q+5 M6I=@;9O&@J<7WQYV-%T#Y]=36#:7J5A)$*J/B=YDK UW/V1YI!7JM:4H^$OQ M@/M_R._K2<$2=NB8]RL]M'\F"KSI47N2[!5F::A?4D[@9]T+12Z)W\ = MP_ O!V#ALJHIV_3;,7V%>PI\N#'LOK<"#OG<8 LI:S-R#+34494I-5"?C=("'F:%M=? MHP@TX38*-"Z3L-!N';^,W/W[\Z&1=5[&0[#%VL&9<^Z*! M.08CXT\YK^R+\LV2 MBVA6,KW%SF6-V6V\&/RDZHB(D?ML^&<0M4C*CE292*TU[I\\:IQ*#'%8DK&$ M-^W1'5R9Z:JP <90WM10JZ:GD#J[UA^9M6_;LROLDO1[05[6PK5<*D,A'D0W M4&MJQM(&HUTK)Q)?O\0W3[['4DMWD2T90BJ\8HSS$E[24EOT0$#$;_ -#VY/X-P 0#KGO MK1ZY'A-O&ZRMU=HX>P>UFE&(TD@! $*M+Q!MJ$_ +09]#2U2O:820B3_+Y2 MM39U!+./RV1Q,V=

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

7T? 5:G:FI7%#RRZ[?!!*9G&+&XV4J_7\&]?+^55> M_+XL'R7/5:ZYJ:ZDFE%"48(BF)JS6\RHA"3#"@8(Q4D<89RE@0V!G&UE:M31 M&NI8DO8\DN\N^4*KO*";'W0E;A^K8]3W/^6* MYZ6)L_^[S.^_ZPG,C>8?>B^;O\@OJYS+N5!QQHSPEQ*)A%B%*60",_V/R>T) M5R>&@G]399F+D_70"Z%F;:8H+2K"XJ-]26PFP%-L&N'YD_C#JS\ M 5V?0<=IP)Y!][K&<5!Y;@+N*M]GH./]#+3^@P: ]J\25!!X3&P:M\]\Y46- M9/6X:57C=L5!5M;(S?[$0\U@E$8I8"%6F,H@#1"'!$NG9;YJA*)6,<2N]) ^V3&UX>O_FX]V[ M&[!N[7,XFKBR4RP.B\:#>N#APCC2$5*:@=87(Q30>F-.CK8;@6^VM>.,-=(8T?'>YG23Y ?CL<=*538QWIN0'B[V#)4^/=-?0>M=\G3_D M):>+_]8+@P_ZDW*>I(E >OT%,]U+$&>A'J\H$U#RB)!$9&D66XU79]J8VCC4 MF@EJ.X$Q%%26VHMFG8+S_$CC":2A1Q!W?)Q4LBX@T$L@Z]0S1]/&NN!45Q;K MTJ4]SW1T'U8AK&_I6MX7JUR6S38BSE@2L32$81QBB#G*(.-9 B7%&8G3$(=* M.IWHG&II2PCY.N$YV?Z]-)+$V]S M&R/H5U>%:-,O*"+ZNZ0X#,V9#Y:$P2Q36,\L AH'D5)AZ"2CYV["U C(F _4 MHOC1'(46V\17NK7=,?.E1[_84=&P: _,4288L@*[-=]LB/YB/ #Y\D^=A..= M%X/DU?0'T5OQ1V<#1J[XV!>@PS*/O9_4.WW9MK#OVV)9:J.:6MB!3&DLL((\ MXZ:B#9.0H91K\OK4EE%RMJM#I>HGP<5E%(97E5UGJ M]2[_;A*LY9-<%)42WURR.$@43J&,4CUU#$0$619+&+ ,AR*(D J=,J!=#9@< M-=+'?$T756+!JK$8R#I9RC'HT+DO+"ER0(2'7]!6IE=Y,NT2-E^"QG[0.E"K M/.Q<\%EXHA]XWDI0.#8_ P[B M #(21U!2$C+,* JHT]2PCQ%3XSZ;$F*?^I;:Z=5+=HPX-/8#LZ)-23$;V(:T"ZHL[8X;/ZD>-6O/3-\_;'_\KU9%.S\/,GP\%U,46F M_R>2$ J.*,0I#R")40R1#$(5<1I+15SHT*[9J1%@1[IW:VPU%_E\\[=>U1,M MT;>C.?^8#DQLU\#I3&9NZ'BB+\M&1R4L-R!>4I3CW5>O4KM%KMMM:YUXQO$SJ\)S=[U.ODR=P&%J5/Q\E%S_ M>%>8CVXWZU+/T"3N=+]K[S)3,? MZZMVT/P+9>_XZ>>))/52X:-O"O>5S7PI"P_ZWYH M:E$BA$(42P)E0&*(%4.04<;TLB&,2!)%"1)N9=)/-#2U07&/[PQK]:L+>A)7 MRP6"![2&7AILI"'RK9$SL#/3XV+@ A"^E@&GFAEW 7#!V8.I_Z7KKQ?3.58* M_>/23!'W(I+F.&4A8DI @8(08AJ&,$,$0Y7$1+"(9ZER2GCO8+>O:D)]9BZQ90^9(N>:WYNRTXWU^*Q[;3[+AHX*X8F*;V>V%G_UZ* MVM:%3CCE,*H^C@ .H/9C:\&KJ0 Y0G1.'FI,!#L;ARAI>0$(7S1SJIEQN>2"LP>$<>GZ'IH+ M_Z47;+^MBA_K[W^EJW_(==E\;^,P2W :2TB1XJ:Z=P9)E"&8*,)1&K"(8JL2 M".<:F1H;O'^0JWLSMC[45CJDX9^"\?SK[PN<@5]]8R&L302-C9=??7N,'#0( M/& UDKC G9Y%FQ4Z73Z#*N9#EN"[P?&^QK'YB@%:ZC]7@7"=+YZ9=)MI^(]B MM:BWO%>YU--N?87\J3G 9-F8SPI174HYEPL3/JP_;AZ?+\U/I7YX\6 F$1P\ MK@JQX76)CGRI5M1,,_AZL]+-?,^YN<7$*&LSW^L_R=42O-^8\MVSRI*_YD(L M9/6G&;A1JYS3&?ADLCW C7YK]*_5@V_*G()??N3: G.7_&EHT.Q/:"O_-]5@ MU%=MS)'/(J=_\B7"?>%[<583X=2]XXD=7+!^3\7@TK6]*Q&O3,7!=[+^[\>E MF7PNUU52XSQ5D2 !UF-!J"*(@R2 +&("QHPQ*EF$8J+F2WEOOH!V\\.S[5F] MS:1^F[NM#KC5]MWLD)J7*M^9Z5R@^ S"=K/$ZU$;K51Q91_XI;7T3P:[CQ;8 M]2E3?!D3?[6*S[0U=L'BRVX?J5IL<5./2>17\WK<+INJZ'.%HR1(H@@R&@10 M+QYC2%22:$#CD*,@532S"JT^\NRI31G_G?R:8K.['$:_)K'#9.@%9!;SQ/Y M#/RZ5X8!;5F?2>$+'!SF@OWQ&&D*Z("+VVSGN.=G)SDO;AEO;G/?M?]4ZS6)IFKRKS;+-=?5O(AWSQ\ENLYCW"8D(!IBJ($8BXHI"GF M,*:(14$8AD0Y!>TXM#TU'NL8"T1C+?CEL;;W3U51'=?H0_M^L#QI' ;=H0\? M7XK,=9%^MT7ZRQ;ISV>0[A&AZ(R9MW!%^Y9'CEUTAN0PD-']$9ZR>?4/[6=- M ;^]4(ZE:*LA'8_U>%MHOA4!YI2+$ :(Z^5_99UO]1A#]N(=B6=%7U4;9 MB=:;\T ('.IIK^!&'HS_:+?-CO@.6>=+S$BZG9S$U\X#CS':)CC6\TJ(;>/TRY'7ZIY^(^AO12%^Y(O%G(8!DV%(( EB"K'0 M_$%8JF"4T"@12D91ZK1N:A\\M9&QMF.NEI;-@^=M1QX*4S+SG_X.^] MDPCTUWW];.2BZ=#FU$:%UN1:?[R.(]J:/0/&[%X**3;PV[WAGD$=^.7_5"SO&[FG MNSVQ)^_"* ZX^(OBO]CBV%'[MA ;[>T,57N=ZL MEK?+KHM] %"'WSB_5&KB6%B7*E:@Z8K:/?#+IZ(\LW?0 M9Y/<$4U_6]^V#8^]H>T(R)%M:M*?3X8#1.6:"8DE@*/E\7:[H8#]AM:Z, ^VB*$I3FK,XSM';<[P&P M@8F^P/3)"I(C#.).!#<^>;65J M+-NUT+&VV'DTSS. -XR&WG1R@L?ZQ;=R_]QKKQ_0>>7U;[O7_?RS1WG9K=QK M7W6[BSU%A!F!SCJ:8+$H?IAMU#DG2F:!2F 42_/:9S%D#",HD/XWQFDJ8MKF MZ]Q=$>=UV+35]WP_=>=N#/VXUE! 6TNO+>5P!';KU:$7%%\QGFH'Y];D 8.B M3N,S5(S3D19?-V3I- 07(Y#.W'H= 6WG,1TM3Q/,C47*!:<"Q$B<<4QQ/'Y'P=Y24N@4Z1)#$-""0<&?V.+(!, MZ)\2DA$2!"$B!+EE:/K'^_\1J-U8_AKX1F;XSL)P3S_9F?U4:Z_" MZA=-(<(@3O;#,1)K!,$ TCM-,.8JH]3-C:BO/QDS0M;/7F6C/7K&EIJ&Q'IBQ M^L#<@ZBN0> M@:Y&9&!B<0'#FE#..GV$)TK)?[TOGOY3WU=3A/YAQPS'GS;*"W_6D?8]/G]1 MOSG*FSHZ\-MW*=>?#,[ZS6\WN/7\(S43#R/;"C$VQ4N#+(;5#EA*XD"D3H5B M3CWL114IH+65L?];@N$[>84?G ;^/7N"YGSW.$R&I[F!V<:&G4.<-GA ME^.\Q1U]\]W*]:TRH:'ES5)\DZNGG,OR6[$0D"]>-[S-XVE&#'Y0&IH86H,K,*K2U-108 M2WTF]%Q"PULZS\F&1D[FN>3P82K/Q3NNW>OH;*',(T)0)"2'(M0S?4PPA5F0 M"/UKQ$(JL.")U1GYV5:F1@@WG*\V4FSKFE=?^6+]7:ZZ!>?Z;EITX>51$BF4 MAA#)V&B!A0I2G.K5E,(HC>-$_XG,G^2*%:,!W&UM.(B__:"/7>5\_;Y4=*7]ER-NGMY>.79Q/UK57+)Y MV"S,$<\[^;B2/*]G<_)Q(1N5@YM:(*?Z_&0\_5PRC'F5E:UP!K',$,SB ,&4 M!S22-* 9P3U.#GW9-]$CQD^R+/]L)(!;)S7I[+QT(QMO76G'3Z/VS#B4UG$) M='V:@:U7M01RQZ\9>)%;-=M/KO)'B;X!]\2BWLP:E7A]@_F2J[T_OX>PZVVY MEL6]7.:\?),7#U*8.+:/2]ZH=6*)6 ,Y!1=8?@".IRO;X MXKFIR]HA/7XOYS0+%.8&T%W27LTK[/;;G+D0;WORA6+TK-FRM-@L]@S9JO.57R67^1-E"?BT6 M"U6L3$WC.55!G.$T@S1+4HA-Q >5*M7_8*E"'"=2.(D?.ELP-?9LC04[:V>[ M"/\JU?OM2H^'YNRT+,$?QA7PH?;%\<#9O;>@^5][P==+01KOGWKJ(L78-WNF?-.@*@< ;,=]\\-CIL M=^^QX:^)XV/#WMJ=]7?#]FB_?X\/?J#?U>C\6]W#'RM0!U'GW//?OR)G_?C7 M4N'<<^Z,\N;^=3[JMWS67=P$HF$4ITE ) Q":?(.DLR<#F40\4PO@Q%*D; J M2'JIH:G1UD$!$6-JSSB_D^#:+F.OAVSP]6DOM*XLK'((Q2!55#K-O&+)E$-G MS]='.7)]SSC@36G*J)8W_/]N\C*OSD#,CRO9?HVS($NP_A]DS&R/)8& !(>Q M4<.)419Q$21.ND(76YP:6;0&@X[%,]#:W#>1:(-UCAFW! M\14Z?+&]<2.(;=T_""2VOK&W.JPIF_QWNEK1Y?JY"IRCB^;77);UG'*.XTBI M($EAB F%.$4$LBS-8)*F<2IQ+&GJE!!IU^S4Z* ?FHV]FL4=7]8KP?5L#O'$#M'Z QI&.5J/IB9U? MWI= ;D#ZDY>U:71LA5D'((Z(S+K<[6-I];98/LG5VN@.US^651!)SF4XCSA# MU)3Y1BQ$$), 0X;B& 8IBV@:8QYSI[0JZY:G1F@[^\"C,; JC_+[MW>F=DJ] M%>.H+FC?!WV69)Z0'7N-UC&[_:6"O+)\J#6;!5:#+.+.M?N*JSH+.,XO\VP> MT(^WOO'O4FP6\E;=:#(4^6)C IB_2:ZG$X8#C]H%TWUM$T=@G.K MWM.5J66G6[ON@9U_X/U>M[[=[];62:"]K&MA@3_NS,D5,.Z"RE^/R^3A.L,3 MV0]@X*BCPG OQP^!FRI_PEIOJZ"4VZ60@]B:]V*7')MRY=BD?/G'7/(E FL MH@B&53T8EG!(LR"!*0XX1VFFD7<:/^R;GMJX4,4B[!GL?O1H";K]H:1_*$V;/0&TX^*/Y[R#,ZHZ;QV-.RX9'/P!U ^38T:CC$[QL4IHR](NB MW'3G.C@F22Q%!A%!$N(@(#"+DQC25"$ATA3%;D7?+S9U"OJ@$*!3."&"!FD"L%:^OL9GS"&A,89Q(J(@B5,>IJ!NMF/QU^^Z@>F]=CJUM=U)V>@[=;64=#QM&+]CJ]@ MYVREVP/_(?MD,\C0H#&3GJ<#$LT"_'D8%;ZS? =!2=ZL;7-ZRL),?F M84A3GE("42 5Q*&)D-6?0"KB!%$2!BAUBIT_W=34-GT:\[JJ=G]V(_0SL-J1 MLA^P!B;6O8H?+6A_M(9ZW.>YC(8G5CO3T*C,=-GAE^QB<4<_AO@JG^1R([]* M$Q>KUZI?Y$H5JP>S7+UEB_R^XJ4V:?LN?]"7W*IO^M-2U0SV*5_*CVOY4,Y- M_HW2K %5F!JMMC2&F9($QBKB88(RI1!V811_IDV-@1K/S!*T\0UTG ,[[SHR M"K6#9C;2=1'\89P$E9>.(?P>>]Z.]%ZG/P?L' M]"79#]!"[S-$+J4H3;A%E+_J <_FRQ M@V)E+6C,!5M[O1XLVD'C[USQ0GMC'RO:N7_D5-'RQIY1O29TBU'](+.0UJOH M>E5LSC#OI5D6OWG>7=*(!MT8'8S&CK_)4C.B$;ILR;$P']WNA!'^KM?AW\TU M3W)%[W<4^[91XM[0Q9UFQJ"U9]4VG&QG2.L"/.F/C8R%-"KTJD=RV'00MPTJGHS!$QH9*H_A&^,R MZ,(".K@ ]@RZUS78@ J<63N0S$#GF_:^\TTS'^NK=C#-0 L4:)#JS.X[6 $# MEL[[^_G:CI^$/((1Y#@6$ N:0:JDA(S0)$TQHRESJBC7??C4R.2N6.M9T/OE M4Z[IO@J5<@ZE[D)GN:_1$Y"AMS!H?3YV2;C>?;/BB+^^]B6ZCQYW"^*(4P>[ M#<>NZ7O*M !R8,:[ SIDVK##QQ!WGVQJ50*S< M?LDB=C>Y48DI;W^CGR;,$S\LZ/T\YA2'C O()(OU$B ED(1"P30.].P_$"). ME0UM'#QY:A2Q-0X8Z^SHX!"N\Z_^52 ,_)I;^F_]2I_T]9:Q)*22P0QE M#&(F$/LF*IPB*?= MR'P=2@._IUOC0&6=$10K/>[1G?;=5S3^80/C1M*?=/ @"O[TE7WSC!_S-5V8 M\X6ER$W-()/+7,DF;*1HFBN6Y3S(:(QBEL TS;@>=)E^[1$3D".LI I8++'3 MOIMMPU,C@\;N^O6O#7?.+;6$W'*3?P @A][H;S#LV#P#7:O!SFR?6:%N0'E+ M +5L=N1<3S_WK)_Z436_2%&5P/BX?/^3R[*\55]6^9+GCW0Q9XI& M@@1Z8:"7!Q!K^H(LRP@,4T:50(I0Y'0>>8TQ4Z.QCPKRUN:Z&@_(34BE,=O$ M SVVAGO26K7I+SN^&ZL7!N; \XJL>]WSM[9[WF^[Y\O%[O$GU>J Z]#JK3:F M3$/0U0$T:XU7EV>ZT6VY6L_-(VF3,_E_-G21JV<]SVS+HVT3\.(XHIF,,>2$ MZT4?HRDDJ?XGRC*%540P%E;S0/LFIT:=W]Z_!:V0X@R$$0Q(7>Z*;O.==\Z M;8E!B\R^OGURGCB'07I@>AP.9&MB=,?M'/WIIW6H3_^VHSV'AD8A-W?'6PKK M<:=_98^M@$,<$X$5,3G7608Q0OHG&A+($Q0I%,4DEIJJ3(R%Y4Z51:-.9+5M M>N@0DJ+2<.![&@Z_+(QX@YY6&!=F8%E+,=2_@C7]Z;JLM>H2F>$(98& (4X8 MQ"I1>O1($\AQA$D@DE2D3E-R[UTRPOAQ>Z0S&MCK/AD =\M-1L]H#KWM>%F9 M9&R!D5>0"YF>^,A#E^*PKQ(U\LFKI4XEU5!NE+)4LWQVD4DA I/6=- M-0D%+(*4:SI""1&(2"8X<$ MJ"T%M:G^J,0&$$\45[%KK0==\RW9:LA>/4]R$^FKH;90XZ>1B#O>KZ#U]7)RQV@=+0I>[;U5-TZ]P_>,_7^S MXZW'U1&ZI!Z.34/5&!M&**S&V2&;'F5X'@&[=E0?HZF^B0QFWYVOJ^F%_D6N MGF3+"DBA($@2/:@'2D*L(@2I,/+J6982(N,HR9P4_<]4N)(+:LZE MY,/CHGB6IAZ9R3[5WZX98'(I5=Z45*FVG5RS'4YW@-TBPQ.L X^C>U:"QLP! M\ALMT/"6]W"ZI9%3'RZZ?)C]A($NJ_Z2&^^\E<(1PC&B#(4Z1,&F10EXL-"2(XB9CD M439?RGM:)8U;;W$/9*[5BT?J%^_ Z*$WQSN9VH#6IKMQUE!];,=WK]EEXW!E MZR'HN&@$ 5LG0==+T"PDMULW9B#J^ 4:5V?=#_WQ[<"]X8FKA[)R5)X?&.J7 M8\30S?46YJB'+FW.1S,9OM=O7MDD?/.0L3A#"#*& HB)T(-$EE"8A$F:1(@D M+'::L9YK;&I3UJZM)G;JL;'668SC-+QV_.P+M(%)]B5>K:$#9-S;(.)/:^-T M4V-K;%QT^HBVQN5[KCP@6XJ/R[7^(N1;YMH5,]L&&%&>:IE M+$H@C].$BXQ(J9R.[9U:GQJSM,97,XN=^>W$HUNVSS'DJU_G.)Z]^89\I,,X M+VCW/Z!S0'O/XR_)U4$=_=E=K:49#'H5Z MBL4%-6(&"9W$^ LU^+I:0-U4Q1&.XB4O; MKM<=I9!&^ J,OV"_HD?_I=?NK=\FLFOZ"_GSO33!-?T)@_]EE_?G.V#(E?Z% MEJ^(?JX;URS9D.1H''L!I1^97@S0P_];XU ;.P,Y$S^&PIQ#P&?]ZT,;X M :^GW#P:X7KR8N\K]B_%(N?/V]+C1F&C 41E%+R4&$64>XT^_%NX=2HL:W6L%<"!/R2+T%I_')-0_+? MHW;T^:K]-##+^BS.T?%3SP,K3SV7UABB$WQ6R/!JW_B%+H: ]VB]BD$:ZBO_ M\KB2/*]%).7C0C9YQ36.#9P_-%7N MO&FK6#0YLH:*/0B'6BD.]_;CH _Y,E_+3_F3/)@3=UMY7\M!WBC]NO^WGDE] MT#?,4QKS($UC&!,3I4F2!#(9!E F*:8QR5B((A=JNL*6J3'6G5Z+2VHL=*.G M:[K#CK5& GE@,JN]@)4;!ROT3K'DKDLS4'4(,.X XX\_IO, JB<"O,:247G1 M V0OZ=+'(]V5I=X:Y1>Y>J2K]?-G_96]^9F7>O M4&LZ^MC1M)G..=558CI[78]D^9O%HI'NT,]=Y;*-@Q4H"Q3'#(90;X4^5,N-G2Q> 8+ M$_BP_DZ7(/Y?9H=M7>>;F,/*134NUZ>5ECMM9_O@/ _X0G9@+C"@MJ(^C8V7 MPX\=OJ?V:=T>L!HI+WOW1>2MK;]Z2J2^ ,+93.A3]XZ7RGS!^KU +/97)55[7>[K=K&^51?OUVY7B, M$&D.$2 8Q8R$D41)"F@5! M1FC( [>RT5=9,S4J?.D,*#:5HJ'E6]N+&Z_K3CNR'*V3!F;/@?NGA]Z#!UR] M*4)<8\O(FA$>8#M4E?#QT!X+]?=*2;[N/.^GB5]>\GR1-]',50FK6[73:EXL MBA]&P>5V^:%8R?Q^:<8&67Z1^CU9KN<,RXPG9DV?2@QQDDE(0QE"O;Z7$A,2 M8Y',G^2*%5:+?.\&NC!"U\SAB*&IU6 25AI-'&"^=J!<%_P?D%6Q&KQSR.ZP MOO7?O1:[!Z_:90.3^-:WEI9-5LF^>S/0. AN54>'?NLCN%V"QDM0NSD#C:.O MVK,.>QZOVL,C[9:\4D^[[;L,UA%G=VS\MSK>7L]@B.WM$@W7BGM%W/?+=;Y^ M-H:L'HM:):\JNUOO8#V_+82!WAZ M5>ZU>?YH]7P=G.U6^76YS4?MWR;:LYQ' 24$,PP1-?5_$QY"(C6U"$%40&DD M9;I5GK/;L#G>D-4+L)^6/O01_G<3!FO$<5[6 EY89""[8&RWAW(%;J]4%[BU M<:C:P"\Q&*0^\+:15ZP1_-+1\W6"#Z[N1PCO&[W7;V8)6T=\-R>K2,8!R3(% MIW5/XTF12QABB00 M5:%1B0P@21,,&VT5T/-'LZ79&9=J+[KXDV\LW]./;3\7R_DZN'DQ!T.;K'/( $Y8&D"9) M!G&0F9=?8CP17\5RAOQ/YMR;3[=%OCC*,A$D*8P#(6>@46AA(PG 0RHQ#@6)),X M[*$^-I"Y/=9V8TB.-1Z!1_TIH%NK/1;"O*:++1>%K]ACKU?V\9?:R3]5._*5 M/%B^U/.DQB=@G&J36PY.['?.MI>,5B[20X>,4&'R&BLG4Y32 ]0N=2Q]--*J4B$L=0"4XAQDI"&@<4"LY4F""] M $V=$A-M&IW:S+*U$<@ZWP/R[I[W8I!-NL>S:[#-/VAXA M;WG2%DV.G"=M#\)AGK3#O7TK$3P\F#,(O0:NMBK*F\WZ>[$RFHGS1(0Q34,, M%58"8A9P2 (5PRP4""$BLDQ8G41:M#4UEJE-K<-^9HVT#J!;<_L+[IS#VXYW M/*$X,-TT 'ZK :P-!3M+?98EN B'MZH$IUL:N2C!19LH% MFL@<:Z5?6S];KJR,)K6Q*#A1E#*L$PB&4"<<022$*9"#64?I_.\++_O-&43HZZT94X.7Y! MSTD&_R[%9B%O55L HJKL4.950,J;Y\YO3>*J2A7'F$&8[^SWO]X">Z,(?A-_6F<;Z\ M-VDNOW$B%XV]U1X- M-S_(G>6.^[I6J%ON\/I&.R3.C4]]:767E>=2F=$+)UQ:P59OC M;@:[P'"P+>QT*21-R+@G2N.)$(Z.2PWE'7[+!A:M[II\I:CQ.:=/E2,^>T\_ OEKOBQ6E8Q '0ZH:2DOS/']RJ0-OY/U M?^>9)$DJ<0*#),P@CI )WT,$IE+%+,E2))13>J]=LU,CE5WZ_U)W=K%BH=.0&Q$MBZO:VT(^"[\628_+B> M/6I'DJ_;2P,3ZD7I[EF]J6Z["NV14%A09"1KF%DC1QFD M 4*0)RE"C"HB'8M&V[4[M9EM-WY &P[:M-G*]+[!&>>1=XW)\(;GB*$8!U V M81? & XJRP>)P+#"RGO@Q?E67RG>P@J*TV$6=K?WS9;FIR3'1]_SQT2P(S;3CO_0_ M9G7HFA=W$E?+H DO: T=*:&--!SS6U&(LD+KFUP]Y5R"/VJCAR&9R]AX2Y$[ MV=#(&7*7'#Y,D+MX1]_$?K;^N"S7JTHH^VVQU.N^M3FQN].8E]^+A;A;4:'? MEW?TN9PG!&/*-(.L2.AP> >F)J;7*\754I. M5>Y=+H7Y>8X2C%+! QA%)(%8B!BRC"(8\Q E%., B=@AZ.-J@R8:_K&UKYX[ ME%O;+9=[UW?4>1HC=4Q#A5# MQNJ@D8J##-U1;E5 ?(![MN#'50V,5]O#!PY[93R\/+!O!//^V=C'Y0VORO:6 M7R67^5.5KH0D"@(5F7+:F)B$"@%9$J0PR*(TXC@RFP-N OLVS?88J$8[;S=S MNX-T;$BH@].TPVNKX1&VT/D+5#:HLF1 MPZ;M03@,HG:X][H PK?% \N7U?#Z954\Y4:ZD"X^+E6Q>J@^_;C,USE=- ;H M27YUP/.XD&NY$S#<1GW/$YSQA*D$)MB$Y?-.WE:\2^3D0U*>" M1H=JKN>Y_/=BM39ZZF^*U:KXH5LKYP$E-"4XA'%JI&BEE)"%@D(1D5ADH<0J MS-RBL8ZT,KUPJLK(OH4-CN%H>:)^'39#GYY7H&QK&W@\'#_MMJ^#\",MC'OH M?=K%@P/N,Y>ZEZ+\)OG&A(&&$;O+]9IYKG"&@C0Q$@ *0QQ*"FD62XA(E(0X M40&SKSOY\N%3F[)51IDI6AC]POX$6G/M"TH>H'?^/;X6DX%?8%-5O#QE!O=ZHXGK[DV'NYP\ZM\EY=\490;_3VH]7+"- TX2SGDL="K MMSB((0W3",J8ZL^Y%'$4]XN*LVA]:B]X-Z#KV 9Q"3H>7"MH9-,[EN/\4)@/ M/0/P"O<5070.L'D/I;-I^Y4"ZAQ@.1U6Y_*0GEDCJWNZS/]9K7#>%LNR6.2B M#3+^HMMH#Y-NU0>].EIRO0+:2CQV;-F%CG&%)2(H@"R-(X@58I %>KV2L9C0 M#&AHQ*B&F: MZ4YE*0P5$3'#(DDH<1GH7K-+1QD+-P\/=/5L>O%;?K^L(O?-Z>=N[ZJ*>'.O M@NR[8^W&R-?LKH&'T:YK50S6SKGJ;>RZ9[ISZR#8>=@9:?5 .T0TZ5 =X"L! MR+=YXZ;_# 3N0?+/4.WT+G_U8FZAZ6GSL*D.34XE*GV6:Y.:5)K<)%EG)YF* M>R@,<,15"#&*]3^*!Y!&&8%AE$@2QT2$@>.@[]&ZZ8WWOR]7DA=Z7#!U;2A? M;^C*,,J]MGT&EK(ZR5J?*:TW>'_:#0NOU$<#CP@='X!%KNCQ6*@C":->:R4. M +V_+!N[:IAO2(\4%_/>A"_R_Z+?G^]4MU E9.@A:1?75NCY_^9TNLYQ2$)49QQ&0J$G<(4W)J?VNS>I"MN[?W/7SJ6.N=#./5"7U;V MA>W Q'LQJA1\DD\:172@ G=LQH3&A 8"!P!G%HI)Y(ED') M4BD8Y0P'0;^]_[/M3HT+C[^T'1?Z[O"?1]]U;]\;IJ_"@1WK1\J,M\++^W;^ M^59?:2/?"HK36_AVM_>.DJ^U,]\6U:ZB7/+G3UN]Q2R4C&,F84QE"C$+4\U0 M4001"@B6,18*8S>Y[S.M38V7.L*Q'7.OD+8\C[4='WE#<& 6N@:\/N'OET'Q M%_=^IJVQ ]XONWTDTMWBIIX3'WEOYD]?Y6.Q,L\^=EP@6)S*B +Z3RCACB&(EUN=WOY=8W0W0-EQFF.!M>44QR]^0P=*+?FIS;+^92O\_OZ;-)DUNYYX"H& MY-0-=N0T'+@#\U3'\'U0JRVDG>T#<58_W+P)"CDU/K+(4!]@#H6'>CVE[[2J M$F[^32_H5W1A4J3%0[[,3?E;4_[@_<]'N2QEV9:Q)3R6,4M@'! %,8[T5"N5 M1H"7B)"E 8Z44XDFI]:GQFZ-\3-P7YM?O7QTSP$@&P]9FHN;8\\9^L!R^'LK<]#>B@1F7"6S8/9VFK? M&1GK;QM-*$0R,G5_>0A)H 2D+ AB%JA(Q*D-D1U__-28JF.@@_K,(6KGF>9Z M+ :?-FUMN\P4-G@X2.Q%=X\G5G+1X3X/F]%6] M Q_D:F7VX7]^RBG+%WH%)7"O ML1IGB3&XMS5_/U\P\Q4 ME*_GYM47<8AA*'"@F8$PF,51"#/%<1Q%+!&,NC"#;<-3XXI/'V_>?/ST\>[C M^V_@YO,[\/[__/[Q[K_=6,(:=#O>& +*@9FD8W*UF*T-!7^TIGI^T:Q L%8&*((LB1. M]'1013 +: "30$99*!,3!>;"3"Z-3XV=C*'_\6]A$ORE,M>QQK$+ZG;4-!26 M ]-3:W:53F:$S"J#P5\E->96YZ/^M]GZ8.6KG+%+T^/6,NX!RD$AXS[/Z$=< MV^?6X=":(SN,V7Q]Q.WRJY'$6.7+>WW!Y\*D&M6_5HG%M30"QQ$E88!@D*1Z MN8MC!5E$)32*X K+*);22GC&NV53I+SZ_9RU0>AF1M&=8;3N@6()M@Y65W5= M;-*Z>\E>^.OWD&5)0O4\6W'!=+^S#-(P$I!G/,LXQ@FGD5O\SJOT_#A1/MV^ M/].QK]RE=D/EJW33P..HI_YQ'DJ]8^EIG/5GUZB#L';W MW]=2W&CZHO?R\\9,"6[5M^]4OQ6WFW6YUM]=TWZ[0)>AY$EBBNZ&"8(X"V-( M0J:@3+"@. QB)83+*.UJP-0&X\9NP(N'!SW8EF:!6+WOS0=2KQ*?Z,),H,O* M)U#LG/JS&T$[=Q;+,I0Q:H1N)(4X2&-(,YE!$D6*,9(E-' <6H?LKG%&T'=R M63P84=5B-33\=L/@D) ./-JUIH/V+:B-KR1FZB][Q_X9>)1IC%"M&(1$RAGJD89 PQ: (:"P2 M)@0B3LO#[L.G-JBTME4G39) M%&;1?&U_>MP;MA$.BZL#Z2NPLN/KO@@,S,5;LSR?31YSUUOF4^?1(R M,] ,4I/W6'NO6(?WC/OG:^^>N[&G7+(1Z;KA?+61W5W$S]JMS6IEJH(&'.M% M$\:08A1"3*72$PT>PU2*6"$:AFGF%.1XL<6I$4MEL*.L[454[0C%*U8#$THM M+=@8^R+><6NO1P596VA\2<)>;&]K?%GFO#H,F0=I+*E@*>1!0"%.$@59J"+(629"%G*I0K=4P]?R9&H$ M6#M2'4S(QA6P+L"3_AC0-9#Z\T*!9TD=6?+UOBIV[/LO\048F-4K!V'E(>BB M #HP /8,NM>UI;(K+&:@06,&.M^C]YWOD?EXMK_9O\4%;($!YT/T>M0%>^7. M]59][+7\&+G&V2MWUV$EM=8D3J6$*@U,I%T60IJB#,HHC@B3(J7(:=_Q2GNF M-E9NK0:/6[/-Z%B?[3\:R\&Z-OV:/0KW?NNS@S%H;XR]O]%Q9@9VW?1EKYLJ MCT#E$KB[T$U7[H'T!G>0'1)W:UYQ_Z0W=.=W5_H_]IJ3'2.#_D$[7"NW;#3Q MWVKJJ$:34K=NHK5X-9+,4803DF44,H01Q(@32 )NMG@Y0H$(>!+W./*Q;G]J M5/N>KI:F@"DP7Q? M^:#8FL_@( 9^\$O^1+\_NV=(>4ZE,I1V-RUJUS.D0;I M@'$.F.J"$'4'[,P'._MGAE^K4'%>+Q%\'S\Y@^?U7,J^]5_&7Q?!M2,LGY -S%"5J69*US76;#<8 M^8+&7G]D9 N,)_:YV-RH=&/K_$M^L;YOV/#TBL'F22:(B/5"5E CDZ(8AEDH M(AC%*$PE04&HG,3%G5J?&M6\V4Z:ZKASQ]F2&_*QBI6D/((",PIQR#DDF$@H M$QF)5'>'B 8*-'?&?IPH\]9\2%_D!QSD ("-V6_5W53/= MQ6Z_S-FQOA8N6Q*3ZNRA-XK]]W//O8S14/>Z!S*\U:^P=S):5QS?W:;&8H^J M9RZ(^)(\LVIS7+TS%Q@.Q,Z<;O95Y??M=Q-O\7&YU42X5549XDH9X6NQ6'PH M5B;J8HXQIBP1(43,".(JCB"-C$Q0&&J.2A5+N9,B8W]3IL90M=UF%^'1E*:E ME;V.Z>U7=(QM8,(8< \>DW"L&.8._XYX6J'V"@7_81P"C4<>)Y[7PSI8T5]K M0UZY + K8)>+ 3L_L4>!@YOH5Y3&G8B';W*9%ZO/Q7JK58\BQ@7**$PH51!G M+((DHP@JE64,"1%+JNSV92U;G-Y.;,=:4%;F@J6Q%PC]BNKO<.Q0#, "\20C M.%9I"L,THA 33B C-(*4QPIAFG#]L76-";]XCS$050;_+Q/)<11TOUB?'W8& M0'#@L:4!K_N-KB%_88G:V"8?&8\G#._,E6MQ)_GU9+(K[YU8F&04T$ C#A,L,XH01 M2-(XA0IGB&92\=@NV,2JM:D1\4!L,=A:[E+^Y!+(%!_N$;F &/H=:K^I! ME^!S*2;D$<:Q:@OU^1(ZUABR1.5\R:%+#QFQ I&E/_L%B6QOZKMEL\J?JNIL MFKJKK>N;ATI2028XS8BD$"4LA5BD'+(P%C!D01*B3(99ZACV<:JIZ:TK6OM M;:#K7LL)1&UW4JY':?!]DM9$DSMN!U6/K8_S.'C;V#C1S,C;%N>=/=R4N'!] M/S+XLFJJ\E2I%/6911)'6:HR#J,PDQ!'0B]ZDS2!A%(D, U)3*T**YYI8VKS MJZV)=5K8#/Q[\&L0@D>Z D^U_',8_QJ AWRQR'=Q7[36$_JG%'_1"^+VT[PL MS>FT7I%TX\+H6@^:O.)O@,*9V:N(JL3;EY^&;MQSK /M:.?*;AF8<78]\JWN MD4:&^V.%KC_2.8.")[XYUL*H5'/&Q9"@@J41.!7 N-SD]^JDMGE5' M#.MM2:G'NE2+L1M4ACM&,EF ;\L5/B$=G#JN1K,'C=@"Y(U5+C8X,LG8 G#( M.=9W]A3 X=^EV"SDK3+9I56TS9W\N7ZCS?_''#/"4Q0$D G%(([U/(NSKKT%)KXT3BRU#!TMOU?B0\M2VI02Z-,+EA3C#=NA2>:8LM.5L/I2:QJF'L.%QJ:@ M>W2AUH+E76XD)&0^?[]ZV,=SW^9,LRS^#1D,5/)JE3;%TE_AZZZ0/[(K(>-);,_#6M^+O$6<]2F&] M?0T5WR,N'9.H>GF)EVJ[1PH%5I4!?U\6K)2K)[-N^;A\W*SUG[4W^2*O)A&[ MI72U.<*WS<,#73V;M7H= MX%N:D&\CZK( "'S1DS1SUM,)^KZJ .O5O6M'0*_89P.3V)%"R<<+(U<.FO() M.Q=!Y2/8=W+0S9F!^F&80JY76_>:Y5Q]07NAJ*NW9GRHQ-8)Y!1)$3"%H$HX M@YAE&X$CY2?.2++\4BYP_ M[R8+G&4\1$EB-$;T6B\A"!*I_XD4EF&<*1:E3N)99]J:&D741CHF+^5XF%;4Z.';_G],EVX+L68[O91K_^OM1/K"(&ZU(:9LND?/]3KGA>RDJ>_:O97FFUW)J_F)>N M*;TQQPD+<:HPQ%EB4@]" 2F*0RA(R!@+D>+*J1SX2'9/C=LZ%L[:<.3>>I-C M]?TUI_.OVJ.O?C#_\$Z8] H O]63R <8;"N ML(MK&*[YGDKV)I]NP]<;LVMWLQ1?Y<(<0-[P=?Y4%5O18 VIH.=[;WCM>S[PVYP& 3E@>G= M%\#NROBN8/F2R+=N=URM?%^DB)?@T51.N\,6J*.590RD[2491F!6"$&*0M32$(NHH G8:#B^:-@/(W$EHV..@R[ ?%R#':\VY?6Z4X$4+19A%8>*PC!A'.*,AY"10/\4L3BD+%5A[%0%X#ISIC9@-Q8#^9/7 MZILK4VPZ?]"7.ZMQ7-5-MB?^8X$_,/$=5T#M!+W-0-LUK4.@XQ$P+C55!X<4 M0>V#[F!"J$[&O+(8:A_@+@NB]GIJ[R(M*W,Z^D[6__VX?-=H%-3*_'?TIRSG M*,!I9H+94TEB3:E$0<*%G@RFA/.4"R$H:F/;[YPJK5QNW.IMW@]]OQM515JT M4AIY721T;:QVKHEBT0MVW.D/U-%*JU9V@E]:B_]D4&V-!DWIU;NSJ/:I0&*/ MDK_Z(19MCEW]PQZ&([4['&[NQT^WZ^]R93:_5_*["1E_DKLJK7KJN:!E684; M5/E^XG\VY=JW;S\V4>8W2U$]YTMAA-_6^:JN-;(C7,.SG^6ZY53] MXZW2UL]YB@6)4@Q98G)ZPE1"&C,&*5=Q$D8"Q\*IHL>K>C.Y.>EFO5E)T,@B MU/.=0H'[:LIC-I/^- -+N3:?:4IU(]37_=K8$?6_S)=AX &@LA_L =&2?CWS MG8'CT^C.Y'@&7B(&=I#5];H-:#- E?YJF\'$WU RB7[T-$2]KB^C#GV3Z+:7 M0^HTC.HW5!M=A&*YUGV@+[K_N-0OFBS739!>*#,94(5A4.W@1RR 5* 8IIRF M2"BJ!UJGD]]SC4UMH-NW%;3&.JX1SL)K-^+X FW@ >$$7@,$0-H XHE9SS8U M*O'9./V2EZSNZ;OOJ\F.U^E=9[+;5ZVC!U BFZT 5Z]"=4[MN[[KVANV.[H 8#[Z)^P+>KO6S4U53 M?>[7]L3.VQ:M:_LC[\KVA.=P([;O@[PDG UDT<[#E[('>U>>;TD:KTAJE=7]8&.YI5/.67YHHI=>R'6 M21*M3H49 MDCO.]%=/=>DK.X89H0<&IB%'\$>39.V!Y@!JK2Y6O)J0:P^HSFF\]GERO5 MNO- ]L@,L@3'6T;0I?9&S@2R=/\P \CVQBM"X*H"CXNWQ;-+4Y MC)XKZM6U ++-IM8OF,@7&U-R#11U&FJUEGB2Y=K06??O5<'&G*_; F)@L\S7 M5^3>>^AQ.SXZ4DK\:I"^GVOB/[O&#N M,^SO.H/&CPGT N#1@$$_3^X93;BZI\MF2_^M9IQBD8MVN_^+MJ2M\GNK/N1+ MNN0Y77S3G]1M;[.F19K()$X2B-(X@ICA &8TX% R@8*8DY2$5K+_7JV:&N%W MG9J!/;-'N)_UF_"N>*#Y>L&J/P QE#P1VVJJP)P MSXZQ/,P='NZA3WS[(.U^\'L=3KY.AWM:,>X1\G50'9PS7_FXGB6"F\V3N^*& M_]]-KN?6F]+LGI2R#OQ]2\OOS5_$7$0T4)E"D#&N(,YP!%F4,,A0+%!$XU@J MZ5;$QJ7Y'ANN0V];&,O*O.J1;39*5?V--C8[E@QVZ0P[WO,.\$AEA-O-UW4! M&O/ SO(9^%QC;:QO_^ZS+GD/T'R5%G9I>MPBPSU .2@WW.<9_A28HR8>7C'% M(\&9*7INU""PA$RE"K) ADFJ$")"7:O '$TSVZ"CP/P?_Q8FP5_J_*K;K11S M_>F^'G/D08\YNEJ/N0>B [/4:3WF:"0]YF@T/>9H*GK,D;L>\\M;W"M]-C7' M/NC)&%W\MZ2K]TOQ3L\PYCA(N?*AHU7P MO.16MWCGQ6O['OFN=5?F>C"L8]CTU.3]SV8YUD:XS$408!%( M.81!"3+(-, M!A)*$H0\CK( $^YVJ'NYT:D103UWR+>6 ]JH%NFED.N9JP7DMJ>J?H$<_-QT MBUZK^606-[]L;0:MT1XUGEPP\G;.:='DR">9]B O]=KI$>SE)IG>K5"%$F@U#] G% ] 8FB!&:((17S($:R MC_B27>L3C8&KI!^*)2AI'9G^V!@_ X_&_.J@2K8^. ;*VO6*'55Y!'FD<-J= MIH;!M]ZRS-NSOM;\2H!C#=Y?1-@]VM8),%\!N':-CAN3ZP3$09BNV]VO66#Y M+5WP3:UIUXU-CZ*4,,41#'',(*920,HYA@E%24B9D$GLE DYI+%3F[5U=RTZ M6I/G"OI>E5LPZ!?!<3OIE;MWQ/TH+U6:9Z#C\V Y%&/TSJ1J-Y\P]5^PD/-Y MT(>IZGRAS9X%'K9R2>9P0HAJ4D,77V@N/NH6'_,U752QA^QEO9VOLCX$E-^T MR3F77RJ]>6/R_;)Z2N7Q/. ,\11Q&!,50YR9_0+,* P1501E+)&!DP+UT 9/ M;=1J8HJK"&]8^02HZ7= ZUH?SXZ*^T/WM]W -*5>''APNOGR\>WL4J2W.4=I M!%\KV?^BK(>DQB>/VO\C >^K:L#0YHY;;V D\ \J%8S5KJ\:!\V/MVR1W[=1 MDW4TO DY>5,MV+[0U3KG^:->NLV3E!%%5:2'%JP'&<8$9$02F DSPO D$&'6 M8S/H:L,FND_T_N%Q43Q+"7C7^FLK'KAVFMU(,4X?O&;=@_:WG4-5@/G.)<#J MK270\6K(N@<] 1ZL](&K/:]<_: G?)<+(/1]<#]6?FO\U\^OQX&\_,>;YSO] MI)N?>3E/DS@)4I-Q+B,%,0H#F,4QAC05-,**4"FQRZ3^3%O3FX]W3 7&5F!, M!7\88QUWB,Y!;,>.GH ;.BB@'V;.5&:!AB>2.M?2J/1CX?)+8K&YI1]E=!1O MFA"%N108L003F"(3+L S"3-$.:1)J#$-8IQF9+XN] 34CBD.FW BB&U#PWW9 M[TP;@#=Q,(N^"EQ'L+2CA.L0&I@).L;-FMI.'J!PK'.<$US V7)>X ^]H><&IX$;();8$A=?LX0+K8T[4[!S_6"V M8'E;S^,'SE>;O\8Y:F420;3.*00AWJ!04+,8**YA(DDP"2TBC&V M:6QJ?%*9-VN+IYG G<($'3IN]I]#UW*CWA-F0V^RUV;NE46;@9VI'C?0+0#Q MM?E]KJEQ-ZXMG#[8=+:YY^IUQJW:RQ\]GS[:S(2V4A:4((:E"O5T)200IS2" M69H%4$B.XX2D*.9.)1,\V34U+GI[N);Y<^_%S%4=YKP"&JL;AMXXWLN!KPX+ MFR#IXV469N#80FL0_1'/8/M?J%UEU6NM[GQ >69)Z.7Q?85-C:0\7V],V(LY MY[Y9"OV97#W)3_E2?ES+AW*>JB0.4IK"*(ZPGOF9@@]&2XK++(QPD$@4$Q=B MMFET:JR[9W,=$6"F@8W9X ]C.*@L=]QUMNH!.Z;UC>O -.H#TAX"I_88>=,X MM6AR9)E3>Q .E4X=[G4CI>53N9Z;6/"R4F(JA&[F9K$H?E#MU7;?-1$X1#C4 M;"1"S48R95!/&SED)(JX_M*A,+%B(ZO6ID9#E;W5:_)86PSHUF0[WK$#^3SA M>(=N8*:I4;NIA.%JU';67M[X[@&?*'A5IZ4:L<>#<:_9J<)I3=E.\-1<;6ZI M"#B,4%B1L-U#1F%?)W]:VG6[:00Q.O/IHC 1TYV:0#$BE'$&)<44XB1)($-4 M0$*EH$9Q5"(YF"K=$8.FQMJNU?>&Z26[2>28V(^Z3B\O+]3+NE!B[1'X8Y#Z M0+[P?0V-NV/F3%?L[@QX5ZG>G7MN/P+^?;FJ8WC_6=4L:B++RKOO=/WW8K,0 M'Q_T-WQ="Y7G3V;[]JN1*(FBF"LL&"0XBB$.PAB2-,F@R,* IW'(].+=%'#. _'!P<%9_"^'9_[=60G=CNW-SDK42H!&"[!1HW[P MBY/Z-&Z =$2T X48E5ZO VJ?5*\<;:A#\X=0=/U%Z*JDBL(_BY4L5X_:6MY& MZLYIQI#$(8*I"&*(0EVN(HN5U9J$,DL0RG)J%1YC-.O4B'(C+7C:B@O*C;RV M?DP3X$T=F8[A].[)K.6=@2VD/9%W4@EN'LMGEQ?@5E YD.3@(&C.FB$V$, M"9;J8@LIS&+)H@P+0JA5 M@>>+,TZ-@?L"=\&3OXA&YE\M@Y8NPVU&L$Y!]$R<._BUP92_M.+^ZB5^R!@= M1R1W>;Y1R;CFWW2:UO3/:^_ERM]ROZV5"-^U;5)[NINE3H% MM7K?=K/\O"J8^*))\F/YIU@U/Q6/Q7HN62H9010*1+#.'XT@386 ,DMS96I* M]3^K(K(^A9T:Q74"@RW]^^_I.VYU-#U#+ O9>%]W"')W M4HYHH1ZM!]/HI>W0=KEKK4"MS S4BC5_ ;5JCJU3SPO@TF#U)>KX-JQGT(^: MM;[G'-Q\NDD::.58O[1-SSA-XHC%"8Q1D$*4Q!QBQA,HP@RI/T4>!U874*LOYIT8C-XM%DT<(9"=L5T?0ND"![5*8T8M'@#VS M3BV8="Y:N!F.?NX/=R&07/0QFW@ M, ."TFM3ZEZMC6CS_B,I2!(+K)@,91"I$S3$L6 PX5E, B8#BC+C(/3]T:?& M4_]7B/\:Q;H)8I3^-0DL J4/<#M/.U>CX?N>MS[AU;)=KH9@@(9%F/@UJ(P4 M%FZ%CET4^"GMST9]'WQHO"CO4_+N1'6??&B8,:9K?S97(5UX^#LAQ6I5!]_4 MI:[??MD7,C#(O*(]#H!O1MQDC,]!)WQP1M?R]^LN_ M="ORJ_O8F:% .K+1K*9[%42"SA*9D4+^6(Y--S8C;=N7HY3A4)I>(]CB;\9@K]#QSUG#@ MAK<@.8.(ZQ8BQZ9ZG18@9Y0^V<+CW&>&EC]?%3^(#DB^7>I,Y_I8>;/D_R[X MP\YY1A@B%'.8HS2' M21BR/(D9IYG1#8+IA).CT59 L.XD'!QE8HRY@<_.,9*C49[N+/?4Q'+HU-\6 MVXW,CH&TAA58[_D2;SPVL.JU.[<7Z M ]%-\-8O=6.$*$XP3F4.HXPJDY?H(S7" 8P)H3F*DE"BR*K0],$44Z/@1D+0 MB3BLU<0AD&8VYW7P>.952V3LRT6?5-Y5A>C#"<8M"GU2P8,ZT*>?'/9JU[>F M=0<;9<6UUU-)%+%8X@0RF4B(\BB$N<0A3!!#1$9(\MS*779DCJF]W,K@?5[5 M29NLE=,R#N,8CF:O]I7H>'ZWFY")3CP/M>#/J._H[3XVPZBO]QD5]]_O+\H0S ,XSE@20L'5>0JA4$*2B 0*&O&,Y3'A63*@7]_I M&0?<^XW1B*^K/*E[?A:=\*"DE9*C8L+Z_N\,Y&:4<"6"8\5W=DAM;_MFA;9%>]B9L=YP1#P3 MF#D8UB1T7&='?+(W^*C4<%RQ_;?\Q%,N,[H/RUB\.2AC44O1NYFKSXKWW\FR M20FL_D-4:]WIIZT[@U)=%#W',$V)#DH(VIZ?DA$B99@E.*(#3G=CR3_1LV(C M9'WY5E^Z54YRNSTLOQF;36HU_^=4)6JHMA\WT?C)UDK_-F=<68CM=Z7P5+MH MQ&7SFBGN0>P)9(W[6PRS#'*/\]MM?%P4\_?+M9KIGOR\Y6J>0A:LEO'3OX]UUQ02.OV=9R M&>#S>X%3V'P;N4,1,Z988S2.<&(EV%\?RA]_4V,T=*A^V++@Y9%'H2UC!3N> M,?_ R!9Q,_N=W"^6,:6H/7-D]/RO<_PPZ]!*\S@_/B1->F;E2;!)&/FQZ*G,4)#7$*4YPB MB#!GD(HT@3PB 1.9Q*&TBE0[.]O4B+TG[ ST,IJ&]ZT\#[89&3N#T#.Q7H7> M%4D09U!QGN9P;*Y72F0XH_;I5(5S'QH8[5I6Z^JFJDI6:*_B/XKU]_<_B_7= MJNL6M$V$N%OMM,6L/I>+@KUL6V\)$24R("'$&$F(*!80)PF".>4"LYRG>6)4 M+L2]:%,CJAUA+8-JW:V7&7V]SBIXYKI:*;#5"ORIU ):+_7R@$U+M5Y.F/KG M7>5FH%$/_-'^Z:61FGOT7441NQ-LW.ACYX >1"V[GV&HI;A;@J!2/W3_UA9N MWC%IE[SK7C2G69Z+B$C(XEC?K",&,4ES&$C,,XY%Q&5L9T8.%65JU/U9R:A/ MFUV_-5M['Z:J5%?7U+0B6I9$?@"L.=)SAU_D[$48FKT44M9'[2^ MB\6U046V"V)Q;^(1YA&O1HXV>&BO._[1K8$.\]9V54_/7A]'QW=UA M*\+X-QH#03IZ:3%T+%>5.74UE2XYYX;_\[E:UW$W_\6?&7?!7_6J2QA! ,\ZR7K;36ICXF=+D>+<(*MAC[K<%[ MU%L!SE/SOG+ES0MP7"ZY>6F 8;SVVS-1.^A:]+KD5K^3G\7C\Z,Z>M9UH>8A MRSEFC$,>Q1*B&.>0,"DAQQ$)XRA/!+7J5FLPY]2LNXW(EAXQ$WC-2,LQ:)[I MJI56&6 ]<6>@%1AT$L_ MR4O*J:+QKJ,3K$ RQ$/FR[ M+Y:B?Q/HW=>"M= Z>J-X( M9=[K=CAS&;,\D'$($:/*X)(1@22.0ICQ-,E2*C@GN9W!Y5*\Z=EDWY8KP/F+^V:WI]9TR'7!L[!=W>1X$ZTL:\6G(-ZY++! M_1RN=H$O&V)J9]03OGL6]^57L5XO1%?%5)TCUZ18U'\-YWD@\I Q C,<"XC" M5$(29@@*D9 XR[, 4VYYG>M"KJG9L$IT4&W$K<^);"MOS?_@EX6FC&NI?]@R M#F5][XOS*H2O5ZO)U2K8YE?W'_5$GBC M_6%2O3+C7P7E9;*_;OB!=TRMW^I.OI=2L/5F6U%;R!>U[6B9EKH*8GW4N->5 M-[9A?(1$>-#[GW#[TG M&VNCNS#HK@O4WQ?/^F;M_4]6-WG2*C2*S7,L8H1DID/B=2_@A$#*2 2%LKF3 MD$1IPO%\7:[)PHR;QQ7?BLTW2OBUSQL9=9D)IK1K;'3]@]CJ:1E0/^XWPFP+ MF.XZ^XZ<4JKHLOIJ17L:SO]5EM%5A/^XPH^;!? J"W.0*? Z4@S;.;^(I[;]M$YI+5?K>[%Z?"?H^G?2 M9"_<+ILVK^5R_;VZ6WT45367>1 RE(0PR@(,44Q2B'.A]C\:(Q[F6!UVE-7&W$UR#HR,^'R3"J*Q\#4C[W'K56-=Z<7:RNFH2 MKR\/ZLRPGN,FQI$@6/%BQ!A$N9"0(IG#/.$\18Q02JR\\I;S3\U7LR-T;=^M M&K$!TW(/==.8K86M9\8YPMZ)Q0LVYJ\5L]E?RKEA!<]JA M8C?,T-IV;X7NV;&X77+Q\_\5+_,SV@3Q/0T[@\4PTUL@,J%5W0OLK:M3MCSAR M;;H3"AW6I#OUX#"#Y4:-R>ON>3_$5\$49^BLJ4]J==MT/,'4"XSS!(8!R2$* M@P02+ *8!H*+.(A8F&$;"^72A%-[S?OR@JW ,Z!%MLQ\- ;=S!1Q":5G2K@2 M16M[PQ0:1P;&Q>E&M2A,E=\W(8P_-[B[3K$6']7@_':Y5M^.0G>/J'.YW[S\ M3OY9KMXN2%7532)C)O.,!@B26'$-8A&#E(08QC&/@BR)PLBNH*7%W%,CH$9T M6,L.ML*W11%TF<-:?E K,*A)I\W"F#&3)[@]DY13I(+^UY&[<0&/;EUY;0^S/<&,%M3YQ"\'+&C MU=2C$N 04/8Y;M 8]L[^M[H1W$J0MR57AFF,1"(215$XE[K-A%0F:H)A&J44 MX5S02*:F/O[^P).C'^V^UL(!+9VY0W\'K,M^_*$0>.8*0^VMG/;'5!WDJ]\9 M:#07_3'Q^Y[YH[\?Z)"OSZ:;'IVI#%#(P@#&)&<0D32"))<,8L0D$D@&F!B] M'G]J+=_/UZ_O[KY;.]%W #%WG@V'P[2AO?$T^FIH>U]F5!WQW\'']W4<5 M._!N'W]JV%OZL5P^[$83:5=Y/^#H\ZI8LN))7]1]$C_7]W^*Q8\VTFB>D#0( M<(:AQ#B * JQ>JE#W0X.QR022:#^9_-27R7-U#A ?;5B.P:X;C',"&,TB#WS MB];C,/QQ_3(#_RG("MPM'6SX3C%SQ$_7R3(JG3F!;9_]W SJLM_=/(PPX3B6 M,$I3#A$2$BKZ"Z""3,1JH @%1A64ST\S-7JK>\JU[F?6]V^*IHBUB^YR5[6( MFQ!972QF^DF]4776SP7L''5N<^V^G4K%4;N:HNZKAJX*[6S5:2KU'7.0<64) MB022%$40Y7&DCCMQ#&60RH3&),M2J\O__0FF1@F=?$T"VI ;_ ,(S0C@&F \ MO_I6F PHQ'E<<6?U-O>&'[FLYG'E#JMGGGANV&M)2@0*<1[6;*F0+;72OM=&]V IM M]X:?09?Q'+-$$)AE1-E121S"/$8(4LY"Q$0N*&8V">:.T!TA&?Q>S^$,1S/. M=(..9_9LOG8]*1M3J9'3'8U>QL(1H9Z9:%1JO:SP/LD:?&(8W=XN%:&(:JW9 M^VVYK)U:OPO=;G:>RY2&>5@?K!)%"$D*J0P(C,(PHFDL4L:L[*?34TV-;CM) MP4I;#:R5U9)JSR!K1A%N\/),$1NH:@.K$Q/\T0CJT-:ZC(8CDC@ST:@D<5GA M?9(P^,1 SXMXT =E/6:Q?"Z6#W=/[?5PU7ZC99AG-,(A3#)"($H#93RD@L-, MYG%(TE20E%@Y82[-.#7*V$H*RHVHEDZ8BR@;^F-<8N>9/GJP;:7TP![&F+CR MR5R<;USWC*GZ!YX:XP\.8Y;6'5?=ES?LOY^+E?B\TJ_/^D773US?++DN4_+T M6)_^4B:22+%+P-(((G56@80K(C\-1&Z@5N*W8X/,& MY%KRIHC4^XLH6_.6/6".",QBXE&9S!Z0?4H;,()]Q\]_B.+ANV*!FQ^*+A]$ MNW]S'*441P%,TIA!%,8YI%PRF @11$BF+,V9:;//HS-,S2KJA 2ME.:=/8\# M>)YEG,#BF4SV$7%HZUQ4_XHNGL?'':V!YUFU^KT[SS_H/.'TYK%WEX$!C">!+':4 ARI@Z&M$\A7F64YCDZK7'$==5/1WEH!J(,S6&L _3N7(Y MS R5\4#VS#=GDU%G]8UW7?6RKY6/(!XW@/K/5#419BK)JQ; 6>2SVHSJJA=) M^^.V!]8\)12S0 J82*&H$^<9)#E5K!G$.4=)&$8!ZTY[3?W*KVNR6IM1J($ M TY\^V+X>ZF[%A7E1EQ UH"*AV*YK#U0$KRH-_C:UB*'JQ*Q#.5J'X-AJ+N_ M! F!6% $@P %*0N"-.+9[JJ\7QH>QGVN22?$V"LBU*'0VUJ8;62N8'W-]BS= MWWSTD[; QUOOE,,97[DORDD(+O<\.?W1J_N9D)4F-UVMN(L?*Y@ZKK_3I68$ MW^N/$:88L83%$,L40T0"!M67+X ASEG((D[3U"XJ=)@<4S.W^RGRHE4$/(D5 MJ+0J,T"U,K4SBS?J#&YI8K5:AA<;_M? ,[_M-#+IX%=*-%4(%--MX&\U&:N+ MR1 \W3]\NNPKO'\I5 M>[^S?/BH:\!W$2FK;6 MI81*C\;9 >YZB_.^OS@;;4"MSB;@S4&E48>@NJK=?H4DXY9POQZR@TKN#H8< MZO)8%3^(KHBHDZ6T@V7Y<">W_WJC6U?I=U1$**1Q$$".:*#[JP809^JO$K,\ MCU$6Y3*WZZ]J-O'42'4K(?A0+,F2%74)8%V2^M&^,Y,Q_*:':O>@>C]9;T36 M+9!:H;4=VD.ZDQO\\;E<%.S%C]EIBYZS<[?AM",?ONW .#R!6W[>_BY;5VZ] MDTV1P^=J73Z*55M?F'&)PSP@D$M=:RH23$?],9B&A.9QD@58&-]GGYQE:LS4 M26=9M/D\DIOT+[LL/V[W@RQ_5 M>OYY53S6^5OS-$!$A'D."4VE>J-UG9@@QS"5(M6'O"#C1NT7=H>=VBMVX2G]NYJ$PB@.:R+:>WH4YCDN84K(U;07_*TL^9_%8K$IO12$0AD0$D.D^]NB+(\ACN,()BQ". CC+$\S MR[PCB^FGQE4'!<1GH%8 _+)1 70Z_&I2\,G%$ID=D_P![YD/G6,^)-MI '3N M,J!L)A\[*VH ,$ 93E$C!_-D;9UG':D&XJU:SC#W%0).YOJ,::'2;@5:[ MMJWW#'QJ%E:IZ+))JWO@G35O=2C:R$U=W8-ZV.S5PQQ#S>;]AMQUT:_OY4*- M4>DLE?7+EW*Q^%"N=*7Y>9*P1'),H,2$Z6AS!&G >? MGN'H!6$6O3V6Z93&UG;^![-YZ=XS[ ?!Z$ MGC/[V6[VD0WH0= <6M##AG$5,:[L]N?'ISJ XINN(T<63#.TLMX5^S8T7+#V M>=VR5KLQ[F2_W%RGP3R2 6=9%$*)9 B1)(D.%4PAXHQ% A.99+'=E:L_8:=& MLK4G51E/.R4HBU;8:V.>':ZQZ;WN-%;.^UWPL2CKGJK@6]TV::ML;2-WZFX^ MIQ6>@>XKL--EZ?;25\!!H+;[M?$6X>U0U%<.#77FN9#UFNH?:ZYT5X'2M>2P]J\37E M[Q;_ZOVNU1IF/!(2!Y%-Y5/3B:TX=ZPZJ >AZEUI M?\MF&J;@F]&K#T@],V@C\FP_NGRV#2^?Z8I"5(#/I'#8*L\6*E>=,4RG';<) MAB48!_TN;#]_3;>N._FNJ)[*BBQ^6Y7/3XI#F_M(]:^L*< F^*;^6NMQWES) M1UF&.4X0S.K4;(DBB.,(PRA*9!80C$1NE?!XO4A3,RF[>Y\F5^=_#VD/=M4* MF3'=N+C[]C2T2H!:BQG8Z 'ZBFQ+/\XV\1;=8OGK8.8"8J==SZX2Z!4ZI;D M\'AW-2@>IS62EKZ/\KGNHNG)SE J,HA5&JV15'$N8L MS2$-1)P*%(4Q"TQ;EIZ>9FJ,V4@*6E%GH!$6*&DM.YJ>0?8\*[K#RS/3#87* MJOWI920&-4,],^QHK5$OJ]9OE&KP].!8+26KLNYJ:KF3WY:KC0_JGOQLG8S; M4+$VJ.BS6.E40O4/]^7[G^11.S#5XU_$^GFUK'8NZ4-)9::.F5D0A1!E-(,X MPPA&&-%-DX M\X[0CU@7B;S_LYRGA"<)CZC:PXCN$Y,%D$9Q $F'VL8 MR;UYKA1_5M7;\I$6RZ8(3U/O8"X"D2+")<0REQ#))%36>81@3L*,!V$:,6F4 MT'YYJJD15ET+ORH&5"0Z Z<9/;D!R3,)=4*"OI2@+9/AM5S&97@<$<^9B4:E ME\L*[Y.(P2<&WLLL%G7$?]L&I^O#Q.,8)9C$,,>9+M)#&:0TYS#+CXID3FB2C3CP/7:O.(^#J\N'X).->*)Q5 M]."2X/S3 PI@Z$@4Q2!U.8A2OG]>E4UW3?:B2T',48KC3+ 8AAG3?5MX#G,A ME&V0)H2S6"9!%AE7Q3@_U]1>^L-2&7V);2ME7,#Y/"\X1L^W8VI,X"PJ<+@# M<*2R'-< :5>OPPR:LT4\+@PQ7F4/,UUVRGT8?L1-$OP-_^=SM=9?G[OG]9TT M2+&\6_9JG7U4@MZNQ6,UIU02IDPPR/-('=F$S"$)]!TM#8F0C.:!M"M,ZTG0 MR1'[?@[U5E%0/M<9T68)U4!]MJ^7P#KT#4.'?R[4KP8OV!L#K0\W?RLWA\ M?GQ3KE;EG\7RX2U1[YY^*%O4EDM/Y"M N"QT0#03@7 6ATLKTALEL;P:L03X+ZO1#3;ZIS+ M!NE.6^8FGYIH:A[7& MC0[_V I[15&]TR";T9,CZ#RST6#4AJ3^7<+#74+?R9G&3M.[I/*1Y+N+'W%V M=;K-T;WERG93YAS9MI)L&FSSFR7ODF8*4=7IW()W<=OUDY]7XHD4O.TWJ9ZO M;;[F=W,1,R$YI3!/E:F%@EP1$N,8LI"1F,F,\M0JP.15M)@:U;6R5G6WJ?:@ MU^9<- )??0L\PC=C\ 7SM-;[%>ZN9_WD^CX&[>J##H7Z^]'# ;1 S/:^+C/0 MH@%:.'I?K M?*!=7XN,MJ+_;]A%T>.V+_/&6R2!&8$1A!I>]$FHF'>K9$^+S M2J=HKU]T:92UFD\7VWK2?I-YRF46D41ME'&80Y1E%-(LQY!'E(4BC&68BDUQ M6*N"5C9B&#'?7OW743:\1MX9>-(2U_0D.IFM2U59K8O9-N4#YM$*2M62UT> MGNQZ3^A _[P!_?U%T(<4AQH"G;MZ3U:SCUW":0@T1ZHR#1IF&/'IBB"-4WBQ M*/\D2M%*C?Y%5&+U0U3O!']F=9#7/*5QBD44P20+B#H:H!SB@*::]A(48A;1 M$ ]@/-/Y)TIU_U@5:_&7?PO3X.]W4JK7L/7SZ.]BJ8\>" MQHMD1G].,1^IG>_[MZ!KY3H#800#/ ,;/HZHSWC: M43G/%HQ]LK/^_-"8"%WKB.F@]^5#._I<\C1C(J8P1F$ 49XQB-.0P#S3">@Q MCDD8SI_JHG=?UV2U-HUJ.)S*YD7:G]#C894L-." K $5#\5RV;8I?!'$,OCT M*+P9$BQ 8%%"^][9?J/"&XWW2C0"L5'[D U MC:^X#B;OL1$]\3JR=AG+<%I[9W$(1Z88.8;@M)*']_]GGAT0P_M>2J&;78J- M^WLWV?+V42W\^DY^78NG;T_MV5VH+X\ZH%$:A%FHCLLHTRVGPCR"%!,.,>8T M"W(1A,J,- WPO4*0J3F)&U$U4U1*6/C\I'_\^F=156T5)8L0UFO6YSS!C(FZ M9Q+:: %ZEVJ[BLQ NRIW:BF4,N#;T]8%VR@TTJI81!V/M#HCA21[7B6[J&4' MT)X-:;YF_/'BG1V@L!,,[6*\ 9O87O!'DRZ5L2!$J4P@8CB#*,T)I'D>PY1$ M*4YQS")NE)5ZUJ'C>%O;BO"ZGFADB8\'@UR(T M$C5;(V5'MN=0.,NB1S\X'CV>DWN']\X^.,S-T95)_5"N/J]*)@2O=%>M^IKL M=OE#'0-TH9.F3WTAJGF8QV'&&5O>H=7"#*R +\+HH,/Z_2B/]Z5 MCZ18&IHL^^"=9YTK(/%]0S04#6/:.*'[.3I0'^E1@?K;E@;V1QOE]3ZA0O?: MGOKUT,AWKAL,%6OQ49WN^'XGZ-_)/\O56YV8]$DM:[-*\TA?ND0HA5$N1I&-+>+B+>686JO^58%N- Z@",]TVL]0*T(T)I8!\_YJP6:Z)&N4T47N>!=)-V: M_ 2+KM&(A9OGJ@4S<)1YQ_]5VYN=#F0\YO> >M^+6OQ:F6=MG>.=:O4;P5T:[G90.;/6#:<=V42W ^/0+K?\_,", MH$U&[VZ#XR^BKI2BNQ]77[^3E:"*0'GGZ-QDG2_R?=?_YC\5CT9R-JCE#L8A1EL(TT"W?,Y)!FDOU MUR0(DSR-TPQ' ZZT/8@Z41])+7L3AUK+K']<;*6VXV,?*VQ&TJ^U8.,P]YG. M2QL-P4;#^DH=;!9VJR7XNEWCCP9K;,WV'E?!T1;@0\)1]P6/$.]O%CZG&IRV MKQLTM9+HW-A/8OVY3O(I6/NO>@^;DR#(\T3M"($,$40(A3 /::A,T#@(6("B MB.>;;<&\_[SI_$.X?H0V]$I8\-1*"_3>KVF#*7FMD_3-5L'0OG8)ZFAI^74W MNU:Z.@5_!C2\G=R;7VG)P2]-\-^O3O/RK4!SEY!O-NW8F?A68!Q)P;?[_$#V M*A]U!!1[JSO/K;I(X03G 2)(P"#! J(\89!(D<,\C](L"&0B Z,6"&=GF9I# MX)N^9^6U/7(FPL\"14.JN18;W[S2RE?;>#?/Z^_ERFVHM1$0KKCBZ!SC$L,Y M-0]8X.S#0Q/1M^W6M.=RGJ&;@2D#;I.@]_,S>\VM0\?R*;T73B+P[A\B 3.CC:CO+@MX;?N0, MZ./*'68_GWANZ!O\0RR?Q1?QV+2)56:!+%>/.MW_CBZ*A_I@.HT278S@C5B5 CT[!+( _)V^GH ^(R[ZJU*!_$LF#5FT)9A%QG&-PNV5NB M+Z%7@CR^TY%9BWO!OB_+1?G0G4 B26(::%,.!4A7NN P#^((4IG25!=3S@(C MR^XJ*:9&Z#T]P%81G=S?EDC;*@0:C MO!X6T9ACK,M(D9A^7A.[Z,MKX3P;>3EX\/&B+J_5?R?B\NK!AAU6/HEU4U7C M8UE5"Q/.U^>W'SNA6.\U(=QM%+9V= MR;\+F8AEP.(XA3@36+MG!,2Y9##-::+A2B3C\Q]B14O3@]I@T/JS3!TVLP// M8"@\[XX:@[;Z>Q(KH.^B/.K+][DEOU.OR7JP>=2UZH7^8LX0F1-OB M. H81#P7BA*EA!)E28PI3VELY'RQFW9JMOB[YU53/5<=MLM:8/W57G#KF4$:F6=@(S6HQ=;_T.&\$7U6_^@%70OCV0O* M(UG+#M&V,Y&M03MK$YN/-IX1;*WACM5K_^EA9FX=H5K',?=C6'NAS&]>MH^T M0:PW?Y(5_T"*E2Y!+>IV([5DU3]$\?!]+?B-,KC(@_B/U,SQ%7 MW\RNG>::>M[R^LD$?;5W,@KH"SB:=*"5GP&M?EW47X > #.P^::T&( M"$"C MX,X.'W_E'!GY(PH^Z@EB_ 79/YZ\@@3VU:_>-@V\BQ^BJ:;:Q*K=R1O>&/8W M/XMJSA.9I8S&4#W"(1)YH/L=1) @K/:M5*>D&;70-IUP:AO.5F;0"#UKHS/K MH/A6F9[)UA:5=ZR >B*DEQ&TXQ6J\M&Z7X1+ZO/ M#;2YVVX\=_)WHCL+Z'H!=_)CN7S0!KT.M*FO7N_%S_4;I54L6?&D_F53'+-< MG@\*<[,XAH:M1\A]FZ>MZ)J?ML+7B4]*?*CEKW%N(TV U@'42C@,.AF*GRLC MT7;Z<4V]@> <&&Q#QW&5@M0O0G GU2M=KKZ*U8^""9TST&1^S ,F\R#*$!1A MKN/_]!63# 44691$ F5Q0+-A#40'2&/TGKY"!>:>Z/I-?=+"@ZJ1'K"F_KCN M]Z:KM!6*-)=B#5UCFF^FS]E8DE4;M6[:'+PUP0J?-QPB"$*. QQ"2D$,=9('$D MDP@;U>LZ.1R_RQ[.JU'Q[B$P \3*:WE6Z2O5:M MOB/R_(-#C4*ZOEWJEJ9ZX"^"BX9.E 7*1-L9CCR(.8TR$B01A2A'&4092B#5 M78A3E/"$YE$6)$:M1BWGG=J+OA54'Z"9M9UF!K:IW>4<0N]V%-7!H)W(=7VE M#LY:ZDV3226W2X/("BAG!H[9K",;+%90'!H@=A\?QDG'(IVJK7N=DBP)<)9! M'D2*BF*10IRD(8P2G.>7>P@S7!R1RH7)1N42,\7W*<3P4P-[-NKJ0NJK45O12<2"@"8"XHCJ6X&< M0$(PAR%'&8TBB5!N5?2\/_C46$'+UG;*L3B!'(7-C V&@N'YW3?&P;Z_X1&% M734O[ \];F?"(TH=M!T\]LR C))>5X2F^8'ZH?NWMOQX30:]E@ESS!),LY3! M($MC=?2@ :1I@F&\EF_38.=<_TXW^)_G@C%0]>_9 MW;9CZ;J/Z9\WO]AT-VBP_S@:]A;Y)I[78*3,$R]K89>#<@609[-1AHP[7E[* M%5KO9*A<,\[ D^)VI#OYKJB>RHHL?EN5ST^WR[:+A2[*7BZ5J?DL>&MUELM- MDP+"PTS$60!YBK$Z2P:Y3DX.8$9BJBQ&&@2!56>):P6:W(9S>_/F]N/M_>W[ MK^#FTSOP_O]\N[W_3\O3Y[6+9'@^'1%ZW[M2*SVHQ9^!C0*@KP'8J##K4Z&7 M3A.NP'5U#+Y6G'$/RH[ .SA*NQIW:/&^2J@/?7\G?HA%^53G:BSKQ(YG14U? M2[G^DZS$YW)1L)>MLRD-*&6$$);8&](0MBQJ[>8?9,J9W\LSZ\LQKO3@G0:3$#C1[@C_9/+W[# MJQ!U5B-OB PCE\2[ J;#"GC7##:T26-7CT,WZ&0.HM#J&U3:&+Y@9A7I=!L_TN5O!IUZ&K0); M0[2J+W!!JT23GNRR\^- )VU@+2=?^1>D /A.6P*.72@H3$HJ^)'G6#7NULN MJO^JKR/TF9P0E$-U0 ^4O<@9)!PQJ%N0Z:ZVB0B97>#)Z,Y";$9?KH#S[M$=@-F D)++8#B+(SDSU5/HP8,?C,X'R&(VVV?RM+ M_F>Q6"B[[G:Y5M^,@BY$VXT^R]49,Q6Q[@]!="2;SI\E%(9I+#@+:(PP&I8G M9B>(T>LR?HI8)W%]*BK7W]5.7FPD!^1\-WI'2V3*13X0?X4KIY[T,["#_U:# M]B[$:8+ ,/3(Z$ZP\<:&"!VF==Y?9.;H)KOHJ'.N]]SD6" MDDSDD(9(A_#R")(T2F"0YR1$'">26A7:.CG3U"RH1E"==$.?JV(IJ@I4K:CU M.;'[B^41\0S2$1=1@B,HL4 0R3"$.,1JGXDP8SP-,TPCRQJW+K >J=[M!NUR M$WOG%VZS[<()A)ZWA2UVV[C%3DR'M7$O(>&J3N[)><:MF7M)W8/ZN1<_<%WD M4V\?^**K5Y7R6]69/C0*@YQR"O.,*^J(6 0Q#R.8LBQ'011@G 46UJG%U!.U M1VLQ82GA')UD M )9I0-*YH5XE!LE MU-A1R8?'4#@-\^\6-\NZV9)%I$I9S\[(;JH100]&4U" M2"Q0LN #%VB-Q 'J#EZRR]!]V M+1ZK>98D*>D(XC3E,,TXC1(.9*!L#H!'\PPM9/OQIGTAQ81U#): M7AH+]?GJI.J.SE6'XX]ZGCJIWOXYZO2#0[9?QE;/@HLF MA+@B2UX[IS?[2RCC%#&40!2B'**ZPY 4"%*:I!%),AH$1O$2)I--[35OQ06= MO#W?_;!-_ +6)A:/.P1]&SXC@V=C"+D#<2Q[Z"HP+6TD,W3.FTH7QAC18C+3 M9M=P,OS,P'K$7:61._F65-\_+,H_J\VW. T#E#(N8!Y%*40B%) JOH6QR/(X M%%&.K":338UN-[+6=;R4M* 6UYHNC( VL[9

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�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